<SEC-DOCUMENT>0001829126-23-008312.txt : 20231229
<SEC-HEADER>0001829126-23-008312.hdr.sgml : 20231229
<ACCEPTANCE-DATETIME>20231229152916
ACCESSION NUMBER:		0001829126-23-008312
CONFORMED SUBMISSION TYPE:	N-2ASR
PUBLIC DOCUMENT COUNT:		22
FILED AS OF DATE:		20231229
DATE AS OF CHANGE:		20231229
EFFECTIVENESS DATE:		20231229

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GABELLI EQUITY TRUST INC
		CENTRAL INDEX KEY:			0000794685
		ORGANIZATION NAME:           	
		IRS NUMBER:				222736509
		STATE OF INCORPORATION:			MD
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		N-2ASR
		SEC ACT:		1940 Act
		SEC FILE NUMBER:	811-04700
		FILM NUMBER:		231527411

	BUSINESS ADDRESS:	
		STREET 1:		ONE CORP CENTER
		CITY:			RYE
		STATE:			NY
		ZIP:			10580
		BUSINESS PHONE:		9149215070

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GABELLI EQUITY TRUST INC
		CENTRAL INDEX KEY:			0000794685
		ORGANIZATION NAME:           	
		IRS NUMBER:				222736509
		STATE OF INCORPORATION:			MD
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		N-2ASR
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-276314
		FILM NUMBER:		231527410

	BUSINESS ADDRESS:	
		STREET 1:		ONE CORP CENTER
		CITY:			RYE
		STATE:			NY
		ZIP:			10580
		BUSINESS PHONE:		9149215070
<IS-FILER-A-NEW-REGISTRANT>N
<IS-FILER-A-WELL-KNOWN-SEASONED-ISSUER>Y
<FILED-PURSUANT-TO-GENERAL-INSTRUCTION-A2>Y
<IS-FUND-24F2-ELIGIBLE>N
</SEC-HEADER>
<DOCUMENT>
<TYPE>N-2ASR
<SEQUENCE>1
<FILENAME>gabelliequitytrust_n2asr.htm
<DESCRIPTION>N-2ASR
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:cef="http://xbrl.sec.gov/cef/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:gab="http://gabelli.com/20231229">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02B_CEF%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_03D_gab_gabelli.com_20231229 -->
<!-- Field: Set; Name: xdx; ID: xdx_04C_20231229_20231229 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DDocumentType_N%2D2ASR -->
<!-- Field: Set; Name: xdx; ID: xdx_057_edei%2D%2DEntityCentralIndexKey_0000794685 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_065_Ratio_4_xbrli%2D%2Dpure -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2023-12-29" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2023-12-29" name="dei:DocumentType">N-2ASR</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2023-12-29" name="dei:EntityCentralIndexKey">0000794685</ix:nonNumeric>
  <ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2023-06-30_custom_CumulativePreferredShares5.875SerieAPreferredMember" id="xdx2ixbrl0110" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2022-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember" id="xdx2ixbrl0111" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2021-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember" id="xdx2ixbrl0112" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2020-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember" id="xdx2ixbrl0113" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2019-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember" id="xdx2ixbrl0114" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2023-06-30_custom_CumulativePreferredShares5.875SerieAPreferredMember" id="xdx2ixbrl0117" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2022-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember" id="xdx2ixbrl0118" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2021-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember" id="xdx2ixbrl0119" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2020-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember" id="xdx2ixbrl0120" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2019-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember" id="xdx2ixbrl0121" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2023-06-30_custom_CumulativePreferredShares5.450SerieJPreferredMember" id="xdx2ixbrl0166" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2022-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember" id="xdx2ixbrl0167" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2023-06-30_custom_CumulativePreferredShares5.450SerieJPreferredMember" id="xdx2ixbrl0173" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2022-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember" id="xdx2ixbrl0174" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2018-12-31_custom_CumulativePreferredShares5.000SerieKPreferredMember" id="xdx2ixbrl0185" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2018-12-31_custom_CumulativePreferredShares5.000SerieKPreferredMember" id="xdx2ixbrl0192" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2020-12-31_custom_CumulativePreferredShares4.250SerieMCumulativePreferredMember" id="xdx2ixbrl0197" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2019-12-31_custom_CumulativePreferredShares4.250SerieMCumulativePreferredMember" id="xdx2ixbrl0198" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2018-12-31_custom_CumulativePreferredShares4.250SerieMCumulativePreferredMember" id="xdx2ixbrl0199" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2015-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember" id="xdx2ixbrl0272" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2014-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember" id="xdx2ixbrl0273" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2013-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember" id="xdx2ixbrl0274" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2015-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember" id="xdx2ixbrl0278" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2014-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember" id="xdx2ixbrl0279" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2013-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember" id="xdx2ixbrl0280" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="gab-20231229.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2023-12-29">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2023-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292023-12-29_dei_BusinessContactMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2023-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-29_custom_PurchaseTransactionFeeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:PurchaseTransactionFeeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-29_custom_SaleTransactionFeeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:SaleTransactionFeeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292023-12-29_custom_CommonSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CommonSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2023-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292023-12-29_custom_PreferredSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:PreferredSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2023-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredSharesAuctionRateSeriesCPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredSharesAuctionRateSeriesCPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredSharesAuctionRateSeriesCPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredSharesAuctionRateSeriesCPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredSharesAuctionRateSeriesCPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredSharesAuctionRateSeriesCPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_CumulativePreferredShares5.875SerieAPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.875SerieAPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.875SerieAPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.875SerieAPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.875SerieAPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.875SerieAPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.875SerieAPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredSharesAuctionRateSeriesEPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredSharesAuctionRateSeriesEPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredSharesAuctionRateSeriesEPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredSharesAuctionRateSeriesEPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredSharesAuctionRateSeriesEPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredSharesAuctionRateSeriesEPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_CumulativePreferredShares5.000SerieGPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieGPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieGPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieGPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieGPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieGPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieGPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_CumulativePreferredShares5.000SerieHPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieHPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieHPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieHPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieHPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieHPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieHPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_CumulativePreferredShares5.450SerieJPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.450SerieJPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.450SerieJPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.450SerieJPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.450SerieJPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.450SerieJPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.450SerieJPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_CumulativePreferredShares5.000SerieKPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieKPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_CumulativePreferredShares5.000SerieKPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieKPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_CumulativePreferredShares5.000SerieKPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieKPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_CumulativePreferredShares5.000SerieKPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieKPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_CumulativePreferredShares5.000SerieKPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieKPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_CumulativePreferredShares5.000SerieKPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieKPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_CumulativePreferredShares4.250SerieMCumulativePreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares4.250SerieMCumulativePreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_CumulativePreferredShares4.250SerieMCumulativePreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares4.250SerieMCumulativePreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_CumulativePreferredShares4.250SerieMCumulativePreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares4.250SerieMCumulativePreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_CumulativePreferredShares4.250SerieMCumulativePreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares4.250SerieMCumulativePreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_CumulativePreferredShares4.250SerieMCumulativePreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares4.250SerieMCumulativePreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_CumulativePreferredShares4.250SerieMCumulativePreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares4.250SerieMCumulativePreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredSharesAuctionRateSeriesCPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredSharesAuctionRateSeriesCPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredSharesAuctionRateSeriesCPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredSharesAuctionRateSeriesCPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredSharesAuctionRateSeriesCPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.875SerieAPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.875SerieAPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.875SerieAPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.875SerieAPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.875SerieAPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredSharesAuctionRateSeriesEPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredSharesAuctionRateSeriesEPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredSharesAuctionRateSeriesEPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredSharesAuctionRateSeriesEPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredSharesAuctionRateSeriesEPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieGPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieGPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieGPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieGPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieGPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieHPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieHPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieHPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieHPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieHPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.450SerieJPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.450SerieJPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.450SerieJPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.450SerieJPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.450SerieJPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_custom_CumulativePreferredShares5.875SerieDPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.875SerieDPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_custom_CumulativePreferredShares5.875SerieDPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.875SerieDPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_CumulativePreferredShares5.875SerieDPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.875SerieDPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-12-31_custom_CumulativePreferredShares5.875SerieDPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.875SerieDPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-12-31_custom_CumulativePreferredShares5.875SerieDPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.875SerieDPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292023-12-29_custom_HowTheFundManagesRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:HowTheFundManagesRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2023-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-10-012021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-10-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-10-012022-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292023-12-29_custom_CommonShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CommonShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2023-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292023-12-29_custom_SeriesCPreferredSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:SeriesCPreferredSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2023-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292023-12-29_custom_SeriesDPreferredSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:SeriesDPreferredSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2023-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292023-12-29_custom_SeriesEPreferredSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:SeriesEPreferredSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2023-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292023-12-29_custom_SeriesGPreferredSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:SeriesGPreferredSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2023-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292023-12-29_custom_SeriesHPreferredSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:SeriesHPreferredSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2023-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292023-12-29_custom_SeriesJPreferredSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:SeriesJPreferredSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2023-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292023-12-29_custom_SeriesKPreferredSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:SeriesKPreferredSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2023-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292023-12-29_custom_SeriesMPreferredSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:SeriesMPreferredSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2023-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292023-12-29_custom_SeriesNPreferredSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:SeriesNPreferredSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2023-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292023-12-29_custom_PreferredShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:PreferredShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2023-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292023-12-29_custom_SubscriptionRightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000794685</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">gab:SubscriptionRightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2023-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Ratio">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="Fact000052" toRefs="Footnote000077"></ix:relationship>
  <ix:relationship fromRefs="Fact000054" toRefs="Footnote000077"></ix:relationship>
  <ix:relationship fromRefs="Fact000056" toRefs="Footnote000078"></ix:relationship>
  <ix:relationship fromRefs="Fact000058" toRefs="Footnote000078"></ix:relationship>
  <ix:relationship fromRefs="Fact000060" toRefs="Footnote000078"></ix:relationship>
  <ix:relationship fromRefs="Fact000062" toRefs="Footnote000079"></ix:relationship>
  <ix:relationship fromRefs="Fact000066" toRefs="Footnote000080"></ix:relationship>
  <ix:relationship fromRefs="Fact000070" toRefs="Footnote000081"></ix:relationship>
  <ix:relationship fromRefs="Fact000074" toRefs="Footnote000082"></ix:relationship>
  <ix:relationship fromRefs="Fact000421" toRefs="Footnote000451"></ix:relationship>
  <ix:relationship fromRefs="Fact000422" toRefs="Footnote000451"></ix:relationship>
  <ix:relationship fromRefs="Fact000423" toRefs="Footnote000451"></ix:relationship>
  <ix:relationship fromRefs="Fact000427" toRefs="Footnote000451"></ix:relationship>
  <ix:relationship fromRefs="Fact000428" toRefs="Footnote000451"></ix:relationship>
  <ix:relationship fromRefs="Fact000429" toRefs="Footnote000451"></ix:relationship>
  <ix:relationship fromRefs="Fact000424" toRefs="Footnote000452"></ix:relationship>
  <ix:relationship fromRefs="Fact000425" toRefs="Footnote000452"></ix:relationship>
  <ix:relationship fromRefs="Fact000426" toRefs="Footnote000452"></ix:relationship>
  <ix:relationship fromRefs="Fact000436" toRefs="Footnote000453"></ix:relationship>
  <ix:relationship fromRefs="Fact000437" toRefs="Footnote000453"></ix:relationship>
  <ix:relationship fromRefs="Fact000438" toRefs="Footnote000453"></ix:relationship>
  <ix:relationship fromRefs="Fact000445" toRefs="Footnote000454"></ix:relationship>
  <ix:relationship fromRefs="Fact000446" toRefs="Footnote000454"></ix:relationship>
  <ix:relationship fromRefs="Fact000447" toRefs="Footnote000454"></ix:relationship>
  <ix:relationship fromRefs="Fact000448" toRefs="Footnote000455"></ix:relationship>
  <ix:relationship fromRefs="Fact000449" toRefs="Footnote000455"></ix:relationship>
  <ix:relationship fromRefs="Fact000450" toRefs="Footnote000455"></ix:relationship>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As filed with the Securities and Exchange Commission on December&#160;29, 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities Act File No. 333-&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investment Company Act File No. <span id="xdx_907_edei--InvestmentCompanyActFileNumber_c20231229__20231229_zvLFfRC6fH4c"><ix:nonNumeric contextRef="AsOf2023-12-29" name="dei:InvestmentCompanyActFileNumber">811-04700</ix:nonNumeric></span></b></span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UNITED STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITIES AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Washington, D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b>FORM <span id="xdx_90C_edei--EntityInvCompanyType_c20231229__20231229_z5dH72YPzTQi"><ix:nonNumeric contextRef="AsOf2023-12-29" name="dei:EntityInvCompanyType">N-2</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Check Appropriate Box or Boxes)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746; <b>Registration Statement under the Securities Act of 1933</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#9744;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> Pre-Effective Amendment No.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#9744; <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Post-Effective Amendment No.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>and/or</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="xdx_902_edei--InvestmentCompanyActRegistration_c20231229__20231229_zLsUkUpKpUOj"><ix:nonNumeric contextRef="AsOf2023-12-29" format="ixt:booleantrue" name="dei:InvestmentCompanyActRegistration">&#9746;</ix:nonNumeric></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Registration Statement under the Investment Company Act of 1940</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="xdx_901_edei--InvestmentCompanyRegistrationAmendment_c20231229__20231229_zwRQfhsFo3Gc"><ix:nonNumeric contextRef="AsOf2023-12-29" format="ixt:booleantrue" name="dei:InvestmentCompanyRegistrationAmendment">&#9746;</ix:nonNumeric></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amendment No. <span id="xdx_904_edei--InvestmentCompanyRegistrationAmendmentNumber_c20231229__20231229_z04n5tH7xtr"><ix:nonNumeric contextRef="AsOf2023-12-29" name="dei:InvestmentCompanyRegistrationAmendmentNumber">68</ix:nonNumeric></span></b><br /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b><span id="xdx_90D_edei--EntityRegistrantName_c20231229__20231229_zEAgc4Kq8jw4"><ix:nonNumeric contextRef="AsOf2023-12-29" name="dei:EntityRegistrantName">THE GABELLI EQUITY TRUST INC.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Exact Name of Registrant as Specified in Charter)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_901_edei--EntityAddressAddressLine1_c20231229__20231229_zXdP1v3XTNEh"><ix:nonNumeric contextRef="AsOf2023-12-29" name="dei:EntityAddressAddressLine1">One Corporate Center</ix:nonNumeric></span>, <span id="xdx_902_edei--EntityAddressCityOrTown_c20231229__20231229_z4BYcTStUyVi"><ix:nonNumeric contextRef="AsOf2023-12-29" name="dei:EntityAddressCityOrTown">Rye</ix:nonNumeric></span>, <span id="xdx_90A_edei--EntityAddressStateOrProvince_c20231229__20231229_zhJ6i3g27Vf4"><ix:nonNumeric contextRef="AsOf2023-12-29" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">New York</ix:nonNumeric></span> <span id="xdx_90F_edei--EntityAddressPostalZipCode_c20231229__20231229_z1DZuTEVDKMb"><ix:nonNumeric contextRef="AsOf2023-12-29" name="dei:EntityAddressPostalZipCode">10580-1422</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Address of Principal Executive Offices)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Registrant&#8217;s Telephone Number, Including Area Code: <span id="xdx_908_edei--CityAreaCode_c20231229__20231229_z23bp5FIYLV9"><ix:nonNumeric contextRef="AsOf2023-12-29" name="dei:CityAreaCode">(800)</ix:nonNumeric></span> <span id="xdx_90C_edei--LocalPhoneNumber_c20231229__20231229_zPmMBoAqkLq1"><ix:nonNumeric contextRef="AsOf2023-12-29" name="dei:LocalPhoneNumber">422-3554</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_905_edei--ContactPersonnelName_c20231229__20231229__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zQyxffQg5uM7"><ix:nonNumeric contextRef="From2023-12-292023-12-29_dei_BusinessContactMember" name="dei:ContactPersonnelName">John C. Ball</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_902_edei--EntityAddressAddressLine1_c20231229__20231229__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zqMtVYAKr5m2"><ix:nonNumeric contextRef="From2023-12-292023-12-29_dei_BusinessContactMember" name="dei:EntityAddressAddressLine1">The Gabelli Equity Trust Inc.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90D_edei--EntityAddressAddressLine2_c20231229__20231229__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zEiTdCPeJZZ8"><ix:nonNumeric contextRef="From2023-12-292023-12-29_dei_BusinessContactMember" name="dei:EntityAddressAddressLine2">One Corporate Center</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90C_edei--EntityAddressCityOrTown_c20231229__20231229__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_z6aLN0uzPvmc"><ix:nonNumeric contextRef="From2023-12-292023-12-29_dei_BusinessContactMember" name="dei:EntityAddressCityOrTown">Rye</ix:nonNumeric></span>, <span id="xdx_902_edei--EntityAddressStateOrProvince_c20231229__20231229__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zTahtiQAEnbi"><ix:nonNumeric contextRef="From2023-12-292023-12-29_dei_BusinessContactMember" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">New York</ix:nonNumeric></span> <span id="xdx_90F_edei--EntityAddressPostalZipCode_c20231229__20231229__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zrc9XPNNLZ4a"><ix:nonNumeric contextRef="From2023-12-292023-12-29_dei_BusinessContactMember" name="dei:EntityAddressPostalZipCode">10580-1422</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--CityAreaCode_c20231229__20231229__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zaHAOgbrNSji"><ix:nonNumeric contextRef="From2023-12-292023-12-29_dei_BusinessContactMember" name="dei:CityAreaCode">(914)</ix:nonNumeric></span> <span id="xdx_909_edei--LocalPhoneNumber_c20231229__20231229__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zsx5kHHkWuoa"><ix:nonNumeric contextRef="From2023-12-292023-12-29_dei_BusinessContactMember" name="dei:LocalPhoneNumber">921-5100</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Name and Address of Agent for Service)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Copies to:</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table border="0" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; width: 49%">
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Peter Goldstein, Esq.</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The Gabelli Equity Trust Inc.</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>One Corporate Center</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Rye, New York 10580-1422</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(914) 921-5100</b></span></p> </td>
    <td style="text-align: center; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; width: 49%">
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>P. Jay Spinola, Esq.</b><br /><b>Bissie K. Bonner, Esq.</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Willkie Farr &amp; Gallagher LLP</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>787 Seventh Avenue</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>New York, New York 10019-6099</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(212) 728-8000</b></span></p> </td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Approximate Date of Proposed Public Offering</b>: <span id="xdx_903_edei--ApproximateDateOfCommencementOfProposedSaleToThePublic_c20231229__20231229_zQk17xyOSITh"><ix:nonNumeric contextRef="AsOf2023-12-29" name="dei:ApproximateDateOfCommencementOfProposedSaleToThePublic">As soon as practicable after the effective date of this Registration Statement.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, check the following box&#160;<span id="xdx_90A_edei--DividendOrInterestReinvestmentPlanOnly_c20231229__20231229_zcM29Im0Rkk8"><ix:nonNumeric contextRef="AsOf2023-12-29" format="ixt:booleanfalse" name="dei:DividendOrInterestReinvestmentPlanOnly">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If any securities being registered on this Form will be offered on a delayed or continuous basis in reliance on Rule&#160;415 under the Securities Act of 1933 (&#8220;Securities Act&#8221;), other than securities offered in connection with a dividend reinvestment plan, check the following box.&#160;<span id="xdx_904_edei--DelayedOrContinuousOffering_c20231229__20231229_znnpW8L4xpw8"><ix:nonNumeric contextRef="AsOf2023-12-29" format="ixt:booleantrue" name="dei:DelayedOrContinuousOffering">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If this Form is a registration statement pursuant to General Instruction A.2 or a post-effective amendment thereto, check the following box&#160;<span id="xdx_900_ecef--PrimaryShelfFlag_c20231229__20231229_zPx4lb44ZdM1"><ix:nonNumeric contextRef="AsOf2023-12-29" format="ixt:booleantrue" name="cef:PrimaryShelfFlag">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If this Form is a registration statement pursuant to General Instruction B or a post-effective amendment thereto that will become effective upon filing with the Commission pursuant to Rule&#160;462(e) under the Securities Act, check the following box&#160;<span id="xdx_905_edei--EffectiveUponFiling462e_c20231229__20231229_zbOdoKS6Ptlj"><ix:nonNumeric contextRef="AsOf2023-12-29" format="ixt:booleantrue" name="dei:EffectiveUponFiling462e">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction B to register additional securities or additional classes of securities pursuant to Rule&#160;413(b) under the Securities Act, check the following box&#160;<span id="xdx_90A_edei--AdditionalSecuritiesEffective413b_c20231229__20231229_zOKp652DpcA"><ix:nonNumeric contextRef="AsOf2023-12-29" format="ixt:booleanfalse" name="dei:AdditionalSecuritiesEffective413b">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It is proposed that this filing will become effective (check appropriate box):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table border="0" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--EffectiveWhenDeclaredSection8c_c20231229__20231229_zpehWPm7STMh"><ix:nonNumeric contextRef="AsOf2023-12-29" format="ixt:booleanfalse" name="dei:EffectiveWhenDeclaredSection8c">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">when declared effective pursuant to Section&#160;8(c) of the Securities Act</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If appropriate, check the following box:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table border="0" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 0.25in"><span id="xdx_90A_edei--NewEffectiveDateForPreviousFiling_c20231229__20231229_zrAPc26yQLw3"><ix:nonNumeric contextRef="AsOf2023-12-29" format="ixt:booleanfalse" name="dei:NewEffectiveDateForPreviousFiling">&#9744;</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This [post-effective] amendment designates a new effective date for a previously filed [post-effective amendment] [registration statement].</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table border="0" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 0.25in"><span id="xdx_907_edei--AdditionalSecurities462b_c20231229__20231229_z0PzPxCPkRFi"><ix:nonNumeric contextRef="AsOf2023-12-29" format="ixt:booleanfalse" name="dei:AdditionalSecurities462b">&#9744;</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Form is filed to register additional securities for an offering pursuant to Rule&#160;462(b) under the Securities Act, and the Securities Act registration statement number of the earlier effective registration statement for the same offering is: ______.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table border="0" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--NoSubstantiveChanges462c_c20231229__20231229_zFoK7P8w1vA4"><ix:nonNumeric contextRef="AsOf2023-12-29" format="ixt:booleanfalse" name="dei:NoSubstantiveChanges462c">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Form is a post-effective amendment filed pursuant to Rule&#160;462(c) under the Securities Act, and the Securities Act registration statement number of the earlier effective registration statement for the same offering is: ______.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table border="0" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 0.25in"><span id="xdx_909_edei--ExhibitsOnly462d_c20231229__20231229_ziYmWAfnG4pj"><ix:nonNumeric contextRef="AsOf2023-12-29" format="ixt:booleanfalse" name="dei:ExhibitsOnly462d">&#9744;</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Form is a post-effective amendment filed pursuant to Rule&#160;462(d) under the Securities Act, and the Securities Act registration statement number of the earlier effective registration statement for the same offering is: ______.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check each box that appropriately characterizes the Registrant:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table border="0" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecef--RegisteredClosedEndFundFlag_c20231229__20231229_zVDSrkpSp6yf"><ix:nonNumeric contextRef="AsOf2023-12-29" format="ixt:booleantrue" name="cef:RegisteredClosedEndFundFlag">&#9746;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registered Closed-End Fund (closed-end company that is registered under the Investment Company Act of 1940 (the &#8220;Investment Company Act&#8221;)).</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table border="0" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecef--BusinessDevelopmentCompanyFlag_c20231229__20231229_zJlPWPKZc4T7"><ix:nonNumeric contextRef="AsOf2023-12-29" format="ixt:booleanfalse" name="cef:BusinessDevelopmentCompanyFlag">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Business Development Company (closed-end company that intends or has elected to be regulated as a business development company under the Investment Company Act.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table border="0" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecef--IntervalFundFlag_c20231229__20231229_z6UQLCIbn8rc"><ix:nonNumeric contextRef="AsOf2023-12-29" format="ixt:booleanfalse" name="cef:IntervalFundFlag">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interval Fund (Registered Closed-End Fund or a Business Development Company that makes periodic repurchase offers under Rule&#160;23c-3 under the Investment Company Act).</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table border="0" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecef--PrimaryShelfQualifiedFlag_c20231229__20231229_zifqzz0XL127"><ix:nonNumeric contextRef="AsOf2023-12-29" format="ixt:booleantrue" name="cef:PrimaryShelfQualifiedFlag">&#9746;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.2 Qualified (qualified to register securities pursuant to General Instruction A.2 of this Form).</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table border="0" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 0.25in">&#9746;<span id="xdx_90B_edei--EntityWellKnownSeasonedIssuer_c20231229__20231229_zNselqsVgaG1" style="display: none"><ix:nonNumeric contextRef="AsOf2023-12-29" name="dei:EntityWellKnownSeasonedIssuer">Yes</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Well-Known Seasoned Issuer (as defined by Rule&#160;405 under the Securities Act).</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table border="0" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span><span id="xdx_904_edei--EntityEmergingGrowthCompany_c20231229__20231229_z4weUodCAQnc"><ix:nonNumeric contextRef="AsOf2023-12-29" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging Growth Company (as defined by Rule&#160;12b-2 under the Securities and Exchange Act of 1934).</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table border="0" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 0.25in">&#9744;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If an Emerging Growth Company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;7(a)(2)(B) of the Securities Act.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table border="0" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 0.25in"><span id="xdx_907_ecef--NewCefOrBdcRegistrantFlag_c20231229__20231229_z73OXQYT2J39"><ix:nonNumeric contextRef="AsOf2023-12-29" format="ixt:booleanfalse" name="cef:NewCefOrBdcRegistrantFlag">&#9744;</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New Registrant (registered or regulated under the Investment Company Act for less than 12 calendar months preceding this filing).</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Base Prospectus dated December&#160;29, 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROSPECTUS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b>The
Gabelli Equity Trust Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Preferred
Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Subscription
Rights to Purchase Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Subscription
Rights to Purchase Preferred Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Subscription
Rights to Purchase Common Stock and Preferred Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Investment Objectives</i>. The Gabelli Equity Trust Inc. (the &#8220;Fund&#8221;) is a diversified, closed-end management investment company registered under the Investment Company Act of 1940, as amended (the &#8220;1940 Act&#8221;). The Fund&#8217;s primary investment objective is to achieve long term growth of capital by investing primarily in a portfolio of equity securities consisting of common stock, preferred stock, convertible or exchangeable securities, and warrants and rights to purchase such securities. Income is a secondary investment objective. Gabelli Funds, LLC (the &#8220;Investment Adviser&#8221;) serves as investment adviser to the Fund. Under normal market conditions, the Fund will invest at least 80% of the value of its total assets in equity securities. The Fund was organized as a Maryland corporation on May&#160;20, 1986, and commenced its investment operations on August&#160;21, 1986. An investment in the Fund is not appropriate for all investors. We cannot assure you that the Fund&#8217;s objectives will be achieved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We may offer, from time to time, in one or more offerings, shares of our common stock or preferred stock, each having a par value of $0.001 per share, or subscription rights to purchase our common stock and/or preferred stock. Shares may be offered at prices and on terms to be set forth in one or more supplements to this Prospectus (each a &#8220;Prospectus Supplement&#8221;). You should read this Prospectus and the applicable Prospectus Supplement carefully before you invest in our shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our shares may be offered directly to one or more purchasers, including existing stockholders in a rights offering, through agents designated from time to time by us, or to or through underwriters or dealers. The Prospectus Supplement relating to the offering will identify any agents or underwriters involved in the sale of our shares, and will set forth any applicable purchase price, fee, commission, or discount arrangement between us and our agents or underwriters, or among our underwriters, or the basis upon which such amount may be calculated. The Prospectus Supplement relating to any sale of shares of preferred stock will set forth the liquidation preference and information about the dividend period, dividend rate, any call protection or non-call period, and other matters. The Prospectus Supplement relating to any offering of subscription rights will set forth the number of shares (preferred or common) issuable upon the exercise of each right (or number of rights) and the other terms of such rights offering. We may not sell any of our securities through agents, underwriters or dealers without delivery of a Prospectus Supplement describing the method and terms of the particular offering. Shares of our common stock are listed on the New York Stock Exchange (&#8220;NYSE&#8221;) under the symbol &#8220;GAB.&#8221; Currently, the Fund&#8217;s Series G Cumulative Preferred Stock, 5.00% Series H Cumulative Preferred Stock and 5.00% Series K Cumulative Preferred Stock are listed on the NYSE under the symbol &#8220;GAB PrG,&#8221; &#8220;GAB PrH&#8221; and &#8220;GAB PrK,&#8221; respectively. The Fund&#8217;s Series C Auction Rate Cumulative Preferred Stock, Series E Auction Rate Preferred Stock, 4.25% Series M Cumulative Preferred Stock and 5.25% Series N Cumulative Preferred Stock, are not traded on a stock exchange. Any future series of fixed rate preferred stock may, but is not required to, be listed on a stock exchange. On December&#160;28, 2023, the last reported NYSE sale price of shares of our common stock was $5.13 per share. The net asset value of shares of the Fund&#8217;s common stock at the close of business on December&#160;28, 2023 was $5.21 per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares of closed-end funds often trade at a discount from net asset value. This creates a risk of loss for an investor purchasing shares in a public offering.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 3; Options: NewSection -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investing in the Fund&#8217;s shares involves risks, including risks related to a leveraged capital structure. See &#8220;Risk Factors and Special Considerations&#8221; on page 18.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved these securities or determined if this Prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Prospectus may not be used to consummate sales of shares by us through agents, underwriters, or dealers unless accompanied by a Prospectus Supplement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Prospectus sets forth concisely the information about the Fund that a prospective investor should know before investing. You should read this Prospectus, which contains important information about the Fund, before deciding whether to invest in the shares, and retain it for future reference. A Statement of Additional Information, dated December&#160;29, 2023, containing additional information about the Fund, has been filed with the Securities and Exchange Commission and is incorporated by reference in its entirety into this Prospectus. You may request a free copy of our annual and semiannual reports, request a free copy of the Statement of Additional Information, request other information about us and make stockholder inquiries by calling (800) GABELLI (422-3554) or by writing to the Fund, or obtain a copy (and other information regarding the Fund) from the Securities and Exchange Commission&#8217;s web site (http://www.sec.gov). Our annual and semiannual reports are also available on our website (www.gabelli.com). The Statement of Additional Information is only updated in connection with an offering and is therefore not available on the Fund&#8217;s website.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our shares do not represent a deposit or obligation of, and are not guaranteed or endorsed by, any bank or other insured depository institution, and are not federally insured by the Federal Deposit Insurance Corporation, the Federal Reserve Board or any other government agency.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>You should rely only on the information contained or incorporated by reference in this Prospectus. The Fund has not authorized anyone to provide you with different information. The Fund is not making an offer to sell these securities in any state where the offer or sale is not permitted. You should not assume that the information contained in this Prospectus is accurate as of any date other than the date of this Prospectus.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TABLE OF CONTENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: justify; width: 90%"><b>&#160;</b></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right; width: 9%"><b>Page</b></td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; width: 90%; text-align: justify"><a href="#a_001">PROSPECTUS SUMMARY</a></td>
    <td style="padding-bottom: 3pt; width: 1%">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; width: 9%; text-align: right">4</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_002">SUMMARY OF FUND EXPENSES</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">10</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_003">FINANCIAL HIGHLIGHTS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">12</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_004">USE OF PROCEEDS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">18</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_005">THE FUND</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">18</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_006">INVESTMENT OBJECTIVES AND POLICIES</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">18</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_007">RISK FACTORS AND SPECIAL CONSIDERATIONS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">18</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_008">HOW THE FUND MANAGES RISK</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">18</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_009">MANAGEMENT OF THE FUND</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">19</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_010">PORTFOLIO TRANSACTIONS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">24</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_011">DIVIDENDS AND DISTRIBUTIONS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">24</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_012">ISSUANCE OF COMMON STOCK</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">25</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_013">AUTOMATIC DIVIDEND REINVESTMENT AND VOLUNTARY CASH PURCHASE PLANS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">25</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_014">DESCRIPTION OF THE CAPITAL STOCK</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">25</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_015">ANTI-TAKEOVER PROVISIONS OF THE FUND&#8217;S GOVERNING DOCUMENTS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">35</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_016">CLOSED-END FUND STRUCTURE</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">39</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_017">REPURCHASE OF COMMON STOCK</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">39</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_018">RIGHTS OFFERINGS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">40</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_019">NET ASSET VALUE</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">40</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_020">LIMITATION ON DIRECTORS&#8217; AND OFFICERS&#8217; LIABILITY</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">41</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_021">TAXATION</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">41</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_022">CUSTODIAN, TRANSFER AGENT AND DIVIDEND DISBURSING AGENT</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">45</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_023">PLAN OF DISTRIBUTION</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">45</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_024">LEGAL MATTERS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">47</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_025">INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">47</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_026">ADDITIONAL INFORMATION</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">47</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_027">INCORPORATION BY REFERENCE</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">47</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: justify"><a href="#a_028">PRIVACY PRINCIPLES OF THE FUND</a></td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: right">48</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 5 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_001"></span>PROSPECTUS SUMMARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>This is only a summary. This summary may not contain all of the information that you should consider before investing in our shares. You should review the more detailed information contained in this Prospectus and the Statement of Additional Information dated December&#160;29, 2023 (the &#8220;SAI&#8221;).</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The Fund</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Gabelli Equity Trust Inc. is a closed-end, diversified management investment company organized as a Maryland corporation on May&#160;20, 1986. Throughout this Prospectus, we refer to The Gabelli Equity Trust Inc. as the &#8220;Fund&#8221; or as &#8220;we.&#8221; See &#8220;The Fund.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund&#8217;s outstanding shares of common stock, par value $0.001 per share, are listed on the New York Stock Exchange under the symbol &#8220;GAB.&#8221; As of September&#160;30, 2023, the net assets of the Fund attributable to its common stock were $1,440,929,426. As of September&#160;30, 2023, the Fund had outstanding 300,659,233 shares of common stock; 2,492 shares of Series C Auction Rate Cumulative Preferred Stock, liquidation preference $25,000 per share (the &#8220;Series C Auction Rate Preferred&#8221;); 1,108 shares of Series E Auction Rate Preferred Stock, liquidation preference $25,000 per share (the &#8220;Series E Auction Rate Preferred&#8221;); 2,572,905 shares of Series G Cumulative Preferred Stock, liquidation preference $25 per share (the &#8220;Series G Preferred&#8221;); 4,116,414 shares of 5.00% Series H Cumulative Preferred Stock, liquidation preference $25 per share (the &#8220;Series H Preferred&#8221;); 3,887,650 shares of 5.00% Series K Cumulative Preferred Stock, liquidation preference $25 per share (the &#8220;Series K Preferred&#8221;); and 685,500 shares of 4.25% Series M Cumulative Preferred Stock, liquidation preference $100 per share (the &#8220;Series M Preferred&#8221;). On December&#160;28, 2023, the Fund issued 147,750 shares of 5.25% Series N Cumulative Preferred Stock, par value $0.001 per share (the &#8220;Series N Preferred&#8221;), a new series of preferred stock. The Series C Auction Rate Preferred, Series E Auction Rate Preferred, Series G Preferred, Series H Preferred, Series K Preferred, Series M Preferred and Series N Preferred have the same seniority with respect to distributions and liquidation preference. All series of our preferred stock, including any series we may designate in the future, constitute a single class of our stock, which we refer to collectively as &#8220;preferred stock.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The Offering</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We may offer, from time to time, in one or more offerings, our common stock, $0.001 par value per share, and our preferred stock, $0.001 par value per share. The shares may be offered at prices and on terms to be set forth in one or more supplements to this Prospectus (each a &#8220;Prospectus Supplement&#8221;). We may also offer subscription rights to purchase our common stock and/or preferred stock. The offering price per share of our common stock will not be less than the net asset value per share of our common stock at the time we make the offering, exclusive of any underwriting commissions or discounts, provided that transferable rights offerings that meet certain conditions may be offered at a price below the then current net asset value. See &#8220;Rights Offerings.&#8221; You should read this Prospectus and the applicable Prospectus Supplement carefully before you invest in our shares. Our shares may be offered directly to one or more purchasers, through agents designated from time to time by us, or to or through underwriters or dealers. The Prospectus Supplement relating to the offering will identify any agents, underwriters or dealers involved in the sale of our shares, and will set forth any applicable purchase price, fee, commission or discount arrangement between us and our agents or underwriters, or among our underwriters, or the basis upon which such amount may be calculated. The Prospectus Supplement relating to any sale of preferred stock will set forth the liquidation preference and information about the dividend period, dividend rate, any call protection or non-call period and other matters. The Prospectus Supplement relating to any offering of subscription rights will set forth the number of shares (preferred or common) issuable upon the exercise of each right (or number of rights) and the other terms of such rights offering. We may not sell any of our securities through agents, underwriters or dealers without delivery of a Prospectus Supplement describing the method and terms of the particular offering. Shares of our common stock are listed on the New York Stock Exchange (&#8220;NYSE&#8221;) under the symbol &#8220;GAB.&#8221; Currently, the Fund&#8217;s Series G Preferred, Series H Preferred and Series K Preferred are listed on the NYSE under the symbol &#8220;GAB PrG,&#8221; &#8220;GAB PrH&#8221; and &#8220;GAB PrK,&#8221; respectively. The Fund&#8217;s Series C Auction Rate Preferred, Series E Auction Rate Preferred, Series M Preferred and Series N Preferred are not traded on a stock exchange. Any future series of fixed rate preferred stock may, but is not required to, be listed on a stock exchange. On December&#160;28, 2023 the last reported NYSE sale price of shares of our common stock was $5.13 per share. The net asset value of shares of the Fund&#8217;s common stock at the close of business on December&#160;28, 2023 was $5.21 per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 6 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investment Objectives and Policies</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Please refer to the <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000794685/000138713123003229/gab-ncsr_123122.htm">section of the Fund&#8217;s most recent annual report on Form N-CSR entitled &#8220;Additional Fund Information&#8212;Summary of Updated Information Regarding the Fund&#8212;Investment Objective and Strategies,&#8221;</a> which is incorporated by reference herein, for a discussion of the Fund&#8217;s investment objectives and policies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently, 337,024,900 shares of the Fund&#8217;s capital stock, which includes the common stock being registered with this registration statement, are classified as common stock, par value $0.001 per share. Holders of the common stock are entitled to one vote per share held. Holders of the common stock are entitled to share equally in distributions authorized by the Fund&#8217;s Board of Directors (the &#8220;Board&#8221;) payable to the holders of such shares and in the net assets of the Fund available on liquidation for distribution to holders of such shares. The shares of common stock have noncumulative voting rights and no conversion, preemptive or other subscription rights, and are not redeemable. In the event of liquidation, each share of the Fund&#8217;s common stock is entitled to its proportion of the Fund&#8217;s assets after payment of debts and expenses and the amounts payable to holders of the Fund&#8217;s preferred stock ranking senior to the shares of common stock of the Fund. As of September&#160;30, 2023, 300,659,233 shares of common stock of the Fund were outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Preferred Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently, 32,975,100 shares of the Fund&#8217;s capital stock, which includes the preferred stock being registered with this registration statement, have been classified by the Board of the Fund or any duly authorized committee thereof as preferred stock, par value $0.001 per share. The Fund&#8217;s Board may reclassify authorized and unissued shares of the Fund, including shares of capital stock previously classified as common stock, as preferred stock prior to the completion of any offering. The number of shares and terms of each series of preferred stock may be fixed by the Board and may materially limit and/or qualify the rights of holders of the Fund&#8217;s common stock. If the Fund&#8217;s Board determines that it is advisable and in the best interests of the Fund for the Fund to utilize additional leverage, the Fund may issue additional series of fixed rate preferred stock (&#8220;Fixed Rate Preferred Stock&#8221;). Any Fixed Rate Preferred Stock issued by the Fund will pay distributions at a fixed rate, which may be reset after an initial period. As of September&#160;30, 2023, 2,492 shares of Series C Auction Rate Preferred, 1,108 shares of Series E Auction Rate Preferred, 2,572,905 shares of Series G Preferred, 4,116,414 shares of Series H Preferred, 3,887,650 shares of Series K Preferred and 685,500 shares of Series M Preferred were issued and outstanding. On December&#160;28, 2023, the Fund issued 147,750 shares of Series N Preferred. Leverage creates a greater risk of loss as well as a potential for more gains for the common stock than if leverage were not used. See &#8220;Risk Factors and Special Considerations&#8212;Leverage Risk&#8221; and &#8220;Certain Investment Practices&#8212;Leveraging.&#8221; The Fund may also engage in investment management techniques which will not be considered senior securities if the Fund establishes in a segregated account cash or other liquid securities equal to the Fund&#8217;s obligations in respect of such techniques. The Fund may borrow money in accordance with its investment restrictions, including as a temporary measure for extraordinary or emergency purposes. The Fund will not borrow for investment purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November&#160;16, 2023, the Fund commenced a tender offer for all of its outstanding Series C Auction Rate Preferred and Series E Auction Rate Preferred. The tender offer is scheduled to expire on January&#160;5, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other Forms of Leverage</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund may engage in derivatives transactions that may give rise to a form of leverage. Under Rule&#160;18f-4 under the 1940 Act, among other things, the Fund must either use derivatives in a limited manner or comply with an outer limit on fund leverage risk based on value-at-risk. See &#8220;Information Objective and Policies&#8212;Derivatives Transactions Subject to Rule&#160;18f-4 Under the 1940 Act&#8221; in the SAI for additional information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund may borrow money to the extent permitted by applicable law in accordance with its investment restrictions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 7 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dividends and Distributions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Preferred Stock Distributions.</i> In accordance with the charter of the Fund (as amended or supplemented from time to time, including any supplement made pursuant to articles supplementary of the Fund establishing a series of preferred stock (the &#8220;Articles Supplementary&#8221;), the &#8220;Charter&#8221;) and as required by the 1940 Act, all shares of preferred stock of the Fund must have the same seniority with respect to distributions. Accordingly, no full distribution will be declared or paid on any series of preferred stock of the Fund for any dividend period, or part thereof, unless full cumulative dividends and distributions due have been declared and made on all outstanding preferred stock of the Fund. Any partial distributions on such preferred stock will be made as nearly pro rata as possible in proportion to the respective amounts of distributions accumulated but unmade on each such series of preferred stock on the relevant dividend payment date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The distributions to the Fund&#8217;s preferred stockholders for the fiscal year ended December&#160;31, 2022, were comprised of net investment income, short term capital gains and long term capital gains, and return of capital. See &#8220;Composition of Distributions.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Common Stock Distributions</i>. In order to allow its common stockholders to realize a predictable, but not assured, level of cash flow and some liquidity periodically on their investment without having to sell shares, the Fund has adopted a managed distribution policy, which may be modified at any time by the Board, of paying a minimum annual distribution of 10% of the average net asset value of the Fund to common stockholders. The Fund has made quarterly distributions with respect to shares of its common stock since 1987. A portion of the distributions to common stockholders during twenty-one of the thirty-three fiscal years that distributions were paid since the Fund&#8217;s inception has included a return of capital. Under the Fund&#8217;s distribution policy, the Fund declares and pays quarterly distributions from net investment income, capital gains, and paid-in capital. The actual source of the distribution for tax purposes is determined after the end of the year. Pursuant to this policy, distributions during the year may be made in excess of required distributions. To the extent such distributions are made from current earnings or accumulated earnings and profits, they are considered ordinary income or long term capital gains. The Fund&#8217;s current distribution policy may restrict the Fund&#8217;s ability to pass through to stockholders all of its net realized long term capital gains as a capital gain dividend, subject to the maximum federal income tax rate of 20% (plus an additional 3.8% Medicare contribution surcharge on income and net gain from investments), and may cause such gains to be treated as ordinary income subject to a maximum federal income tax rate of 37% plus the 3.8% Medicare contribution surcharge.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the fiscal year ended December&#160;31, 2022, the Fund made distributions of $0.60 per share of common stock, approximately $0.31 of which was deemed a return of capital. See &#8220;Composition of Distributions.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Composition of Distributions. <b>Distributions sourced from paid-in capital should not be considered as dividend yield or the total return from an investment in the Fund&#8217;s preferred or common stock. Stockholders who periodically receive the payment of a dividend or other distribution consisting of a return of capital may be under the impression that they are receiving net profits when they are not. Stockholders should not assume that the source of a distribution from the Fund is net profit.</b></i> In the event that for any calendar year Fund does not generate a total return from dividends and interest received and net realized capital gains in an amount equal to or in excess of the total distributions on shares of the Fund&#8217;s common stock or preferred stock in such year, as applicable, the excess distributions will generally be treated as a tax free return of capital (to the extent of the shareholder&#8217;s tax basis in the shares). The amount treated as a tax free return of capital will reduce the net asset value of the shares of the Fund&#8217;s stock and a shareholder&#8217;s adjusted tax basis in the shares of the common stock or preferred stock, as applicable, which may negatively affect the price a stockholder receives upon the sale of its shares and may increase the stockholder&#8217;s potential taxable gain or may reduce the potential taxable loss on the sale of the shares of the stock. Any amount in excess of a stockholder&#8217;s remaining outstanding basis will constitute gain to such stockholder. Return of capital as part of a distribution may have the effect of decreasing the asset coverage per share with respect to the shares of the Fund&#8217;s preferred stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The composition of each distribution is estimated based on the earnings of the Fund as of the record date for each distribution. The actual composition of each of the current year&#8217;s distributions will be based on the Fund&#8217;s investment activity through December&#160;31, 2023. The actual composition of each distribution may change based on the Fund&#8217;s investment activity through the end of the calendar year. The Board monitors and reviews the Fund&#8217;s preferred stock and common stock distribution policies on a regular basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 8 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Limitations on Distributions</i>. If at any time the Fund has borrowings outstanding, the Fund will be prohibited from paying any distributions on any of its shares of common stock (other than in additional shares), and from repurchasing any of its shares of common or preferred stock, unless the value of its total assets, less certain ordinary course liabilities, exceeds 300% of the amount of the debt outstanding and exceeds 200% of the sum of the amount of the debt and preferred stock outstanding. In addition, in such circumstances the Fund will be prohibited from paying any distributions on its shares of preferred stock unless the value of its total assets, less certain ordinary course liabilities, exceeds 200% of the amount of the debt outstanding. The 1940 Act contains an exception, however, that permits dividends to be declared upon any preferred stock issued by the Fund if the Fund&#8217;s indebtedness has an asset coverage of at least 200% at the time of declaration after deducting the amount of the dividend. In addition, if the Fund issues non-public indebtedness (for example, if it enters into a loan agreement in a privately arranged transaction with a bank), it may be able to continue to pay dividends on its capital shares even if the asset coverage ratio on its indebtedness falls below 300%. See &#8220;Dividends and Distributions.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of Proceeds</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund will use the net proceeds from the offering to purchase portfolio securities in accordance with its investment objectives and policies as appropriate investment opportunities are identified, which is expected to substantially be completed within three months; however, changes in market conditions could result in the Fund&#8217;s anticipated investment period extending to as long as six months. This could occur because the Investment Adviser follows a value-oriented investment strategy; therefore, market conditions could result in the Investment Adviser delaying the investment of proceeds if it believes the margin of risk in making additional investments is not favorable in light of its value-oriented investment strategy. See &#8220;Investment Objectives and Policies&#8212;Investment Methodology of the Fund.&#8221; Depending on market conditions and operations, a portion of the cash held by the Fund, including any proceeds raised from the offering, may be used to pay distributions in accordance with the Fund&#8217;s distribution policy. The Fund may also use the proceeds to redeem or repurchase existing series of preferred stock, in whole or in part. See &#8220;Use of Proceeds&#8221; in the Prospectus Supplement for a discussion of whether the Fund expects to use the proceeds from the offering to redeem or repurchase existing series of preferred stock, in whole or in part.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exchange Listing</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund&#8217;s outstanding shares of common stock are listed on the NYSE, under the trading or &#8220;ticker&#8221; symbol &#8220;GAB.&#8221; Currently, the Series G Preferred, Series H Preferred and Series K Preferred are listed on the NYSE under the symbol &#8220;GAB PrG,&#8221; &#8220;GAB PrH&#8221; and &#8220;GAB PrK,&#8221; respectively. See &#8220;Description of the Capital Stock.&#8221; Any additional series of Fixed Rate Preferred Stock issued by the Fund may also be listed on the NYSE. Subscription rights issued by the Fund may also be listed on a securities exchange.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Market Price of Shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common shares of closed-end investment companies often trade at prices lower than their net asset value. Common shares of closed-end investment companies may trade during some periods at prices higher than their net asset value and during other periods at prices lower than their net asset value. The Fund cannot assure you that its common stock will trade at a price higher than, equal to, or below net asset value. The Fund&#8217;s net asset value will be reduced immediately following an offering by the sales load and the amount of the offering expenses paid by the Fund.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition to net asset value, the market price of the Fund&#8217;s common stock may be affected by such factors as the Fund&#8217;s dividend and distribution levels and stability, market liquidity, market supply and demand, unrealized gains, general market and economic conditions, and other factors. See &#8220;Risk Factors and Special Considerations,&#8221; &#8220;Description of the Capital Stock&#8221; and &#8220;Repurchase of Common Stock.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund&#8217;s common stock is designed primarily for long term investors, and you should not purchase shares of common stock of the Fund if you intend to sell them shortly after purchase.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fixed rate preferred stock, if issued, may also trade at premiums to or discounts from its liquidation preference for a variety of reasons, including changes in interest rates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 9 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risk Factors and Special Considerations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Risk is inherent in all investing. Please refer to the <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000794685/000138713123003229/gab-ncsr_123122.htm">section of the Fund&#8217;s most recent annual report on Form N-CSR entitled &#8220;Additional Fund Information&#8212;Summary of Updated Information Regarding the Fund&#8212;Principal Risk Factors,&#8221;</a> which is incorporated by reference herein, for a discussion of the risks of investing in the Fund. You should carefully consider those risks and the risks described below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of the date of this Prospectus, the Fund is classified as a &#8220;diversified&#8221; investment company under the 1940 Act. Accordingly, the risk factor entitled &#8220;Non-Diversified Status&#8221; included in the Fund&#8217;s most recent annual report referenced above is no longer applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Special Risks of Preferred Stock to Holders of Common Stock.</i> The issuance of preferred stock causes the net asset value and market value of the common stock to become more volatile. If the dividend rate on the preferred stock approaches the net rate of return on the Fund&#8217;s investment portfolio, the benefit of leverage to the holders of the common stock would be reduced. If the dividend rate on the preferred stock plus the management fee annual rate of 1.00% (as applicable) exceeds the net rate of return on the Fund&#8217;s portfolio, the leverage will result in a lower rate of return to the holders of common stock than if the Fund had not issued preferred stock. Any decline in the net asset value of the Fund&#8217;s investments would be borne entirely by the holders of common stock. In addition, the Fund would pay (and the holders of common stock will bear) all costs and expenses relating to the issuance and ongoing maintenance of the preferred stock, including the advisory fees on the incremental assets attributable to such stock. See &#8220;Risk Factors and Special Considerations&#8212;Leverage Risk&#8212;Preferred Stock Risk.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Our Subscription Rights</i>. There is a risk that changes in yield or changes in the credit quality of the Fund may result in the underlying shares of preferred stock purchasable upon exercise of the subscription rights being less attractive to investors at the conclusion of the subscription period. This may reduce or eliminate the value of the subscription rights. Investors who receive subscription rights may find that there is no market to sell rights they do not wish to exercise. If investors exercise only a portion of the rights, the number of shares of preferred stock or shares of common stock issued may be reduced, and the preferred stock or common stock may trade at less favorable prices than larger offerings for similar securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Taxation</i>. The Fund has qualified, and intends to remain qualified, for federal income tax purposes as a regulated investment company. Qualification requires, among other things, compliance by the Fund with certain distribution requirements. Statutory limitations on distributions on the common stock if the Fund fails to satisfy the 1940 Act&#8217;s asset coverage requirements could jeopardize the Fund&#8217;s ability to meet such distribution requirements. The Fund presently intends, however, to purchase or redeem preferred stock to the extent necessary in order to maintain compliance with such asset coverage requirements. See &#8220;Taxation&#8221; for a more complete discussion of these and other federal income tax considerations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Management and Fees</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gabelli Funds, LLC serves as the Fund&#8217;s investment adviser. The Investment Adviser&#8217;s fee is computed weekly and paid monthly at the annual rate of 1.00% of the Fund&#8217;s average weekly net assets. The Fund&#8217;s average weekly net assets will be deemed to be the average weekly value of the Fund&#8217;s total assets minus the sum of the Fund&#8217;s liabilities (such liabilities exclude (i) the aggregate liquidation preference of outstanding shares of preferred stock and accumulated dividends, if any, on those shares and (ii) the liabilities for any money borrowed). The fee paid by the Fund may be higher when leverage in the form of preferred stock or borrowings is utilized, giving the Investment Adviser an incentive to utilize such leverage. Because the management fees are based on a percentage of average weekly net assets that includes assets attributable to the Fund&#8217;s use of leverage in the form of preferred stock or money borrowed, the Investment Adviser may have a conflict of interest in the input it provides to the Board regarding whether to use or increase the Fund&#8217;s use of such leverage because leverage may have the effect of increasing the Investment Adviser&#8217;s compensation. The Board bases its decision, with input from the Investment Adviser, regarding whether and how much leverage to use for the Fund on its assessment of whether such use of leverage is in the best interests of the Fund, and the Board seeks to manage the Investment Adviser&#8217;s potential conflict of interest by retaining the final decision on these matters and by periodically reviewing the Fund&#8217;s performance and use of leverage. The Investment Adviser has agreed to reduce the management fee on the incremental assets attributable to the currently outstanding Series C Auction Rate Preferred and Series E Auction</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 10 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rate Preferred during the fiscal year if the total return of the net asset value of the common stock, including distributions and advisory fees subject to reduction for that year, does not exceed the stated dividend rate or corresponding swap rate of those particular series of preferred stock for the period. In other words, if the effective cost of the leverage for the Series C Auction Rate Preferred and Series E Auction Rate Preferred exceeds the total return (based on net asset value) on the Fund&#8217;s common stock, the Investment Adviser will waive that portion of its management fee on the incremental assets attributable to the leverage for that series of preferred stock to mitigate the negative impact of the leverage on the common stockholder&#8217;s total return. This fee waiver was voluntarily undertaken by the Investment Adviser and will remain in effect as long as the Series C Auction Rate Preferred and Series E Auction Rate Preferred are outstanding. This fee waiver does not apply to the Fund&#8217;s Series G Preferred, Series H Preferred, Series K Preferred, Series M Preferred or Series N Preferred and, unless otherwise stated, will not apply to any preferred stock issued from this offering. The Fund&#8217;s total return on the net asset value of the common stock is monitored on a monthly basis to assess whether the total return on the net asset value of the common stock exceeds the stated dividend rate or corresponding swap rate of each particular series of preferred stock for the period. The test to confirm the accrual of the management fee on the assets attributable to each particular series of preferred stock is annual. The Fund will accrue for the management fee on these assets during the fiscal year if it appears probable that the Fund will incur the management fee on those additional assets. See &#8220;Management of the Fund.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended December&#160;31, 2022, the Fund&#8217;s total return on the net asset value of the common stock did not exceed the stated dividend rate of the outstanding shares of Series C Auction Rate Preferred and Series E Auction Rate Preferred. Thus, management fees with respect to the liquidation value of the Series C Auction Rate Preferred and Series E Auction Rate Preferred were reduced by $899,999.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A discussion regarding the basis for the Board&#8217;s approval of the continuation of the investment advisory contract of the Fund is available in the Fund&#8217;s semi-annual report to stockholders dated June&#160;30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Repurchase of Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund&#8217;s Board has authorized the Fund (and the Fund accordingly reserves freedom of action) to repurchase shares of its common stock in the open market when the shares are trading at a discount of 10% or more from net asset value. Although the Board has authorized such repurchases, the Fund is not required to repurchase any shares of common stock. The Board has not established a limit on the amount of common stock that could be repurchased. Such repurchases are subject to certain notice and other requirements under the 1940 Act. The Fund has repurchased shares of its common stock under this authorization. See &#8220;Repurchase of Common Stock.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Anti-Takeover Provisions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
provisions of the Governing Documents may be regarded as &#8220;anti-takeover&#8221; provisions. Pursuant to these provisions, only one
of the three classes of directors is elected each year, and the affirmative vote of the holders of 66&#8532;% of the outstanding shares
of each class of stock of the Fund normally entitled to vote in the election of directors, each such class voting as a separate class,
is required to authorize the conversion of the Fund from a closed-end to an open-end investment company. In addition, the Fund&#8217;s
bylaws contain a provision providing that the Board has adopted a resolution electing for the Fund to be subject to the provisions of
the Maryland Control Share Acquisition Act, provided that shares of preferred stock of the Fund are not subject to the Maryland Control
Share Acquisition Act. The overall effect of these provisions is to render more difficult the accomplishment of a merger with, or the
assumption of control by, a principal stockholder, or the conversion of the Fund to open-end status. These provisions may have the effect
of depriving Fund stockholders of an opportunity to sell their stock at a premium above the prevailing market price. See &#8220;Anti-Takeover
Provisions of the Fund&#8217;s Governing Documents.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Custodian, Transfer Agent and Dividend Disbursing Agent</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Bank of New York Mellon Corporation (&#8220;BNY Mellon&#8221;), located at 240 Greenwich Street, New York, New York 10286, serves as the custodian (the &#8220;Custodian&#8221;) of the Fund&#8217;s assets pursuant to a custody agreement. Under the custody agreement, the Custodian holds the Fund&#8217;s assets in compliance with the 1940 Act. For its services, the Custodian will receive a monthly fee paid by the Fund based upon, among other things, the average value of the total assets of the Fund, plus certain charges for securities transactions and out-of-pocket expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 11 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rules adopted under the 1940 Act permit the Fund to maintain its foreign securities in the custody of certain eligible foreign banks and securities depositories. Pursuant to those rules, any foreign securities in the portfolio of the Fund may be held by sub-custodians approved by the Board in accordance with the regulations of the SEC. Selection of any such sub-custodians will be made by the Board following a consideration of a number of factors, including but not limited to the reliability and financial stability of the institution, the ability of the institution to perform capably custodial services for the Fund, the reputation of the institution in its national market, the political and economic stability of the country or countries in which the sub-custodians are located, and risks of potential nationalization or expropriation of assets of the Fund.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computershare Trust Company, N.A. (&#8220;Computershare&#8221;), located at 150 Royall Street, Canton, Massachusetts 02021, serves as the Fund&#8217;s dividend disbursing agent, as agent under the Fund&#8217;s Automatic Dividend Reinvestment and Voluntary Cash Purchase Plan (the &#8220;Plan&#8221;) and as transfer agent and registrar with respect to the Fund&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computershare also serves as the transfer agent, registrar, dividend disbursing agent and redemption agent with respect to the Series G Preferred, Series H Preferred, Series K Preferred, Series M Preferred and Series N Preferred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BNY Mellon, located at 100 Church Street, New York, New York 10286, serves as the auction agent, transfer agent, registrar, dividend disbursing agent and redemption agent with respect to the Series C Auction Rate Preferred and the Series E Auction Rate Preferred. See &#8220;Custodian, Transfer Agent and Dividend Disbursing Agent.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_002"></span>SUMMARY OF FUND EXPENSES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following tables are intended to assist you in understanding the various costs and expenses directly or indirectly associated with investing in shares of our common stock, as a percentage of net assets attributable to our common stock. All expenses of the Fund will be borne, directly or indirectly, by the common stockholders. Amounts are for the current fiscal year after giving effect to anticipated net proceeds of the offering, assuming that we incur the estimated offering expenses, including the offering expenses of preferred stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0"><b>Stockholder Transaction Expenses</b></p>

<ix:nonNumeric contextRef="AsOf2023-12-29" escape="true" name="cef:ShareholderTransactionExpensesTableTextBlock"><p id="xdx_80F_ecef--ShareholderTransactionExpensesTableTextBlock_z0COtgujwqFk" style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 68%; text-align: left">Sales Load (as a percentage of offering price)</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right"><span id="xdx_90C_ecef--SalesLoadPercent_dp_c20231229__20231229_fKDEp_zILxwfGXDf01" title="Sales Load (as a percentage of offering price)"><ix:nonFraction name="cef:SalesLoadPercent" contextRef="AsOf2023-12-29" id="Fact000052" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">1.86</ix:nonFraction></span></td>
    <td style="white-space: nowrap; width: 1%; text-align: left">%(1)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Offering Expenses (excluding Preferred Stock Offering Expenses) (as a percentage of offering price)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_908_ecef--OtherTransactionExpensesPercent_dp_c20231229__20231229_fKDEp_zmKdEQnPv1y" title="Offering Expenses (excluding Preferred Share Offering Expenses) (as a percentage of offering price)"><ix:nonFraction name="cef:OtherTransactionExpensesPercent" contextRef="AsOf2023-12-29" id="Fact000054" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">0.23</ix:nonFraction></span></td>
    <td style="white-space: nowrap; text-align: left">%(1)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Dividend Reinvestment Plan Fees</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_90E_ecef--DividendReinvestmentAndCashPurchaseFees_dn_c20231229__20231229_fKDIp_ztmWUdSZnKxg" title="Dividend Reinvestment Plan Fees"><ix:nonFraction name="cef:DividendReinvestmentAndCashPurchaseFees" contextRef="AsOf2023-12-29" id="Fact000056" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">None</ix:nonFraction></span></td>
    <td style="white-space: nowrap; text-align: left">(2)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Voluntary Cash Purchase Plan Purchase Transaction Fee</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_909_ecef--SeniorSecuritiesCvgPerUnit_iI_c20231229__cef--RiskAxis__custom--PurchaseTransactionFeeMember_fKDIp_zALBRjMMeF37" title="Voluntary Cash Purchase Plan Purchase Transaction Fee"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2023-12-29_custom_PurchaseTransactionFeeMember" id="Fact000058" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.75</ix:nonFraction></span></td>
    <td style="white-space: nowrap; text-align: left">(2)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Voluntary Cash Purchase Plan Sale Transaction Fee</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_909_ecef--SeniorSecuritiesCvgPerUnit_iI_c20231229__cef--RiskAxis__custom--SaleTransactionFeeMember_fKDIp_zYEjCvehWdy" title="Voluntary Cash Purchase Plan Sale Transaction Fee"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2023-12-29_custom_SaleTransactionFeeMember" id="Fact000060" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.50</ix:nonFraction></span></td>
    <td style="white-space: nowrap; text-align: left">(2)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Preferred Stock Offering Expenses (as a percentage of net assets attributable to common stock)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_90B_ecef--OtherTransactionExpense1Percent_dp_c20231229__20231229_fKDMp_zaNINUF1T07g" title="Preferred Share Offering Expenses (as a percentage of net assets attributable to common shares)"><ix:nonFraction name="cef:OtherTransactionExpense1Percent" contextRef="AsOf2023-12-29" id="Fact000062" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">0.04</ix:nonFraction></span></td>
    <td style="white-space: nowrap; text-align: left">%(3)</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_810_z7tMWcO1jLk3" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="AsOf2023-12-29" escape="true" name="cef:AnnualExpensesTableTextBlock"><p id="xdx_809_ecef--AnnualExpensesTableTextBlock_zpl5YWSdHXh5" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Percentage&#160;of<br /> Net Assets<br /> Attributable&#160;to<br /> Common Stock</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Annual Expenses</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 68%; text-align: left">Management Fees</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right"><span id="xdx_903_ecef--ManagementFeesPercent_dp_c20231229__20231229_fKDQp_zS28PLRjUBzj" title="Management Fees"><ix:nonFraction name="cef:ManagementFeesPercent" contextRef="AsOf2023-12-29" id="Fact000066" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">1.37</ix:nonFraction></span></td>
    <td style="white-space: nowrap; width: 1%; text-align: left">%(4)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Interest on Borrowed Funds</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_907_ecef--InterestExpensesOnBorrowingsPercent_dpn_c20231229__20231229_zWjbgkkTQZ59" title="Interest on Borrowed Funds"><ix:nonFraction name="cef:InterestExpensesOnBorrowingsPercent" contextRef="AsOf2023-12-29" format="ixt-sec:numwordsen" decimals="INF" scale="-2" unitRef="Ratio">None</ix:nonFraction></span></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Other Expenses</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_900_ecef--OtherAnnualExpensesPercent_dp_c20231229__20231229_fKDUp_ziGetCgtXND2" title="Other Expenses"><ix:nonFraction name="cef:OtherAnnualExpensesPercent" contextRef="AsOf2023-12-29" id="Fact000070" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">0.16</ix:nonFraction></span></td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">%(5)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Total Annual Expenses</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_90B_ecef--TotalAnnualExpensesPercent_dp_c20231229__20231229_zUtRN3hSM2r7" title="Total Annual Expenses"><ix:nonFraction name="cef:TotalAnnualExpensesPercent" contextRef="AsOf2023-12-29" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">1.53</ix:nonFraction></span></td>
    <td style="white-space: nowrap; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Dividends on Preferred Stock</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_903_ecef--WaiversAndReimbursementsOfFeesPercent_dp_c20231229__20231229_fKDYp_znf7R5y6bcF9" title="Dividends on Preferred Stock"><ix:nonFraction name="cef:WaiversAndReimbursementsOfFeesPercent" contextRef="AsOf2023-12-29" id="Fact000074" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">2.17</ix:nonFraction></span></td>
    <td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">%(6)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Total Annual Expenses and Dividends on Preferred Stock</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90F_ecef--NetExpenseOverAssetsPercent_dp_c20231229__20231229_zN2fCQMjGJSh" title="Total Annual Expenses and Dividends on Preferred Stock"><ix:nonFraction name="cef:NetExpenseOverAssetsPercent" contextRef="AsOf2023-12-29" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">3.70</ix:nonFraction></span></td>
    <td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 12 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in"></td>
    <td style="width: 0.25in; text-align: left"><span id="xdx_F0B_zdPHy79JEOpj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span id="xdx_F18_zfwBx6Eu71Yd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000077" xml:lang="en-US">Estimated maximum amount based on offering of $300 million in shares of common stock and $200 million in shares of preferred stock. The estimates assume a 1.00% sales load on common stock and $1,150,000 in common offering expenses, and 3.15% sales load on preferred stock and $720,000 in preferred offering expenses. The sales load on preferred stock is an expense borne by the Fund and indirectly by the holders of its common stock. Actual sales loads and offering expenses may be higher or lower than these estimates and will be set forth in the Prospectus Supplement if applicable.</ix:footnote></span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span id="xdx_F03_z2l2S1YoK6F9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span id="xdx_F10_zIM4p7k5Ysv3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000078" xml:lang="en-US">There are no fees charged to stockholders for participating in the Fund&#8217;s Automatic Dividend Reinvestment and Voluntary Cash Purchase Plan. However, stockholders participating in the Plan that elect to make additional cash purchases under the Plan would pay $0.75 per transaction plus a per share fee (which includes any applicable brokerage commissions) to purchase shares and $2.50 per transaction plus a per share fee (which includes any applicable brokerage commissions) to sell shares. See &#8220;Automatic Dividend Reinvestment and Voluntary Cash Purchase Plans.&#8221;</ix:footnote></span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span id="xdx_F0C_zLBKaybG7Rp6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span id="xdx_F19_zVUHVGYRd7F5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000079" xml:lang="en-US">Assumes issuance of $200 million in liquidation preference of fixed rate preferred stock, net assets attributable to common stock of approximately $1.77 billion (which includes the issuance of $300 million in common stock) and $720,000 in preferred offering expenses. The actual amounts in connection with any offering will be set forth in the Prospectus Supplement if applicable.</ix:footnote></span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span id="xdx_F0F_zvPcJ9HEmkti" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span id="xdx_F1F_zPVtcQyy3XKh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000080" xml:lang="en-US">The Investment Adviser&#8217;s fee is 1.00% annually of the Fund&#8217;s average weekly net assets. The Fund&#8217;s average weekly net assets will be deemed to be the average weekly value of the Fund&#8217;s total assets minus the sum of the Fund&#8217;s liabilities (such liabilities exclude (i) the aggregate liquidation preference of outstanding shares of preferred stock and accumulated dividends, if any, on those shares and (ii) the liabilities for any money borrowed). Consequently, because the Fund has preferred stock outstanding, the investment management fees and other expenses as a percentage of net assets attributable to common stock will be higher than if the Fund did not utilize a leveraged capital structure.</ix:footnote></span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span id="xdx_F00_zQr0XxwS3RVj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span id="xdx_F13_z7yBtLwBHrPl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000081" xml:lang="en-US">&#8220;Other Expenses&#8221; are based on estimated amounts for the current year assuming completion of the proposed issuances.</ix:footnote></span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span id="xdx_F0A_z3A0psgKBOs6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span id="xdx_F12_zHcHRSuTde45" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000082" xml:lang="en-US">Dividends on Preferred Stock represent the aggregate of (1) the estimated annual distributions on the existing preferred stock outstanding and (2) the distributions that would be made assuming $200 million of preferred stock is issued with a fixed dividend rate of 6.00%. There can, of course, be no guarantee that any preferred stock would be issued or, if issued, the terms thereof.</ix:footnote></span></td> </tr>
  </table>

</ix:nonNumeric><p id="xdx_81E_zn9R8B9cDnil" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The purpose of the table above and the example below is to help you understand all fees and expenses that you, as a holder of common stock, would bear directly or indirectly.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following example illustrates the expenses (including the maximum estimated sales load on common stock of $3,000,000 and on preferred stock of $6,300,000 and estimated offering expenses of $1,870,000 from the issuance of $300 million in common stock and $200 million in preferred stock) you would pay on a $1,000 investment in common stock followed by the preferred stock offering, assuming a 5% annual portfolio total return.* The actual amounts in connection with any offering will be set forth in the Prospectus Supplement if applicable.</span></p>

<ix:nonNumeric contextRef="AsOf2023-12-29" escape="true" name="cef:ExpenseExampleTableTextBlock"><p id="xdx_80B_ecef--ExpenseExampleTableTextBlock_zUN4xkLdPXHc" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">1 Year</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">3 Years</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">5 Years</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">10 Years</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 52%; text-align: left">Total Expenses Incurred</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><span id="xdx_903_ecef--ExpenseExampleYear01_c20231229__20231229__cef--RiskAxis__custom--CommonSharesMember_zVs3TSFehnb4"><ix:nonFraction name="cef:ExpenseExampleYear01" contextRef="From2023-12-292023-12-29_custom_CommonSharesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">60</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><span id="xdx_907_ecef--ExpenseExampleYears1to3_c20231229__20231229__cef--RiskAxis__custom--CommonSharesMember_zuZkudbdaLfk"><ix:nonFraction name="cef:ExpenseExampleYears1to3" contextRef="From2023-12-292023-12-29_custom_CommonSharesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">136</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><span id="xdx_90D_ecef--ExpenseExampleYears1to5_c20231229__20231229__cef--RiskAxis__custom--CommonSharesMember_zC9r06c1oij6"><ix:nonFraction name="cef:ExpenseExampleYears1to5" contextRef="From2023-12-292023-12-29_custom_CommonSharesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">214</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><span id="xdx_908_ecef--ExpenseExampleYears1to10_c20231229__20231229__cef--RiskAxis__custom--CommonSharesMember_zn7irLysb8n"><ix:nonFraction name="cef:ExpenseExampleYears1to10" contextRef="From2023-12-292023-12-29_custom_CommonSharesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">417</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The example should not be considered a representation of future expenses</b>. The example is based on Total Annual Expenses and Dividends on Preferred Stock shown in the table above and assumes that the amounts set forth in the table do not change and that all distributions are reinvested at net asset value. Actual expenses may be greater or less than those assumed. Moreover, the Fund&#8217;s actual rate of return may be greater or less than the hypothetical 5% return shown in the example.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The above example includes Dividends on Preferred Stock. If Dividends on Preferred Stock were not included in the example calculation, the expenses would be as follows (based on the same assumptions as above).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">1 Year</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">3 Years</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">5 Years</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">10 Years</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 52%; text-align: left">Total Expenses Incurred</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><span id="xdx_90C_ecef--ExpenseExampleYear01_c20231229__20231229__cef--RiskAxis__custom--PreferredSharesMember_zwuHuqdYxBk3"><ix:nonFraction name="cef:ExpenseExampleYear01" contextRef="From2023-12-292023-12-29_custom_PreferredSharesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">38</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><span id="xdx_907_ecef--ExpenseExampleYears1to3_c20231229__20231229__cef--RiskAxis__custom--PreferredSharesMember_zVt8JUa61Zyb"><ix:nonFraction name="cef:ExpenseExampleYears1to3" contextRef="From2023-12-292023-12-29_custom_PreferredSharesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">69</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><span id="xdx_908_ecef--ExpenseExampleYears1to5_c20231229__20231229__cef--RiskAxis__custom--PreferredSharesMember_zpcZHLuWZgkf"><ix:nonFraction name="cef:ExpenseExampleYears1to5" contextRef="From2023-12-292023-12-29_custom_PreferredSharesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">104</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><span id="xdx_906_ecef--ExpenseExampleYears1to10_c20231229__20231229__cef--RiskAxis__custom--PreferredSharesMember_zD7O0HntnEyf"><ix:nonFraction name="cef:ExpenseExampleYears1to10" contextRef="From2023-12-292023-12-29_custom_PreferredSharesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">200</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_81F_zkGO32gmwocg" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 13 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_003"></span>FINANCIAL HIGHLIGHTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The selected data below sets forth the per share operating performance and ratios for the periods presented. The financial information was derived from and should be read in conjunction with the Financial Statements of the Fund and Notes thereto, which are incorporated by reference into this Prospectus and the SAI. The financial information for the five fiscal years ended December&#160;31, 2022, 2021, 2020, 2019, and 2018 has been audited by PricewaterhouseCoopers LLP, the Fund&#8217;s independent registered public accounting firm, whose unqualified report on such Financial Statements is incorporated by reference into the SAI. The financial information for the period ended June&#160;30, 2023 is unaudited.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selected data for a share outstanding throughout each period:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">
        <p style="margin-top: 0; margin-bottom: 0">Six Months Ended June&#160;30,</p>
        <p style="margin-top: 0; margin-bottom: 0">2023</p></td>
    <td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="18" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December&#160;31,</td>
    <td style="white-space: nowrap; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">(Unaudited)</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2018</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Operating Performance:</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 40%; text-align: left; padding-bottom: 1pt">Net asset value, beginning of year</td>
    <td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td>
    <td style="border-bottom: Black 1pt solid; width: 7%; text-align: right">5.08</td>
    <td style="white-space: nowrap; width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td>
    <td style="border-bottom: Black 1pt solid; width: 7%; text-align: right">6.41</td>
    <td style="white-space: nowrap; width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td>
    <td style="border-bottom: Black 1pt solid; width: 7%; text-align: right">5.86</td>
    <td style="white-space: nowrap; width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td>
    <td style="border-bottom: Black 1pt solid; width: 7%; text-align: right">5.88</td>
    <td style="white-space: nowrap; width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td>
    <td style="border-bottom: Black 1pt solid; width: 7%; text-align: right">5.25</td>
    <td style="white-space: nowrap; width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td>
    <td style="border-bottom: Black 1pt solid; width: 7%; text-align: right">6.47</td>
    <td style="white-space: nowrap; width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Net investment income</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">0.02</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">0.03</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">0.04</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">0.04</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">0.06</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">0.07</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Net realized and unrealized gain/(loss) on investments in securities, futures contracts, and foreign currency transactions</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">0.54</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.71</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">1.31</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">0.60</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">1.26</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.57</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Total from investment operations</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">0.56</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.68</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">1.35</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">0.64</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">1.32</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.50</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Distributions to Preferred Stockholders: (a)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Net investment income</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(0.01</td>
    <td style="white-space: nowrap; text-align: left">)*</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(0.00</td>
    <td style="white-space: nowrap; text-align: left">)(b)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(0.01</td>
    <td style="white-space: nowrap; text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(0.01</td>
    <td style="white-space: nowrap; text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(0.01</td>
    <td style="white-space: nowrap; text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(0.01</td>
    <td style="white-space: nowrap; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Net realized gain</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.03</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)*</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.06</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.06</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.06</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.07</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.07</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Total distributions to preferred stockholders</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.04</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.06</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.07</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.07</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.08</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.08</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 1pt">Net Increase/(Decrease) in Net Assets Attributable to Common Stockholders Resulting from Operations</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">0.52</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.74</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">1.28</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">0.57</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">1.24</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.58</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Distributions to Common Stockholders:</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Net investment income</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(0.01</td>
    <td style="white-space: nowrap; text-align: left">)*</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(0.02</td>
    <td style="white-space: nowrap; text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(0.03</td>
    <td style="white-space: nowrap; text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(0.04</td>
    <td style="white-space: nowrap; text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(0.05</td>
    <td style="white-space: nowrap; text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(0.06</td>
    <td style="white-space: nowrap; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Net realized gain</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(0.01</td>
    <td style="white-space: nowrap; text-align: left">)*</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(0.27</td>
    <td style="white-space: nowrap; text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(0.42</td>
    <td style="white-space: nowrap; text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(0.29</td>
    <td style="white-space: nowrap; text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(0.50</td>
    <td style="white-space: nowrap; text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(0.54</td>
    <td style="white-space: nowrap; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Return of capital</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.28</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)*</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.31</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.18</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.27</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.05</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.04</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Total distributions to common stockholders</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.30</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.60</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.63</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.60</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.60</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.64</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Fund Share Transactions:</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Increase/(decrease) in net asset value from common share transactions</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(0.10</td>
    <td style="white-space: nowrap; text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">0.00</td>
    <td style="white-space: nowrap; text-align: left">(b)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">0.00</td>
    <td style="white-space: nowrap; text-align: left">(b)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Increase in net asset value from common shares issued upon reinvestment of distributions</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">0.00</td>
    <td style="white-space: nowrap; text-align: left">(b)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">0.01</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">0.00</td>
    <td style="white-space: nowrap; text-align: left">(b)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Increase in net asset value from repurchase of preferred shares</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">0.00</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">(b)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">0.00</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">(b)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">0.01</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Offering costs and adjustment to offering costs for preferred shares charged to paid-in capital</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.00</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)(b)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.01</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Offering costs and adjustment to offering costs for common shares charged to paid-in capital</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(0.00</td>
    <td style="white-space: nowrap; text-align: left">)(b)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total Fund share transactions</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">0.00</td>
    <td style="white-space: nowrap; text-align: left">(b)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">0.01</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(0.10</td>
    <td style="white-space: nowrap; text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">0.01</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(0.01</td>
    <td style="white-space: nowrap; text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(0.00</td>
    <td style="white-space: nowrap; text-align: left">)(b)</td></tr>
  </table>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 14 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">
        <p style="margin-top: 0; margin-bottom: 0">Six Months Ended June&#160;30,</p>
        <p style="margin-top: 0; margin-bottom: 0">2023</p></td>
    <td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="18" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December&#160;31,</td>
    <td style="white-space: nowrap; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">(Unaudited)</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2018</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt; width: 40%">Net Asset Value Attributable to Common Stockholders, End of Period</td>
    <td style="padding-bottom: 2.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; width: 1%">$</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right; width: 7%">5.30</td>
    <td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left; width: 1%">&#160;</td>
    <td style="padding-bottom: 2.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; width: 1%">$</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right; width: 7%">5.08</td>
    <td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left; width: 1%">&#160;</td>
    <td style="padding-bottom: 2.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; width: 1%">$</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right; width: 7%">6.41</td>
    <td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left; width: 1%">&#160;</td>
    <td style="padding-bottom: 2.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; width: 1%">$</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right; width: 7%">5.86</td>
    <td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left; width: 1%">&#160;</td>
    <td style="padding-bottom: 2.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; width: 1%">$</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right; width: 7%">5.88</td>
    <td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left; width: 1%">&#160;</td>
    <td style="padding-bottom: 2.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; width: 1%">$</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right; width: 7%">5.25</td>
    <td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left; width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 2.5pt">NAV total return &#8224;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">10.64</td>
    <td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">%</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">(11.17</td>
    <td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">)%</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">22.31</td>
    <td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">%</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">13.25</td>
    <td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">%</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">24.03</td>
    <td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">%</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">(10.17</td>
    <td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 2.5pt">Market value, end of period</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">5.80</td>
    <td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">5.48</td>
    <td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">7.19</td>
    <td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">6.27</td>
    <td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">6.09</td>
    <td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">5.10</td>
    <td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 2.5pt">Investment total return &#8224;&#8224;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">11.83</td>
    <td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">%</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">(15.60</td>
    <td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">)%</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">28.83</td>
    <td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">%</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">16.59</td>
    <td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">%</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">32.19</td>
    <td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">%</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">(8.43</td>
    <td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Ratios to Average Net Assets and Supplemental Data:</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Net assets including liquidation value of preferred shares, end of period (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">2,008,731</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">1,931,241</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">2,382,135</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">1,977,843</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">1,966,007</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">1,743,519</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Net assets attributable to common shares, end of period (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">1,584,381</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">1,506,193</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">1,870,648</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">1,534,206</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">1,512,190</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">1,330,606</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Ratio of net investment income to average net assets attributable to common shares before preferred distributions</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">0.67</td>
    <td style="white-space: nowrap; text-align: left">%(c)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">0.46</td>
    <td style="white-space: nowrap; text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">0.57</td>
    <td style="white-space: nowrap; text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">0.81</td>
    <td style="white-space: nowrap; text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1.01</td>
    <td style="white-space: nowrap; text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1.07</td>
    <td style="white-space: nowrap; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Ratio of operating expenses to average net assets attributable to common shares: before fee reductions (d)(e)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1.61</td>
    <td style="white-space: nowrap; text-align: left">%(c)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1.58</td>
    <td style="white-space: nowrap; text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1.37</td>
    <td style="white-space: nowrap; text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1.48</td>
    <td style="white-space: nowrap; text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1.33</td>
    <td style="white-space: nowrap; text-align: left">%(f)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1.37</td>
    <td style="white-space: nowrap; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Ratio of operating expenses to average net assets attributable to common shares: net of fee reductions, if any (d)(g)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1.61</td>
    <td style="white-space: nowrap; text-align: left">%(c)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1.52</td>
    <td style="white-space: nowrap; text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1.37</td>
    <td style="white-space: nowrap; text-align: left">%(f)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1.48</td>
    <td style="white-space: nowrap; text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1.33</td>
    <td style="white-space: nowrap; text-align: left">%(f)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1.27</td>
    <td style="white-space: nowrap; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Portfolio turnover rate</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3</td>
    <td style="white-space: nowrap; text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">9</td>
    <td style="white-space: nowrap; text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">12</td>
    <td style="white-space: nowrap; text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">13</td>
    <td style="white-space: nowrap; text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">11</td>
    <td style="white-space: nowrap; text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">17</td>
    <td style="white-space: nowrap; text-align: left">%</td></tr>
</table>

<ix:nonNumeric contextRef="AsOf2023-12-29" escape="true" name="cef:SecurityTitleTextBlock"><p id="xdx_80E_ecef--SecurityTitleTextBlock_zjTfPbCN6asl" style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; width: 40%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td>
    <td id="xdx_495_20230630_z7tgzvwZFrnk" style="text-align: right; width: 7%">&#160;</td>
    <td style="white-space: nowrap; text-align: left; width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td>
    <td id="xdx_496_20221231_zyBtHqkqKHYe" style="text-align: right; width: 7%">&#160;</td>
    <td style="white-space: nowrap; text-align: left; width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td>
    <td id="xdx_49B_20211231_zJCsKvxBe2vb" style="text-align: right; width: 7%">&#160;</td>
    <td style="white-space: nowrap; text-align: left; width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td>
    <td id="xdx_49E_20201231_z1cNGZ9tYkdi" style="text-align: right; width: 7%">&#160;</td>
    <td style="white-space: nowrap; text-align: left; width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td>
    <td id="xdx_497_20191231_z2bwPciCV3zk" style="text-align: right; width: 7%">&#160;</td>
    <td style="white-space: nowrap; text-align: left; width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td>
    <td id="xdx_493_20181231_zyt2fZN0mah8" style="text-align: right; width: 7%">&#160;</td>
    <td style="white-space: nowrap; text-align: left; width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Cumulative Preferred Stock:</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">Auction Rate Series C Preferred</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredSharesAuctionRateSeriesCPreferredMember_ziznl8LjOuXl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation value, end of period (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2023-06-30_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">62,300</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2022-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">62,300</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2021-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">62,300</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2020-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">62,300</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2019-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">72,000</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2018-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">72,000</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total shares outstanding (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation preference per share</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation value (h)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredSharesAuctionRateSeriesCPreferredMember_zRaHmKzIbtsg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Asset coverage per share (i)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2023-06-30_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">118,342</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2022-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">113,590</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2021-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">116,432</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2020-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">111,456</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2019-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">108,305</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2018-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">105,562</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">5.875% Series D Preferred (j)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.875SerieAPreferredMember_zQjVFda9Kltf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation value, end of period (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0110">&#8212;</span></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0111">&#8212;</span></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0112">&#8212;</span></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0113">&#8212;</span></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0114">&#8212;</span></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2018-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">59,097</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total shares outstanding (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,364</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation preference per share</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Average market value (k)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.62</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.875SerieAPreferredMember_zBAciZw3cXth" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Asset coverage per share (i)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0117">&#8212;</span></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0118">&#8212;</span></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0119">&#8212;</span></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0120">&#8212;</span></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0121">&#8212;</span></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2018-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">105.56</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">Auction Rate Series E Preferred</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredSharesAuctionRateSeriesEPreferredMember_z04eiOXEQOdk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation value, end of period (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2023-06-30_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,700</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2022-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,700</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2021-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,700</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2020-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,700</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2019-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,000</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2018-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,000</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total shares outstanding (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation preference per share</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation value (h)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredSharesAuctionRateSeriesEPreferredMember_zS2rlYq1vEXg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Asset coverage per share (i)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2023-06-30_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">118,342</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2022-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">113,590</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2021-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">116,432</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2020-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">111,456</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2019-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">108,305</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2018-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">105,562</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  </table>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 15 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">
        <p style="margin-top: 0; margin-bottom: 0">Six Months Ended June&#160;30,</p>
        <p style="margin-top: 0; margin-bottom: 0">2023</p></td>
    <td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="18" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December&#160;31,</td>
    <td style="white-space: nowrap; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">(Unaudited)</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2018</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left; width: 40%">5.000% Series G Preferred</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td>
    <td style="text-align: right; width: 7%">&#160;</td>
    <td style="white-space: nowrap; text-align: left; width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td>
    <td style="text-align: right; width: 7%">&#160;</td>
    <td style="white-space: nowrap; text-align: left; width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td>
    <td style="text-align: right; width: 7%">&#160;</td>
    <td style="white-space: nowrap; text-align: left; width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td>
    <td style="text-align: right; width: 7%">&#160;</td>
    <td style="white-space: nowrap; text-align: left; width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td>
    <td style="text-align: right; width: 7%">&#160;</td>
    <td style="white-space: nowrap; text-align: left; width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td>
    <td style="text-align: right; width: 7%">&#160;</td>
    <td style="white-space: nowrap; text-align: left; width: 1%">&#160;</td></tr>
  <tr id="xdx_40D_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.000SerieGPreferredMember_z5KK79wW9Z8i" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation value, end of period (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2023-06-30_custom_CumulativePreferredShares5.000SerieGPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">64,647</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2022-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">65,060</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2021-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">69,491</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2020-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">69,491</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2019-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">69,495</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2018-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">69,495</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total shares outstanding (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,586</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,602</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,780</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,780</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,780</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,780</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation preference per share</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Average market value (k)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">22.59</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">23.59</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.66</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.25</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">24.57</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">23.92</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.000SerieGPreferredMember_zohtagmRw4S3" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Asset coverage per share (i)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2023-06-30_custom_CumulativePreferredShares5.000SerieGPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">118.34</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2022-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">113.59</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2021-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">116.43</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2020-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">111.46</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2019-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">108.30</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2018-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">105.56</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">5.000% Series H Preferred</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.000SerieHPreferredMember_zf0fugCsjixg" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation value, end of period (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2023-06-30_custom_CumulativePreferredShares5.000SerieHPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">102,910</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2022-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">103,195</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2021-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">104,322</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2020-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">104,322</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2019-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">104,322</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2018-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">104,322</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total shares outstanding (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">4,116</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">4,128</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">4,173</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">4,173</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">4,173</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">4,173</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation preference per share</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Average market value (k)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">22.64</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">23.58</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.55</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.30</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">24.68</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">24.18</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.000SerieHPreferredMember_zcCLyYyn5rO4" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Asset coverage per share (i)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2023-06-30_custom_CumulativePreferredShares5.000SerieHPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">118.34</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2022-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">113.59</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2021-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">116.43</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2020-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">111.46</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2019-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">108.30</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2018-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">105.56</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">5.450% Series J Preferred (l)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.450SerieJPreferredMember_zYlG1f8QJ8fh" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation value, end of period (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0166">&#8212;</span></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0167">&#8212;</span></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2021-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">80,000</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2020-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">80,000</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2019-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">80,000</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2018-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">80,000</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total shares outstanding (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3,200</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3,200</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3,200</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3,200</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation preference per share</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Average market value (k)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">26.03</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">26.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.98</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.14</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.450SerieJPreferredMember_zuzfh1jDXbyc" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Asset coverage per share (i)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0173">&#8212;</span></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0174">&#8212;</span></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2021-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">116.43</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2020-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">111.46</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2019-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">108.30</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2018-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">105.56</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">5.000% Series K Preferred</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.000SerieKPreferredMember_zpojXgxxxhU3" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation value, end of period (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2023-06-30_custom_CumulativePreferredShares5.000SerieKPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">98,243</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2022-12-31_custom_CumulativePreferredShares5.000SerieKPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">98,243</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2021-12-31_custom_CumulativePreferredShares5.000SerieKPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">99,825</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2020-12-31_custom_CumulativePreferredShares5.000SerieKPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">99,825</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2019-12-31_custom_CumulativePreferredShares5.000SerieKPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,000</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0185">&#8212;</span></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total shares outstanding (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3,930</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3,930</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3,993</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3,993</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">4,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation preference per share</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">25.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Average market value (k)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">22.74</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">23.70</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">26.40</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.86</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.24</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.000SerieKPreferredMember_zqBbxIMEX4V9" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Asset coverage per share (i)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2023-06-30_custom_CumulativePreferredShares5.000SerieKPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">118.34</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2022-12-31_custom_CumulativePreferredShares5.000SerieKPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">113.59</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2021-12-31_custom_CumulativePreferredShares5.000SerieKPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">116.43</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2020-12-31_custom_CumulativePreferredShares5.000SerieKPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">111.46</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2019-12-31_custom_CumulativePreferredShares5.000SerieKPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">108.30</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0192">&#8212;</span></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">4.250% Series M Cumulative Preferred Shares</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredShares4.250SerieMCumulativePreferredMember_zyegUutqQJ12" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation value, end of period (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2023-06-30_custom_CumulativePreferredShares4.250SerieMCumulativePreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">68,550</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2022-12-31_custom_CumulativePreferredShares4.250SerieMCumulativePreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">68,550</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2021-12-31_custom_CumulativePreferredShares4.250SerieMCumulativePreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">67,850</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0197">&#8212;</span></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0198">&#8212;</span></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0199">&#8212;</span></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total shares outstanding (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">686</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">686</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">679</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation preference per share</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">100.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">100.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">100.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Average market value (k)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">100.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">100.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">100.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredShares4.250SerieMCumulativePreferredMember_zB882vMWthMf" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Asset coverage per share (i)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2023-06-30_custom_CumulativePreferredShares4.250SerieMCumulativePreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">473.37</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2022-12-31_custom_CumulativePreferredShares4.250SerieMCumulativePreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">113.59</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2021-12-31_custom_CumulativePreferredShares4.250SerieMCumulativePreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">116.43</ix:nonFraction></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">Asset Coverage (m)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">473</td>
    <td style="white-space: nowrap; text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">454</td>
    <td style="white-space: nowrap; text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">466</td>
    <td style="white-space: nowrap; text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">446</td>
    <td style="white-space: nowrap; text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">433</td>
    <td style="white-space: nowrap; text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">422</td>
    <td style="white-space: nowrap; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#x2020;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on net asset value per share, adjusted for reinvestment of distributions at net asset value on the ex-dividend dates and adjustments for the rights offering. Total return for a period of less than one year is not annualized.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#x2020;&#x2020;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Based on market value per share, adjusted for reinvestment of distributions at prices determined under the Fund&#8217;s dividend reinvestment plan. Total return for a period of less than one year is not annualized.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on year to date book income. Amounts are subject to change and recharacterization at year end.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Calculated based on average common shares outstanding on the record dates throughout the periods.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount represents less than $0.005 per share.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annualized.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund received credits from a designated broker who agreed to pay certain Fund operating expenses. For all years presented there was no impact on the expense ratios.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ratio of operating expenses to average net assets including liquidation value of preferred shares before fee reductions for the six months ended June&#160;30, 2023 and the years ended December&#160;31, 2022, 2021, 2020, 2019, and 2018 would have been 1.26%, 1.24%, 1.10%, 1.10%, 1.03%, and 1.09%, respectively.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In 2019, due to failed auctions relating to previous fiscal years, the Fund reversed accumulated auction fees. The 2019 ratio of operating expenses to average net assets attributable to common shares and the ratio of operating expenses to average net assets including liquidation value of preferred shares, excluding the reversal of auction agent fees, were 1.39% and 1.08%, respectively.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ratio of operating expenses to average net assets including liquidation value of preferred shares net of fee reductions for the six months ended June&#160;30, 2023 and the years ended December&#160;31, 2022, 2021, 2020, 2019, and 2018 would have been 1.22%, 1.20%, 1.10%, 1.10%, 1.03%, and 1.01%, respectively.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since February&#160;2008, the weekly auctions have failed. Holders that have submitted orders have not been able to sell any or all of their shares in the auction.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asset coverage per share is calculated by combining all series of preferred stock.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund redeemed and retired all of the 2,363,860 shares of Series D Preferred on December&#160;26, 2019.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on weekly prices.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund redeemed and retired all of the 3,200,000 shares of Series J Preferred on January&#160;31, 2022.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asset coverage is calculated by combining all series of preferred stock.</span></td> </tr>
  </table>

</ix:nonNumeric><p id="xdx_81A_zX9K8h2mX1Ha" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Page; Sequence: 16 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="18" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December&#160;31,</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2017</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2016</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2015</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2014</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2013</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Operating Performance:</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 50%; text-align: left; padding-bottom: 1pt">Net asset value, beginning of year</td>
    <td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td>
    <td style="border-bottom: Black 1pt solid; width: 7%; text-align: right">5.84</td>
    <td style="white-space: nowrap; width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td>
    <td style="border-bottom: Black 1pt solid; width: 7%; text-align: right">5.70</td>
    <td style="white-space: nowrap; width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td>
    <td style="border-bottom: Black 1pt solid; width: 7%; text-align: right">6.78</td>
    <td style="white-space: nowrap; width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td>
    <td style="border-bottom: Black 1pt solid; width: 7%; text-align: right">7.23</td>
    <td style="white-space: nowrap; width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td>
    <td style="border-bottom: Black 1pt solid; width: 7%; text-align: right">5.60</td>
    <td style="white-space: nowrap; width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Net investment income</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">0.04</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">0.07</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">0.06</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">0.07</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">0.06</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Net realized and unrealized gain/(loss) on investments, futures contracts, swap contracts, and foreign currency transactions</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">1.42</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">0.75</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.44</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">0.30</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">2.26</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Total from investment operations</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">1.46</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">0.82</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.38</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">0.37</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">2.32</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Distributions to Preferred Shareholders:(a)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Net investment income</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(0.00</td>
    <td style="white-space: nowrap; text-align: left">)(b)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(0.01</td>
    <td style="white-space: nowrap; text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(0.01</td>
    <td style="white-space: nowrap; text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(0.01</td>
    <td style="white-space: nowrap; text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(0.01</td>
    <td style="white-space: nowrap; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Net realized gain</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.08</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.06</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.05</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.05</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.06</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Total distributions to preferred shareholders</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.08</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.07</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.06</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.06</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.07</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 1pt">Net Increase/(Decrease) in Net Assets Attributable to Common Shareholders Resulting from Operations</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">1.38</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">0.75</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.44</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">0.31</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">2.25</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Distributions to Common Shareholders:</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Net investment income</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(0.04</td>
    <td style="white-space: nowrap; text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(0.08</td>
    <td style="white-space: nowrap; text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(0.05</td>
    <td style="white-space: nowrap; text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(0.05</td>
    <td style="white-space: nowrap; text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(0.05</td>
    <td style="white-space: nowrap; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Net realized gain</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(0.57</td>
    <td style="white-space: nowrap; text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(0.52</td>
    <td style="white-space: nowrap; text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(0.44</td>
    <td style="white-space: nowrap; text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(0.49</td>
    <td style="white-space: nowrap; text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(0.57</td>
    <td style="white-space: nowrap; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Return of capital</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.00</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)(b)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.00</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)(b)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.15</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.10</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Total distributions to common shareholders</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.61</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.60</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.64</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.64</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.62</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Fund Share Transactions:</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Increase/decrease in net asset value from common share transactions</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(0.14</td>
    <td style="white-space: nowrap; text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(0.12</td>
    <td style="white-space: nowrap; text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">0.00</td>
    <td style="white-space: nowrap; text-align: left">(b)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Increase in net asset value from repurchase of preferred shares</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">0.00</td>
    <td style="white-space: nowrap; text-align: left">(b)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">0.00</td>
    <td style="white-space: nowrap; text-align: left">(b)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">0.00</td>
    <td style="white-space: nowrap; text-align: left">(b)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">0.00</td>
    <td style="white-space: nowrap; text-align: left">(b)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">0.00</td>
    <td style="white-space: nowrap; text-align: left">(b)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Offering costs and adjustment to offering costs for preferred shares charged to paid-in capital</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(0.01</td>
    <td style="white-space: nowrap; text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">0.00</td>
    <td style="white-space: nowrap; text-align: left">(b)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Offering costs for common shares charged to paid-in capital</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.00</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)(b)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Total Fund share transactions</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.14</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.01</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">0.00</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">(b)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">(0.12</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">0.00</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">(b)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net Asset Value Attributable to Common Shareholders, End of Year</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">6.47</td>
    <td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">5.84</td>
    <td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">5.70</td>
    <td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">6.78</td>
    <td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">7.23</td>
    <td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 2.5pt">NAV total return &#8224;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">24.64</td>
    <td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">%</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">13.66</td>
    <td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">%</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">(6.85</td>
    <td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">)%</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">4.68</td>
    <td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">%</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">41.90</td>
    <td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 2.5pt">Market value, end of year</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">6.19</td>
    <td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">5.52</td>
    <td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">5.31</td>
    <td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">6.47</td>
    <td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">7.75</td>
    <td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 2.5pt">Investment total return &#8224;&#8224;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">24.65</td>
    <td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">%</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">15.71</td>
    <td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">%</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">(8.54</td>
    <td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">)%</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">(6.08</td>
    <td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">)%</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">52.44</td>
    <td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Ratios to Average Net Assets and Supplemental Data:</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Net assets including liquidation value of preferred shares, end of year (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">2,045,240</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">1,693,448</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">1,582,823</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">1,820,361</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">1,712,663</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Net assets attributable to common shares, end of year (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">1,632,327</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">1,280,115</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">1,249,157</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">1,486,491</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">1,378,436</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Ratio of net investment income to average net assets attributable to common shares before preferred distributions</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">0.64</td>
    <td style="white-space: nowrap; text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1.23</td>
    <td style="white-space: nowrap; text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">0.91</td>
    <td style="white-space: nowrap; text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">0.82</td>
    <td style="white-space: nowrap; text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">0.84</td>
    <td style="white-space: nowrap; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Ratio of operating expenses to average net assets attributable to common shares:</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; text-align: left">before fee reductions</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1.42</td>
    <td style="white-space: nowrap; text-align: left">%(c)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1.44</td>
    <td style="white-space: nowrap; text-align: left">%(c)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1.36</td>
    <td style="white-space: nowrap; text-align: left">%(c)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1.37</td>
    <td style="white-space: nowrap; text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1.40</td>
    <td style="white-space: nowrap; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; text-align: left">net of fee reductions, if any</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1.42</td>
    <td style="white-space: nowrap; text-align: left">%(c)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1.44</td>
    <td style="white-space: nowrap; text-align: left">%(c)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1.25</td>
    <td style="white-space: nowrap; text-align: left">%(c)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1.33</td>
    <td style="white-space: nowrap; text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1.40</td>
    <td style="white-space: nowrap; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Ratio of operating expenses to average net assets including liquidation value of preferred shares:</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; text-align: left">before fee reductions</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1.10</td>
    <td style="white-space: nowrap; text-align: left">%(c)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1.10</td>
    <td style="white-space: nowrap; text-align: left">%(c)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1.10</td>
    <td style="white-space: nowrap; text-align: left">%(c)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1.10</td>
    <td style="white-space: nowrap; text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1.10</td>
    <td style="white-space: nowrap; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; text-align: left">net of fee reductions, if any</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1.10</td>
    <td style="white-space: nowrap; text-align: left">%(c)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1.10</td>
    <td style="white-space: nowrap; text-align: left">%(c)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1.01</td>
    <td style="white-space: nowrap; text-align: left">%(c)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1.07</td>
    <td style="white-space: nowrap; text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1.10</td>
    <td style="white-space: nowrap; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Portfolio turnover rate</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">11.4</td>
    <td style="white-space: nowrap; text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">12.7</td>
    <td style="white-space: nowrap; text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">8.9</td>
    <td style="white-space: nowrap; text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">10.9</td>
    <td style="white-space: nowrap; text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">10.0</td>
    <td style="white-space: nowrap; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 17 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in">&#160;</p>

<ix:nonNumeric contextRef="AsOf2023-12-29" escape="true" name="cef:OtherSecuritiesTableTextBlock"><p id="xdx_80B_ecef--OtherSecuritiesTableTextBlock_zw1RGBmoDIGf" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_497_20171231_zTtgvQ06Wg4j" style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_497_20161231_zgmT6FlJdRMi" style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_49F_20151231_zVfd6ZxFSv64" style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_490_20141231_zFeUNFmmRfHh" style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_496_20131231_zqMxG7jjrpUe" style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="18" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December&#160;31,</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2017</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2016</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2015</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2014</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2013</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Cumulative Preferred Stock:</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">Auction Rate Series C Preferred</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredSharesAuctionRateSeriesCPreferredMember_zDa3Suzhj5B7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 50%; text-align: left">Liquidation value, end of year (in 000&#8217;s)</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 7%; text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2017-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">72,000</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 7%; text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2016-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">72,000</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 7%; text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2015-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">72,000</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 7%; text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2014-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">72,000</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 7%; text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2013-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">72,000</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total shares outstanding (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation preference per share</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation value(d)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredSharesAuctionRateSeriesCPreferredMember_zlobUkONpU9f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Asset coverage per share(e)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2017-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">123,830</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2016-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">102,426</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2015-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">118,593</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2014-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">136,308</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2013-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">128,106</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">5.875% Series D Preferred</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.875SerieAPreferredMember_zUJfJw8IW7uk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation value, end of year (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2017-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">59,097</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2016-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">59,097</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2015-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">59,097</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2014-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">59,097</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2013-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">59,097</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total shares outstanding (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,364</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,364</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,364</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,364</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,364</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation preference per share</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Average market value(f)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">26.16</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">26.22</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.69</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.21</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.27</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.875SerieAPreferredMember_zH14xhzjzOP9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Asset coverage per share(e)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2017-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">123.83</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2016-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">102.43</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2015-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">118.59</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2014-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">136.31</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2013-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">128.11</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">Auction Rate Series E Preferred</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredSharesAuctionRateSeriesEPreferredMember_zmkLD8nFbdY" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation value, end of year (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2017-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,000</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2016-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,000</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2015-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,000</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2014-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,000</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2013-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,000</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total shares outstanding (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation preference per share</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation value(d)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredSharesAuctionRateSeriesEPreferredMember_zkcPOtk5rHr4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Asset coverage per share(e)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2017-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">123,830</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2016-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">102,426</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2015-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">118,593</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2014-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">136,308</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2013-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">128,106</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">5.000% Series G Preferred</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.000SerieGPreferredMember_zHcuZDVqyih5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation value, end of year (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2017-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">69,495</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2016-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">69,743</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2015-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">69,925</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2014-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">70,099</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2013-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">70,373</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total shares outstanding (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,780</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,791</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,797</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,804</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,815</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation preference per share</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Average market value(f)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">24.50</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">24.67</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">23.78</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">23.32</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">23.91</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.000SerieGPreferredMember_z31W2Zfh5rW" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Asset coverage per share(e)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2017-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">123.83</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2016-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">102.43</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2015-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">118.59</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2014-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">136.31</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2013-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">128.11</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">5.000% Series H Preferred</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.000SerieHPreferredMember_z1RPRsXtzmSd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation value, end of year (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2017-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">104,322</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2016-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">104,494</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2015-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">104,644</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2014-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">104,674</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2013-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">104,757</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total shares outstanding (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">4,173</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">4,180</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">4,186</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">4,187</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">4,190</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation preference per share</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Average market value(f)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">24.64</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">24.33</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">22.82</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">23.85</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.000SerieHPreferredMember_zvoU9oaDF8ie" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Asset coverage per share(e)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2017-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">123.83</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2016-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">102.43</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2015-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">118.59</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2014-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">136.31</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2013-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">128.11</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">5.450% Series J Preferred</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.450SerieJPreferredMember_z1mYjValdsh4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation value, end of period (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2017-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">80,000</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2016-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">80,000</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0272">&#8212;</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0273">&#8212;</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0274">&#8212;</span></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total shares outstanding (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3,200</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3,200</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation preference per share</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Average market value(f)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.36</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.43</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.450SerieJPreferredMember_z7qt99O2yjag" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Asset coverage per share(e)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2017-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">123.83</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2016-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">102.43</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0278">&#8212;</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0279">&#8212;</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0280">&#8212;</span></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">Asset Coverage(g)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">495</td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">410</td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">474</td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">545</td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">512</td>
    <td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 18 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: center"><b>&#160;</b></td>
    <td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="18" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year Ended December&#160;31,</b></span></td>
    <td style="padding-bottom: 1pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2017</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2016</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2015</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2014</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2013</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Cumulative Preferred Stock:</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">Auction Rate Series C</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredSharesAuctionRateSeriesCPreferredMember_zieGgcOK9s7f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; width: 50%; text-align: left">Liquidation value, end of year (in 000&#8217;s)</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 7%; text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2017-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">72,000</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 7%; text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2016-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">72,000</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 7%; text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2015-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">72,000</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 7%; text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2014-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">72,000</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 7%; text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2013-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">72,000</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total shares outstanding (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation preference per share</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation value(c)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredSharesAuctionRateSeriesCPreferredMember_zrlfaIX7czv" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Asset coverage per share</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2017-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">123,830</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2016-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">102,426</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2015-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">118,593</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2014-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">136,308</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2013-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">128,106</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">5.875% Series D</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.875SerieDPreferredMember_zSzoJNjRvAF7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation value, end of year (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2017-12-31_custom_CumulativePreferredShares5.875SerieDPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">59,097</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2016-12-31_custom_CumulativePreferredShares5.875SerieDPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">59,097</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2015-12-31_custom_CumulativePreferredShares5.875SerieDPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">59,097</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2014-12-31_custom_CumulativePreferredShares5.875SerieDPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">59,097</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2013-12-31_custom_CumulativePreferredShares5.875SerieDPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">59,097</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total shares outstanding (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,364</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,364</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,364</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,364</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,364</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation preference per share</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Average market value(d)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">26.16</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">26.22</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.69</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.21</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.27</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.875SerieDPreferredMember_z0u8A9dwo5ob" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Asset coverage per share</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2017-12-31_custom_CumulativePreferredShares5.875SerieDPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">123.83</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2016-12-31_custom_CumulativePreferredShares5.875SerieDPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">102.43</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2015-12-31_custom_CumulativePreferredShares5.875SerieDPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">118.59</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2014-12-31_custom_CumulativePreferredShares5.875SerieDPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">136.31</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2013-12-31_custom_CumulativePreferredShares5.875SerieDPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">128.11</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">Auction Rate Series E</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredSharesAuctionRateSeriesEPreferredMember_zMirsp0Kdbob" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation value, end of year (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2017-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,000</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2016-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,000</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2015-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,000</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2014-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,000</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2013-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,000</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total shares outstanding (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation preference per share</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation value(c)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredSharesAuctionRateSeriesEPreferredMember_zwM5TvAOPjWf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Asset coverage per share</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2017-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">123,830</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2016-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">102,426</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2015-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">118,593</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2014-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">136,308</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2013-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">128,106</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">5.000% Series G</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.000SerieGPreferredMember_zdvuzgbzNke4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation value, end of year (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2017-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">69,495</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2016-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">69,743</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2015-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">69,925</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2014-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">70,099</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2013-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">70,373</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total shares outstanding (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,780</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,791</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,797</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,804</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,815</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation preference per share.</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Average market value(d)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">24.50</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">24.67</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">23.78</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">23.32</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">23.92</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.000SerieGPreferredMember_zvEadDiIWxWe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Asset coverage per share</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2017-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">123.83</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2016-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">102.43</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2015-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">118.59</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2014-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">136.31</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2013-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">128.11</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">5.000% Series H</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.000SerieHPreferredMember_z0hnwJfYAyyi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation value, end of year (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2017-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">104,322</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2016-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">104,494</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2015-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">104,644</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2014-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">104,674</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2013-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">104,757</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total shares outstanding (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">4,173</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">4,180</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">4,186</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">4,187</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">4,190</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation preference per share.</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Average market value(d)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">24.64</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">24.33</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">22.82</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">23.85</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.000SerieHPreferredMember_zb7YKWk7uJQd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Asset coverage per share</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2017-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">123.83</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2016-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">102.43</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2015-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">118.59</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2014-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">136.31</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction name="cef:SeniorSecuritiesCvgPerUnit" contextRef="AsOf2013-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">128.11</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">Asset Coverage(e)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">495</td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">410</td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">474</td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">545</td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">512</td>
    <td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#x2020;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on net asset value per share, adjusted for reinvestment of distributions at net asset value on the ex-dividend dates and adjustments for the rights offering.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#x2020;&#x2020;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Based on market value per share, adjusted for reinvestment of distributions at prices determined under the Fund&#8217;s dividend reinvestment plan and adjustments for the rights offering.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Calculated based on average common shares outstanding on the record dates throughout the years.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount represents less than $0.005 per share.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund received credits from a designated broker who agreed to pay certain Fund operating expenses. For the years ended December&#160;31, 2017, 2016, and 2015, there was no impact on the expense ratios.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since February&#160;2008, the weekly auctions have failed. Holders that have submitted orders have not been able to sell any or all of their shares in the auction.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asset coverage per share is calculated by combining all series of preferred stock.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on weekly prices.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asset coverage is calculated by combining all series of preferred stock.</span></td> </tr>
  </table>

</ix:nonNumeric><p id="xdx_81F_zMZsSZH4D6Q" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 19 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_004"></span>USE OF PROCEEDS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Investment Adviser expects that it will initially invest the proceeds of the offering in high quality short term debt securities and instruments. The Investment Adviser anticipates that the investment of the proceeds will be made in accordance with the Fund&#8217;s investment objectives and policies as appropriate investment opportunities are identified, which is expected to substantially be completed within three months; however, changes in market conditions could result in the Fund&#8217;s anticipated investment period extending to as long as six months. This could occur because the Investment Adviser follows a value-oriented investment strategy; therefore, market conditions could result in the Investment Adviser delaying the investment of proceeds if it believes the margin of risk in making additional investments is not favorable in light of its value-oriented investment strategy. See &#8220;Investment Objectives and Policies&#8212;Investment Methodology of the Fund.&#8221; Depending on market conditions and operations, a portion of the cash held by Fund, including any proceeds raised from the offering, may be used to pay distributions in accordance with the Fund&#8217;s distribution policy. The Fund may also use the proceeds to redeem or repurchase existing series of preferred stock, in whole or in part. See &#8220;Use of Proceeds&#8221; in the Prospectus Supplement for a discussion of whether the Fund expects to use the proceeds from the offering to redeem or repurchase existing series of preferred stock, in whole or in part.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_005"></span>THE FUND</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund is a diversified, closed-end management investment company registered under the 1940 Act. The Fund was organized as a Maryland corporation on May&#160;20, 1986. The Fund commenced its investment operations on August&#160;21, 1986. The Fund&#8217;s principal office is located at One Corporate Center, Rye, New York 10580-1422, and its telephone number is (800) 422-3554.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="AsOf2023-12-29" escape="true" name="cef:InvestmentObjectivesAndPracticesTextBlock"><p id="xdx_A8B_ecef--InvestmentObjectivesAndPracticesTextBlock_zU5jS1NbMAMj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_006"></span>INVESTMENT OBJECTIVES AND POLICIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">Please refer to the <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000794685/000138713123003229/gab-ncsr_123122.htm">section of the Fund&#8217;s most recent annual report on Form N-CSR entitled &#8220;Additional Fund Information &#8211; Summary of Updated Information Regarding the Fund &#8211; Investment Objective and Strategies,&#8221;</a> which is incorporated by reference herein, for a discussion of the Fund&#8217;s investment objectives and policies.</p>

</ix:nonNumeric><p id="xdx_A94_z3gF46al3vB3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="AsOf2023-12-29" escape="true" name="cef:RiskFactorsTableTextBlock"><p id="xdx_A8C_ecef--RiskFactorsTableTextBlock_zhbvpeBFAS4b" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_007"></span>RISK FACTORS AND SPECIAL CONSIDERATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Risk is inherent in all investing. Please refer to the <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000794685/000138713123003229/gab-ncsr_123122.htm">section of the Fund&#8217;s most recent annual report on Form N-CSR entitled &#8220;Additional Information &#8211; Summary of Updated Information Regarding the Fund &#8211; Principal Risk Factors,&#8221;</a> which is incorporated by reference herein, for a discussion of investing in the Fund. You should carefully consider those risks and the risk described below. As of the date of this Prospectus, the Fund is classified as a &#8220;diversified&#8221; investment company under the 1940 Act. Accordingly, the risk factor entitled &#8220;Non-Diversified Status&#8221; included in the Fund&#8217;s most recent annual report referenced above is no longer applicable.</p>

</ix:nonNumeric><p id="xdx_A98_zsMUppBnufEk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<div id="xdx_98C_ecef--RiskTextBlock_c20231229__20231229__cef--RiskAxis__custom--HowTheFundManagesRiskMember_zuychOaz7pAi"><ix:nonNumeric contextRef="From2023-12-292023-12-29_custom_HowTheFundManagesRiskMember" escape="true" name="cef:RiskTextBlock">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_008"></span>HOW THE FUND MANAGES RISK</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investment Restrictions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund has adopted certain investment limitations, some of which are fundamental policies of the Fund, designed to limit investment risk and maintain portfolio diversification. Under the 1940 Act, a fundamental policy may not be changed without the vote of a majority, as defined in the 1940 Act, of the outstanding voting securities of the Fund (voting together as a single class). The Fund may become subject to guidelines that are more limiting than its current investment restrictions in order to obtain and maintain ratings from Moody&#8217;s and Fitch Ratings, Inc. (&#8220;Fitch&#8221;) on certain series of its preferred stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 20 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Interest Rate Transactions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund may enter into interest rate swap or cap transactions. The use of interest rate swaps and caps is a highly specialized activity that involves investment techniques and risks different from those associated with ordinary portfolio security transactions. In an interest rate swap, the Fund would agree to pay to the other party to the interest rate swap (which is known as the &#8220;counterparty&#8221;) periodically a fixed rate payment in exchange for the counterparty agreeing to pay to the Fund periodically a variable rate payment that is intended to approximate the Fund&#8217;s variable rate payment obligation on its outstanding Series C Auction Rate Preferred and Series E Auction Rate Preferred (together, the &#8220;Auction Rate Preferred Stock&#8221;). In an interest rate cap, the Fund would pay a premium to the counterparty to the interest rate cap and, to the extent that a specified variable rate index exceeds a predetermined fixed rate, would receive from the counterparty payments of the difference based on the notional amount of such cap. Interest rate swap and cap transactions introduce additional risk because the Fund would remain obligated to pay preferred stock dividends or distributions when due in accordance with the Articles Supplementary of the relevant series of the Auction Rate Preferred Stock even if the counterparty defaulted. Depending on the general state of short term interest rates and the returns on the Fund&#8217;s portfolio securities at that point in time, such a default could negatively affect the Fund&#8217;s ability to make dividend or distribution payments on the Auction Rate Preferred Stock. In addition, at the time an interest rate swap or cap transaction reaches its scheduled termination date, there is a risk that the Fund will not be able to obtain a replacement transaction or that the terms of the replacement will not be as favorable as on the expiring transaction. If this occurs, it could have a negative impact on the Fund&#8217;s ability to make dividend or distribution payments on the Auction Rate Preferred Stock. To the extent there is a decline in interest rates, the value of the interest rate swap or cap could decline, resulting in a decline in the asset coverage for the Auction Rate Preferred Stock. A sudden and dramatic decline in interest rates may result in a significant decline in the asset coverage. Under the Articles Supplementary for each series of preferred stock, if the Fund fails to maintain the required asset coverage on the outstanding preferred stock or fails to comply with other covenants, the Fund may be required to redeem some or all of these shares. The Fund generally may redeem any series of Auction Rate Preferred Stock, in whole or in part, at its option at any time (usually on a dividend or distribution payment date), other than during a non-call period. Such redemption would likely result in the Fund seeking to terminate early all or a portion of any swap or cap transactions. Early termination of a swap could result in a termination payment by the Fund to the counterparty, while early termination of a cap could result in a termination payment to the Fund.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund will usually enter into swaps or caps on a net basis; that is, the two payment streams will be netted out in a cash settlement on the payment date or dates specified in the instrument, with the Fund receiving or paying, as the case may be, only the net amount of the two payments. The Fund will monitor any such swap with a view to ensuring that the Fund remains in compliance with all applicable regulatory investment policy and tax requirements.</span></p>

</ix:nonNumeric></div>

<p id="xdx_A9A_z1STaJR7Uaf6" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_009"></span>MANAGEMENT OF THE FUND</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>General</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Board (which, together with the Fund&#8217;s officers, is described in the SAI) has overall responsibility for the management of the Fund. The Board decides upon matters of general policy and reviews the actions of the Investment Adviser.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The Investment Adviser</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Investment Adviser is a New York limited liability company which serves as an investment adviser to registered investment companies with combined aggregate net assets of approximately $19.1 billion as of September&#160;30, 2023. The Investment Adviser is a registered adviser under the Investment Advisers Act of 1940, as amended, and is a wholly owned subsidiary of GAMCO Investors, Inc. (&#8220;GAMI&#8221;). Mr.&#160;Mario J. Gabelli owns a majority of the stock of GGCP, Inc. (&#8220;GGCP&#8221;), which holds a majority of the capital stock and voting power of GAMI. The Investment Adviser has several affiliates that provide investment advisory services: GAMCO Asset Management Inc. (&#8220;GAMCO&#8221;), a wholly owned subsidiary of GAMI, acts as investment adviser for individuals, pension trusts, profit sharing trusts, endowments, and as a sub-adviser to certain third party investment funds, which include registered investment companies, having assets under management of approximately $10.0 billion as of September&#160;30, 2023; Teton Advisors, Inc., and its wholly owned investment adviser, Keeley Teton Advisers, LLC, with assets under</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 21 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">management of approximately $1.3 billion as of September&#160;30, 2023, acts as investment adviser to The TETON Westwood Funds, the KEELEY Funds, and separately managed accounts; and Gabelli &amp; Company Investment Advisers, Inc. (formerly, Gabelli Securities, Inc.), a wholly owned subsidiary of Associated Capital Group, Inc. (&#8220;Associated Capital&#8221;), acts as investment adviser for certain alternative investment products, consisting primarily of risk arbitrage and merchant banking limited partnerships and offshore companies, with assets under management of approximately $1.5 billion as of September&#160;30, 2023. Teton Advisors, Inc. was spun off by GAMI in March&#160;2009 and is an affiliate of GAMI by virtue of Mr.&#160;Gabelli&#8217;s ownership of GGCP, the principal shareholder of Teton Advisors, Inc., as of June&#160;30, 2023. Associated Capital was spun off from GAMI on November&#160;30, 2015, and is an affiliate of GAMI by virtue of Mr.&#160;Gabelli&#8217;s ownership of GGCP, the principal shareholder of Associated Capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Investment Adviser has sole investment discretion for the Fund&#8217;s assets under the supervision of the Fund&#8217;s Board and in accordance with the Fund&#8217;s stated policies. The Investment Adviser will select investments for the Fund and will place purchase and sale orders on behalf of the Fund.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Investment Adviser is obligated to pay expenses associated with providing the services contemplated by the Fund&#8217;s investment advisory agreement (the &#8220;Advisory Agreement&#8221;), including compensation of and office space for its officers and employees connected with investment and economic research, trading and investment management and administration of the Fund (but excluding costs associated with the calculation of the net asset value and allocated costs of the chief compliance officer function and officers of the Fund that are employed by the Fund and are not employed by the Investment Adviser), and the fees of all Directors of the Fund who are affiliated with the Investment Adviser.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition to the fees of the Investment Adviser, the Fund is responsible for the payment of all other expenses incurred in the operation of the Fund, which include, among other things, offering expenses, expenses for legal and Independent Registered Public Accounting Firm services, rating agency fees, costs of printing proxies, stock certificates and stockholder reports, charges of the custodian, any sub-custodian, auction agent, transfer agent(s) and dividend disbursing agent expenses in connection with its respective automatic dividend reinvestment and voluntary cash purchase plan, SEC fees, fees and expenses of unaffiliated directors, accounting and pricing costs, including costs of calculating the net asset value of the Fund, membership fees in trade associations, fidelity bond coverage for its officers and employees, directors&#8217; and officers&#8217; errors and omission insurance coverage, interest, brokerage costs, taxes, stock exchange listing fees and expenses, expenses of qualifying its shares for sale in various states, litigation and other extraordinary or non-recurring expenses, and other expenses properly payable by the Fund.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Advisory Agreement</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the terms of the Advisory Agreement, the Investment Adviser manages the portfolio of the Fund in accordance with its stated investment objectives and policies, makes investment decisions for the Fund, and places orders to purchase and sell securities on behalf of the Fund and manages the Fund&#8217;s other business and affairs, all subject to the supervision and direction of the Board. In addition, under the Advisory Agreement, the Investment Adviser oversees the administration of all aspects of the Fund&#8217;s business and affairs and provides, or arranges for others to provide, at the Investment Adviser&#8217;s expense, certain enumerated services, including maintaining the Fund&#8217;s books and records, preparing reports to its stockholders and supervising the calculation of the net asset value of its stock. All expenses of computing the Fund&#8217;s net asset value, including any equipment or services obtained solely for the purpose of pricing shares of stock or valuing the Fund&#8217;s investment portfolio, will be an expense of the Fund under the Advisory Agreement unless the Investment Adviser voluntarily assumes responsibility for such expense. During fiscal year 2022, the Fund reimbursed the Investment Adviser $45,000 in connection with the cost of computing the Fund&#8217;s net asset value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Advisory Agreement combines investment advisory and administrative responsibilities in one agreement. For services rendered by the Investment Adviser on behalf of the Fund under the Advisory Agreement, the Fund pays the Investment Adviser a fee computed weekly and paid monthly at the annual rate of 1.00% of the Fund&#8217;s average weekly net assets. The Fund&#8217;s average weekly net assets will be deemed to be the average weekly value of the Fund&#8217;s total assets minus the sum of the Fund&#8217;s liabilities (such liabilities exclude (i) the aggregate liquidation preference of outstanding shares of preferred stock and accumulated dividends, if any, on those shares and (ii) the liabilities for any money borrowed). The fee paid by the Fund may be higher when leverage in the form of preferred stock or borrowings is utilized, giving the Investment Adviser an incentive to utilize such leverage. Because the</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 22 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">management fees are based on a percentage of average weekly net assets that includes assets attributable to the Fund&#8217;s use of leverage in the form of preferred stock or money borrowed, the Investment Adviser may have a conflict of interest in the input it provides to the Board regarding whether to use or increase the Fund&#8217;s use of such leverage because leverage may have the effect of increasing the Investment Adviser&#8217;s compensation. The Board bases its decision, with input from the Investment Adviser, regarding whether and how much leverage to use for the Fund on its assessment of whether such use of leverage is in the best interests of the Fund, and the Board seeks to manage the Investment Adviser&#8217;s potential conflict of interest by retaining the final decision on these matters and by periodically reviewing the Fund&#8217;s performance and use of leverage. The Investment Adviser has agreed to reduce the management fee on the incremental assets attributable to the Series C Auction Rate Preferred and Series E Auction Rate Preferred during the fiscal year if the total return of the net asset value of the common stock, including distributions and management fees subject to reduction for that year, does not exceed the stated dividend rate or corresponding swap rate of each particular series of preferred stock for the period. In other words, if the effective cost of the leverage for the Series C Auction Rate Preferred and Series E Auction Rate Preferred exceeds the total return (based on net asset value) on the Fund&#8217;s common stock, the Investment Adviser will waive that portion of its management fee on the incremental assets attributable to the leverage for that series of preferred stock to mitigate the negative impact of the leverage on the common stockholder&#8217;s total return. This fee waiver was voluntarily undertaken by the Investment Adviser and will remain in effect as long as the Series C Auction Rate Preferred and Series E Auction Rate Preferred are outstanding. This fee waiver does not apply to the Series G Preferred, Series H Preferred, Series K Preferred, Series M Preferred or Series N Preferred and, unless otherwise stated, will not apply to any preferred stock issued in this offering. The Fund&#8217;s total return on the net asset value of its common stock is monitored on a monthly basis to assess whether the total return on the net asset value of its common stock exceeds the stated dividend rate or corresponding swap rate of each particular series of outstanding preferred stock for the period. The test to confirm the accrual of the management fee on the assets attributable to each particular series of preferred stock is annual. The Fund will accrue for the management fee on these assets during the fiscal year if it appears probable that the Fund will incur the management fee on those assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended December&#160;31, 2022, the Fund&#8217;s total return on the net asset value of the common stock did not exceed the stated dividend rate of the outstanding shares of Series C Auction Rate Preferred and Series E Auction Rate Preferred. Thus, management fees were not accrued on the liquidation value of Series C Auction Rate Preferred and Series E Auction Rate Preferred and management fees were reduced by $899,999.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Advisory Agreement provides that in the absence of willful misfeasance, bad faith, gross negligence or reckless disregard of its obligations and duties thereunder, the Investment Adviser is not liable for any error of judgment or mistake of law or for any loss suffered by the Fund. As part of the Advisory Agreement, the Fund has agreed that the name &#8220;Gabelli&#8221; is the Investment Adviser&#8217;s property, and that in the event the Investment Adviser ceases to act as an investment adviser to the Fund, the Fund will change its name to one not including &#8220;Gabelli.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to its terms, the Advisory Agreement will remain in effect with respect to the Fund from year to year if approved annually (i) by the Fund&#8217;s Board or by the holders of a majority of the Fund&#8217;s outstanding voting securities and (ii) by a majority of the Directors who are not &#8220;interested persons&#8221; (as defined in the 1940 Act) of any party to the Advisory Agreement, by vote cast in person at a meeting called for the purpose of voting on such approval.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A discussion regarding the basis of the Board&#8217;s approval of the Advisory Agreement is available in the Fund&#8217;s semiannual report to stockholders for the six months ended June&#160;30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Selection of Securities Brokers</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Advisory Agreement contains provisions relating to the selection of securities brokers to effect the portfolio transactions of the Fund. Under those provisions, the Investment Adviser may (i) direct Fund portfolio brokerage to G.research, LLC, an affiliate of the Fund and the Investment Adviser (&#8220;G.research&#8221;), or other broker-dealer affiliates of the Investment Adviser and (ii) pay commissions to brokers other than G.research that are higher than might be charged by another qualified broker to obtain brokerage and/or research services considered by the Investment Adviser to be useful or desirable for its investment management of the Fund and/or its other advisory accounts or those of any investment adviser affiliated with it. The SAI contains further information about the Advisory Agreement, including a more complete description of the advisory and expense arrangements, exculpatory and brokerage provisions, as well as information on the brokerage practices of the Fund.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 23 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Portfolio Managers</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mario J. Gabelli, CFA, is currently and has been responsible for the day-to-day management of the Fund since its inception. Mr.&#160;Gabelli serves as Chairman and Chief Executive Officer of GAMCO Investors, Inc., Chief Investment Officer &#8212; Value Portfolios for GAMI, the Investment Adviser and GAMCO, Chief Executive Officer and Chief Investment Officer of GGCP, Executive Chairman of Associated Capital, and a director or officer of other companies affiliated with GAMI. Mr.&#160;Gabelli serves as portfolio manager for and is a director of several funds in the Gabelli fund family (&#8220;Gabelli/GAMCO Fund Complex&#8221; or &#8220;Fund Complex&#8221;). Because of the diverse nature of Mr.&#160;Gabelli&#8217;s responsibilities, he will devote less than all of his time to the day-to-day management of the Fund. Mr.&#160;Gabelli is a summa cum laude graduate of Fordham University and holds an M.B.A. degree from Columbia Business School and Honorary Doctorates from Fordham University and Roger Williams University.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kevin V. Dreyer, a Managing Director of GAMI and Co-Chief Investment Officer of GAMI&#8217;s Value team, became a portfolio manager of the Fund in July&#160;2013. Mr.&#160;Dreyer joined Gabelli in 2005 as a research analyst. He currently manages several funds within the Gabelli/GAMCO Fund Complex and serves as a portfolio manager on GAMCO Asset Management Inc.&#8217;s institutional and high net worth separate accounts team. Mr.&#160;Dreyer received a B.S.E. from the University of Pennsylvania and an M.B.A. from Columbia Business School.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert D. Leininger, CFA, became a portfolio manager of the Fund in June&#160;2015. He joined GAMI in 1993 as a security analyst. Mr.&#160;Leininger moved to Rorer Asset Management LLC in Philadelphia in 1997, where he was a partner in the firm and member of the investment policy committee. In August&#160;2009, he joined Copeland Capital Management as a partner and portfolio manager before rejoining GAMI in 2010 where he currently serves as a portfolio manager for the Investment Adviser and on GAMCO Asset Management Inc.&#8217;s institutional and high net worth separate accounts team. He is a member of the Financial Analyst Society of Philadelphia. Mr.&#160;Leininger is a magna cum laude graduate of Amherst College with a degree in Economics and holds an M.B.A. from the Wharton School at the University of Pennsylvania.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Christopher J. Marangi, a Managing Director of GAMI and Co-Chief Investment Officer of GAMI&#8217;s Value team, became a portfolio manager of the Fund in July&#160;2013. Mr.&#160;Marangi joined Gabelli in 2003 as a research analyst. He currently manages several funds within the Gabelli/GAMCO Fund Complex and serves as a portfolio manager on GAMCO Asset Management Inc.&#8217;s institutional and high net worth separate accounts team. Mr.&#160;Marangi graduated magna cum laude and Phi Beta Kappa with a B.A. in Political Economy from Williams College and holds an M.B.A. with honors from Columbia Business School.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Daniel M. Miller, a Managing Director of GAMI and Executive Vice President of Marketing for the mutual funds business, became a portfolio manager of the Fund in June&#160;2015. He also serves as a portfolio manager of other funds in the Gabelli/GAMCO Fund Complex and on GAMCO Asset Management Inc.&#8217;s institutional and high net worth separate accounts team. Mr.&#160;Miller graduated magna cum laude with a degree in finance from the University of Miami in Coral Gables, Florida.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ashish Sinha became a portfolio manager of the Fund in December&#160;2020. Mr.&#160;Sinha joined GAMCO UK in 2012 as a research analyst. Prior to joining the Firm, Mr.&#160;Sinha was a research analyst at Morgan Stanley in London for seven years and has covered European Technology, Mid-Caps and Business Services. He also worked in planning and strategy at Birla Sun Life Insurance in India. Currently Mr.&#160;Sinha is a portfolio manager of Gabelli Funds, LLC and an Assistant Vice President of GAMCO Asset Management UK. Mr.&#160;Sinha has a BSBA degree from the Institute of Management Studies and an MB from IIFT.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gustavo Pifano became a portfolio manager of the Fund in December&#160;2020. Mr.&#160;Pifano joined the firm in 2008 and is based in London. He serves as an assistant vice president of research and covers the industrial and consumer sectors with a focus on small-cap stocks. Gustavo is a member of the risk management group and responsible for the firm&#8217;s UK compliance oversight and AML reporting functions. Gustavo holds a BBA in finance from University of Miami and an MBA from University of Oxford Said Business School.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 24 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ian Lapey became a portfolio manager of the Fund in December&#160;2020. Mr.&#160;Lapey joined Gabelli in October&#160;2018 as a portfolio manager. Prior to joining Gabelli, Mr.&#160;Lapey was a research analyst and partner at Moerus Capital Management LLC. Prior to joining Moerus, he was a partner, research analyst, and a portfolio manager at Third Avenue Management. Mr.&#160;Lapey holds an MBA in Finance and Statistics from the Stern School of Business at New York University. He also holds a Master&#8217;s degree in Accounting from Northeastern University and a BA in Economics from Williams College.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sara E. Wojda became a portfolio manager of the Fund in December&#160;2020. Ms. Wojda joined the firm in 2014 as a Research Analyst and covers the Diagnostics and Life Sciences industries. Since moving to London in 2018, she has expanded the firm&#8217;s global healthcare coverage and assisted with Gabelli&#8217;s UK-based funds. Sara graduated summa cum laude from Babson College with a BS in Business Management, double majoring in Economics and Accounting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Howard F. Ward, CFA, became a portfolio manager of the Fund in December&#160;2020. Mr.&#160;Ward joined Gabelli Funds in 1995 and currently serves as GAMCO&#8217;s Chief Investment Officer of Growth Equities as well as a Gabelli Funds, LLC portfolio manager for several funds within the Fund Complex. Prior to joining Gabelli, Mr.&#160;Ward served as Managing Director and Lead Portfolio Manager for several Scudder mutual funds. He also was an Investment Officer in the Institutional Investment Department with Brown Brothers, Harriman &amp; Co. Mr.&#160;Ward received his BA in Economics from Northwestern University.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hendi Susanto became a portfolio manager of the Fund in January&#160;2021. Mr.&#160;Susanto joined Gabelli in 2007 as the lead technology research analyst. He spent his early career in supply chain management consulting and operations in the technology industry. He currently is a portfolio manager of Gabelli Funds, LLC and a Vice President of Associated Capital Group Inc. Mr.&#160;Susanto received a BS degree summa cum laude from the University of Minnesota, an MS from M.I.T., and an MBA from the Wharton School of Business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joseph Gabelli became a portfolio manager of the Fund in January&#160;2021. Mr.&#160;Gabelli rejoined GAMCO Investors, Inc. on May&#160;1, 2018, after serving as a data strategy consultant for Alt/S, an early-stage media and marketing analytics firm, beginning in July&#160;2017. From 2008 until June&#160;2017, Mr.&#160;Joseph Gabelli served as an equity research analyst covering the global food and beverage industry for GAMCO Investors, Inc. and its affiliate, Associated Capital Group, Inc. He began his investment career at Integrity Capital Management, a Boston-based equity hedge fund, where he focused on researching small and micro-cap companies in the technology, healthcare and consumer discretionary sectors. Mr.&#160;Gabelli holds a B.A. from Boston College, and an M.B.A. from Columbia Business School, where he graduated with Dean&#8217;s Honors and Distinction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Macrae (Mac) Sykes became a portfolio manager of the Fund in August&#160;2021. Mr.&#160;Sykes covers the global financial services sector and joined the firm as an analyst in 2008. He has nearly 25 years of industry experience and began his career at Donaldson, Lufkin &amp; Jenrette. Mr.&#160;Sykes was ranked #1 investment services analyst by the Wall Street Journal in 2010, was a runner-up in the annual StarMine analyst awards for stock picking in 2014 and 2018, received several honorable mentions for brokers and asset managers from Institutional Investor and was a contributing author to The Warren Buffett Shareholder: Stories from inside the Berkshire Hathaway Annual Meeting by Lawrence Cunningham and Stephanie Cuba. Mr.&#160;Sykes holds a BA in economics from Hamilton College and an MBA in finance from Columbia Business School.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The SAI provides additional information about the Portfolio Managers&#8217; compensation, other accounts managed by the Portfolio Managers and the Portfolio Managers&#8217; ownership of securities in the Fund.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sub-Administrator</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Investment Adviser has entered into a sub-administration agreement with BNY Mellon Investment Servicing (US) Inc. (the &#8220;Sub-Administrator&#8221;) pursuant to which the Sub-Administrator provides certain administrative services necessary for the Fund&#8217;s operations that do not include the investment and portfolio management services provided by the Investment Adviser. For these services and the related expenses borne by the Sub-Administrator, the Investment Adviser pays a prorated monthly fee at the annual rate of 0.0275% of the first $10 billion of the aggregate average net assets of the Fund and all other funds advised by the Investment Adviser and Teton Advisors, Inc. and administered by the Sub-Administrator, 0.0125% of the aggregate average net assets exceeding $10 billion but less than $15 billion, 0.01% of the aggregate average net assets in excess of $15 billion but less than $20 billion and 0.008% of the aggregate average net assets in excess of $20 billion. The Sub-Administrator has its principal office at 103 Bellevue Parkway, Wilmington, Delaware 19809.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 25 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_010"></span>PORTFOLIO TRANSACTIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal transactions are not entered into with affiliates of the Fund. However, G.research may execute portfolio transactions on stock exchanges and in the OTC markets on an agency basis and receive a stated commission therefor. For a more detailed discussion of the Fund&#8217;s brokerage allocation practices, see &#8220;Portfolio Transactions&#8221; in the SAI.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_011"></span>DIVIDENDS AND DISTRIBUTIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund intends to pay a quarterly distribution of an amount, if any, determined each quarter by the Board. Under the Fund&#8217;s current distribution policy, the Fund intends to pay a minimum annual distribution of 10% of the average net asset value of the Fund within a calendar year or an amount sufficient to satisfy the minimum distribution requirements of the Code, whichever is greater. The average net asset value of the Fund is based on the average net asset values as of the last day of the four preceding calendar quarters during the year. Each quarter, the Board reviews the amount of any potential distribution and the income, capital gain, or capital available. The Board continues to monitor the Fund&#8217;s distribution level, taking into consideration the Fund&#8217;s net asset value and the financial market environment. The Fund&#8217;s distribution policy is subject to modification by the Board at any time, and the Fund will make distributions only when, as and if authorized by the Board and declared by the Fund. The distribution rate should not be considered the dividend yield or total return on an investment in the Fund. This policy permits common stockholders to realize a predictable, but not assured, level of cash flow and some liquidity periodically with respect to their shares of common stock without having to sell their shares. The Fund may retain for reinvestment, and pay the resulting federal income taxes on, its net capital gain, if any, although the Fund reserves the authority to distribute its net capital gain in any year. To avoid paying income tax at the corporate level, the Fund distributes substantially all of its investment company taxable income and net capital gain. A portion of all distributions to common stockholders for each of the past five years have constituted a return of capital. Stockholders who periodically receive the payment of a dividend or other distribution consisting of a return of capital may be under the impression that they are receiving net profits when they are not. Stockholders should not assume that the source of a distribution from the Fund is net profit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long term capital gains, qualified dividend income, ordinary income, and paid-in capital, if any, will be allocated on a pro-rata basis to all distributions to common stockholders for the year. The estimated components of each distribution are updated and provided to stockholders of record in a notice accompanying the distribution and are available on our website (www.gabelli.com). Pursuant to this policy, distributions during the year may be made in excess of required distributions. To the extent such distributions are made from current earnings and profits, they are considered ordinary income or long term capital gains. The Fund&#8217;s current distribution policy may restrict the Fund&#8217;s ability to pass through to stockholders all of its net realized long term capital gains as a capital gain dividend, generally subject to federal income tax rates for an individual of either 15% or 20%, and may cause such gains to be treated as ordinary income subject to a maximum federal income tax rate of 37% plus the 3.8% Medicare contribution surcharge. Distributions sourced from paid-in capital should not be considered as dividend yield or the total return from an investment in the Fund. Stockholders who periodically receive the payment of a dividend or other distribution consisting of a return of capital may be under the impression that they are receiving net profits when they are not. Stockholders should not assume that the source of a distribution from the Fund is net profit. The final determination of the sources of all distributions in a particular year will be made after year end and can vary from the quarterly estimates. All stockholders with taxable accounts will receive written notification regarding the components and tax treatment for all 2023 distributions in early 2024 via Form 1099-DIV.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If, for any calendar year, the total quarterly distributions to common stockholders and the amount of distributions on any preferred stock issued by the Fund exceed investment company taxable income and net capital gain (prior to any adjustment for a capital loss carryover from a prior year), the excess will generally be treated as a tax free return of capital up to the amount of a stockholder&#8217;s tax basis in the stock. Any distributions to the holders of common or preferred stock which constitute tax free return of capital will reduce a stockholder&#8217;s tax basis in such stock and may increase such stockholder&#8217;s potential taxable gain or may reduce his or her potential taxable loss on the sale of the stock. Any amounts distributed to a stockholder in excess of the basis in the stock will generally be taxable to the stockholder as capital gain.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 26 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the event the Fund distributes amounts in excess of its investment company taxable income and net capital gain, such distributions will decrease the Fund&#8217;s total assets and, therefore, have the likely effect of increasing its expense ratio, as the Fund&#8217;s fixed expenses will become a larger percentage of the Fund&#8217;s average net assets. In addition, in order to make such distributions, the Fund might have to sell a portion of its investment portfolio at a time when independent investment judgment might not dictate such action.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund, along with other closed-end registered investment companies advised by the Investment Adviser, has obtained an exemption from Section&#160;19(b) of the 1940 Act and Rule&#160;19b-1 thereunder permitting it to make periodic distributions of long term capital gains provided that any distribution policy of the Fund with respect to its common stock calls for periodic (e.g., quarterly or semiannually, but in no event more frequently than monthly) distributions in an amount equal to a fixed percentage of the Fund&#8217;s average net asset value over a specified period of time or market price per share of common stock at or about the time of distribution or payment of a fixed dollar amount. The exemption also permits the Fund to make distributions with respect to its preferred stock in accordance with such stock&#8217;s terms. See &#8220;Automatic Dividend Reinvestment and Voluntary Cash Purchase Plans.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_012"></span>ISSUANCE OF COMMON STOCK</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the twelve months ended December&#160;31, 2022, the Fund did not issue common shares of beneficial interest, other than shares of beneficial interest issued pursuant to its dividend reinvestment policy. G.research, an affiliate of Gabelli Funds, LLC, the Fund&#8217;s Investment Adviser, may act as dealer-manager for future offerings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_013"></span>AUTOMATIC DIVIDEND REINVESTMENT AND VOLUNTARY CASH PURCHASE PLANS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Please refer to the <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000794685/000138713123003229/gab-ncsr_123122.htm">section of the Fund&#8217;s most recent annual report on Form N-CSR entitled &#8220;Additional Fund Information &#8211; Automatic Dividend Reinvestment and Voluntary Cash Purchase Plans,&#8221;</a> which is incorporated by reference herein, for a discussion of the Fund&#8217;s dividend reinvestment and voluntary cash repurchase plans.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_014"></span>DESCRIPTION OF THE CAPITAL STOCK</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The following is a brief description of the terms of the Fund&#8217;s common stock, preferred stock, subscription rights to purchase common stock subscription rights to purchase preferred stock and subscription rights to purchase common and preferred stock. This description does not purport to be complete and is qualified by reference to the Fund&#8217;s Governing Documents. For complete terms of the common stock and preferred stock, please refer to the actual terms of such series, which are or will be set forth in the Governing Documents. For complete terms of the subscription rights, please refer to the actual terms of such subscription rights which will be set forth in the subscription rights agreement relating to such subscription rights.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-12-292023-12-29_custom_CommonShareMember" escape="true" name="cef:OutstandingSecurityTitleTextBlock"><p id="xdx_805_ecef--OutstandingSecurityTitleTextBlock_hcef--RiskAxis__custom--CommonShareMember_zKmgR8jxX1wj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to an amendment to the Fund&#8217;s Charter that was approved by stockholders in 2004, the Board may increase or decrease the aggregate number of shares of stock of the Fund or the number of shares of any class or series that the Fund has authority to issue without stockholder approval. The Fund is currently authorized to issue 337,024,900 shares of common stock, par value $0.001 per share. Holders of the common stock are entitled to one vote per share held. Holders of the common stock are entitled to share equally in distributions authorized by the Board and payable to the holders of such shares and in the net assets of the Fund available on liquidation for distribution to holders of such shares. The shares of common stock have noncumulative voting rights and no conversion, preemptive or other subscription rights, and are not redeemable. In the event of liquidation, each share of the Fund&#8217;s common stock is entitled to its proportion of the Fund&#8217;s assets after payment of debts and expenses and the amounts payable to holders of the Fund&#8217;s preferred stock ranking senior to the shares of common stock of the Fund as described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offerings of stock require approval by the Board. Any additional offering of common stock will be subject to the requirements of the 1940 Act, which provides that common stock may not be issued at a price below the then current net asset value, exclusive of sales load, except in connection with an offering to existing holders of common stock or with the consent of a majority of the Fund&#8217;s outstanding voting securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 27 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:nonNumeric contextRef="AsOf2023-12-29" escape="true" name="cef:SharePriceTableTextBlock"><p id="xdx_891_ecef--SharePriceTableTextBlock_zczBTBcvccLb" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund&#8217;s outstanding common stock is listed and traded on the NYSE under the symbol &#8220;GAB.&#8221; The average weekly trading volume of the common stock on the NYSE during the period from January&#160;1, 2022 through December&#160;31, 2022 was 2,642,587 shares. The Fund determines its NAV on a daily basis. The following table sets forth, for the quarters indicated, the highest and lowest daily closing prices on the NYSE per common share, and the NAV per common share and the premium to or discount from NAV, on the date of each of the high and low market prices. The table also sets forth the number of common shares traded on the NYSE during the respective quarters.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Market Price</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Corresponding<br />Net Asset Value<br />(&#8220;NAV&#8221;) Per<br />Share</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Corresponding<br />Premium or<br />Discount<br />as a %<br />of NAV</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: left">Quarter Ended</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">High</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Low</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">High</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Low</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">High</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Low</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March&#160;31, 2021</span></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 7%; text-align: right"><span id="xdx_909_ecef--HighestPriceOrBid_c20210101__20210331_zPQn2Ykwikbf"><ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">7.05</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 7%; text-align: right"><span id="xdx_903_ecef--LowestPriceOrBid_c20210101__20210331_z0X0WYhy0GJ2"><ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">6.07</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 7%; text-align: right"><span id="xdx_908_ecef--HighestPriceOrBidNav_c20210101__20210331_z8Oox7IO7Zy8"><ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">6.67</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 7%; text-align: right"><span id="xdx_908_ecef--LowestPriceOrBidNav_c20210101__20210331_zFPZu6PGhdAd"><ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.78</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 7%; text-align: right"><span id="xdx_906_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20210101__20210331_zIJIFvq2SpH"><ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">5.70</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: left">%</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 7%; text-align: right"><span id="xdx_909_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20210101__20210331_zr79rJHXn1vl"><ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">5.02</ix:nonFraction></span></td>
    <td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June&#160;30, 2021</span></td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_906_ecef--HighestPriceOrBid_c20210401__20210630_zPQuQX4DpsI8"><ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">7.54</ix:nonFraction></span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_904_ecef--LowestPriceOrBid_c20210401__20210630_zdKgIBEaWiod"><ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">6.67</ix:nonFraction></span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_90E_ecef--HighestPriceOrBidNav_c20210401__20210630_zmDs2s6AMPZ7"><ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">6.83</ix:nonFraction></span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_90F_ecef--LowestPriceOrBidNav_c20210401__20210630_zCCZghoylbIe"><ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">6.48</ix:nonFraction></span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_90F_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20210401__20210630_zTw4BtNgRaEi"><ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">10.40</ix:nonFraction></span></td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_90E_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20210401__20210630_zMN7j9sZH8j2"><ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">2.93</ix:nonFraction></span></td>
    <td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September&#160;30, 2021</span></td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_90B_ecef--HighestPriceOrBid_c20210701__20210930_zzvr1ezylsvc"><ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">7.07</ix:nonFraction></span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_902_ecef--LowestPriceOrBid_c20210701__20210930_zY58DLFzoE1h"><ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">6.52</ix:nonFraction></span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_907_ecef--HighestPriceOrBidNav_c20210701__20210930_zPd6uAzbLlC2"><ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">6.62</ix:nonFraction></span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_907_ecef--LowestPriceOrBidNav_c20210701__20210930_zw7HUFGq64Cf"><ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">6.26</ix:nonFraction></span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_901_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20210701__20210930_zLJwf5KEk0ab"><ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">6.80</ix:nonFraction></span></td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_90B_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20210701__20210930_z4UoR2cFdBT5"><ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">4.15</ix:nonFraction></span></td>
    <td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December&#160;31, 2021</span></td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_902_ecef--HighestPriceOrBid_c20211001__20211231_zGLSoRbSM8lc"><ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2021-10-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">7.37</ix:nonFraction></span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_909_ecef--LowestPriceOrBid_c20211001__20211231_zBLAut2UyUmh"><ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2021-10-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">6.64</ix:nonFraction></span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_90A_ecef--HighestPriceOrBidNav_c20211001__20211231_zDs7lTSCKwZ3"><ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2021-10-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">6.46</ix:nonFraction></span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_90E_ecef--LowestPriceOrBidNav_c20211001__20211231_z8I9QEE7a1r7"><ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2021-10-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">6.28</ix:nonFraction></span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_90E_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20211001__20211231_z0yVQnbUpBve"><ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2021-10-012021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">14.09</ix:nonFraction></span></td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_901_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20211001__20211231_zTo6Yc4VZWwa"><ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2021-10-012021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">5.73</ix:nonFraction></span></td>
    <td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March&#160;31, 2022</span></td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_909_ecef--HighestPriceOrBid_c20220101__20220331_zv4HL5aEACve"><ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">7.24</ix:nonFraction></span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_902_ecef--LowestPriceOrBid_c20220101__20220331_zxR7zHk2CYp2"><ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">6.76</ix:nonFraction></span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_90A_ecef--HighestPriceOrBidNav_c20220101__20220331_z6lMWfqijXi1"><ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">6.45</ix:nonFraction></span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_907_ecef--LowestPriceOrBidNav_c20220101__20220331_zN9OL4WO8H2b"><ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.79</ix:nonFraction></span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_906_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20220101__20220331_zlPFJwupSjKl"><ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">12.25</ix:nonFraction></span></td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_90D_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20220101__20220331_zfWHgDEsTlX1"><ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">16.75</ix:nonFraction></span></td>
    <td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June&#160;30, 2022</span></td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_901_ecef--HighestPriceOrBid_c20220401__20220630_zlkJuqKDvDw5"><ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">7.05</ix:nonFraction></span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_901_ecef--LowestPriceOrBid_c20220401__20220630_zPg6jvxDP6p4"><ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.54</ix:nonFraction></span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_90A_ecef--HighestPriceOrBidNav_c20220401__20220630_zGhosLxVmCI8"><ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.95</ix:nonFraction></span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_902_ecef--LowestPriceOrBidNav_c20220401__20220630_zhWE3h6l1TF1"><ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.73</ix:nonFraction></span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_904_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20220401__20220630_zNIQD6Tynh21"><ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">18.49</ix:nonFraction></span></td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_904_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20220401__20220630_zrzXcHRCTF3i"><ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">17.12</ix:nonFraction></span></td>
    <td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September&#160;30, 2022</span></td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_90D_ecef--HighestPriceOrBid_c20220701__20220930_zTtzoUDASF0e"><ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">6.53</ix:nonFraction></span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_90A_ecef--LowestPriceOrBid_c20220701__20220930_zR3OmP299GXh"><ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.50</ix:nonFraction></span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_905_ecef--HighestPriceOrBidNav_c20220701__20220930_zEOGYutkZT0b"><ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.37</ix:nonFraction></span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_900_ecef--LowestPriceOrBidNav_c20220701__20220930_zbSAdU003rdf"><ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.47</ix:nonFraction></span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_905_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20220701__20220930_z1aOixqVsh29"><ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">21.60</ix:nonFraction></span></td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_90B_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20220701__20220930_zxdTuOLQ1m89"><ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2022-07-012022-09-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">23.04</ix:nonFraction></span></td>
    <td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December&#160;31, 2022</span></td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_90C_ecef--HighestPriceOrBid_c20221001__20221231_zmVYoSoZ8YXd"><ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2022-10-012022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">6.16</ix:nonFraction></span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_906_ecef--LowestPriceOrBid_c20221001__20221231_zXbn6q1z8lz2"><ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2022-10-012022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.97</ix:nonFraction></span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_908_ecef--HighestPriceOrBidNav_c20221001__20221231_z0TJgXXgSpjb"><ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2022-10-012022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.53</ix:nonFraction></span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_909_ecef--LowestPriceOrBidNav_c20221001__20221231_zyCzlA3ua6K5"><ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2022-10-012022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.54</ix:nonFraction></span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_909_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20221001__20221231_z0hXHkWwbEib"><ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2022-10-012022-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">11.39</ix:nonFraction></span></td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_906_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20221001__20221231_zWKaFtTUWLqi"><ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2022-10-012022-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">9.47</ix:nonFraction></span></td>
    <td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March&#160;31, 2023</span></td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_907_ecef--HighestPriceOrBid_c20230101__20230331_zYunadAE1eLd"><ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.99</ix:nonFraction></span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_901_ecef--LowestPriceOrBid_c20230101__20230331_zspe6oXWVOI8"><ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.41</ix:nonFraction></span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_908_ecef--HighestPriceOrBidNav_c20230101__20230331_zlEkpfytnkk"><ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.53</ix:nonFraction></span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_90F_ecef--LowestPriceOrBidNav_c20230101__20230331_znwXeeucRXJh"><ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.93</ix:nonFraction></span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_90C_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20230101__20230331_zVtAhkL5VTCa"><ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">8.32</ix:nonFraction></span></td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_900_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20230101__20230331_zuIaNK8n2NBa"><ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">9.74</ix:nonFraction></span></td>
    <td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June&#160;30, 2023</span></td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_901_ecef--HighestPriceOrBid_c20230401__20230630_z5puDW6SZ4s3"><ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2023-04-012023-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.80</ix:nonFraction></span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_90B_ecef--LowestPriceOrBid_c20230401__20230630_zRotsob4VTD5"><ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2023-04-012023-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.33</ix:nonFraction></span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_90D_ecef--HighestPriceOrBidNav_c20230401__20230630_zCj0qKPeBH5"><ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2023-04-012023-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.30</ix:nonFraction></span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_907_ecef--LowestPriceOrBidNav_c20230401__20230630_zLCXSYO6Dn75"><ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2023-04-012023-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.02</ix:nonFraction></span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_908_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20230401__20230630_zAMyRtXxfAOl"><ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-04-012023-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">9.43</ix:nonFraction></span></td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_907_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20230401__20230630_zRGVi5tAyWF4"><ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-04-012023-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">6.18</ix:nonFraction></span></td>
    <td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September&#160;30, 2023</span></td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_90E_ecef--HighestPriceOrBid_c20230701__20230930_za93zKGKdmQ3"><ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2023-07-012023-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.87</ix:nonFraction></span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_908_ecef--LowestPriceOrBid_c20230701__20230930_zB6c0sskB8H6"><ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2023-07-012023-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.13</ix:nonFraction></span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_904_ecef--HighestPriceOrBidNav_c20230701__20230930_zbLscm2TjPD1"><ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2023-07-012023-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.30</ix:nonFraction></span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_909_ecef--LowestPriceOrBidNav_c20230701__20230930_zdo5Iufyj94i"><ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2023-07-012023-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.79</ix:nonFraction></span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_906_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20230701__20230930_zr9mrRNBlbOh"><ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-07-012023-09-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">10.75</ix:nonFraction></span></td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_905_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20230701__20230930_zUipaRuFO9qa"><ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-07-012023-09-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">7.10</ix:nonFraction></span></td>
    <td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December&#160;28, 2023, the last reported price for our common shares was $5.13 and the net asset value per share on December&#160;28, 2023 was $5.21 per share. Accordingly, our common stock traded at a discount to net asset value of -1.54% on December&#160;28, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund&#8217;s net asset value per share will be reduced immediately following the offering of common stock by the amount of the sales load and offering expenses paid by the Fund. See &#8220;Use of Proceeds.&#8221; Unlike open-end funds, closed-end funds like the Fund do not continuously offer shares and do not provide daily redemptions. Rather, if a stockholder determines to buy additional shares of common stock or sell shares already held, the stockholder may do so by trading through a broker on the NYSE or otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares of closed-end investment companies often trade on an exchange at prices lower than net asset value. The Fund&#8217;s shares of common stock have traded in the market at both premiums to and discounts from net asset value. Over the Fund&#8217;s thirty-seven year history, the range fluctuated from a 38% premium in 2002 to a 27% discount in 1987. Beginning in early 2001, the market price of the Fund exceeded the net asset value and this premium continued through September&#160;2005. The previous extended period over which the premium existed occurred during the twenty month period from August&#160;1993 to March&#160;1995. As of September&#160;30, 2023, the market price of the Fund closed at an approximate 7.1% premium to its net asset value. Because the market value of the common stock may be influenced by such factors as dividend and distribution levels (which are in turn affected by expenses), dividend and distribution stability, net asset value, market liquidity, relative demand for and supply of such shares in the market, unrealized gains, general market and economic conditions and other factors beyond the control of the Fund, the Fund cannot assure you that shares of common stock will trade at a price equal to or higher than net asset value in the future. The common stock is designed primarily for long term investors and you should not purchase the shares of the common stock if you intend to sell them soon after purchase.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund&#8217;s common stockholders vote together with the holders of preferred stock, as a single class, to elect the Fund&#8217;s Board (other than two directors elected exclusively by holders of the Fund&#8217;s preferred stock) and, except as described below, on additional matters with respect to which the 1940 Act, the Governing Documents or resolutions adopted by the Directors provide for a vote of the Fund&#8217;s common stockholders. Holders of the Fund&#8217;s preferred stock vote together as a single class to elect two of the directors of the Fund and vote together as a single class, separately from holders of the Fund&#8217;s common stock, to approve any plan of reorganization adversely affecting the preferred stock and to approve certain amendments to the Charter, whether by merger, consolidation or otherwise, that materially and adversely affect the contract rights of the existing preferred stock as set forth in the Charter. In addition, the affirmative vote of the holders of 66 &#x2154;% of the outstanding shares of each class of stock of the Fund normally entitled to vote in the election of directors, each such class voting as a separate class, is required to authorize the conversion of the Fund from a closed-end to an open-end investment company. See &#8220;Anti-Takeover Provisions of the Fund&#8217;s Governing Documents.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 28 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund may repurchase its shares of common stock from time to time as and when it deems such repurchase advisable from legally available funds, subject to rights of holders of the Fund&#8217;s outstanding preferred stock and maintaining required asset coverage for each series of outstanding preferred stock. The Board has adopted a policy to authorize such repurchases when the shares are trading at a discount of 10% or more (or such other percentage as the Board may determine from time to time) from the net asset value of the shares. Although the Board has authorized such repurchases, the Fund is not required to repurchase its shares. The policy does not limit the amount of common stock that can be repurchased. The percentage of the discount from net asset value at which share repurchases will be authorized may be changed at any time by the Board. Through December&#160;31, 2022, the Fund has not repurchased shares of its common stock under this authorization.</span></p>

</ix:nonNumeric></ix:nonNumeric><p id="xdx_81C_zBPJe3IzRDPe" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-12-292023-12-29_custom_PreferredSharesMember" escape="true" name="cef:OutstandingSecurityTitleTextBlock"><p id="xdx_80F_ecef--OutstandingSecurityTitleTextBlock_hcef--RiskAxis__custom--PreferredSharesMember_zk9q2j9Kjwu" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Preferred Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently, 32,975,100 shares of the Fund&#8217;s capital stock have been classified by the Board as preferred stock, par value $0.001 per share. The Fund&#8217;s Board may reclassify authorized and unissued shares of the Fund, including shares of capital stock previously classified as common stock, as preferred stock prior to the completion of any offering. The terms of each series of preferred stock may be fixed by the Board and may materially limit and/or qualify the rights of the holders of the Fund&#8217;s common stock. As of September&#160;30, 2023, the Fund had 2,492 outstanding shares of Series C Auction Rate Preferred, 1,108 outstanding shares of Series E Auction Rate Preferred, 2,572,905 outstanding shares of Series G Preferred, 4,116,414 outstanding shares of Series H Preferred, 3,887,650 outstanding shares of Series K Preferred and 685,500 outstanding shares of Series M Preferred. On December&#160;28, 2023, the Fund issued 147,750 shares of Series N Preferred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November&#160;16, 2023, the Fund commenced a tender offer for all of its outstanding Series C Auction Rate Preferred and Series E Auction Rate Preferred. The tender offer is scheduled to expire on January&#160;5, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Distributions on the Series C Auction Rate Preferred accumulate at a variable maximum rate based on short term rates. At present, the maximum rate is equal to 175% of the &#8220;AA&#8221; Financial Composite Commercial Paper Rate determined on each calculation date. Prior to the failing of auctions for the Fund&#8217;s Series C Auction Rate Preferred, these securities paid dividends set at a weekly auction. The liquidation preference of the Series C Auction Rate Preferred is $25,000 per share plus accumulated but unpaid dividends (whether or not earned or declared). The Fund generally may redeem the outstanding Series C Auction Rate Preferred, in whole or in part, at any time other than during a non-call period. The Series C Auction Rate Preferred is not traded on any public exchange.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Distributions on the Series E Auction Rate Preferred accumulate at a variable maximum rate based on short term rates. At present, the maximum rate is equal to 175% of the &#8220;AA&#8221; Financial Composite Commercial Paper Rate determined on each calculation date. Prior to the failing of auctions for the Fund&#8217;s Series E Auction Rate Preferred, these securities paid dividends set at a weekly auction. The liquidation preference of the Series E Auction Rate Preferred is $25,000 per share plus accumulated but unpaid dividends (whether or not earned or declared). The Fund generally may redeem the outstanding Series E Auction Rate Preferred, in whole or in part, at any time other than during a non-call period. The Series E Auction Rate Preferred is not traded on any public exchange.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Distributions on the Series G Preferred accumulate at an annual rate of 5.00% of the liquidation preference of $25 per share plus accumulated but unpaid dividends (whether or not earned or declared), are cumulative from the date of original issuance thereof, and are payable quarterly on March&#160;26, June&#160;26, September&#160;26 and December&#160;26 of each year. The Fund&#8217;s outstanding Series G Preferred is redeemable at the liquidation preference plus accumulated but unpaid dividends (whether or not earned or declared) through the date of redemption at the option of the Fund at any time. The Series G Preferred is listed and traded on the NYSE under the symbol &#8220;GAB PrG.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Distributions on the Series H Preferred accumulate at an annual rate of 5.00% of the liquidation preference of $25 per share plus accumulated but unpaid dividends (whether or not earned or declared), are cumulative from the date of original issuance thereof, and are payable quarterly on March&#160;26, June&#160;26, September&#160;26 and December&#160;26 of each year. The Fund&#8217;s outstanding Series H Preferred is redeemable at the liquidation preference plus accumulated but unpaid dividends (whether or not earned or declared) through the date of redemption at the option of the Fund at any time. The Series H Preferred is listed and traded on the NYSE under the symbol &#8220;GAB PrH.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 29 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Distributions on the Series K Preferred accumulate at an annual rate of 5.00% of the liquidation preference of $25 per share plus accumulated but unpaid dividends (whether or not earned or declared), are cumulative from the date of original issuance thereof, and are payable quarterly on March&#160;26, June&#160;26, September&#160;26 and December&#160;26 of each year. The Fund&#8217;s outstanding Series K Preferred is redeemable at the liquidation preference plus accumulated but unpaid dividends (whether or not earned or declared) through the date of redemption at the option of the Fund following the expiration of the five year call protection on December&#160;16, 2024. The Series K Preferred is listed and traded on the NYSE under the symbol &#8220;GAB PrK.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Distributions on the Series M Preferred accumulate at an annual rate of 4.25% of the liquidation preference of $100 per share plus accumulated but unpaid dividends (whether or not earned or declared), are cumulative from the date of original issuance thereof, and are payable quarterly on March&#160;26, June&#160;26, September&#160;26 and December&#160;26 of each year. The Fund&#8217;s outstanding Series M Preferred is puttable during the 60-day period prior to March&#160;26, 2027, is callable at our option upon not less than 30 nor more than 60 days&#8217; prior notice at any time commencing on December&#160;26, 2027 and thereafter, and is subject to mandatory redemption by the Fund on March&#160;26, 2032, in each case at the liquidation preference, plus any accumulated and unpaid dividends. The Series M Preferred is not traded on any public exchange.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Distributions
on the Series N Preferred accumulate at an annual rate of 5.25% of the liquidation preference of $100 per share plus accumulated but
unpaid dividends (whether or not earned or declared), are  cumulative from the date of original issuance thereof, and are
payable semiannually June&#160;26 and December&#160;26 of each year, commencing on June&#160;26, 2024. The Fund&#8217;s outstanding
Series N Preferred is puttable during the 60-day period prior to each of June&#160;26, 2024 and December&#160;26, 2024, and is
callable at our option upon 30 days&#8217; prior notice at any time commencing on December&#160;26, 2024 and thereafter, and is
subject to mandatory redemption by the Fund on December&#160;26, 2025, in each case at the liquidation preference, plus any
accumulated and unpaid dividends. The Series N Preferred is not traded on any public exchange.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the Fund issues any additional series of preferred stock, it will pay dividends to the holders at either a fixed rate or a rate that will be reset, as described in the Prospectus Supplement accompanying each preferred stock offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="AsOf2023-12-29" escape="true" name="cef:OutstandingSecuritiesTableTextBlock"><p id="xdx_898_ecef--OutstandingSecuritiesTableTextBlock_zO0dEgMIKJJh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table shows (i) the classes of capital stock authorized, (ii) the number of shares outstanding in each class, and (iii) the number of shares authorized in each class as of December&#160;18, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: left">Title of Class</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount<br /> Outstanding</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount<br /> Authorized</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td id="xdx_987_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--CommonSharesMember_zKVbTqM1GdG3" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"><ix:nonNumeric contextRef="From2023-12-292023-12-29_custom_CommonSharesMember" escape="true" name="cef:OutstandingSecurityTitleTextBlock">Common Stock</ix:nonNumeric></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td id="xdx_982_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--CommonSharesMember_zcv9EQE2V2N3" style="width: 9%; text-align: right"><ix:nonFraction name="cef:OutstandingSecurityHeldShares" contextRef="From2023-12-292023-12-29_custom_CommonSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">300,659,233</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td id="xdx_98B_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--CommonSharesMember_z7rW8DmoFDNb" style="width: 9%; text-align: right"><ix:nonFraction name="cef:OutstandingSecurityAuthorizedShares" contextRef="From2023-12-292023-12-29_custom_CommonSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">337,024,900</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_985_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--SeriesCPreferredSharesMember_fKDEp_zr5cmvWrTL49" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><ix:nonNumeric contextRef="From2023-12-292023-12-29_custom_SeriesCPreferredSharesMember" escape="true" id="Fact000421" name="cef:OutstandingSecurityTitleTextBlock"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series C Auction Rate Preferred<sup>(1)</sup></span></ix:nonNumeric></td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_98E_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--SeriesCPreferredSharesMember_fKDEp_zt1dQ1BB79r2" style="text-align: right"><ix:nonFraction name="cef:OutstandingSecurityHeldShares" contextRef="From2023-12-292023-12-29_custom_SeriesCPreferredSharesMember" id="Fact000422" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,492</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_98A_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--SeriesCPreferredSharesMember_fKDEp_z1mvkGKtneRe" style="text-align: right"><ix:nonFraction name="cef:OutstandingSecurityAuthorizedShares" contextRef="From2023-12-292023-12-29_custom_SeriesCPreferredSharesMember" id="Fact000423" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,812</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td id="xdx_989_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--SeriesDPreferredSharesMember_fKDIp_zy6XRIylzwf2" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><ix:nonNumeric contextRef="From2023-12-292023-12-29_custom_SeriesDPreferredSharesMember" escape="true" id="Fact000424" name="cef:OutstandingSecurityTitleTextBlock"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.875% Series D Cumulative Preferred Stock (the &#8220;Series D Preferred&#8221;)<sup>(2)</sup></span></ix:nonNumeric></td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_981_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--SeriesDPreferredSharesMember_fKDIp_zgppFgOEUkz7" style="text-align: right"><ix:nonFraction name="cef:OutstandingSecurityHeldShares" contextRef="From2023-12-292023-12-29_custom_SeriesDPreferredSharesMember" id="Fact000425" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_985_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--SeriesDPreferredSharesMember_fKDIp_zxOfKDmTMaJh" style="text-align: right"><ix:nonFraction name="cef:OutstandingSecurityAuthorizedShares" contextRef="From2023-12-292023-12-29_custom_SeriesDPreferredSharesMember" id="Fact000426" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">636,140</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_98E_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--SeriesEPreferredSharesMember_fKDEp_zbqKO6rCTlLg" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><ix:nonNumeric contextRef="From2023-12-292023-12-29_custom_SeriesEPreferredSharesMember" escape="true" id="Fact000427" name="cef:OutstandingSecurityTitleTextBlock"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series E Auction Rate Preferred<sup>(1)</sup></span></ix:nonNumeric></td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_981_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--SeriesEPreferredSharesMember_fKDEp_zYQIY8RwemW1" style="text-align: right"><ix:nonFraction name="cef:OutstandingSecurityHeldShares" contextRef="From2023-12-292023-12-29_custom_SeriesEPreferredSharesMember" id="Fact000428" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,108</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_98F_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--SeriesEPreferredSharesMember_fKDEp_zVQJpILax6a4" style="text-align: right"><ix:nonFraction name="cef:OutstandingSecurityAuthorizedShares" contextRef="From2023-12-292023-12-29_custom_SeriesEPreferredSharesMember" id="Fact000429" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,988</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td id="xdx_980_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--SeriesGPreferredSharesMember_zuokzI2UEO35" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><ix:nonNumeric contextRef="From2023-12-292023-12-29_custom_SeriesGPreferredSharesMember" escape="true" name="cef:OutstandingSecurityTitleTextBlock">Series G Preferred</ix:nonNumeric></td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_98F_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--SeriesGPreferredSharesMember_zZQYulGfeP08" style="text-align: right"><ix:nonFraction name="cef:OutstandingSecurityHeldShares" contextRef="From2023-12-292023-12-29_custom_SeriesGPreferredSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,520,627</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_98C_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--SeriesGPreferredSharesMember_zQvVudRpnmLh" style="text-align: right"><ix:nonFraction name="cef:OutstandingSecurityAuthorizedShares" contextRef="From2023-12-292023-12-29_custom_SeriesGPreferredSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,959,830</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_983_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--SeriesHPreferredSharesMember_z8kju9w66ue9" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><ix:nonNumeric contextRef="From2023-12-292023-12-29_custom_SeriesHPreferredSharesMember" escape="true" name="cef:OutstandingSecurityTitleTextBlock">Series H Preferred</ix:nonNumeric></td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_989_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--SeriesHPreferredSharesMember_zZPRfpRck7m8" style="text-align: right"><ix:nonFraction name="cef:OutstandingSecurityHeldShares" contextRef="From2023-12-292023-12-29_custom_SeriesHPreferredSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,083,160</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_985_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--SeriesHPreferredSharesMember_zY3FrYEZN685" style="text-align: right"><ix:nonFraction name="cef:OutstandingSecurityAuthorizedShares" contextRef="From2023-12-292023-12-29_custom_SeriesHPreferredSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,109,167</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td id="xdx_98C_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--SeriesJPreferredSharesMember_fKDMp_zti0TaJNrMp3" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><ix:nonNumeric contextRef="From2023-12-292023-12-29_custom_SeriesJPreferredSharesMember" escape="true" id="Fact000436" name="cef:OutstandingSecurityTitleTextBlock"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.45% Series J Cumulative Preferred Stock (the &#8220;Series J Preferred&#8221;)<sup>(3)</sup></span></ix:nonNumeric></td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_98D_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--SeriesJPreferredSharesMember_fKDMp_zJIDGKAacer4" style="text-align: right"><ix:nonFraction name="cef:OutstandingSecurityHeldShares" contextRef="From2023-12-292023-12-29_custom_SeriesJPreferredSharesMember" id="Fact000437" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_98D_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--SeriesJPreferredSharesMember_fKDMp_zp6hcx1szaY3" style="text-align: right"><ix:nonFraction name="cef:OutstandingSecurityAuthorizedShares" contextRef="From2023-12-292023-12-29_custom_SeriesJPreferredSharesMember" id="Fact000438" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,300,000</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_983_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--SeriesKPreferredSharesMember_zsVvgQAlAHR" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><ix:nonNumeric contextRef="From2023-12-292023-12-29_custom_SeriesKPreferredSharesMember" escape="true" name="cef:OutstandingSecurityTitleTextBlock">Series K Preferred</ix:nonNumeric></td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_981_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--SeriesKPreferredSharesMember_zhucs1J6Nf5l" style="text-align: right"><ix:nonFraction name="cef:OutstandingSecurityHeldShares" contextRef="From2023-12-292023-12-29_custom_SeriesKPreferredSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,813,640</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_981_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--SeriesKPreferredSharesMember_zfJMUPLjDnxc" style="text-align: right"><ix:nonFraction name="cef:OutstandingSecurityAuthorizedShares" contextRef="From2023-12-292023-12-29_custom_SeriesKPreferredSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,813,640</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td id="xdx_981_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--SeriesMPreferredSharesMember_ze9EHkEuyjoh" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><ix:nonNumeric contextRef="From2023-12-292023-12-29_custom_SeriesMPreferredSharesMember" escape="true" name="cef:OutstandingSecurityTitleTextBlock">Series M Preferred</ix:nonNumeric></td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_989_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--SeriesMPreferredSharesMember_zLXgIyIT3Bfj" style="text-align: right"><ix:nonFraction name="cef:OutstandingSecurityHeldShares" contextRef="From2023-12-292023-12-29_custom_SeriesMPreferredSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">685,500</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_986_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--SeriesMPreferredSharesMember_zOlp3NekX1Xa" style="text-align: right"><ix:nonFraction name="cef:OutstandingSecurityAuthorizedShares" contextRef="From2023-12-292023-12-29_custom_SeriesMPreferredSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_988_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--SeriesNPreferredSharesMember_fKDQp_zcVA0VGv5dj" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><ix:nonNumeric contextRef="From2023-12-292023-12-29_custom_SeriesNPreferredSharesMember" escape="true" id="Fact000445" name="cef:OutstandingSecurityTitleTextBlock"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series N Preferred<sup>(4)</sup></span></ix:nonNumeric></td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_988_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--SeriesNPreferredSharesMember_fKDQp_z7bJ0UCCnRB1" style="text-align: right"><ix:nonFraction name="cef:OutstandingSecurityHeldShares" contextRef="From2023-12-292023-12-29_custom_SeriesNPreferredSharesMember" id="Fact000446" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_984_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--SeriesNPreferredSharesMember_fKDQp_zambtTnL1GK3" style="text-align: right"><ix:nonFraction name="cef:OutstandingSecurityAuthorizedShares" contextRef="From2023-12-292023-12-29_custom_SeriesNPreferredSharesMember" id="Fact000447" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">350,000</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td id="xdx_981_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--PreferredShareMember_fKDUp_zOhGvNFx41He" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><ix:nonNumeric contextRef="From2023-12-292023-12-29_custom_PreferredShareMember" escape="true" id="Fact000448" name="cef:OutstandingSecurityTitleTextBlock"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred Stock<sup>(5)</sup></span></ix:nonNumeric></td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_981_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--PreferredSharesMember_fKDUp_zQnRN00lu7H4" style="text-align: right"><ix:nonFraction name="cef:OutstandingSecurityHeldShares" contextRef="From2023-12-292023-12-29_custom_PreferredSharesMember" id="Fact000449" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_98B_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--PreferredSharesMember_fKDUp_znXyVFL7CTCf" style="text-align: right"><ix:nonFraction name="cef:OutstandingSecurityAuthorizedShares" contextRef="From2023-12-292023-12-29_custom_PreferredSharesMember" id="Fact000450" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">18,799,523</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F06_zC8C67MHA0l8">(1)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span id="xdx_F16_zTt5jbBZjG64" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000451" xml:lang="en-US">The Fund commenced a tender offer for all of its outstanding Series C Auction Rate Preferred and Series E Auction Rate Preferred on November&#160;16, 2023. The tender offer is scheduled to expire on January&#160;5, 2024.</ix:footnote></span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F01_zFaEaP71LMtf">(2)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span id="xdx_F10_zebcZKHFTBtj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000452" xml:lang="en-US">The Fund redeemed all of its outstanding Series D Preferred on December&#160;26, 2019.</ix:footnote></span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F00_zKUL6PUiZT1j">(3)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span id="xdx_F1C_zy4U0XwRlpqb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000453" xml:lang="en-US">The Fund redeemed all of its outstanding Series J Preferred on January&#160;31, 2022.</ix:footnote></span></td> </tr>
  </table>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 30 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left; text-indent: 0in; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F0A_znGbxbrpUrph">(4)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span id="xdx_F13_zEZPV1JdEGt3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000454" xml:lang="en-US">On December&#160;1, 2023, the Fund&#8217;s Board approved an offering of up to 350,000 shares of the Series N Preferred for an aggregate maximum offering amount of up to $35,000,000. On December&#160;12, 2023, the Fund filed Articles Supplementary with the State Department of Assessments and Taxation of Maryland classifying and designating 350,000 shares of preferred stock, without further designation as to class or series, as shares of Series N Preferred. The Series N Preferred are not registered under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), or listed on a securities exchange. The Fund issued 147,750 Series N Preferred in an initial closing for the offering of the Series N Preferred on December&#160;28, 2023.</ix:footnote></span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F04_zWBR6q3wGmIh">(5)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span id="xdx_F1C_zHGrLoGacqd2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000455" xml:lang="en-US">&#8220;Preferred Stock&#8221; refers to the Fund&#8217;s authorized and unissued shares of preferred stock without further designation as to class or series.</ix:footnote></span></td> </tr>
  </table>

</ix:nonNumeric><p id="xdx_8AB_zPCX9UiFHhP8" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of October&#160;31, 2023, the Fund did not hold any shares of capital stock for its account. Upon a liquidation, each holder of preferred stock will be entitled to receive out of the assets of the Fund available for distribution to stockholders (after payment of claims of the Fund&#8217;s creditors but before any distributions with respect to the Fund&#8217;s common stock or any other class of capital stock of the Fund ranking junior to the preferred stock as to liquidation payments) an amount per share equal to such share&#8217;s liquidation preference plus any accumulated but unpaid distributions (whether or not earned or declared, excluding interest thereon) to the date of distribution, and such stockholders shall be entitled to no further participation in any distribution or payment in connection with such liquidation. Each series of preferred stock ranks on a parity with all other series of preferred stock of the Fund as to the payment of distributions and the distribution of assets upon liquidation, and is junior to the Fund&#8217;s obligations with respect to any outstanding senior securities representing debt. The preferred stock carries one vote per share on all matters on which such shares are entitled to vote. The issued and outstanding preferred stock is fully paid and non-assessable and has no preemptive, exchange or conversion rights. The Board may by resolution classify or reclassify any authorized but unissued shares of stock of the Fund from time to time by setting or changing the preferences, conversion or other rights, voting powers, restrictions, limitations as to dividends or other distributions and terms and conditions of redemption. The Fund will not issue any class of capital stock senior to the preferred stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Rating Agency Guidelines</i>. New issuances of shares of preferred stock may, but are not required to, be issued with a specified rating by a nationally recognized statistical rating organization. To the extent the Fund seeks a rating agency for its shares of preferred stock, the Fund expects that it will be required under Moody&#8217;s and Fitch guidelines to maintain assets having in the aggregate a discounted value at least equal to the Basic Maintenance Amount (as defined below) for its outstanding preferred stock with respect to the separate guidelines Moody&#8217;s and Fitch has each established for determining discounted value. To the extent any particular portfolio holding does not satisfy the applicable rating agency&#8217;s guidelines, all or a portion of such holding&#8217;s value will not be included in the calculation of discounted value (as defined by such rating agency). The Moody&#8217;s and Fitch guidelines also impose certain diversification requirements and industry concentration limitations on the Fund&#8217;s overall portfolio, and apply specified discounts to securities held by the Fund (except certain money market securities). The &#8220;Basic Maintenance Amount&#8221; is calculated as set out in the organizational documents for each series of preferred stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the Fund does not cure in a timely manner a failure to maintain a discounted value of its portfolio equal to the Basic Maintenance Amount in accordance with the requirements of the applicable rating agency or agencies then rating the preferred stock at the request of the Fund, the Fund may, and in certain circumstances will be required to, mandatorily redeem preferred stock, as described below under &#8220;&#8212;Redemption.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund may, but is not required to, adopt any modifications to the rating agency guidelines that may hereafter be established by Moody&#8217;s and Fitch. Failure to adopt any such modifications, however, may result in a change in the relevant rating agency&#8217;s ratings or a withdrawal of such ratings altogether. In addition, any rating agency providing a rating for the preferred stock at the request of the Fund may, at any time, change or withdraw any such rating. The Board, without further action by the stockholders, may amend, alter, add to or repeal certain of the definitions and related provisions that have been adopted by the Fund pursuant to the rating agency guidelines if the Board determines that such modification is necessary to prevent a reduction in rating of the preferred stock by Moody&#8217;s and Fitch, as the case may be, is in the best interests of the holders of common stock and is not adverse to the holders of preferred stock in view of advice to the Fund by Moody&#8217;s and Fitch (or such other rating agency then rating the preferred stock at the request of the Fund) that such modification would not adversely affect, as the case may be, its then current rating of the preferred stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 31 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As described by Moody&#8217;s and Fitch, the ratings assigned to each series of preferred stock are assessments of the capacity and willingness of the Fund to pay the obligations of each such series. The ratings on these series of preferred stock are not recommendations to purchase, hold or sell shares of any series, inasmuch as the ratings do not comment as to market price or suitability for a particular investor. The rating agency guidelines also do not address the likelihood that an owner of preferred stock will be able to sell such shares on an exchange, in an auction or otherwise. The ratings are based on current information furnished to Moody&#8217;s and Fitch by the Fund and the Investment Adviser and information obtained from other sources. The ratings may be changed, suspended or withdrawn as a result of changes in, or the unavailability of, such information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The rating agency guidelines apply to each series of preferred stock only so long as such rating agency is rating such series at the request of the Fund. The Fund pays fees to Moody&#8217;s and Fitch for rating the preferred stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Asset Maintenance Requirements</i>. In addition to the requirements summarized under &#8220;&#8212;Rating Agency Guidelines&#8221; above, the Fund must also satisfy asset maintenance requirements under the 1940 Act with respect to its preferred stock. Under the 1940 Act, debt or additional preferred stock may be issued only if immediately after such issuance the value of the Fund&#8217;s total assets (less ordinary course liabilities) is at least 300% of the amount of any debt outstanding and at least 200% of the amount of any preferred stock and debt outstanding. The Fund is required under the applicable Articles Supplementary to determine whether it has, as of the last business day of each March, June, September and December of each year (for its Series E Auction Rate Preferred, Series H Preferred, Series K Preferred, Series M Preferred and Series N Preferred), at the time the Fund declares or pays any dividend or distribution on its common stock (other than a dividend payable solely in shares of common stock) and at the time the Fund purchases any of its common stock (for its Series G Preferred), and as of the last business day of each week (for its Series C Auction Rate Preferred), an &#8220;asset coverage&#8221; (as defined in the 1940 Act) of at least 200% (or such higher or lower percentage as may be required at the time under the 1940 Act) with respect to all outstanding senior securities of the Fund that are debt or stock, including any outstanding preferred stock. If the Fund fails to maintain the asset coverage required under the 1940 Act on such dates and such failure is not cured on or before 60 days, in the case of the Fixed Rate Preferred Stock, or 10 business days, in the case of the Auction Rate Preferred Stock, the Fund may, and in certain circumstances will be required to, mandatorily redeem the minimum number of shares of preferred stock sufficient to satisfy such asset coverage. See &#8220;&#8212;Redemption&#8221; below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Distributions</i>. In connection with the offering of one or more additional series of preferred stock, an accompanying Prospectus Supplement will specify whether dividends on such preferred stock will be based on a constant fixed rate or on a fixed rate that changes after an initial period (e.g., one year). Holders of additional shares of such &#8220;Fixed Rate Preferred Stock&#8221; will be entitled to receive, out of funds legally available therefor, cumulative cash distributions, at an annual rate set forth in the applicable Prospectus Supplement, payable with such frequency as set forth in the applicable Prospectus Supplement. Such distributions will accumulate from the date on which such shares are issued.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Restrictions on Dividends and Other Distributions for the Preferred Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">So long as any preferred stock is outstanding, the Fund may not pay any dividend or other distribution (other than a dividend or other distribution paid in common stock or in options, warrants or rights to subscribe for or purchase common stock) in respect of the common stock or call for redemption, redeem, purchase or otherwise acquire for consideration any common stock (except by conversion into or exchange for shares of the Fund ranking junior to the preferred stock as to the payment of dividends or distributions and the distribution of assets upon liquidation), unless:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Fund has declared and paid (or provided to the relevant dividend paying agent) all cumulative distributions on the Fund&#8217;s outstanding preferred stock due on or prior to the date of such common stock dividend or distribution;</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Fund has redeemed the full number of shares of preferred stock to be redeemed pursuant to any mandatory redemption provision in the Fund&#8217;s Governing Documents; and</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">after making the distribution, the Fund meets applicable asset coverage requirements described under &#8220;&#8212;Rating Agency Guidelines&#8221; and &#8220;&#8212;Asset Maintenance Requirements.&#8221;</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 32 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No full distribution will be declared or made on any series of preferred stock for any dividend period, or part thereof, unless full cumulative distributions due through the most recent dividend payment dates therefor for all outstanding series of preferred stock of the Fund ranking on a parity with such series as to distributions have been or contemporaneously are declared and made. If full cumulative distributions due have not been made on all outstanding preferred stock of the Fund ranking on a parity with such series of preferred stock as to the payment of distributions, any distributions being paid on the preferred stock will be paid as nearly pro rata as possible in proportion to the respective amounts of distributions accumulated but unmade on each such series of preferred stock on the relevant dividend payment date. The Fund&#8217;s obligation to make distributions on the preferred stock will be subordinate to its obligations to pay interest and principal, when due, on any senior securities representing debt.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Redemption</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Mandatory Redemption Relating to Asset Coverage Requirements.</i> The Fund may, at its option, consistent with its Governing Documents and the 1940 Act, and in certain circumstances will be required to, mandatorily redeem preferred stock in the event that:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Fund fails to maintain the asset coverage requirements specified under the 1940 Act on a quarterly valuation date and such failure is not cured on or before 60 days, in the case of the existing Fixed Rate Preferred Stock, following such failure; or</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Fund fails to maintain the asset coverage requirements as calculated in accordance with the applicable rating agency guidelines as of any monthly valuation date, and such failure is not cured on or before 10 business days after such valuation date.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The redemption price for preferred stock subject to mandatory redemption will be the liquidation preference, as stated in the Articles Supplementary of each existing series of preferred stock or the Prospectus Supplement accompanying the issuance of any additional series of preferred stock, including an amount equal to any accumulated but unpaid distributions (whether or not earned or declared) to the date fixed for redemption.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The number of shares of preferred stock that will be redeemed in the case of a mandatory redemption will equal the minimum number of outstanding shares of preferred stock, the redemption of which, if such redemption had occurred immediately prior to the opening of business on the applicable cure date, would have resulted in the relevant asset coverage requirement having been met or, if the required asset coverage cannot be so restored, all of the shares of preferred stock. In the event that shares of preferred stock are redeemed due to a failure to satisfy the 1940 Act asset coverage requirements, the Fund may, but is not required to, redeem a sufficient number of shares of preferred stock so that the Fund&#8217;s assets exceed the asset coverage requirements under the 1940 Act after the redemption by 10% (that is, 210% asset coverage). In the event that shares of preferred stock are redeemed due to a failure to satisfy applicable rating agency guidelines, the Fund may, but is not required to, redeem a sufficient number of shares of preferred stock so that the Fund&#8217;s discounted portfolio value (as determined in accordance with the applicable rating agency guidelines) after redemption exceeds the asset coverage requirements of each applicable rating agency by up to 10% (that is, 110% rating agency asset coverage).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the Fund does not have funds legally available for the redemption of, or is otherwise unable to redeem, all the shares of preferred stock to be redeemed on any redemption date, the Fund will redeem on such redemption date that number of shares for which it has legally available funds, or is otherwise able to redeem, from the holders whose shares are to be redeemed ratably on the basis of the redemption price of such shares, and the remainder of those shares to be redeemed will be redeemed on the earliest practicable date on which the Fund will have funds legally available for the redemption of, or is otherwise able to redeem, such shares upon written notice of redemption.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If fewer than all shares of the Fund&#8217;s outstanding preferred stock are to be redeemed, the Fund, at its discretion and subject to the limitations of the Charter, the 1940 Act, and Maryland law, will select one or more series of preferred stock from which shares will be redeemed and the amount of preferred stock to be redeemed from each such series. If fewer than all shares of a series of preferred stock are to be redeemed, such redemption will be made as among the holders of that series pro rata in accordance with the respective number of shares of such series held by each such holder on the record date for such redemption. If fewer than all shares of preferred stock held by any holder are to be redeemed, the notice of redemption mailed to such holder will specify the number of shares to be redeemed from such holder, which may be expressed as a percentage of shares held on the applicable record date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 33 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Optional Redemption of Fixed Rate Preferred Stock</i>. Shares of any additional series of Fixed Rate Preferred Stock will not be subject to optional redemption by the Fund until the date, if any, specified in the applicable Prospectus or Prospectus Supplement, unless such redemption is necessary, in the judgment of the Fund, to maintain the Fund&#8217;s status as a regulated investment company under the Code. Commencing on such date and thereafter, the Fund may at any time redeem such Fixed Rate Preferred Stock in whole or in part for cash at a redemption price per share equal to the liquidation preference per share plus accumulated and unpaid distributions (whether or not earned or declared) to the redemption date. Such redemptions are subject to the notice requirements set forth under &#8220;&#8212;Redemption Procedures&#8221; and the limitations of the Charter, the 1940 Act and Maryland law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Redemption Procedures</i>. A notice of redemption with respect to an optional redemption will be given to the holders of record of preferred stock selected for redemption not less than (a) 15 days (subject to NYSE requirements), nor more than 40 days prior (in the case of the Series H Preferred, Series K Preferred, Series G Preferred, Series C Auction Rate Preferred, Series J Preferred, Series D Preferred, and Series F Preferred), (b) not less than 7 days, not more than 40 days prior (in the case of the Series E Auction Rate Preferred), (c) not less than 30 days, nor more than 60 days prior (in the case of the Series M Preferred) or (d) 30 days prior (in the case of the Series N Preferred) to the date fixed for redemption. Preferred stockholders may receive shorter notice in the event of a mandatory redemption. Each notice of redemption will state (i) the redemption date, (ii) the number or percentage of shares of preferred stock to be redeemed (which may be expressed as a percentage of such shares outstanding), (iii) the CUSIP number(s) of such shares, (iv) the redemption price (specifying the amount of accumulated distributions to be included therein), (v) the place or places where such shares are to be redeemed, (vi) that distributions on the shares to be redeemed will cease to accrue on such redemption date, (vii) the provision of the Articles Supplementary for the applicable series of preferred stock under which the redemption is being made and (viii) (except in the case of the Series C Auction Rate Preferred) any conditions precedent to such redemption. No defect in the notice of redemption or in the mailing thereof will affect the validity of the redemption proceedings, except as required by applicable law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The holders of preferred stock, whether subject to a variable or fixed rate, will not have the right to redeem any of their shares at their option, unless specifically provided in the Charter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liquidation Preference</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Fund, the holders of preferred stock then outstanding will be entitled to receive a preferential liquidating distribution, which is expected to equal the original purchase price per share of preferred stock plus accumulated and unpaid dividends, whether or not earned or declared, before any distribution of assets is made to holders of common stock. After payment of the full amount of the liquidating distribution to which they are entitled, the holders of preferred stock will not be entitled to any further participation in any distribution of assets by the Fund.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Voting Rights</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except as otherwise stated in this Prospectus, specified in the Charter or resolved by the Board or as otherwise required by applicable law, holders of preferred stock shall be entitled to one vote per share held on each matter submitted to a vote of the stockholders of the Fund and will vote together with holders of common stock and of any other preferred stock then outstanding as a single class.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the election of the Fund&#8217;s Directors, holders of the outstanding shares of preferred stock, voting together as a separate class, will be entitled at all times to elect two of the Fund&#8217;s Directors, and the remaining Directors will be elected by holders of common stock and holders of preferred stock, voting together as a single class. In addition, if (i) at any time dividends and distributions on outstanding shares of preferred stock are unpaid in an amount equal to at least two full years&#8217; dividends and distributions thereon and sufficient cash or specified securities have not been deposited with the applicable paying agent for the payment of such accumulated dividends and distributions or (ii) at any time holders of any other series of preferred stock are entitled to elect a majority of the Directors of the Fund under the 1940 Act or the applicable Articles Supplementary creating such shares, then the number of Directors constituting the Board automatically will be increased by the smallest number that, when added to the two Directors elected exclusively by the holders of preferred stock as described above, would then constitute a simple majority of the Board as so increased by such smallest number. Such additional Directors will be elected by</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 34 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the holders of the outstanding shares of preferred stock, voting together as a separate class, at a special meeting of stockholders which will be called as soon as practicable and will be held not less than ten nor more than twenty days after the mailing date of the meeting notice. If the Fund fails to send such meeting notice or to call such a special meeting, the meeting may be called by any preferred stockholder on like notice. The terms of office of the persons who are Directors at the time of that election will continue. If the Fund thereafter pays, or declares and sets apart for payment in full, all dividends and distributions payable on all outstanding shares of preferred stock for all past dividend periods or the holders of other series of preferred stock are no longer entitled to elect such additional Directors, the additional voting rights of the holders of the preferred stock as described above will cease, and the terms of office of all of the additional Directors elected by the holders of the preferred stock (but not of the Directors with respect to whose election the holders of common stock were entitled to vote or the two Directors the holders of preferred stock have the right to elect as a separate class in any event) will terminate at the earliest time permitted by law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">So long as shares of preferred stock are outstanding, the Fund will not, without the affirmative vote of the holders of a majority (as defined in the 1940 Act) of the shares of preferred stock outstanding at the time, and present and voting on such matter, voting together as a separate class, amend, alter or repeal the provisions of the Charter whether by merger, consolidation or otherwise, so as to materially and adversely affect any of the rights, preferences or powers expressly set forth in the Charter with respect to such shares of preferred stock, unless the Fund obtains written confirmation from Moody&#8217;s, Fitch or any such other rating agency then rating the preferred stock that such amendment, alteration or repeal would not impair the rating then assigned by such rating agency to the preferred stock, in which case the vote or consent of the holders of the preferred stock is not required. Also, to the extent permitted under the 1940 Act, in the event shares of more than one series of preferred stock are outstanding, the Fund will not approve any action that materially and adversely affects the rights, preferences or powers expressly set forth in the Charter with respect to such shares of a series of preferred stock differently than those of shares of any other series of preferred stock without the affirmative vote of the holders of at least a majority, as defined in the 1940 Act, of the outstanding shares of preferred stock of each series materially adversely affected and outstanding at such time (each such materially adversely affected series voting as a separate class to the extent its rights are affected differently). For purposes of this paragraph, no matter shall be deemed to adversely affect any right, preference or power unless such matter (i) adversely alters or abolishes any preferential right of such series; (ii) creates, adversely alters or abolishes any right in respect of redemption of such series; or (iii) creates or adversely alters (other than to abolish) any restriction on transfer applicable to such series.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the Charter and applicable provisions of the 1940 Act and Maryland law, the affirmative vote of the holders of a majority, as defined under the 1940 Act, of the outstanding shares of the preferred stock, voting together as a separate class, will be required to approve any plan of reorganization adversely affecting the preferred stock or any action requiring a vote of security holders under Section&#160;13(a) of the 1940 Act (other than a conversion of the Fund from a closed-end to an open-end investment company), including, among other things, changes in the Fund&#8217;s investment objectives or changes in the investment restrictions described as fundamental policies under &#8220;Investment Objectives and Policies&#8221; in this Prospectus and the SAI, &#8220;How the Fund Manages Risk&#8212;Investment Restrictions&#8221; in this Prospectus and &#8220;Investment Restrictions&#8221; in the SAI. Under the Charter, the affirmative vote of the holders of 66 &#x2154;% of the outstanding shares of each class of stock of the Fund normally entitled to vote in the election of directors, each such class voting as a separate class, is required to authorize the conversion of the Fund from a closed-end to an open-end investment company. For purposes of this paragraph, except as otherwise required under the 1940 Act, the vote of the holders of a majority of the outstanding shares of preferred stock means, in accordance with Section&#160;2(a)(42) of the 1940 Act, the vote, at the annual or a special meeting of the stockholders of the Fund duly called (i) of 67% or more of the shares of preferred stock present at such meeting, if the holders of more than 50% of the outstanding shares of preferred stock are present or represented by proxy, or (ii) more than 50% of the outstanding shares of preferred stock, whichever is less. The class vote of holders of preferred stock described above will in each case be in addition to any other approvals by shareholders that may be required under the 1940 Act to authorize the action in question.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The calculation of the elements and definitions of certain terms of the rating agency guidelines may be modified by action of the Board without further action by the stockholders if the Board determines that such modification is necessary to prevent a reduction in rating of the shares of preferred stock by Moody&#8217;s and/or Fitch (or such other rating agency then rating the preferred stock at the request of the Fund), as the case may be, or is in the best interests of the holders of common stock and is not adverse to the holders of preferred stock in view of advice to the Fund by the relevant rating agencies that such modification would not adversely affect its then-current rating of the preferred stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 35 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The foregoing voting provisions will not apply to any series of preferred stock if, at or prior to the time when the act with respect to which such vote otherwise would be required will be effected, such stock will have been redeemed or called for redemption and sufficient cash or cash equivalents provided to the applicable paying agent to effect such redemption. The holders of preferred stock will have no preemptive rights or rights to cumulative voting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Limitation on Issuance of Preferred Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">So long as the Fund has preferred stock outstanding, subject to receipt of approval from the rating agencies of each series of preferred stock outstanding, and subject to compliance with the Fund&#8217;s investment objectives, policies and restrictions, the Fund may issue and sell shares of one or more other series of additional preferred stock provided that the Fund will, immediately after giving effect to the issuance of such additional preferred stock and to its receipt and application of the proceeds thereof (including, without limitation, to the redemption of preferred stock to be redeemed out of such proceeds), have an &#8220;asset coverage&#8221; for all senior securities of the Fund which are stock, as defined in the 1940 Act, of at least 200% of the sum of the liquidation preference of the shares of preferred stock of the Fund then outstanding and all indebtedness of the Fund constituting senior securities, and no such additional preferred stock will have any preference or priority over any other preferred stock of the Fund upon the distribution of the assets of the Fund or in respect of the payment of dividends or distributions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund will consider from time to time whether to offer additional preferred stock or securities representing indebtedness and may issue such additional securities if the Board concludes that such an offering would be consistent with the Charter and applicable law, and in the best interest of the Fund.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Book Entry</i>. Shares of Fixed Rate Preferred Stock sold through this offering will initially be held in the name of Cede &amp; Co. as nominee for DTC. The Fund will treat Cede &amp; Co. as the holder of record of such shares for all purposes. In accordance with the procedures of DTC, however, purchasers of Fixed Rate Preferred Stock will be deemed the beneficial owners of shares purchased for purposes of dividends, voting and liquidation rights.</span></p>

</ix:nonNumeric><p id="xdx_81B_zeI78KbckUwh" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-12-292023-12-29_custom_SubscriptionRightsMember" escape="true" name="cef:OutstandingSecurityTitleTextBlock"><p id="xdx_808_ecef--OutstandingSecurityTitleTextBlock_hcef--RiskAxis__custom--SubscriptionRightsMember_zfCDS9xErOT7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Subscription Rights</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>General</i>. We may issue subscription rights to holders of our (i) common stock to purchase common and/or preferred stock or (ii) preferred stock to purchase preferred stock (subject to applicable law). Subscription rights may be issued independently or together with any other offered security and may or may not be transferable by the person purchasing or receiving the subscription rights. In connection with a subscription rights offering to holders of our common stock or preferred stock, we would distribute certificates or other documentation evidencing the subscription rights and a prospectus supplement to our common or preferred stockholders as of the record date that we set for determining the stockholders eligible to receive subscription rights in such subscription rights offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The applicable prospectus supplement would describe the following terms of the subscription rights in respect of which this prospectus is being delivered:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the period of time the offering would remain open (which will be open a minimum number of days such that all record holders would be eligible to participate in the offering and will not be open longer than 120 days);</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the underwriter or distributor, if any, of the subscription rights and any associated underwriting fees or discounts applicable to purchases of the rights;</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the title of such subscription rights;</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the exercise price for such subscription rights (or method of calculation thereof);</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the number of such subscription rights issued in respect of each share of common stock or each share of preferred stock;</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the number of rights required to purchase a single share of common stock or share of preferred stock;</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 36 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the terms of the preferred stock, if any, for which a holder of such rights may subscribe;</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the extent to which such subscription rights are transferable and the market on which they may be traded if they are transferable;</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if applicable, a discussion of the material U.S. federal income tax considerations applicable to the issuance or exercise of such subscription rights;</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the date on which the right to exercise such subscription rights will commence, and the date on which such right will expire (subject to any extension);</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the extent to which such subscription rights include an over-subscription privilege with respect to unsubscribed securities and the terms of such over-subscription privilege;</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any termination right we may have in connection with such subscription rights offering; and</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any other terms of such subscription rights, including exercise, settlement and other procedures and limitations relating to the transfer and exercise of such subscription rights.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Exercise of Subscription Rights</i>. A certain number of subscription rights would entitle the holder of the subscription right(s) to purchase for cash such number of shares of common stock or shares of preferred stock at such exercise price as in each case is set forth in, or be determinable as set forth in, the prospectus supplement relating to the subscription rights offered thereby. Subscription rights would be exercisable at any time up to the close of business on the expiration date for such subscription rights set forth in the prospectus supplement. After the close of business on the expiration date, all unexercised subscription rights would become void. Upon expiration of the rights offering and the receipt of payment and the subscription rights certificate or other appropriate documentation properly executed and completed and duly executed at the corporate trust office of the subscription rights agent, or any other office indicated in the prospectus supplement, the shares of common stock or shares of preferred stock purchased as a result of such exercise will be issued as soon as practicable. To the extent permissible under applicable law, we may determine to offer any unsubscribed offered securities directly to persons other than stockholders, to or through agents, underwriters or dealers or through a combination of such methods, as set forth in the applicable prospectus supplement.</span></p>

</ix:nonNumeric><p id="xdx_81D_zh0jEp1gjxQj" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_015"></span>ANTI-TAKEOVER PROVISIONS OF THE FUND&#8217;S GOVERNING DOCUMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund presently has provisions in its Governing Documents that could have the effect of limiting, in each case:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the ability of other entities or persons to acquire control of the Fund;</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Fund&#8217;s freedom to engage in certain transactions; or</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the ability of the Fund&#8217;s Directors or stockholders to amend the Governing Documents or effectuate changes in the Fund&#8217;s management.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These provisions of the Governing Documents may be regarded as &#8220;anti-takeover&#8221; provisions. The Board is divided into three classes, each having a term ending at the third annual meeting following the election of such class. Each year the term of one class of Directors will expire. Accordingly, only those Directors in one class may be changed in any one year, and it would require two annual meeting cycles to change a majority of the Board. Further, one Director in two of the three classes of the Fund is elected exclusively by the holders of the Fund&#8217;s preferred stock and cannot be removed or replaced by the holders of the common stock. The affirmative vote of a majority of the shares present at a meeting of stockholders duly called and at which a quorum is present is required to elect a Director. A classified Board may have the effect of maintaining the continuity of management and, thus, make it more difficult for the stockholders of the Fund to change the majority of Directors. A Director of the Fund may be removed only for cause by a vote of a majority of the votes entitled to be cast for the election of Directors of the Fund.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 37 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the affirmative vote of the holders of 66&#8532;% of the outstanding shares of each class of stock of the Fund normally entitled
to vote in the election of directors, each such class voting as a separate class, is required to authorize the conversion of the Fund
from a closed-end to an open-end investment company or generally to authorize any of the following transactions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the merger or consolidation of the Fund or any subsidiary of the Fund with or into any Principal Shareholder, as such term is defined in the Charter (&#8220;Principal Shareholder&#8221;);</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the issuance of any securities of the Fund for cash to any Principal Shareholder;</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the sale, lease or exchange of all or any substantial part of the assets of the Fund to any Principal Shareholder (except assets having an aggregate fair market value of less than $1,000,000 over a 12 month period); or</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the sale, lease or exchange to the Fund or any subsidiary of the Fund, in exchange for securities of the Fund, of any assets of any Principal Shareholder (except assets having an aggregate fair market value of less than $1,000,000 over a 12 month period).</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such vote would not be required, however, when, under certain circumstances, the Board approves the transaction or when each class of voting securities of the entity that is the other party to any of the above-listed transactions is (directly or indirectly) majority owned by the Fund or its subsidiaries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The foregoing voting requirements, which have been considered and determined to be in the best interests of stockholders by the Directors, are greater than applicable minimum voting requirements imposed by the 1940 Act and applicable Maryland law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund&#8217;s Bylaws provide that the affirmative vote of two-thirds of the entire Board of Directors shall be required to approve or declare advisable:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any amendment to the Charter to make the Fund&#8217;s common stock a &#8220;redeemable security&#8221; or to convert the Fund, whether by merger or otherwise, from a &#8220;closed-end company&#8221; to an &#8220;open-end company&#8221; (as defined in the 1940 Act);</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The liquidation or dissolution of the Fund and any amendment to the Charter to effect any such liquidation or dissolution; or</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any merger, consolidation, share exchange or sale or exchange of all or substantially all of the assets of the Fund that Maryland law requires be approved by the stockholders of the Fund.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further, unless a higher percentage is provided for under the Charter, the affirmative vote of a majority (as defined in the 1940 Act) of the votes entitled to be cast by holders of outstanding shares of the Fund&#8217;s preferred stock, voting together as a separate class, will be required to approve any plan of reorganization adversely affecting such stock or any action requiring a vote of security holders under Section&#160;13(a) of the 1940 Act, including, among other things, changing the Fund&#8217;s subclassification as a closed-end investment company, changing the Fund&#8217;s investment objectives or changing its fundamental investment restrictions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maryland corporations that have a class of securities registered under the Securities Exchange Act of 1934, as amended (the &#8220;1934 Act&#8221;), and have at least three outside directors, such as the Fund, may by board resolution elect to become subject to certain corporate governance provisions set forth in the Maryland General Corporation Law, even if such provisions are inconsistent with the corporation&#8217;s charter and bylaws. Accordingly, notwithstanding the Fund&#8217;s Governing Documents, under Maryland law the Board may elect by resolution (and the filing of Articles Supplementary) to, among other things:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">provide that the calling of special meetings by stockholders be required only at the request of stockholders entitled to cast at least a majority of the votes entitled to be cast at such meeting;</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 38 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reserve for the Board the right to fix the number of Fund Directors;</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">classify the Board into three classes of directors of as equal number as practicable;</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">provide that Directors are subject to removal only by the vote of the stockholders entitled to cast two-thirds of the votes entitled to be cast generally in the election of Directors; and</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">retain for the Board sole authority to fill any vacancies on the Board, with any Director so appointed to serve for the balance of the unexpired term rather than only until the next annual meeting of stockholders.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Governing Documents of the Fund presently: (i) divide the Board into three classes of Directors; (ii) require holders of not less than a majority of the votes entitled to be cast at such meeting to call a special meeting of stockholders; and (iii) provide that only the Board may fix the number of the Fund&#8217;s Directors. On December&#160;3, 2010, in accordance with Maryland law, the Board elected by resolution and approved Articles Supplementary to vest in the Board the sole power to fill any vacancies on the Board, with any Director so elected to serve for the full term of the directorship in which the vacancy occurred and until his or her successor is duly elected and qualifies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the Maryland General Corporation Law, if the directors have been divided into classes (as the Fund&#8217;s Directors are), unless the charter provides otherwise (which the Charter does not), a director may be removed only for cause by the affirmative vote of a majority of all the votes entitled to be cast generally for the election of directors. The Board could elect in the future to be subject to the provision of Maryland law that would increase the vote required to remove a Director to two-thirds of all the votes entitled to be cast.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund&#8217;s Bylaws provide that, with respect to an annual meeting of stockholders, nominations of persons for election to the Board of Directors and the proposal of business to be considered by stockholders may be made only (1) by or at the direction of the Board of Directors or (2) by a stockholder who was a stockholder of record from the time the stockholder gives notice as provided for in the Bylaws to the time of the annual meeting, who is entitled to vote at the meeting in the election of each such nominee or on such other business and who has complied with the advance notice procedures of and provided the information and other materials required by the Bylaws. With respect to special meetings of stockholders, only the business specified in the Fund&#8217;s notice of the meeting may be brought before the meeting. Nominations of persons for election to the Board of Directors at a special meeting may be made only (1) by or at the direction of the Board of Directors or (2) provided that the Board of Directors has determined that Directors will be elected at the special meeting, by a stockholder who was a stockholder of record from the time the stockholder gives notice as provided for in the Bylaws to the time of the special meeting, who is entitled to vote at the meeting in the election of each such nominee and who has complied with the advance notice provisions of and provided the information and other materials required by the Bylaws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund&#8217;s Bylaws provide that special meetings of stockholders may be called by the Board of Directors and certain of the Fund&#8217;s officers. Additionally, the Fund&#8217;s Bylaws provide that, subject to the satisfaction of certain procedural and informational requirements by the stockholders requesting the meeting, a special meeting of stockholders will be called by the secretary of the Fund upon the written request of stockholders entitled to cast a majority of all the votes entitled to be cast at such meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The provisions of the Governing Documents and Maryland law described above could have the effect of depriving the owners of stock in the Fund of opportunities to sell their shares at a premium over prevailing market prices, by discouraging a third party from seeking to obtain control of the Fund in a tender offer or similar transaction. The overall effect of these provisions is to render more difficult the accomplishment of a merger or the assumption of control by a principal stockholder. The Governing Documents of the Fund are on file with the SEC. For access to the full text of these provisions, see &#8220;Additional Information.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 39 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Maryland Control Share Acquisition Act</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February&#160;16, 2023, the Fund elected, by resolution unanimously adopted by the Board of Directors of the Fund in accordance with Section&#160;3-702(c)(4) of the MGCL, to be subject to the Maryland Control Share Acquisition Act (the &#8220;Control Share Act&#8221;), effective immediately. The Control Share Act only applies to acquisitions of Fund shares on or after February&#160;16, 2023, and does not apply to the voting rights of any class or series of stock of the Fund other than the Fund&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the MGCL, the Control Share Act provides that a holder of control shares of a Maryland corporation acquired in a control share acquisition has no voting rights with respect to those shares except to the extent approved by a vote of two-thirds of the votes entitled to be cast on the matter. Shares owned by the acquiror, by officers or by directors who are employees of the corporation are excluded from shares entitled to vote on the matter. Control shares are voting shares of stock which, if aggregated with all other shares of stock owned by the acquiror or in respect of which the acquiror is able to exercise or direct the exercise of voting power (except solely by virtue of a revocable proxy), would entitle the acquiror to exercise voting power in electing directors within one of the following ranges of voting power:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">one-tenth or more but less than one-third;</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">one-third or more but less than a majority; or</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a majority or more of all voting power.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The requisite shareholder approval must be obtained each time an acquiror crosses one of the thresholds of voting power set forth above. Control shares do not include shares the acquiring person is then entitled to vote as a result of having previously obtained shareholder approval. A control share acquisition means the acquisition of issued and outstanding control shares, subject to certain exceptions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A person who has made or proposes to make a control share acquisition may compel the board of directors of the corporation to call a special meeting of shareholders to be held within 50 days of demand to consider the voting rights of the shares. The right to compel the calling of a special meeting is subject to the satisfaction of certain conditions, including an undertaking to pay the expenses of the meeting. If no request for a meeting is made, the corporation may itself present the question at any shareholders meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If voting rights are not approved at the meeting or if the acquiring person does not deliver an acquiring person statement as required by the statute, then the corporation may redeem for fair value any or all of the control shares, except those for which voting rights have previously been approved. The right of the corporation to redeem control shares is subject to certain conditions and limitations, including, compliance with the 1940 Act. Fair value is determined, without regard to the absence of voting rights for the control shares, as of the date of the last control share acquisition by the acquiror or of any meeting of shareholders at which the voting rights of the shares are considered and not approved. If voting rights for control shares are approved at a shareholders meeting and the acquiror becomes entitled to vote a majority of the shares entitled to vote, all other shareholders may exercise appraisal rights. The fair value of the shares as determined for purposes of appraisal rights may not be less than the highest price per share paid by the acquiror in the control share acquisition. Notwithstanding the foregoing, the Fund additionally elected that no stockholder of the Fund shall be entitled to exercise the rights of an objecting stockholder under Section&#160;3-708 of the MGCL.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Control Share Act does not apply (a) to shares acquired in a merger, consolidation or share exchange if the corporation is a party to the transaction or (b) to acquisitions approved or exempted by the charter or bylaws of the corporation. In connection with the Fund&#8217;s election to be subject to the Control Share Act, the Fund&#8217;s Board of Directors amended the Fund&#8217;s bylaws to exempt the Fund&#8217;s preferred stock from the Control Share Act. This exemption applies to the Fund&#8217;s outstanding preferred stock and to any preferred stock it may issue in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The foregoing is only a summary of the material terms of the Control Share Act. Shareholders should consult their own counsel with respect to the application of the Control Share Act to any particular circumstance. Some uncertainty around the general application under the 1940 Act of state control share statutes exists as a result of recent court decisions. Additionally, in some circumstances uncertainty may also exist in how to enforce the control share restrictions contained in state control share statutes against beneficial owners who hold their shares through financial intermediaries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 40 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_016"></span>CLOSED-END FUND STRUCTURE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund is a diversified, closed-end management investment company (commonly referred to as a closed-end fund). Closed-end funds differ from open-end funds (which are generally referred to as mutual funds) in that closed-end funds generally list their shares for trading on a stock exchange and do not redeem their shares at the request of a stockholder. This means that if you wish to sell your shares of a closed-end fund you must trade them on the market like any other stock at the prevailing market price at that time. In a mutual fund, if the stockholder wishes to sell shares of the fund, the mutual fund will redeem or buy back the shares at &#8220;net asset value.&#8221; Also, mutual funds generally offer new shares on a continuous basis to new investors, and closed-end funds generally do not. The continuous inflows and outflows of assets in a mutual fund can make it difficult to manage the fund&#8217;s investments. By comparison, closed-end funds are generally able to stay more fully invested in securities that are consistent with their investment objectives, to have greater flexibility to make certain types of investments and to use certain investment strategies such as financial leverage and investments in illiquid securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares of closed-end funds often trade at a discount to their net asset value. Because of this possibility and the recognition that any such discount may not be in the interest of stockholders, the Fund&#8217;s Board might consider from time to time engaging in open-market repurchases, tender offers for shares or other programs intended to reduce a discount. We cannot guarantee or assure, however, that the Fund&#8217;s Board will decide to engage in any of these actions. Nor is there any guarantee or assurance that such actions, if undertaken, would result in the shares trading at a price equal or close to net asset value per share. The Board might also consider converting the Fund to an open-end mutual fund, which would require the affirmative vote of the holders of 66 &#x2154;% of the outstanding shares of each class of stock of the Fund normally entitled to vote in the election of directors, each such class voting as a separate class. We cannot assure you that the Fund&#8217;s shares of common stock will not trade at a discount.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_017"></span>REPURCHASE OF COMMON STOCK</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund is a diversified, closed-end management investment company and as such its stockholders do not, and will not, have the right to require the Fund to repurchase their shares. The Fund, however, may repurchase shares of its common stock from legally available funds from time to time as and when it deems such a repurchase advisable. The Board has authorized common stock repurchases to be made when shares of the Fund&#8217;s common stock are trading at a discount from net asset value of 10% or more (or such other percentage as the Board of the Fund may determine from time to time). Although the Board has authorized such repurchases, the Fund is not required to repurchase shares of its common stock, and the Fund will consider repurchases when shares of its common stock are trading at such a discount from net asset value. The Board has not established a limit on the number of shares that could be purchased during such period. Pursuant to the 1940 Act, the Fund may repurchase shares of its common stock on a securities exchange (provided that the Fund has informed its stockholders within the preceding six months of its intention to repurchase such shares) or pursuant to tenders and may also repurchase shares privately if the Fund meets certain conditions regarding, among other things, distribution of net income for the preceding fiscal year, status of the seller, price paid, brokerage commissions, prior notice to stockholders of an intention to purchase shares and purchasing in a manner and on a basis that does not discriminate unfairly against the other stockholders through their interests in the Fund.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares repurchased by the Fund will revert to the status of authorized but unissued shares of common stock and will be available for reissuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund may issue preferred stock or incur debt to finance share repurchase transactions. While the Fund may incur debt to finance common stock repurchases, such debt financing would require further approval of the Board, and the Fund does not currently intend to incur debt to finance common stock repurchases. The Prospectus Supplement for an offering of preferred stock issued in whole or in part for the purpose of financing share repurchase transactions will provide, in addition to the terms of such offering, the maximum amount of preferred stock that may be issued for such purpose. Any gain in the value of the investments of the Fund during the term of the borrowing that exceeds the interest paid on the amount borrowed would cause the net asset value of the Fund&#8217;s shares to increase more rapidly than in the absence of borrowing. Conversely, any decline in the value of the investments of the Fund would cause the net asset value of the Fund&#8217;s shares to decrease more rapidly than in the absence of borrowing. Borrowing money thus creates an opportunity for greater capital gains but at the same time increases exposure to capital risk. See &#8220;Risk Factors and Special Considerations&#8212;Leverage Risk.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 41 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund considers the potential impact on net asset value and the Fund&#8217;s expense ratio when repurchasing shares of its common stock. When the Fund repurchases shares of its common stock for a price below net asset value, the net asset value of the shares of common stock that remain outstanding will be enhanced, but this does not necessarily mean that the market price of the outstanding shares of common stock will be affected, either positively or negatively. Further, interest on borrowings to finance share repurchase transactions will reduce the net income of the Fund. The repurchase of common stock will reduce the total assets of the Fund available for investment and may increase the Fund&#8217;s expense ratio, as well as its portfolio turnover rate and transaction costs in the event that portfolio holdings are liquidated to finance share repurchases. Common stock repurchases also may affect the Fund&#8217;s ability to achieve its investment objective and could impact the Fund&#8217;s ability to qualify as a regulated investment company under the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund does not currently have an established tender offer program or established schedule for considering tender offers. No assurance can be given that the Board will decide to make any such tender offers in the future, or, if undertaken, that they will reduce any market discount.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_018"></span>RIGHTS OFFERINGS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund may in the future, and at its discretion, choose to make offerings of subscription rights to (i) its common stockholders to purchase common stock and/or preferred stock or (ii) its preferred stockholders to purchase preferred stock. A future rights offering may be transferable or non-transferable. Any such future rights offering will be made in accordance with the 1940 Act. Under the laws of the State of Maryland and the Charter, the Board is authorized to approve rights offerings without obtaining stockholder approval. The staff of the SEC has interpreted the 1940 Act as not requiring stockholder approval of a transferable rights offering to purchase common stock at a price below the then current net asset value so long as certain conditions are met, including: (i) a good faith determination by a fund&#8217;s Board that such offering would result in a net benefit to existing stockholders; (ii) the offering fully protects stockholders&#8217; preemptive rights and does not discriminate among stockholders (except for the possible effect of not offering fractional rights); (iii) management uses its best efforts to ensure an adequate trading market in the rights for use by stockholders who do not exercise such rights; and (iv) the ratio of a transferable rights offering does not exceed one new share for each three rights held.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_019"></span>NET ASSET VALUE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The net asset value of the Fund&#8217;s shares is computed based on the market value of the securities it holds and determined daily as of the close of the regular trading day on the NYSE, normally 4:00 p.m., Eastern Time. The Investment Adviser has been designated as the Fund&#8217;s valuation designee to perform fair value determinations for the Fund pursuant to Rule&#160;2a-5 under the 1940 Act, in accordance with established procedures and under the general oversight of the Board. For purposes of determining the Fund&#8217;s net asset value per share, portfolio securities listed or traded on a nationally recognized securities exchange or traded in the U.S. OTC market for which market quotations are readily available are valued at the last quoted sale price or a market&#8217;s official closing price as of the close of business on the day the securities are being valued. If there were no sales that day, the security is valued at the average of the closing bid and asked prices or, if there were no asked prices quoted on that day, then the security is valued at the closing bid price on that day. If no bid or asked prices are quoted on such day, the security is valued at the most recently available price or by such other method as the Investment Adviser shall determine in good faith to reflect its fair market value. Portfolio securities traded on more than one national securities exchange or market are valued according to the broadest and most representative market, as determined by the Investment Adviser.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Portfolio securities primarily traded on a foreign market are generally valued at the preceding closing values of such securities on the relevant market, but may be fair valued in good faith by the Investment Adviser pursuant to established procedures if market conditions change significantly after the close of the foreign market but prior to the close of business on the day the securities are being valued. Debt instruments with remaining maturities of 60 days or less that are not credit impaired are valued at amortized cost, unless the Investment Adviser determines such amount does not reflect the securities&#8217; fair value, in which case these securities will be fair valued as determined by the Investment Adviser in good faith. Debt instruments having a maturity greater than 60 days for which market quotations are readily available are valued at the average of the latest bid and asked prices. If there were no asked prices quoted on such day, the security is valued using the closing bid price. Futures contracts are valued at the closing settlement price of the exchange or board of trade on which the applicable contract is traded.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 42 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options are valued using market quotations. When market quotations are not readily available, options are valued from broker quotes. In limited circumstances when neither market quotations nor broker quotes are readily available, options are valued using a Black Scholes model.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities and assets for which market quotations are not readily available are fair valued in good faith by the Investment Adviser. Fair valuation methodologies and procedures may include, but are not limited to: analysis and review of available financial and non-financial information about the company; comparisons to the valuation and changes in valuation of similar securities, including a comparison of foreign securities to the equivalent U.S. dollar value ADR securities at the close of the U.S. exchange; and evaluation of any other information that could be indicative of the value of the security.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund obtains valuations on the basis of prices provided by one or more pricing services approved by the Board. All other investment assets, including restricted and not readily marketable securities, are valued in good faith by the Investment Adviser under established procedures and under the oversight of the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition, whenever developments in one or more securities markets after the close of the principal markets for one or more portfolio securities and before the time as of which the Fund determines its net asset value would, if such developments had been reflected in such principal markets, likely have more than a minimal effect on the Fund&#8217;s net asset value per share, the Fund may fair value such portfolio securities based on available market information as of the time the Fund determines its net asset value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>NYSE Closings</i>. The holidays (as observed) on which the NYSE is closed, and therefore days upon which stockholders cannot purchase or sell shares, currently are: New Year&#8217;s Day, Martin Luther King, Jr. Day, Presidents&#8217; Day, Good Friday, Memorial Day, Independence Day, Juneteenth, Labor Day, Thanksgiving Day, and Christmas Day, and on the preceding Friday or subsequent Monday when a holiday falls on a Saturday or Sunday, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_020"></span>LIMITATION ON DIRECTORS&#8217; AND OFFICERS&#8217; LIABILITY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Governing Documents provide that the Fund will indemnify its Directors and officers and may indemnify its employees or agents against liabilities and expenses incurred in connection with litigation in which they may be involved because of their positions with the Fund, to the fullest extent permitted by law. However, nothing in the Governing Documents protects or indemnifies a Director, officer, employee or agent of the Fund against any liability to which such person would otherwise be subject in the event of such person&#8217;s willful misfeasance, bad faith, gross negligence or reckless disregard of the duties involved in the conduct of his or her position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_021"></span>TAXATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following discussion is a brief summary of certain federal income tax considerations affecting the Fund and the purchase, ownership and disposition of the Fund&#8217;s shares. A more complete discussion of the tax rules applicable to the Fund and its stockholders can be found in the SAI that is incorporated by reference into this Prospectus. This discussion assumes you are a U.S. person (as defined for U.S. federal income tax purposes) and that you hold your shares as capital assets. This discussion is based upon current provisions of the Code, the regulations promulgated thereunder and judicial and administrative authorities, all of which are subject to change or differing interpretations by the courts or the Internal Revenue Service (the &#8220;IRS&#8221;), possibly with retroactive effect. No ruling has been or will be sought from the IRS regarding any matter discussed herein. Counsel to the Fund has not rendered and will not render any legal opinion regarding any tax consequences relating to the Fund or an investment in the Fund. No attempt is made to present a detailed explanation of all federal tax concerns affecting the Fund and its stockholders (including stockholders owning large positions in the Fund).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 43 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The discussion set forth herein does not constitute tax advice and potential investors are urged to consult their own tax advisers to determine the tax consequences to them of investing in the Fund.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Taxation of the Fund</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund has elected to be treated and has qualified, and intends to continue to qualify, as a regulated investment company under Subchapter M of the Code. Accordingly, the Fund must, among other things, meet the following requirements regarding the source of its income and the diversification of its assets:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund must derive in each taxable year at least 90% of its gross income from the following sources, which are referred to herein as &#8220;Qualifying Income&#8221;: (a) dividends, interest (including tax-exempt interest), payments with respect to certain securities loans, and gains from the sale or other disposition of stock, securities or foreign currencies, and other income (including but not limited to gain from options, futures and forward contracts) derived with respect to its business of investing in such stock, securities or foreign currencies; and (b) interests in publicly traded partnerships that are treated as partnerships for U.S. federal income tax purposes and that derive less than 90% of their gross income from the items described in (a) above (each a &#8220;Qualified Publicly Traded Partnership&#8221;).</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund must diversify its holdings so that, at the end of each quarter of each taxable year (a) at least 50% of the market value of the Fund&#8217;s total assets is represented by cash and cash items (including receivables), U.S. government securities, the securities of other regulated investment companies and other securities, with such other securities limited, in respect of any one issuer, to an amount not greater than 5% of the value of the Fund&#8217;s total assets and not more than 10% of the outstanding voting securities of such issuer and (b) not more than 25% of the market value of the Fund&#8217;s total assets is invested in the securities (other than U.S. government securities and the securities of other regulated investment companies) of (I) any one issuer, (II) any two or more issuers in which the Fund owns 20% or more of the voting stock and that are determined to be engaged in the same business or similar or related trades or businesses or (III) any one or more Qualified Publicly Traded Partnerships.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a regulated investment company, the Fund generally will not be subject to U.S. federal income tax on income and gains that the Fund distributes to its stockholders, provided that it distributes each taxable year at least the sum of (i) 90% of the Fund&#8217;s investment company taxable income (which includes, among other items, dividends, interest and the excess of any net short term capital gain over net long term capital loss and other taxable income, other than any net long term capital gain, reduced by deductible expenses) determined without regard to the deduction for dividends paid and (ii) 90% of the Fund&#8217;s net tax-exempt interest (the excess of its gross tax-exempt interest over certain disallowed deductions). The Fund intends to distribute substantially all of such income at least annually. The Fund will be subject to income tax at regular corporate rates on any taxable income or gains that it does not distribute to its stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Code imposes a 4% nondeductible excise tax on the Fund to the extent the Fund does not distribute by the end of any calendar year an amount at least equal to the sum of (i) 98% of its ordinary income (not taking into account any capital gain or loss, and taking into account certain deferrals and elections) for the calendar year and (ii) 98.2% of its capital gain in excess of its capital loss (adjusted for certain ordinary losses) for a one-year period generally ending on October&#160;31 of the calendar year (unless an election is made to use the Fund&#8217;s fiscal year). In addition, the minimum amounts that must be distributed in any year to avoid the excise tax will be increased or decreased to reflect any under-distribution or over-distribution, as the case may be, from the previous year. While the Fund intends to distribute any income and capital gain in the manner necessary to minimize imposition of the 4% excise tax, there can be no assurance that sufficient amounts of the Fund&#8217;s taxable income and capital gain will be distributed to entirely avoid the imposition of the excise tax. In that event, the Fund will be liable for the excise tax only on the amount by which it does not meet the foregoing distribution requirement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 44 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Taxation of Stockholders</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Distributions paid to you by the Fund from its net realized long term capital gains, if any, that the Fund reports as capital gains dividends (&#8220;capital gain dividends&#8221;) are taxable as long term capital gains, regardless of how long you have held your shares. All other dividends paid to you by the Fund (including dividends from short term capital gains) from its current or accumulated earnings and profits (&#8220;ordinary income dividends&#8221;) are generally subject to tax as ordinary income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Special rules apply, however, to ordinary income dividends paid to individuals. If you are an individual, any such ordinary income dividend that you receive from the Fund generally will be eligible for taxation at the Federal rates applicable to long term capital gains (generally subject to federal income tax rates for an individual of either 15% or 20% depending on whether an individual&#8217;s income exceeds certain threshold amounts) to the extent that (i) the ordinary income dividend is attributable to &#8220;qualified dividend income&#8221; (i.e., generally dividends paid by U.S. corporations and certain foreign corporations) received by the Fund, (ii) the Fund satisfies certain holding period and other requirements with respect to the stock on which such qualified dividend income was paid and (iii) you satisfy certain holding period and other requirements with respect to your shares. There can be no assurance as to what portion of the Fund&#8217;s ordinary income dividends will constitute qualified dividend income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A 3.8% Medicare contribution surcharge is imposed on net investment income, including interest, dividends, and capital gain, of U.S. individuals with income exceeding $200,000 (or $250,000 if married filing jointly), and of estates and trusts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any distributions you receive that are in excess of the Fund&#8217;s current or accumulated earnings and profits will be treated as a tax free return of capital to the extent of your adjusted tax basis in your shares, and thereafter as capital gain from the sale of shares. The amount of any Fund distribution that is treated as a tax free return of capital will reduce your adjusted tax basis in your shares, thereby increasing your potential gain or reducing your potential loss on any subsequent sale or other disposition of your shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends and other taxable distributions are taxable to you even if they are reinvested in additional shares of common stock of the Fund. Dividends and other distributions paid by the Fund are generally treated under the Code as received by you at the time the dividend or distribution is made. If, however, the Fund pays you a dividend in January that was declared in the previous October, November or December and you were the stockholder of record on a specified date in one of such months, then such dividend will be treated for tax purposes as being paid by the Fund and received by you on December&#160;31 of the year in which the dividend was declared.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund will send you information after the end of each year setting forth the amount and tax status of any distributions paid to you by the Fund.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The sale or other disposition of shares of the Fund will generally result in capital gain or loss to you, and will be long term capital gain or loss if you have held such shares for more than one year at the time of sale. Any loss upon the sale or exchange of shares held for six months or less will be treated as long term capital loss to the extent of any capital gain dividends received (including amounts credited as an undistributed capital gain dividend) by you with respect to such shares. Any loss you realize on a sale or exchange of shares will be disallowed if you acquire other shares (whether through the automatic reinvestment of dividends or otherwise) within a 61-day period beginning 30 days before and ending 30 days after your sale or exchange of the shares. In such case, your tax basis in the shares acquired will be adjusted to reflect the disallowed loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund may be required to withhold, for U.S. federal backup withholding tax purposes, 24% of the dividends, distributions and redemption proceeds payable to stockholders who fail to provide the Fund (or its agent) with their correct taxpayer identification number (in the case of individuals, generally, their social security number) or to make required certifications, or who have been notified by the IRS that they are subject to backup withholding. Certain stockholders are exempt from backup withholding. Backup withholding is not an additional tax and any amount withheld may be refunded or credited against your U.S. federal income tax liability, if any, provided that you furnish the required information to the IRS.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 45 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Taxation of Holders of Subscription Rights for Preferred Stockholders</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As more fully described below, upon receipt of a subscription right, a preferred stockholder generally will be treated as receiving a taxable distribution in an amount equal to the fair market value of the subscription right the preferred stockholder receives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To the extent that the distribution is made out of the Fund&#8217;s earnings and profits, the subscription right will be a taxable dividend to the preferred stockholder. If the amount of the distribution received by the preferred stockholder exceeds such stockholder&#8217;s proportionate share of the Fund&#8217;s earnings and profits, the excess will reduce the preferred stockholder&#8217;s tax basis in the shares with respect to which the subscription right was issued (the old shares). To the extent that the excess is greater than the preferred stockholder&#8217;s tax basis in the old shares, such excess will be treated as gain from the sale of the old shares. If the preferred stockholder held the old shares for more than one year, such gain will be treated as long term capital gain.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A preferred stockholder&#8217;s tax basis in the subscription rights received will equal the fair market value of the subscription rights on the date of the distribution.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A preferred stockholder who allows the subscription rights received to expire generally will recognize a short term capital loss. Capital losses are deductible only to the extent of capital gains (subject to an exception for individuals under which $3,000 of capital losses may be offset against ordinary income).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A preferred stockholder who sells the subscription rights will recognize a gain or loss equal to the difference between the amount realized on the sale and the preferred stockholder&#8217;s tax basis in the subscription rights as described above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A preferred stockholder will not recognize any gain or loss upon the exercise of the subscription rights received in the rights offering. The tax basis of the shares acquired through exercise of the subscription rights (the new shares) will equal the sum of the subscription price for the new shares and the preferred stockholder&#8217;s tax basis in the subscription rights as described above. The holding period for the new shares acquired through exercise of the subscription rights will begin on the day following the date on which the subscription rights are exercised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Taxation of Subscription Rights for Common Stockholders</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The value of a subscription right will not be includible in the income of a common stockholder at the time the subscription right is issued.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The basis of a subscription right issued to a common stockholder will be zero, and the basis of the share with respect to which the subscription right was issued (the old share) will remain unchanged, unless either (a) the fair market value of the subscription right on the date of distribution is at least 15% of the fair market value of the old share, or (b) such stockholder affirmatively elects (in the manner set out in Treasury regulations under the Code) to allocate to the subscription right a portion of the basis of the old share. If either (a) or (b) applies, such stockholder must allocate basis between the old share and the subscription right in proportion to their fair market values on the date of distribution.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The basis of a subscription right purchased in the market will generally be its purchase price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The holding period of a subscription right issued to a common stockholder will include the holding period of the old share. No gain or loss will be recognized by a common stockholder upon the exercise of a subscription right.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No loss will be recognized by a common stockholder if a subscription right distributed to such common stockholder expires unexercised because the basis of the old share may be allocated to a subscription right only if the subscription right is exercised. If a subscription right that has been purchased in the market expires unexercised, there will be a recognized loss equal to the basis of the subscription right.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 46 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any gain or loss on the sale of a subscription right will be a capital gain or loss if the subscription right is held as a capital asset (which in the case of subscription rights issued to common stockholders will depend on whether the old share of common stock is held as a capital asset), and will be a long-term capital gain or loss if the holding period is deemed to exceed one year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Conclusion</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The foregoing is a general and abbreviated summary of the provisions of the Code and the Treasury regulations in effect as they directly govern the taxation of the Fund and its stockholders. These provisions are subject to change by legislative or administrative action, and any such change may be retroactive.]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_022"></span>CUSTODIAN, TRANSFER AGENT AND DIVIDEND DISBURSING AGENT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BNY Mellon, located at 240 Greenwich Street, New York, New York 10286, serves as the Custodian of the Fund&#8217;s assets pursuant to a custody agreement. Under the custody agreement, the Custodian holds the Fund&#8217;s assets in compliance with the 1940 Act. For its services, the Custodian receives a monthly fee paid by the Fund based upon, among other things, the average weekly value of the total assets of the Fund, plus certain charges for securities transactions and out-of-pocket expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rules adopted under the 1940 Act permit the Fund to maintain its foreign securities in the custody of certain eligible foreign banks and securities depositories. Pursuant to those rules, any foreign securities in the portfolio of the Fund may be held by sub-custodians approved by the Board in accordance with the regulations of the SEC. Selection of any such sub-custodians will be made by the Board following a consideration of a number of factors, including but not limited to the reliability and financial stability of the institution, the ability of the institution to perform capably custodial services for the Fund, the reputation of the institution in its national market, the political and economic stability of the country or countries in which the sub-custodians are located, and risks of potential nationalization or expropriation of assets of the Fund.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computershare, located at 150 Royall Street, Canton, Massachusetts 02021, serves as the Fund&#8217;s dividend disbursing agent, as agent under the Fund&#8217;s Plan and as transfer agent and registrar with respect to the common stock of the Fund.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computershare also serves as the Fund&#8217;s transfer agent, registrar, dividend disbursing agent and redemption agent with respect to the Series G Preferred, Series H Preferred, Series K Preferred, Series M Preferred and Series N Preferred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BNY Mellon, located at One Wall Street, New York, New York 10286, serves as the auction agent, transfer agent, registrar, dividend disbursing agent and redemption agent with respect to the Series C Auction Rate Preferred and Series E Auction Rate Preferred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_023"></span>PLAN OF DISTRIBUTION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We may sell securities through underwriters or dealers, directly to one or more purchasers, including existing holders of our common stock or preferred stock in a rights offering, through agents, to or through underwriters or dealers, or through a combination of any such methods of sale. The applicable Prospectus Supplement will identify any underwriter or agent involved in the offer and sale of our securities, any sales loads, discounts, commissions, fees or other compensation paid to any underwriter, dealer or agent, the offering price, net proceeds and use of proceeds and the terms of any sale. In the case of a rights offering to existing holders of our common stock or preferred stock, the applicable prospectus supplement will set forth the number of rights required to purchase a single share of common stock or a single share of preferred stock and the other terms of such rights offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 47 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The distribution of our shares may be effected from time to time in one or more transactions at a fixed price or prices, which may be changed, at prevailing market prices at the time of sale, at prices related to such prevailing market prices, or at negotiated prices, provided, however, that the offering price per share in the case of common stock, must equal or exceed the net asset value per share, exclusive of any underwriting commissions or discounts, of our common stock. Sales of our common stock or preferred stock for which there is a market may be made in negotiated transactions or transactions that are deemed to be &#8220;at the market&#8221; as defined in Rule&#160;415 under the Securities Act, including sales made directly on the NYSE or sales made to or through a market maker other than on an exchange.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We may sell our shares directly to, and solicit offers from, institutional investors or others who may be deemed to be underwriters as defined in the Securities Act for any resales of the securities. In this case, no underwriters or agents would be involved. We may use electronic media, including the Internet, to sell offered securities directly.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the sale of our shares, underwriters or agents may receive compensation from us in the form of discounts, concessions or commissions. Underwriters may sell our shares to or through dealers, and such dealers may receive compensation in the form of discounts, concessions or commissions from the underwriters and/or commissions from the purchasers for whom they may act as agents. Underwriters, dealers and agents that participate in the distribution of our shares may be deemed to be underwriters under the Securities Act, and any discounts and commissions they receive from us and any profit realized by them on the resale of our shares may be deemed to be underwriting discounts and commissions under the Securities Act. Any such underwriter or agent will be identified and any such compensation received from us will be described in the applicable Prospectus Supplement. The maximum commission or discount to be received by any FINRA member or independent broker-dealer will not exceed eight percent. We will not pay any compensation to any underwriter or agent in the form of warrants, options, consulting or structuring fees or similar arrangements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If a Prospectus Supplement so indicates, we may grant the underwriters an option to purchase additional shares at the public offering price, less the underwriting discounts and commissions, within 45 days from the date of the Prospectus Supplement, to cover any overallotments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under agreements into which we may enter, underwriters, dealers and agents who participate in the distribution of our shares may be entitled to indemnification by us against certain liabilities, including liabilities under the Securities Act. Underwriters, dealers and agents may engage in transactions with us, or perform services for us, in the ordinary course of business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If so indicated in the applicable Prospectus Supplement, we will ourselves, or will authorize underwriters or other persons acting as our agents to solicit offers by certain institutions to purchase our shares from us pursuant to contracts providing for payment and delivery on a future date. Institutions with which such contacts may be made include commercial and savings banks, insurance companies, pension funds, investment companies, educational and charitable institutions and others, but in all cases such institutions must be approved by us. The obligation of any purchaser under any such contract will be subject to the condition that the purchase of the shares shall not at the time of delivery be prohibited under the laws of the jurisdiction to which such purchaser is subject. The underwriters and such other agents will not have any responsibility in respect of the validity or performance of such contracts. Such contracts will be subject only to those conditions set forth in the Prospectus Supplement, and the Prospectus Supplement will set forth the commission payable for solicitation of such contracts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To the extent permitted under the 1940 Act and the rules and regulations promulgated thereunder, the underwriters may from time to time act as brokers or dealers and receive fees in connection with the execution of our portfolio transactions after the underwriters have ceased to be underwriters and, subject to certain restrictions, each may act as a broker while it is an underwriter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A Prospectus and accompanying Prospectus Supplement in electronic form may be made available on the websites maintained by underwriters. The underwriters may agree to allocate a number of securities for sale to their online brokerage account holders. Such allocations of securities for Internet distributions will be made on the same basis as other allocations. In addition, securities may be sold by the underwriters to securities dealers who resell securities to online brokerage account holders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In order to comply with the securities laws of certain states, if applicable, our shares offered hereby will be sold in such jurisdictions only through registered or licensed brokers or dealers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 48 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_024"></span>LEGAL MATTERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain legal matters will be passed on by Willkie Farr &amp; Gallagher LLP, 787 Seventh Avenue, New York, New York 10019-6099, counsel to the Fund, in connection with the offering of the Fund&#8217;s securities. Counsel for the Fund will rely, as to certain matters of Maryland law, on Venable LLP, 750 E. Pratt Street, Baltimore, Maryland 21202.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_025"></span>INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PricewaterhouseCoopers LLP serves as the independent registered public accounting firm of the Fund and audits the financial statements of the Fund. PricewaterhouseCoopers LLP is located at 300 Madison Avenue, New York, New York 10017.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_026"></span>ADDITIONAL INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund is subject to the informational requirements of the 1934 Act and the 1940 Act, and in accordance therewith files reports and other information with the SEC. Reports, proxy statements and other information filed by the Fund with the SEC pursuant to the informational requirements of such Acts can be inspected and copied at the public reference facilities maintained by the SEC, 100 F Street, N.E., Washington, D.C. 20549. The SEC maintains a web site at http://www.sec.gov containing reports, proxy and information statements and other information regarding registrants, including the Fund, that file electronically with the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund&#8217;s common stock, Series G Preferred, Series H Preferred and Series K Preferred are listed on the NYSE. Reports, proxy statements and other information concerning the Fund and filed with the SEC by the Fund will be available for inspection at the NYSE, 11 Wall Street, New York, New York, 10005.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Prospectus constitutes part of a Registration Statement filed by the Fund with the SEC under the Securities Act and the 1940 Act. This Prospectus omits certain of the information contained in the Registration Statement, and reference is hereby made to the Registration Statement and related exhibits for further information with respect to the Fund and the securities offered hereby. Any statements contained herein concerning the provisions of any document are not necessarily complete, and, in each instance, reference is made to the copy of such document filed as an exhibit to the Registration Statement or otherwise filed with the SEC. Each such statement is qualified in its entirety by such reference. The complete Registration Statement may be obtained from the SEC upon payment of the fee prescribed by its rules and regulations or free of charge through the SEC&#8217;s web site (http://www.sec.gov).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_027"></span>INCORPORATION BY REFERENCE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Prospectus is part of a registration statement that we have filed with the SEC. We are allowed to &#8220;incorporate by reference&#8221; the information that we file with the SEC, which means that we can disclose important information to you by referring you to those documents. We incorporate by reference into this Prospectus the documents listed below and any future filings we make with the SEC under Sections&#160;13(a), 13(c), 14 or 15(d) of the Exchange Act, including any filings on or after the date of this Prospectus from the date of filing (excluding any information furnished, rather than filed), until we have sold all of the offered securities to which this Prospectus and any accompanying prospectus supplement relates or the offering is otherwise terminated. The information incorporated by reference is an important part of this Prospectus. Any statement in a document incorporated by reference into this Prospectus will be deemed to be automatically modified or superseded to the extent a statement contained in (1) this Prospectus or (2) any other subsequently filed document that is incorporated by reference into this Prospectus modifies or supersedes such statement. The documents incorporated by reference herein include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Fund&#8217;s Statement of Additional Information, dated December 29, 2023, filed with this Prospectus;</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our <a href="https://www.sec.gov/Archives/edgar/data/794685/000138713123003229/gab-ncsr_123122.htm">annual report</a> on Form&#160;N-CSR&#160;for the fiscal year ended&#160;December 31, 2022, filed with the SEC on March 9, 2023;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our <a href="https://www.sec.gov/Archives/edgar/data/794685/000182912623005964/gab_ncsrs.htm">semi-annual report</a> on Form N-CSR for the fiscal period ended June 30, 2023, filed with the SEC on September 6, 2023;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 49 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the description of our Series G Preferred, to the extent not otherwise included in this Prospectus, contained in our <a href="https://www.sec.gov/Archives/edgar/data/794685/000119312512322308/d386533d8a12b.htm">Registration Statement on Form 8-A</a> (File No. 001-09234) filed with the SEC on July 30, 2012 including any amendment or report filed for the purpose of updating such description prior to the termination of the offering registered hereby;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the description of our Series H Preferred, to the extent not otherwise included in this Prospectus, contained in our <a href="https://www.sec.gov/Archives/edgar/data/794685/000119312512406927/d417915d8a12b.htm">Registration Statement on Form 8-A</a> (File No. 001-09234) filed with the SEC on September 27, 2012, including any amendment or report filed for the purpose of updating such description prior to the termination of the offering registered hereby; and</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the description of our Series K Preferred, to the extent not otherwise included in this Prospectus, contained in our <a href="https://www.sec.gov/Archives/edgar/data/794685/000119312519313789/d118280d8a12b.htm">Registration Statement on Form 8-A</a> (File No. 001-09234) filed with the SEC on December 13, 2019, including any amendment or report filed for the purpose of updating such description prior to the termination of the offering registered hereby.</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We will provide without charge to each person, including any beneficial owner, to whom this Prospectus is delivered, upon written or oral request, a copy of any and all of the documents that have been or may be incorporated by reference in this Prospectus or the accompanying prospectus supplement. You should direct requests for documents by writing to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investor Relations</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Gabelli Equity Trust Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">One Corporate Center</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rye, NY 10580-1422</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(914) 921-5070</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Prospectus, the SAI and the Fund&#8217;s annual and semi-annual reports are also available on our website at http://www.gabelli.com. Information contained in, or that can be accessed through, our website is not incorporated by reference into this Prospectus or the accompanying prospectus supplement and should not be considered to be part of this Prospectus or the accompanying prospectus supplement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_028"></span>PRIVACY PRINCIPLES OF THE FUND</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund is committed to maintaining the privacy of its stockholders and to safeguarding their non-public personal information. The following information is provided to help you understand what personal information the Fund collects, how the Fund protects that information and why, in certain cases, the Fund may share information with select other parties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally, the Fund does not receive any non-public personal information relating to its stockholders, although certain non-public personal information of its stockholders may become available to the Fund. The Fund does not disclose any non-public personal information about its stockholders or former stockholders to anyone, except as permitted by law or as is necessary in order to service stockholder accounts (for example, to a transfer agent or third party administrator).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund restricts access to non-public personal information about its stockholders to employees of the Fund, the Investment Adviser, and its affiliates with a legitimate business need for the information. The Fund maintains physical, electronic and procedural safeguards designed to protect the non-public personal information of its stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*&#160;&#160;&#160;&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;&#160;&#160;&#160;*</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No dealer, salesperson or other person has been authorized to give any information or to make any representations in connection with this offering other than those contained in this Prospectus in connection with the offer contained herein, and, if given or made, such other information or representations must not be relied upon as having been authorized by the Fund, the Investment Adviser or the underwriters. Neither the delivery of this Prospectus nor any sale made hereunder will, under any circumstances, create any implication that there has been no change in the affairs of the Fund since the date hereof or that the information contained herein is correct as of any time subsequent to its date. This Prospectus does not constitute an offer to sell or a solicitation of an offer to buy any securities other than the securities to which it relates. This Prospectus does not constitute an offer to sell or the solicitation of an offer to buy such securities in any circumstance in which such an offer or solicitation is unlawful.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<!-- Field: Page; Sequence: 50 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b>THE GABELLI EQUITY TRUST INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Preferred Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Subscription Rights to Purchase Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Subscription Rights to Purchase Preferred Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Subscription Rights to Purchase Common Stock and Preferred Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>PROSPECTUS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 29, 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 51 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><b>The information in this Prospectus Supplement is not complete and may be changed. The Fund may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This Prospectus Supplement is not an offer to sell these securities and is not soliciting offers to buy these securities in any state where the offer or sale is not permitted.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><b>SUBJECT TO COMPLETION, DATED [&#9679;], 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed Pursuant to Rule&#160;424(b)([&#9679;])<br />Registration Statement No. 333-[&#9679;]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>THE GABELLI EQUITY TRUST INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROSPECTUS SUPPLEMENT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(To Prospectus dated [&#9679;], 2023)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>The Gabelli Equity Trust Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We are offering for sale [&#9679;] shares of our common stock. Our common stock is traded on the New York Stock Exchange (&#8220;NYSE&#8221;) under the symbol &#8220;GAB.&#8221; On [&#9679;], the last reported net asset value per share of our common stock was $[&#9679;] and the last reported sales price per share of our common stock was $[&#9679;]. Our Series G Cumulative Preferred Stock (&#8220;Series G Preferred&#8221;), our 5.00% Series H Cumulative Preferred Stock (&#8220;Series H Preferred&#8221;) and our 5.00% Series K Cumulative Preferred Stock (&#8220;Series K Preferred&#8221;) are listed on the NYSE under the symbol &#8220;GAB PrG,&#8221; &#8220;GAB PrH&#8221; and &#8220;GAB PrK,&#8221; respectively. Our Series C Auction Rate Cumulative Preferred Stock (&#8220;Series C Auction Rate Preferred&#8221;), Series E Auction Rate Preferred Stock (&#8220;Series E Auction Rate Preferred&#8221;), 4.25% Series M Cumulative Preferred Stock (&#8220;Series M Preferred&#8221;) and 5.25% Series N Cumulative Preferred Stock (&#8220;Series N Preferred&#8221;) are not traded on a stock exchange.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund is a diversified, closed-end management investment company registered under the Investment Company Act of 1940, as amended (the &#8220;1940 Act&#8221;). The Fund&#8217;s primary investment objective is to achieve long term growth of capital by investing primarily in a portfolio of equity securities consisting of common stock, preferred stock, convertible or exchangeable securities, and warrants and rights to purchase such securities. Income is a secondary investment objective. Under normal market conditions, the Fund will invest at least 80% of the value of its total assets in equity securities. The Fund&#8217;s investment adviser is Gabelli Funds, LLC (the &#8220;Investment Adviser&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Sales of our common stock, if any, under this Prospectus Supplement and the accompanying Prospectus may be made in negotiated transactions or transactions that are deemed to be &#8220;at the market&#8221; as defined in Rule&#160;415 under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), including sales made directly on the NYSE or sales made to or through a market maker other than on an exchange.]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An investment in the Fund is not appropriate for all investors. We cannot assure you that the Fund&#8217;s investment objectives will be achieved. You should read this Prospectus Supplement and the accompanying Prospectus before deciding whether to invest in our common stock and retain it for future reference. The Prospectus Supplement and the accompanying Prospectus contain important information about us. Material that has been incorporated by reference and other information about us can be obtained from us by calling 800-GABELLI (422-3554) or from the Securities and Exchange Commission&#8217;s (&#8220;SEC&#8221;) website (http://www.sec.gov).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investing in common stock involves certain risks, including risks related to a leveraged capital structure, that are described in the &#8220;Risk Factors and Special Considerations&#8221; section beginning on page 18 of the accompanying Prospectus.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 52; Options: NewSection -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NEITHER THE SEC NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED THESE SECURITIES OR DETERMINED IF THIS PROSPECTUS SUPPLEMENT IS TRUTHFUL OR COMPLETE. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left; padding-bottom: 1pt">&#160;</td>
    <td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Per Share</b></span></td>
    <td style="vertical-align: bottom; padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td>
    <td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td>
    <td style="vertical-align: bottom; padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; width: 76%; vertical-align: top">Public offering price</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> [&#9679;</span></td>
    <td style="width: 1%; text-align: left">]</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;</span></td>
    <td style="width: 1%; text-align: left">]</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Underwriting discounts and commissions</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;</span></td>
    <td style="text-align: left">]</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;</span></td>
    <td style="text-align: left">]</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Proceeds, before expenses, to the Fund (1)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> [&#9679;</span></td>
    <td style="text-align: left">]</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> [&#9679;</span></td>
    <td style="text-align: left">]</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The aggregate expenses of the offering (excluding underwriting discounts and commissions) are estimated to be $ [&#9679;], which represents approximately $ [&#9679;] per share.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The underwriters may also purchase up to [&#9679;] shares of additional common stock from us at the public offering price, less underwriting discounts and commissions, to cover over-allotments, if any, within 30 days after the date of this Prospectus Supplement. If the overallotment option is exercised in full, the total proceeds, before expenses, to the Fund would be $[&#9679;] and the total underwriting discounts and commissions would be $[&#9679;]. The underwriters are expected to deliver the common stock will be ready for delivery in book-entry form with The Depository Trust Company on or about [&#9679;],[&#9679;].</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The date of this Prospectus Supplement is [&#9679;], 2023.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 53 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>You should rely only on the information contained or incorporated by reference in this Prospectus Supplement and the accompanying Prospectus. Neither the Fund nor the underwriters have authorized anyone to provide you with different information. The Fund is not making an offer to sell these securities in any jurisdiction where the offer or sale is not permitted. You should not assume that the information contained in this Prospectus Supplement and the accompanying Prospectus is accurate as of any date other than the date of this Prospectus Supplement and the accompanying Prospectus, respectively. Our business, financial condition, results of operations and prospects may have changed since those dates. In this Prospectus Supplement and in the accompanying Prospectus, unless otherwise indicated, &#8220;Fund,&#8221; &#8220;us,&#8221; &#8220;our&#8221; and &#8220;we&#8221; refer to The Gabelli Equity Trust Inc., a Maryland corporation. This Prospectus Supplement also includes trademarks owned by other persons.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TABLE OF CONTENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Prospectus Supplement</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: top; text-align: left">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></td></tr>
  <tr style="vertical-align: top; text-align: left">
    <td style="padding-bottom: 3pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in; width: 90%; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#s_001">CAUTIONARY NOTICE REGARDING FORWARD-LOOKING STATEMENTS</a></span></td>
    <td style="padding-bottom: 3pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-4</span></td></tr>
  <tr style="vertical-align: top; text-align: left">
    <td style="padding-bottom: 3pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#s_002">TABLE OF FEES AND EXPENSES</a></span></td>
    <td style="padding-bottom: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-4</span></td></tr>
  <tr style="vertical-align: top; text-align: left">
    <td style="padding-bottom: 3pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#s_003">USE OF PROCEEDS</a></span></td>
    <td style="padding-bottom: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-5</span></td></tr>
  <tr style="vertical-align: top; text-align: left">
    <td style="padding-bottom: 3pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#s_004">CAPITALIZATION</a></span></td>
    <td style="padding-bottom: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-6</span></td></tr>
  <tr style="vertical-align: top; text-align: left">
    <td style="padding-bottom: 3pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#s_005">FINANCIAL HIGHLIGHTS</a></span></td>
    <td style="padding-bottom: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-6</span></td></tr>
  <tr style="vertical-align: top; text-align: left">
    <td style="padding-bottom: 3pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#s_006">PRICE RANGE OF COMMON STOCK</a></span></td>
    <td style="padding-bottom: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-6</span></td></tr>
  <tr style="vertical-align: top; text-align: left">
    <td style="padding-bottom: 3pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#s_007">UNDERWRITING</a></span></td>
    <td style="padding-bottom: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-6</span></td></tr>
  <tr style="vertical-align: top; text-align: left">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#s_008">LEGAL MATTERS</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-6</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Prospectus</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; width: 90%; text-align: justify"><a href="#a_001">PROSPECTUS SUMMARY</a></td>
    <td style="padding-bottom: 3pt; width: 1%">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; width: 9%; text-align: right">4</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_002">SUMMARY OF FUND EXPENSES</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">10</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_003">FINANCIAL HIGHLIGHTS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">12</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_004">USE OF PROCEEDS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">18</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_005">THE FUND</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">18</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_006">INVESTMENT OBJECTIVES AND POLICIES</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">18</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_007">RISK FACTORS AND SPECIAL CONSIDERATIONS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">18</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_008">HOW THE FUND MANAGES RISK</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">18</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_009">MANAGEMENT OF THE FUND</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">19</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_010">PORTFOLIO TRANSACTIONS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">24</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_011">DIVIDENDS AND DISTRIBUTIONS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">24</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_012">ISSUANCE OF COMMON STOCK</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">25</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_013">AUTOMATIC DIVIDEND REINVESTMENT AND VOLUNTARY CASH PURCHASE PLANS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">25</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_014">DESCRIPTION OF THE CAPITAL STOCK</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">25</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_015">ANTI-TAKEOVER PROVISIONS OF THE FUND&#8217;S GOVERNING DOCUMENTS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">35</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_016">CLOSED-END FUND STRUCTURE</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">39</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_017">REPURCHASE OF COMMON STOCK</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">39</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_018">RIGHTS OFFERINGS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">40</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_019">NET ASSET VALUE</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">40</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_020">LIMITATION ON DIRECTORS&#8217; AND OFFICERS&#8217; LIABILITY</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">41</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_021">TAXATION</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">41</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_022">CUSTODIAN, TRANSFER AGENT AND DIVIDEND DISBURSING AGENT</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">45</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_023">PLAN OF DISTRIBUTION</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">45</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_024">LEGAL MATTERS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">47</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_025">INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">47</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_026">ADDITIONAL INFORMATION</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">47</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_027">INCORPORATION BY REFERENCE</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">47</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: justify"><a href="#a_028">PRIVACY PRINCIPLES OF THE FUND</a></td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: right">48</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>&#160;</p>

<!-- Field: Page; Sequence: 54 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="s_001"></span>CAUTIONARY NOTICE REGARDING FORWARD-LOOKING STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Prospectus Supplement, the accompanying Prospectus and the Statement of Additional Information (the (&#8220;SAI&#8221;) contain &#8220;forward-looking statements.&#8221; Forward-looking statements can be identified by the words &#8220;may,&#8221; &#8220;will,&#8221; &#8220;intend,&#8221; &#8220;expect,&#8221; &#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; and similar terms and the negative of such terms. Such forward-looking statements may be contained in this Prospectus Supplement as well as in the accompanying Prospectus and in the SAI. By their nature, all forward-looking statements involve risks and uncertainties, and actual results could differ materially from those contemplated by the forward-looking statements. Several factors that could materially affect our actual results are the performance of the portfolio of securities we hold, the price at which our shares will trade in the public markets and other factors discussed in our periodic filings with the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although we believe that the expectations expressed in our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and are subject to inherent risks and uncertainties, such as those disclosed in the &#8220;Risk Factors and Special Considerations&#8221; section of the accompanying prospectus. All forward-looking statements contained or incorporated by reference in this Prospectus Supplement or the accompanying Prospectus, or in the SAI, are made as of the date of this Prospectus Supplement or the accompanying Prospectus, or SAI, as the case may be. Except for our ongoing obligations under the federal securities laws, we do not intend, and we undertake no obligation, to update any forward-looking statement. The forward-looking statements contained in this Prospectus Supplement, the accompanying Prospectus and the SAI are excluded from the safe harbor protection provided by Section&#160;27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently known risk factors that could cause actual results to differ materially from our expectations include, but are not limited to, the factors described in the &#8220;Risk Factors and Special Considerations&#8221; section of the accompanying Prospectus. We urge you to review carefully those sections for a more detailed discussion of the risks of an investment in our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="s_002"></span>TABLE OF FEES AND EXPENSES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following tables are intended to assist you in understanding the various costs and expenses directly or indirectly associated with investing in our common stock as a percentage of net assets attributable to common stock. Amounts are for the current fiscal year after giving effect to anticipated net proceeds of the offering, assuming that we incur the estimated offering expenses, including preferred stock offering expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shareholder Transaction Expenses </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Sales Load (as a percentage of offering price)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;</span></td>
    <td style="text-align: left">]%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Offering Expenses (as a percentage of offering price)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;</span></td>
    <td style="text-align: left">]%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Dividend Reinvestment Plan Fees</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</span></td>
    <td style="text-align: left">(1)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 68%; text-align: left">Voluntary Cash Purchase Plan Purchase Transaction Fee</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">0.75</td>
    <td style="width: 1%; text-align: left">(1)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Voluntary Cash Purchase Plan Sale Transaction Fee</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">2.50</td>
    <td style="text-align: left">(1)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; vertical-align: top"><b>&#160;</b></td>
    <td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><b>Percentage&#160;of<br /> Net Assets<br /> Attributable&#160;to<br /> Common Stock</b></td>
    <td style="white-space: nowrap; padding-bottom: 1pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><b>Annual Expenses</b></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 68%; text-align: left">Management Fees</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: right; width: 9%; vertical-align: bottom">[&#9679;</td>
    <td style="white-space: nowrap; width: 1%">]%(2)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Interest on Borrowed Funds</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right; vertical-align: bottom">[&#9679;</td>
    <td style="white-space: nowrap">]</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Other Expenses</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom">[&#9679;</td>
    <td style="white-space: nowrap">]%(3)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Total Annual Expenses</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right; vertical-align: bottom">[&#9679;</td>
    <td style="white-space: nowrap">]%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Dividends on Preferred Stock</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right; vertical-align: bottom">[&#9679;</td>
    <td style="padding-bottom: 2.5pt; white-space: nowrap">]%(4)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Total Annual Expenses and Dividends on Preferred Stock</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right; vertical-align: bottom">[&#9679;</td>
    <td style="padding-bottom: 2.5pt; white-space: nowrap">]%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 55 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There are no fees charged to stockholders for participating in the Fund&#8217;s Automatic Dividend Reinvestment and Voluntary Cash Purchase Plan. However, stockholders participating in the Plan that elect to make additional cash purchases under the Plan would pay $0.75 per transaction plus a per share fee (which includes any applicable brokerage commissions) to purchase shares and $2.50 per transaction plus a per share fee (which includes any applicable brokerage commissions) to sell shares.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Investment Adviser&#8217;s fee is 1.00% annually of the Fund&#8217;s average weekly net assets. The Fund&#8217;s average weekly net assets will be deemed to be the average weekly value of the Fund&#8217;s total assets minus the sum of the Fund&#8217;s liabilities (such liabilities exclude (i) the aggregate liquidation preference of outstanding shares of preferred stock and accumulated dividends, if any, on those shares and (ii) the liabilities for any money borrowed). Consequently, because the Fund has shares of preferred stock outstanding, the investment management fees and other expenses as a percentage of net assets attributable to common stock are higher than if the Fund did not utilize a leveraged capital structure.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Other Expenses&#8221; are based on estimated amounts for the current year assuming completion of the proposed issuances.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends on Preferred Stock represent distributions on the existing preferred stock outstanding. There can, of course, be no guarantee that any preferred stock would be issued or, if issued, the terms thereof.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The purpose of the table above and the example below is to help you understand all fees and expenses that you, as a holder of common stock, would bear directly or indirectly.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Example</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following example illustrates the expenses (including the maximum estimated sales load of $[&#9679;] and estimated offering expenses of $[&#9679;] from the issuance of $[&#9679;] million in common stock) you would pay on a $1,000 investment in common stock, assuming a 5% annual portfolio total return.* The actual amounts in connection with any offering will be set forth in the Prospectus Supplement if applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1 Year</b></span></td>
    <td style="vertical-align: bottom; padding-bottom: 1pt; text-align: center"><b>&#160;</b></td>
    <td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3 Years</b></span></td>
    <td style="vertical-align: bottom; padding-bottom: 1pt; text-align: center"><b>&#160;</b></td>
    <td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5 Years</b></span></td>
    <td style="vertical-align: bottom; padding-bottom: 1pt; text-align: center"><b>&#160;</b></td>
    <td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10 Years</b></span></td>
    <td style="vertical-align: bottom; padding-bottom: 1pt; text-align: center"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 52%; text-align: left">Total Expenses Incurred</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;</span></td>
    <td style="width: 1%; text-align: left">]</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;</span></td>
    <td style="width: 1%; text-align: left">]</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;</span></td>
    <td style="width: 1%; text-align: left">]</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;</span></td>
    <td style="width: 1%; text-align: left">]</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The example should not be considered a representation of future expenses. The example assumes that the amounts set forth in the Annual Expenses table are accurate and that all distributions are reinvested at net asset value. Actual expenses may be greater or less than those assumed. Moreover, the Fund&#8217;s actual rate of return may be greater or less than the hypothetical 5% return shown in the example.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="s_003"></span>USE OF PROCEEDS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We estimate the total net proceeds of the offering to be $[&#9679;] ($[&#9679;] if the over-allotment option is exercised in full), based on the public offering price of $[&#9679;] per share and after deducting underwriting discounts and commissions and estimated offering expenses payable by us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Investment Adviser expects that it will initially invest the proceeds of the offering in high-quality short term debt securities and instruments. The Investment Adviser anticipates that the investment of the proceeds will be made in accordance with the Fund&#8217;s investment objectives and policies as appropriate investment opportunities are identified, which is expected to be substantially completed within three months; however, changes in market conditions could result in the Fund&#8217;s anticipated investment period extending to as long as six months. This could occur because the Investment Adviser follows a value-oriented investment strategy; therefore, market conditions could result in the Investment Adviser delaying the investment of proceeds if it believes the margin of risk in making additional investments is not favorable in light of its value-oriented investment strategy. See &#8220;Investment Objectives and Policies&#8212;Investment Methodology of the Fund&#8221; in the accompanying Prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 56 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="s_004"></span>CAPITALIZATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[To be provided.]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="s_005"></span>FINANCIAL HIGHLIGHTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[To be provided.]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="s_006"></span>PRICE RANGE OF COMMON STOCK</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth for the quarters indicated, the high and low sale prices on the New York Stock Exchange per share of our common stock and the net asset value and the premium or discount from net asset value per share at which the shares of common stock were trading, expressed as a percentage of net asset value, at each of the high and low sale prices provided.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[To be provided.]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The last reported price for our common stock on [&#9679;], 2023 was $[&#9679;] per share. As of [&#9679;], 2023, the net asset value per share of the Fund&#8217;s common stock was $[&#9679;]. Accordingly, our common stock traded at a [premium to] [discount from] net asset value of [&#9679;]% on [&#9679;], 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund&#8217;s shares of common stock have traded in the market at both premiums to and discounts from net asset value. [Over the Fund&#8217;s thirty-seven year history, the range fluctuated from a 38% premium in June&#160;2002 to a 27% discount in December&#160;1987.] Beginning in early 2001, the market price of the Fund exceeded the net asset value and this premium continued through September&#160;2005. The previous extended period over which the premium existed occurred during the twenty month period from August&#160;1993 to March&#160;1995. As of [&#9679;], 2023, the market price of the Fund closed at an approximate [&#9679;]% [premium] to its net asset value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="s_007"></span>UNDERWRITING</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[To be provided.]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="s_008"></span>LEGAL MATTERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain legal matters will be passed on by Willkie Farr &amp; Gallagher LLP, New York, New York, counsel to the Fund in connection with the offering of the common stock. Certain legal matters in connection with this offering will be passed upon for the underwriters by [&#9679;]. Willkie Farr &amp; Gallagher LLP and [&#9679;] may rely as to certain matters of Maryland law on the opinion of Venable LLP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[The Fund&#8217;s unaudited financial statements as of and for the six months ended June&#160;30, 202[&#9679;] should be read in conjunction with the audited financial statements of the Fund and the Notes thereto included in the Annual Report to the Fund&#8217;s shareholders for the fiscal year ended December&#160;31, 202[&#9679;].] The audited annual financial statements of the Fund for the fiscal year ended December&#160;31, 202[&#9679;] [and the unaudited semiannual financial statements of the Fund for the six months ended June&#160;30, 202[&#9679;]] are incorporated by reference into this Prospectus Supplement, the accompanying Prospectus and the SAI. Portions of the Fund&#8217;s annual report [and semiannual report] other than the financial statements and related footnotes thereto are not incorporated into, and do not form a part of, this Prospectus Supplement, the accompanying Prospectus or the SAI.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 57 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b>THE GABELLI EQUITY TRUST INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>PROSPECTUS SUPPLEMENT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;[&#9679;], 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 58 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><b>The information in this Prospectus Supplement is not complete and may be changed. The Fund may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This Prospectus Supplement is not an offer to sell these securities and is not soliciting offers to buy these securities in any state where the offer or sale is not permitted.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><b>SUBJECT TO COMPLETION, DATED [&#9679;], 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed Pursuant to Rule&#160;424(b)([&#9679;])<br />Registration Statement No. 333-[&#9679;]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>THE GABELLI EQUITY TRUST INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROSPECTUS SUPPLEMENT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(To Prospectus dated [&#9679;], 2023)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$[&#9679;]</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>% Series [&#9679;] Preferred Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Liquidation Preference $[&#9679;] per share)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Gabelli Equity Trust Inc. (the &#8220;Fund,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221;) is offering [&#9679;] shares of [&#9679;]% Series [&#9679;] Preferred Stock, par value $0.001 per share (the &#8220;Series [&#9679;] Preferred Shares&#8221;). The Series [&#9679;] Preferred Shares will constitute a separate series of the Fund&#8217;s preferred stock. Investors in Series [&#9679;] Preferred Shares will be entitled to receive cumulative cash dividends at a rate of [&#9679;]% per annum. Dividends and distributions on Series [&#9679;] Preferred Shares will be payable [&#9679;].</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Series [&#9679;] Preferred Shares are redeemable at our option on or after [&#9679;], and are subject to mandatory redemption by us in certain circumstances. See &#8220;Special Characteristics and Risks of the Series [&#9679;] Preferred Shares&#8212;Redemption.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund is a diversified, closed-end management investment company registered under the Investment Company Act of 1940, as amended (the &#8220;1940 Act&#8221;). The Fund&#8217;s primary investment objective is to achieve long term growth of capital by investing primarily in a portfolio of equity securities consisting of common stock, preferred stock, convertible or exchangeable securities, and warrants and rights to purchase such securities. Income is a secondary investment objective. Under normal market conditions, the Fund will invest at least 80% of the value of its total assets in equity securities. The Fund&#8217;s investment adviser is Gabelli Funds, LLC (the &#8220;Investment Adviser&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund&#8217;s common shares are listed on the New York Stock Exchange (&#8220;NYSE&#8221;) under the symbol &#8220;GAB.&#8221; Currently, the Fund&#8217;s Series G Cumulative Preferred Stock (&#8220;Series G Preferred&#8221;), 5.00% Series H Cumulative Preferred Stock (&#8220;Series H Preferred&#8221;) and 5.00% Series K Cumulative Preferred Stock (&#8220;Series K Preferred&#8221;) are listed on the NYSE under the symbol &#8220;GAB PrG,&#8221; &#8220;GAB PrH&#8221; and &#8220;GAB PrK,&#8221; respectively. The Fund&#8217;s Series C Auction Rate Cumulative Preferred Stock (&#8220;Series C Auction Rate Preferred&#8221;), Series E Auction Rate Preferred Stock (&#8220;Series E Auction Rate Preferred&#8221;), 4.25% Series M Cumulative Preferred Stock (&#8220;Series M Preferred&#8221;) and 5.25% Series N Cumulative Preferred Stock (&#8220;Series N Preferred&#8221;) are not traded on a stock exchange. Any future series of fixed rate preferred stock would also likely be listed on a stock exchange. On [&#9679;], 2023, the last reported NYSE sale price of shares of our common stock was $[&#9679;] per share. The net asset value of shares of the Fund&#8217;s common stock at the close of business on [&#9679;], 2023 was $[&#9679;] per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Application [has been] [will be] made to list the Series [&#9679;] Preferred Shares on the [&#9679;]. If the application is approved, the Series [&#9679;] Preferred Shares are expected to commence trading on the [&#9679;] within [&#9679;] days of the date of issuance.]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 59; Options: NewSection -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">P-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Sales of our preferred stock, if any, under this Prospectus Supplement and the accompanying Prospectus may be made in negotiated transactions or transactions that are deemed to be &#8220;at the market&#8221; as defined in Rule&#160;415 under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), including sales made directly on the NYSE or sales made to or through a market maker other than on an exchange.]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An investment in the Fund is not appropriate for all investors. We cannot assure you that the Fund&#8217;s investment objectives will be achieved. You should read this Prospectus Supplement and the accompanying Prospectus before deciding whether to invest in Series [&#9679;] Preferred Shares and retain it for future reference. The Prospectus Supplement and the accompanying Prospectus contain important information about us. Material that has been incorporated by reference and other information about us can be obtained from us by calling 800-GABELLI (422-3554) or from the Securities and Exchange Commission&#8217;s (&#8220;SEC&#8221;) website (http://www.sec.gov).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investing in Series [&#9679;] Preferred Shares involves certain risks, including risks related to a leveraged capital structure, that are described in the &#8220;Special Characteristics and Risks of the Series [&#9679;] Preferred Shares&#8221; section of this Prospectus Supplement and the &#8220;Risk Factors and Special Considerations&#8221; section beginning on page 18 of the accompanying Prospectus.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NEITHER THE SEC NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED THESE SECURITIES OR DETERMINED IF THIS PROSPECTUS SUPPLEMENT IS TRUTHFUL OR COMPLETE. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left; padding-bottom: 1pt">&#160;</td>
    <td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Per Share</b></span></td>
    <td style="vertical-align: bottom; padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td>
    <td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td>
    <td style="vertical-align: bottom; padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; width: 76%; vertical-align: top">Public offering price</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;</span></td>
    <td style="width: 1%; text-align: left">]</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;</span></td>
    <td style="width: 1%; text-align: left">]</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Underwriting discounts and commissions</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;</span></td>
    <td style="text-align: left">]</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;</span></td>
    <td style="text-align: left">]</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Proceeds, before expenses, to the Fund (1)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;</span></td>
    <td style="text-align: left">]</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;</span></td>
    <td style="text-align: left">]</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The aggregate expenses of the offering (excluding underwriting discounts and commissions) are estimated to be $[&#9679;].</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Underwriters are expected to deliver the Series [&#9679;] Preferred Shares in book-entry form through The Depository Trust Company on or about [&#9679;].</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The date of this Prospectus Supplement is [&#9679;], 2023.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 60 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">P-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>You should rely only on the information contained or incorporated by reference in this Prospectus Supplement and the accompanying Prospectus. Neither the Fund nor the underwriters have authorized anyone to provide you with different information. The Fund is not making an offer to sell these securities in any jurisdiction where the offer or sale is not permitted. You should not assume that the information contained in this Prospectus Supplement and the accompanying Prospectus is accurate as of any date other than the date of this Prospectus Supplement and the accompanying Prospectus, respectively. Our business, financial condition, results of operations and prospects may have changed since those dates. In this Prospectus Supplement and in the accompanying Prospectus, unless otherwise indicated, &#8220;Fund,&#8221; &#8220;us,&#8221; &#8220;our&#8221; and &#8220;we&#8221; refer to The Gabelli Equity Trust Inc., a Maryland corporation. This Prospectus Supplement also includes trademarks owned by other persons.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TABLE OF CONTENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Prospectus Supplement</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom"><b>Page</b></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 3pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in; width: 90%; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#p_001">CAUTIONARY NOTICE REGARDING FORWARD-LOOKING STATEMENTS</a> </span></td>
    <td style="padding-bottom: 3pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">P-4</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 3pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#p_002">SUMMARY OF THE TERMS OF THE SERIES [&#9679;] PREFERRED SHARES</a></span></td>
    <td style="padding-bottom: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">P-5</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 3pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#p_003">DESCRIPTION OF THE SERIES [&#9679;] PREFERRED SHARES</a></span></td>
    <td style="padding-bottom: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">P-7</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 3pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#p_004">USE OF PROCEEDS</a></span></td>
    <td style="padding-bottom: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">P-8</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 3pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#p_005">CAPITALIZATION</a></span></td>
    <td style="padding-bottom: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">P-8</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 3pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#p_006">ASSET COVERAGE RATIO</a></span></td>
    <td style="padding-bottom: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">P-8</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 3pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#p_007">SPECIAL CHARACTERISTICS AND RISKS OF THE SERIES [&#9679;] PREFERRED SHARES</a></span></td>
    <td style="padding-bottom: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">P-9</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 3pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#p_008">U.S. FEDERAL INCOME TAX CONSEQUENCES OF THE OFFERING</a></span></td>
    <td style="padding-bottom: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">P-13</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 3pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#p_009">CERTAIN EMPLOYEE BENEFIT PLAN AND IRA CONSIDERATIONS</a></span></td>
    <td style="padding-bottom: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">P-13</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 3pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#p_010">UNDERWRITING</a></span></td>
    <td style="padding-bottom: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">P-13</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#p_011">LEGAL MATTERS</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">P-13</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Prospectus</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; width: 90%; text-align: justify"><a href="#a_001">PROSPECTUS SUMMARY</a></td>
    <td style="padding-bottom: 3pt; width: 1%">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; width: 9%; text-align: right">4</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_002">SUMMARY OF FUND EXPENSES</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">10</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_003">FINANCIAL HIGHLIGHTS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">12</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_004">USE OF PROCEEDS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">18</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_005">THE FUND</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">18</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_006">INVESTMENT OBJECTIVES AND POLICIES</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">18</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_007">RISK FACTORS AND SPECIAL CONSIDERATIONS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">18</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_008">HOW THE FUND MANAGES RISK</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">18</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_009">MANAGEMENT OF THE FUND</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">19</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_010">PORTFOLIO TRANSACTIONS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">24</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_011">DIVIDENDS AND DISTRIBUTIONS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">24</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_012">ISSUANCE OF COMMON STOCK</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">25</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_013">AUTOMATIC DIVIDEND REINVESTMENT AND VOLUNTARY CASH PURCHASE PLANS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">25</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_014">DESCRIPTION OF THE CAPITAL STOCK</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">25</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_015">ANTI-TAKEOVER PROVISIONS OF THE FUND&#8217;S GOVERNING DOCUMENTS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">35</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_016">CLOSED-END FUND STRUCTURE</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">39</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_017">REPURCHASE OF COMMON STOCK</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">39</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_018">RIGHTS OFFERINGS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">40</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_019">NET ASSET VALUE</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">40</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_020">LIMITATION ON DIRECTORS&#8217; AND OFFICERS&#8217; LIABILITY</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">41</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_021">TAXATION</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">41</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_022">CUSTODIAN, TRANSFER AGENT AND DIVIDEND DISBURSING AGENT</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">45</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_023">PLAN OF DISTRIBUTION</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">45</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_024">LEGAL MATTERS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">47</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_025">INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">47</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_026">ADDITIONAL INFORMATION</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">47</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_027">INCORPORATION BY REFERENCE</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">47</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: justify"><a href="#a_028">PRIVACY PRINCIPLES OF THE FUND</a></td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: right">48</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 61 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">P-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="p_001"></span>CAUTIONARY NOTICE REGARDING FORWARD-LOOKING STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Prospectus Supplement, the accompanying Prospectus and the Statement of Additional Information (the &#8220;SAI&#8221;) contain &#8220;forward-looking statements.&#8221; Forward-looking statements can be identified by the words &#8220;may,&#8221; &#8220;will,&#8221; &#8220;intend,&#8221; &#8220;expect,&#8221; &#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; and similar terms and the negative of such terms. Such forward-looking statements may be contained in this Prospectus Supplement as well as in the accompanying Prospectus and in the SAI. By their nature, all forward-looking statements involve risks and uncertainties, and actual results could differ materially from those contemplated by the forward-looking statements. Several factors that could materially affect our actual results are the performance of the portfolio of securities we hold, the price at which our shares (including the Series [&#9679;] Preferred Shares) will trade in the public markets and other factors discussed in our periodic filings with the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although we believe that the expectations expressed in our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and are subject to inherent risks and uncertainties, such as those disclosed in the &#8220;Risk Factors and Special Considerations&#8221; section of the accompanying Prospectus and &#8220;Special Characteristics and Risks of the Series [&#9679;] Preferred Shares&#8221; in this Prospectus Supplement. All forward-looking statements contained or incorporated by reference in this Prospectus Supplement or the accompanying Prospectus, or in the SAI are made as of the date of this Prospectus Supplement or the accompanying Prospectus, or SAI, as the case may be. Except for our ongoing obligations under the federal securities laws, we do not intend, and we undertake no obligation, to update any forward-looking statement. The forward-looking statements contained in this Prospectus Supplement, the accompanying Prospectus and the SAI are excluded from the safe harbor protection provided by Section&#160;27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently known risk factors that could cause actual results to differ materially from our expectations include, but are not limited to, the factors described in the &#8220;Risk Factors and Special Considerations&#8221; section of the accompanying Prospectus as well as in the &#8220;Special Characteristics and Risks of the Series [&#9679;] Preferred Shares&#8221; section of this Prospectus Supplement. We urge you to review carefully those sections for a more detailed discussion of the risks of an investment in the Series [&#9679;] Preferred Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 62 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">P-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="p_002"></span>SUMMARY OF THE TERMS OF THE SERIES [&#9679;] PREFERRED SHARES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>This Prospectus Supplement sets forth certain terms of the Series [</i>&#9679;<i>] Preferred Shares that we are offering pursuant to this Prospectus Supplement and the accompanying Prospectus that is attached to the back of this Prospectus Supplement. This section outlines certain specific legal and financial terms of the Series [</i>&#9679;<i>] Preferred Shares that are more generally described under the heading &#8220;Special Characteristics and Risks of the Series [</i>&#9679;<i>] Preferred Shares&#8221; herein and in the accompanying Prospectus under the heading &#8220;Description of the Securities.&#8221; Capitalized terms used in this Prospectus Supplement and not otherwise defined shall have the meanings ascribed to them in the accompanying Prospectus or in the Articles Supplementary governing and establishing the terms of the Series [</i>&#9679;<i>] Preferred Shares.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; width: 27%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The Fund</b></span></td>
    <td style="width: 3%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Gabelli Equity Trust Inc., a Maryland corporation, is a diversified, closed-end management investment company registered under the 1940 Act. The Fund&#8217;s primary investment objective is to achieve long term growth of capital by investing primarily in a portfolio of equity securities consisting of common stock, preferred stock, convertible or exchangeable securities, and warrants and rights to purchase such securities. Income is a secondary investment objective. Gabelli Funds, LLC serves as investment adviser to the Fund. Under normal market conditions, the Fund will invest at least 80% of the value of its total assets in equity securities. The Fund was incorporated in Maryland on May&#160;20, 1986 and commenced its investment operations on August&#160;21, 1986. Shares of the Fund&#8217;s common stock are traded on the NYSE under the symbol &#8220;GAB.&#8221;</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities Offered</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;] Series [&#9679;] Preferred Shares. Series [&#9679;] Preferred Shares will constitute a separate series of preferred stock of the Fund. The Series [&#9679;] Preferred Shares have the same priority with respect to payment of distributions and liquidation preference as the Series C Auction Rate Preferred, Series E Auction Rate Preferred, Series G Preferred, Series H Preferred, Series K Preferred, Series M Preferred and Series N Preferred.</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dividend Rate</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends and distributions on Series [&#9679;] Preferred Shares are cumulative from their original issue date at the annual rate of [&#9679;]% of the $[&#9679;] per-share liquidation preference on the Series [&#9679;] Preferred Shares.</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dividend Payment Date</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders of Series [&#9679;] Preferred Shares shall be entitled to receive, when, as and if authorized by, or under authority granted by, the Board of Directors and declared by the Fund, out of funds legally available therefor, cumulative cash dividends and distributions. Dividends and distributions will be paid [&#9679;], commencing on [&#9679;].</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liquidation Preference</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$[&#9679;] per share.</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of Proceeds</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[The Fund expects to use the proceeds of the offering of the Series [&#9679;] Preferred Shares to redeem the outstanding shares of its [&#9679;]% Series [&#9679;] Preferred Shares (the &#8220;Series [&#9679;] Preferred&#8221;). Amounts in excess of the redemption amount for all outstanding Series [&#9679;] Preferred may be used to redeem or repurchase other existing series of preferred stock of the Fund, in whole or in part, in accordance with the terms of any such series of preferred stock or for investment purposes consistent with the investment objectives of the Fund.] OR [The Fund does not expect to use the proceeds of the offering to redeem or repurchase existing series of preferred stock.]</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Investment Adviser anticipates that any investment of the proceeds will be made in accordance with the Fund&#8217;s investment objectives and policies as appropriate investment opportunities are identified, which is expected to be substantially completed within approximately three months of the issue date; however, the identification of appropriate investment opportunities pursuant to the Fund&#8217;s investment style or changes in market conditions may cause the investment period to extend as long as six months from the issue date. This could occur because the Investment Adviser follows a value-oriented investment strategy; therefore, market conditions could result in the Investment Adviser delaying the investment of proceeds if it believes the margin of risk in making additional investments is not favorable in light of its value-oriented investment strategy. See &#8220;Investment Objectives and Policies&#8212;Investment Methodology of the Fund&#8221; in the accompanying Prospectus.</span></td> </tr>
  </table>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 63 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">P-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; width: 27%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 3%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pending such redemption and/or investment, the proceeds of the offering of the Series [&#9679;] Preferred Shares will be held in high quality short term debt securities and similar instruments. See &#8220;Use of Proceeds.&#8221;</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-Call Period/Redemption</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[The Series [&#9679;] Preferred Shares generally may not be called for redemption at the option of the Fund prior to [&#9679;]. The Fund reserves the right, however, to redeem the Series [&#9679;] Preferred Shares at any time if it is necessary, in the judgment of the Board of Directors, to maintain its status as a regulated investment company under Subchapter M of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;). The Fund also may be required under certain circumstances to redeem Series [&#9679;] Preferred Shares, before or after [&#9679;], in order to meet certain regulatory or rating agency asset coverage requirements.</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commencing [&#9679;], and thereafter, to the extent permitted by the 1940 Act and Maryland law, the Fund may at any time, upon notice of redemption, redeem the Series [&#9679;] Preferred Shares in whole or in part at the liquidation preference per share plus accumulated unpaid dividends and distributions (whether or not earned or declared) through and including the date of redemption.]</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock Exchange Listing</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Application [will be] [has been] made to list the Series [&#9679;] Preferred Shares on the [&#9679;]. Prior to the offering, there has been no public market for Series [&#9679;] Preferred Shares. If the application is approved, it is anticipated that trading on the [&#9679;] will begin within [&#9679;] days from the date of this Prospectus Supplement. Before the Series [&#9679;] Preferred Shares are listed on the [&#9679;], the underwriters may, but are not obligated to, make a market in the Series [&#9679;] Preferred Shares. Consequently, it is anticipated that, prior to the commencement of trading on the [&#9679;], an investment in the Series [&#9679;] Preferred Shares will be illiquid.</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Taxation</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund expects that distributions made on the Series [&#9679;] Preferred Shares will consist of (i) long term capital gain (gain from the sale of a capital asset held longer than one year), (ii) qualified dividend income (dividend income from certain domestic and foreign corporations, provided certain holding period and other requirements are met by both the Fund and the stockholder), and (iii) investment company taxable income (other than qualified dividend income, including interest income, short term capital gain and income from certain hedging and interest rate transactions). Distributions paid to investors by the Fund from its investment company taxable income which includes the excess of net short term capital gains over net long term capital losses (together referred to hereinafter as &#8220;ordinary income dividends&#8221;) are generally taxable to investors as ordinary income to the extent of the earnings and profits of the Fund. Such distributions (if reported by the Fund) may, however, qualify (provided holding periods and other requirements are met) (i) for the dividends received deduction in the case of corporate stockholders to the extent that the income of the Fund consists of dividend income from U.S. corporations, and (ii) as qualified dividend income generally eligible for the reduced maximum federal tax rate to individuals applicable to net long term capital gains. Distributions made to investors from an excess of net long term capital gains over net short term capital losses (&#8220;capital gain dividends&#8221;), including capital gain dividends credited to investors but retained by the Fund, are taxable to investors as long term capital gains if they have been properly designated by the Fund, regardless of the length of time investors have owned shares of stock of the Fund. The maximum federal income tax rate on net long term capital gain of individuals is generally either 15% or 20% depending on whether an individual&#8217;s income exceeds certain threshold amounts. In addition, certain U.S. stockholders who are individuals, estates or trusts and whose income exceeds certain thresholds will be required to pay a 3.8% Medicare surcharge on their net investment income. We cannot assure you, however, as to what percentage of future distributions made on the Series [&#9679;] Preferred Shares will consist of long term capital gain and qualified dividend income. See &#8220;<i>U.S. Federal Income Tax Consequences of the Offering.</i>&#8221;</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ERISA</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>See &#8220;Certain Employee Benefit Plan and IRA Considerations.&#8221;</i></span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dividend Paying Agent</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;].</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 64 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">P-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="p_003"></span>DESCRIPTION OF THE SERIES [&#9679;] PREFERRED SHARES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following is a brief description of the terms of the Series [&#9679;] Preferred Shares. This is intended to be a summary of the material provisions of the Fund&#8217;s Articles Supplementary designating and fixing the rights of the Series [&#9679;] Preferred Shares (the &#8220;Articles&#8221;). Since this disclosure is only a summary, you should refer to the Articles for a complete description of the obligations of the Fund and your rights. The Articles are attached as an exhibit to post-effective amendment number [&#9679;] to the Fund&#8217;s registration statement. Copies may be obtained as described under &#8220;Additional Information&#8221; in the accompanying Prospectus. Any capitalized terms in this section and the &#8220;Special Characteristics and Risks of the Series [&#9679;] Preferred Shares&#8221; section of this Prospectus Supplement that are not defined have the meaning assigned to them in the Articles.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund&#8217;s charter (the &#8220;Charter&#8221;) authorizes its Board of Directors to reclassify any authorized but unissued shares of the Fund&#8217;s capital stock, $0.001 par value per share, without the approval of common stockholders. The Articles authorize the issuance of up to [&#9679;] Series [&#9679;] Preferred Shares. All Series [&#9679;] Preferred Shares will have a liquidation preference of $[&#9679;] per share. Holders of Series [&#9679;] Preferred Shares shall be entitled to receive cumulative cash dividends and distributions at the rate of [&#9679;]% per annum (computed on the basis of a 360-day year consisting of twelve 30-day months) of the $[&#9679;] per-share liquidation preference on the Series [&#9679;] Preferred Shares. Dividends and distributions on Series [&#9679;] Preferred Shares will accumulate from the date of their original issue, which is [&#9679;].</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Series [&#9679;] Preferred Shares, when issued by the Fund and paid for pursuant to the terms of this Prospectus Supplement and the accompanying Prospectus, will be fully paid and non-assessable and will have no preemptive, exchange or conversion rights. Any Series [&#9679;] Preferred Shares purchased or redeemed by the Fund will be reclassified as authorized and unissued shares of preferred stock of the Fund without further designation as to class or series. The Board of Directors may by resolution classify or reclassify any authorized and unissued Series [&#9679;] Preferred Shares from time to time by setting or changing the preferences, conversion or other rights, voting powers, restrictions, limitations as to dividends and distributions, qualifications or terms or conditions of redemption of such shares. The affirmative vote of the holders of a majority, as defined in the 1940 Act, of the outstanding Series [&#9679;] Preferred Shares (or shares of any other series of the Fund&#8217;s preferred stock), voting separately from the holders of any other series of the Fund&#8217;s preferred stock (to the extent its rights are affected differently), will be required with respect to any matter that materially and adversely affects the rights, preferences or powers of that series in a manner different from that of other series or classes of the Fund&#8217;s capital stock. The affirmative vote of the holders of a majority, as defined in the 1940 Act, of the outstanding shares of the Fund&#8217;s preferred stock, voting together as a separate class (including the Series [&#9679;] Preferred Shares), shall be required to amend, alter or repeal the provisions of the Fund&#8217;s Charter or bylaws, whether by merger, consolidation or otherwise, if such amendment, alteration or repeal would affect adversely the rights, preferences or powers expressly set forth in any articles supplementary of the Fund&#8217;s preferred stock, including the Articles, unless, in each case, the Fund obtains written confirmation from any rating agency then rating such series of preferred stock, including the Series [&#9679;] Preferred Shares, at the Fund&#8217;s request that such amendment, alteration or repeal would not impair the rating then assigned by such rating agency to the Series [&#9679;] Preferred Shares, in which case the vote or consent of the holders of such series of preferred stock, including the Series [&#9679;] Preferred Shares, is not required. No matter shall be deemed to adversely affect any rights, preferences or powers of the Series [&#9679;] Preferred Shares unless such matter (i) adversely alters or abolishes any preferential right of such series; (ii) creates, adversely alters or abolishes any right in respect of redemption of such series; or (iii) creates or adversely alters (other than to abolish) any restriction on transfer applicable to such series. An increase in the number of authorized shares of preferred stock of the Fund pursuant to the Charter or the issuance of additional shares of any series of preferred stock of the Fund (including the Series [&#9679;] Preferred Shares) pursuant to the Charter shall not in and of itself be considered to adversely affect the contract rights of the holders of the Series [&#9679;] Preferred Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The disclosure set forth in this Description of the Series [&#9679;] Preferred Shares and under the heading &#8220;Special Characteristics and Risks of the Series [&#9679;] Preferred Shares&#8221; is intended to be a summary of the material provisions of the Series [&#9679;] Preferred Shares. Since this Description of the Series [&#9679;] Preferred Shares is only a summary, you should refer to the Articles for a complete description of the obligations of the Fund and your rights. The disclosure set forth in this Description of the Series [&#9679;] Preferred Shares and under the heading &#8220;Special Characteristics and Risks of the Series [&#9679;] Preferred Shares&#8221; supplements the description of the preferred stock set forth under the caption &#8220;Description of the Capital Stock &#8211; Preferred Stock&#8221; in the accompanying Prospectus, and in the event that any provision described in the disclosure set forth in this Description of the Series [&#9679;] Preferred Shares and under the heading &#8220;Special Characteristics and Risks of the Series [&#9679;] Preferred Shares&#8221; is inconsistent with any description contained in the accompanying Prospectus, the disclosure set forth in this Description of the Series [&#9679;] Preferred Shares and under the heading &#8220;Special Characteristics and Risks of the Series [&#9679;] Preferred Shares&#8221; will apply and supersede the description in the accompanying Prospectus.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 65 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">P-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="p_004"></span>USE OF PROCEEDS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund estimates the total net proceeds of the offering to be $[&#9679;] based on the public offering price of $[&#9679;] per share and after deduction of the underwriting discounts and commissions and estimated offering expenses payable by the Fund.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[The Fund expects to use the proceeds of the offering of the Series [&#9679;] Preferred Shares to redeem the outstanding Series [&#9679;] Preferred Shares. Amounts in excess of the redemption amount for all outstanding Series [&#9679;] Preferred Shares may be used to redeem or repurchase other existing series of preferred stock of the Fund, in whole or in part, in accordance with the terms of any such series of preferred stock or for investment purposes consistent with the investment objectives of the Fund.] OR [The Fund does not expect to use the proceeds of the offering to redeem or repurchase existing series of preferred stock.]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Investment Adviser anticipates that any investment of the proceeds will be made in accordance with the Fund&#8217;s investment objectives and policies as appropriate investment opportunities are identified, which is expected to be substantially completed within approximately three months of the issue date; however, the identification of appropriate investment opportunities pursuant to the Fund&#8217;s investment style or changes in market conditions may cause the investment period to extend as long as six months from the issue date. This could occur because the Investment Adviser follows a value-oriented investment strategy; therefore, market conditions could result in the Investment Adviser delaying the investment of proceeds if it believes the margin of risk in making additional investments is not favorable in light of its value-oriented investment strategy. See &#8220;Investment Objectives and Policies&#8212;Investment Methodology of the Fund&#8221; in the accompanying Prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pending such redemption and/or investment, the proceeds of the offering of the Series [&#9679;] Preferred Shares will be held in high quality short term debt securities and similar instruments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="p_005"></span>CAPITALIZATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[To be provided.]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="p_006"></span>ASSET COVERAGE RATIO</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to the 1940 Act, the Fund generally will not be permitted to declare any dividend, or declare any other distribution, upon any outstanding shares of common stock, or purchase any such common stock, unless, in every such case, all shares of preferred stock issued by the Fund have at the time of declaration of any such dividend or distribution or at the time of any such purchase an asset coverage of at least 200% (&#8220;1940 Act Asset Coverage Requirement&#8221;) after deducting the amount of such dividend, distribution, or purchase price, as the case may be. As of the date of this Prospectus Supplement, all of the Fund&#8217;s outstanding shares of preferred stock are expected to have asset coverage on the date of issuance of the Series [&#9679;] Preferred Shares of approximately [&#9679;]%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition to the 1940 Act Asset Coverage Requirement, the Fund is subject to certain restrictions on investments imposed by guidelines of one or more rating agencies, which have issued ratings for certain of the shares of preferred stock and may issue a rating for the Series [&#9679;] Preferred Shares. [See &#8220;Special Characteristics and Risks of the Series [&#9679;] Preferred Shares&#8212;Risks&#8212;Credit Rating Risk&#8221; in this Prospectus Supplement.]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 66 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">P-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="p_007"></span>SPECIAL CHARACTERISTICS AND RISKS OF THE SERIES [&#9679;] PREFERRED SHARES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dividends</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders of Series [&#9679;] Preferred Shares shall be entitled to receive cumulative cash dividends and distributions at the rate of [&#9679;]% per annum (computed on the basis of a 360-day year consisting of twelve 30-day months) of the $[&#9679;] per-share liquidation preference on the Series [&#9679;] Preferred Shares. Dividends and distributions on Series [&#9679;] Preferred Shares will accumulate from the date of their original issue, which is [&#9679;].</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends and distributions will be payable quarterly on [&#9679;] (each a &#8220;Dividend Payment Date&#8221;) commencing on [&#9679;] (or, if any such day is not a business day, then on the next succeeding business day) to holders of record of Series [&#9679;] Preferred Shares as they appear on the stock register of the Fund at the close of business on the fifth preceding business day. Dividends and distributions on Series [&#9679;] Preferred Shares shall accumulate from the date on which the Series [&#9679;] Preferred Shares are originally issued. Each period beginning on and including a Dividend Payment Date (or the date of original issue, in the case of the first dividend period after the first issuance of the Series [&#9679;] Preferred Shares) and ending on but excluding the next succeeding Dividend Payment Date is referred to herein as a &#8220;Dividend Period.&#8221; Dividends and distributions on account of arrears for any past Dividend Period or in connection with the redemption of Series [&#9679;] Preferred Shares may be declared and paid at any time, without reference to any Dividend Payment Date, to holders of record on such date as shall be fixed by the Board of Directors that is not more than 30 days before such payment date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No full dividends or distributions will be declared or paid on Series [&#9679;] Preferred Shares for any Dividend Period or part thereof unless full cumulative dividends and distributions due through the most recent Dividend Payment Dates therefor on all outstanding shares of any series of preferred stock of the Fund ranking on a parity with the Series [&#9679;] Preferred Shares as to the payment of dividends and distributions have been or contemporaneously are declared and paid through the most recent Dividend Payment Dates therefor. If full cumulative dividends and distributions due have not been paid on all outstanding shares of the Fund&#8217;s parity preferred stock, any dividends and distributions being paid on such shares of preferred stock (including the Series [&#9679;] Preferred Shares) will be paid as nearly pro rata as possible in proportion to the respective amounts of dividends and distributions accumulated but unpaid on each such series of preferred stock on the relevant Dividend Payment Date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Restrictions on Dividend, Redemption and Other Payments</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the 1940 Act, the Fund is not permitted to issue preferred stock (such as the Series [&#9679;] Preferred Shares) unless immediately after such issuance the Fund will have an asset coverage of at least 200% (or such other percentage as may in the future be specified in or under the 1940 Act as the minimum asset coverage for senior securities representing stock of a closed-end investment company as a condition of declaring distributions, purchases or redemptions of its stock). In general, the term &#8220;asset coverage&#8221; for this purpose means the ratio which the value of the total assets of the Fund, less all liabilities and indebtedness not represented by senior securities, bears to the aggregate amount of senior securities representing indebtedness of the Fund plus the aggregate of the involuntary liquidation preference of the preferred stock. The involuntary liquidation preference refers to the amount to which the preferred stock would be entitled on the involuntary liquidation of the Fund in preference to a security junior to them. The Fund also is not permitted to declare any cash dividend or other distribution on its common stock or purchase its common stock unless, at the time of such declaration or purchase, the Fund satisfies this 200% asset coverage requirement after deducting the amount of the distribution or purchase price, as applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition, the Fund may be limited in its ability to declare any cash distribution on its capital stock (including the Series [&#9679;] Preferred Shares) or purchase its capital stock (including the Series [&#9679;] Preferred Shares) unless, at the time of such declaration or purchase, the Fund has an asset coverage on its indebtedness, if any, of at least 300% after deducting the amount of such distribution or purchase price, as applicable. The 1940 Act contains an exception, however, that permits dividends to be declared upon any preferred stock issued by the Fund (including the Series [&#9679;] Preferred Shares) if the Fund&#8217;s indebtedness has an asset coverage of at least 200% at the time of declaration after deducting the amount of the dividend. In general, the term &#8220;asset coverage&#8221; for this purpose means the ratio which the value of the total assets of the Fund, less all liabilities and indebtedness not represented by senior securities, bears to the aggregate amount of senior securities representing indebtedness of the Fund.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 67 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">P-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The term &#8220;senior security&#8221; does not include any promissory note or other evidence of indebtedness in any case where such a loan is for temporary purposes only and in an amount not exceeding 5% of the value of the total assets of the Fund at the time when the loan is made. A loan is presumed under the 1940 Act to be for temporary purposes if it is repaid within 60 days and is not extended or renewed; otherwise it is presumed not to be for temporary purposes. For purposes of determining whether the 200% and 300% asset coverage requirements described above apply in connection with dividends or distributions on or purchases or redemptions of Series [&#9679;] Preferred Shares, the asset coverages may be calculated on the basis of values calculated as of a time within 48 hours (not including Sundays or holidays) next preceding the time of the applicable determination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Voting Rights</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Articles provide that, except as otherwise provided in the Fund&#8217;s Charter (including the Articles) or a resolution of the Board of Directors, or as required by applicable law, holders of Series [&#9679;] Preferred Shares shall have no power to vote on any matter except matters submitted to a vote of the Fund&#8217;s common stock. In any matter submitted to a vote of the holders of the common stock, each holder of Series [&#9679;] Preferred Shares shall be entitled to one vote for each Series [&#9679;] Preferred Share held and the holders of all outstanding shares of preferred stock, including Series [&#9679;] Preferred Shares, and the shares of common stock shall vote together as a single class; provided, however, that at any meeting of the stockholders of the Fund held for the election of directors, the holders of the outstanding shares of preferred stock, including the Series [&#9679;] Preferred Shares, shall be entitled, voting together as a separate class, to the exclusion of the holders of all other classes of capital stock of the Fund, to elect a number of the Fund&#8217;s directors, such that following the election of directors at the meeting of the stockholders, the Board of Directors will contain two directors elected by the holders of the outstanding shares of preferred stock, including the Series [&#9679;] Preferred Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During any period in which any one or more of the conditions described below shall exist (such period being referred to herein as a &#8220;Voting Period&#8221;), the number of directors constituting the Board of Directors shall be automatically increased by the smallest number of additional directors that, when added to the two directors elected exclusively by the holders of outstanding shares of preferred stock, would constitute a majority of the Board of Directors as so increased by such smallest number, and the holders of outstanding shares of preferred stock, including the Series [&#9679;] Preferred Shares, voting together as a separate class (to the exclusion of the holders of all other classes of capital stock of the Fund) shall be entitled to elect such smallest number of additional directors and the two directors the holders of shares of preferred stock, including the Series [&#9679;] Preferred Shares, are otherwise entitled to elect. The Fund and the Fund&#8217;s Board of Directors shall take all necessary actions, including amending the Fund&#8217;s bylaws, to effect an increase in the number of directors as described in the preceding sentence. A Voting Period shall commence:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if at any time accumulated dividends and distributions (whether or not earned or declared, and whether or not funds are then legally available in an amount sufficient therefor) on the outstanding Series [&#9679;] Preferred Shares equal to at least two full years&#8217; dividends and distributions shall be due and unpaid and sufficient cash or specified securities shall not have been deposited with Computershare Trust Company, N.A., and its successors or any other dividend-disbursing agent appointed by the Fund, for the payment of such accumulated dividends and distributions; or</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if at any time holders of any other shares of preferred stock are entitled to elect a majority of the Directors of the Fund under the 1940 Act or articles supplementary classifying and designating such shares.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Redemption</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Mandatory Redemption</i>. Under certain circumstances, the Series [&#9679;] Preferred Shares will be subject to mandatory redemption by the Fund out of funds legally available therefor in accordance with the Articles and applicable law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 68 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">P-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the Fund fails to have asset coverage, as determined in accordance with Section&#160;18(h) of the 1940 Act, of at least 200% with respect to all outstanding senior securities of the Fund which are stock, including all outstanding Series [&#9679;] Preferred Shares (or such other asset coverage as may in the future be specified in or under the 1940 Act as the minimum asset coverage for senior securities which are stock of a closed-end investment company as a condition of declaring dividends on its common stock), and such failure is not cured as of the cure date specified in the Articles, (i) the Fund shall give a notice of redemption with respect to the redemption of a sufficient number of shares of its preferred stock, which at the Fund&#8217;s determination (to the extent permitted by the 1940 Act and Maryland law) may include any proportion of Series [&#9679;] Preferred Shares, to enable it to meet the asset coverage requirements, and, at the Fund&#8217;s discretion, such additional number of Series [&#9679;] Preferred Shares or shares of any other series of preferred stock of the Fund in order for the Fund to have asset coverage with respect to the Series [&#9679;] Preferred Shares and any other series of preferred stock of the Fund remaining outstanding after such redemption as great as 210%, and (ii) deposit an amount with Computershare Trust Company, N.A., and its successors or any other dividend-disbursing agent appointed by the Fund, having an initial combined value sufficient to effect the redemption of the Series [&#9679;] Preferred Shares or other series of preferred stock of the Fund to be redeemed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On such cure date, the Fund shall redeem, out of funds legally available therefor, the number of shares of its preferred stock, which, to the extent permitted by the 1940 Act and Maryland law, at the option of the Fund may include any proportion of Series [&#9679;] Preferred Shares or shares of any other series of preferred stock of the Fund, is equal to the minimum number of shares the redemption of which, if such redemption had occurred immediately prior to the opening of business on such cure date, would have resulted in the Fund having asset coverage immediately prior to the opening of business on such cure date in compliance with the 1940 Act or, if asset coverage cannot be so restored, all of the outstanding Series [&#9679;] Preferred Shares, at a price equal to $[&#9679;] per share plus accumulated but unpaid dividends and distributions (whether or not earned or declared by the Fund) through and including the date of redemption. See &#8220;Description of the Capital Stock&#8212;Preferred Stock&#8212;Redemption&#8221; in the Prospectus for a discussion of the consequences that would arise if the Fund fails to maintain the asset coverage requirements as calculated in accordance with the applicable rating agency guidelines set forth in the Articles as of any monthly valuation date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Optional Redemption</i>. Prior to [&#9679;], the Series [&#9679;] Preferred Shares are not subject to optional redemption by the Fund unless the redemption is necessary, in the judgment of the Board of Directors, to maintain the Fund&#8217;s status as a regulated investment company under Subchapter M of the Code. Commencing [&#9679;] and thereafter, to the extent permitted by the 1940 Act and Maryland law, the Fund may at any time upon notice in the manner provided in the Articles redeem the Series [&#9679;] Preferred Shares in whole or in part at a price equal to the liquidation preference per share plus accumulated but unpaid dividends (whether or not earned or declared) through and including the date of redemption.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liquidation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the event of any liquidation, dissolution or winding up of the affairs of the Fund, whether voluntary or involuntary, the holders of Series [&#9679;] Preferred Shares shall be entitled to receive out of the assets of the Fund available for distribution to stockholders, after satisfying claims of creditors but before any distribution or payment shall be made in respect of the Fund&#8217;s common stock or any other stock of the Fund ranking junior to the Series [&#9679;] Preferred Shares as to liquidation payments, a liquidation distribution in the amount of $[&#9679;] per share (the &#8220;Liquidation Preference&#8221;), plus an amount equal to all unpaid dividends and distributions accumulated to and including the date fixed for such distribution or payment (whether or not earned or declared by the Fund, but excluding interest thereon), and such holders shall be entitled to no further participation in any distribution or payment in connection with any such liquidation, dissolution or winding up of the Fund.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If, upon any liquidation, dissolution or winding up of the affairs of the Fund, whether voluntary or involuntary, the assets of the Fund available for distribution among the holders of all outstanding Series [&#9679;] Preferred Shares and all outstanding shares of any other series of the Fund&#8217;s preferred stock ranking on a parity with the Series [&#9679;] Preferred Shares as to payment upon liquidation is insufficient to permit the payment in full to such holders of Series [&#9679;] Preferred Shares of the Liquidation Preference plus accumulated and unpaid dividends and distributions and the amounts due upon liquidation with respect to all outstanding shares of such other series of, preferred stock of the Fund, then such available assets shall be distributed among the holders of Series [&#9679;] Preferred Shares and such other series of preferred stock of the Fund ratably in proportion to the respective preferential liquidation amounts to which they are entitled. Unless and until the Liquidation Preference plus accumulated and unpaid dividends and distributions has been paid in full to the holders of Series [&#9679;] Preferred Shares, no dividends or distributions will be made to holders of the Fund&#8217;s common stock or any other stock of the Fund ranking junior to the Series [&#9679;] Preferred Shares as to liquidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 69 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">P-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock Exchange Listing</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Application will be made to list the Series [&#9679;] Preferred Shares on the [&#9679;]. If the application is approved, the Series [&#9679;] Preferred Shares are expected to commence trading on the [&#9679;] within [&#9679;] days of the date of issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk is inherent in all investing. Therefore, before investing in the Series [&#9679;] Preferred Shares you should consider the risks carefully. See &#8220;Risk Factors and Special Considerations&#8221; in the accompanying Prospectus. Primary risks associated with an investment in the Series [&#9679;] Preferred Shares include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Market Price Risk</i>. The market price for the Series [&#9679;] Preferred Shares will be influenced by changes in interest rates, the perceived credit quality of the Series [&#9679;] Preferred Shares and other factors, and may be higher or lower than the liquidation preference of the Series [&#9679;] Preferred Shares. There is currently no market for the Series [&#9679;] Preferred Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidity Risk</i>. Currently, there is no public market for the Series [&#9679;] Preferred Shares. As noted above, an application will be made to list the Series [&#9679;] Preferred Shares on the [&#9679;]. However, during an initial period which is not expected to exceed [&#9679;] days after the date of its issuance, the Series [&#9679;] Preferred Shares will not be listed on any securities exchange. Before the Series [&#9679;] Preferred Shares are listed on the [&#9679;], the underwriters may, but are not obligated to, make a market in the Series [&#9679;] Preferred Shares. No assurances can be provided that listing on any securities exchange or market making by the underwriters will result in the market for Series [&#9679;] Preferred Shares being liquid at any time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Redemption Risk</i>. The Fund may at any time redeem Series [&#9679;] Preferred Shares to the extent necessary to meet regulatory asset coverage requirements or requirements imposed by credit rating agencies. For example, if the value of the Fund&#8217;s investment portfolio declines, thereby reducing the asset coverage for the Series [&#9679;] Preferred Shares, the Fund may be obligated under the terms of the Series [&#9679;] Preferred Shares to redeem some or all of the Series [&#9679;] Preferred Shares. In addition, commencing [&#9679;], the Fund will be able to call the Series [&#9679;] Preferred Shares at the option of the Fund. Investors may not be able to reinvest the proceeds of any redemption in an investment providing the same or a higher dividend rate than that of the Series [&#9679;] Preferred Shares. Although unlikely, precipitous declines in the value of the Fund&#8217;s assets could result in the Fund having insufficient assets to redeem all of the Series [&#9679;] Preferred Shares for the full redemption price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Subordination Risk.</i> The Series [&#9679;] Preferred Shares are not a debt obligation of the Fund. The Series [&#9679;] Preferred Shares are junior in respect of distributions and liquidation preference to any indebtedness incurred by the Fund, and have the same priority with respect to payment of distributions and liquidation preference as the Series C Auction Rate Preferred, Series E Auction Rate Preferred, Series G Preferred, Series H Preferred, Series K Preferred, Series M Preferred, Series N Preferred and any other series of preferred stock that the Fund may issue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<i>Credit Rating Risk</i>. The Fund is seeking a credit rating on the Series [&#9679;] Preferred Shares. Any credit rating that is issued on the Series [&#9679;] Preferred Shares could be reduced or withdrawn while an investor holds Series [&#9679;] Preferred Shares. A reduction or withdrawal of the credit rating would likely have an adverse effect on the market value of the Series [&#9679;] Preferred Shares. In addition, a credit rating does not eliminate or mitigate the risks of investing in the Series [&#9679;] Preferred Shares.]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Distribution Risk</i>. The Fund may not meet the asset coverage requirements or earn sufficient income from its investments to make distributions on the Series [&#9679;] Preferred Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Interest Rate Risk</i>. The Series [&#9679;] Preferred Shares pay dividends at a fixed rate[, which resets after an initial period]. Prices of fixed income investments tend to vary inversely with changes in market yields. The market yields on securities comparable to the Series [&#9679;] Preferred Shares may increase, which would likely result in a decline in the value of the Series [&#9679;] Preferred Shares. Additionally, if interest rates rise, securities comparable to the Series [&#9679;] Preferred Shares may pay higher dividend rates and holders of the Series [&#9679;] Preferred Shares may not be able to sell the Series [&#9679;] Preferred Shares at their liquidation preference and reinvest the proceeds at market rates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<i>Dividend Rate Adjustment Risk</i>. The dividend rate of the Series [&#9679;] Preferred Shares automatically adjusts to a rate of [&#9679;]% per annum after a period of [&#9679;] months commencing on the date the Series [&#9679;] Preferred Shares are first issued. If interest rates rise during this time, holders of Series [&#9679;] Preferred Shares may receive a below market dividend rate which may cause the market price of the Series [&#9679;] Preferred Shares to decline.]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 70 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">P-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="p_008"></span>U.S. FEDERAL INCOME TAX CONSEQUENCES OF THE OFFERING</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[To be provided.]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="p_009"></span>CERTAIN EMPLOYEE BENEFIT PLAN AND IRA CONSIDERATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[To be provided.]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="p_010"></span>UNDERWRITING</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[To be provided.]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="p_011"></span>LEGAL MATTERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain legal matters will be passed on by Willkie Farr &amp; Gallagher LLP, counsel to the Fund in connection with the offering of the Series [&#9679;] Preferred Shares. Certain legal matters in connection with this offering will be passed upon for the underwriters by [&#9679;]. Willkie Farr &amp; Gallagher LLP and [&#9679;] may rely as to certain matters of Maryland law on the opinion of Venable LLP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[The Fund&#8217;s unaudited financial statements as of and for the six months ended June&#160;30, 202[&#9679;] should be read in conjunction with the audited financial statements of the Fund and the Notes thereto included in the Annual Report to the Fund&#8217;s shareholders for the fiscal year ended December&#160;31, 202[&#9679;].] The audited annual financial statements of the Fund for the fiscal year ended December&#160;31, 202[&#9679;] [and the unaudited semiannual financial statements of the Fund for the six months ended June&#160;30, 202[&#9679;]] are incorporated by reference into this Prospectus Supplement, the accompanying Prospectus and the SAI. Portions of the Fund&#8217;s annual report [and semiannual report] other than the financial statements and related footnotes thereto are not incorporated into, and do not form a part of, this Prospectus Supplement, the accompanying Prospectus or the SAI.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 71 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">P-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b>THE GABELLI EQUITY TRUST INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[&#9679;] Shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[&#9679;]% Series [&#9679;] [&#9679;] Preferred Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Liquidation Preference $ [&#9679;] per share)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>PROSPECTUS SUPPLEMENT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;[&#9679;], 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 72 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><b>The information in this Prospectus Supplement is not complete and may be changed. The Fund may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This Prospectus Supplement is not an offer to sell these securities and is not soliciting offers to buy these securities in any state where the offer or sale is not permitted.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><b>SUBJECT TO COMPLETION, DATED [&#9679;], 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed Pursuant to Rule&#160;424(b)([&#9679;])<br />Registration Statement No. 333-[&#9679;]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>THE GABELLI EQUITY TRUST INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROSPECTUS SUPPLEMENT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(To Prospectus dated [&#9679;], 2023)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[&#9679;] Rights for [&#9679;] Shares of Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Subscription Rights to Acquire Shares of Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Gabelli Equity Trust Inc. (the &#8220;Fund&#8221;, &#8220;we&#8221;, &#8220;us&#8221; or &#8220;our&#8221;) is issuing subscription rights (the &#8220;Rights&#8221;) to our common stockholders (the &#8220;Common Shareholders&#8221;) to purchase additional shares of common stock (each a &#8220;Common Share&#8221; and collectively, the &#8220;Common Shares&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund is a diversified, closed-end management investment company registered under the Investment Company Act of 1940, as amended (the &#8220;1940 Act&#8221;). The Fund&#8217;s primary investment objective is to achieve long term growth of capital by investing primarily in a portfolio of equity securities consisting of common stock, preferred stock, convertible or exchangeable securities, and warrants and rights to purchase such securities. Income is a secondary investment objective. Under normal market conditions, the Fund will invest at least 80% of the value of its total assets in equity securities. The Fund&#8217;s investment adviser is Gabelli Funds, LLC (the &#8220;Investment Adviser&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Common Shares are listed on the New York Stock Exchange (&#8220;NYSE&#8221;) under the symbol &#8220;GAB.&#8221; On [&#9679;], 2023 (the last trading date prior to the Common Shares trading ex-Rights), the last reported net asset value per share of the Common Shares was $[&#9679;] and the last reported sales price per share of Common Shares on the NYSE was $[&#9679;].</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares of our Series G Cumulative Preferred Stock (the &#8220;Series G Preferred Shares&#8221;), our 5.00% Series H Cumulative Preferred Stock (the &#8220;Series H Preferred Shares&#8221;) and our 5.00% Series K Cumulative Preferred Stock (the &#8220;Series K Preferred Shares&#8221;) are traded on the NYSE under the symbol &#8220;GAB PrG,&#8221; &#8220;GAB PrH&#8221; and &#8220;GAB PrK&#8221; respectively. On [&#9679;], 2023, the last reported sales prices per share of Series G Preferred Shares, Series H Preferred Shares and Series K Preferred Shares on the NYSE were $[&#9679;], $[&#9679;], and $[&#9679;], respectively. Our Series C Auction Rate Cumulative Preferred Stock (the &#8220;Series C Auction Rate Preferred&#8221;), Series E Auction Rate Preferred Stock (the &#8220;Series E Auction Rate Preferred&#8221;), 4.25% Series M Cumulative Preferred Stock (&#8220;Series M Preferred&#8221;) and 5.25% Series N Cumulative Preferred Stock (&#8220;Series N Preferred&#8221;) are not traded on a stock exchange.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An investment in the Fund is not appropriate for all investors. We cannot assure you that the Fund&#8217;s investment objectives will be achieved. You should read this Prospectus Supplement and the accompanying Prospectus before deciding whether to invest in the Common Shares and retain it for future reference. The Prospectus Supplement and the accompanying Prospectus contain important information about us. Material that has been incorporated by reference, including the Fund&#8217;s audited annual financial statements [and unaudited financial statements], and other information about us can be obtained from us by calling 800-GABELLI (422-3554) or from the Securities and Exchange Commission&#8217;s (&#8220;SEC&#8221;) website (http://www.sec.gov). For additional information all holders of Rights should contact the Fund by telephone at 800-GABELLI (422-3554) or 914-921-5070, or by written request to The Gabelli Equity Trust Inc., One Corporate Center, Rye, New York 10580-1422.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 73; Options: NewSection -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">R-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investing in Common Shares through Rights involves certain risks, including risks related to a leveraged capital structure, that are described in the &#8220;Special Characteristics and Risks of the Rights Offering&#8221; section beginning on page R-18 of this Prospectus Supplement.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHAREHOLDERS WHO DO NOT FULLY EXERCISE THEIR RIGHTS MAY, AT THE COMPLETION OF THE OFFERING, OWN A SMALLER PROPORTIONAL INTEREST IN THE FUND THAN IF THEY EXERCISED THEIR RIGHTS. AS A RESULT OF THE OFFERING YOU MAY EXPERIENCE SUBSTANTIAL DILUTION [OR ACCRETION] OF THE AGGREGATE NET ASSET VALUE OF YOUR COMMON SHARES DEPENDING UPON WHETHER THE FUND&#8217;S NET ASSET VALUE PER COMMON SHARE IS ABOVE [OR BELOW] THE SUBSCRIPTION PRICE ON THE EXPIRATION DATE.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[ANY COMMON SHARES ISSUED AS A RESULT OF THE RIGHTS OFFERING WILL NOT BE RECORD DATE SHARES FOR THE FUND&#8217;S QUARTERLY DISTRIBUTION TO BE PAID ON [&#9679;], 2023 AND WILL NOT BE ENTITLED TO RECEIVE SUCH DISTRIBUTION.]</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NEITHER THE SEC NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED THESE SECURITIES OR DETERMINED IF THIS PROSPECTUS SUPPLEMENT IS TRUTHFUL OR COMPLETE. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[NO SECURITIES REGULATORY AUTHORITY IN CANADA HAS EXPRESSED AN OPINION ABOUT THESE SECURITIES AND IT IS AN OFFENSE TO CLAIM OTHERWISE. THIS OFFERING WILL NOT BE MADE IN ANY PROVINCE OF CANADA WHERE IT IS NOT PERMITTED BY LAW.]</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: left">&#160;</td>
    <td style="text-align: left; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Per Share</b></span></td>
    <td style="vertical-align: bottom; font-weight: bold; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total (1)</b></span></td>
    <td style="vertical-align: bottom; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 76%; text-align: left">Subscription price of Common Shares to shareholders exercising Rights</td>
    <td style="text-align: left; width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;</span></td>
    <td style="width: 1%; text-align: left">]</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;</span></td>
    <td style="width: 1%; text-align: left">]</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Underwriting discounts and commissions</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;</span></td>
    <td style="text-align: left">]</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;</span></td>
    <td style="text-align: left">]</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Proceeds, before expenses, to the Fund (2)</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;</span></td>
    <td style="text-align: left">]</td>
    <td>&#160;</td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;</span></td>
    <td style="text-align: left">]</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on a Dealer Manager solicitation fee of $[&#9679;] per Common Share.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The aggregate expenses of the offering (excluding underwriting discounts and commissions) are estimated to be $[&#9679;]. This estimate includes a total amount of $[&#9679;] for expenses of [&#9679;], the dealer manager for the Rights offering, that are subject to reimbursement by the Fund. See &#8220;Distribution Arrangements.&#8221;</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Common Shares are expected to be ready for delivery in book-entry form through the Depository Trust Company on or about [&#9679;], 2023. If the offer is extended, the Common Shares are expected to be ready for delivery in book-entry form through the Depository Trust Company on or about [&#9679;], 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The date of this Prospectus Supplement is [&#9679;], 2023.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 74 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">R-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>You should rely only on the information contained or incorporated by reference in this Prospectus Supplement and the accompanying Prospectus. The Fund has not authorized anyone to provide you with different information. The Fund is not making an offer to sell these securities in any jurisdiction where the offer or sale is not permitted. You should not assume that the information contained in this Prospectus Supplement and the accompanying Prospectus is accurate as of any date other than the date of this Prospectus Supplement and the accompanying Prospectus, respectively. Our business, financial condition, results of operations and prospects may have changed since those dates. In this Prospectus Supplement and in the accompanying Prospectus, unless otherwise indicated, &#8220;Fund,&#8221; &#8220;us,&#8221; &#8220;our&#8221; and &#8220;we&#8221; refer to The Gabelli Equity Trust Inc., a Maryland corporation. This Prospectus Supplement also includes trademarks owned by other persons.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TABLE OF CONTENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Prospectus Supplement</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 90%; text-align: justify">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 9%; text-align: right"><b>Page</b></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 3pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#r_001">CAUTIONARY NOTICE REGARDING FORWARD-LOOKING STATEMENTS</a></span></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">R-4</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 3pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#r_002">SUMMARY OF THE TERMS OF THE RIGHTS OFFERING</a></span></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">R-5</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 3pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#r_003">DESCRIPTION OF RIGHTS OFFERING</a></span></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">R-8</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 3pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#r_004">TABLE OF FEES AND EXPENSES</a></span></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">R-16</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 3pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#r_005">USE OF PROCEEDS</a></span></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">R-17</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 3pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#r_006">CAPITALIZATION</a></span></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">R-18</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 3pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#r_007">PRICE RANGE OF COMMON SHARES</a></span></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">R-18</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 3pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#r_008">SPECIAL CHARACTERISTICS AND RISKS OF THE RIGHTS OFFERING</a></span></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">R-18</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 3pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#r_009">U.S. FEDERAL INCOME TAX CONSEQUENCES OF THE OFFERING</a></span></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">R-20</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 3pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#r_010">DISTRIBUTION ARRANGEMENTS</a></span></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">R-21</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#r_011">LEGAL MATTERS</a></span></td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">R-22</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Prospectus</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; width: 90%; text-align: justify"><a href="#a_001">PROSPECTUS SUMMARY</a></td>
    <td style="padding-bottom: 3pt; width: 1%">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; width: 9%; text-align: right">4</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_002">SUMMARY OF FUND EXPENSES</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">10</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_003">FINANCIAL HIGHLIGHTS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">12</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_004">USE OF PROCEEDS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">18</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_005">THE FUND</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">18</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_006">INVESTMENT OBJECTIVES AND POLICIES</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">18</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_007">RISK FACTORS AND SPECIAL CONSIDERATIONS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">18</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_008">HOW THE FUND MANAGES RISK</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">18</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_009">MANAGEMENT OF THE FUND</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">19</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_010">PORTFOLIO TRANSACTIONS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">24</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_011">DIVIDENDS AND DISTRIBUTIONS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">24</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_012">ISSUANCE OF COMMON STOCK</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">25</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_013">AUTOMATIC DIVIDEND REINVESTMENT AND VOLUNTARY CASH PURCHASE PLANS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">25</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_014">DESCRIPTION OF THE CAPITAL STOCK</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">25</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_015">ANTI-TAKEOVER PROVISIONS OF THE FUND&#8217;S GOVERNING DOCUMENTS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">35</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_016">CLOSED-END FUND STRUCTURE</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">39</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_017">REPURCHASE OF COMMON STOCK</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">39</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_018">RIGHTS OFFERINGS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">40</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_019">NET ASSET VALUE</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">40</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_020">LIMITATION ON DIRECTORS&#8217; AND OFFICERS&#8217; LIABILITY</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">41</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_021">TAXATION</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">41</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_022">CUSTODIAN, TRANSFER AGENT AND DIVIDEND DISBURSING AGENT</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">45</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_023">PLAN OF DISTRIBUTION</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">45</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_024">LEGAL MATTERS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">47</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_025">INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">47</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_026">ADDITIONAL INFORMATION</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">47</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_027">INCORPORATION BY REFERENCE</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">47</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: justify"><a href="#a_028">PRIVACY PRINCIPLES OF THE FUND</a></td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: right">48</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 75 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">R-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="r_001"></span>CAUTIONARY NOTICE REGARDING FORWARD-LOOKING STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Prospectus Supplement, the accompanying Prospectus and the Statement of Additional Information (the &#8220;SAI&#8221;) contain &#8220;forward-looking statements.&#8221; Forward-looking statements can be identified by the words &#8220;may,&#8221; &#8220;will,&#8221; &#8220;intend,&#8221; &#8220;expect,&#8221; &#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; and similar terms and the negative of such terms. Such forward-looking statements may be contained in this Prospectus Supplement as well as in the accompanying Prospectus and in the SAI. By their nature, all forward-looking statements involve risks and uncertainties, and actual results could differ materially from those contemplated by the forward-looking statements. Several factors that could materially affect our actual results are the performance of the portfolio of securities we hold, the price at which our shares will trade in the public markets and other factors discussed in our periodic filings with the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although we believe that the expectations expressed in our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and are subject to inherent risks and uncertainties, such as those disclosed in the &#8220;Risk Factors and Special Considerations&#8221; section of the accompanying Prospectus and &#8220;Special Characteristics and Risks of the Rights Offering&#8221; in this Prospectus Supplement. All forward-looking statements contained or incorporated by reference in this Prospectus Supplement or the accompanying Prospectus, or in the SAI, are made as of the date of this Prospectus Supplement or the accompanying Prospectus, or SAI, as the case may be. Except for our ongoing obligations under the federal securities laws, we do not intend, and we undertake no obligation, to update any forward-looking statement. The forward-looking statements contained in this Prospectus Supplement, the accompanying Prospectus and the SAI are excluded from the safe harbor protection provided by Section&#160;27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently known risk factors that could cause actual results to differ materially from our expectations include, but are not limited to, the factors described in the &#8220;Risk Factors and Special Considerations&#8221; section of the accompanying Prospectus as well as in the &#8220;Special Characteristics and Risks of the Rights Offering&#8221; section of this Prospectus Supplement. We urge you to review carefully those sections for a more detailed discussion of the risks of an investment in the Common Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 76 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">R-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="r_002"></span>SUMMARY OF THE TERMS OF THE RIGHTS OFFERING</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; width: 27%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Terms of the Offer</b></span></td>
    <td style="width: 3%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;] transferable subscription right (a &#8220;Right&#8221;) will be issued for each share of common stock of the Fund (each, a &#8220;Common Share,&#8221; and collectively, the &#8220;Common Shares&#8221;) held as of the close of business on the record date. Rights are expected to trade on the [&#9679;]. The Rights will allow common shareholders to subscribe for new Common Shares of the Fund. [&#9679;] Common Shares of the Fund are outstanding as of [&#9679;], 2023. [&#9679;] Rights will be required to purchase one Common Share. [An over-subscription privilege will be offered, [subject to the right of the Board of Directors of the Fund (the &#8220;Board&#8221;) to eliminate the over-subscription privilege.]] [&#9679;] Common Shares of the Fund will be issued if all Rights are exercised. [Additional Common Shares will be issued if the over-subscription privilege is exercised.] See &#8220;<i>Terms of the Rights Offering</i>.&#8221; [<b>Any Common Shares issued as a result of the Rights offering will not be record date shares for the Fund&#8217;s quarterly distribution to be paid on [&#9679;], 2023 and will not be entitled to receive such distribution.</b>]</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount Available for Primary Subscription</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approximately $[&#9679;]. The proceeds of the Rights offering will be reduced by the expenses of the offering. See &#8220;Use of Proceeds.&#8221;</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription Rights to Acquire Shares of Common Stock</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Subscription Price</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;] Rights may be exercised at a price of $[&#9679;] per Common Share (the &#8220;Subscription Price&#8221;). See &#8220;<i>Terms of the Rights Offering</i>.&#8221;</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Record Date</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rights will be issued to holders of record of the Fund&#8217;s Common Shares as of the close of business on [&#9679;], 2023 (the &#8220;Record Date&#8221;). See &#8220;<i>Terms of the Rights Offering</i>.&#8221;</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of Rights Issued</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;] Right[s] will be issued in respect of each Common Share of the Fund outstanding as of the close of business on the Record Date. See &#8220;<i>Terms of the Rights Offering</i>.&#8221;</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of Rights Required to Purchase One Common Share</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A holder of Rights may purchase [&#9679;] Common Share[s] of the Fund for every [&#9679;] Rights exercised. The number of Rights to be issued to a shareholder as of the close of business on the Record Date will be rounded up to the nearest number of Rights evenly divisible by [&#9679;]. See &#8220;<i>Terms of the Rights Offering</i>.&#8221;</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Over-Subscription Privilege</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Holders of Common Shares as of the close of business on the Record Date (&#8220;Record Date Shareholders&#8221;) who fully exercise all Rights initially issued to them are entitled to buy those Common Shares, referred to as &#8220;primary over-subscription shares,&#8221; that were not purchased by other Rights holders at the same Subscription Price. If enough primary over-subscription shares are available, all such requests will be honored in full. If the requests for primary over-subscription shares exceed the primary over-subscription shares available, the available primary over-subscription shares will be allocated pro rata among those fully exercising Record Date Shareholders who over-subscribe based on the number of Rights originally issued to them by the Fund. Common Shares acquired pursuant to the over-subscription privilege are subject to allotment.</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[In addition, in the event that the Fund&#8217;s per share net asset value at the end of the Subscription Period (described below) is equal to or less than the Subscription Price, the Fund, in its sole discretion, may determine to issue additional Common Shares in an amount of up to [&#9679;]% of the shares issued pursuant to the primary subscription, referred to as &#8220;secondary over-subscription shares.&#8221; Should the Fund determine to issue some or all of the secondary over-subscription shares, they will be allocated only among Record Date Shareholders who submitted over-subscription requests. Secondary over-subscription shares will be allocated pro rata among those fully exercising Record Date Shareholders who over-subscribe based on the number of Rights originally issued to them by the Fund<i>.</i>] <i>Rights acquired in the secondary market may not participate in the over-subscription privilege.</i></span></td> </tr>
  </table>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 77 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">R-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; width: 27%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 3%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 70%">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding the above, the Board has the right in its absolute discretion to eliminate the over-subscription privilege with respect to [either primary or both primary over-subscription shares and secondary] over-subscription shares if it considers it to be in the best interest of the Fund to do so. The Board may make that determination at any time, without prior notice to Rights holders or others, up to and including the [&#9679;] day following the Expiration Date (as defined below).]</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the event that the Fund&#8217;s per share net asset value at the end of the Subscription Period is greater than the subscription price (i.e., Common Shares will be issued at a price below the Fund&#8217;s then current net asset value), the over-subscription shares issued by the Fund will not result in the ratio of the Rights offering exceeding one new share for each three Rights. See &#8220;<i>Over-Subscription Privilege</i>.&#8221;]</span></p> </td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Transfer of Rights</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Rights will be transferable. See &#8220;<i>Terms of the Rights Offering</i>,&#8221; &#8220;<i>Sales by Rights Agent</i>&#8221; and &#8220;<i>Method of Selling or Transferring Rights</i>.&#8221;</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Subscription Period</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Rights may be exercised at any time after issuance and prior to expiration of the Rights (the &#8220;Subscription Period&#8221;), which will be 5:00 PM Eastern Time on [&#9679;], 2023 (the &#8220;Expiration Date&#8221;), unless otherwise extended. See &#8220;<i>Terms of the Rights Offering</i>&#8221; and &#8220;<i>Method of Exercise of Rights</i>.&#8221;</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Offering Expenses</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The expenses of the offering are expected to be approximately $[&#9679;] and will be borne by holders of the Fund&#8217;s Common Shares. See &#8220;<i>Use of Proceeds</i>.&#8221;</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[Solicitation Fee</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$[&#9679;] per Common Share to broker-dealers that have executed and delivered a soliciting dealer agreement and have solicited the exercise of Rights. See &#8220;<i>Distribution Arrangements</i>.&#8221;</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sale of Rights</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Rights are transferable and will be admitted for trading on the [&#9679;] under the symbol &#8220;[&#9679;]&#8221;. Although no assurance can be given that a market for the Rights will develop, trading in the Rights on the [&#9679;] is expected to begin three Business Days prior to the Record Date and may be conducted until the close of trading on the last [&#9679;] trading day prior to the Expiration Date. For purposes of this Prospectus Supplement, a &#8220;Business Day&#8221; shall mean any day on which trading is conducted on the [&#9679;].</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The value of the Rights, if any, will be reflected by their market price on the [&#9679;]. Rights may be sold by individual holders or may be submitted to [&#9679;] (the &#8220;Rights Agent&#8221;) for sale. Any Rights submitted to the Rights Agent for sale must be received by the Rights Agent prior to 5:00 PM, Eastern Time, on [&#9679;], 2023, [&#9679;] Business Days prior to the Expiration Date (or, if the subscription period is extended, prior to 5:00 PM, Eastern Time, on the [&#9679;] Business Day prior to the extended Expiration Date).</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rights that are sold will not confer any right to acquire any Common Shares in any [primary or secondary] over-subscription privilege, and any Record Date Shareholder who sells any Rights will not be eligible to participate in the [primary or secondary] over-subscription privilege, if any.</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading of the Rights on the [&#9679;] will be conducted on a when-issued basis until and including the date on which the Subscription Certificates (as defined below) are mailed to Record Date Shareholders of record and thereafter will be conducted on a regular-way basis until and including the last [&#9679;] trading day prior to the completion of the Subscription Period. The shares are expected to begin trading ex-Rights [&#9679;] Business Day[s] prior to the Record Date.</span></td> </tr>
  </table>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 78 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">R-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; width: 27%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 3%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the Rights Agent receives Rights for sale in a timely manner, it will use its best efforts to sell the Rights on the [&#9679;]. The Rights Agent will also attempt to sell any Rights attributable to shareholders of record whose addresses are outside the United States, or who have an APO or FPO address. See &#8220;Foreign Restrictions.&#8221;</span></td> </tr>
  </table>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; width: 27%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 3%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any commissions will be paid by the selling Rights holders. Neither the Fund nor the Rights Agent will be responsible if the Rights cannot be sold and neither has guaranteed any minimum sales price for the Rights. If the Rights can be sold, sales of these Rights will be deemed to have been effected at the weighted average price received by the Rights Agent on the day such Rights are sold, less any applicable brokerage commissions, taxes and other expenses.</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders are urged to obtain a recent trading price for the Rights on the [&#9679;] from their broker, bank, financial advisor or the financial press.</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Banks, broker-dealers and trust companies that hold shares for the accounts of others are advised to notify those persons that purchase Rights in the secondary market that such Rights will not participate in any over-subscription privilege. See &#8220;Terms of the Rights Offering&#8221; and &#8220;Sales by Rights Agent.&#8221;</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of Proceeds</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund estimates the net proceeds of the offering to be approximately $[&#9679;]. This figure is based on the Subscription Price per Common Share of $[&#9679;] and assumes all new Common Shares offered are sold and that the expenses related to the offering estimated at approximately $[&#9679;] are paid.</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Investment Adviser anticipates that the investment of the proceeds will be made in accordance with the Fund&#8217;s investment objectives and policies as appropriate investment opportunities are identified, which is expected to be substantially completed in approximately three months; however, the identification of appropriate investment opportunities pursuant to the Fund&#8217;s investment style or changes in market conditions may cause the investment period to extend as long as six months. This could occur because the Investment Adviser follows a value-oriented investment strategy; therefore, market conditions could result in the Investment Adviser delaying the investment of proceeds if it believes the margin of risk in making additional investments is not favorable in light of its value-oriented investment strategy. See &#8220;Investment Objectives and Policies&#8212;Investment Methodology of the Fund&#8221; in the accompanying Prospectus. Pending such investment, the proceeds will be held in high quality short term debt securities and instruments. [In addition, in the discretion of the Board, the proceeds of the offering may be used to redeem a portion of the Fund&#8217;s outstanding preferred shares.] Depending on market conditions and operations, a portion of the cash held by the Fund, including any proceeds raised from the offering, may be used to pay distributions in accordance with the Fund&#8217;s distribution policy. See &#8220;Use of Proceeds.&#8221;</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Taxation/Employee Benefit Plans and IRAs</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See <i>&#8220;U.S. Federal Income Tax Consequences of the Offering&#8221;</i> and <i>&#8220;Certain Employee Benefit Plan and IRA Considerations.&#8221;</i></span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Rights Agent</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[To be provided.]</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Administrative Agent</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[To be provided.]</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 79 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">R-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="r_003"></span>DESCRIPTION OF THE RIGHTS OFFERING</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Terms of the Rights Offering</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund is issuing to common shareholders of record as of the Record Date rights to subscribe for Common Shares of the Fund. Each Record Date Shareholder of record is being issued [&#9679;] transferable Right for each Common Share owned on the Record Date. The Rights entitle the holder to acquire for $[&#9679;] (the &#8220;Subscription Price&#8221;) one new Common Share for each [&#9679;] Rights held. Fractional shares will not be issued upon the exercise of the Rights. Accordingly, Common Shares may be purchased only pursuant to the exercise of Rights in integral multiples of [&#9679;]. The number of Rights to be issued to a Record Date Shareholder of record will be rounded up to the nearest number of Rights evenly divisible by [&#9679;]. In the case of Common Shares held of record by Cede &amp; Co. (&#8220;Cede&#8221;), as nominee for the Depository Trust Company (&#8220;DTC&#8221;), or any other depository or nominee, the number of Rights issued to Cede or such other depository or nominee will be adjusted to permit rounding up (to the nearest number of Rights evenly divisible by [&#9679;]) of the Rights to be received by beneficial owners for whom it is the holder of record only if Cede or such other depository or nominee provides to the Fund on or before the close of business on [&#9679;], 2023 written representation of the number of Rights required for such rounding. Rights may be exercised at any time during the period (the &#8220;Subscription Period&#8221;) which commences on [&#9679;], 2023, and ends at [5:00] PM Eastern Time on [&#9679;], 2023 (the &#8220;Expiration Date&#8221;), unless otherwise extended. The right to acquire one Common Share for each [&#9679;] Rights held during the Subscription Period (or any extension thereof) at the Subscription Price will be referred to in the remainder of this Prospectus Supplement as the &#8220;Subscription.&#8221; [&#9679;] Common Shares of the Fund are outstanding as of [&#9679;], 2023; [&#9679;] Common Shares of the Fund will be issued if all Rights are exercised. <i>Rights will expire on the Expiration Date and thereafter may not be exercised. Any Common Shares issued as a result of the Rights offering will not be Record Date shares for the Fund&#8217;s quarterly distribution to be paid on [&#9679;], 2023 and will not be entitled to receive such distribution.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rights may be evidenced by subscription certificates (&#8220;Subscription Certificates&#8221;) or may be uncertificated and evidenced by other appropriate documentation. The number of Rights issued to each holder will be stated on the Subscription Certificate delivered to the holder. The method by which Rights may be exercised and Common Shares paid for is set forth below in &#8220;Method of Exercise of Rights&#8221; and &#8220;Payment for Shares.&#8221; A holder of Rights will have no right to rescind a purchase after the Rights Agent has received payment. See &#8220;Payment for Shares&#8221; below. It is anticipated that the Common Shares issued pursuant to an exercise of Rights will be listed on the [&#9679;].</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Holders of Rights who are Record Date Shareholders are entitled to subscribe for additional Common Shares at the same Subscription Price pursuant to the over-subscription privilege, subject to certain limitations, allotment and the right of the Board to eliminate the over-subscription privilege. See &#8220;Over-Subscription Privilege&#8221; below.]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For purposes of determining the maximum number of Common Shares that may be acquired pursuant to the offer, broker-dealers, trust companies, banks or others whose shares are held of record by Cede or by any other depository or nominee will be deemed to be the holders of the Rights that are held by Cede or such other depository or nominee on their behalf.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Rights are transferable and will be admitted for trading on the [&#9679;] under the symbol &#8220;[&#9679;]&#8221;. Assuming a market exists for the Rights, the Rights may be purchased and sold through usual brokerage channels and also sold through the Rights Agent. Although no assurance can be given that a market for the Rights will develop, trading in the Rights on the [&#9679;] is expected to begin three Business Days prior to the Record Date and may be conducted until the close of trading on the last [&#9679;] trading day prior to the Expiration Date. Trading of the Rights on the [&#9679;] is expected to be conducted on a when-issued basis until and including the date on which the Subscription Certificates are mailed to Record Date Shareholders of record and thereafter is expected to be conducted on a regular way basis until and including the last [&#9679;] trading day prior to the Expiration Date. The method by which Rights may be transferred is set forth below under &#8220;Method of Selling or Transferring Rights.&#8221; The Common Shares are expected to begin trading ex-Rights [&#9679;] Business Day[s] prior to the Record Date as determined and announced by the NYSE.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nominees who hold the Fund&#8217;s Common Shares for the account of others, such as banks, broker-dealers, trustees or depositories for securities, should notify the respective beneficial owners of such shares as soon as possible to ascertain such beneficial owners&#8217; intentions and to obtain instructions with respect to the Rights. If the beneficial owner so instructs, the nominee should complete the Subscription Certificate and submit it to the Rights Agent with proper payment. In addition, beneficial owners of the Common Shares or Rights held through such a nominee should contact the nominee and request the nominee to effect transactions in accordance with such beneficial owner&#8217;s instructions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 80 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">R-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Participants in the Fund&#8217;s Automatic Dividend Reinvestment and Voluntary Cash Purchase Plan (the &#8220;Plan&#8221;) will be issued Rights in respect of the Common Shares held in their accounts in the Plan. Participants wishing to exercise these Rights must exercise the Rights in accordance with the procedures set forth in &#8220;Method of Exercise of Rights&#8221; and &#8220;Payment for Shares.&#8221;]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Conditions of the Rights Offering</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The rights offering is being made in accordance with the 1940 Act without stockholder approval. The staff of the SEC has interpreted the 1940 Act as not requiring stockholder approval of a transferable rights offering to purchase shares of common stock at a price below the then current net asset value so long as certain conditions are met, including: (i) a good faith determination by a fund&#8217;s board that such offering would result in a net benefit to existing stockholders; (ii) the offering fully protects stockholders&#8217; preemptive rights and does not discriminate among stockholders (except for the possible effect of not offering fractional rights); (iii) management uses its best efforts to ensure an adequate trading market in the rights for use by stockholders who do not exercise such rights; and (iv) the ratio of a transferable rights offering does not exceed one new share of stock for each three rights held.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Important Dates to Remember</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Please note that the dates in the table below may change if the rights offering is extended.]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 60%; border-collapse: collapse; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; width: 29%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EVENT</b></span></td>
    <td style="padding-bottom: 1pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; width: 29%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DATE</b></span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Record Date</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;], 2023</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription Period*</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;], 2023 through [&#9679;], 2023&#x2020;</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Final Date Rights Will Trade</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;], 2023&#x2020;</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expiration Date*</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;], 2023&#x2020;</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment for Shares and Subscription Certificate or Notice of Guaranteed Delivery Due*</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;], 2023&#x2020;</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance Date</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;], 2023&#x2020;</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Confirmation Date</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;], 2023&#x2020;</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A shareholder exercising Rights must deliver by 5:00 PM Eastern Time on [&#9679;], 2023 (unless otherwise extended) either (a) a Subscription Certificate and payment for Common Shares or (b) a notice of guaranteed delivery [and payment for shares].</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#x2020;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless the offer is extended.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Over-Subscription Privilege</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Board has the right in its absolute discretion to eliminate the over-subscription privilege with respect to [either or both primary over-subscription and secondary] over-subscription shares if it considers it to be in the best interest of the Fund to do so. The Board may make that determination at any time, without prior notice to Rights holders or others, up to and including the [&#9679;] day following the Expiration Date. If the primary over-subscription privilege is not eliminated, it will operate as set forth below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rights holders who are Record Date Shareholders and who fully exercise their Rights are entitled to subscribe for additional Common Shares at the same Subscription Price pursuant to the over-subscription privilege, subject to certain limitations and subject to allotment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Record Date Shareholders who fully exercise all Rights initially issued to them are entitled to buy those Common Shares, referred to as &#8220;primary over-subscription shares,&#8221; that were not purchased by other holders of Rights at the same Subscription Price. If enough primary over-subscription shares are available, all such requests will be honored in full. If the requests for primary over-subscription shares exceed the primary over-subscription shares available, the available primary over-subscription shares will be allocated pro rata among those fully exercising Record Date Shareholders who over-subscribe based on the number of Rights originally issued to them by the Fund. Common Shares acquired pursuant to the over-subscription privilege are subject to allotment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 81 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">R-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[In addition, in the event that the Fund&#8217;s per share net asset value at the end of the Subscription Period is equal to or less than the Subscription Price, the Fund, in its sole discretion, may determine to issue additional Common Shares in an amount of up to [&#9679;]% of the shares issued pursuant to the primary subscription, referred to as &#8220;secondary over-subscription shares.&#8221; Should the Fund determine to issue some or all of the secondary over-subscription shares, they will be allocated only among Record Date Shareholders who submitted over-subscription requests. Secondary over-subscription shares will be allocated pro rata among those fully exercising Record Date Shareholders who over-subscribe based on the number of Rights originally issued to them by the Fund.] <i>Rights acquired in the secondary market may not participate in the over-subscription privilege.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Record Date Shareholders who are fully exercising their Rights during the Subscription Period should indicate, on the Subscription Certificate that they submit with respect to the exercise of the Rights issued to them, how many Common Shares they are willing to acquire pursuant to the over-subscription privilege.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To the extent sufficient Common Shares are not available to fulfill all over-subscription requests, unsubscribed Common Shares (the &#8220;Excess Shares&#8221;) will be allocated pro rata among those Record Date Shareholders who over-subscribe based on the number of Rights issued to them by the Fund. The allocation process may involve a series of allocations in order to assure that the total number of Common Shares available for over-subscriptions is distributed on a pro rata basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The formula to be used in allocating the Excess Shares is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="text-align: justify; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Shareholder&#8217;s Record Date Position</span></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: justify; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</span></td>
    <td style="width: 0.5in">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Excess Shares Remaining</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: justify">Total Record Date Position of All Over-Subscribers</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Banks, broker-dealers, trustees and other nominee holders of Rights will be required to certify to the Rights Agent, before any over-subscription privilege may be exercised with respect to any particular beneficial owner, as to the aggregate number of Rights exercised during the Subscription Period and the number of Common Shares subscribed for pursuant to the over-subscription privilege by such beneficial owner and that such beneficial owner&#8217;s subscription was exercised in full. Nominee holder over-subscription forms and beneficial owner certification forms will be distributed to banks, broker-dealers, trustees and other nominee holders of Rights with the Subscription Certificates. Nominees should also notify holders purchasing Rights in the secondary market that such Rights may not participate in the over-subscription privilege.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund will not offer or sell any Common Shares that are not subscribed for during the Subscription Period or pursuant to the over-subscription privilege.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[In the event that the Fund&#8217;s per share net asset value at the end of the Subscription Period is greater than the subscription price (i.e., Common Shares will be issued at a price below the Fund&#8217;s then current net asset value), the over-subscription shares issued by the Fund will not result in the ratio of the Rights offering exceeding one new share for each three Rights held.]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Insider Participation in Rights Offering</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund has been advised that the Investment Adviser and the Fund&#8217;s Directors and officers that own Common Shares may exercise some or all of the Rights initially issued to them, and may request additional Common Shares pursuant to the over-subscription privilege. An exercise of the over-subscription privilege by such persons will increase their proportionate voting power and share of the Fund&#8217;s assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mario J. Gabelli, a Director of the Fund and control person of the Investment Adviser, or his affiliated entities, may exercise some or all of the Rights initially issued to them, and may request additional Common Shares pursuant to the over-subscription privilege. Mr.&#160;Gabelli, or his affiliated entities, may also offer to sell, or otherwise transfer, some or all of the Rights initially issued to them. If Mr.&#160;Gabelli, or his affiliated entities, sells or otherwise transfers some or all of the Rights initially issued to them, Mr.&#160;Gabelli intends to sell or transfer such Rights in accordance with the resale and/or transfer procedures set forth in this Prospectus Supplement under the headings &#8220;Description of the Rights Offering &#8212; Sales by Rights Agent&#8221; and &#8220;Description of the Rights Offering &#8212; Method of Selling or Transferring Rights&#8221;. Mr.&#160;Gabelli will be the beneficial owner of [&#9679;] Rights<sup>1</sup> and may offer to sell, or otherwise transfer, up to all of such Rights. If Mr.&#160;Gabelli determines to sell or transfer all of the Rights that he may offer hereby, he will beneficially own no Rights after the completion of this Rights offering. Mr.&#160;Gabelli reserves the right to sell or transfer no Rights or an amount of Rights that is otherwise less than all of the Rights set forth in this paragraph.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>1</sup></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.&#160;Gabelli will be deemed to be the direct beneficial owner of [&#9679;] Rights owned directly by Mr.&#160;Gabelli, [&#9679;] Rights owned by a family partnership for which Mr.&#160;Gabelli serves as general partner, and [&#9679;] Rights owned by Associated Capital Group, Inc. or its affiliates.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<!-- Field: Page; Sequence: 82 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">R-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.&#160;Gabelli is Chairman of the Board of Directors, a portfolio manager of the Fund and Chief Investment Officer of the Fund. Mr.&#160;Gabelli is Chairman, Chief Executive Officer, and Chief Investment Officer &#8212; Value Portfolios of GAMCO Investors, Inc. (&#8220;GAMI&#8221;), an asset manager and financial services company. He is also the Chief Investment Officer of Value Portfolios of the Investment Adviser and GAMCO Asset Management Inc. (&#8220;GAMCO&#8221;), both of which are asset management subsidiaries of GAMI. In addition, Mr.&#160;Gabelli is Chief Executive Officer, Chief Investment Officer, a director and the controlling shareholder of GGCP, Inc. (&#8220;GGCP&#8221;), a private company that holds a majority interest in GAMI, and the Chairman of MJG Associates, Inc., which acts as an investment manager of various investment funds and other accounts. He is also Executive Chairman of Associated Capital Group, Inc., a public company that provides alternative management and institutional research services, and is a majority-owned subsidiary of GGCP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sales by Rights Agent</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders of Rights who are unable or do not wish to exercise any or all of their Rights may instruct the Rights Agent to sell any unexercised Rights. The Subscription Certificates representing the Rights to be sold by the Rights Agent must be received prior to 5:00 PM, Eastern Time, on [&#9679;], 2023, [&#9679;] Business Days prior to the Expiration Date (or, if the subscription period is extended, prior to 5:00 PM Eastern Time, on the [&#9679;] Business Day prior to the extended Expiration Date). Upon the timely receipt of the appropriate instructions to sell Rights, the Rights Agent will use its best efforts to complete the sale and will remit the proceeds of sale, net of any commissions, to the holders. The Rights Agent will also attempt to sell any Rights attributable to shareholders of record whose addresses are outside the United States [and Canada], or who have an APO or FPO address. The selling Rights holder will pay all brokerage commissions incurred by the Rights Agent. [G.research, LLC] (the &#8220;Dealer Manager&#8221;), a registered broker-dealer, may also act on behalf of its clients to purchase or sell Rights in the open market and be compensated for its services at a commission of up to $[&#9679;] per Right, provided that, if the Rights trade at a value of $0.01 or less at the time of such sale, then no commission will be charged. The Dealer Manager is a wholly-owned subsidiary of Institutional Services Holdings, LLC, which in turn is a wholly owned subsidiary of Associated Capital Group, Inc., an affiliate of the Investment Adviser, which is, in turn, indirectly majority-owned by Mario J. Gabelli. As a result of these relationships, Mr.&#160;Gabelli is a &#8220;controlling person&#8221; of the Dealer Manager.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Rights Agent will automatically attempt to sell any unexercised Rights that remain unclaimed as a result of Subscription Certificates being returned by the postal authorities as undeliverable as of the [&#9679;] Business Day prior to the Expiration Date. These sales will be made net of commissions, taxes and any other expenses paid on behalf of the nonclaiming holders of Rights. Proceeds from those sales will be held by [Computershare Trust Company, N.A.,] in its capacity as the Fund&#8217;s transfer agent, for the account of the nonclaiming holder of Rights until the proceeds are either claimed or escheated. There can be no assurance that the Rights Agent will be able to complete the sale of any of these Rights and neither the Fund nor the Rights Agent has guaranteed any minimum sales price for the Rights. All of these Rights will be sold at the market price, if any, through an exchange or market trading the Rights. If the Rights can be sold, sales of the Rights will be deemed to have been effected at the weighted average price received by the Rights Agent on the day such Rights are sold, less any applicable brokerage commissions, taxes and other expenses. Holders of Rights attempting to sell any unexercised Rights in the open market through a broker-dealer other than the Dealer Manager should consider the commissions and fees charged by the broker-dealer prior to selling their Rights on the open market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders are urged to obtain a recent trading price for the Rights on the [&#9679;] from their broker, bank, financial advisor or the financial press.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Method of Selling or Transferring Rights</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Sales on the [&#9679;].</i> The Rights are transferable and will be admitted for trading on the [&#9679;] under the symbol &#8220;[&#9679;]&#8221;. Although no assurance can be given that a market for the Rights will develop, trading in the Rights on the [&#9679;] is expected to begin [&#9679;] Business Days prior to the Record Date and may be conducted until the close of trading on the last [&#9679;] trading day prior to the Expiration Date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 83 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">R-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The value of the Rights, if any, will be reflected by the market price. Rights may be sold by individual holders or may be submitted to the Rights Agent for sale. Any Rights submitted to the Rights Agent for sale must be received by the Rights Agent prior to 5:00PM, Eastern Time, on [&#9679;], 2023, three Business Days prior to the Expiration Date (or, if the subscription period is extended, prior to 5:00 PM, Eastern Time on the third Business Day prior to the extended Expiration Date).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Rights that are sold will not confer any right to acquire any Common Shares in any [primary or secondary] over-subscription privilege, and any Record Date Shareholder who sells any Rights will not be eligible to participate in the [primary or secondary] over-subscription privilege, if any.]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading of the Rights on the [&#9679;] will be conducted on a when-issued basis until and including the date on which the Subscription Certificates (as defined below) are mailed to Record Date Shareholders and thereafter will be conducted on a regular-way basis until and including the last [&#9679;] trading day prior to the Expiration Date. The Common Shares are expected to begin trading ex-Rights [&#9679;] Business Day[s] prior to the Record Date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other Transfers</i>. The Rights evidenced by a single Subscription Certificate may be transferred in whole by endorsing the Subscription Certificate for transfer in accordance with the accompanying instructions. A portion of the Rights evidenced by a single Subscription Certificate (but not fractional Rights) may be transferred by delivering to the Rights Agent a Subscription Certificate properly endorsed for transfer, with instructions to register the portion of the Rights evidenced thereby in the name of the transferee (and to issue a new Subscription Certificate to the transferee evidencing the transferred Rights). In this event, a new Subscription Certificate evidencing the balance of the Rights will be issued to the Rights holder or, if the Rights holder so instructs, to an additional transferee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders wishing to transfer all or a portion of their Rights (but not fractional Rights) should promptly transfer such Rights to ensure that: (i) the transfer instructions will be received and processed by the Rights Agent, (ii) a new Subscription Certificate will be issued and transmitted to the transferee or transferees with respect to transferred Rights, and to the transferor with respect to retained Rights, if any, and (iii) the Rights evidenced by the new Subscription Certificates may be exercised or sold by the recipients thereof prior to the Expiration Date. Neither the Fund nor the Rights Agent shall have any liability to a transferee or transferor of Rights if Subscription Certificates are not received in time for exercise or sale prior to the Expiration Date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except for the fee for its services charged by the Rights Agent (which will be paid by the Fund as described below), all commissions, fees and other expenses (including brokerage commissions and transfer taxes) incurred in connection with the purchase, sale, transfer or exercise of Rights will be for the account of the transferor of the Rights, and none of these commissions, fees or expenses will be borne by the Fund or the Rights Agent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund anticipates that the Rights will be eligible for transfer through, and that the exercise of the Rights may be effected through, the facilities of DTC (Rights exercised through DTC are referred to as &#8220;DTC Exercised Rights&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Rights Agent</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Rights Agent is [&#9679;]. The Rights Agent will receive from the Fund an amount estimated to be $[&#9679;], comprised of the fee for its services and the reimbursement for certain expenses related to the Rights offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Inquiries</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For additional information all holders of Rights should contact the Fund by telephone at 800-GABELLI (422-3554) or 914-921-5070, or by written request to The Gabelli Equity Trust Inc., One Corporate Center, Rye, New York 10580-1422.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Administrative Agent</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;] is serving as administrative agent for this Rights offering. [&#9679;] will perform administrative services in connection with the Rights offering, including consultation and preparation in connection with the search of, and distribution of materials to, brokers and banks, and other nominees. [&#9679;] will also perform other administrative and back office services at the Fund&#8217;s authorization and instruction. For its services, [&#9679;] will receive a fee of $[&#9679;] from the Fund, plus reimbursement of its out-of-pocket expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 84 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">R-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Method of Exercise of Rights</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rights may be exercised by completing and signing the Subscription Certificate and mailing it in the envelope provided, or otherwise delivering the completed and signed Subscription Certificate to the Rights Agent, together with payment for the Common Shares as described below under &#8220;Payment for Shares.&#8221; Rights may also be exercised through the broker of a holder of Rights, who may charge the holder of Rights a servicing fee in connection with such exercise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Completed Subscription Certificates and payment must be received by the Rights Agent prior to 5:00 PM Eastern Time, on the Expiration Date (unless payment is effected by means of a notice of guaranteed delivery as described below under &#8220;Payment for Shares&#8221;). Your broker, bank, trust company or other intermediary may impose a deadline for exercising Rights earlier than 5:00 PM, Eastern Time, on the Expiration Date. The Subscription Certificate and payment should be delivered to the Rights Agent at the following address:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If By First Class Mail:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Gabelli Equity Trust Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If By Registered, Certified or Express Mail or Overnight Courier:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Gabelli Equity Trust Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Payment for Shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders of Rights who acquire Common Shares in the Subscription may choose between the following methods of payment:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.5in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A holder of Rights can send the Subscription Certificate, together with payment in the form of a check (which must include the name of the shareholder on the check) for the Common Shares subscribed for in the Rights offering and, if eligible, for any additional Common Shares subscribed for pursuant to the over-subscription privilege, to the Rights Agent based on the Subscription Price of $[&#9679;] per Common Share. To be accepted, the payment, together with the executed Subscription Certificate, must be received by the Rights Agent at one of the addresses noted above prior to 5:00 PM Eastern Time on the Expiration Date. The Rights Agent will deposit all share purchase checks received by it prior to the final due date into a segregated account pending proration and distribution of Common Shares. The Rights Agent will not accept cash as a means of payment for Common Shares.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.5in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alternatively, a subscription will be accepted by the Rights Agent if, prior to 5:00 PM Eastern Time on the Expiration Date, the Rights Agent has received a written notice of guaranteed delivery by mail or email from a bank, trust company, or a NYSE member, guaranteeing delivery of a properly completed and executed Subscription Certificate. In order for the notice of guarantee to be valid, full payment for the Common Shares at the Subscription Price of $[&#9679;] per Common Share must be received with the notice. The Rights Agent will not honor a notice of guaranteed delivery unless a properly completed and executed Subscription Certificate is received by the Rights Agent by the close of business on the [third] Business Day after the Expiration Date. The notice of guaranteed delivery must be emailed to the Rights Agent at [&#9679;] or delivered to the Rights Agent at one of the addresses noted above.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXCEPT AS OTHERWISE SET FORTH BELOW, A PAYMENT PURSUANT TO THIS METHOD MUST BE IN UNITED STATES DOLLARS BY CHECK (WHICH MUST INCLUDE THE NAME OF THE SHAREHOLDER ON THE CHECK) DRAWN ON A BANK LOCATED IN THE CONTINENTAL UNITED STATES [(OR FOR ELIGIBLE CANADIAN RESIDENTS, A BANK LOCATED IN CANADA)], MUST BE PAYABLE TO THE GABELLI EQUITY TRUST INC. AND MUST ACCOMPANY AN EXECUTED SUBSCRIPTION CERTIFICATE TO BE ACCEPTED.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 85 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">R-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If a holder of Rights who acquires Common Shares pursuant to the subscription makes payment of an insufficient amount, the Fund reserves the right to take any or all of the following actions: (i) reallocate such subscribed and unpaid-for Common Shares to Record Date Shareholders exercising the over-subscription privilege who did not receive the full over-subscription requested; (ii) apply any payment actually received by it toward the purchase of the greatest whole number of Common Shares which could be acquired by such holder upon exercise of the Rights or over-subscription privilege; and (iii) exercise any and all other rights or remedies to which it may be entitled, including, without limitation, the right to set off against payments actually received by it with respect to such subscribed Common Shares (in other words, retain such payments) and to enforce the exercising Rights holder&#8217;s relevant payment obligation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any payment required from a holder of Rights must be received by the Rights Agent prior to 5:00 PM Eastern Time on the Expiration Date. Issuance and delivery of certificates for the Common Shares purchased are subject to collection of checks. If sent by mail it is recommended that the certificates and payments be sent by registered mail, properly insured, with return receipt requested, and that a sufficient number of days be allowed to ensure delivery to the Rights Agent and clearance of payment prior to 5:00 PM, Eastern Time, on the Expiration Date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within [&#9679;] Business Days following the Expiration Date (the &#8220;Confirmation Date&#8221;), a confirmation will be sent by the Rights Agent to each holder of Rights (or, if the Common Shares are held by Cede or any other depository or nominee, to Cede or such other depository or nominee), showing (i) the number of Common Shares acquired pursuant to the Subscription, (ii) the number of Common Shares, if any, acquired pursuant to the over-subscription privilege, and (iii) the per share and total purchase price for the Common Shares. Any payment required from a holder of Rights must be received by the Rights Agent on or prior to the Expiration Date. Any excess payment to be refunded by the Fund to a holder of Rights, or to be paid to a holder of Rights as a result of sales of Rights on its behalf by the Rights Agent, will be mailed by the Rights Agent to the holder within [&#9679;] Business Days after the Expiration Date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A holder of Rights will have no right to rescind a purchase after the Rights Agent has received payment either by means of a notice of guaranteed delivery or a check, which must include the name of the shareholder on the check.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders, such as broker-dealers, trustees or depositories for securities, who hold Common Shares for the account of others, should notify the respective beneficial owners of the Common Shares as soon as possible to ascertain such beneficial owners&#8217; intentions and to obtain instructions with respect to the Rights. If the beneficial owner so instructs, the record holder of the Rights should complete Subscription Certificates and submit them to the Rights Agent with the proper payment. In addition, beneficial owners of Common Shares or Rights held through such a holder should contact the holder and request that the holder effect transactions in accordance with the beneficial owner&#8217;s instructions. <b>Banks, broker-dealers, trustees and other nominee holders that hold Common Shares of the Fund for the accounts of others are advised to notify those persons that purchase Rights in the secondary market that such Rights may not participate in any over-subscription privilege offered</b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE INSTRUCTIONS ACCOMPANYING THE SUBSCRIPTION CERTIFICATES SHOULD BE READ CAREFULLY AND FOLLOWED IN DETAIL. DO NOT SEND SUBSCRIPTION CERTIFICATES TO THE FUND.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE METHOD OF DELIVERY OF SUBSCRIPTION CERTIFICATES AND PAYMENT OF THE SUBSCRIPTION PRICE TO THE RIGHTS AGENT WILL BE AT THE ELECTION AND RISK OF THE RIGHTS HOLDERS, BUT IF SENT BY MAIL IT IS RECOMMENDED THAT THE CERTIFICATES AND PAYMENTS BE SENT BY REGISTERED MAIL, PROPERLY INSURED, WITH RETURN RECEIPT REQUESTED, AND THAT A SUFFICIENT NUMBER OF DAYS BE ALLOWED TO ENSURE DELIVERY TO THE RIGHTS AGENT AND CLEARANCE OF PAYMENT PRIOR TO [5:00 PM] EASTERN TIME, ON THE EXPIRATION DATE. BECAUSE UNCERTIFIED PERSONAL CHECKS MAY TAKE AT LEAST FIVE BUSINESS DAYS TO CLEAR, YOU ARE STRONGLY URGED TO PAY, OR ARRANGE FOR PAYMENT, BY MEANS OF A CERTIFIED OR CASHIER&#8217;S CHECK, WHICH MUST INCLUDE THE NAME OF THE SHAREHOLDER ON THE CHECK.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 86 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">R-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All questions concerning the timeliness, validity, form and eligibility of any exercise of Rights will be determined by the Fund, whose determinations will be final and binding. The Fund in its sole discretion may waive any defect or irregularity, or permit a defect or irregularity to be corrected within such time as it may determine, or reject the purported exercise of any Right. Subscriptions will not be deemed to have been received or accepted until all irregularities have been waived or cured within such time as the Fund determines in its sole discretion. Neither the Fund nor the Rights Agent will be under any duty to give notification of any defect or irregularity in connection with the submission of Subscription Certificates or incur any liability for failure to give such notification.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Foreign Restrictions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offering documents, including Subscription Certificates, will not be mailed to Record Date Shareholders whose addresses are outside the United States (for these purposes, the United States includes the District of Columbia and the territories and possessions of the United States) or is an A.P.O. or a F.P.O. address (the &#8220;Foreign Shareholders&#8221;) if such mailing cannot be made into the non-U.S. jurisdiction without additional registration and incurring other expense that the Board has determined is not in the best interest of the Fund and its shareholders. In such cases, unless determined to be not in the best interest of the Fund and its shareholders in accordance with the previous sentence, the Rights Agent will send a letter via regular mail to Foreign Shareholders who own Common Shares directly (&#8220;Direct Foreign Shareholders&#8221;), as opposed to in &#8220;street name&#8221; with a broker or other financial intermediary, to notify them of the Rights offering. Direct Foreign Shareholders who wish to exercise their Rights should contact the Fund, as described above under &#8220;Inquiries,&#8221; to facilitate the exercise of such Rights and for instructions or any other special requirements that may apply in order for such Direct Foreign Shareholder to exercise its Rights. Direct Foreign Shareholders who wish to sell their Rights should contact the Rights Agent and follow the procedures described above under &#8220;Sales by Rights Agent.&#8221; Direct Foreign Shareholders are encouraged to contact the Fund or the Rights Agent as far in advance of the Expiration Date as possible to ensure adequate time for their Rights to be exercised or sold. Foreign Shareholders who own Common Shares in &#8220;street name&#8221; through a broker or other financial intermediary should contact such broker or other financial intermediary with respect to any exercise or sale of Rights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Certain Employee Benefit Plan and IRA Considerations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Holders of Rights that are employee benefit plans subject to limitations imposed by the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), such as employee plans subject to the Employee Retirement Income Security Act of 1974, as amended (&#8220;ERISA&#8221;), Keogh Plans and Individual Retirement Accounts (&#8220;IRA&#8221;) (each a &#8220;Benefit Plan&#8221; and collectively, &#8220;Benefit Plans&#8221;), should be aware that the use of additional contributions of cash outside of the Benefit Plan to exercise Rights may be treated as additional contributions to the Benefit Plan. When taken together with contributions previously made, such deemed additional contributions may be in excess of tax limitations and subject the Rights holder to excise taxes for excess or nondeductible contributions. In the case of Benefit Plans qualified under Section&#160;401(a) of the Code, additional contributions could cause the maximum contribution limitations of Section&#160;415 of the Code or other qualification rules to be violated. Benefit Plans contemplating making additional contributions to exercise Rights should consult with their legal and tax counsel prior to making such contributions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Benefit Plans and other tax exempt entities, including governmental plans, should also be aware that if they borrow to finance their exercise of Rights, they may become subject to the tax on unrelated business taxable income (&#8220;UBTI&#8221;) under Section&#160;511 of the Code. If any portion of an IRA is used as security for a loan, the portion so used may also be treated as distributed to the IRA depositor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A Benefit Plan may also be subject to laws, such as ERISA, that impose certain requirements on the Benefit Plan and on those persons who are fiduciaries with respect to the Benefit Plans. Such requirements may include prudence and diversification requirements and require that investments be made in accordance with the documents governing the Benefit Plan. The exercise of Rights by a fiduciary for a Benefit Plan should be considered in light of such fiduciary requirements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 87 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">R-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition, ERISA and the Code prohibit certain transactions involving the assets of a Benefit Plan and certain persons (referred to as &#8220;parties in interest&#8221; for purposes of ERISA and &#8220;disqualified persons&#8221; for purposes of the Code) having certain relationships to such Benefit Plans, unless a statutory or administrative exemption is applicable to the transaction. A party in interest or disqualified person who engages in a nonexempt prohibited transaction may be subject to excise taxes and other penalties and liabilities under ERISA and the Code (or with respect to certain Benefit Plans, such as IRAs, a prohibited transaction may cause the Benefit Plan to lose its tax-exempt status). In this regard, the U.S. Department of Labor has issued prohibited transaction class exemptions (&#8220;PTCEs&#8221;) that may apply to the exercise of the Rights and holding of the Common Shares. These class exemptions include, without limitation, PTCE 84-14 respecting transactions determined by independent qualified professional asset managers, PTCE 90-1 respecting insurance company pooled separate accounts, PTCE 91-38 respecting bank collective investment funds, PTCE 95-60 respecting life insurance company general accounts and PTCE 96-23 respecting transactions determined by in-house asset managers, PTCE 84-24 governing purchases of shares in investment companies) and PTCE 75-1 respecting sales of securities. In addition, Section&#160;408(b)(17) of ERISA and Section&#160;4975(d)(20) of the Code each provides a limited exemption, commonly referred to as the &#8220;service provider exemption,&#8221; from the prohibited transaction provisions of ERISA and Section&#160;4975 of the Code for certain transactions between a Benefit Plan and a person that is a party in interest and/or a disqualified person (other than a fiduciary or an affiliate that, directly or indirectly, has or exercises any discretionary authority or control or renders any investment advice with respect to the assets of any Benefit Plan involved in the transaction) solely by reason of providing services to the Benefit Plan or by relationship to a service provider, provided that the Benefit Plan receives no less, nor pays no more, than adequate consideration. There can be no assurance that all of the conditions of any such exemptions or any other exemption will be satisfied at the time that the Rights are exercised, or thereafter while the Common Shares are held, if the facts relied upon for utilizing a prohibited transaction exemption change.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due to the complexity of these rules and the penalties for noncompliance, fiduciaries of Benefit Plans should consult with their legal and tax counsel regarding the consequences of their exercise of Rights under ERISA, the Code and other similar laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="r_004"></span>TABLE OF FEES AND EXPENSES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following tables are intended to assist you in understanding the various costs and expenses directly or indirectly associated with investing in our Common Shares as a percentage of net assets attributable to Common Shares. Amounts are for the current fiscal year after giving effect to anticipated net proceeds of the Rights offering, assuming that we incur the estimated offering expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shareholder Transaction Expenses </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Record Date Sales Load (as a percentage of offering price)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;</span></td>
    <td style="text-align: left">]%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Offering Expenses (as a percentage of offering price)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;</span></td>
    <td style="text-align: left">]%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Dividend Reinvestment Plan Fees</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</span></td>
    <td style="text-align: left">(1) </td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 68%; text-align: left">Voluntary Cash Purchase Plan Purchase Transaction Fee</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">0.75</td>
    <td style="width: 1%; text-align: left">(1)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Voluntary Cash Purchase Plan Sale Transaction Fee</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">2.50</td>
    <td style="text-align: left">(1)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Percentage&#160;of<br /> Net Assets <br /> Attributable&#160;to<br /> Common Shares</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Annual Expenses</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 68%; text-align: left">Management Fees</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;</span></td>
    <td style="white-space: nowrap; width: 1%; text-align: left">]%(2)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Interest on Borrowed Funds</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;</span></td>
    <td style="white-space: nowrap; text-align: left">]</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Other Expenses</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;</span></td>
    <td style="white-space: nowrap; text-align: left">]%(3)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Total Annual Fund Operating Expenses</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;</span></td>
    <td style="white-space: nowrap; text-align: left">]%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Dividends on Preferred Stock</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">&#160;</td>
    <td style="padding-bottom: 2.5pt; white-space: nowrap">%(4)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Total Annual Fund Operating Expenses and Dividends on Preferred Stock</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;</span></td>
    <td style="padding-bottom: 2.5pt; white-space: nowrap">]%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 88 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">R-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="text-align: justify; width: 0in"></td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There are no fees charged to stockholders for participating in the Fund&#8217;s Automatic Dividend Reinvestment and Voluntary Cash Purchase Plan. However, stockholders participating in the Plan that elect to make additional cash purchases under the Plan would pay $0.75 per transaction plus a per share fee (which includes any applicable brokerage commissions) to purchase shares and $2.50 per transaction plus a per share fee (which includes any applicable brokerage commissions) to sell shares. See &#8220;<i>Automatic Dividend Reinvestment and Voluntary Cash Purchase Plans</i>&#8221; in the Prospectus.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="text-align: justify; width: 0in"></td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Investment Adviser&#8217;s fee is 1.00% annually of the Fund&#8217;s average weekly net assets. The Fund&#8217;s average weekly net assets will be deemed to be the average weekly value of the Fund&#8217;s total assets minus the sum of the Fund&#8217;s liabilities (such liabilities exclude (i) the aggregate liquidation preference of outstanding shares of preferred stock and accumulated dividends, if any, on those shares and (ii) the liabilities for any money borrowed). Consequently, because the Fund has shares of preferred stock outstanding, the investment management fees and other expenses as a percentage of net assets attributable to common stock are higher than if the Fund did not utilize a leveraged capital structure.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="text-align: justify; width: 0in"></td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Other Expenses&#8221; are based on estimated amounts for the current year assuming completion of the proposed issuance.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="text-align: justify; width: 0in"></td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Dividends on Preferred Stock represent distributions on the existing preferred stock outstanding.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The purpose of the table above and the examples below is to help you understand all fees and expenses that you, as a holder of Common Shares, would bear directly or indirectly.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Example</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following example illustrates the expenses you would pay on a $1,000 investment in Common Shares, assuming a 5% annual portfolio total return.*</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-indent: -0.125in; padding-left: 0.125in; text-align: center">&#160;</td>
    <td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1 Year</b></span></td>
    <td style="vertical-align: bottom; padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td>
    <td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3 Years</b></span></td>
    <td style="vertical-align: bottom; padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td>
    <td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5 Years</b></span></td>
    <td style="vertical-align: bottom; padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td>
    <td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10 Years</b></span></td>
    <td style="vertical-align: bottom; padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 52%; text-align: left">Total Expenses Incurred</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">[&#9679;</td>
    <td style="width: 1%; text-align: left">]</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;</span></td>
    <td style="width: 1%; text-align: left">]</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;</span></td>
    <td style="width: 1%; text-align: left">]</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;</span></td>
    <td style="width: 1%; text-align: left">]</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="text-align: justify; width: 0in"></td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The example should not be considered a representation of future expenses. The example assumes that the amounts set forth in the Annual Expenses table are accurate and that all distributions are reinvested at net asset value. Actual expenses may be greater or less than those assumed. Moreover, the Fund&#8217;s actual rate of return may be greater or less than the hypothetical 5% return shown in the example.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The example above includes Dividends on Preferred Stock. If Dividends on Preferred Stock were not included in the example calculation, the expenses would be as follows (based on the same assumptions as above).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-indent: -0.125in; padding-left: 0.125in; text-align: center">&#160;</td>
    <td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1 Year</b></span></td>
    <td style="vertical-align: bottom; padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td>
    <td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3 Years</b></span></td>
    <td style="vertical-align: bottom; padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td>
    <td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5 Years</b></span></td>
    <td style="vertical-align: bottom; padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td>
    <td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10 Years</b></span></td>
    <td style="vertical-align: bottom; padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 52%; text-align: left">Total Expenses Incurred</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">[&#9679;</td>
    <td style="width: 1%; text-align: left">]</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;</span></td>
    <td style="width: 1%; text-align: left">]</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;</span></td>
    <td style="width: 1%; text-align: left">]</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;</span></td>
    <td style="width: 1%; text-align: left">]</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="r_005"></span>USE OF PROCEEDS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund estimates the net proceeds of the Rights offering to be approximately $[&#9679;], based on the Subscription Price per share of Common Share $[&#9679;], assuming all new Common Shares offered are sold and that the expenses related to the Rights offering estimated at approximately $[&#9679;] are paid.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 89 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">R-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Investment Adviser expects that it will initially invest the proceeds of the offering in high quality short term debt securities and instruments. The Investment Adviser anticipates that the investment of the proceeds will be made in accordance with the Fund&#8217;s investment objectives and policies as appropriate investment opportunities are identified, which is expected to be substantially completed within three months; however, the identification of appropriate investment opportunities pursuant to the Fund&#8217;s investment style or changes in market conditions may cause the investment period to extend as long as six months. This could occur because the Investment Adviser follows a value-oriented investment strategy; therefore, market conditions could result in the Investment Adviser delaying the investment of proceeds if it believes the margin of risk in making additional investments is not favorable in light of its value-oriented investment strategy. See &#8220;Investment Objectives and Policies&#8212;Investment Methodology of the Fund&#8221; in the accompanying Prospectus. [In addition, in the discretion of the Board, the proceeds of the offering may be used to redeem a portion of the Fund&#8217;s outstanding preferred stock.] Depending on market conditions and operations, a portion of the cash held by the Fund, including any proceeds raised from the offering, may be used to pay distributions in accordance with the Fund&#8217;s distribution policy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="r_006"></span>CAPITALIZATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[To be provided.]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="r_007"></span>PRICE RANGE OF COMMON SHARES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth for the quarters indicated, the high and low sale prices on the NYSE per share of our Common Shares and the net asset value and the premium or discount from net asset value per share at which the Common Shares were trading, expressed as a percentage of net asset value, at each of the high and low sale prices provided.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[To be provided.]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The last reported price for our Common Shares on [&#9679;], 2023 was $[&#9679;] per share. As of [&#9679;], 2023, the net asset value per share of the Fund&#8217;s Common Shares was $[&#9679;]. Accordingly, our Common Shares traded at a [premium to] [discount from] net asset value of [&#9679;]% on [&#9679;], 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund&#8217;s Common Shares have traded in the market at both premiums to and discounts from net asset value. [Over the Fund&#8217;s thirty-seven year history, the range fluctuated from a 38% premium in June&#160;2002 to a 27% discount in December&#160;1987.] Beginning in early 2001, the market price of the Fund exceeded the net asset value and this premium continued through September&#160;2005. The previous extended period over which the premium existed occurred during the twenty month period from August&#160;1993 to March&#160;1995. As of [&#9679;], 2023, the market price of the Fund closed at an approximate [&#9679;]% premium to its net asset value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="r_008"></span>SPECIAL CHARACTERISTICS AND RISKS OF THE RIGHTS OFFERING</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk is inherent in all investing. Therefore, before investing in the Common Shares you should consider the risks associated with such an investment carefully. See &#8220;Risk Factors and Special Considerations&#8221; in the Prospectus. The following summarizes some of the matters that you should consider before investing in the Fund through the Rights offering:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dilution. </i>Shareholders who do not exercise their Rights may, at the completion of the Subscription Period, own a smaller proportional interest in the Fund than if they exercised their Rights. As a result of the Rights offering, you may experience dilution in net asset value per share if the subscription price is below the net asset value per share as of the Expiration Date. If the Subscription Price per share is below the net asset value per Common Share of the Fund as of the Expiration Date, you will experience an immediate dilution of the aggregate net asset value of your shares if you do not participate in the Rights offering and you will experience a reduction in the net asset value per share of your shares whether or not you participate in the Rights offering. Such dilution may be offset (in whole or in part) by the accretive nature of the Rights offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 90 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">R-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Non-Exercising Shareholders</i>. If you do not exercise all of your Rights, you may own a smaller proportional interest in the Fund when the Rights offering is over. In addition, you will experience an immediate dilution of the aggregate net asset value per Common Share if you do not participate in the Rights offering and will experience a reduction in the net asset value per Common Share whether or not you exercise your Rights, if the Subscription Price is below the Fund&#8217;s net asset value per Share on the Expiration Date, because:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the offered common shares are being sold at less than their current net asset value;</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">you will indirectly bear the expenses of the Rights offering; and</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the number of common shares outstanding after the Rights offering will have increased proportionately more than the increase in the amount of the Fund&#8217;s net assets.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On the other hand, if the Subscription Price is above the Fund&#8217;s net asset value per Common Share on the Expiration Date, you may experience an immediate accretion of the aggregate net asset value per shares of your Common Shares even if you do not exercise your Rights and an immediate increase in the net asset value per share of your Common Shares whether or not you participate in the Rights offering, because:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the offered common shares are being sold at more than their current net asset value after deducting the expenses of the Rights offering; and</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the number of common shares outstanding after the Rights offering will have increased proportionately less than the increase in the amount of the Fund&#8217;s net assets.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Furthermore, if you do not participate in the over-subscription privilege, if any, your percentage ownership may also be diluted.] The Fund cannot state precisely the amount of any dilution because it is not known at this time what the net asset value per Common Share will be on the Expiration Date or what proportion of the Rights will be exercised. The impact of the Rights offering on net asset value per Common Share is shown by the following examples, assuming the Rights offering is fully subscribed and a $[&#9679;] Subscription Price:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[Scenario 1: (assumes net asset value per share is above subscription price)<sup>(1)</sup></b></span></td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; width: 68%; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NAV<sup>(2)</sup></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#8212;</span></td>
    <td style="width: 1%; text-align: left">]</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top">Subscription Price</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#8212;</span></td>
    <td style="text-align: left">]</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reduction in NAV($)<sup>(3)</sup></span></td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#8212;</span></td>
    <td style="text-align: left">]</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Reduction in NAV(%)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#8212;</span></td>
    <td style="text-align: left">]]</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[Scenario 2: (assumes net asset value per share is below subscription price)<sup>(1)</sup></b></span></td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NAV<sup>(2)</sup></span></td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#8212;</span></td>
    <td style="text-align: left">]</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top">Subscription Price</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#8212;</span></td>
    <td style="text-align: left">]</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase in NAV($)<sup>(3)</sup></span></td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#8212;</span></td>
    <td style="text-align: left">]</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Increase in NAV(%)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#8212;</span></td>
    <td style="text-align: left">]]</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Both examples assume the full primary subscription and secondary over-subscription privilege are exercised. Actual amounts may vary due to rounding.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For illustrative purposes only; reflects the Fund&#8217;s net asset value per Common Shares as of [&#9679;], 2023. It is not known at this time what the net asset value per Common Share will be on the Expiration Date.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumes $[&#9679;] in estimated offering expenses.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 91 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">R-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If you do not wish to exercise your Rights, you should consider selling them as set forth in this Prospectus Supplement. Any cash you receive from selling your Rights may serve as partial compensation for any possible dilution of your interest in the Fund. The Fund cannot give assurance, however, that a market for the Rights will develop or that the Rights will have any marketable value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[The Fund&#8217;s largest shareholders could increase their percentage ownership in the Fund through the exercise of the primary subscription and over-subscription privilege.]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Leverage. </i>Leverage creates a greater risk of loss, as well as a potential for more gain, for the Common Shares than if leverage were not used. Following the completion of the Rights offering, the Fund&#8217;s amount of leverage outstanding will decrease. The leverage of the Fund as of [&#9679;], 2023 was approximately [&#9679;]% of the Fund&#8217;s net assets. After the completion of the Rights offering, the amount of leverage outstanding is expected to decrease to [&#9679;]% of the Fund&#8217;s net assets. The use of leverage for investment purposes creates opportunities for greater total returns but at the same time increases risk. When leverage is employed, the net asset value and market price of the Common Shares and the yield to holders of Common Shares may be more volatile. Any investment income or gains earned with respect to the amounts borrowed in excess of the interest due on the borrowing will augment the Fund&#8217;s income. Conversely, if the investment performance with respect to the amounts borrowed fails to cover the interest on such borrowings, the value of the Fund&#8217;s Common Shares may decrease more quickly than would otherwise be the case, and distributions on the Common Shares could be reduced or eliminated. Interest payments and fees incurred in connection with such borrowings will reduce the amount of net income available for distribution to holders of the Common Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because the fee paid to the Investment Adviser is calculated on the basis of the Fund&#8217;s average weekly net assets, which include the proceeds of leverage, the dollar amount of the management fee paid by the Fund to the Investment Adviser will be higher (and the Investment Adviser will be benefited to that extent) when leverage is utilized. The Investment Adviser will utilize leverage only if it believes such action would result in a net benefit to the Fund&#8217;s shareholders after taking into account the higher fees and expenses associated with leverage (including higher management fees).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Investment Adviser has agreed to reduce the management fee on the incremental assets attributable to the Fund&#8217;s Series C Auction Rate Preferred and Series E Auction Rate Preferred if the total return of the NAV of the shares of common stock of the Fund, including distributions and advisory fees subject to reduction, does not exceed the stated dividend rate of the Series C Auction Rate Preferred and Series E Auction Rate Preferred for the year. The Fund&#8217;s total return on the NAV of shares of the Fund&#8217;s common stock is monitored on a monthly basis to assess whether the total return on the NAV of such shares exceeds the stated dividend rate of the Series C Auction Rate Preferred and Series E Auction Rate Preferred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund&#8217;s leveraging strategy may not be successful.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Increase in Share Price Volatility; Decrease in Share Price</i>. The Rights offering may result in an increase in trading of the Common Shares, which may increase volatility in the market price of the Common Shares. The Rights offering may result in an increase in the number of shareholders wishing to sell their Common Shares, which would exert downward price pressure on the price of Common Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Under-Subscription</i>. It is possible that the Rights offering will not be fully subscribed. Under-subscription of the Rights offering would have an impact on the net proceeds of the Rights offering and whether the Fund achieves any benefits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="r_009"></span>U.S. FEDERAL INCOME TAX CONSEQUENCES OF THE OFFERING</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following is a general summary of the U.S. federal income tax consequences of the Rights offering to Record Date Shareholders who are U.S. persons for U.S. federal income tax purposes. The following summary supplements the discussion set forth in the accompanying Prospectus and SAI and is subject to the qualifications and assumptions set forth therein. The discussion set forth herein does not constitute tax advice and potential investors are urged to consult their own tax advisers to determine the tax consequences of investing in the Fund.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 92 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">R-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please refer to the &#8220;Taxation&#8221; sections in the Fund&#8217;s Prospectus and SAI for a description of the consequences of investing in the Common Shares of the Fund. Special tax considerations relating to this Rights offering are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: middle; width: 0.25in; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The value of a Right will not be includible in the income of a Common Shareholder at the time the subscription Right is issued.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: middle; width: 0.25in; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The basis of a Right issued to a Common Shareholder will be zero, and the basis of the share with respect to which the Right was issued (the old share) will remain unchanged, unless either (a) the fair market value of the Right on the date of distribution is at least 15% of the fair market value of the old share, or (b) such Common Shareholder affirmatively elects (in the manner set out in Treasury regulations under the Code) to allocate to the Right a portion of the basis of the old share. If either (a) or (b) applies, such Common Shareholder must allocate basis between the old share and the Right in proportion to their fair market values on the date of distribution.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: middle; width: 0.25in; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The basis of a Right purchased in the market will generally be its purchase price.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: middle; width: 0.25in; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The holding period of a Right issued to a Common Shareholder will include the holding period of the old share.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: middle; width: 0.25in; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No loss will be recognized by a Common Shareholder if a Right distributed to such Common Shareholder expires unexercised because the basis of the old share may be allocated to a Right only if the Right is exercised. If a Right that has been purchased in the market expires unexercised, there will be a recognized loss equal to the basis of the Right.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: middle; width: 0.25in; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any gain or loss on the sale of a Right will be a capital gain or loss if the Right is held as a capital asset (which in the case of a Right issued to Record Date Shareholders will depend on whether the old share is held as a capital asset), and will be a long term capital gain or loss if the holding period is deemed to exceed one year.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: middle; width: 0.25in; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No gain or loss will be recognized by a Common Shareholder upon the exercise of a Right, and the basis of any Common Share acquired upon exercise (the new Common Share) will equal the sum of the basis, if any, of the Right and the subscription price for the new Common Share. The holding period for the new Common Share will begin on the date when the Right is exercised (or, in the case of a Right purchased in the market, potentially the day after the date of exercise).</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The foregoing is a general and abbreviated summary of the provisions of the Code and the Treasury regulations in effect as they directly govern the taxation of the Fund and its Common Shareholders, with respect to U.S. federal income taxation only. Other tax issues such as state and local taxation may apply. Investors are urged to consult their own tax advisers to determine the tax consequences of investing in the Fund. These provisions are subject to change by legislative or administrative action, and any such change may be retroactive.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="r_010"></span>DISTRIBUTION ARRANGEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">G.research, LLC, which is a broker-dealer and member of the Financial Industry Regulatory Authority, Inc. will act as Dealer Manager for the Rights offering. Under the terms and subject to the conditions contained in the Dealer Manager Agreement among the Fund, the Investment Adviser, and the Dealer Manager (the &#8220;Dealer Manager Agreement&#8221;), the Dealer Manager will provide financial structuring services and marketing services in connection with the offering and will solicit the exercise of Rights and participation in the over-subscription privilege. The Fund will not pay the Dealer Manager a fee for its financial structuring, marketing and soliciting services. The Fund and the Investment Adviser have each agreed to indemnify the Dealer Manager or contribute to losses arising out of certain liabilities, including liabilities under the Securities Act. The Dealer Manager Agreement also provides that the Dealer Manager will not be subject to any liability to the Fund in rendering the services contemplated by the Dealer Manager Agreement except for any act of bad faith, willful misconduct or gross negligence of the Dealer Manager or reckless disregard by the Dealer Manager of its obligations and duties under the Dealer Manager Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 93 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">R-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the period the Rights are issued and outstanding, the Dealer Manager may facilitate the trading market for Rights and the placement of Common Shares pursuant to the exercise of Rights, including by facilitating the sale of Rights by shareholders who do not wish to exercise their Rights. The Dealer Manager may act on behalf of its clients to purchase or sell Rights in the open market and may receive commissions from its clients for such services. The Dealer Manager may also interact with brokers and dealers soliciting the exercise of Rights. Prior to the expiration of the Rights offering, the Dealer Manager may purchase or exercise Rights at prices determined at the time of such exercise and generally conduct other activities associated with the duties of a Dealer Manager in a rights offering. The Dealer Manager is not required to purchase Rights as principal for its own account in order to seek to facilitate the trading market for Rights or otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the ordinary course of their businesses, the Dealer Manager and/or its affiliates may engage in investment banking or financial transactions with the Fund, the Investment Adviser and their affiliates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund will pay the out of pocket expenses of the Dealer Manager, including the printing or other production, mailing and delivery expenses incurred in connection with Offering Materials (as defined in the Dealer Manager Agreement), including all reasonable out of pocket fees and expenses, if any and not to exceed $1,000, incurred by the Dealer Manager and other brokers, dealers and financial institutions in connection with their customary mailing and handling of materials related to the Rights offering to their customers. These reimbursements will not exceed [&#9679;]% of the total public offering price of the Common Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The principal business address of G.research, LLC is One Corporate Center, Rye, New York 10580-1422.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Dealer Manager is a wholly owned subsidiary of Institutional Services Holdings, LLC, which in turn is a wholly owned subsidiary of Associated Capital Group, Inc., an affiliate of the Investment Adviser, which is, in turn, indirectly majority-owned by Mario J. Gabelli. <i>As a result of these relationships, Mr.&#160;Gabelli is a &#8220;controlling person&#8221; of the Dealer Manager.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="r_011"></span>LEGAL MATTERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain legal matters will be passed on by Willkie Farr &amp; Gallagher LLP, counsel to the Fund, in connection with this Rights offering and the offering of the Common Shares. Willkie Farr &amp; Gallagher LLP may rely as to certain matters of Maryland law on the opinion of Venable LLP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[The Fund&#8217;s unaudited financial statements as of and for the six months ended June&#160;30, 202[&#9679;] should be read in conjunction with the audited financial statements of the Fund and the Notes thereto included in the Annual Report to the Fund&#8217;s shareholders for the fiscal year ended December&#160;31, 202[&#9679;].] The audited annual financial statements of the Fund for the fiscal year ended December&#160;31, 202[&#9679;] [and the unaudited semiannual financial statements of the Fund for the six months ended June&#160;30, 202[&#9679;]] are incorporated by reference into this Prospectus Supplement, the accompanying Prospectus and the SAI. Portions of the Fund&#8217;s annual report [and semiannual report] other than the financial statements and related footnotes thereto are not incorporated into, and do not form a part of, this Prospectus Supplement, the accompanying Prospectus or the SAI.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 94 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">R-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b>THE GABELLI EQUITY TRUST INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[&#9679;] Rights for [&#9679;] Shares of Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Subscription Rights to Acquire Shares of Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Issuable
Upon Exercise of Rights to Subscribe for Such Shares of Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>PROSPECTUS SUPPLEMENT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;[&#9679;], 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 95 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><b>The information in this Prospectus Supplement is not complete and may be changed. The Fund may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This Prospectus Supplement is not an offer to sell these securities and is not soliciting offers to buy these securities in any state where the offer or sale is not permitted.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><b>SUBJECT TO COMPLETION, DATED [&#9679;], 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed Pursuant to Rule&#160;424(b)([&#9679;])<br />Registration Statement No. 333-[&#9679;]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>THE GABELLI EQUITY TRUST INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROSPECTUS SUPPLEMENT</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(To Prospectus dated [&#9679;], 2023)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Rights for Shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Subscription Rights for [&#9679;]% Series [&#9679;] [&#9679;] Preferred Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Gabelli Equity Trust Inc. (the &#8220;Fund&#8221;, &#8220;we&#8221;, &#8220;us&#8221; or &#8220;our&#8221;) is issuing subscription rights (the &#8220;Rights&#8221;) to our [common] [preferred] stockholders to purchase shares of [&#9679;]% Series [&#9679;] [&#9679;] Preferred Stock (the &#8220;Series [&#9679;] Preferred Shares&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund is a diversified, closed-end management investment company registered under the Investment Company Act of 1940, as amended (the &#8220;1940 Act&#8221;). The Fund&#8217;s primary investment objective is to achieve long term growth of capital by investing primarily in a portfolio of equity securities consisting of common stock, preferred stock, convertible or exchangeable securities, and warrants and rights to purchase such securities. Income is a secondary investment objective. Under normal market conditions, the Fund will invest at least 80% of the value of its total assets in equity securities. The Fund&#8217;s investment adviser is Gabelli Funds, LLC (the &#8220;Investment Adviser&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares of our common stock are listed on the New York Stock Exchange (&#8220;NYSE&#8221;) under the symbol &#8220;GAB.&#8221; On [&#9679;], 2023 (the last trading date prior to the Common Stock trading ex-Rights), the last reported net asset value per share of the Common Stock was $[&#9679;] and the last reported sales price per share of Common Stock on the NYSE was $[&#9679;]. Shares of our Series G Cumulative Preferred Stock (&#8220;Series G Preferred&#8221;), our 5.00% Series H Cumulative Preferred Stock (&#8220;Series H Preferred&#8221;) and our 5.00% Series K Cumulative Preferred Stock (&#8220;Series K Preferred&#8221;) are listed on the NYSE under the symbol &#8220;GAB PrG,&#8221; &#8220;GAB PrH,&#8221; and &#8220;GAB PrK,&#8221; respectively. On [&#9679;], 2023 (the last trading day prior to the Series [&#9679;] Preferred Shares trading ex-Rights), the last reported sales price per share of Series [&#9679;] Preferred Shares on the NYSE was $[&#9679;].</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Application [has been] [will be] made to list the Series [&#9679;] Preferred Shares on the [&#9679;]. If the application is approved, the Series [&#9679;] Preferred Shares are expected to commence trading on the [&#9679;] within [&#9679;] days of the date of issuance.]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An investment in the Fund is not appropriate for all investors. We cannot assure you that the Fund&#8217;s investment objectives will be achieved. You should read this Prospectus Supplement and the accompanying Prospectus before deciding whether to invest in preferred stock and retain it for future reference. The Prospectus Supplement and the accompanying Prospectus contain important information about us. Material that has been incorporated by reference and other information about us can be obtained from us by calling 800-GABELLI (422-3554) or from the Securities and Exchange Commission&#8217;s (&#8220;SEC&#8221;) website (http://www.sec.gov). For additional information all holders of rights should contact the Information Agent, [&#9679;], toll-free at [&#9679;] or please send written request to: [&#9679;].</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investing in preferred stock through Rights involves certain risks, including risks related to a leveraged capital structure, that are described in the &#8220;Special Characteristics and Risks of the Rights Offering&#8221; section of this Prospectus Supplement and the &#8220;Risk Factors and Special Considerations&#8221; section beginning on page 18 of the accompanying Prospectus.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 96; Options: NewSection -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PR-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NEITHER THE SEC NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED THESE SECURITIES OR DETERMINED IF THIS PROSPECTUS SUPPLEMENT IS TRUTHFUL OR COMPLETE. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in; vertical-align: top">&#160;</td>
    <td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Per Share</b></span></td>
    <td style="padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td>
    <td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td>
    <td style="padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left">Subscription price of Series [&#9679;] Preferred Shares to shareholders exercising Rights</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;</span></td>
    <td style="width: 1%; text-align: left">]</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;</span></td>
    <td style="width: 1%; text-align: left">]</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Underwriting discounts and
    commissions (1)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;</span></td>
    <td style="text-align: left">]</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;</span></td>
    <td style="text-align: left">]</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Proceeds, before expenses, to the Fund (2)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;</span></td>
    <td style="text-align: left">]</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;</span></td>
    <td style="text-align: left">]</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="text-align: justify; width: 0in"></td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on a Dealer Manager solicitation fee of $[&#9679;] per share of preferred stock.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="text-align: justify; width: 0in"></td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The aggregate expenses of the offering (excluding underwriting discounts and commissions) are estimated to be $[&#9679;].</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preferred stock is expected to be ready for delivery in book-entry form through the Depository Trust Company on or about [&#9679;], 2023. If the offer is extended, the preferred stock is expected to be ready for delivery in book-entry form through the Depository Trust Company on or about [&#9679;], 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The date of this Prospectus Supplement is [&#9679;], 2023.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 97 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PR-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>You should rely only on the information contained or incorporated by reference in this Prospectus Supplement and the accompanying Prospectus. The Fund has not authorized anyone to provide you with different information. The Fund is not making an offer to sell these securities in any jurisdiction where the offer or sale is not permitted. You should not assume that the information contained in this Prospectus Supplement and the accompanying Prospectus is accurate as of any date other than the date of this Prospectus Supplement and the accompanying Prospectus, respectively. Our business, financial condition, results of operations and prospects may have changed since those dates. In this Prospectus Supplement and in the accompanying Prospectus, unless otherwise indicated, &#8220;Fund,&#8221; &#8220;us,&#8221; &#8220;our&#8221; and &#8220;we&#8221; refer to The Gabelli Equity Trust Inc., a Maryland corporation. This Prospectus Supplement also includes trademarks owned by other persons.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TABLE OF CONTENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Prospectus Supplement</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 90%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 9%; text-align: right">
        <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></p></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 3pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#pr_001">CAUTIONARY NOTICE REGARDING FORWARD-LOOKING STATEMENTS</a></span></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PR-4</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 3pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#pr_002">SUMMARY OF THE TERMS OF THE RIGHTS OFFERING</a></span></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PR-5</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 3pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#pr_003">TERMS OF THE SERIES [&#9679;] PREFERRED SHARES</a></span></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PR-6</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 3pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#pr_004">DESCRIPTION OF THE SERIES [&#9679;] PREFERRED SHARES</a></span></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PR-9</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 3pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#pr_005">DESCRIPTION OF THE RIGHTS OFFERING</a></span></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PR-10</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 3pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#pr_006">USE OF PROCEEDS</a></span></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PR-16</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 3pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#pr_007">CAPITALIZATION</a></span></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PR-16</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 3pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#pr_008">ASSET COVERAGE RATIO</a></span></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PR-16</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 3pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#pr_009">SPECIAL CHARACTERISTICS AND RISKS OF THE SHARES</a></span></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PR-16</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 3pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#pr_010">TAXATION</a></span></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PR-19</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 3pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#pr_011">UNDERWRITING</a></span></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PR-19</span></td></tr>
  <tr style="vertical-align: top">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#pr_012">LEGAL MATTERS</a></span></td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PR-19</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Prospectus</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; width: 90%; text-align: justify"><a href="#a_001">PROSPECTUS SUMMARY</a></td>
    <td style="padding-bottom: 3pt; width: 1%">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; width: 9%; text-align: right">4</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_002">SUMMARY OF FUND EXPENSES</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">10</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_003">FINANCIAL HIGHLIGHTS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">12</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_004">USE OF PROCEEDS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">18</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_005">THE FUND</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">18</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_006">INVESTMENT OBJECTIVES AND POLICIES</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">18</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_007">RISK FACTORS AND SPECIAL CONSIDERATIONS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">18</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_008">HOW THE FUND MANAGES RISK</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">18</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_009">MANAGEMENT OF THE FUND</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">19</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_010">PORTFOLIO TRANSACTIONS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">24</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_011">DIVIDENDS AND DISTRIBUTIONS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">24</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_012">ISSUANCE OF COMMON STOCK</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">25</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_013">AUTOMATIC DIVIDEND REINVESTMENT AND VOLUNTARY CASH PURCHASE PLANS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">25</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_014">DESCRIPTION OF THE CAPITAL STOCK</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">25</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_015">ANTI-TAKEOVER PROVISIONS OF THE FUND&#8217;S GOVERNING DOCUMENTS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">35</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_016">CLOSED-END FUND STRUCTURE</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">39</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_017">REPURCHASE OF COMMON STOCK</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">39</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_018">RIGHTS OFFERINGS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">40</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_019">NET ASSET VALUE</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">40</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_020">LIMITATION ON DIRECTORS&#8217; AND OFFICERS&#8217; LIABILITY</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">41</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_021">TAXATION</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">41</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_022">CUSTODIAN, TRANSFER AGENT AND DIVIDEND DISBURSING AGENT</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">45</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_023">PLAN OF DISTRIBUTION</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">45</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_024">LEGAL MATTERS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">47</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_025">INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">47</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_026">ADDITIONAL INFORMATION</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">47</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_027">INCORPORATION BY REFERENCE</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">47</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: justify"><a href="#a_028">PRIVACY PRINCIPLES OF THE FUND</a></td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: right">48</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 98 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PR-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pr_001"></span>CAUTIONARY NOTICE REGARDING FORWARD-LOOKING STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Prospectus Supplement, the accompanying Prospectus and the Statement of Additional Information (the &#8220;SAI&#8221;) contain &#8220;forward-looking statements.&#8221; Forward-looking statements can be identified by the words &#8220;may,&#8221; &#8220;will,&#8221; &#8220;intend,&#8221; &#8220;expect,&#8221; &#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; and similar terms and the negative of such terms. Such forward-looking statements may be contained in this Prospectus Supplement as well as in the accompanying Prospectus and in the SAI. By their nature, all forward-looking statements involve risks and uncertainties, and actual results could differ materially from those contemplated by the forward-looking statements. Several factors that could materially affect our actual results are the performance of the portfolio of securities we hold, the price at which our shares will trade in the public markets and other factors discussed in our periodic filings with the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although we believe that the expectations expressed in our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and are subject to inherent risks and uncertainties, such as those disclosed in the &#8220;Risk Factors and Special Considerations&#8221; section of the accompanying Prospectus and &#8220;Special Characteristics and Risks of the Rights Offering&#8221; in this Prospectus Supplement. All forward-looking statements contained or incorporated by reference in this Prospectus Supplement or the accompanying Prospectus, or in the SAI, are made as of the date of this Prospectus Supplement or the accompanying Prospectus, or SAI, as the case may be. Except for our ongoing obligations under the federal securities laws, we do not intend, and we undertake no obligation, to update any forward-looking statement. The forward-looking statements contained in this Prospectus Supplement, the accompanying Prospectus and the SAI are excluded from the safe harbor protection provided by Section&#160;27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently known risk factors that could cause actual results to differ materially from our expectations include, but are not limited to, the factors described in the &#8220;Risk Factors and Special Considerations&#8221; section of the accompanying Prospectus as well as in the &#8220;Special Characteristics and Risks of the Rights Offering&#8221; section of this Prospectus Supplement. We urge you to review carefully those sections for a more detailed discussion of the risks of an investment in the preferred stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 99 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PR-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pr_002"></span>SUMMARY OF THE TERMS OF THE RIGHTS OFFERING</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; width: 27%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Terms of the Offer</b></span></td>
    <td style="width: 3%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;] [transferable] [non-transferable] subscription rights (a &#8220;Right&#8221;) will be issued for each [&#9679;] share of the Fund held as of the close of business on the record date and are expected to trade in the [&#9679;] exchange. These Rights will allow [&#9679;] shareholders to subscribe for new [shares] of the Fund. [&#9679;] shares of [&#9679;] are outstanding as of [&#9679;], 2023. [&#9679;] Right[s] will be required to purchase [&#9679;] share of [&#9679;]. [An over-subscription privilege will be offered.] [&#9679;] shares of [&#9679;] will be issued if all Rights are exercised. See &#8220;Terms of the Offering.&#8221;</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount Available for Primary Subscription</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$[&#9679;]</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription Rights for Series [&#9679;] Preferred Shares.</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise Price</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rights may be exercised at a price of $ [&#9679;] per share of Series [&#9679;]Preferred Shares (the &#8220;Subscription Price&#8221;). See &#8220;<i>Terms of the Offer</i>.&#8221;</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Record Date</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rights will be issued to holders of record of the Fund&#8217;s [Common Stock][Series [&#9679;] Preferred Shares] on [&#9679;], 2023 (the &#8220;Record Date&#8221;). See &#8220;<i>Terms of the Offer</i>.&#8221;</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of Rights Issued</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;] Right[s] will be issued in respect of each share of [Common Stock][Preferred Stock] of the Fund outstanding on the Record Date. See &#8220;<i>Terms of the Offer</i>.&#8221;</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of Rights Required to Purchase One Preferred Share</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A holder of Rights may purchase [&#9679;] share of Series [&#9679;] Preferred Shares of the Fund for every [&#9679;] Rights exercised. The number of Rights to be issued to a stockholder on the Record Date will be rounded up to the nearest number of Rights evenly divisible by [&#9679;]. See &#8220;<i>Terms of the Offer</i>.&#8221;</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Over-Subscription Privilege</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Rights holders who are shareholders of [&#9679;] on the Record Date are entitled to subscribe for additional [&#9679;] shares at the same Subscription Price, subject to certain limitations and subject to allotment. To the extent sufficient shares of [&#9679;] are not available to fulfill all over-subscription requests, unsubscribed shares of [&#9679;] will be allocated pro-rata among those shareholders who over-subscribe based on the number of the Fund&#8217;s shares of [&#9679;] owned on the Record Date. See &#8220;Over-Subscription Privilege.&#8221;]</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Transfer of Rights</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Rights [will be] [will not be] transferable. See &#8220;Terms of the Offering,&#8221; &#8220;Sales by Rights Agent,&#8221; and &#8220;Method of Transferring Rights.&#8221;</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Subscription Period</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Rights may be exercised at any time after issuance and prior to expiration of the Rights, which will be 5:00 PM Eastern Time on [&#9679;], 2023 (the &#8220;Expiration Date&#8221;) (the &#8220;Subscription Period&#8221;). See &#8220;<i>Terms of the Offer</i>&#8221; and &#8220;<i>Method of Exercise of Rights</i>.&#8221;</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Offer Expenses</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The expenses of the Offer are expected to be approximately $[&#9679;]. See &#8220;<i>Use of Proceeds</i>.&#8221;</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Solicitation Fee</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$[&#9679;] per [&#9679;] share to broker-dealers that have executed and delivered a soliciting dealer agreement and have solicited the exercise of Rights, subject to a maximum payment of $[&#9679;] to any single broker-dealer. See &#8220;Underwriting.&#8221;</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of Proceeds</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund estimates the net proceeds of the Offer to be approximately $[&#9679;]. This figure is based on the Exercise Price per share of $ [&#9679;] and assumes all new shares of Series [&#9679;] Preferred Shares offered are sold and that the expenses related to the Offer estimated at approximately $[&#9679;] are paid.</span></td> </tr>
  </table>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 100 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PR-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 27%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 3%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[The Fund currently intends to call within [&#9679;] months after expiration of the Subscription Period all outstanding shares of [&#9679;] that are not surrendered by holders to purchase [&#9679;] in the offering. Amounts in excess of the redemption amount for all outstanding shares of [&#9679;] will be used for investment purposes consistent with the investment objectives of the Fund.]</span></td> </tr>
  </table>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; width: 27%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 3%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Investment Adviser anticipates that investment of the proceeds will be made in accordance with the Fund&#8217;s investment objectives and policies as appropriate investment opportunities are identified, which is expected to be substantially completed within approximately three months of the issue date; however, the identification of appropriate investment opportunities pursuant to the Fund&#8217;s investment style or changes in market conditions may cause the investment period to extend as long as six months from the issue date. This could occur because the Investment Adviser follows a value-oriented investment strategy; therefore, market conditions could result in the Investment Adviser delaying the investment of proceeds if it believes the margin of risk in making additional investments is not favorable in light of its value-oriented investment strategy. See &#8220;Investment Objectives and Policies&#8212;Investment Methodology of the Fund&#8221; in the accompanying Prospectus. The proceeds may also be used to redeem or repurchase shares of existing series of the Fund&#8217;s preferred stock, in whole or in part. Pending such investment and/or redemption, the proceeds will be held in high quality short term debt securities and instruments. See &#8220;<i>Use of Proceeds</i>&#8221;.</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Taxation/ERISA</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See &#8220;<i>Certain Employee Benefit Plan and IRA Considerations</i>.&#8221;</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Rights Agent</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[To be provided.]</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pr_003"></span>TERMS OF THE SERIES [&#9679;] PREFERRED SHARES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; width: 27%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The Fund</b></span></td>
    <td style="width: 3%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Gabelli Equity Trust Inc. is a diversified, closed-end management investment company registered under the 1940 Act. The Fund&#8217;s primary investment objective is to achieve long term growth of capital by investing primarily in a portfolio of equity securities consisting of common stock, preferred stock, convertible or exchangeable securities, and warrants and rights to purchase such securities. Income is a secondary investment objective. Gabelli Funds, LLC serves as investment adviser to the Fund. Under normal market conditions, the Fund will invest at least 80% of the value of its total assets in equity securities. The Fund was organized as a Maryland corporation on May&#160;20, 1986 and commenced its investment operations on August&#160;21, 1986. Shares of the Fund&#8217;s common stock are listed on the NYSE under the symbol &#8220;GAB.&#8221;</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities Offered</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;] Series [&#9679;] Preferred Shares. Series [&#9679;] Preferred Shares will constitute a separate series of preferred stock of the Fund. The Series [&#9679;] Preferred Shares have the same priority with respect to payment of distributions and liquidation preference as the Series C Auction Rate Cumulative Preferred Stock (the &#8220;Series C Auction Rate Preferred&#8221;), Series E Auction Rate Preferred Stock (the &#8220;Series E Auction Rate Preferred&#8221;), Series G Preferred, Series H Preferred, Series K Preferred, 4.25% Series M Cumulative Preferred Stock (&#8220;Series M Preferred&#8221;) and 5.25% Series N Cumulative Preferred Stock (&#8220;Series N Preferred&#8221;).</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dividend Rate</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends and distributions on Series [&#9679;] Preferred Shares are cumulative from their original issue date at the annual rate of [&#9679;]% of the $[&#9679;] per-share liquidation preference on the Series [&#9679;] Preferred Shares.</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dividend Payment Date</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders of Series [&#9679;] Preferred Shares shall be entitled to receive, when, as and if authorized by, or under authority granted by, the Board of Directors and declared by the Fund, out of funds legally available therefor, cumulative cash dividends and distributions. Dividends and distributions will be paid [&#9679;], commencing on [&#9679;].</span></td> </tr>
  </table>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 101 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PR-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; width: 27%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liquidation Preference</b></span></td>
    <td style="width: 3%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$[&#9679;] per share.</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of Proceeds</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[The Fund expects to use the proceeds of the offering of the Series [&#9679;] Preferred Shares to redeem the outstanding shares of its Series [&#9679;] Preferred Shares. Amounts in excess of the redemption amount for all outstanding Series [&#9679;] Preferred may be used to redeem or repurchase other existing series of preferred stock of the Fund, in whole or in part, or for investment purposes consistent with the investment objectives of the Fund.] OR [The Fund does not expect to use the proceeds of the offering to redeem or repurchase existing series of preferred stock.]</span></td> </tr>
  </table>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; width: 27%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 3%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Investment Adviser anticipates that the investment of the proceeds will be made in accordance with the Fund&#8217;s investment objectives and policies as appropriate investment opportunities are identified, which is expected to be substantially completed within approximately three months of the issue date; however, the identification of appropriate investment opportunities pursuant to the Fund&#8217;s investment style or changes in market conditions may cause the investment period to extend as long as six months from the issue date. This could occur because the Investment Adviser follows a value-oriented investment strategy; therefore, market conditions could result in the Investment Adviser delaying the investment of proceeds if it believes the margin of risk in making additional investments is not favorable in light of its value-oriented investment strategy. See &#8220;Investment Objectives and Policies&#8212;Investment Methodology of the Fund&#8221; in the accompanying Prospectus. The proceeds may also be used to redeem or repurchase shares of existing series of the Fund&#8217;s preferred stock, in whole or in part.</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pending such investment and/or redemption, the proceeds of the offering of the Series [&#9679;] Preferred Shares will be held in high quality short term debt securities and similar instruments. See &#8220;Use of Proceeds.&#8221;</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-Call Period/Redemption</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[The Series [&#9679;] Preferred Shares generally may not be called for redemption at the option of the Fund prior to [&#9679;]. The Fund reserves the right, however, to redeem the Series [&#9679;] Preferred Shares at any time if it is necessary, in the judgment of the Board of Directors, to maintain its status as a regulated investment company under Subchapter M of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;). The Fund may also be required under certain circumstances to redeem Series [&#9679;] Preferred Shares, before or after [&#9679;], in order to meet certain regulatory or rating agency asset coverage requirements.</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commencing [&#9679;], and thereafter, to the extent permitted by the 1940 Act and Maryland law, the Fund may at any time, upon notice of redemption, redeem the Series [&#9679;] Preferred Shares in whole or in part at the liquidation preference per share plus accumulated unpaid dividends and distributions (whether or not earned or declared) through the date of redemption.]</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock Exchange Listing</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Application [will be] [has been] made to list the Series [&#9679;] Preferred Shares on the [&#9679;]. Prior to the offering, there has been no public market for Series [&#9679;] Preferred Shares. If the application is approved, it is anticipated that trading on the [&#9679;] will begin within [&#9679;] days from the date of this Prospectus Supplement. Before the Series [&#9679;] Preferred Shares are listed on the [&#9679;], the underwriters may, but are not obligated to, make a market in Series [&#9679;] Preferred Shares. Consequently, it is anticipated that, prior to the commencement of trading on the [&#9679;], an investment in Series [&#9679;] Preferred Shares will be illiquid.</span></td> </tr>
  </table>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 102 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PR-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; width: 27%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Taxation</b></span></td>
    <td style="width: 3%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund expects that distributions made on the Series [&#9679;] Preferred Shares will consist of (i) long term capital gain (gain from the sale of a capital asset held longer than one year), (ii) qualified dividend income (dividend income from certain domestic and foreign corporations, provided certain holding period and other requirements are met by both the Fund and the stockholder), and (iii) investment company taxable income (other than qualified dividend income, including interest income, short term capital gain and income from certain hedging and interest rate transactions). Distributions paid to investors by the Fund from its investment company taxable income which includes the excess of net short term capital gains over net long term capital losses (together referred to hereinafter as &#8220;ordinary income dividends&#8221;) are generally taxable to investors as ordinary income to the extent of the earnings and profits of the Fund. Such distributions (if reported by the Fund) may, however, qualify (provided holding periods and other requirements are met) (i) for the dividends received deduction in the case of corporate stockholders to the extent that the income of the Fund consists of dividend income from U.S. corporations, and (ii) as qualified dividend income generally eligible for the reduced maximum federal tax rate to individuals applicable to net long term capital gains. Distributions made to investors from an excess of net long term capital gains over net short term capital losses (&#8220;capital gain dividends&#8221;), including capital gain dividends credited to investors but retained by the Fund, are taxable to investors as long term capital gains if they have been properly designated by the Fund, regardless of the length of time investors have owned shares of stock of the Fund. The maximum federal income tax rate on net long term capital gain of individuals is generally either 15% or 20% depending on whether an individual&#8217;s income exceeds certain threshold amounts. In addition, certain U.S. stockholders who are individuals, estates or trusts and whose income exceeds certain thresholds will be required to pay a 3.8% Medicare surcharge on their net investment income. We cannot assure you, however, as to what percentage of future distributions made on the Series [&#9679;] Preferred Shares will consist of long term capital gain and qualified dividend income. See &#8220;<i>U.S. Federal Income Tax Consequences of the Offering.</i>&#8221;</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ERISA</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See <i>&#8220;Certain Employee Benefit Plan and IRA Considerations.&#8221;</i></span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dividend Paying Agent</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;].</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 103 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PR-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pr_004"></span>DESCRIPTION OF THE SERIES [&#9679;] PREFERRED SHARES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following is a brief description of the terms of the Series [&#9679;] Preferred Shares. This is intended to be a summary of the material provisions of the Fund&#8217;s Articles Supplementary designating and fixing the rights of the Series [&#9679;] Preferred Shares (the &#8220;Articles&#8221;). Since this disclosure is only a summary, you should refer to the Statement of Additional Information for a complete description of the obligations of the Fund and your rights. The Articles are attached as an exhibit to post-effective amendment number [&#9679;] to the Fund&#8217;s registration statement. Copies may be obtained as described under &#8220;Additional Information&#8221; in the accompanying Prospectus. Any capitalized terms in this section and the &#8220;Special Characteristics and Risks of the Series [&#9679;] Preferred Shares&#8221; section of this Prospectus Supplement that are not defined have the meaning assigned to them in the Articles.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund&#8217;s charter (the &#8220;Charter&#8221;) authorizes its Board of Directors to reclassify any authorized but unissued shares of the Fund&#8217;s capital stock, $0.001 par value per share, without the approval of common stockholders. The Articles authorize the issuance of up to [&#9679;] Series [&#9679;] Preferred Shares. All Series [&#9679;] Preferred Shares will have a liquidation preference of $[&#9679;] per share. Holders of Series [&#9679;] Preferred Shares shall be entitled to receive cumulative cash dividends and distributions at the rate of [&#9679;]% per annum (computed on the basis of a 360-day year consisting of twelve 30-day months) of the $[&#9679;] per-share liquidation preference on the Series [&#9679;] Preferred Shares. Dividends and distributions on Series [&#9679;] Preferred Shares will accumulate from the date of their original issue, which is [&#9679;].</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Series [&#9679;] Preferred Shares, when issued by the Fund and paid for pursuant to the terms of this Prospectus Supplement and the accompanying Prospectus, will be fully paid and non-assessable and will have no preemptive, exchange or conversion rights. Any Series [&#9679;] Preferred Shares purchased or redeemed by the Fund will be reclassified as authorized and unissued shares of preferred stock of the Fund without further designation as to class or series. The Board of Directors may by resolution classify or reclassify any authorized and unissued Series [&#9679;] Preferred Shares from time to time by setting or changing the preferences, conversion or other rights, voting powers, restrictions, limitations as to dividends and other distributions, qualifications and terms and conditions of redemption of such shares. The affirmative vote of the holders of a majority, as defined in the 1940 Act, of the outstanding Series [&#9679;] Preferred Shares (or shares of any other series of the Fund&#8217;s preferred stock), voting separately from the holders of any other series of the Fund&#8217;s preferred stock (to the extent its rights are affected differently), shall be required with respect to any matter that materially and adversely affects the rights, preferences or powers of that series in a manner different from that of other series or classes of the Fund&#8217;s capital stock. The affirmative vote of the holders of a majority, as defined in the 1940 Act, of the outstanding shares of the Fund&#8217;s preferred stock, voting together as a separate class (including the Series [&#9679;] Preferred Shares), shall be required to amend, alter or repeal the provisions of the Fund&#8217;s Charter or bylaws, whether by merger, consolidation or otherwise, if such amendment, alteration or repeal would affect adversely the rights, preferences or powers expressly set forth in any articles supplementary of the Fund&#8217;s preferred stock, including the Articles, unless, in each case, the Fund obtains written confirmation from any rating agency then rating the Series [&#9679;] Preferred Shares at the Fund&#8217;s request that such amendment, alteration or repeal would not impair the rating then assigned by such rating agency to the Series [&#9679;] Preferred Shares, in which case the vote or consent of the holders of the Series [&#9679;] Preferred Shares is not required. No matter shall be deemed to adversely affect any rights, preferences or powers of the Series [&#9679;] Preferred Shares unless such matter (i) adversely alters or abolishes any preferential right of such series; (ii) creates, adversely alters or abolishes any right in respect of redemption of such series; or (iii) creates or adversely alters (other than to abolish) any restriction on transfer applicable to such series. An increase in the number of authorized shares of preferred stock of the Fund pursuant to the Charter or the issuance of additional shares of any series of preferred stock of the Fund (including the Series [&#9679;] Preferred Shares) pursuant to the Charter shall not in and of itself be considered to adversely affect the rights, preferences or powers of the Series [&#9679;] Preferred Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The disclosure set forth in this Description of the Series [&#9679;] Preferred Shares and under the heading &#8220;Special Characteristics and Risks of the Series [&#9679;] Preferred Shares&#8221; is intended to be a summary of the material provisions of the Series [&#9679;] Preferred Shares. Since this Description of the Series [&#9679;] Preferred Shares is only a summary, you should refer to the Articles for a complete description of the obligations of the Fund and your rights. The disclosure set forth in this Description of the Series [&#9679;] Preferred Shares and under the heading &#8220;Special Characteristics and Risks of the Series [&#9679;] Preferred Shares&#8221; supplements the description of the preferred stock set forth under the caption &#8220;Description of the Capital Stock &#8211; Preferred Stock&#8221; in the accompanying Prospectus, and in the event that any provision described in the disclosure set forth in this Description of the Series [&#9679;] Preferred Shares and under the heading &#8220;Special Characteristics and Risks of the Series [&#9679;] Preferred Shares&#8221; is inconsistent with any description contained in the accompanying Prospectus, the disclosure set forth in this Description of the Series [&#9679;] Preferred Shares and under the heading &#8220;Special Characteristics and Risks of the Series [&#9679;] Preferred Shares&#8221; will apply and supersede the description in the accompanying Prospectus.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 104 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PR-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pr_005"></span>DESCRIPTION OF THE RIGHTS OFFERING</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Terms of the Rights Offering</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund is issuing to stockholders of record of shares of [&#9679;] as of [&#9679;] (&#8220;the Record Date&#8221;, and such stockholders, the &#8220;Record Date Preferred Shareholders&#8221;) Rights to subscribe for the [&#9679;]. Each [&#9679;] is being issued [&#9679;] transferable Rights for each [&#9679;] share owned on the Record Date. The Rights entitle the holders to acquire for (i) $[&#9679;] in cash, (ii) by surrender of shares of [&#9679;] at liquidation preference, or (iii) any combination of cash and such shares (the &#8220;Subscription Price&#8221;) one [&#9679;] Share for each [&#9679;] Rights. Fractional shares will not be issued upon the exercise of the Rights. Accordingly, [&#9679;] Shares may be purchased only pursuant to the exercise of Rights in integral multiples of [&#9679;]. Rights may be exercised at any time during the period which commences on [&#9679;], and ends at 5:00 PM Eastern Time on [&#9679;] (the &#8220;Subscription Period&#8221;). The right to acquire [&#9679;] additional [&#9679;] Share for [&#9679;] Rights held during the Subscription Period at the Subscription Price will be referred to in the remainder of this prospectus supplement as the &#8220;Subscription.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rights may be evidenced by subscription certificates or other appropriate documentation (&#8220;Subscription Certificates&#8221;). The number of Rights issued to each holder will be stated on the Subscription Certificate delivered to the holder. The method by which Rights may be exercised and shares paid for is set forth below in &#8220;Method of Exercise of Rights&#8221; and &#8220;Payment for Shares.&#8221; A Rights holder will have no right to rescind a purchase after [&#9679;] (the &#8220;Rights Agent&#8221;) has received payment. See &#8220;Payment for Shares&#8221; below. It is anticipated that the [&#9679;] Shares issued pursuant to an exercise of Rights will be listed on the [&#9679;].</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Rights holders who are Record Date [&#9679;] Shareholders are entitled to subscribe for additional [&#9679;] Shares at the same Subscription Price pursuant to the over-subscription privilege, subject to certain limitations and subject to allotment. See &#8220;Over-Subscription Privilege&#8221; below.]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For purposes of determining the maximum number of shares a Record Date [&#9679;] Shareholder may acquire pursuant to the offer, broker-dealers, trust companies, banks or others whose shares are held of record by Cede &amp; Co. (&#8220;Cede&#8221;), as nominee for the Depository Trust Company or by any other depository or nominee will be deemed to be the holders of the Rights that are held by Cede or such other depository or nominee on their behalf.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Rights are transferable until [5:00 PM] Eastern Time [&#9679;] (the &#8220;Expiration Date&#8221;) and are expected to be admitted for trading on the [&#9679;]. Assuming a market exists for the Rights, the Rights may be purchased and sold through usual brokerage channels and sold through the Rights Agent. Although no assurance can be given that a market for the Rights will develop, trading in the Rights through the [&#9679;] is expected to begin [&#9679;] business days before the Record Date and may be conducted until the close of trading through the last [&#9679;] trading day prior to the Expiration Date. Trading of the Rights on the [&#9679;] is expected to be conducted on a when-issued basis until and including the date on which the Subscription Certificates are mailed to Record Date [&#9679;] Shareholders and thereafter is expected to be conducted on a regular way basis until and including the last [&#9679;] trading day prior to the Expiration Date. [The method by which Rights may be transferred is set forth below under &#8220;Method of Transferring Rights.&#8221;] The [&#9679;] shares are expected to begin trading ex-Rights[&#9679;] business days prior to the Record Date as determined and announced by [&#9679;].</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nominees who hold the Fund&#8217;s [&#9679;] shares for the account of others, such as banks, broker-dealers, trustees or depositories for securities, should notify the respective beneficial owners of such shares as soon as possible to ascertain such beneficial owners&#8217; intentions and to obtain instructions with respect to the Rights. If the beneficial owner so instructs, the nominee will complete the Subscription Certificate and submit it to the Rights Agent with proper payment. In addition, beneficial owners of the [&#9679;] shares or Rights held through such a nominee should contact the nominee and request the nominee to effect transactions in accordance with such beneficial owner&#8217;s instructions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 105 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PR-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Important Dates to Remember</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please note that the dates in the table below may change if the rights offering is extended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 60%; border-collapse: collapse; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; width: 29%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EVENT</b></span></td>
    <td style="padding-bottom: 1pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: middle; width: 29%; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DATE</b></span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Record Date</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: middle; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;], 2023</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription Period</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: middle; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;], 2023 through [&#9679;], 2023</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expiration Date*</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: middle; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment for Guarantees of Delivery Due*</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: middle; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance Date</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: middle; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]**</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Confirmation Date</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: middle; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A stockholder exercising Rights must deliver by [5:00 PM] Eastern Time on [&#9679;] either (a) a Subscription Certificate and payment for shares or (b) a notice of guaranteed delivery.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless the offer is extended to a date no later than [&#9679;].</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[Over-Subscription Privilege</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rights holders who are Record Date [&#9679;] Shareholders and who fully exercise their Rights are entitled to subscribe for additional [&#9679;] Shares at the same Subscription Price pursuant to the over-subscription privilege, subject to certain limitations and subject to allotment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Record Date [&#9679;] Shareholders who are fully exercising their Rights during the subscription period should indicate, on the Subscription Certificate which they submit with respect to the exercise of the Rights issued to them, how many [&#9679;] Shares they are willing to acquire pursuant to the over-subscription privilege. Rights acquired in the secondary market may not participate in the over-subscription privilege.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To the extent sufficient [&#9679;] Shares are not available to fulfill all over-subscription requests, unsubscribed [&#9679;] Shares will be allocated pro-rata among those Record Date [&#9679;] Shareholders who over-subscribe based on the number of the Fund&#8217;s [&#9679;] shares owned on the Record Date. The allocation process may involve a series of allocations in order to assure that the total number of [&#9679;] Shares available for over-subscriptions is distributed on a pro rata basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Banks, broker-dealers, trustees and other nominee holders of rights will be required to certify to the Rights Agent, before any over-subscription privilege may be exercised with respect to any particular beneficial owner, as to the aggregate number of Rights exercised during the Subscription Period and the number of [&#9679;] Shares subscribed for pursuant to the over-subscription privilege by such beneficial owner and that such beneficial owner&#8217;s Subscription was exercised in full. Nominee holder over-subscription forms and beneficial owner certification forms will be distributed to banks, broker-dealers, trustees and other nominee holders of rights with the Subscription Certificates. Nominees should also notify holders purchasing Rights in the secondary market that such Rights may not participate in the over-subscription privilege.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund will not offer or sell any [&#9679;] Shares that are not subscribed for during the Subscription Period or pursuant to the over-subscription privilege.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[The Fund has been advised that the Investment Adviser and each of the Fund&#8217;s Directors may exercise some or all of the Rights initially issued to them, and may request additional [&#9679;] Shares pursuant to the over-subscription privilege. In addition, Mario J. Gabelli or his affiliated entities may also purchase [&#9679;] Shares during the Subscription Period and pursuant to the over-subscription privilege.]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 106 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PR-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sales by Rights Agent</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders of Rights who are unable or do not wish to exercise any or all of their Rights may instruct the Rights Agent to sell any unexercised Rights. The Subscription Certificates representing the Rights to be sold by the Rights Agent must be received on or before [&#9679;]. Upon the timely receipt of the appropriate instructions to sell Rights, the Rights Agent will use its best efforts to complete the sale and will remit the proceeds of sale, net of any commissions, to the holders. If the Rights can be sold, sales of the Rights will be deemed to have been effected at the weighted average price received by the Rights Agent on the day such Rights are sold. The selling Rights holder will pay all brokerage commissions incurred by the Rights Agent, [&#9679;], (the &#8220;Dealer Manager&#8221;) a registered broker-dealer and an affiliate of the Investment Adviser. The Dealer Manager may also act on behalf of its clients to purchase or sell Rights in the open market. The Rights Agent will automatically attempt to sell any unexercised Rights that remain unclaimed as a result of Subscription Certificates being returned by the postal authorities as undeliverable as of the fourth business day prior to the Expiration Date. These sales will be made net of any commissions on behalf of the nonclaiming holders of Rights. Proceeds from those sales will be held by [&#9679;], in its capacity as the Fund&#8217;s transfer agent, for the account of the nonclaiming holder of rights until the proceeds are either claimed or escheated. There can be no assurance that the Rights Agent will be able to complete the sale of any of these Rights and neither the Fund nor the Rights Agent has guaranteed any minimum sales price for the Rights. [All of these Rights will be sold at the market price, if any, through an exchange or market trading the Rights.]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[Method of Transferring Rights</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Rights evidenced by a single Subscription Certificate may be transferred in whole by endorsing the Subscription Certificate for transfer in accordance with the accompanying instructions. A portion of the Rights evidenced by a single Subscription Certificate (but not fractional Rights) may be transferred by delivering to the Rights Agent a Subscription Certificate properly endorsed for transfer, with instructions to register the portion of the Rights evidenced thereby in the name of the transferee (and to issue a new Subscription Certificate to the transferee evidencing the transferred Rights). In this event, a new Subscription Certificate evidencing the balance of the Rights will be issued to the Rights holder or, if the Rights holder so instructs, to an additional transferee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders wishing to transfer all or a portion of their Rights (but not fractional Rights) should allow at least [&#9679;] business days prior to the Expiration Date for (i) the transfer instructions to be received and processed by the Rights Agent, (ii) a new Subscription Certificate to be issued and transmitted to the transferee or transferees with respect to transferred Rights, and to the transferor with respect to retained Rights, if any, and (iii) the Rights evidenced by the new Subscription Certificates to be exercised or sold by the recipients thereof. Neither the Fund nor the Rights Agent shall have any liability to a transferee or transferor of Rights if Subscription Certificates are not received in time for exercise or sale prior to the Expiration Date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except for the fees charged by the Rights Agent (which will be paid by the Fund as described below), all commissions, fees and other expenses (including brokerage commissions and transfer taxes) incurred in connection with the purchase, sale or exercise of Rights will be for the account of the transferor of the Rights, and none of these commissions, fees or expenses will be paid by the Fund or the Rights Agent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund anticipates that the Rights will be eligible for transfer through, and that the exercise of the Subscription may be effected through, the facilities of DTC (Rights exercised through DTC are referred to as &#8220;DTC Exercised Rights&#8221;).]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Rights Agent</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Rights Agent is [&#9679;]. The Rights Agent will receive from the Fund an amount estimated to be $[&#9679;] comprised of the fee for its services and the reimbursement for certain expenses related to the rights offering. INQUIRIES BY ALL HOLDERS OF RIGHTS SHOULD BE DIRECTED TO: THE INFORMATION AGENT, [&#9679;]; HOLDERS MAY ALSO CONSULT THEIR BROKERS OR NOMINEES.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 107 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PR-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Method of Exercise of Rights</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rights may be exercised by completing and signing the reverse side of the Subscription Certificate and mailing it in the envelope provided, or otherwise delivering the completed and signed Subscription Certificate to the Rights Agent, together with payment for the [&#9679;] Shares (including any surrender of [&#9679;] shares) as described below under &#8220;Payment for Shares.&#8221; Rights may also be exercised through a Rights holder&#8217;s broker, who may charge the Rights holder a servicing fee in connection with such exercise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Completed Subscription Certificates must be received by the Rights Agent prior to 5:00 PM Eastern Time, on the Expiration Date (unless payment is effected by means of a notice of guaranteed delivery as described below under &#8220;Payment for Shares&#8221;). The Subscription Certificate and payment should be delivered to the Rights Agent at the following address:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If By Mail:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Gabelli Equity Trust Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If By Overnight Courier:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Gabelli Equity Trust Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Payment for Shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders of Rights who acquire [&#9679;] Shares in the Subscription may choose between the following methods of payment:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.5in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A subscription will be accepted by the Rights Agent if, prior to 5:00 PM Eastern Time, on the Expiration Date, the Rights Agent has received a written notice of guaranteed delivery from a bank, a trust company, or a [&#9679;] member, guaranteeing delivery of (i) payment of the full Subscription Price for the [&#9679;] Shares subscribed for in the Subscription and, if eligible, for any additional [&#9679;] Shares subscribed for pursuant to the over-subscription privilege, and (ii) a properly completed and executed Subscription Certificate. The Rights Agent will not honor a notice of guaranteed delivery if a properly completed and executed Subscription Certificate and full payment is not received by the Rights Agent by the close of business on the third business day after the Expiration Date. The notice of guaranteed delivery may be delivered to the Rights Agent in the same manner as Subscription Certificates at the addresses set forth above, or may be transmitted to the Rights Agent by facsimile transmission [(fax number [&#9679;]; telephone number to confirm receipt [&#9679;].]</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.5in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alternatively, a holder of Rights can send the Subscription Certificate together with payment in the form of (i) a check (which must include the name of the stockholders); (ii) by surrender of shares of [&#9679;] at liquidation preference; or (iii) any combination of a check and such shares for the [&#9679;] Shares subscribed for in the Subscription and, if eligible, for any additional [&#9679;] Shares subscribed for pursuant to the over-subscription privilege, to the Rights Agent based on the Subscription Price of $[&#9679;] per [&#9679;] Share. To be accepted, the payment (including surrender of the number of [&#9679;] shares forming a portion of such payment), together with the executed Subscription Certificate, must be received by the Rights Agent at the addresses noted above prior to [5:00 PM] Eastern Time on the Expiration Date. The Rights Agent will deposit all share purchase checks received by it prior to the final due date into a segregated interest-bearing account, and will hold any surrendered shares of [&#9679;], in each case pending proration and distribution of [&#9679;] Shares. The Rights Agent will not accept cash as a means of payment for [&#9679;] Shares.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 108 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PR-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[EXCEPT AS OTHERWISE SET FORTH BELOW AND EXCEPT FOR SURRENDERS OF [&#9679;] SHARES, A PAYMENT PURSUANT TO THIS METHOD MUST BE IN UNITED STATES DOLLARS BY CHECK (WHICH MUST INCLUDE THE NAME OF THE STOCKHOLDER ON THE CHECK) DRAWN ON A BANK LOCATED IN THE CONTINENTAL UNITED STATES, MUST BE PAYABLE TO THE GABELLI EQUITY TRUST INC. AND MUST ACCOMPANY AN EXECUTED SUBSCRIPTION CERTIFICATE TO BE ACCEPTED. ]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any payment required from a holder of Rights must be received by the Rights Agent prior to [5:00 PM] Eastern Time on the Expiration Date, or if the Rights holder has elected to make payment by means of a notice of guaranteed delivery, by the close of business on the [&#9679;] business day after the Expiration Date. All payments by a holder of Rights must be in United States dollars by check (which must include the name of the stockholder on the check) drawn on a bank located in the continental United States and payable to The Gabelli Equity Trust Inc. except that holders of Rights who are residents of Canada may make payment in United States dollars by check drawn on a bank located in Canada. Whichever of the two methods of payment described above is used, issuance and delivery of certificates for the [&#9679;] Shares purchased are subject to collection of checks and [&#9679;] shares, as well as actual payment pursuant to any notice of guaranteed delivery.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within ten business days following the Expiration Date (the &#8220;Confirmation Date&#8221;), a confirmation will be sent by the Rights Agent to each holder of Rights (or, if the [&#9679;] shares are held by Cede or any other depository or nominee, to Cede or such other depository or nominee), showing (i) the number of [&#9679;] Shares acquired pursuant to the Subscription, (ii) [the number of [&#9679;] Shares, if any, acquired pursuant to the over-subscription privilege, and (iii)] the per share and total purchase price for the [&#9679;] Shares. Any payment required from a holder of Rights must be received by the Rights Agent on the Expiration Date, or if the Rights holder has elected to make payment by means of a notice of guaranteed delivery, on the [&#9679;] business day after the Expiration Date. Any excess payment (including any excess surrendered shares of [&#9679;]) to be refunded by the Fund to a holder of Rights, or to be paid to a holder of Rights as a result of sales of Rights on his behalf by the Rights Agent, and all interest accrued on the holder&#8217;s excess payment will be mailed by the Rights Agent to the holder within fifteen business days after the Expiration Date. Interest on the excess payment will accrue through the date that is one business day prior to the mail date of the reimbursement check. [If any Rights holder exercises its right to acquire [&#9679;] Shares pursuant to the over-subscription privilege, any excess payment which would otherwise be refunded to the Rights holder will be applied by the Fund toward payment for [&#9679;] Shares acquired pursuant to exercise of the over-subscription privilege.]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A Rights holder will have no right to rescind a purchase after the Rights Agent has received payment either by means of a notice of guaranteed delivery, delivery of [&#9679;] shares, or a check.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If a holder of Rights who acquires [&#9679;] Shares pursuant to the Subscription does not make payment of any amounts due, the Fund reserves the right to take any or all of the following actions: (i) find other purchasers for such subscribed-for and unpaid-for [&#9679;] Shares; (ii) apply any payment actually received by it toward the purchase of the greatest whole number of [&#9679;] Shares which could be acquired by such holder upon exercise of the Subscription or over-subscription privilege; (iii) sell all or a portion of the [&#9679;] Shares purchased by the holder in the open market and apply the proceeds to the amounts owed; and (iv) exercise any and all other rights or remedies to which it may be entitled, including, without limitation, the right to set off against payments actually received by it with respect to such subscribed [&#9679;] Shares and to enforce the relevant guaranty of payment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders, such as broker-dealers, trustees or depositories for securities, who hold [&#9679;] shares for the account of others, should notify the respective beneficial owners of the [&#9679;] shares as soon as possible to ascertain such beneficial owners&#8217; intentions and to obtain instructions with respect to the Rights. If the beneficial owner so instructs, the record holder of the Rights should complete Subscription Certificates and submit them to the Rights Agent with the proper payment. In addition, beneficial owners of [&#9679;] shares or Rights held through such a holder should contact the holder and request the holder to effect transactions in accordance with the beneficial owner&#8217;s instructions. Banks, broker-dealers, trustees and other nominee holders that hold [&#9679;] shares of the Fund for the accounts of others are advised to notify those persons that purchase Rights in the secondary market that such Rights may not participate in the over-subscription privilege.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 109 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PR-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE INSTRUCTIONS ACCOMPANYING THE SUBSCRIPTION CERTIFICATES SHOULD BE READ CAREFULLY AND FOLLOWED IN DETAIL. DO NOT SEND SUBSCRIPTION CERTIFICATES TO THE FUND.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE METHOD OF DELIVERY OF SUBSCRIPTION CERTIFICATES AND PAYMENT OF THE SUBSCRIPTION PRICE TO THE RIGHTS AGENT WILL BE AT THE ELECTION AND RISK OF THE RIGHTS HOLDERS, BUT IF SENT BY MAIL IT IS RECOMMENDED THAT THE CERTIFICATES AND PAYMENTS BE SENT BY REGISTERED MAIL, PROPERLY INSURED, WITH RETURN RECEIPT REQUESTED, AND THAT A SUFFICIENT NUMBER OF DAYS BE ALLOWED TO ENSURE DELIVERY TO THE RIGHTS AGENT AND CLEARANCE OF PAYMENT PRIOR TO [5:00 PM] EASTERN TIME, ON THE EXPIRATION DATE. BECAUSE UNCERTIFIED PERSONAL CHECKS MAY TAKE AT LEAST FIVE BUSINESS DAYS TO CLEAR, YOU ARE STRONGLY URGED TO PAY, OR ARRANGE FOR PAYMENT, BY MEANS OF A CERTIFIED OR CASHIER&#8217;S CHECK WHICH MUST INCLUDE THE NAME OF THE STOCKHOLDER ON THE CHECK.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All questions concerning the timeliness, validity, form and eligibility of any exercise of Rights will be determined by the Fund, whose determinations will be final and binding. The Fund in its sole discretion may waive any defect or irregularity, or permit a defect or irregularity to be corrected within such time as it may determine, or reject the purported exercise of any Right. Subscriptions will not be deemed to have been received or accepted until all irregularities have been waived or cured within such time as the Fund determines in its sole discretion. Neither the Fund nor the Rights Agent will be under any duty to give notification of any defect or irregularity in connection with the submission of Subscription Certificates or incur any liability for failure to give such notification.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Foreign Restrictions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offering documents, including Subscription Certificates, will not be mailed to Record Date Shareholders whose addresses are outside the United States (for these purposes, the United States includes the District of Columbia and the territories and possessions of the United States) (the &#8220;Foreign Shareholders&#8221;) if such mailing cannot be made into the non-U.S. jurisdiction without additional registration and incurring other expense that the Board has determined is not in the best interest of the Fund and its shareholders. In such cases, unless determined to be not in the best interest of the Fund and its shareholders in accordance with the previous sentence, the Rights Agent will send a letter via regular mail to Foreign Shareholders who own Common Shares directly (&#8220;Direct Foreign Shareholders&#8221;), as opposed to in &#8220;street name&#8221; with a broker or other financial intermediary, to notify them of the Rights offering. Direct Foreign Shareholders who wish to exercise their Rights should contact the Fund, as described above under &#8220;Inquiries,&#8221; to facilitate the exercise of such Rights and for instructions or any other special requirements that may apply in order for such Direct Foreign Shareholder to exercise its Rights. Direct Foreign Shareholders who wish to sell their Rights should contact the Rights Agent and follow the procedures described above under &#8220;Sales by Rights Agent.&#8221; Direct Foreign Shareholders are encouraged to contact the Fund or the Rights Agent as far in advance of the Expiration Date as possible to ensure adequate time for their Rights to be exercised or sold. Foreign Shareholders who own [&#9679;] shares in &#8220;street name&#8221; through a broker or other financial intermediary should contact such broker or other financial intermediary with respect to any exercise or sale of Rights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Certain Employee Benefit Plan and IRA Considerations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[To be provided.]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 110 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PR-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pr_006"></span>USE OF PROCEEDS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund estimates the net proceeds of the Offer to be $[&#9679;], based on the Subscription Price per share of $[&#9679;], assuming all new shares of Series [&#9679;] Preferred Stock offered are sold and that the expenses related to the Offer estimated at approximately $[&#9679;] are paid and after deduction of the underwriting discounts and commissions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Investment Adviser expects that it will initially invest the proceeds of the offering in high-quality short term debt securities and instruments. The Investment Adviser anticipates that the investment of the proceeds will be made in accordance with the Fund&#8217;s investment objectives and policies as appropriate investment opportunities are identified, which is expected to be substantially completed within three months of the issue date; however, the identification of appropriate investment opportunities pursuant to the Fund&#8217;s investment style or changes in market conditions may cause the investment period to extend as long as six months from the issue date. This could occur because the Investment Adviser follows a value-oriented investment strategy; therefore, market conditions could result in the Investment Adviser delaying the investment of proceeds if it believes the margin of risk in making additional investments is not favorable in light of its value-oriented investment strategy. See &#8220;Investment Objectives and Policies&#8212;Investment Methodology of the Fund&#8221; in the accompanying Prospectus. The proceeds may also be used to redeem or repurchase shares of existing series of the Fund&#8217;s preferred stock, in whole or in part. Pending such investment and/or redemption, the proceeds will be held in high quality short term debt securities and instruments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pr_007"></span>CAPITALIZATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth the unaudited capitalization of the Fund as of [&#9679;].</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[To be provided.]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pr_008"></span>ASSET COVERAGE RATIO</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to the Investment Company Act of 1940, as amended (the &#8220;1940 Act&#8221;), the Fund will not be permitted to declare any dividend, or declare any other distribution, upon any outstanding shares of common stock, or purchase any such common stock, unless, in every such case, all shares of preferred stock issued by the Fund have at the time of declaration of any such dividend or distribution or at the time of any such purchase an asset coverage of at least 200% (&#8220;1940 Act Asset Coverage Requirement&#8221;) after deducting the amount of such dividend, distribution, or purchase price, as the case may be. The Fund&#8217;s outstanding shares of preferred stock are expected to have an initial asset coverage on the date of issuance of approximately [&#9679;]%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition to the 1940 Act Asset Coverage Requirement, the Fund is subject to certain restrictions on investments imposed by guidelines of one or more rating agencies, which have issued ratings for certain of the preferred shares and may issue a rating for the Series [&#9679;] Preferred Shares. [See &#8220;Special Characteristics and Risks of the Series [&#9679;] Preferred Shares&#8212;Risks&#8212;Credit Rating Risk&#8221; in this Prospectus Supplement.]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pr_009"></span>SPECIAL CHARACTERISTICS AND RISKS OF THE SHARES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dividends</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[To be provided.]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Voting Rights</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Articles provide that, except as otherwise provided in the Charter (including the Articles), or as required by applicable law, holders of Series [&#9679;] Preferred Shares shall have no power to vote on any matter except matters submitted to a vote of the Fund&#8217;s common stock. In any matter submitted to a vote of the holders of the common stock, each holder of Series [&#9679;] Preferred Shares shall be entitled to one vote for each Series [&#9679;] Preferred Share held and the holders of all outstanding shares of the Fund&#8217;s preferred stock, including Series [&#9679;] Preferred Shares, and the shares of common stock shall vote together as a single class; provided, however, that at any meeting of the stockholders of the Fund held for the election of Directors, the holders of the outstanding shares of the Fund&#8217;s preferred stock, including Series [&#9679;] Preferred Shares, shall be entitled, as a class, to the exclusion of the holders of all other classes of capital stock of the Fund, to elect a number of the Fund&#8217;s directors, such that following the election of directors at the meeting of the stockholders, the Fund&#8217;s Board of Directors shall contain two directors elected by the holders of the outstanding shares of preferred stock, including the Series [&#9679;] Preferred Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 111 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PR-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During any period in which any one or more of the conditions described below shall exist (such period being referred to herein as a &#8220;Voting Period&#8221;), the number of directors constituting the Fund&#8217;s Board of Directors shall be increased by the smallest number of additional directors that, when added to the two directors elected exclusively by the holders of outstanding shares of preferred stock, would constitute a simple majority of the Fund&#8217;s Board of Directors as so increased by such smallest number, and the holders of outstanding shares of preferred stock, including the Series [&#9679;] Preferred Shares, voting together as a separate class (to the exclusion of the holders of all other classes of capital stock of the Fund) shall be entitled to elect such smallest number of additional directors and the two directors the holders of shares of preferred stock, including the Series [&#9679;] Preferred Shares, are otherwise entitled to elect. The Fund and the Fund&#8217;s Board of Directors shall take all necessary actions, including amending the Fund&#8217;s bylaws, to effect an increase in the number of directors as described in the preceding sentence. A Voting Period shall commence:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.5in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if at any time accumulated dividends and distributions on the outstanding Series [&#9679;] Preferred Shares equal to at least two full years&#8217; dividends and distributions shall be due and unpaid and sufficient cash or specified securities shall not have been deposited with Computershare Trust Company, N.A., and its successors or any other dividend-disbursing agent appointed by the Fund, for the payment of such accumulated dividends and distributions; or</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.5in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if at any time holders of any other shares of preferred stock are entitled to elect a majority of the Directors of the Fund under the 1940 Act or articles supplementary creating such shares.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[Puts and Redemptions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund will redeem all or any part of the [&#9679;] Shares that holders have properly submitted for redemption [and not withdrawn] during the 30-day period prior to each of [&#9679;] and [&#9679;], at the liquidation preference, plus any accumulated and unpaid dividends.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund may redeem all or any part of the [&#9679;] Shares, upon not less than 30 nor more than 60 days&#8217; prior notice, at the liquidation preference, plus any accumulated and unpaid dividends, at any time on or after [&#9679;].]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock Exchange Listing</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An application will be made to list the [&#9679;] Shares on the [&#9679;]. If the application is approved, the [&#9679;] Shares are expected to commence trading on the [&#9679;] within [&#9679;] days of the date of issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk is inherent in all investing. Therefore, before investing in the [&#9679;] Shares you should consider the risks carefully. See &#8220;Risk Factors and Special Considerations&#8221; in the accompanying Prospectus. Primary risks specially associated with an investment in the Series [&#9679;] Preferred include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Market Price Risk</i></b>. The market price for the Series [&#9679;] Preferred will be influenced by changes in interest rates, the perceived credit quality of the Series [&#9679;] Preferred and other factors, and may be higher or lower than the liquidation preference of the Series [&#9679;] Preferred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Liquidity Risk</i></b>. Prior to this offering, there has been no public market for the Series [&#9679;] Preferred. As noted above, an application will be made to list the Series [&#9679;] Preferred on the [&#9679;]. However, during an initial period which is not expected to exceed [&#9679;] days after the date of its issuance, the Series [&#9679;] Preferred will not be listed on any securities exchange. Before the Series [&#9679;] Preferred Shares are listed on the [&#9679;], the underwriters may, but are not obligated to, make a market in the Series [&#9679;] Preferred. No assurances can be provided that listing on any securities exchange or market making by the dealer-manager will result in the market for Series [&#9679;] Preferred being liquid at any time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 112 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PR-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Redemption Risk</i></b>. The Fund may at any time redeem Series [&#9679;] Preferred Shares to the extent necessary to meet regulatory asset coverage requirements or requirements imposed by credit rating agencies. For example, if the value of the Fund&#8217;s investment portfolio declines, thereby reducing the asset coverage for the Series [&#9679;] Preferred Shares, the Fund may be obligated under the terms of the Series [&#9679;] Preferred Shares to redeem some or all of the Series [&#9679;] Preferred Shares. In addition, commencing [&#9679;], the Fund will be able to call the Series [&#9679;] Preferred Shares at the option of the Fund. Investors may not be able to reinvest the proceeds of any redemption in an investment providing the same or a higher dividend rate than that of the Series [&#9679;] Preferred Shares. Although unlikely, precipitous declines in the value of the Fund&#8217;s assets could result in the Fund having insufficient assets to redeem all of the Series [&#9679;] Preferred Shares for the full redemption price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Subordination Risk. </i></b>The Series [&#9679;] Preferred Shares are not a debt obligation of the Fund. The Series [&#9679;] Preferred Shares are junior in respect of distributions and liquidation preference to any indebtedness incurred by the Fund, and have the same priority with respect to payment of distributions and liquidation preference as the Series C Auction Rate Preferred, Series E Auction Rate Preferred, Series G Preferred, Series H Preferred, Series K Preferred, Series M Preferred, Series N Preferred and any other series of preferred stock that the Fund may issue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<b><i>Credit Rating Risk</i></b>. The Fund is seeking a credit rating on the Series [&#9679;] Preferred Shares. Any credit rating that is issued on the Series [&#9679;] Preferred Shares could be reduced or withdrawn while an investor holds Series [&#9679;] Preferred Shares. A reduction or withdrawal of the credit rating would likely have an adverse effect on the market value of the Series [&#9679;] Preferred Shares. In addition, a credit rating does not eliminate or mitigate the risks of investing in the Series [&#9679;] Preferred Shares.]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Distribution Risk</i></b>. The Fund may not meet the asset coverage requirements or earn sufficient income from its investments to make distributions on the Series [&#9679;] Preferred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Interest Rate Risk</i></b>. The Series [&#9679;] Preferred Shares pay dividends at a fixed rate[, which resets after an initial period]. Prices of fixed income investments tend to vary inversely with changes in market yields. The market yields on securities comparable to the Series [&#9679;] Preferred Shares may increase, which would likely result in a decline in the value of the Series [&#9679;] Preferred Shares. Additionally, if interest rates rise, securities comparable to the Series [&#9679;] Preferred Shares may pay higher dividend rates and holders of the Series [&#9679;] Preferred Shares may not be able to sell the Series [&#9679;] Preferred Shares at their liquidation preference and reinvest the proceeds at market rates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>[Dividend Rate Adjustment Risk</i></b>. The dividend rate of the Series [&#9679;] Preferred Shares automatically adjusts to a rate of [&#9679;]% per annum after a period of [&#9679;] months commencing on the date the Series [&#9679;] Preferred Shares are first issued. If interest rates rise during this time, holders of Series [&#9679;] Preferred Shares may receive a below market dividend rate which may cause the market price of the Series [&#9679;] Preferred Shares to decline.]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<b><i>The Investment Adviser and Mr.&#160;Gabelli have Certain Conflicts of Interest Relating to the Preferred Stock</i></b>. As of [&#9679;], Mario Gabelli was the beneficial owner of [&#9679;] Shares, representing [&#9679;]% of the Fund&#8217;s outstanding Series [&#9679;] Preferred Shares. The other Directors collectively own [&#9679;] of the [&#9679;]. Mr.&#160;Gabelli has advised the Fund that he may participate in the rights offering to purchase Series [&#9679;] Preferred Shares. The Directors, or a committee thereof, determine the dividend rate on the Series [&#9679;] Preferred Shares at such times and in such manner as is specified in this Registration Statement. Because of the possible perception of a conflict of interest, Mr.&#160;Gabelli has agreed to recuse himself from all discussions by the Board of Directors or committee thereof related to the determination of the dividend rate for the Series [&#9679;] Preferred Shares for any period following initial issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Investment Adviser receives advisory compensation in respect of the total assets of the Fund, including assets representing the liquidation preference of the Series [&#9679;] Preferred Shares (but not with respect to the Fund&#8217;s Series C Auction Rate Preferred and Series E Auction Rate Preferred), without regard to whether the Fund earns an incremental return from such assets for the benefit of the common stockholders. In addition, Mr.&#160;Gabelli receives incentive-based variable compensation based on a percentage of net revenues received by the Investment Adviser for managing the Fund, which will be greater to the extent that the Fund has preferred shares outstanding. Consequently, both the Investment Adviser, which is controlled by Mr.&#160;Gabelli, and Mr.&#160;Gabelli himself have a conflict of interest with respect to the Series [&#9679;] Preferred Shares inasmuch as each stands to benefit from the issuance of such shares whether or not such issuance benefits holders of the shares of common stock.]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 113 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PR-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pr_010"></span>TAXATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please refer to the &#8220;Taxation&#8221; sections in the Fund Prospectus and Fund Statement of Additional Information for a description of the consequences of investing in the preferred shares of the Fund.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pr_011"></span>UNDERWRITING</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;], which is a broker-dealer and member of the Financial Industry Regulatory Authority will act as dealer manager for the rights offering (henceforth, the &#8220;Dealer Manager&#8221;). Under the terms and subject to the conditions contained in the Dealer Manager Agreement among the Fund, the Investment Adviser, and the Dealer Manager (the &#8220;Dealer Manager Agreement&#8221;), the Dealer Manager will provide financial structuring services and marketing services in connection with the offering and will solicit the exercise of Rights [and participation in the over-subscription privilege]. The Fund has agreed to pay the Dealer Manager a fee for its financial structuring, marketing and soliciting services equal to $[&#9679;] per [&#9679;] Rights exercised pursuant to the rights offering. The Dealer Manager fee will be borne by the Fund and indirectly by all of the Fund&#8217;s common stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Dealer Manager will reallow to other broker-dealers that have executed and delivered a soliciting dealer agreement and have solicited the exercise of Rights solicitation fees equal to $[&#9679;] for each [&#9679;] Share issued pursuant to exercise of Rights as a result of their soliciting efforts. Fees will be paid to the broker-dealer designated on the applicable portion of the Subscription Certificates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund and the Investment Adviser have each agreed to indemnify the Dealer Manager or contribute to losses arising out of certain liabilities, including liabilities under the Securities Act. The Dealer Manager Agreement also provides that the Dealer Manager will not be subject to any liability to the Fund in rendering the services contemplated by the Dealer Manager Agreement except for any act of bad faith, willful misconduct or gross negligence of the Dealer Manager or reckless disregard by the Dealer Manager of its obligations and duties under the Dealer Manager Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Prior to the expiration of the rights offering, the Dealer Manager may independently offer for sale Rights or [&#9679;] Shares to be acquired by it through purchasing and exercising Rights, at prices it sets, although the Dealer Manager will not charge commissions for the sale of such Rights on behalf of holders of Rights. The Dealer Manager&#8217;s fee for its financial structuring, marketing and soliciting services is independent of any gains or losses that may be realized by the Dealer Manager through the purchase and exercise of Rights or purchase and sale of [&#9679;] Shares.]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the ordinary course of their businesses, the Dealer Manager and/or its affiliates may engage in investment banking or financial transactions with the Fund, the Investment Adviser and their affiliates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The principal business address of [&#9679;] is [&#9679;].</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pr_012"></span>LEGAL MATTERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain legal matters will be passed on by Willkie Farr &amp; Gallagher LLP, counsel to the Fund, in connection with this rights offering and the offering of the Series [&#9679;] Preferred Shares of the Fund. Willkie Farr &amp; Gallagher LLP may rely as to certain matters of Maryland law on the opinion of Venable LLP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[The Fund&#8217;s unaudited financial statements as of and for the six months ended June&#160;30, 202[&#9679;] should be read in conjunction with the audited financial statements of the Fund and the Notes thereto included in the Annual Report to the Fund&#8217;s shareholders for the fiscal year ended December&#160;31, 202[&#9679;].] The audited annual financial statements of the Fund for the fiscal year ended December&#160;31, 202[&#9679;] [and the unaudited semiannual financial statements of the Fund for the six months ended June&#160;30, 202[&#9679;]] are incorporated by reference into this Prospectus Supplement, the accompanying Prospectus and the SAI. Portions of the Fund&#8217;s annual report [and semiannual report] other than the financial statements and related footnotes thereto are not incorporated into, and do not form a part of, this Prospectus Supplement, the accompanying Prospectus or the SAI.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 114 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PR-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b>THE GABELLI EQUITY TRUST INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares of [&#9679;] % Series [&#9679;] [&#9679;] Preferred Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Issuable
Upon Exercise of Rights to Subscribe for Such Shares of Preferred Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>PROSPECTUS SUPPLEMENT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;[&#9679;], 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<!-- Field: Page; Sequence: 115 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><b>The information in this Prospectus Supplement is not complete and may be changed. The Fund may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This Prospectus Supplement is not an offer to sell these securities and is not soliciting offers to buy these securities in any state where the offer or sale is not permitted.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><b>SUBJECT TO COMPLETION, DATED [&#9679;], 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed Pursuant to Rule&#160;424(b)([&#9679;])<br />Registration Statement No. 333-[&#9679;]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>THE GABELLI EQUITY TRUST INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROSPECTUS SUPPLEMENT<br />(To Prospectus dated [&#9679;], 2023)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[&#9679;] Rights</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Subscription Rights to Acquire Common Stock and Preferred Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Gabelli Equity Trust Inc. (the &#8220;Fund,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221;) is issuing subscription rights (the &#8220;Rights&#8221;) to our common stockholders to purchase additional shares of our common stock (&#8220;common shares&#8221;) and newly issued shares of preferred stock (&#8220;preferred shares&#8221;). The Rights may only be exercised to purchase an equal number of common shares and preferred shares and may not be exercised to purchase only common shares or preferred shares or an unequal number of common shares and preferred shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund is a diversified, closed-end management investment company registered under the Investment Company Act of 1940, as amended (the &#8220;1940 Act&#8221;). The Fund&#8217;s primary investment objective is to achieve long term growth of capital by investing primarily in a portfolio of equity securities consisting of common stock, preferred stock, convertible or exchangeable securities, and warrants and rights to purchase such securities. Income is a secondary investment objective. Under normal market conditions, the Fund will invest at least 80% of the value of its total assets in equity securities. The Fund&#8217;s investment adviser is Gabelli Funds, LLC (the &#8220;Investment Adviser&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares of our common stock are listed on the New York Stock Exchange (&#8220;NYSE&#8221;) under the symbol &#8220;GAB.&#8221; On [&#9679;], 2023, the last reported net asset value per share of our common stock was $[&#9679;] and the last reported sales price per share of our common stock on the NYSE was $[&#9679;]. Shares of our Series G Cumulative Preferred Stock (the &#8220;Series G Preferred Shares&#8221;), our 5.00% Series H Cumulative Preferred Stock (the &#8220;Series H Preferred Shares&#8221;) and our 5.00% Series K Cumulative Preferred Stock (the &#8220;Series K Preferred Shares&#8221;) are listed on the NYSE under the symbol &#8220;GAB PrG,&#8221; &#8220;GAB PrH&#8221; and &#8220;GAB PrK,&#8221; respectively. On [&#9679;], 2023, the last reported sales prices per share of Series G Preferred Shares, Series H Preferred Shares and Series K Preferred Shares on the NYSE were $[&#9679;], $[&#9679;] and $[&#9679;] respectively. Our Series C Auction Rate Cumulative Preferred Stock (the &#8220;Series C Auction Rate Preferred&#8221;), Series E Auction Rate Preferred Stock (the &#8220;Series E Auction Rate Preferred&#8221;), 4.25% Series M Cumulative Preferred Stock (&#8220;Series M Preferred&#8221;) and 5.25% Series N Cumulative Preferred Stock (&#8220;Series N Preferred&#8221;) are not traded on a stock exchange.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An investment in the Fund is not appropriate for all investors. We cannot assure you that the Fund&#8217;s investment objectives will be achieved. You should read this Prospectus Supplement and the accompanying Prospectus before deciding whether to invest in the Fund and retain it for future reference. The Prospectus Supplement and the accompanying Prospectus contain important information about us. Material that has been incorporated by reference and other information about us can be obtained from us by calling 800-GABELLI (422-3554) or from the Securities and Exchange Commission&#8217;s (&#8220;SEC&#8221;) website (http://www.sec.gov). For additional information all holders of rights should contact the Information Agent, [&#9679;].</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investing in common shares and preferred shares through Rights involves certain risks that are described in the &#8220;Special Characteristics and Risks of the Rights Offering&#8221; section of this Prospectus Supplement. Investing in Series [&#9679;] Preferred Shares involves certain risks, including risks related to a leveraged capital structure, that are described in the &#8220;Special Characteristics and Risks of the Series [&#9679;] Preferred Shares&#8221; section of this Prospectus Supplement and the &#8220;Risk Factors and Special Considerations&#8221; section beginning on page 18 of the accompanying Prospectus.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 116; Options: NewSection -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">U-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NEITHER THE SEC NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED THESE SECURITIES OR DETERMINED IF THIS PROSPECTUS SUPPLEMENT IS TRUTHFUL OR COMPLETE. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left; padding-bottom: 1pt">&#160;</td>
    <td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Per Share</b></span></td>
    <td style="padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td>
    <td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td>
    <td style="padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 76%; text-align: left">Subscription price per common share to holders exercising Rights (1)</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;</span></td>
    <td style="width: 1%; text-align: left">]</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">[&#9679;</td>
    <td style="width: 1%; text-align: left">]</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Subscription price per common share to holders exercising Rights (1)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">[&#9679;</td>
    <td style="text-align: left">]</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">[&#9679;</td>
    <td style="text-align: left">]</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Underwriting discounts and commissions</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">[&#9679;</td>
    <td style="text-align: left">]</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">[&#9679;</td>
    <td style="text-align: left">]</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left; padding-bottom: 1pt">Proceeds, before expenses, to the Fund (1)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">[&#9679;</td>
    <td style="padding-bottom: 1pt; text-align: left">]</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">[&#9679;</td>
    <td style="padding-bottom: 1pt; text-align: left">]</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Rights may only be exercised to purchase an equal number of common shares and preferred shares and may not be exercised to purchase only common shares or preferred shares or an unequal number of common shares and preferred shares.</span></td> </tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on a Dealer Manager solicitation fee of $[&#9679;] per common share issued.</span></td> </tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The aggregate expenses of the offering (excluding underwriting discounts and commissions) are estimated to be $[&#9679;].</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[NO SECURITIES REGULATORY AUTHORITY IN CANADA HAS EXPRESSED AN OPINION ABOUT THESE SECURITIES AND IT IS AN OFFENSE TO CLAIM OTHERWISE. THIS OFFERING WILL NOT BE MADE IN ANY PROVINCE OF CANADA WHERE IT IS NOT PERMITTED BY LAW.]</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHAREHOLDERS WHO DO NOT FULLY EXERCISE THEIR RIGHTS MAY, AT THE COMPLETION OF THE OFFERING, OWN A SMALLER PROPORTIONAL INTEREST IN THE FUND THAN IF THEY EXERCISED THEIR RIGHTS. AS A RESULT OF THE OFFERING YOU MAY EXPERIENCE SUBSTANTIAL DILUTION [OR ACCRETION] OF THE AGGREGATE NET ASSET VALUE OF YOUR COMMON SHARES DEPENDING UPON WHETHER THE FUND&#8217;S NET ASSET VALUE PER COMMON SHARE IS ABOVE [OR BELOW] THE SUBSCRIPTION PRICE ON THE EXPIRATION DATE.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The common shares and preferred shares are expected to be ready for delivery in book-entry form through the Depository Trust Company on or about [&#9679;], 2023. If the offer is extended, the common shares and preferred shares are expected to be ready for delivery in book-entry form through the Depository Trust Company on or about [&#9679;], 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The date of this Prospectus Supplement is [&#9679;], 2023.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 117 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">U-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>You should rely only on the information contained or incorporated by reference in this Prospectus Supplement and the accompanying Prospectus. The Fund has not authorized anyone to provide you with different information. The Fund is not making an offer to sell these securities in any jurisdiction where the offer or sale is not permitted. You should not assume that the information contained in this Prospectus Supplement and the accompanying Prospectus is accurate as of any date other than the date of this Prospectus Supplement and the accompanying Prospectus, respectively. Our business, financial condition, results of operations and prospects may have changed since those dates. In this Prospectus Supplement and in the accompanying Prospectus, unless otherwise indicated, &#8220;Fund,&#8221; &#8220;us,&#8221; &#8220;our&#8221; and &#8220;we&#8221; refer to The Gabelli Equity Trust Inc., a Maryland corporation. This Prospectus Supplement also includes trademarks owned by other persons.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TABLE OF CONTENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Prospectus Supplement</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; width: 90%; vertical-align: top">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right; width: 9%"><b>Page</b></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 3pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"><a href="#u_001">CAUTIONARY NOTICE REGARDING FORWARD-LOOKING STATEMENTS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right">U-4</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 3pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"><a href="#u_002">SUMMARY OF THE TERMS OF THE RIGHTS OFFERING</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right">U-5</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 3pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"><a href="#u_003">DESCRIPTION OF THE PREFERRED SHARES</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right">U-9</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 3pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"><a href="#u_004">TERMS OF THE PREFERRED SHARES</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right">U-10</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 3pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"><a href="#u_005">DESCRIPTION OF THE RIGHTS OFFERING</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right">U-12</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 3pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"><a href="#u_006">USE OF PROCEEDS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right">U-19</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 3pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"><a href="#u_007">CAPITALIZATION</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right">U-19</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 3pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"><a href="#u_008">ASSET COVERAGE RATIO</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right">U-20</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 3pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"><a href="#u_009">SPECIAL RISKS OF THE OFFERING AND THE SERIES [&#9679;] PREFERRED SHARES</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right">U-20</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 3pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"><a href="#u_010">TAXATION</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right">U-23</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 3pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"><a href="#u_011">UNDERWRITING</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="vertical-align: bottom; padding-bottom: 3pt; text-align: right">U-24</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"><a href="#u_012">LEGAL MATTERS</a></td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: right">U-25</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Prospectus</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; width: 90%; text-align: justify"><a href="#a_001">PROSPECTUS SUMMARY</a></td>
    <td style="padding-bottom: 3pt; width: 1%">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; width: 9%; text-align: right">4</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_002">SUMMARY OF FUND EXPENSES</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">10</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_003">FINANCIAL HIGHLIGHTS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">12</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_004">USE OF PROCEEDS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">18</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_005">THE FUND</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">18</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_006">INVESTMENT OBJECTIVES AND POLICIES</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">18</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_007">RISK FACTORS AND SPECIAL CONSIDERATIONS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">18</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_008">HOW THE FUND MANAGES RISK</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">18</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_009">MANAGEMENT OF THE FUND</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">19</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_010">PORTFOLIO TRANSACTIONS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">24</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_011">DIVIDENDS AND DISTRIBUTIONS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">24</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_012">ISSUANCE OF COMMON STOCK</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">25</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_013">AUTOMATIC DIVIDEND REINVESTMENT AND VOLUNTARY CASH PURCHASE PLANS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">25</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_014">DESCRIPTION OF THE CAPITAL STOCK</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">25</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_015">ANTI-TAKEOVER PROVISIONS OF THE FUND&#8217;S GOVERNING DOCUMENTS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">35</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_016">CLOSED-END FUND STRUCTURE</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">39</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_017">REPURCHASE OF COMMON STOCK</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">39</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_018">RIGHTS OFFERINGS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">40</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_019">NET ASSET VALUE</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">40</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_020">LIMITATION ON DIRECTORS&#8217; AND OFFICERS&#8217; LIABILITY</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">41</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_021">TAXATION</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">41</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_022">CUSTODIAN, TRANSFER AGENT AND DIVIDEND DISBURSING AGENT</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">45</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_023">PLAN OF DISTRIBUTION</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">45</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_024">LEGAL MATTERS</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">47</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_025">INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">47</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_026">ADDITIONAL INFORMATION</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">47</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top; text-align: justify"><a href="#a_027">INCORPORATION BY REFERENCE</a></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt; vertical-align: bottom; text-align: right">47</td></tr>
  <tr>
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: justify"><a href="#a_028">PRIVACY PRINCIPLES OF THE FUND</a></td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: right">48</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 118 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">U-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="u_001"></span>CAUTIONARY NOTICE REGARDING FORWARD-LOOKING STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Prospectus Supplement, the accompanying Prospectus and the Statement of Additional Information (the &#8220;SAI&#8221;) contain &#8220;forward-looking statements.&#8221; Forward-looking statements can be identified by the words &#8220;may,&#8221; &#8220;will,&#8221; &#8220;intend,&#8221; &#8220;expect,&#8221; &#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; and similar terms and the negative of such terms. Such forward-looking statements may be contained in this Prospectus Supplement as well as in the accompanying Prospectus and in the SAI. By their nature, all forward-looking statements involve risks and uncertainties, and actual results could differ materially from those contemplated by the forward-looking statements. Several factors that could materially affect our actual results are the performance of the portfolio of securities we hold, the price at which our shares will trade in the public markets and other factors discussed in our periodic filings with the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although we believe that the expectations expressed in our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and are subject to inherent risks and uncertainties, such as those disclosed in the &#8220;Risk Factors and Special Considerations&#8221; section of the accompanying Prospectus and &#8220;Special Risks of the Offering and the Series [&#9679;] Preferred Shares&#8221; in this Prospectus Supplement. All forward-looking statements contained or incorporated by reference in this Prospectus Supplement or the accompanying Prospectus, or in the SAI, are made as of the date of this Prospectus Supplement or the accompanying Prospectus, or SAI, as the case may be. Except for our ongoing obligations under the federal securities laws, we do not intend, and we undertake no obligation, to update any forward-looking statement. The forward-looking statements contained in this Prospectus Supplement, the accompanying Prospectus and the SAI are excluded from the safe harbor protection provided by Section&#160;27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently known risk factors that could cause actual results to differ materially from our expectations include, but are not limited to, the factors described in the &#8220;Risk Factors and Special Considerations&#8221; section of the accompanying Prospectus as well as in the &#8220;Special Risks of the Offering and the Series [&#9679;] Preferred Shares&#8221; section of this Prospectus Supplement. We urge you to review carefully those sections for a more detailed discussion of the risks of an investment in the preferred shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 119 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">U-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="u_002"></span>SUMMARY OF THE TERMS OF THE RIGHTS OFFERING</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; width: 27%; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Terms of the Offer</b></span></td>
    <td style="text-align: justify; width: 3%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">One transferable subscription right (a &#8220;Right&#8221;) will be issued for each common share of the Fund held on the record date (the &#8220;Offer&#8221;). The Rights are expected to trade on the [NYSE]. The Rights will allow holders of common shares to purchase additional common shares and newly issued preferred shares. [&#9679;] Rights will be required to purchase one common share and one preferred share. The Rights may only be exercised to purchase an equal number of common shares and preferred shares and may not be exercised to purchase only common shares or preferred shares or an unequal number of common shares and preferred shares.</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of [&#9679;], 2023, [&#9679;] common shares are outstanding, [&#9679;] shares of Series C Auction Rate Preferred are outstanding, [&#9679;] shares of Series E Auction Rate Preferred are outstanding, [&#9679;] shares of Series G Preferred are outstanding, [&#9679;] shares of Series H Preferred are outstanding, [&#9679;] shares of Series K Preferred are outstanding, [&#9679;] shares of Series M Preferred are outstanding, and [&#9679;] shares of Series N Preferred are outstanding. [An over-subscription privilege will be offered.] [&#9679;] common shares and [&#9679;] preferred shares of the Fund will be issued if all Rights are exercised. See &#8220;<i>Description of the Rights Offering&#8212;Terms of the Rights Offering</i>.&#8221;</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title</b></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription Rights to Acquire Common Shares and Preferred Shares</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Subscription Price</b></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rights may be exercised at a price of $[&#9679;] (the &#8220;Subscription Price&#8221;), which represents $[&#9679;] per common share and $[&#9679;] per preferred share. The purchase price will be payable in cash. See &#8220;Description of the Rights Offering&#8212;Terms of the Rights Offering.&#8221;</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Record Date</b></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rights will be issued to holders of record of the Fund&#8217;s common shares at the close of business on [&#9679;], [&#9679;] (the &#8220;Record Date&#8221;). <i>See &#8220;Terms of the Rights Offering</i>.&#8221;</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of Rights Issued</b></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">One Right will be issued in respect of each common share of the Fund held on the Record Date. <i>See &#8220;Description of the Rights Offering&#8212;Terms of the Rights Offering.&#8221;</i></span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of Rights Required to Purchase One Common Share and One Preferred Share</b></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A holder of Rights may purchase one common share and one preferred share for every [&#9679;] Rights exercised. [The number of Rights issued to a shareholder will be rounded up to the nearest number of Rights evenly divisible by [&#9679;].] A holder of Rights may only purchase an equal number of common shares and preferred shares and may not exercise any Rights so as to purchase only common shares or preferred or an unequal number of common shares and preferred shares. <i>See &#8220;Description of the Rights Offering&#8212;Terms of the Rights Offering.&#8221;</i></span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Over-Subscription Privilege</b></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Rights holders who are holders of common shares on the Record Date (&#8220;Record Date Shareholders&#8221;) who fully exercise all Rights initially issued to them are entitled to subscribe for additional common shares and preferred shares at the same Subscription Price, subject to certain limitations and subject to allotment. Over-subscription requests will be honored only to the extent fewer than all of the Rights are exercised. Unsubscribed common shares and preferred shares will be allocated pro-rata among those shareholders who over-subscribe based on the number of common shares owned on the Record Date. Rights acquired in the secondary market may not participate in the over-subscription privilege. <i>See &#8220;Description of the Rights Offering&#8212;Over-Subscription Privilege.&#8221;</i>]</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Transfer of Rights</b></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Rights will be transferable<i>. See &#8220;Description of the Rights Offering&#8212;Terms of the Rights Offering,&#8221; &#8220;&#8212;Sales by Rights Agent,&#8221; and &#8220;&#8212;Method of Selling or Transferring Rights.&#8221;</i></span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 120 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">U-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 27%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Subscription Period</b></span></td>
    <td style="text-align: justify; width: 3%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Rights may be exercised at any time after issuance and prior to expiration of the Rights, which will be [5:00 PM] Eastern Time on [&#9679;], 2023 (the &#8220;Expiration Date&#8221;) (the &#8220;Subscription Period&#8221;). <i>See &#8220;Description of the Rights Offering&#8212;Terms of the Offer&#8221; and &#8220;&#8212;Method of Exercise of Rights.&#8221;</i></span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Offer Expenses</b></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The expenses of the Offer are expected to be approximately $[&#9679;] and will be borne by holders of the Fund&#8217;s common shares. <i>See &#8220;Use of Proceeds.&#8221;</i></span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Solicitation Fee</b></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$[&#9679;] per common share issued to broker-dealers that have executed and delivered a soliciting dealer agreement and have solicited the exercise of Rights. <i>See &#8220;Underwriting.&#8221;</i></span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sale of Rights</b></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Rights are expected to be transferable until the completion of the Subscription Period and will be admitted for trading on the [NYSE]. Although no assurance can be given that a market for the Rights will develop, trading in the Rights on the [NYSE] will begin three Business Days prior to the Record Date and may be conducted until the close of trading on the last [NYSE] trading day prior to the completion of the Subscription Period. For purposes of this Prospectus Supplement, a &#8220;Business Day&#8221; will mean any day on which trading is conducted on the [NYSE].</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The value of the Rights, if any, may be reflected by the market price. Rights may be sold by individual holders or may be submitted to the Rights Agent (defined below) for sale. Any Rights submitted to the Rights Agent for sale must be received by the Rights Agent on or before [&#9679;], 2023, three Business Days prior to the completion of the Subscription Period, due to normal settlement procedures.</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Rights that are sold will not confer any right to acquire any common shares and preferred shares in the over-subscription, and any holder of common shares on the Record Date who sells any of its Rights in respect of such shares will not be eligible to participate in the over-subscription.</b></span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading of the Rights on the [NYSE] will be conducted on a when-issued basis until and including the date on which the Subscription Certificates are mailed to Record Date Shareholders and thereafter will be conducted on a regular-way basis until and including the last [NYSE] trading day prior to the completion of the Subscription Period. The common shares will begin trading ex-Rights two Business Days prior to the Record Date.</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the Rights Agent receives Rights for sale in a timely manner, it will use its best efforts to sell the Rights on the [NYSE]. The Rights Agent will also attempt to sell any Rights attributable to shareholders whose record addresses are outside the United States, or who have an Army Post Office (&#8220;APO&#8221;) or Fleet Post Office (&#8220;FPO&#8221;) address and who are not eligible to participate in the offering<i>. See &#8220;Description of the Rights Offering&#8212;Foreign Restrictions.&#8221;</i></span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any commissions on any such sales will be paid by the selling Rights holders. Neither the Fund nor the Rights Agent will be responsible if Rights cannot be sold and neither has guaranteed any minimum sales price for any Rights. If any Rights can be sold, sales of these Rights will be deemed to have been effected at the weighted average price received by the Rights Agent on the day such Rights are sold, less any applicable brokerage commissions, taxes and other expenses. Shareholders are urged to obtain a recent trading price for the Rights on the [NYSE] from their broker, bank, financial advisor or the financial press.</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Banks, broker-dealers and trust companies that hold shares for the accounts of others are advised to notify those persons that purchase Rights in the secondary market that such Rights will not be eligible to participate in the over-subscription privilege. </b><i>See &#8220;Description of the Rights Offering&#8212;Terms of the Rights Offering&#8221; and &#8220;&#8212;Sales by Rights Agent.&#8221;</i></span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 121 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">U-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 27%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of Proceeds</b></span></td>
    <td style="text-align: justify; width: 3%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund estimates the net proceeds of the Offer to be approximately $[&#9679;]. This figure is based on the Subscription Price of $[&#9679;], which represents $[&#9679;] per common share and $[&#9679;] per preferred share and assumes all new common shares and preferred shares offered are sold and that the expenses related to the Offer estimated at approximately $[&#9679;] are paid.</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Investment Adviser anticipates that the investment of the proceeds will be made in accordance with the Fund&#8217;s investment objectives and policies as appropriate investment opportunities are identified, which is expected to be substantially completed within approximately three months of the issue date; however, the identification of appropriate investment opportunities pursuant to the Fund&#8217;s investment style or changes in market conditions may cause the investment period to extend as long as six months from the issue date. This could occur because the Investment Adviser follows a value-oriented investment strategy; therefore, market conditions could result in the Investment Adviser delaying the investment of proceeds if it believes the margin of risk in making additional investments is not favorable in light of its value-oriented investment strategy. See &#8220;Investment Objectives and Policies&#8212;Investment Methodology of the Fund&#8221; in the accompanying Prospectus. The proceeds may also be used to redeem or repurchase shares of existing series of the Fund&#8217;s preferred stock, in whole or in part. Pending such investment and/or redemption, the proceeds will be held in high quality short term debt securities and similar instruments. <i>See &#8220;Use of Proceeds.&#8221;</i></span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Taxation/ERISA</b></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>See &#8220;Taxation&#8221; and &#8220;Certain Employee Benefit Plan and IRA Considerations.&#8221;</i></span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Rights Agent</b></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TERMS OF THE SERIES [&#9679;] PREFERRED SHARES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; width: 27%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The Fund</b></span></td>
    <td style="text-align: justify; width: 3%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Gabelli Equity Trust Inc., a Maryland corporation, is a diversified, closed-end management investment company registered under the 1940 Act. The Fund&#8217;s primary investment objective is to achieve long term growth of capital by investing primarily in a portfolio of equity securities consisting of common stock, preferred stock, convertible or exchangeable securities, and warrants and rights to purchase such securities. Income is a secondary investment objective. Gabelli Funds, LLC serves as investment adviser to the Fund. Under normal market conditions, the Fund will invest at least 80% of the value of its total assets in equity securities. The Fund was incorporated in Maryland on May&#160;20, 1986 and commenced its investment operations on August&#160;21, 1986. Shares of the Fund&#8217;s common stock are traded on the NYSE under the symbol &#8220;GAB.&#8221;</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities Offered</b></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;] Series [&#9679;] Preferred Shares. Series [&#9679;] Preferred Shares will constitute a separate series of preferred stock of the Fund. The Series [&#9679;] Preferred Shares have the same priority with respect to payment of distributions and liquidation preference as the Series C Auction Rate Preferred, Series E Auction Rate Preferred, Series G Preferred, Series H Preferred, Series K Preferred, Series M Preferred and Series N Preferred.</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dividend Rate</b></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends and distributions on Series [&#9679;] Preferred Shares are cumulative from their original issue date at the annual rate of [&#9679;]% of the $[&#9679;] per-share liquidation preference on the Series [&#9679;] Preferred Shares.</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dividend Payment Date</b></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders of Series [&#9679;] Preferred Shares shall be entitled to receive, when, as and if authorized by, or under authority granted by, the Board of Directors and declared by the Fund, out of funds legally available therefor, cumulative cash dividends and distributions. Dividends and distributions will be paid [&#9679;], commencing on [&#9679;].</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liquidation Preference</b></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$[&#9679;] per share.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 122 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">U-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; width: 27%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of Proceeds</b></span></td>
    <td style="text-align: justify; width: 3%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[The Fund expects to use the proceeds of the offering of the Series [&#9679;] Preferred Shares to redeem the outstanding shares of its Series [&#9679;] Preferred Shares. Amounts in excess of the redemption amount for all outstanding Series [&#9679;] Preferred may be used to redeem or repurchase other existing series of preferred shares of the Fund, in whole or in part, in accordance with the terms of any such series of preferred stock or for investment purposes consistent with the investment objectives of the Fund.] OR [The Fund does not expect to use the proceeds of the offering to redeem or repurchase existing series of preferred stock.]</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Investment Adviser anticipates that any investment of the proceeds will be made in accordance with the Fund&#8217;s investment objectives and policies as appropriate investment opportunities are identified, which is expected to be substantially completed within approximately three months of the issue date; however, the identification of appropriate investment opportunities pursuant to the Fund&#8217;s investment style or changes in market conditions may cause the investment period to extend as long as six months from the issue date. This could occur because the Investment Adviser follows a value-oriented investment strategy; therefore, market conditions could result in the Investment Adviser delaying the investment of proceeds if it believes the margin of risk in making additional investments is not favorable in light of its value-oriented investment strategy. See &#8220;Investment Objectives and Policies&#8212;Investment Methodology of the Fund&#8221; in the accompanying Prospectus.</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pending such redemption and/or investment, the proceeds of the offering of the Series [&#9679;] Preferred Shares will be held in high quality short term debt securities and similar instruments. See &#8220;Use of Proceeds.&#8221;</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-Call Period/Redemption</b></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[The Series [&#9679;] Preferred Shares generally may not be called for redemption at the option of the Fund prior to [&#9679;]. The Fund reserves the right, however, to redeem the Series [&#9679;] Preferred Shares at any time if it is necessary, in the judgment of the Board of Directors, to maintain its status as a regulated investment company under Subchapter M of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;). The Fund also may be required under certain circumstances to redeem Series [&#9679;] Preferred Shares, before or after [&#9679;], in order to meet certain regulatory or rating agency asset coverage requirements.</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commencing [&#9679;], and thereafter, to the extent permitted by the 1940 Act and Maryland law, the Fund may at any time, upon notice of redemption, redeem the Series [&#9679;] Preferred Shares in whole or in part at the liquidation preference per share plus accumulated unpaid dividends and distributions (whether or not earned or declared) through the date of redemption.]</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock Exchange Listing</b></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Application [will be] [has been] made to list the Series [&#9679;] Preferred Shares on the [&#9679;]. Prior to the offering, there has been no public market for Series [&#9679;] Preferred Shares. If the application is approved, it is anticipated that trading on the [&#9679;] will begin within [&#9679;] days from the date of this Prospectus Supplement. Before the Series [&#9679;] Preferred Shares are listed on the [&#9679;], the underwriters may, but are not obligated to, make a market in Series [&#9679;] Preferred Shares. Consequently, it is anticipated that, prior to the commencement of trading on the [&#9679;], an investment in Series [&#9679;] Preferred Shares will be illiquid.</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Taxation</b></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund expects that distributions made on the Series [&#9679;] Preferred Shares will consist of (i) long term capital gain (gain from the sale of a capital asset held longer than one year), (ii) qualified dividend income (dividend income from certain domestic and foreign corporations, provided certain holding period and other requirements are met by both the Fund and the stockholder), and (iii) investment company taxable income (other than qualified dividend income, including interest income, short term capital gain and income from certain hedging and interest rate transactions). Distributions paid to investors by the Fund from its investment company taxable income which includes the excess of net short term capital gains</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 123 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">U-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; width: 27%">&#160;</td>
    <td style="text-align: justify; width: 3%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> over net long term capital losses (together referred to hereinafter as &#8220;ordinary income dividends&#8221;) are generally taxable to investors as ordinary income to the extent of the earnings and profits of the Fund. Such distributions (if reported by the Fund) may, however, qualify (provided holding periods and other requirements are met) (i) for the dividends received deduction in the case of corporate stockholders to the extent that the income of the Fund consists of dividend income from U.S. corporations, and (ii) as qualified dividend income generally eligible for the reduced maximum federal tax rate to individuals applicable to net long term capital gains. Distributions made to investors from an excess of net long term capital gains over net short term capital losses (&#8220;capital gain dividends&#8221;), including capital gain dividends credited to investors but retained by the Fund, are taxable to investors as long term capital gains if they have been properly designated by the Fund, regardless of the length of time investors have owned shares of stock of the Fund. The maximum federal income tax rate on net long term capital gain of individuals is generally either 15% or 20% depending on whether an individual&#8217;s income exceeds certain threshold amounts. In addition, certain U.S. stockholders who are individuals, estates or trusts and whose income exceeds certain thresholds will be required to pay a 3.8% Medicare surcharge on their net investment income. We cannot assure you, however, as to what percentage of future distributions made on the Series [&#9679;] Preferred Shares will consist of long term capital gain and qualified dividend income. See &#8220;<i>U.S. Federal Income Tax Consequences of the Offering.</i>&#8221;</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; width: 27%">&#160;</td>
    <td style="text-align: justify; width: 3%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 70%">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ERISA</b></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>See &#8220;Certain Employee Benefit Plan and IRA Considerations.&#8221;</i></span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dividend Paying Agent</b></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;].</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="u_003"></span>DESCRIPTION OF THE SERIES [&#9679;] PREFERRED SHARES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following is a brief description of the terms of the Series [&#9679;] Preferred Shares. This is intended to be a summary of the material provisions of the Fund&#8217;s Articles Supplementary designating and fixing the rights of the Series [&#9679;] Preferred Shares (the &#8220;Articles&#8221;). Since this disclosure is only a summary, you should refer to the Articles for a complete description of the obligations of the Fund and your rights. The Articles are attached as an exhibit to post-effective amendment number [&#9679;] to the Fund&#8217;s registration statement. Copies may be obtained as described under &#8220;Additional Information&#8221; in the accompanying Prospectus. Any capitalized terms in this section and the &#8220;Special Characteristics and Risks of the Offering and the Series [&#9679;] Preferred Shares&#8221; section of this Prospectus Supplement that are not defined have the meaning assigned to them in the Articles.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund&#8217;s charter (the &#8220;Charter&#8221;) authorizes its Board of Directors to reclassify any authorized but unissued shares of the Fund&#8217;s capital stock, $0.001 par value per share, without the approval of common stockholders. The Articles authorize the issuance of up to [&#9679;] Series [&#9679;] Preferred Shares. All Series [&#9679;] Preferred Shares will have a liquidation preference of $[&#9679;] per share. Holders of Series [&#9679;] Preferred Shares shall be entitled to receive cumulative cash dividends and distributions at the rate of [&#9679;]% per annum (computed on the basis of a 360-day year consisting of twelve 30-day months) of the $[&#9679;] per-share liquidation preference on the Series [&#9679;] Preferred Shares. Dividends and distributions on Series [&#9679;] Preferred Shares will accumulate from the date of their original issue, which is [&#9679;].</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Series [&#9679;] Preferred Shares, when issued by the Fund and paid for pursuant to the terms of this Prospectus Supplement and the accompanying Prospectus, will be fully paid and non-assessable and will have no preemptive, exchange or conversion rights. Any Series [&#9679;] Preferred Shares purchased or redeemed by the Fund will be reclassified as authorized and unissued shares of preferred stock of the Fund without further designation as to class or series. The Board of Directors may by resolution classify or reclassify any authorized and unissued Series [&#9679;] Preferred Shares from time to time by setting or changing the preferences, conversion or other rights, voting powers, restrictions, limitations as to dividends and distributions, qualifications or terms or conditions of redemption of such shares. The affirmative vote of the holders of a majority, as defined in the 1940 Act, of the outstanding Series [&#9679;] Preferred Shares (or shares of any other series of the Fund&#8217;s preferred stock), voting separately from the holders of any other series of the Fund&#8217;s preferred stock (to the extent its rights are affected differently), will be required with respect to any matter that materially and adversely affects the rights, preferences or powers of that series in a manner different from that of other series or classes of the Fund&#8217;s capital stock. The affirmative vote of the holders of a</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 124 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">U-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">majority, as defined in the 1940 Act, of the outstanding shares of the Fund&#8217;s preferred stock, voting together as a separate class (including the Series [&#9679;] Preferred Shares), will be required to amend, alter or repeal the provisions of the Fund&#8217;s Charter or bylaws, whether by merger, consolidation or otherwise, if such amendment, alteration or repeal would affect adversely the rights, preferences or powers expressly set forth in any articles supplementary of the Fund&#8217;s preferred stock, including the Articles, unless, in each case, the Fund obtains written confirmation from any rating agency then rating the Series [&#9679;] Preferred Shares at the Fund&#8217;s request that such amendment, alteration or repeal would not impair the rating then assigned by such rating agency to the Series [&#9679;] Preferred Shares, in which case the vote or consent of the holders of the Series [&#9679;] Preferred Shares is not required. No matter shall be deemed to adversely affect any rights, preferences or powers of the Series [&#9679;] Preferred Shares unless such matter (i) adversely alters or abolishes any preferential right of such series; (ii) creates, adversely alters or abolishes any right in respect of redemption of such series; or (iii) creates or adversely alters (other than to abolish) any restriction on transfer applicable to such series. An increase in the number of authorized shares of preferred stock of the Fund pursuant to the Charter or the issuance of additional shares of any series of preferred stock of the Fund (including the Series [&#9679;] Preferred Shares) pursuant to the Charter shall not in and of itself be considered to adversely affect the contract rights of the holders of the Series [&#9679;] Preferred Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The disclosure set forth in this Description of the Series [&#9679;] Preferred Shares and under the heading &#8220;Special Characteristics and Risks of the Offering and the Series [&#9679;] Preferred Shares&#8221; is intended to be a summary of the material provisions of the Series [&#9679;] Preferred Shares. Since this Description of the Series [&#9679;] Preferred Shares is only a summary, you should refer to the Articles for a complete description of the obligations of the Fund and your rights. The disclosure set forth in this Description of the Series [&#9679;] Preferred Shares and under the heading &#8220;Special Characteristics and Risks of the Offering and the Series [&#9679;] Preferred Shares&#8221; supplements the description of the preferred stock set forth under the caption &#8220;Description of the Capital Stock &#8211; Preferred Stock&#8221; in the accompanying Prospectus, and in the event that any provision described in the disclosure set forth in this Description of the Series [&#9679;] Preferred Shares and under the heading &#8220;Special Characteristics and Risks of the Offering and the Series [&#9679;] Preferred Shares&#8221; is inconsistent with any description contained in the accompanying Prospectus, the disclosure set forth in this Description of the Series [&#9679;] Preferred Shares and under the heading &#8220;Special Characteristics and Risks of the Offering and the Series [&#9679;] Preferred Shares&#8221; will apply and supersede the description in the accompanying Prospectus.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="u_004"></span>TERMS OF THE SERIES [&#9679;] PREFERRED SHARES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dividends and Distributions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the twelve month period commencing on the date shares of the Series [&#9679;] Preferred are first issued (the &#8220;Initial Dividend Period&#8221;), holders of Series [&#9679;] Preferred will be entitled to receive, when, as and if authorized by, or under authority granted by, the Board of Directors, out of funds legally made available therefor, cumulative cash dividends and distributions at the rate of [&#9679;]% per annum (computed on the basis of a 360-day year consisting of twelve 30-day months) of the $[&#9679;] per share liquidation preference on the Series [&#9679;] Preferred. After the Initial Dividend Period, holders of Series [&#9679;] Preferred will be entitled to receive, when, as and if authorized by, or under authority granted by, the Board of Directors, out of funds legally made available therefor, cumulative cash dividends and distributions at the rate of [&#9679;]% per annum (computed on the basis of a 360-day year consisting of twelve 30-day months) of the $[&#9679;] per share liquidation preference on the Series [&#9679;] Preferred for all future dividend periods, when, as and if such dividends are declared.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends in both the Initial Dividend Period and thereafter will in each case be payable quarterly on [March&#160;26, June&#160;26, September&#160;26 and December&#160;26] in each year (each a &#8220;Dividend Payment Date&#8221;) commencing on [&#9679;] 26, [2023] (or, if any such day is not a business day, then on the next succeeding business day) to holders of record of Series [&#9679;] Preferred as they appear on the stock register of the Fund at the close of business on the fifth preceding Business Day. Dividends and distributions on Series [&#9679;] Preferred shall accumulate from the date on which the Series of [&#9679;] Preferred are originally issued. Each period beginning on and including a Dividend Payment Date (or the date of original issue, in the case of the first dividend period after issuance of the Series [&#9679;] Preferred) and ending on but excluding the next succeeding Dividend Payment Date is referred to herein as a &#8220;Dividend Period.&#8221; Dividends and distributions on account of arrears for any past Dividend Period or in connection with the redemption of Series [&#9679;] Preferred may be declared and paid at any time, without reference to any Dividend Payment Date, to holders of record on such date as shall be fixed by the Board of Directors that is not more than 30 days before such payment date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 125 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">U-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No full dividends or distributions will be declared or paid on Series [&#9679;] Preferred for any Dividend Period or part thereof unless full cumulative dividends and distributions due through the most recent Dividend Payment Dates therefor for all outstanding shares of any series of preferred stock of the Fund ranking on a parity with the Series [&#9679;] Preferred as to the payment of dividends and distributions have been or contemporaneously are declared and paid through the most recent Dividend Payment Dates therefor. If full cumulative dividends and distributions due have not been paid on all outstanding shares of the Fund&#8217;s parity preferred stock, any dividends and distributions being paid on such shares of preferred stock (including the Series [&#9679;] Preferred) will be paid as nearly pro rata as possible in proportion to the respective amounts of dividends and distributions accumulated but unpaid on each such series of preferred stock on the relevant Dividend Payment Date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Voting Rights</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Articles provide that, except as otherwise provided in the Fund&#8217;s governing documents (including the Articles) or a resolution of the Board of Directors, or as required by applicable law, holders of Series [&#9679;] Preferred Shares shall have no power to vote on any matter except matters submitted to a vote of the Fund&#8217;s common stock. In any matter submitted to a vote of the holders of the common stock, each holder of Series [&#9679;] Preferred Shares shall be entitled to one vote for each Series [&#9679;] Preferred Share held and the holders of all outstanding shares of preferred stock, including Series [&#9679;] Preferred Shares, and the shares of common stock shall vote together as a single class; provided, however, that at any meeting of the stockholders of the Fund held for the election of directors, the holders of the outstanding shares of preferred stock, including the Series [&#9679;] Preferred Shares, shall be entitled, as a class, to the exclusion of the holders of all other classes of capital stock of the Fund, to elect a number of the Fund&#8217;s directors, such that following the election of directors at the meeting of the stockholders, the Board of Directors will contain two directors elected by the holders of the outstanding shares of preferred stock, including the Series [&#9679;] Preferred Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During any period in which any one or more of the conditions described below shall exist (such period being referred to herein as a &#8220;Voting Period&#8221;), the number of directors constituting the Board of Directors shall be automatically increased by the smallest number of additional directors that, when added to the two directors elected exclusively by the holders of outstanding shares of preferred stock, would constitute a majority of the Board of Directors as so increased by such smallest number, and the holders of outstanding shares of preferred stock, including the Series [&#9679;] Preferred Shares, voting together as a separate class (to the exclusion of the holders of all other classes of capital stock of the Fund) shall be entitled to elect such smallest number of additional directors and the two directors the holders of shares of preferred stock, including the Series [&#9679;] Preferred Shares, are otherwise entitled to elect. The Fund and the Board of Directors shall take all necessary actions, including amending the Fund&#8217;s bylaws, to effect an increase in the number of directors as described in the preceding sentence. A Voting Period shall commence:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.5in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if at any time accumulated dividends and distributions (whether or not earned or declared, and whether or not funds are then legally available in an amount sufficient therefor) on the outstanding Series [&#9679;] Preferred Shares equal to at least two full years&#8217; dividends and distributions shall be due and unpaid and sufficient cash or specified securities shall not have been deposited with Computershare Trust Company, N.A., and its successors or any other dividend-disbursing agent appointed by the Fund, for the payment of such accumulated dividends and distributions; or</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if at any time holders of any other shares of preferred stock are entitled to elect a majority of the Directors of the Fund under the 1940 Act or articles supplementary classifying and designating such shares.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[Holder Put Option]</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[To be described if such rights will be provided.]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 126 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">U-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Calling of Series [&#9679;] Preferred</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior to [&#9679;], 20[&#9679;] the shares of Series [&#9679;] Preferred are not subject to optional redemption by the Fund unless the redemption is necessary, in the judgment of the Board of Directors, to maintain the Fund&#8217;s status as a regulated investment company under Subchapter M of the Internal Revenue Code of 1986, as amended. Commencing on [&#9679;], 20[&#9679;] and thereafter, to the extent permitted by the 1940 Act and Maryland law, the Fund may at any time upon notice redeem the Series [&#9679;] Preferred in whole or in part at a price equal to the liquidation preference per share plus accumulated but unpaid dividends through the date of redemption.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock Exchange Listing</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An application will be made to list the Series [&#9679;] Preferred on the [NYSE]. The Series [&#9679;] Preferred is expected to commence trading on the [NYSE] within thirty days of the date of issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="u_005"></span>DESCRIPTION OF THE RIGHTS OFFERING</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Terms of the Rights Offering</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund is issuing to common shareholders of record as of the close of business on [&#9679;], 2023 (&#8220;the Record Date,&#8221; and such shareholders, the &#8220;Record Date Shareholders&#8221;) Rights to subscribe for common shares and preferred shares. Each Record Date Shareholder is being issued [one] transferable Right for each common share owned on the Record Date. The Rights entitle the holders to acquire for $[&#9679;] in cash (the &#8220;Subscription Price&#8221;) one common share and one preferred share for every [&#9679;] Rights. Fractional shares will not be issued upon the exercise of the Rights and Rights may be exercised only for an equal number of common shares and preferred shares and not for only common shares or preferred shares or an unequal number of common shares and preferred shares. Rights may be exercised at any time during the period which commences on [&#9679;], 2023, and ends at 5:00 PM Eastern Time on [&#9679;], 2023 (the &#8220;Subscription Period&#8221;). The right to acquire one common share and one preferred share for every [&#9679;] Rights held during the Subscription Period (or any extension thereof) at the Subscription Price will be referred to in the remainder of this prospectus supplement as the &#8220;Subscription.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rights may be evidenced by subscription certificates or may be uncertificated and evidenced by other appropriate documentation (&#8220;Subscription Certificates&#8221;). The number of Rights issued to each holder will be stated on the Subscription Certificate delivered to the holder. The method by which Rights may be exercised and shares paid for is set forth below in &#8220;Method of Exercise of Rights&#8221; and &#8220;Payment for Shares.&#8221; A Rights holder will have no right to rescind a purchase after [&#9679;] (the &#8220;Rights Agent&#8221;) has received payment. See &#8220;Payment for Shares&#8221; below. It is anticipated that the preferred shares issued pursuant to an exercise of Rights will be listed on the NYSE.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rights holders who are Record Date Shareholders are entitled to subscribe for additional common shares and preferred shares at the same Subscription Price pursuant to the over-subscription privilege, subject to certain limitations and subject to allotment. See &#8220;Over-Subscription Privilege&#8221; below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For purposes of determining the maximum number of shares a Record Date Shareholder may acquire pursuant to the offer, broker-dealers, trust companies, banks or others whose shares are held of record by Cede &amp; Co. (&#8220;Cede&#8221;), as nominee for the Depository Trust Company or by any other depository or nominee will be deemed to be the holders of the Rights that are held by Cede or such other depository or nominee on their behalf.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Rights are transferable until [5:00 PM] Eastern Time [&#9679;], 2023 (the &#8220;Expiration Date&#8221;) and are expected to be admitted for trading on the [NYSE]. Assuming a market exists for the Rights, the Rights may be purchased and sold through usual brokerage channels and sold through the Rights Agent. Although no assurance can be given that a market for the Rights will develop, trading in the Rights on the [NYSE] is expected to begin three business days before the Record Date and may be conducted until the close of trading on the last [NYSE] trading day prior to the Expiration Date. Trading of the Rights on the [NYSE] is expected to be conducted on a when-issued basis until and including the date on which the Subscription Certificates are mailed to Record Date Shareholders and thereafter is expected to be conducted on a regular way basis until and including the last [NYSE] trading day prior to the Expiration Date. The method by which Rights may be transferred is set forth below under &#8220;Method of Transferring Rights.&#8221; The common shares are expected to begin trading ex-Rights two business days prior to the Record Date as determined and announced by the [NYSE].</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 127 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">U-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nominees who hold the Fund&#8217;s common shares for the account of others, such as banks, broker-dealers, trustees or depositories for securities, should notify the respective beneficial owners of such shares as soon as possible to ascertain such beneficial owners&#8217; intentions and to obtain instructions with respect to the Rights. If the beneficial owner so instructs, the nominee should complete the Subscription Certificate and submit it to the Rights Agent with proper payment. In addition, beneficial owners of the common shares or Rights held through such a nominee should contact the nominee and request the nominee to effect transactions in accordance with such beneficial owner&#8217;s instructions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Purpose of the Offer</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund&#8217;s Board of Directors has determined that it would be in the best interests of the Fund and the shareholders to increase the assets of the Fund available for investment, thereby permitting the Fund to be in a better position to more fully take advantage of investment opportunities that may arise without having to reduce existing Fund holdings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Offer seeks to reward existing shareholders by giving them the right to purchase additional common shares at a price that may be below market and/or net asset value and newly issued preferred shares at a price that may be below the market value without incurring any commission charge. The distribution to shareholders of transferable Rights, which themselves may have intrinsic value, may also afford non-subscribing shareholders the potential of receiving a cash payment upon sale of such Rights, receipt of which may be viewed as partial compensation for the possible dilution of their interests in the Fund.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Important Dates to Remember</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please note that the dates in the table below may change if the rights offering is extended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 60%; border-collapse: collapse; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top; width: 29%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EVENT</b></span></td>
    <td style="padding-bottom: 1pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top; width: 29%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DATE</b></span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Record Date</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;], 2023</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription Period</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;], 2023 through [&#9679;], 2023</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expiration Date*</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;], 2023</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment for Guarantees of Delivery Due*</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;], 2023</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance Date</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;], 2023</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Confirmation Date</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;], 2023</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A shareholder exercising Rights must deliver by 5:00 PM Eastern Time on [&#9679;], 2023 either (a) a Subscription Certificate and payment for shares or (b) a notice of guaranteed delivery and payment for shares.</span></td> </tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless the offer is extended to a date no later than [&#9679;], 2023.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Over-Subscription Privilege</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rights holders who are Record Date Shareholders and who fully exercise their Rights are entitled to subscribe for additional common shares and preferred shares at the same Subscription Price pursuant to the over-subscription privilege, subject to certain limitations and subject to allotment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Record Date Shareholders who are fully exercising their Rights during the subscription period should indicate, on the Subscription Certificate which they submit with respect to the exercise of the Rights issued to them, how many common shares and preferred shares they are willing to acquire pursuant to the over-subscription privilege. A holder of Rights may only submit an over-subscription request for an equal number of common shares and preferred shares and may not request to purchase only common shares or preferred shares or an unequal number of common shares and preferred shares. <i>Rights acquired in the secondary market may not participate in the over-subscription privilege.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Over-subscription requests will be honored only to the extent fewer than all of the Rights are exercised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 128 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">U-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unsubscribed common shares and preferred shares will be allocated pro-rata among those eligible Record Date Shareholders who over-subscribe based on the number of the Fund&#8217;s common shares owned on the Record Date. The allocation process may involve a series of allocations in order to assure that the total number of common shares and preferred shares available for over-subscriptions or, if less, the total number of common shares and preferred shares sufficient to fill all over-subscriptions, is allocated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Banks, broker-dealers, trustees and other nominee holders of rights will be required to certify to the Rights Agent, before any over-subscription privilege may be exercised with respect to any particular beneficial owner, as to the aggregate number of Rights exercised during the Subscription Period and the number of common shares and preferred shares subscribed for pursuant to the over-subscription privilege by such beneficial owner and that such beneficial owner&#8217;s Subscription was exercised in full. Nominee holder over-subscription forms and beneficial owner certification forms will be distributed to banks, broker-dealers, trustees and other nominee holders of rights with the Subscription Certificates. Nominees should also notify holders purchasing Rights in the secondary market that such Rights may not participate in the over-subscription privilege.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund will not offer or sell any common shares and preferred shares that are not subscribed for during the Subscription Period or pursuant to the over-subscription privilege.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[In the event that the Fund&#8217;s per share net asset value at the end of the Subscription Period is greater than the subscription price (i.e., Common Shares will be issued at a price below the Fund&#8217;s then current net asset value), the over-subscription shares issued by the Fund will not result in the ratio of the Rights offering exceeding one new share for each three Rights held.]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sales by Rights Agent</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders of Rights who are unable or do not wish to exercise any or all of their Rights may instruct the Rights Agent to sell any unexercised Rights. The Subscription Certificates representing the Rights to be sold by the Rights Agent must be received on or before [&#9679;], 2023. Upon the timely receipt of the appropriate instructions to sell Rights, the Rights Agent will use its best efforts to complete the sale and will remit the proceeds of sale, net of any commissions, to the holders. The Rights Agent will also attempt to sell any Rights attributable to shareholders of record whose addresses are outside the United States, or who have an APO or FPO address. If the Rights can be sold, sales of the Rights will be deemed to have been effected at the weighted average price received by the Rights Agent on the day such Rights are sold, less any applicable brokerage commissions, taxes and other expenses. The selling Rights holder will pay all brokerage commissions incurred by the Rights Agent. These sales may be effected by the Rights Agent. [&#9679;] (the &#8220;Dealer Manager&#8221;), a registered broker-dealer may also act on behalf of its clients to purchase or sell Rights in the open market and be compensated for its services at a commission of up to $[&#9679;] per Right, provided that, if the Rights trade at a value of $[&#9679;] or less at the time of such sale, then no commission will be charged. The Rights Agent will automatically attempt to sell any unexercised Rights that remain unclaimed as a result of Subscription Certificates being returned by the postal authorities as undeliverable as of the fourth business day prior to the Expiration Date. These sales will be made net of commissions, taxes and any other expenses paid on behalf of the nonclaiming holders of Rights. Proceeds from those sales will be held by [&#9679;], in its capacity as the Fund&#8217;s transfer agent, for the account of the nonclaiming holder of rights until the proceeds are either claimed or escheated. There can be no assurance that the Rights Agent will be able to complete the sale of any of these Rights and neither the Fund nor the Rights Agent has guaranteed any minimum sales price for the Rights. All of these Rights will be sold at the market price, if any, through an exchange or market trading the Rights. If the Rights can be sold, sales of these Rights will be deemed to have been effected at the weighted average price received by the Rights Agent on the day such Rights are sold, less any applicable brokerage commissions, taxes and other expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders are urged to obtain a recent trading price for the Rights on the [NYSE] from their broker, bank, financial advisor or the financial press.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 129 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">U-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Method of Transferring Rights</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Rights evidenced by a single Subscription Certificate may be transferred in whole by endorsing the Subscription Certificate for transfer in accordance with the accompanying instructions. A portion of the Rights evidenced by a single Subscription Certificate (but not fractional Rights) may be transferred by delivering to the Rights Agent a Subscription Certificate properly endorsed for transfer, with instructions to register the portion of the Rights evidenced thereby in the name of the transferee (and to issue a new Subscription Certificate to the transferee evidencing the transferred Rights). In this event, a new Subscription Certificate evidencing the balance of the Rights will be issued to the Rights holder or, if the Rights holder so instructs, to an additional transferee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders wishing to transfer all or a portion of their Rights (but not fractional Rights) should promptly transfer such Rights to ensure that: (i) the transfer instructions will be received and processed by the Rights Agent, (ii) a new Subscription Certificate will be issued and transmitted to the transferee or transferees with respect to transferred Rights, and to the transferor with respect to retained Rights, if any, and (iii) the Rights evidenced by the new Subscription Certificates may be exercised or sold by the recipients thereof prior to the Expiration Date. Neither the Fund nor the Rights Agent will have any liability to a transferee or transferor of Rights if Subscription Certificates are not received in time for exercise or sale prior to the Expiration Date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except for the fees charged by the Rights Agent (which will be paid by the Fund as described below), all commissions, fees and other expenses (including brokerage commissions and transfer taxes) incurred in connection with the purchase, sale or exercise of Rights will be for the account of the transferor of the Rights, and none of these commissions, fees or expenses will be borne by the Fund or the Rights Agent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund anticipates that the Rights will be eligible for transfer through, and that the exercise of the Subscription may be effected through, the facilities of DTC (Rights exercised through DTC are referred to as &#8220;DTC Exercised Rights&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Rights Agent</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Rights Agent is [&#9679;]. The Rights Agent will receive from the Fund an amount estimated to be $[&#9679;], comprised of the fee for its services and the reimbursement for certain expenses related to the rights offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">INQUIRIES BY ALL HOLDERS OF RIGHTS SHOULD BE DIRECTED TO: [THE INFORMATION AGENT, [&#9679;].; HOLDERS MAY ALSO CONSULT THEIR BROKERS OR NOMINEES.]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Method of Exercise of Rights</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rights may be exercised by completing and signing the reverse side of the Subscription Certificate and mailing it in the envelope provided, or otherwise delivering the completed and signed Subscription Certificate to the Rights Agent, together with payment of the Subscription Price as described below under &#8220;Payment for Shares.&#8221; Rights may also be exercised through a Rights holder&#8217;s broker, who may charge the Rights holder a servicing fee in connection with such exercise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Completed Subscription Certificates must be received by the Rights Agent prior to [5:00 PM] Eastern Time, on the Expiration Date (unless payment is effected by means of a notice of guaranteed delivery as described below under &#8220;Payment for Shares&#8221;). The Subscription Certificate and payment should be delivered to the Rights Agent at the following address:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If By First Class Mail:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Gabelli Equity Trust Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 130 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">U-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If By Overnight Courier:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Gabelli Equity Trust Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment for Shares</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders of Rights who acquire common shares and preferred shares in the Subscription may choose between the following methods of payment:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A subscription will be accepted by the Rights Agent if, prior to [5:00 PM] Eastern Time, on the Expiration Date, the Rights Agent has received a written notice of guaranteed delivery from a bank, a trust company, or a NYSE member, guaranteeing delivery of (i) payment of the full Subscription Price for the common shares and preferred shares subscribed for in the Subscription and, if eligible, for any additional common shares and preferred shares subscribed for pursuant to the over-subscription privilege, and (ii) a properly completed and executed Subscription Certificate. The Rights Agent will not honor a notice of guaranteed delivery if a properly completed and executed Subscription Certificate and full payment is not received by the Rights Agent by the close of business on the third business day after the Expiration Date. The notice of guaranteed delivery may be delivered to the Rights Agent in the same manner as Subscription Certificates at the addresses set forth above, or may be transmitted to the Rights Agent by facsimile transmission (fax number [&#9679;]); telephone number to confirm receipt [&#9679;].</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alternatively, a holder of Rights can send the Subscription Certificate, together with payment in the form of a check (which must include the name of the shareholder) to the Rights Agent, based on the Subscription Price of $[&#9679;], which represents $[&#9679;] per common share and $[&#9679;] per preferred share. To be accepted, the payment, together with the executed Subscription Certificate, must be received by the Rights Agent at the addresses noted above prior to 5:00 PM Eastern Time on the Expiration Date. The Rights Agent will deposit all share purchase checks received by it prior to the final due date into a segregated account, in each case pending proration and distribution of common shares and preferred shares. The Rights Agent will not accept cash as a means of payment for common shares and preferred shares.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXCEPT AS OTHERWISE SET FORTH BELOW, A PAYMENT PURSUANT TO THIS METHOD MUST BE IN UNITED STATES DOLLARS BY CHECK (WHICH MUST INCLUDE THE NAME OF THE SHAREHOLDER) DRAWN ON A BANK LOCATED IN THE CONTINENTAL UNITED STATES [(OR FOR CANADIAN RESIDENTS, A BANK LOCATED IN CANADA)], MUST BE PAYABLE TO THE GABELLI EQUITY TRUST INC. AND MUST ACCOMPANY AN EXECUTED SUBSCRIPTION CERTIFICATE TO BE ACCEPTED.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If a holder of Rights who acquires common shares and preferred shares pursuant to the Subscription makes payment of an insufficient amount, the Fund reserves the right to take any or all of the following actions: (i) reallocate such subscribed and unpaid-for common shares and preferred shares to Record Date Shareholders exercising the over-subscription privilege who did not receive the full over-subscription requested; (ii) apply any payment actually received by it toward the purchase of the greatest whole number of common shares and preferred shares which could be acquired by such holder upon exercise of the Subscription or over-subscription privilege; and (iii) (iv) exercise any and all other rights or remedies to which it may be entitled, including, without limitation, the right to set off against payments actually received by it with respect to such subscribed common shares and preferred shares (in other words, retain such payments) and to enforce the exercising Rights holder&#8217;s relevant payment obligation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any payment required from a holder of Rights must be received by the Rights Agent prior to [5:00 PM] Eastern Time on the Expiration Date, or if the Rights holder has elected to make payment by means of a notice of guaranteed delivery, by the close of business on the third business day after the Expiration Date. Whichever of the two methods of payment described above is used, issuance and delivery of certificates for the common shares and preferred shares purchased are subject to collection of checks, as well as actual payment pursuant to any notice of guaranteed delivery.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 131 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">U-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within [&#9679;] business days following the Expiration Date (the &#8220;Confirmation Date&#8221;), a confirmation will be sent by the Rights Agent to each holder of Rights (or, if the common shares are held by Cede or any other depository or nominee, to Cede or such other depository or nominee), showing (i) the number of common shares and preferred shares acquired pursuant to the Subscription, (ii) the number of common shares and preferred shares, if any, acquired pursuant to the over-subscription privilege, and (iii) the per common share and preferred share and total purchase price for the common shares and preferred shares. Any payment required from a holder of Rights must be received by the Rights Agent on the Expiration Date, or if the Rights holder has elected to make payment by means of a notice of guaranteed delivery, on the third business day after the Expiration Date. Any excess payment to be refunded by the Fund to a holder of Rights, or to be paid to a holder of Rights as a result of sales of Rights on his behalf by the Rights Agent, will be mailed by the Rights Agent to the holder within [&#9679;] business days after the Expiration Date. If any Rights holder exercises its right to acquire common shares and preferred shares pursuant to the over-subscription privilege, any excess payment which would otherwise be refunded to the Rights holder will be applied by the Fund toward payment for common shares and preferred shares acquired pursuant to exercise of the over-subscription privilege.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A Rights holder will have no right to rescind a purchase after the Rights Agent has received payment either by means of a notice of guaranteed delivery or a check.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders, such as broker-dealers, trustees or depositories for securities, who hold common shares for the account of others, should notify the respective beneficial owners of the common shares as soon as possible to ascertain such beneficial owners&#8217; intentions and to obtain instructions with respect to the Rights. If the beneficial owner so instructs, the record holder of the Rights should complete Subscription Certificates and submit them to the Rights Agent with the proper payment. In addition, beneficial owners of common shares or Rights held through such a holder should contact the holder and request the holder to effect transactions in accordance with the beneficial owner&#8217;s instructions. Banks, broker-dealers, trustees and other nominee holders that hold common shares of the Fund for the accounts of others are advised to notify those persons that purchase Rights in the secondary market that such Rights may not participate in the over-subscription privilege.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The instructions accompanying the Subscription Certificates should be read carefully and followed in detail. <b>DO NOT SEND SUBSCRIPTION CERTIFICATES TO THE FUND.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The method of delivery of Subscription Certificates and payment of the subscription price to the Rights Agent will be at the election and risk of the Rights holders, but if sent by mail it is recommended that the certificates and payments be sent by registered mail, properly insured, with return receipt requested, and that a sufficient number of days be allowed to ensure delivery to the Rights Agent and clearance of payment prior to [5:00 PM] Eastern Time, on the Expiration Date. Because uncertified personal checks may take at least five business days to clear, you are strongly urged to pay, or arrange for payment, by means of a certified or cashier&#8217;s check.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All questions concerning the timeliness, validity, form and eligibility of any exercise of Rights will be determined by the Fund, whose determinations will be final and binding. The Fund in its sole discretion may waive any defect or irregularity, or permit a defect or irregularity to be corrected within such time as it may determine, or reject the purported exercise of any Right. Subscriptions will not be deemed to have been received or accepted until all irregularities have been waived or cured within such time as the Fund determines in its sole discretion. Neither the Fund nor the Rights Agent will be under any duty to give notification of any defect or irregularity in connection with the submission of Subscription Certificates or incur any liability for failure to give such notification.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Foreign Restrictions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offering documents, including Subscription Certificates, will not be mailed to Record Date Shareholders whose addresses are outside the United States (for these purposes, the United States includes the District of Columbia and the territories and possessions of the United States) (the &#8220;Foreign Shareholders&#8221;) if such mailing cannot be made into the non-U.S. jurisdiction without additional registration and incurring other expense that the Board has determined is not in the best interest of the Fund and its shareholders. In such cases, unless determined to be not in the best interest of the Fund and its shareholders in accordance with the previous sentence, the Rights Agent will send a letter via regular mail to Foreign Shareholders who own Common Shares directly (&#8220;Direct Foreign Shareholders&#8221;), as opposed to in &#8220;street name&#8221; with a broker or other financial intermediary, to notify them of the</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 132 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">U-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rights offering. Direct Foreign Shareholders who wish to exercise their Rights should contact the Fund, as described above under &#8220;Inquiries,&#8221; to facilitate the exercise of such Rights and for instructions or any other special requirements that may apply in order for such Direct Foreign Shareholder to exercise its Rights. Direct Foreign Shareholders who wish to sell their Rights should contact the Rights Agent and follow the procedures described above under &#8220;Sales by Rights Agent.&#8221; Direct Foreign Shareholders are encouraged to contact the Fund or the Rights Agent as far in advance of the Expiration Date as possible to ensure adequate time for their Rights to be exercised or sold. Foreign Shareholders who own common shares in &#8220;street name&#8221; through a broker or other financial intermediary should contact such broker or other financial intermediary with respect to any exercise or sale of Rights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Certain Employee Benefit Plan and IRA Considerations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rights holders that are employee benefit plans subject to limitations imposed by the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), such as employee plans subject to the Employee Retirement Income Security Act of 1974, as amended (&#8220;ERISA&#8221;), Keogh Plans and Individual Retirement Accounts (&#8220;IRA&#8221;) (each a &#8220;Benefit Plan&#8221; and collectively, &#8220;Benefit Plans&#8221;), should be aware that the use of additional contributions of cash outside of the Benefit Plan to exercise Rights may be treated as additional contributions to the Benefit Plan. When taken together with contributions previously made, such deemed additional contributions may be in excess of tax limitations and subject the Rights holder to excise taxes for excess or nondeductible contributions. In the case of Benefit Plans qualified under Section&#160;401(a) of the Code, additional contributions could cause the maximum contribution limitations of Section&#160;415 of the Code or other qualification rules to be violated. Benefit Plans contemplating making additional contributions to exercise Rights should consult with their legal and tax counsel prior to making such contributions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Benefit Plans and other tax exempt entities, including governmental plans, should also be aware that if they borrow to finance their exercise of Rights, they may become subject to the tax on unrelated business taxable income (&#8220;UBTI&#8221;) under Section&#160;511 of the Code. If any portion of an IRA is used as security for a loan, the portion so used may also be treated as distributed to the IRA depositor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A Benefit Plan may also be subject to laws, such as ERISA, that impose certain requirements on the Benefit Plan and on those persons who are fiduciaries with respect to the Benefit Plans. Such requirements may include prudence and diversification requirements and require that investments be made in accordance with the documents governing the Benefit Plan. The exercise of Rights by a fiduciary for a Benefit Plan should be considered in light of such fiduciary requirements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition, ERISA and the Code prohibit certain transactions involving the assets of a Benefit Plan and certain persons (referred to as &#8220;parties in interest&#8221; for purposes of ERISA and &#8220;disqualified persons&#8221; for purposes of the Code) having certain relationships to such Benefit Plans, unless a statutory or administrative exemption is applicable to the transaction. A party in interest or disqualified person who engages in a nonexempt prohibited transaction may be subject to excise taxes and other penalties and liabilities under ERISA and the Code (or with respect to certain Benefits Plans, such as IRAs, a prohibited transaction may cause the Benefit Plan to lose its tax-exempt status). In this regard, the U.S. Department of Labor has issued prohibited transaction class exemptions (&#8220;PTCEs&#8221;) that may apply to the exercise of the Rights and holding of the common shares and preferred shares. These class exemptions include, without limitation, PTCE 84-14 respecting transactions determined by independent qualified professional asset managers, PTCE 90-1 respecting insurance company pooled separate accounts, PTCE 91-38 respecting bank collective investment funds, PTCE 95-60 respecting life insurance company general accounts and PTCE 96-23 respecting transactions determined by in-house asset managers, PTCE 84-24 governing purchases of shares in investment companies) and PTCE 75-1 respecting sales of securities. In addition, Section&#160;408(b)(17) of ERISA and Section&#160;4975(d)(20) of the Code each provides a limited exemption, commonly referred to as the &#8220;service provider exemption,&#8221; from the prohibited transaction provisions of ERISA and Section&#160;4975 of the Code for certain transactions between a Benefit Plan and a person that is a party in interest and/or a disqualified person (other than a fiduciary or an affiliate that, directly or indirectly, has or exercises any discretionary authority or control or renders any investment advice with respect to the assets of any Benefit Plan involved in the transaction) solely by reason of providing services to the Benefit Plan or by relationship to a service provider, provided that the Benefit Plan receives no less, nor pays no more, than adequate consideration. There can be no assurance that all of the conditions of any such exemptions or any other exemption will be satisfied at the time that the Rights are exercised, or thereafter while the common shares and preferred shares are held, if the facts relied upon for utilizing a prohibited transaction exemption change.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 133 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">U-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due to the complexity of these rules and the penalties for noncompliance, fiduciaries of Benefit Plans should consult with their legal and tax counsel regarding the consequences of their exercise of Rights under ERISA, the Code and other similar laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="u_006"></span>USE OF PROCEEDS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund estimates the net proceeds of the Offer to be $[&#9679;], based on the Subscription Price of $[&#9679;], which represents $[&#9679;] per common share and $[&#9679;] per preferred share, and after deduction of the underwriting discounts and commissions, estimated offering expenses payable by the Fund, and assuming all common shares and preferred shares offered are sold.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Investment Adviser anticipates that investment of the proceeds will be made in accordance with the Fund&#8217;s investment objectives and policies as appropriate investment opportunities are identified, which is expected to be substantially completed in approximately three months; however, the identification of appropriate investment opportunities pursuant to the Fund&#8217;s investment objectives and policies or changes in market conditions may cause the investment period to extend as long as six months. This could occur because the Investment Adviser follows a value-oriented investment strategy; therefore, market conditions could result in the Investment Adviser delaying the investment of proceeds if it believes the margin of risk in making additional investments is not favorable in light of its value-oriented investment strategy. See &#8220;Investment Objectives and Policies&#8212;Investment Methodology of the Fund&#8221; in the accompanying Prospectus. Pending such investment, the proceeds will be held in high quality short term debt securities and instruments. The Investment Adviser may also use the proceeds to redeem or repurchase existing series of preferred stock, in whole or in part.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="u_007"></span>CAPITALIZATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth the unaudited capitalization of the Fund as of December&#160;31, 2022 and its adjusted capitalization assuming all of the common shares and preferred shares offered in this Prospectus Supplement had been issued.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>As of<br /> December&#160;31,<br /> 2022</b></td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Actual</b></td>
    <td style="padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>As adjusted</b></td>
    <td style="padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; width: 76%; vertical-align: top">Preferred shares, $0.001 par value per share. (The &#8220;Actual&#8221; column reflects the absence of any outstanding preferred shares as of December 31, 2022; the &#8220;As adjusted&#8221; column assumes the issuance of [&#9679;] preferred shares, $[&#9679;] liquidation preference per share)</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">&#8212;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"> [&#9679;]</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top">Common shares, $0.001 par value per share. (The &#8220;Actual&#8221; column reflects the [&#9679;] shares outstanding as of December 31, 2022; the &#8220;As adjusted&#8221; column assumes the issuance of [&#9679;] shares)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">[&#9679;]</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">[&#9679;]</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Shareholders&#8217; equity applicable to common shares:</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Paid-in surplus*</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">[&#9679;]</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">[&#9679;]</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Accumulated distributions in excess of net investment income</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">([&#9679;]</td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">([&#9679;]</td>
    <td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Accumulated net realized loss on investments, futures contracts, swap contracts, and foreign currency transactions</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">([&#9679;]</td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">([&#9679;]</td>
    <td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Net unrealized appreciation on investments, futures contracts, and foreign currency transactions</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">[&#9679;]</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">[&#9679;]</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Net assets applicable to common shares</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">[&#9679;]</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">[&#9679;]</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top">Liquidation preference of preferred shares</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">[&#9679;]</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">[&#9679;]</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Net assets, plus the liquidation preference of preferred shares</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">[&#9679;]</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">[&#9679;]</td>
    <td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>&#160;</p>

<!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As adjusted paid-in surplus reflects a deduction for the estimated solicitation fees to broker dealers of $[&#9679;] and estimated offering expenses of the common shares and preferred shares of $[&#9679;].</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 134 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">U-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="u_008"></span>ASSET COVERAGE RATIO</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to the 1940 Act, the Fund generally will not be permitted to declare any dividend, or declare any other distribution, upon any common shares, or purchase any such common shares, unless, in every such case, all preferred shares issued by the Fund have at the time of declaration of any such dividend or distribution or at the time of any such purchase an asset coverage of at least 200% (&#8220;1940 Act Asset Coverage Requirement&#8221;) after deducting the amount of such dividend, distribution, or purchase price, as the case may be. The Fund&#8217;s preferred shares are expected to have an initial asset coverage on the date of issuance of approximately [&#9679;]%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition to the 1940 Act Asset Coverage Requirement, the Fund is subject to certain restrictions on investments imposed by guidelines of one or more rating agencies, which have issued ratings for certain of the shares of preferred stock and may issue a rating for the Series [&#9679;] Preferred Shares. [See &#8220;Special Characteristics and Risks of the Series [&#9679;] Preferred Shares&#8212;Risks&#8212;Credit Rating Risk&#8221; in this Prospectus Supplement.]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="u_009"></span>SPECIAL RISKS OF THE OFFERING AND THE SERIES [&#9679;] PREFERRED SHARES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk is inherent in all investing. Therefore, before investing in the common shares and preferred shares you should consider the risks carefully. See &#8220;Risk Factors and Special Considerations&#8221; in the Prospectus and the special risks and considerations set out below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Principal Risks Associated with an Investment in the Preferred Shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Market Price Risk</i>. The market price for the Series [&#9679;] Preferred Shares will be influenced by changes in interest rates, the perceived credit quality of the Series [&#9679;] Preferred Shares and other factors, and may be higher or lower than the liquidation preference of the Series [&#9679;] Preferred Shares. There is currently no market for the Series [&#9679;] Preferred Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidity Risk</i>. Currently, there is no public market for the Series [&#9679;] Preferred Shares. As noted above, an application will be made to list the Series [&#9679;] Preferred Shares on the [&#9679;]. However, during an initial period which is not expected to exceed [&#9679;] days after the date of its issuance, the Series [&#9679;] Preferred Shares will not be listed on any securities exchange. Before the Series [&#9679;] Preferred Shares are listed on the [&#9679;], the underwriters may, but are not obligated to, make a market in the Series [&#9679;] Preferred Shares. No assurances can be provided that listing on any securities exchange or market making by the underwriters will result in the market for Series [&#9679;] Preferred Shares being liquid at any time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Redemption Risk</i>. The Fund may at any time redeem Series [&#9679;] Preferred Shares to the extent necessary to meet regulatory asset coverage requirements or requirements imposed by credit rating agencies. For example, if the value of the Fund&#8217;s investment portfolio declines, thereby reducing the asset coverage for the Series [&#9679;] Preferred Shares, the Fund may be obligated under the terms of the Series [&#9679;] Preferred Shares to redeem some or all of the Series [&#9679;] Preferred Shares. In addition, commencing [&#9679;], the Fund will be able to call the Series [&#9679;] Preferred Shares at the option of the Fund. Investors may not be able to reinvest the proceeds of any redemption in an investment providing the same or a higher dividend rate than that of the Series [&#9679;] Preferred Shares. Although unlikely, precipitous declines in the value of the Fund&#8217;s assets could result in the Fund having insufficient assets to redeem all of the Series [&#9679;] Preferred Shares for the full redemption price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Subordination Risk.</i> The Series [&#9679;] Preferred Shares are not a debt obligation of the Fund. The Series [&#9679;] Preferred Shares are junior in respect of distributions and liquidation preference to any indebtedness incurred by the Fund, and have the same priority with respect to payment of distributions and liquidation preference as the Series G Preferred Shares, Series H Preferred Shares, Series K Preferred Shares, Series M Preferred Shares, Series N Preferred Shares and any other series of preferred stock that the Fund may issue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<i>Credit Rating Risk</i>. The Fund is seeking a credit rating on the Series [&#9679;] Preferred Shares. Any credit rating that is issued on the Series [&#9679;] Preferred Shares could be reduced or withdrawn while an investor holds Series [&#9679;] Preferred Shares. A reduction or withdrawal of the credit rating would likely have an adverse effect on the market value of the Series [&#9679;] Preferred Shares. In addition, a credit rating does not eliminate or mitigate the risks of investing in the Series [&#9679;] Preferred Shares.]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 135 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">U-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Distribution Risk</i>. The Fund may not meet the asset coverage requirements or earn sufficient income from its investments to make distributions on the Series [&#9679;] Preferred Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Interest Rate Risk</i>. The Series [&#9679;] Preferred Shares pay dividends at a fixed rate[, which resets after an initial period]. Prices of fixed income investments tend to vary inversely with changes in market yields. The market yields on securities comparable to the Series [&#9679;] Preferred Shares may increase, which would likely result in a decline in the value of the Series [&#9679;] Preferred Shares. Additionally, if interest rates rise, securities comparable to the Series [&#9679;] Preferred Shares may pay higher dividend rates and holders of the Series [&#9679;] Preferred Shares may not be able to sell the Series [&#9679;] Preferred Shares at their liquidation preference and reinvest the proceeds at market rates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<i>Dividend Rate Adjustment Risk</i>. The dividend rate of the Series [&#9679;] Preferred Shares automatically adjusts to a rate of [&#9679;]% per annum after a period of [&#9679;] months commencing on the date the Series [&#9679;] Preferred Shares are first issued. If interest rates rise during this time, holders of Series [&#9679;] Preferred Shares may receive a below market dividend rate which may cause the market price of the Series [&#9679;] Preferred Shares to decline.]</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Principal Risks Associated with Investing in Common Shares in the Offer</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Market Discount</i></b>. As with any stock, the price of the Fund&#8217;s common shares fluctuates with market conditions and other factors. The common shares are currently trading at a [premium/discount ] to their net asset value. Since the inception of the Fund, the common shares have traded at discounts of as much as [&#9679;]%. Shares of closed-end investment companies frequently trade at a discount from their net asset values. This characteristic is a risk separate and distinct from the risk that the Fund&#8217;s net asset value could decrease as a result of its investment activities and may be greater for shareholders expecting to sell their common shares in a relatively short period of time following completion of this Offer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Dilution</i></b>. The net asset value of the common shares will be reduced immediately following this Offer as a result of the payment of certain offering costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If you do not exercise all of your Rights, you may own a smaller proportional interest in the Fund when the Offer is over. In addition, you will experience an immediate dilution of the aggregate net asset value per share of your common shares if you do not participate in the Offer and will experience a reduction in the net asset value per share whether or not you exercise your Rights, if the Subscription Price is below the Fund&#8217;s net asset value per Share on the Expiration Date, because:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the offered common shares are being sold at less than their current net asset value;</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">you will indirectly bear the expenses of the Offer; and</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the number of common shares outstanding after the Offer will have increased proportionately more than the increase in the amount of the Fund&#8217;s net assets.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On the other hand, if the portion of the Subscription Price attributable to the additional common shares is above the Fund&#8217;s net asset value per share on the Expiration Date, you may experience an immediate accretion of the aggregate net asset value per share of your common shares even if you do not exercise your Rights and an immediate increase in the net asset value per share of your common shares whether or not you participate in the Offer, because:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the offered common shares are being sold at more than their current net asset value after deducting the expenses of the Offer; and</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the number of common shares outstanding after the Offer will have increased proportionately less than the increase in the amount of the Fund&#8217;s net assets.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 136 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">U-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore, if you do not fully participate in the Offer, your percentage ownership may also be diluted. The Fund cannot state precisely the amount of any dilution because it is not known at this time what the net asset value per share will be on the Expiration Date or what proportion of the Rights will be exercised. The impact of the Offer on net asset value per share is shown by the following examples, assuming a Subscription Price of $[&#9679;], which represents $[&#9679;] per common share and $[&#9679;] per preferred share:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><b>[Scenario 1: (assumes net asset value per share is above subscription price per common share)<sup>(1)</sup></b></td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; width: 68%; vertical-align: top">NAV<sup>(2)</sup></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">[&#9679;]</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top">Subscription Price per common share</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">[&#9679;]</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Reduction in NAV($)<sup>(3)</sup></td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">[&#9679;]</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Reduction in NAV(%)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">[&#9679;]</td>
    <td style="text-align: left">%]</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">[Scenario 2: (assumes net asset value per share is below subscription price per common share)<sup>(1)</sup></td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top">NAV<sup>(2)</sup></td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">[&#9679;]</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top">Subscription Price per common share</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">[&#9679;]</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Increase in NAV($)<sup>(3)</sup></td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">[&#9679;]</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Increase in NAV(%)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">[&#9679;]</td>
    <td style="text-align: left">]</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Both examples assume the Offer is fully subscribed. Actual amounts may vary due to rounding.</span></td> </tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For illustrative purposes only; reflects the Fund&#8217;s net asset value per Common Shares as of [&#9679;], 2023. It is not known at this time what the net asset value per Common Share will be on the Expiration Date.</span></td> </tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumes $[&#9679;] in estimated offering expenses.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If you do not wish to exercise your Rights, you should consider selling them as set forth in this Prospectus Supplement. Any cash you receive from selling your Rights may serve as partial compensation for any possible dilution of your interest in the Fund. The Fund cannot give assurance, however, that a market for the Rights will develop or that the Rights will have any marketable value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depending on whether all Rights are exercised and, if not, whether any over-subscription privileges are exercised, certain Record Date Shareholders could increase their percentage ownership in the Fund through the exercise of the primary Subscription and/or the over-subscription privilege.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Leverage Risk.</i></b> The Fund will obtain leverage for investment purposes by issuing preferred shares in the Offer. The Fund&#8217;s leveraged capital structure will create special risks not associated with unleveraged funds having similar investment objectives and policies. These include the possibility of greater loss and the likelihood of higher volatility of the net asset value of the Fund and the asset coverage. Such volatility may increase the likelihood of the Fund&#8217;s having to sell investments in order to meet dividend payments on the preferred shares, or to redeem preferred shares, when it may be disadvantageous to do so. Also, if the Fund is utilizing leverage, a decline in net asset value could affect the ability of the Fund to make common share distribution payments, and such a failure to pay dividends or make distributions could result in the Fund&#8217;s ceasing to qualify as a regulated investment company under the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because the advisory fee paid to the Investment Adviser is calculated on the basis of the Fund&#8217;s total assets, rather than only on the basis of net assets attributable to the common shares, the fee will be higher when leverage in the form of preferred stock or borrowings is utilized, giving the Investment Adviser an incentive to utilize leverage.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Principal Risks Associated with a Rights Offering of Common Shares and Preferred Shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Record Date Shareholders Who Do Not Wish to Purchase Preferred Shares will Suffer Dilution to Their Interests in the Fund&#8217;s Common Shares if They Do not Purchase both Preferred Shares and Common Shares</i></b>. The Rights may only be exercised to purchase an equal number of common shares and preferred shares in the Offer and may not be exercised to purchase only common shares or more common shares than preferred shares. As a consequence, a Record Date Shareholder who does not wish to purchase or own preferred shares and who accordingly does not exercise its Rights will suffer dilution in its interest in the common shares and, if the portion of the exercise price attributable to the common shares is less than net asset value per common share, to the net asset value per share of its common shares as well. This risk may be greater because the portion of the exercise price attributable to a preferred share is considerably greater than the portion attributable to a common share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 137 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">U-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Holders of Rights Who Wish to Purchase Preferred Shares in the Offer May Not Do So Without Purchasing Common Shares in the Offer</i></b>. The Rights may only be exercised to purchase an equal number of common shares and preferred shares in the Offer and may not be exercised to purchase only preferred shares or more preferred shares than common shares. As a consequence, a holder of Rights who wishes to purchase only preferred shares and who accordingly does not exercise its Rights may forego an opportunity to purchase preferred shares at what may be an attractive price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Exercise of Rights Requires a Greater Investment than Purchasing Either Common Shares or Preferred Shares</i></b>. In order to exercise its Rights a holder of Rights must purchase both common shares and preferred shares at a combined price of $[&#9679;], representing $[&#9679;] per preferred share and $[&#9679;] per common share. This is a higher amount than the price per share for either security by itself and may represent a greater investment than a holder may wish to make.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The Market Value of a Preferred Share or Common Share May Differ from the Price per Share Described in this Offer</i></b>. The trading price per common share or preferred share may be higher or lower than the price to purchase such share in this Offer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="u_010"></span>TAXATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following summary of certain U.S. federal income tax considerations supplements the discussion set forth in the accompanying Prospectus and Statement of Additional Information under the heading &#8220;Taxation&#8221; and is subject to the qualifications and assumptions set forth therein. Please refer to such discussion for a description of the consequences of investing in the common shares and preferred shares. Certain special tax considerations relating to this offering of Rights are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The value of a Right will not be includible in the income of a shareholder at the time the Right is issued.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The basis of a Right issued to a shareholder will be zero, and the basis of the share with respect to which the Right was issued (the old share) will remain unchanged, unless either (a) the fair market value of the Right on the date of distribution is at least 15% of the fair market value of the old share, or (b) such shareholder affirmatively elects (in the manner set out in Treasury regulations under the Code) to allocate to the Right a portion of the basis of the old share. If either (a) or (b) applies, such shareholder must allocate basis between the old share and the Right in proportion to their fair market values on the date of distribution.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The basis of a Right purchased in the market will generally be its purchase price.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The holding period of a Right issued to a shareholder will include the holding period of the old share.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No loss will be recognized by a shareholder if a Right distributed to such shareholder expires unexercised, because the basis of the old share may be allocated to a Right only if the Right is exercised or sold. If a Right that has been purchased in the market expires unexercised, there will be a recognized loss equal to the basis of the Right.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any gain or loss on the sale of a Right will be a capital gain or loss if the Right is held as a capital asset (which in the case of a Right issued to shareholders will depend on whether the old share is held as a capital asset), and will be a long term capital gain or loss if the holding period is deemed to exceed one year.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No gain or loss will be recognized by a shareholder upon the exercise of a Right.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 138 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">U-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In general, the basis of a share acquired pursuant to the exercise of a subscription right is equal to the sum of (i) the basis, if any, of the right and (ii) subscription price paid for the share. In the case of the Rights, such sum must be allocated between the common share and preferred share received upon exercise of a Right. For this purpose, (i) the basis, if any, of a Right should be allocated between the common share and the preferred share in proportion to the amount of the total fair market value of the Right that is attributable to each of the common share and the preferred share at the time the Right is issued, and (ii) the total subscription price paid for the common share and the preferred share should be allocated between the common share and the preferred share based on their relative fair market values at the time such shares are acquired pursuant to the exercise of the Right. Investors are urged to consult their own tax advisers regarding the calculation of basis of any common shares and preferred shares acquired upon the exercise of Rights.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The holding period for common shares and preferred shares acquired upon the exercise of a Right will begin on the date such shares are acquired pursuant to the exercise of the Right.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The discussion set forth herein does not constitute tax advice. Investors are urged to consult their own tax advisers regarding the U.S. federal, state, local, and foreign tax consequences relating to the Rights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="u_011"></span>UNDERWRITING</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;], which is a broker-dealer and member of the Financial Industry Regulatory Authority will act as dealer manager for the rights offering (henceforth, the &#8220;Dealer Manager&#8221;). Under the terms and subject to the conditions contained in the Dealer Manager Agreement among the Fund, the Investment Adviser, and the Dealer Manager (the &#8220;Dealer Manager Agreement&#8221;), the Dealer Manager will provide financial structuring services and marketing services in connection with the offering and will solicit the exercise of Rights and participation in the over-subscription privilege. The Fund has agreed to pay the Dealer Manager a fee for its financial structuring, marketing and soliciting services equal to $[&#9679;] per common share issued pursuant to the rights offering. The Dealer Manager fee will be borne by the Fund and indirectly by all of the Fund&#8217;s common shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Dealer Manager will reallow to other broker-dealers that have executed and delivered a soliciting dealer agreement and have solicited the exercise of Rights solicitation fees equal to $[&#9679;] per common share issued pursuant to exercise of Rights as a result of their soliciting efforts. Fees will be paid to the broker-dealer designated on the applicable portion of the Subscription Certificates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund and the Investment Adviser have each agreed to indemnify the Dealer Manager or contribute to losses arising out of certain liabilities, including liabilities under the Securities Act. The Dealer Manager Agreement also provides that the Dealer Manager will not be subject to any liability to the Fund in rendering the services contemplated by the Dealer Manager Agreement except for any act of bad faith, willful misconduct or gross negligence of the Dealer Manager or reckless disregard by the Dealer Manager of its obligations and duties under the Dealer Manager Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the period the Rights are issued and outstanding, the Dealer Manager may facilitate the trading market for Rights and the placement of Common Shares pursuant to the exercise of Rights, including by facilitating the sale of Rights by shareholders who do not wish to exercise their Rights. The Dealer Manager may act on behalf of its clients to purchase or sell Rights in the open market and may receive commissions from its clients for such services. The Dealer Manager may also interact with brokers and dealers soliciting the exercise of Rights. Prior to the expiration of the Rights offering, the Dealer Manager may purchase or exercise Rights at prices determined at the time of such exercise and generally conduct other activities associated with the duties of a Dealer Manager in a rights offering. The Dealer Manager is not required to purchase Rights as principal for its own account in order to seek to facilitate the trading market for Rights or otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the ordinary course of their businesses, the Dealer Manager and/or its affiliates may engage in investment banking or financial transactions with the Fund, the Investment Adviser and their affiliates. The principal business address of the Dealer Manager is [&#9679;].</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 139 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">U-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="u_012"></span>LEGAL MATTERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain legal matters will be passed on by Willkie Farr &amp; Gallagher LLP, counsel to the Fund, in connection with this rights offering of common stock and preferred stock contemplated by the Offer. Willkie Farr &amp; Gallagher LLP may rely as to certain matters of Maryland law on the opinion of Venable LLP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[The Fund&#8217;s unaudited financial statements as of and for the six months ended June&#160;30, 202[&#9679;] should be read in conjunction with the audited financial statements of the Fund and the Notes thereto included in the Annual Report to the Fund&#8217;s shareholders for the fiscal year ended December&#160;31, 202[&#9679;].] The audited annual financial statements of the Fund for the fiscal year ended December&#160;31, 202[&#9679;] [and the unaudited semiannual financial statements of the Fund for the six months ended June&#160;30, 202[&#9679;]] are incorporated by reference into this Prospectus Supplement, the accompanying Prospectus and the SAI. Portions of the Fund&#8217;s annual report [and semiannual report] other than the financial statements and related footnotes thereto are not incorporated into, and do not form a part of, this Prospectus Supplement, the accompanying Prospectus or the SAI.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 140 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">U-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b>THE GABELLI EQUITY TRUST INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[&#9679;] Rights</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Subscription Rights to Acquire Common Stock and Preferred Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Issuable Upon Exercise of Rights to Subscribe for Such Common Stock and Preferred Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>PROSPECTUS SUPPLEMENT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;[&#9679;], 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 141 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dated December&#160;29, 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE GABELLI EQUITY TRUST INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>STATEMENT OF ADDITIONAL INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Gabelli Equity Trust Inc. (the &#8220;Fund&#8221;) is a diversified, closed-end management investment company registered under the Investment Company Act of 1940, as amended (the &#8220;1940 Act&#8221;). The Fund&#8217;s primary investment objective is to achieve long term growth of capital by investing primarily in a portfolio of equity securities consisting of common stock, preferred stock, convertible or exchangeable securities, and warrants and rights to purchase such securities. Income is a secondary investment objective. The Fund commenced investment operations on August&#160;21, 1986. Gabelli Funds, LLC (the &#8220;Investment Adviser&#8221; or &#8220;Adviser&#8221;) serves as investment adviser to the Fund.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Statement of Additional Information (the &#8220;SAI&#8221;) does not constitute a prospectus, but should be read in conjunction with the Fund&#8217;s Prospectus relating thereto dated December&#160;29, 2023 and as it may be supplemented. This SAI does not include all information that a prospective investor should consider before investing in shares of the Fund&#8217;s stock, and investors should obtain and read the Fund&#8217;s Prospectus prior to purchasing such shares. A copy of the Fund&#8217;s Registration Statement, including the Prospectus and any Prospectus Supplement, may be obtained from the Securities and Exchange Commission (the &#8220;SEC&#8221;) upon payment of the fee prescribed, or inspected at the SEC&#8217;s office or via its website (www.sec.gov) at no charge.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under normal market conditions, the Fund will invest at least 80% of the value of its total assets in equity securities (the &#8220;80% Policy&#8221;). The 80% Policy may be changed without stockholder approval. The Fund will provide stockholders with notice at least 60 days prior to the implementation of any change in the 80% Policy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Investment Adviser selects investments on the basis of fundamental value and, accordingly, the Fund typically invests in the securities of companies that are believed by the Investment Adviser to be priced lower than justified in relation to their underlying assets. Other important factors in the selection of investments include favorable price/earnings and debt/equity ratios and strong management.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund seeks to achieve its secondary investment objective of income, in part, by investing up to 10% of its total assets in a portfolio consisting primarily of high-yielding, fixed income securities, such as corporate bonds, debentures, notes, convertible securities, preferred stocks and domestic and foreign government obligations. Fixed income securities purchased by the Fund may be rated as low as C by Moody&#8217;s Investors Service, Inc. (&#8220;Moody&#8217;s&#8221;) or D by Standard &amp; Poor&#8217;s, a Division of The McGraw-Hill Companies, Inc. (&#8220;S&amp;P&#8221;) or may be unrated securities considered to be of equivalent quality. Securities that are rated C by Moody&#8217;s are the lowest rated class and can be regarded as having extremely poor prospects of ever obtaining investment-grade standing. Debt rated D by S&amp;P is in default or is expected to default upon maturity of payment date. These debt securities, which are often referred to in the financial press as &#8220;junk bonds,&#8221; are predominantly speculative and involve major risk exposure to adverse conditions. The Fund may invest in fixed income securities of any maturity and any duration when it appears that the Fund will be better able to achieve its investment objective through investments in such securities or when the Fund is temporarily in a defensive position. The average duration and average maturity of the Fund&#8217;s investments in debt securities will vary from time to time depending on the views of the Investment Adviser.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No assurance can be given that the Fund&#8217;s investment objectives will be achieved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 142; Options: NewSection -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TABLE OF CONTENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; text-align: left"><b>&#160;</b></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 3pt; text-align: center"><b>&#160;</b></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 3pt; text-align: right"><b>Page</b></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; width: 90%; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_001">The Fund</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 3pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 3pt; text-align: right; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_002">Investment Objectives and Policies</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 3pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_003">Investment Restrictions</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 3pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_004">Management of the Fund</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 3pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_005">Dividends and Distributions</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 3pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_006">Portfolio Transactions</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 3pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_007">Portfolio Turnover</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 3pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_008">Taxation</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 3pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_009">Beneficial Owners</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 3pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 3pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_010">General Information</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 3pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_011">Appendix A&#8212;Proxy Voting Policy</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A-1</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 143 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="b_001"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE FUND</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund was incorporated in Maryland on May&#160;20, 1986 and is a diversified, closed-end management investment company registered under the 1940 Act. The common stock of the Fund is listed on the New York Stock Exchange (the &#8220;NYSE&#8221;) under the symbol &#8220;GAB.&#8221; The Fund&#8217;s Series G Cumulative Preferred Stock (the &#8220;Series G Preferred&#8221;) is listed and traded on the NYSE under the symbol &#8220;GAB PrG.&#8221; The Fund&#8217;s 5.00% Series H Cumulative Preferred Stock (the &#8220;Series H Preferred&#8221;) is listed and traded on the NYSE under the symbol &#8220;GAB PrH.&#8221; The Fund&#8217;s 5.00% Series K Cumulative Preferred Stock (the &#8220;Series K Preferred&#8221;) is listed and traded on the NYSE under the symbol &#8220;GAB PrK.&#8221; The Fund&#8217;s Series C Auction Rate Cumulative Preferred Stock (&#8220;Series C Auction Rate Preferred&#8221;), Series E Auction Rate Preferred Stock (&#8220;Series E Auction Rate Preferred&#8221;), 4.25% Series M Cumulative Preferred Stock (&#8220;Series M Preferred&#8221;) and 5.25% Series N Cumulative Preferred Stock (&#8220;Series N Preferred&#8221;) are not traded on a stock exchange.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="b_002"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INVESTMENT OBJECTIVES AND POLICIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investment Objectives</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund&#8217;s primary investment objective is to achieve long term growth of capital by investing primarily in a portfolio of equity securities consisting of common stock, preferred stock, convertible or exchangeable securities, and warrants and rights to purchase such securities selected by the Investment Adviser. Income is a secondary investment objective. Under normal market conditions, the Fund will invest at least 80% of the value of its total assets in equity securities. See &#8220;Investment Objectives and Policies&#8221; in the Prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investment Practices</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Special Situations</i>. Although the Fund typically invests in the securities of companies on the basis of fundamental value, the Fund from time to time may, as a non-principal investment strategy, invest in companies that are determined by the Investment Adviser to possess &#8220;special situation&#8221; characteristics. In general, a special situation company is a company whose securities are expected to increase in value solely by reason of a development particularly or uniquely applicable to the company. Developments that may create special situations include, among others, a liquidation, reorganization, recapitalization or merger, material litigation, technological breakthrough or new management or management policies. The principal risk associated with investments in special situation companies is that the anticipated development thought to create the special situation may not occur and the investment therefore may not appreciate in value or may decline in value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Options</i>. The Fund may, subject to guidelines of the Board of Directors (the &#8220;Board&#8221;) and SEC or staff rules and guidance and any other applicable regulatory authority, purchase or sell (i.e., write) options on securities, securities indices and foreign currencies which are listed on a national securities exchange or in the United States over-the-counter (&#8220;OTC&#8221;) markets as a means of achieving additional return or of hedging the value of the Fund&#8217;s portfolio.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund may write covered call options on common stocks that it owns or has an immediate right to acquire through conversion or exchange of other securities in an amount not to exceed 25% of total assets or invest up to 10% of its total assets in the purchase of put options on common stocks that the Fund owns or may acquire through the conversion or exchange of other securities that it owns.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A call option is a contract that gives the holder of the option the right to buy from the writer (seller) of the call option, in return for a premium paid, the security or currency underlying the option at a specified exercise price at any time during the term of the option. The writer of the call option has the obligation, upon exercise of the option, to deliver the underlying security or currency upon payment of the exercise price during the option period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A put option is the reverse of a call option, giving the holder the right, in return for a premium, to sell the underlying security or currency to the writer, at a specified price, and obligating the writer to purchase the underlying security or currency from the holder at that price. The writer of the put, who receives the premium, has the obligation to buy the underlying security or currency upon exercise, at the exercise price during the option period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 144 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the Fund has written an option, it may terminate its obligation by effecting a closing purchase transaction. This is accomplished by purchasing an option of the same series as the option previously written. There can be no assurance that a closing purchase transaction can be effected when the Fund so desires.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An exchange-traded option may be closed out only on an exchange that provides a secondary market for an option of the same series. Although the Fund will generally purchase or write only those options for which there appears to be an active secondary market, there is no assurance that a liquid secondary market on an exchange will exist for any particular option.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A call option is &#8220;covered&#8221; if the Fund owns the underlying instrument covered by the call or has an absolute and immediate right to acquire that instrument without additional cash consideration upon conversion or exchange of another instrument held in its portfolio (or for additional cash consideration held in a segregated account by its custodian). A call option is also covered if the Fund holds a call on the same instrument as the call written where the exercise price of the call held is (i) equal to or less than the exercise price of the call written or (ii) greater than the exercise price of the call written if the difference is maintained by the Fund in cash, U.S. Government Obligations (as defined under &#8220;Investment Restrictions&#8221;) or other high-grade short term obligations in a segregated account with its custodian. A put option is &#8220;covered&#8221; if the Fund maintains cash or other high grade short term obligations with a value equal to the exercise price in a segregated account with its custodian, or else holds a put on the same instrument as the put written where the exercise price of the put held is equal to or greater than the exercise price of the put written. If the Fund has written an option, it may terminate its obligation by effecting a closing purchase transaction. This is accomplished by purchasing an option of the same series as the option previously written. However, once the Fund has been assigned an exercise notice, the Fund will be unable to effect a closing purchase transaction. Similarly, if the Fund is the holder of an option it may liquidate its position by effecting a closing sale transaction. This is accomplished by selling an option of the same series as the option previously purchased. There can be no assurance that either a closing purchase or sale transaction can be effected when the Fund so desires.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund will realize a profit from a closing transaction if the price of the transaction is less than the premium received from writing the option or is more than the premium paid to purchase the option; the Fund will realize a loss from a closing transaction if the price of the transaction is more than the premium received from writing the option or is less than the premium paid to purchase the option. Since call option prices generally reflect increases in the price of the underlying security, any loss resulting from the repurchase of a call option may also be wholly or partially offset by unrealized appreciation of the underlying security. Other principal factors affecting the market value of a put or call option include supply and demand, interest rates, the current market price and price volatility of the underlying security and the time remaining until the expiration date. Gains and losses on investments in options depend, in part, on the ability of the Investment Adviser to predict correctly the effect of these factors. The use of options cannot serve as a complete hedge since the price movement of securities underlying the options will not necessarily follow the price movements of the portfolio securities subject to the hedge.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An option position may be closed out only on an exchange that provides a secondary market for an option of the same series or in a private transaction. Although the Fund will generally purchase or write only those options for which there appears to be an active secondary market, there is no assurance that a liquid secondary market on an exchange will exist for any particular option. In such event, it might not be possible to effect closing transactions in particular options, so the Fund would have to exercise its options in order to realize any profit and would incur brokerage commissions upon the exercise of call options and upon the subsequent disposition of underlying securities for the exercise of put options. If the Fund, as a covered call option writer, is unable to effect a closing purchase transaction in a secondary market, it will not be able to sell the underlying security until the option expires or until the Fund delivers the underlying security upon exercise or otherwise covers the position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition to options on securities, the Fund may also purchase and sell call and put options on securities indices. A stock index reflects in a single number the market value of many different stocks.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Relative values are assigned to the stocks included in an index and the index fluctuates with changes in the market values of the stocks. The options give the holder the right to receive a cash settlement during the term of the option based on the difference between the exercise price and the value of the index. By writing a put or call option on a securities index, the Fund is obligated, in return for the premium received, to make delivery of this amount. The Fund may offset its position in the stock index options prior to expiration by entering into a closing transaction on an exchange, or it may let the option expire unexercised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 145 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund may also buy or sell put and call options on foreign currencies. A put option on a foreign currency gives the purchaser of the option the right to sell a foreign currency at the exercise price until the option expires. A call option on a foreign currency gives the purchaser of the option the right to purchase the currency at the exercise price until the option expires. Currency options traded on U.S. or other exchanges may be subject to position limits which may limit the ability of the Fund to reduce foreign currency risk using such options. OTC options differ from exchange-traded options in that they are two-party contracts with price and other terms negotiated between buyer and seller and generally do not have as much market liquidity as exchange-traded options. OTC options are considered illiquid securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use of options on securities indices entails the risk that trading in the options may be interrupted if trading in certain securities included in the index is interrupted. The Fund will not purchase these options unless the Investment Adviser is satisfied with the development, depth and liquidity of the market and the Investment Adviser believes the options can be closed out.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price movements in the portfolio of the Fund may not correlate precisely with the movements in the level of an index and, therefore, the use of options on indices cannot serve as a complete hedge and will depend, in part, on the ability of the Investment Adviser to predict correctly movements in the direction of the stock market generally or of a particular industry. Because options on securities indices require settlement in cash, the Fund may be forced to liquidate portfolio securities to meet settlement obligations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although the Investment Adviser will attempt to take appropriate measures to minimize the risks relating to the Fund&#8217;s writing of put and call options, there can be no assurance that the Fund will succeed in any option writing program it undertakes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Futures Contracts and Options on Futures.</i> A &#8220;sale&#8221; of a futures contract (or a &#8220;short&#8221; futures position) means the assumption of a contractual obligation to deliver the assets underlying the contract at a specified price at a specified future time. A &#8220;purchase&#8221; of a futures contract (or a &#8220;long&#8221; futures position) means the assumption of a contractual obligation to acquire the assets underlying the contract at a specified price at a specified future time. Certain futures contracts, including stock and bond index futures, are settled on a net cash payment basis rather than by the sale and delivery of the assets underlying the futures contracts. No consideration will be paid or received by the Fund upon the purchase or sale of a futures contract. Initially, the Fund will be required to deposit with the broker an amount of cash or cash equivalents equal to approximately 1% to 10% of the contract amount (this amount is subject to change by the exchange or board of trade on which the contract is traded and brokers or members of such board of trade may charge a higher amount). This amount is known as &#8220;initial margin&#8221; and is in the nature of a performance bond or good faith deposit on the contract. Subsequent payments, known as &#8220;variation margin,&#8221; to and from the broker will be made daily as the price of the index or security underlying the futures contract fluctuates. At any time prior to the expiration of a futures contract, the Fund may close the position by taking an opposite position, which will operate to terminate its existing position in the contract.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An option on a futures contract gives the purchaser the right, in return for the premium paid, to assume a position in a futures contract at a specified exercise price at any time prior to the expiration of the option. Upon exercise of an option, the delivery of the futures positions by the writer of the option to the holder of the option will be accompanied by delivery of the accumulated balance in the writer&#8217;s futures margin account attributable to that contract, which represents the amount by which the market price of the futures contract exceeds, in the case of a call, or is less than, in the case of a put, the exercise price of the option on the futures contract. The potential loss related to the purchase of an option on futures contracts is limited to the premium paid for the option (plus transaction costs). Because the value of the option purchased is fixed at the point of sale, there are no daily cash payments by the purchaser to reflect changes in the value of the underlying contract; however, the value of the option does change daily and that change would be reflected in the net assets of the Fund.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Futures and options on futures entail certain risks, including but not limited to the following: no assurance that futures contracts or options on futures can be offset at favorable prices, possible reduction of the yield of the Fund due to the use of hedging, possible reduction in value of both the securities hedged and the hedging instrument, possible lack of liquidity due to daily limits on price fluctuations, imperfect correlation between the contracts and the securities being hedged, losses from investing in futures transactions that are potentially unlimited.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 146 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Interest Rate Futures Contracts and Options Thereon.</i> The Fund may purchase or sell interest rate futures contracts to take advantage of, or to protect the Fund against, fluctuations in interest rates affecting the value of debt securities which the Fund holds or intends to acquire. For example, if interest rates are expected to increase, the Fund might sell futures contracts on debt securities the values of which historically have a high degree of positive correlation to the values of the Fund&#8217;s portfolio securities. Such a sale would have an effect similar to selling an equivalent value of the Fund&#8217;s portfolio securities. If interest rates increase, the value of the Fund&#8217;s portfolio securities will decline, but the value of the futures contracts to the Fund will increase at approximately an equivalent rate, thereby keeping the net asset value of the Fund from declining as much as it otherwise would have. The Fund could accomplish similar results by selling debt securities with longer maturities and investing in debt securities with shorter maturities when interest rates are expected to increase. However, since the futures market may be more liquid than the cash market, the use of futures contracts as a risk management technique allows the Fund to maintain a defensive position without having to sell its portfolio securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Similarly, the Fund may purchase interest rate futures contracts when it is expected that interest rates may decline. The purchase of futures contracts for this purpose constitutes a hedge against increases in the price of debt securities (caused by declining interest rates) which the Fund intends to acquire. Since fluctuations in the value of appropriately selected futures contracts should approximate that of the debt securities that will be purchased, the Fund can take advantage of the anticipated rise in the cost of the debt securities without actually buying them. Subsequently, the Fund can make its intended purchase of the debt securities in the cash market and concurrently liquidate its futures position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The purchase of a call option on a futures contract is similar in some respects to the purchase of a call option on an individual security. Depending on the pricing of the option compared to either the price of the futures contract upon which it is based or the price of the underlying debt securities, it may or may not be less risky than ownership of the futures contract or underlying debt securities. As with the purchase of futures contracts, when the Fund is not fully invested it may purchase a call option on a futures contract to hedge against a market advance due to declining interest rates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The purchase of a put option on a futures contract is similar to the purchase of protective put options on portfolio securities. The Fund will purchase a put option on a futures contract to hedge its portfolio against the risk of rising interest rates and consequent reduction in the value of portfolio securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The writing of a call option on a futures contract constitutes a partial hedge against declining prices of the securities that are deliverable upon exercise of the futures contract. If the futures price at expiration of the option is below the exercise price, the Fund will retain the full amount of the option premium, which provides a partial hedge against any decline that may have occurred in its portfolio holdings. The writing of a put option on a futures contract constitutes a partial hedge against increasing prices of the securities that are deliverable upon exercise of the futures contract. If the futures price at expiration of the option is higher than the exercise price, the Fund will retain the full amount of the option premium, which provides a partial hedge against any increase in the price of debt securities that it intends to purchase. If a put or call option the Fund has written is exercised, the Fund will incur a loss which will be reduced by the amount of the premium it received. Depending on the degree of correlation between changes in the value of its portfolio securities and changes in the value of its futures positions, the Fund&#8217;s losses from options on futures it has written may to some extent be reduced or increased by changes in the value of its portfolio securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Currency Futures and Options Thereon. </i>Generally, foreign currency futures contracts and options thereon are similar to the interest rate futures contracts and options thereon discussed previously. By entering into currency futures and options thereon, the Fund will seek to establish the rate at which it will be entitled to exchange U.S. dollars for another currency at a future time. By selling currency futures, the Fund will seek to establish the number of dollars it will receive at delivery for a certain amount of a foreign currency. In this way, whenever the Fund anticipates a decline in the value of a foreign currency against the U.S. dollar, the Fund can attempt to &#8220;lock in&#8221; the U.S. dollar value of some or all of the securities held in its portfolio that are denominated in that currency. By purchasing currency futures, the Fund can establish the number of dollars it will be required to pay for a specified amount of a foreign currency in a future month. Thus, if the Fund intends to buy securities in the future and expects the U.S. dollar to decline against the relevant foreign currency during the period before the purchase is effected, the Fund can attempt to lock in the price in U.S. dollars of the securities it intends to acquire.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 147 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The purchase of options on currency futures will allow the Fund, for the price of the premium and related transaction costs it must pay for the option, to decide whether or not to buy (in the case of a call option) or to sell (in the case of a put option) a futures contract at a specified price at any time during the period before the option expires. If the Investment Adviser, in purchasing an option, has been correct in its judgment concerning the direction in which the price of a foreign currency would move as against the U.S. dollar, the Fund may exercise the option and thereby take a futures position to hedge against the risk it had correctly anticipated or close out the option position at a gain that will offset, to some extent, currency exchange losses otherwise suffered by the Fund. If exchange rates move in a way the Fund did not anticipate, however, the Fund will have incurred the expense of the option without obtaining the expected benefit; any such movement in exchange rates may also thereby reduce, rather than enhance, the Fund&#8217;s profits on its underlying securities transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Securities Index Futures Contracts and Options Thereon</i>. Purchases or sales of securities index futures contracts are used for hedging purposes to attempt to protect the Fund&#8217;s current or intended investments from broad fluctuations in stock or bond prices. For example, the Fund may sell securities index futures contracts in anticipation of or during a market decline to attempt to offset the decrease in market value of its securities portfolio that might otherwise result. If such decline occurs, the loss in value of portfolio securities may be offset, in whole or part, by gains on the futures position. When the Fund is not fully invested in the securities market and anticipates a significant market advance, it may purchase securities index futures contracts in order to gain rapid market exposure that may, in part or entirely, offset increases in the cost of securities that it intends to purchase. As such purchases are made, the corresponding positions in securities index futures contracts will be closed out. The Fund may write put and call options on securities index futures contracts for hedging purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Limitations on the Purchase and Sale of Futures Contracts and Options on Futures Contracts</i>. The Investment Adviser has claimed an exclusion from the definition of the term &#8220;commodity pool operator&#8221; under the Commodity Exchange Act and therefore is not subject to registration under the Commodity Exchange Act. Accordingly, the Fund&#8217;s investments in derivative instruments described in the Prospectus and this SAI are not limited by or subject to regulation under the Commodity Exchange Act or otherwise regulated by the Commodity Futures Trading Commission. Nevertheless, the Fund&#8217;s investment restrictions place certain limitations and prohibitions on the Fund&#8217;s ability to purchase or sell commodities or commodity contracts. See &#8220;Investment Restrictions.&#8221; Under these restrictions, the Fund may not enter into futures contracts or options on futures contracts unless (i) the aggregate initial margins and premiums do not exceed 5% of the fair market value of the Fund&#8217;s total assets and (ii) the aggregate market value of the Fund&#8217;s outstanding futures contracts and the market value of the currencies and futures contracts subject to outstanding options written by the Fund, as the case may be, do not exceed 50% of the market value of the Fund&#8217;s total assets. In addition, investment in futures contracts and related options generally will be limited by the rating agency guidelines applicable to any of the Fund&#8217;s preferred stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Swap Agreements</i>. The Fund may enter into total rate of return, credit default, interest rate or other types of swaps and related derivatives for various purposes, including to gain economic exposure to an asset or group of assets that may be difficult or impractical to acquire or for hedging and risk management. Swap agreements can be individually negotiated and structured to include exposure to a variety of different types of investments or market factors, including securities, futures, interest rates, currencies, indices and other instruments. Depending on their structure, swap agreements may increase or decrease the Fund&#8217;s exposure to long- or short term interest rates (in the United States or abroad), foreign currency values, mortgage securities, corporate borrowing rates, or other factors such as security prices or inflation rates. Swap agreements can take many different forms and are known by a variety of names.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Swap agreements are two-party contracts entered into primarily by institutional investors for periods ranging from a few weeks to more than one year. In a standard &#8220;swap&#8221; transaction, two parties agree to exchange the returns (or differentials in rates of return) earned or realized on particular predetermined investments or instruments. The gross returns to be exchanged or &#8220;swapped&#8221; between the parties are calculated with respect to a &#8220;notional amount,&#8221; i.e., the return on or increase in value of a particular dollar amount invested at a particular interest rate, in a particular foreign currency, or in a &#8220;basket&#8221; of securities representing a particular index. The &#8220;notional amount&#8221; of the swap agreement is only a fictive basis on which to calculate the obligations that the parties to a swap agreement have agreed to exchange.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 148 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund may enter into swap agreements that would calculate the obligations of the parties to the agreements on a &#8220;net&#8221; basis. Consequently, the Fund&#8217;s obligations (or rights) under a swap agreement will generally be equal only to the net amount to be paid or received under the agreement based on the relative values of the positions held by each party to the agreement (the &#8220;net amount&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forms of swap agreements also include cap, floor and collar agreements. In a typical cap or floor agreement, one party agrees to make payments only under specified circumstances, usually in return for payment of a fee by the other party. For example, the buyer of an interest rate cap obtains the right to receive payments to the extent that a specified interest rate exceeds an agreed-upon level, while the seller of an interest rate floor is obligated to make payments to the extent that a specified interest rate falls below an agreed-upon level. An interest rate collar combines elements of buying a cap and selling a floor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Swap agreements will tend to shift the Fund&#8217;s investment exposure from one type of investment to another. For example, if the Fund agreed to pay fixed rates in exchange for floating rates while holding fixed-rate bonds, the swap would tend to decrease the Fund&#8217;s exposure to long term interest rates. Caps and floors have an effect similar to buying or writing options. Depending on how they are used, swap agreements may increase or decrease the overall volatility of the Fund&#8217;s investments and its share price and yield. The most significant factor in the performance of swap agreements is the change in the specific interest rate, currency, or other factors that determine the amounts of payments due to and from the Fund. If a swap agreement calls for payments by the Fund, the Fund must be prepared to make such payments when due.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund&#8217;s use of swap agreements may not be successful in furthering its investment objective, as the Investment Adviser may not accurately predict whether certain types of investments are likely to produce greater returns than other investments. Moreover, the Fund bears the risk of loss of the amount expected to be received under a swap agreement in the event of the default or bankruptcy of a swap agreement counterparty. The Fund may be able to eliminate its exposure under a swap agreement either by assignment or other disposition, or by entering into an offsetting swap agreement with the same party or a similarly creditworthy party.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Forward Currency Exchange Contracts</i>. The Fund may engage in currency transactions other than on futures exchanges to protect against future changes in the level of future currency exchange rates. The Fund will conduct such currency exchange transactions either on a &#8220;spot&#8221; (i.e., cash) basis at the rate then prevailing in the currency exchange market or on a forward basis, by entering into forward contracts to purchase or sell currency. A forward contract on foreign currency involves an obligation to purchase or sell a specific currency at a future date, which may be any fixed number of days agreed upon by the parties from the date of the contract, at a price set on the date of the contract. Dealing in forward currency exchange will be limited to hedging involving either specific transactions or portfolio positions. Transaction hedging is the purchase or sale of forward currency with respect to specific receivables or payables of the Fund generally arising in connection with the purchase or sale of its portfolio securities and accruals of interest receivable and Fund expenses. Position hedging is the forward sale of currency with respect to portfolio security positions denominated or quoted in that currency or in a currency bearing a high degree of positive correlation to the value of that currency.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund may not position hedge with respect to a particular currency for an amount greater than the aggregate market value (determined at the time of making any sale of forward currency) of the securities held in its portfolio denominated or quoted in, or currently convertible into, such currency.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At or before the maturity of a forward sale contract, the Fund may either sell a portfolio security and make delivery of the currency, or retain the security and offset its contractual obligations to deliver the currency by purchasing a second contract pursuant to which the Fund will obtain, on the same maturity date, the same amount of the currency which it is obligated to deliver. If the Fund retains the portfolio security and engages in an offsetting transaction, the Fund, at the time of execution of the offsetting transaction, will incur a gain or a loss to the extent that movement has occurred in forward contract prices. Should forward prices decline during the period between the Fund&#8217;s entering into a forward contract for the sale of a currency and the date it enters into an offsetting contract for the purchase of the currency, the Fund will realize a gain to the extent the price of the currency it has agreed to purchase is less than the price of the currency it has agreed to sell. Should forward prices increase, the Fund will suffer a loss to the extent the price of the currency it has agreed to purchase exceeds the price of the currency it has agreed to sell. Closing out forward purchase contracts involves similar offsetting transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 149 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The cost to the Fund of engaging in currency transactions varies with factors such as the currency involved, the length of the contract period and the market conditions then prevailing. Because forward transactions in currency exchange are usually conducted on a principal basis, no fees or commissions are involved. The use of foreign currency contracts does not eliminate fluctuations in the underlying prices of the securities, but it does establish a rate of exchange that can be achieved in the future. In addition, although forward currency contracts limit the risk of loss due to a decline in the value of the hedged currency, they also limit any potential gain that might result if the value of the currency increases.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If a decline in any currency is generally anticipated by the Investment Adviser, the Fund may not be able to contract to sell the currency at a price above the level to which the currency is anticipated to decline.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Special Risk Considerations Relating to Futures and Options Thereon</i>. The ability to establish and close out positions in futures contracts and options thereon will be subject to the development and maintenance of liquid markets. Although the Fund generally will purchase or sell only those futures contracts and options thereon for which there appears to be a liquid market, there is no assurance that a liquid market on an exchange will exist for any particular futures contract or option thereon at any particular time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the event no liquid market exists for a particular futures contract or option thereon in which the Fund maintains a position, it will not be possible to effect a closing transaction in that contract or to do so at a satisfactory price and the Fund would have to either make or take delivery under the futures contract or, in the case of a written option, wait to sell the underlying securities until the option expires or is exercised or, in the case of a purchased option, exercise the option. In the case of a futures contract or an option thereon which the Fund has written and which the Fund is unable to close, the Fund would be required to maintain margin deposits on the futures contract or option thereon and to make variation margin payments until the contract is closed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Successful use of futures contracts and options thereon and forward contracts by the Fund is subject to the ability of the Investment Adviser to predict correctly movements in the direction of interest and foreign currency rates. If the Investment Adviser&#8217;s expectations are not met, the Fund will be in a worse position than if a hedging strategy had not been pursued. For example, if the Fund has hedged against the possibility of an increase in interest rates that would adversely affect the price of securities in its portfolio and the price of such securities increases instead, the Fund will lose part or all of the benefit of the increased value of its securities because it will have offsetting losses in its futures positions. In addition, in such situations, if the Fund has insufficient cash to meet daily variation margin requirements, it may have to sell securities to meet the requirements. These sales may be, but will not necessarily be, at increased prices which reflect the rising market. The Fund may have to sell securities at a time when it is disadvantageous to do so.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Additional Risks of Foreign Options, Futures Contracts, Options on Futures Contracts and Forward Contracts</i>. Options, futures contracts and options thereon and forward contracts on securities and currencies may be traded on foreign exchanges. Such transactions may not be regulated as effectively as similar transactions in the U.S., may not involve a clearing mechanism and related guarantees, and are subject to the risk of governmental actions affecting trading in, or the prices of, foreign securities. The value of such positions also could be adversely affected by (i) other complex foreign political, legal and economic factors, (ii) lesser availability than in the U.S. of data on which to make trading decisions, (iii) delays in the Fund&#8217;s ability to act upon economic events occurring in the foreign markets during non-business hours in the U.S., (iv) the imposition of different exercise and settlement terms and procedures and margin requirements than in the U.S. and (v) lesser trading volume.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchanges on which options, futures and options on futures are traded may impose limits on the positions that the Fund may take in certain circumstances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Derivatives Transactions Subject to Rule&#160;18f-4 Under the 1940 Act.</i> Rule&#160;18f-4 under the 1940 Act governs the Fund&#8217;s use of derivative instruments and certain other transactions that create future payment and/or delivery obligations by the Fund. Rule&#160;18f-4 permits the Fund to enter into Derivatives Transactions (as defined below) and certain other transactions notwithstanding the restrictions on the issuance of &#8220;senior securities&#8221; under Section&#160;18 of the 1940 Act. Section&#160;18 of the 1940 Act, among other things, prohibits closed-end funds, including the Fund, from issuing or selling any &#8220;senior security&#8221; representing indebtedness (unless the fund maintains 300% &#8220;asset coverage&#8221;) or any senior security representing stock (unless the fund maintains 200% &#8220;asset coverage&#8221;). In connection with the adoption of Rule&#160;18f-4, the SEC eliminated the asset segregation framework arising from prior SEC guidance for covering Derivatives Transactions and certain financial instruments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 150 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under Rule&#160;18f-4, &#8220;Derivatives Transactions&#8221; include the following: (i) any swap, security-based swap (including a contract for differences), futures contract, forward contract, option (excluding purchased options), any combination of the foregoing, or any similar instrument, under which the Fund is or may be required to make any payment or delivery of cash or other assets during the life of the instrument or at maturity or early termination, whether as margin or settlement payment or otherwise; (ii) any short sale borrowing; (iii) reverse repurchase agreements and similar financing transactions, if the Fund elects to treat these transactions as Derivatives Transactions under Rule&#160;18f-4; and (iv) when-issued or forward-settling securities (e.g., firm and standby commitments, including to-be-announced (&#8220;TBA&#8221;) commitments, and dollar rolls) and non-standard settlement cycle securities, unless the Fund intends to physically settle the transaction and the transaction will settle within 35 days of its trade date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless the Fund is relying on the Limited Derivatives User Exception (as defined below), the Fund must comply with Rule&#160;18f-4 with respect to its Derivatives Transactions. Rule&#160;18f-4, among other things, requires the Fund to (i) appoint a Derivatives Risk Manager, (ii) maintain a Derivatives Risk Management Program designed to identify, assess, and reasonably manage the risks associated with Derivatives Transactions; (iii) comply with certain value-at-risk (VaR)-based leverage limits (VaR is an estimate of an instrument&#8217;s or portfolio&#8217;s potential losses over a given time horizon and at a specified confidence level); and (iv) comply with certain Board reporting and recordkeeping requirements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rule&#160;18f-4 provides an exception from the requirements to appoint a Derivatives Risk Manager, adopt a Derivatives Risk Management Program, comply with certain VaR-based leverage limits, and comply with certain Board oversight and reporting requirements if the Fund&#8217;s &#8220;derivatives exposure&#8221; (as defined in Rule&#160;18f-4) is limited to 10% of its net assets (as calculated in accordance with Rule&#160;18f-4) and the Fund adopts and implements written policies and procedures reasonably designed to manage its derivatives risks (the &#8220;Limited Derivatives User Exception&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dodd-Frank Act Risk.</i> Title VII of the Dodd-Frank Wall Street Consumer Protection Act of 2010 (the &#8220;Dodd-Frank Act&#8221;) (the &#8220;Derivatives Title&#8221;) imposed a substantially new regulatory structure on derivatives markets, with particular emphasis on swaps (which are subject to oversight by the Commodity Futures Trading Commission) and security-based swaps (which are subject to oversight by the SEC). The regulatory framework covers a broad range of swap market participants, including banks, non-banks, credit unions, insurance companies, broker-dealers and investment advisers. Prudential regulators were granted authority to regulate margining of swaps and security-based swaps of banks and bank-related entities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current regulations for swaps require the mandatory central clearing and mandatory exchange trading of particular types of interest rate swaps and index credit default swaps (together, &#8220;Covered Swaps&#8221;). The Fund is required to clear its Covered Swaps through a clearing broker, which requires, among other things, posting initial margin and variation margin to the Fund&#8217;s clearing broker in order to enter into and maintain positions in Covered Swaps. Covered Swaps generally are required to be executed through a swap execution facility (&#8220;SEF&#8221;), which can involve additional transaction fees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally, under the Dodd-Frank Act, with respect to uncleared swaps (both uncleared swaps and uncleared security-based swaps entered into with banks), swap dealers are required to collect from the Fund both initial and variation margin (comprised of specified liquid instruments and subject to a required haircut). Shares of investment companies (other than certain money market funds) may not be posted as collateral under applicable regulations. As capital and margin requirements for swap dealers and capital and margin requirements for security-based swaps are implemented, such requirements may make certain types of trades and/or trading strategies more costly. There may be market dislocations due to uncertainty during the implementation period of any new regulation and the Investment Adviser cannot know how the derivatives market will adjust to such new regulations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition, regulations adopted by global prudential regulators that are now in effect require certain bank-regulated counterparties and certain of their affiliates to include in &#8220;qualified financial contracts,&#8221; including many derivatives contracts as well as repurchase agreements and securities lending agreements, terms that delay or restrict the rights of counterparties to terminate such contracts, foreclose upon collateral, exercise other default rights or restrict transfers of affiliate credit enhancements (such as guarantees) in the event that the bank-regulated counterparty and/or its affiliates are subject to certain types of resolution or insolvency proceedings</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 151 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Risks of Currency Transactions</i>. Currency transactions are also subject to risks different from those of other portfolio transactions. Because currency control is of great importance to the issuing governments and influences economic planning and policy, purchases and sales of currency and related instruments can be adversely affected by government exchange controls, limitations or restrictions on repatriation of currency, manipulation, or exchange restrictions imposed by governments. These forms of governmental action can result in losses to the Fund if it is unable to deliver or receive currency or monies in settlement of obligations and could also cause hedges it has entered into to be rendered useless, resulting in full currency exposure as well as incurring transaction costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>When Issued, Delayed Delivery Securities and Forward Commitments</i>. The Fund may enter into forward commitments for the purchase or sale of securities, including on a &#8220;when issued&#8221; or &#8220;delayed delivery&#8221; basis, in excess of customary settlement periods for the type of security involved. In some cases, a forward commitment may be conditioned upon the occurrence of a subsequent event, such as approval and consummation of a merger, corporate reorganization or debt restructuring, i.e., a when, as and if issued security. When such transactions are negotiated, the price is fixed at the time of the commitment, with payment and delivery taking place in the future, generally a month or more after the date of the commitment. While it will only enter into a forward commitment with the intention of actually acquiring the security, the Fund may sell the security before the settlement date if it is deemed advisable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities purchased under a forward commitment are subject to market fluctuation, and no interest (or dividends) accrues to the Fund prior to the settlement date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rule&#160;18f-4 under the 1940 Act permits the Fund to enter into when-issued or forward-settling securities (e.g., firm and standby commitments, including TBA commitments, and dollar rolls) and non-standard settlement cycle securities notwithstanding the limitation on the issuance of senior securities in Section&#160;18 of 1940 Act, provided that the Fund intends to physically settle the transaction and the transaction will settle within 35 days of its trade date (the &#8220;Delayed-Settlement Securities Provision&#8221;). If a when-issued, forward-settling or non-standard settlement cycle security does not satisfy the Delayed-Settlement Securities Provision, then it is treated as a Derivatives Transaction under Rule&#160;18f-4. See &#8220;&#8212;Derivatives Transactions Subject to Rule&#160;18f-4 Under the 1940 Act&#8221; above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Foreign Securities</i>. The Fund may invest up to 35% of its total assets in securities of foreign issuers, including emerging markets issuers. Investments in the securities of foreign issuers involve certain considerations and risks not ordinarily associated with investments in securities of domestic issuers. Foreign companies are not generally subject to uniform accounting, auditing and financial standards and requirements comparable to those applicable to U.S. companies. Foreign securities exchanges, brokers and listed companies may be subject to less government supervision and regulation than exists in the United States. Dividend and interest income may be subject to withholding and other foreign taxes, which may adversely affect the net return on such investments. There may be difficulty in obtaining or enforcing a court judgment abroad. In addition, it may be difficult to effect repatriation of capital invested in certain countries. In addition, with respect to certain countries, there are risks of expropriation, confiscatory taxation, political or social instability, or diplomatic developments that could affect assets of the Fund held in foreign countries. Dividend income that the Fund receives from foreign securities may not be eligible for the special tax treatment applicable to qualified dividend income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There may be less publicly available information about a foreign company than a U.S. company. Foreign securities markets may have substantially less volume than U.S. securities markets and some foreign company securities are less liquid than securities of otherwise comparable U.S. companies. A portfolio of foreign securities may also be adversely affected by fluctuations in the rates of exchange between the currencies of different nations and by exchange control regulations. Foreign markets also have different clearance and settlement procedures that could cause the Fund to encounter difficulties in purchasing and selling securities on such markets and may result in the Fund missing attractive investment opportunities or experiencing loss. In addition, a portfolio that includes foreign securities can expect to have a higher expense ratio because of the increased transaction costs on non-U.S. securities markets and the increased costs of maintaining the custody of foreign securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 152 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund also may purchase sponsored American Depositary Receipts (&#8220;ADRs&#8221;) or U.S. dollar denominated securities of foreign issuers. ADRs are receipts issued by U.S. banks or trust companies in respect of securities of foreign issuers held on deposit for use in the U.S. securities markets. While ADRs may not necessarily be denominated in the same currency as the securities into which they may be converted, many of the risks associated with foreign securities may also apply to ADRs. In addition, the underlying issuers of certain depositary receipts, particularly unsponsored or unregistered depositary receipts, are under no obligation to distribute stockholder communications to the holders of such receipts, or to pass through to them any voting rights with respect to the deposited securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Emerging Markets Risk</i>. The Fund may invest in securities of issuers whose primary operations or principal trading market is in an &#8220;emerging market.&#8221; An &#8220;emerging market&#8221; country is any country that is considered to be an emerging or developing country by the International Bank for Reconstruction and Development (the &#8220;World Bank&#8221;). Investing in securities of companies in emerging markets may entail special risks relating to potential political and economic instability and the risks of expropriation, nationalization, confiscation or the imposition of restrictions on foreign investment, the lack of hedging instruments and restrictions on repatriation of capital invested. Emerging securities markets are substantially smaller, less developed, less liquid and more volatile than the major securities markets. The limited size of emerging securities markets and limited trading value compared to the volume of trading in U.S. securities could cause prices to be erratic for reasons apart from factors that affect the quality of the securities. For example, limited market size may cause prices to be unduly influenced by traders who control large positions. Adverse publicity and investor perception, whether or not based on fundamental analysis, may decrease the value and liquidity of portfolio securities, especially in these markets. Other risks include high concentration of market capitalization and trading volume in a small number of issuers representing a limited number of industries, as well as a high concentration of investors and financial intermediaries; overdependence on exports, including gold and natural resources exports, making these economies vulnerable to changes in commodity prices; overburdened infrastructure and obsolete or unseasoned financial systems; environmental problems; potential for sanctions; less developed legal systems; and less reliable securities custodial services and settlement practices.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Convertible Securities</i>. A convertible security entitles the holder to exchange such security for a fixed number of shares of common stock or other equity security, usually of the same company, at fixed prices within a specified period of time and to receive the fixed income of a bond or the dividend preference of a preferred stock until the holder elects to exercise the conversion privilege. The fixed income or dividend component of a convertible security is referred to as the security&#8217;s &#8220;investment value.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A convertible security&#8217;s position in a company&#8217;s capital structure depends upon its particular provisions. In the case of subordinated convertible debentures, the holder&#8217;s claims on assets and earnings are subordinated to the claims of others and are senior to the claims of common stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To the degree that the price of a convertible security rises above its investment value because of a rise in price of the underlying common stock, the value of such security is influenced more by price fluctuations of the underlying common stock and less by its investment value. The price of a convertible security that is supported principally by its conversion value will rise along with any increase in the price of the common stock, and such price generally will decline along with any decline in the price of the common stock except that the security will receive additional support as its price approaches investment value. A convertible security purchased or held at a time when its price is influenced by its conversion value will produce a lower yield than nonconvertible senior securities with comparable investment values. Convertible securities may be purchased by the Fund at varying price levels above their investment values and/or their conversion values in keeping with the Fund&#8217;s investment objective.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many convertible securities in which the Fund will invest have call provisions entitling the issuer to redeem the security at a specified time and at a specified price. This is one of the features of a convertible security which affects valuation. Calls may vary from absolute calls to provisional calls. Convertible securities with superior call protection usually trade at a higher premium. If long term interest rates decline, the interest rates of new convertible securities will also decline. Therefore, in a falling interest rate environment, companies may be expected to call convertible securities with high coupons and the Fund would have to invest the proceeds from such called issues in securities with lower coupons. Thus, convertible securities with superior call protection will permit the Fund to maintain a higher yield than with issues without call protection.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 153 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dilution Risk for Convertible Securities.</i> In the absence of adequate anti-dilution provisions in a convertible security, dilution in the value of the Fund&#8217;s holding may occur in the event the underlying stock is subdivided, additional equity securities are issued for below market value, a stock dividend is declared, or the issuer enters into another type of corporate transaction that has a similar effect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Restricted and Illiquid Securities</i>. The Fund may invest up to a total of 10% of its net assets in securities that are subject to restrictions on resale and securities the markets for which are illiquid, including repurchase agreements with more than seven days to maturity. Illiquid securities include securities the disposition of which is subject to substantial legal or contractual restrictions. The sale of illiquid securities often requires more time and results in higher brokerage charges or dealer discounts and other selling expenses than does the sale of securities eligible for trading on national securities exchanges or in the OTC markets. Restricted securities may sell at a price lower than similar securities that are not subject to restrictions on resale. Unseasoned issuers are companies (including predecessors) that have operated less than three years. The continued liquidity of such securities may not be as well assured as that of publicly traded securities, and accordingly the Board will monitor their liquidity. The Board will review pertinent factors such as trading activity, reliability of price information and trading patterns of comparable securities in determining whether to treat any such security as liquid for purposes of the foregoing 10% test. To the extent the Board treats such securities as liquid, temporary impairments to trading patterns of such securities may adversely affect the Fund&#8217;s liquidity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with pronouncements of the SEC, the Fund may invest in restricted securities that can be traded among qualified institutional buyers under Rule&#160;144A under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), without registration and may treat them as liquid for purposes of the foregoing 10% test if such securities are found to be liquid. The Board has adopted guidelines and delegated to the Investment Adviser, subject to the supervision of the Board, the function of determining and monitoring the liquidity of particular Rule&#160;144A securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="b_003"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INVESTMENT RESTRICTIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund operates under the following restrictions that constitute fundamental policies under the 1940 Act and that, except as otherwise noted, cannot be changed without the affirmative vote of a majority, as defined in the 1940 Act, of the outstanding voting securities of the Fund (voting together as a single class). In addition, the affirmative vote of a majority, as defined in the 1940 Act, of the outstanding preferred stock of the Fund (voting together as a separate class) is also required to change a fundamental policy, as defined in the 1940 Act. For purposes of the preferred stock voting rights described in the foregoing sentence, except as otherwise required under the 1940 Act, the majority of the outstanding preferred stock means, in accordance with Section&#160;2(a)(42) of the 1940 Act, the vote of (i) of 67% or more of the shares of preferred stock present at the stockholders meeting called for such vote, if the holders of more than 50% of the outstanding preferred stock are present or represented by proxy or (ii) more than 50% of the outstanding preferred stock, whichever is less. Except as otherwise noted, all percentage limitations set forth below apply immediately after a purchase or initial investment and any subsequent change in any applicable percentage resulting from market fluctuations does not require any action. The Fund may not:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1. Invest 25% or more of its total assets, taken at market value at the time of each investment, in the securities of issuers in any particular industry. This restriction does not apply to investments in direct obligations of the United States or by its agencies or instrumentalities that are entitled to the full faith and credit of the United States and that, other than United States Treasury Bills, provide for the periodic payment of interest and the full payment of principal at maturity or call for redemption (&#8220;U.S. Government Obligations&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2. Purchase securities of other investment companies, except in connection with a merger, consolidation, acquisition or reorganization, if more than 10% of the market value of the total assets of the Fund would be invested in securities of other investment companies, more than 5% of the market value of the total assets of the Fund would be invested in the securities of any one investment company or the Fund would own more than 3% of any other investment company&#8217;s securities, provided, however, this restriction shall not apply to securities of any investment company organized by the Fund that are to be distributed pro rata as a dividend to its stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 154 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3. Purchase or sell commodities or commodity contracts except that the Fund may purchase or sell futures contracts and related options thereon if immediately thereafter (i) no more than 5% of its total assets are invested in margins and premiums and (ii) the aggregate market value of its outstanding futures contracts and market value of the currencies and futures contracts subject to outstanding options written by the Fund does not exceed 50% of the market value of its total assets. The Fund may not purchase or sell real estate, provided that the Fund may invest in securities secured by real estate or interests therein or issued by companies which invest in real estate or interests therein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4. Purchase any securities on margin or make short sales, except that the Fund may obtain such short term credit as may be necessary for the clearance of purchases and sales of portfolio securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5. Make loans of money, except by the purchase of a portion of publicly distributed debt obligations in which the Fund may invest, and repurchase agreements with respect to those obligations, consistent with its investment objectives and policies. The Fund reserves the authority to make loans of its portfolio securities to financial intermediaries in an aggregate amount not exceeding 20% of its total assets. Any such loans may only be made upon approval of, and subject to any conditions imposed by, the Board. Because these loans would at all times be fully collateralized, the risk of loss in the event of default of the borrower should be slight.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6. Borrow money, except that the Fund may borrow from banks and other financial institutions on an unsecured basis, in an amount not exceeding 10% of its total assets, to finance the repurchase of its stock. The Fund also may borrow money on a secured basis from banks as a temporary measure for extraordinary or emergency purposes. Temporary borrowings may not exceed 5% of the value of the total assets of the Fund at the time the loan is made. The Fund may pledge up to 10% of the lesser of the cost or value of its total assets to secure temporary borrowings. The Fund will not borrow for investment purposes. Immediately after any borrowing, the Fund will maintain asset coverage of not less than 300% with respect to all borrowings. While the borrowing of the Fund exceeds 5% of its respective total assets, the Fund will make no further purchases of securities, although this limitation will not apply to repurchase transactions as described above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7. Issue senior securities, except to the extent permitted by applicable law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8. Underwrite securities of other issuers except insofar as the Fund may be deemed an underwriter under the Securities Act in selling portfolio securities; provided, however, this restriction shall not apply to securities of any investment company organized by the Fund that are to be distributed pro rata as a dividend to its stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9. Invest more than 10% of its total assets in illiquid securities, such as repurchase agreements with maturities in excess of seven days, or securities that at the time of purchase have legal or contractual restrictions on resale.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With respect to (3) above, because most swaps are now considered commodity interests under the Commodity Exchange Act and its rules, this restriction is being interpreted to permit the Fund to engage in transactions in swaps and options on swaps related to financial instruments, such as securities, securities indices, currencies and other financial instruments, but not to engage in transactions in swaps related to physical commodities, such as oil or metals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With respect to (6) above, the 1940 Act permits the Fund to borrow money in amounts of up to one-third of the Fund&#8217;s total assets for any purpose, and to borrow up to 5% of the Fund&#8217;s total assets for temporary purposes. The Fund&#8217;s total assets include the amounts being borrowed. To limit the risks attendant to borrowing, the 1940 Act requires the Fund to have an &#8220;asset coverage&#8221; of at least 300% of the amount of its borrowings at the time the borrowing is incurred. Asset coverage means the ratio that the value of the Fund&#8217;s total assets (including amounts borrowed), minus liabilities other than borrowings, bears to the aggregate amount of all borrowings. Borrowing money to increase portfolio holdings is known as &#8220;leveraging.&#8221; Certain trading practices and investments, such as derivatives, may be considered to be borrowings or involve leverage and thus are subject to the 1940 Act restrictions. The Fund must comply with Rule&#160;18f-4 under the 1940 Act with respect to trading practices and investments that constitute &#8220;Derivatives Transactions&#8221; (as defined above) under the Rule. See &#8220;Investment Objectives and Policies&#8212;Investment Practices&#8212;Derivatives Transactions Subject to Rule&#160;18f-4 Under the 1940 Act.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 155 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The investment restriction in (6) above will be interpreted to permit the Fund to (a) engage in trading practices and investments that may be considered to be borrowing or to involve leverage to the extent permitted by the 1940 Act, (b) engage in securities lending in accordance with SEC staff guidance and interpretations and (c) settle securities transactions within the ordinary settlement cycle for such transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With respect to (7) above, under the 1940 Act, the Fund may issue senior securities (which may be stock, such as preferred shares, and/or securities representing debt, such as notes) only if immediately after such issuance the value of the Fund&#8217;s total assets, less certain ordinary course liabilities, exceeds 300% of the amount of the debt outstanding and exceeds 200% of the amount of preferred shares (measured by liquidation value) and debt outstanding, which is referred to as the &#8220;asset coverage&#8221; required by the 1940 Act. At any time the Fund has debt securities or preferred stock outstanding the Fund may be restricted from declaring cash distributions on, or repurchasing, common or preferred shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund is currently classified as a diversified fund under the 1940 Act. This means that the Fund may not purchase securities of an issuer (other than (i) obligations issued or guaranteed by the U.S. government, its agencies or instrumentalities and (ii) <span style="text-decoration: underline">securities of other investment companies</span>) if, with respect to 75% of its total assets, (a) more than 5% of the Fund&#8217;s total assets would be invested in securities of that issuer or (b) the Fund would hold more than 10% of the outstanding voting securities of that issuer. With respect to the remaining 25% of its total assets, the Fund can invest more than 5% of its assets in one issuer. Under the 1940 Act, the Fund cannot change its classification from diversified to non-diversified without shareholder approval (including approval by holders the outstanding preferred stock of the Fund (voting together as a separate class)).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="b_004"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>MANAGEMENT OF THE FUND</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Information about Directors and Officers</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Please refer to the section of the Fund&#8217;s <a href="https://www.sec.gov/Archives/edgar/data/794685/000113322823001747/gab-html6178_def14a.htm">April 5, 2023 definitive proxy statement on Schedule 14A for the annual meeting of the Fund&#8217;s shareholders entitles &#8220;Information about Directors and Officers,&#8221;</a> which is incorporated by reference herein, for a discussion of the Fund&#8217;s Directors, their principal occupations and other affiliates during the past five years, the number of portfolios that they oversee, and other information about them.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kuni Nakamura passed away on October&#160;15, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Directors&#8212;Leadership Structure and Oversight Responsibilities</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Please refer to the <a href="https://www.sec.gov/Archives/edgar/data/794685/000113322823001747/gab-html6178_def14a.htm">section of the Fund&#8217;s definitive proxy statement on Schedule 14A for the annual meeting of the Fund&#8217;s shareholders entitled &#8220;Directors &#8211; Leadership Structure and Oversight Responsibilities,&#8221;</a> which is incorporated by reference herein, for a discussion of the Board&#8217;s leadership structure and oversight.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board Committees</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Please refer to the <a href="https://www.sec.gov/Archives/edgar/data/794685/000113322823001747/gab-html6178_def14a.htm">sections of the Fund&#8217;s definitive proxy statement on Schedule 14A for the annual meeting of the Fund&#8217;s shareholders entitles &#8220;Directors &#8211; Leadership Structure and Oversight Responsibilities,&#8221; &#8220;The Audit Committee and Audit Committee Report,&#8221; and &#8220;Nominating Committee,&#8221;</a> which are incorporated by reference herein, for a discussion of the Board&#8217;s Committees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Nominating Committee is responsible for identifying and recommending qualified candidates to the Board in the event that a position is vacated or created. The Nominating Committee will consider recommendations by stockholders if a vacancy were to exist. Such recommendations should be forwarded to the Secretary of the Fund. The Directors serving on the Fund&#8217;s Nominating Committee are Frank J. Fahrenkopf, Jr. and Salvatore J. Zizza.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Audit Committee is generally responsible for reviewing and evaluating issues related to the accounting and financial reporting policies and internal controls of the Fund and, as appropriate, the internal controls of certain service providers, overseeing the quality and objectivity of the Fund&#8217;s financial statements and the audit thereof and acting as a liaison between the Board and the Fund&#8217;s independent registered public accounting firm. James P. Conn, William F. Heitmann, and Salvatore J. Zizza, who are not &#8220;interested persons&#8221; of the Fund as defined in the 1940 Act, serve on the Fund&#8217;s Audit Committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 156 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund has an ad hoc Proxy Voting Committee, which, if so determined by the Board, is authorized to exercise voting power and/or dispositive power over specific securities held in the Fund&#8217;s portfolio for such period as the Board may determine.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the fiscal year ended December&#160;31, 2022, the Board held two Nominating Committee meetings and two Audit Committee meetings. The ad hoc Proxy Voting Committee did not meet during the fiscal year ended December&#160;31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund does not have a standing compensation committee, but does have representatives on a multi-fund ad hoc Compensation Committee relating to compensation of the Chief Compliance Officer for the funds and certain officers of the closed-end funds in the Fund Complex.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director Share Ownership</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Please refer to <a href="https://www.sec.gov/Archives/edgar/data/794685/000113322823001747/gab-html6178_def14a.htm">the section of the Fund&#8217;s definitive proxy statement on Schedule 14A for the annual meeting of the Fund&#8217;s shareholders entitled &#8220;Beneficial Ownership of Shares Held in the Fund and the Family of Investment Companies for each Director and Nominee for Election as Director,&#8221;</a> which is incorporated by reference herein, for information relating to share ownership and the amount of shared beneficially owned in the Fund by each Director.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Remuneration of Directors and Officers</b></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Please refer to the <a href="https://www.sec.gov/Archives/edgar/data/794685/000113322823001747/gab-html6178_def14a.htm">sections of the Fund&#8217;s definitive proxy statement on Schedule 14A for the annual meeting of the Fund&#8217;s shareholders entitled &#8220;Beneficial Ownership of Shares Held in the Fund and the Family of Investment Companies for each Director and Nominee for Election as Director&#8221; and &#8220;Other Board Related Matters,&#8221;</a> which are incorporated by reference herein, for information pertaining to the compensation received by each Director for his or her services as a Director of the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Indemnification of Officers and Directors; Limitations on Liability</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject to limitations imposed by the 1940 Act, the Governing Documents of the Fund provide that the Fund will indemnify its Directors and officers and may indemnify its employees or agents against liabilities and expenses incurred in connection with litigation in which they may be involved because of their positions with the Fund, to the fullest extent permitted by law. However, nothing in the Governing Documents protects or indemnifies a Director, officer, employee or agent of the Fund against any liability to which such person would otherwise be subject in the event of such person&#8217;s willful misfeasance, bad faith, gross negligence or reckless disregard of the duties involved in the conduct of his or her position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investment Management</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Investment Adviser is a New York limited liability company which serves as an investment adviser to registered investment companies with combined aggregate net assets of approximately $19.1 billion as of September&#160;30, 2023. The Investment Adviser is a registered adviser under the Investment Advisers Act of 1940, as amended, and is a wholly owned subsidiary of GAMCO Investors, Inc. (&#8220;GAMI&#8221;). Mr.&#160;Mario J. Gabelli owns a majority of the stock of GGCP, Inc. (&#8220;GGCP&#8221;), which holds a majority of the capital stock and voting power of GAMI. The Investment Adviser has several affiliates that provide investment advisory services: GAMCO Asset Management Inc. (&#8220;GAMCO&#8221;), a wholly owned subsidiary of GAMI, acts as investment adviser for individuals, pension trusts, profit sharing trusts, endowments, and as a sub-adviser to certain third party investment funds, which include registered investment companies, having assets under management of approximately $10.0 billion as of September&#160;30, 2023; Teton Advisors, Inc., and its wholly owned investment adviser, Keeley Teton Advisers, LLC, with assets under management of approximately $1.3 billion as of September&#160;30, 2023, acts as investment adviser to The TETON Westwood Funds, the KEELEY Funds, and separately managed accounts; and Gabelli &amp; Company Investment Advisers, Inc. (formerly, Gabelli Securities, Inc.), a wholly owned subsidiary of Associated Capital Group, Inc. (&#8220;Associated Capital&#8221;), acts as investment adviser for certain alternative investment products, consisting primarily of risk arbitrage and merchant banking limited partnerships and offshore companies, with assets under management of approximately $1.5 billion as of September&#160;30, 2023. Teton Advisors, Inc. was spun off by GAMI in March&#160;2009 and is an affiliate of GAMI by virtue of Mr.&#160;Gabelli&#8217;s ownership of GGCP, the principal shareholder of Teton Advisors, Inc., as of June&#160;30, 2023. Associated Capital was spun off from GAMI on November&#160;30, 2015, and is an affiliate of GAMI by virtue of Mr.&#160;Gabelli&#8217;s ownership of GGCP, the principal shareholder of Associated Capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 157 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Investment Adviser will provide a continuous investment program for the portfolios of the Fund and oversee the administration of all aspects of the Fund&#8217;s business and affairs. The Investment Adviser has sole investment discretion for the Fund&#8217;s assets under the supervision of the Board and in accordance with the Fund&#8217;s stated policies. The Investment Adviser will select investments for the Fund and will place purchase and sale orders on behalf of the Fund.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investment Advisory Agreement</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Affiliates of the Investment Adviser may, in the ordinary course of their business, acquire for their own account or for the accounts of their advisory clients, significant (and possibly controlling) positions in the securities of companies that may also be suitable for investment by the Fund. The securities in which the Fund might invest may thereby be limited to some extent. For instance, many companies have adopted so-called &#8220;poison pill&#8221; or other defensive measures designed to discourage or prevent the completion of non-negotiated offers for control of the company. Such defensive measures may have the effect of limiting the shares of the company that might otherwise be acquired by the Fund if the affiliates of the Investment Adviser or their advisory accounts have or acquire a significant position in the same securities. However, the Investment Adviser does not believe that the investment activities of its affiliates will have a material adverse effect upon each the Fund in seeking to achieve its investment objectives. Securities purchased or sold pursuant to contemporaneous orders entered on behalf of the investment company accounts of the Investment Adviser or the advisory accounts managed by its affiliates for their unaffiliated clients are allocated pursuant to principles believed to be fair and not disadvantageous to any such accounts. In addition, all such orders are accorded priority of execution over orders entered on behalf of accounts in which the Investment Adviser or its affiliates have a substantial pecuniary interest. The Adviser may on occasion give advice or take action with respect to other clients that differs from the actions taken with respect to the Fund. The Fund may invest in the securities of companies that are investment management clients of GAMCO Asset Management Inc. In addition, portfolio companies or their officers or directors may be minority stockholders of the Investment Adviser or its affiliates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the terms of the Fund&#8217;s investment advisory agreement (&#8220;Advisory Agreement&#8221;), the Investment Adviser manages the portfolio of the Fund in accordance with its stated investment objectives and policies, makes investment decisions for the Fund, places orders to purchase and sell securities on behalf of the Fund and manages its other business and affairs, all subject to the supervision and direction of the Fund&#8217;s Board. In addition, under the Advisory Agreement, the Investment Adviser oversees the administration of all aspects of the Fund&#8217;s business and affairs and provides, or arranges for others to provide, at the Investment Adviser&#8217;s expense, certain enumerated services, including maintaining the Fund&#8217;s books and records, preparing reports to the Fund&#8217;s stockholders and supervising the calculation of the net asset value of its shares. All expenses of computing the net asset value of the Fund, including any equipment or services obtained solely for the purpose of pricing shares or valuing its investment portfolio, underwriting compensation and reimbursements in connection with sales of its securities, the costs of utilizing a third party to monitor and collect class action settlements on behalf of the Fund, compensation to an administrator for certain SEC filings on behalf of the Fund, the fees and expenses of directors who are not officers or employees of the Investment Adviser of its affiliates, compensation and other expenses of employees of the Fund as approved by the directors, the pro rata costs of the Fund&#8217;s chief compliance officer, charges of the custodian, any sub-custodian and transfer agent and dividend paying agent, expenses in connection with the Automatic Dividend Reinvestment Plan and Voluntary Cash Purchase Plan, accounting and pricing costs, membership fees in trade associations, expenses for legal and independent accountants&#8217; services, costs of printing proxies, share certificates and stockholder reports, fidelity bond coverage for Fund officers and employees, directors&#8217; and officers&#8217; errors and omissions insurance coverage, and stock exchange listing fees will be an expense of the Fund unless the Investment Adviser voluntarily assumes responsibility for such expenses. During fiscal year 2022, the Fund paid or accrued $45,000 to the Investment Adviser in connection with the cost of computing the Fund&#8217;s net asset value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 158 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Advisory Agreement combines investment advisory and certain administrative responsibilities in one agreement. For services rendered by the Investment Adviser on behalf of the Fund&#8217;s Advisory Agreement, the Fund pays the Investment Adviser a fee computed weekly and paid monthly at the annual rate of 1.00% of the average weekly net assets of the Fund. The Fund&#8217;s average weekly net assets will be deemed to be the average weekly value of the Fund&#8217;s total assets minus the sum of the Fund&#8217;s liabilities (such liabilities exclude (i) the aggregate liquidation preference of outstanding shares of preferred stock and accumulated dividends, if any, on those shares and (ii) the liabilities for any money borrowed). The fee paid by the Fund may be higher when leverage in the form of preferred stock or borrowings is utilized, giving the Investment Adviser an incentive to utilize such leverage. Because the management fees are based on a percentage of average weekly net assets that includes assets attributable to the Fund&#8217;s use of leverage in the form of preferred stock or money borrowed, the Investment Adviser may have a conflict of interest in the input it provides to the Board regarding whether to use or increase the Fund&#8217;s use of such leverage. The Board bases its decision, with input from the Investment Adviser, regarding whether and how much leverage to use for the Fund on its assessment of whether such use of leverage is in the best interests of the Fund, and the Board seeks to manage the Investment Adviser&#8217;s potential conflict of interest by retaining the final decision on these matters and by periodically reviewing the Fund&#8217;s performance and use of leverage. The Investment Adviser has agreed to reduce the management fee on the incremental assets attributable to the Series C Auction Rate Preferred and Series E Auction Rate Preferred during the fiscal year if the total return of the net asset value of the common stock, including distributions and management fees subject to reduction, does not exceed the stated dividend rate or corresponding swap rate of each particular series of preferred stock for the period. This fee waiver was voluntarily undertaken by the Investment Adviser and will remain in effect as long as the Series C Auction Rate Preferred and Series E Auction Rate Preferred are outstanding. The Fund&#8217;s total return on the net asset value of its common stock is monitored on a monthly basis to assess whether the total return on the net asset value of its common stock exceeds the stated dividend rate or corresponding swap rate of each particular series of outstanding preferred stock for the period. The test to confirm the accrual of the management fee on the assets attributable to each particular series of preferred stock is annual. The Fund will accrue for the management fee on these assets during the fiscal year if it appears probable that the Fund will incur the additional management fee on those assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended December&#160;31, 2022, the Fund&#8217;s total return on the net asset value of the common stock did not exceed the stated dividend rate of the outstanding shares of Series C Auction Rate Preferred and Series E Auction Rate Preferred. Thus, management fees were not accrued on the liquidation value of Series C Auction Rate Preferred and Series E Auction Rate Preferred and management fees were reduced by $899,999.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Advisory Agreement provides that in the absence of willful misfeasance, bad faith, gross negligence or reckless disregard of its obligations and duties thereunder, the Investment Adviser is not liable for any error of judgment or mistake of law or for any loss suffered by the Fund. As part of the Advisory Agreement, the Fund has agreed that the name &#8220;Gabelli&#8221; is the Investment Adviser&#8217;s property, and that in the event the Investment Adviser ceases to act as an investment adviser to the Fund, the Fund will change its name to one not including &#8220;Gabelli.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to its terms, the Advisory Agreement will remain in effect with respect to the Fund if approved annually (i) by the Fund&#8217;s Board or by the holders of a majority of the Fund&#8217;s outstanding voting securities and (ii) by a majority of the Directors who are not &#8220;interested persons&#8221; (as defined in the 1940 Act) of any party to the Advisory Agreement, by vote cast in person at a meeting called for the purpose of voting on such approval.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A discussion regarding the basis of the Board&#8217;s approval of the Advisory Agreement for the Fund is available in the Fund&#8217;s semiannual report to stockholders for the six months ended June&#160;30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For each of the years ended December&#160;31, 2020, December&#160;31, 2021, and December&#160;31, 2022, the Investment Advisor was paid $17,547,966, $22,276,183 and $20,299,500, respectively, for advisory and administrative services rendered to the Fund.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Portfolio Manager Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Other Accounts Managed</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The table below shows the number of other accounts managed by the portfolio managers and the total assets in each of the following categories: registered investment companies, other paid investment vehicles and other accounts. For each category, the table also shows the number of accounts and the total assets in the accounts with respect to which the advisory fee is based on account performance. The information provided is as of December&#160;31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 159 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: left">Name of Portfolio Manager or Team Member</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Type of Accounts</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total<br /> Number&#160;of<br /> Accounts Managed</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total Assets</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number&#160;of<br />Accounts<br />Managed with<br />Advisory Fee<br /> Based on<br /> Performance</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total Assets with<br />Advisory fee<br />Based on<br /> Performance</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; width: 21%">Mario J. Gabelli, CFA</td>
    <td style="width: 1%">&#160;</td>
    <td style="vertical-align: top; text-align: left; width: 30%">Registered Investment Companies:</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: center; width: 10%">22</td>
    <td style="text-align: left; width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="vertical-align: top; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.6 billion</span></td>
    <td style="text-align: left; width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: center; width: 10%">4</td>
    <td style="text-align: left; width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3 billion</span></td>
    <td style="text-align: left; width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">Other Pooled Investment Vehicles:</td>
    <td>&#160;</td>
    <td style="text-align: center">7</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.0 billion</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">7</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">937 million</span></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">Other Accounts:</td>
    <td>&#160;</td>
    <td style="text-align: center">881</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1 billion</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="vertical-align: bottom; text-align: right">0</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Kevin V. Dreyer</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">Registered Investment Companies</td>
    <td>&#160;</td>
    <td style="text-align: center">5</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8 billion</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">1</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5 billion</span></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">Other Pooled Investment Vehicles:</td>
    <td>&#160;</td>
    <td style="text-align: center">1</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1 million</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="vertical-align: bottom; text-align: right">0</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">Other Accounts:</td>
    <td>&#160;</td>
    <td style="text-align: center">269</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2 billion</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="vertical-align: bottom; text-align: right">0</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Christopher J. Marangi</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">Registered Investment Companies</td>
    <td>&#160;</td>
    <td style="text-align: center">8</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.0 billion</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">2</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.7 billion</span></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">Other Pooled Investment Vehicles:</td>
    <td>&#160;</td>
    <td style="text-align: center">1</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1 million</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="vertical-align: bottom; text-align: right">0</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">Other Accounts:</td>
    <td>&#160;</td>
    <td style="text-align: center">275</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2 billion</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="vertical-align: bottom; text-align: right">0</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Daniel M. Miller</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">Registered Investment Companies</td>
    <td>&#160;</td>
    <td style="text-align: center">2</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39.5 million</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="vertical-align: bottom; text-align: right">0</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">Other Pooled Investment Vehicles:</td>
    <td>&#160;</td>
    <td style="text-align: center">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">$</td>
    <td style="vertical-align: bottom; text-align: right">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="vertical-align: bottom; text-align: right">0</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">Other Accounts:</td>
    <td>&#160;</td>
    <td style="text-align: center">7</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.6 million</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="vertical-align: bottom; text-align: right">0</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Robert D. Leininger, CFA</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">Registered Investment Companies</td>
    <td>&#160;</td>
    <td style="text-align: center">3</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5 billion</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">1</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5 billion</span></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">Other Pooled Investment Vehicles:</td>
    <td>&#160;</td>
    <td style="text-align: center">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">$</td>
    <td style="vertical-align: bottom; text-align: right"> 0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="vertical-align: bottom; text-align: right">0</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">Other Accounts:</td>
    <td>&#160;</td>
    <td style="text-align: center">140</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">166.6 million</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="vertical-align: bottom; text-align: right">0</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Ashish Sinha</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">Registered Investment Companies</td>
    <td>&#160;</td>
    <td style="text-align: center">2</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.4 million</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="vertical-align: bottom; text-align: right">0</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">Other Pooled Investment Vehicles:</td>
    <td>&#160;</td>
    <td style="text-align: center">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">$</td>
    <td style="vertical-align: bottom; text-align: right">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="vertical-align: bottom; text-align: right">0</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">Other Accounts:</td>
    <td>&#160;</td>
    <td style="text-align: center">3</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.5 million</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="vertical-align: bottom; text-align: right">0</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Gustavo Pifano</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">Registered Investment Companies</td>
    <td>&#160;</td>
    <td style="text-align: center">2</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5 billion</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">1</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5 billion</span></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">Other Pooled Investment Vehicles:</td>
    <td>&#160;</td>
    <td style="text-align: center">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">$</td>
    <td style="vertical-align: bottom; text-align: right">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="vertical-align: bottom; text-align: right">0</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">Other Accounts:</td>
    <td>&#160;</td>
    <td style="text-align: center">1</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less than $100,000</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="vertical-align: bottom; text-align: right">0</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Ian Lapey</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">Registered Investment Companies</td>
    <td>&#160;</td>
    <td style="text-align: center">2</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52.1 million</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="vertical-align: bottom; text-align: right">0</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">Other Pooled Investment Vehicles:</td>
    <td>&#160;</td>
    <td style="text-align: center">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">$</td>
    <td style="vertical-align: bottom; text-align: right">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="vertical-align: bottom; text-align: right">0</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">Other Accounts:</td>
    <td>&#160;</td>
    <td style="text-align: center">14</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.1 million</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="vertical-align: bottom; text-align: right">0</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Sara E. Wojda</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">Registered Investment Companies</td>
    <td>&#160;</td>
    <td style="text-align: center">1</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">244.7 million</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="vertical-align: bottom; text-align: right">0</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">Other Pooled Investment Vehicles:</td>
    <td>&#160;</td>
    <td style="text-align: center">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">$</td>
    <td style="vertical-align: bottom; text-align: right">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="vertical-align: bottom; text-align: right">0</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">Other Accounts:</td>
    <td>&#160;</td>
    <td style="text-align: center">4</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.3 million</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="vertical-align: bottom; text-align: right">0</td>
    <td style="text-align: left">&#160;</td></tr>
  </table>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 160 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: left">Name of Portfolio Manager or Team Member</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Type of Accounts</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total<br /> Number&#160;of<br /> Accounts Managed</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total Assets</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number&#160;of<br />Accounts<br />Managed with<br />Advisory Fee<br /> Based on<br /> Performance</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total Assets with<br />Advisory fee<br />Based on<br /> Performance</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Howard F. Ward</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">Registered Investment Companies</td>
    <td>&#160;</td>
    <td style="text-align: center">3</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4 billion</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="vertical-align: bottom; text-align: right">0</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">Other Pooled Investment Vehicles:</td>
    <td>&#160;</td>
    <td style="text-align: center">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: left">$</td>
    <td style="vertical-align: bottom; text-align: right">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="vertical-align: bottom; text-align: right">0</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">Other Accounts:</td>
    <td>&#160;</td>
    <td style="text-align: center">59</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">249.8 million</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="vertical-align: bottom; text-align: right">0</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: left">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; width: 21%">Hendi Susanto</td>
    <td style="width: 1%">&#160;</td>
    <td style="vertical-align: top; text-align: left; width: 30%">Registered Investment Companies</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: center; width: 10%">5</td>
    <td style="text-align: left; width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="vertical-align: bottom; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1 billion</span></td>
    <td style="text-align: left; width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: center; width: 10%">1</td>
    <td style="text-align: left; width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td>
    <td style="vertical-align: bottom; text-align: right; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5 billion</span></td>
    <td style="text-align: left; width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">Other Pooled Investment Vehicles:</td>
    <td>&#160;</td>
    <td style="text-align: center">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: left">$</td>
    <td style="vertical-align: bottom; text-align: right">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="vertical-align: bottom; text-align: right">0</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">Other Accounts:</td>
    <td>&#160;</td>
    <td style="text-align: center">23</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1 million</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="vertical-align: bottom; text-align: right">0</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: left">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Joseph Gabelli</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">Registered Investment Companies</td>
    <td>&#160;</td>
    <td style="text-align: center">1</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">433.6 million</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="vertical-align: bottom; text-align: right">0</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">Other Pooled Investment Vehicles:</td>
    <td>&#160;</td>
    <td style="text-align: center">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: left">$</td>
    <td style="vertical-align: bottom; text-align: right">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="vertical-align: bottom; text-align: right">0</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">Other Accounts:</td>
    <td>&#160;</td>
    <td style="text-align: center">4</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.5 million</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="vertical-align: bottom; text-align: right">0</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: left">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Macrae (Mac) Sykes</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">Registered Investment Companies</td>
    <td>&#160;</td>
    <td style="text-align: center">1</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2 million</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="vertical-align: bottom; text-align: right">0</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">Other Pooled Investment Vehicles:</td>
    <td>&#160;</td>
    <td style="text-align: center">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: left">$</td>
    <td style="vertical-align: bottom; text-align: right">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="vertical-align: bottom; text-align: right">0</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: left">Other Accounts:</td>
    <td>&#160;</td>
    <td style="text-align: center">22</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.2 million</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="vertical-align: bottom; text-align: right">0</td>
    <td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Potential Conflicts of Interest</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As reflected above, the portfolio managers manage accounts in addition to the Fund. Actual or apparent conflicts of interest may arise when a portfolio manager for the Fund also has day-to-day management responsibilities with respect to one or more other accounts. These potential conflicts include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Allocation of Limited Time and Attention</i>. Because the portfolio managers manage many accounts, they may not be able to formulate as complete a strategy or identify equally attractive investment opportunities for each of those accounts as might be the case if they were to devote all of their attention to the management of only a few accounts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Allocation of Limited Investment Opportunities</i>. If the portfolio managers identify an investment opportunity that may be suitable for multiple accounts, the Fund may not be able to take full advantage of that opportunity because the opportunity may be allocated among all or many of these accounts or other accounts managed primarily by other portfolio managers of the Adviser, and their affiliates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Selection of Broker/Dealers</i>. Because of Mr.&#160;Gabelli&#8217;s indirect majority ownership interest in G.research, LLC, he may have an incentive to use G.research to execute portfolio transactions for the Fund.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Pursuit of Differing Strategies.</i> At times, the portfolio managers may determine that an investment opportunity may be appropriate for only some of the accounts for which they exercise investment responsibility, or may decide that certain of these accounts should take differing positions with respect to a particular security. In these cases, the portfolio managers may execute differing or opposite transactions for one or more accounts which may affect the market price of the security or the execution of the transaction, or both, to the detriment of one or more of their accounts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 161 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Variation in Compensation</i>. A conflict of interest may arise where the financial or other benefits available to the portfolio managers differ among the accounts that they manage. If the structure of the Adviser&#8217;s management fee or the portfolio manager&#8217;s compensation differs among accounts (such as where certain accounts pay higher management fees or performance-based management fees), the portfolio managers may be motivated to favor certain accounts over others. The portfolio managers also may be motivated to favor accounts in which they have an investment interest, or in which the Adviser, or its affiliates have investment interests. Similarly, the desire to maintain assets under management or to enhance a portfolio manager&#8217;s performance record or to derive other rewards, financial or otherwise, could influence the portfolio manager in affording preferential treatment to those accounts that could most significantly benefit the portfolio manager. For example, as reflected above, if the portfolio manager manages accounts which have performance fee arrangements, certain portions of his/her compensation will depend on the achievement of performance milestones on those accounts. The portfolio manager could be incented to afford preferential treatment to those accounts and thereby be subject to a potential conflict of interest.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Investment Adviser and the Fund have adopted compliance policies and procedures that are designed to address the various conflicts of interest that may arise for the Investment Adviser and their staff members. However, there is no guarantee that such policies and procedures will be able to detect and prevent every situation in which an actual or potential conflict may arise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ownership of Shares in the Fund</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December&#160;31, 2022, the portfolio managers of the Fund own the following amounts of equity securities of the Fund.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Mario J. Gabelli, CFA</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">Over $1,000,000</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Kevin V. Dreyer</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">$10,001-$50,000</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Christopher J. Marangi</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">$10,001-$50,000</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 68%; text-align: left">Daniel M. Miller</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right">$0</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Robert D. Leininger, CFA</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">$0</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Ashish Sinha</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">$0</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Gustavo Pifano</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">$0</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Ian Lapey</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">$0</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Sara E. Wojda</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">$0</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Howard F. Ward</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">$0</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Hendi Susanto</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">$0</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Joseph Gabelli</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">$0</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Macrae (Mac) Sykes</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">$0</td>
    <td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation Structure for Mario J. Gabelli</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.&#160;Gabelli receives incentive-based variable compensation based on a percentage of net revenues received by the Adviser for managing the Fund. Net revenues are determined by deducting from gross investment management fees the firm&#8217;s expenses (other than Mr.&#160;Gabelli&#8217;s compensation) allocable to the Fund. Four closed-end registered investment companies (including this Fund) managed by Mr.&#160;Gabelli have arrangements whereby the Adviser will only receive its investment advisory fee attributable to the liquidation value of outstanding preferred stock (and Mr.&#160;Gabelli would only receive his percentage of such advisory fee) if certain performance levels are met. Additionally, he receives similar incentive-based variable compensation for managing other accounts within the firm and its affiliates. This method of compensation is based on the premise that superior long-term performance in managing a portfolio should be rewarded with higher compensation as a result of growth of assets through appreciation and net investment activity. The level of compensation is not determined with specific reference to the performance of any account against any specific benchmark. One of the other closed-end registered investment companies managed by Mr.&#160;Gabelli has a performance (fulcrum) fee arrangement for which his compensation is adjusted up or down based on the performance of the investment company relative to an index. Mr.&#160;Gabelli manages other accounts with performance fees. Compensation for managing these accounts has two components. One component is based on a percentage of net revenues to the Investment Adviser for managing the account. The second component is based on absolute performance of the account, with respect to which a percentage of such performance fee is paid to Mr.&#160;Gabelli. As an executive officer of the Adviser&#8217;s parent company, GAMI, Mr.&#160;Gabelli also receives ten percent of the net operating profits of the parent company. He receives no base salary, no annual bonus, and no stock options. Mr.&#160;Gabelli may also enter into and has entered into agreements to defer or waive his compensation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 162 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation Structure for Portfolio Managers Other Than Mario J. Gabelli</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The compensation of the portfolio managers for the Fund is structured to enable the Adviser to attract and retain highly qualified professionals in a competitive environment. The portfolio managers receive a compensation package that includes a minimum draw or base salary, equity-based incentive compensation via awards of restricted stock, and incentive-based variable compensation based on a percentage of net revenue received by the Adviser for managing the Fund to the extent that the amount exceeds a minimum level of compensation. Net revenues are determined by deducting from gross investment management fees certain of the firm&#8217;s expenses (other than the respective portfolio manager&#8217;s compensation) allocable to the respective Fund (the incentive-based variable compensation for managing other accounts is also based on a percentage of net revenues to the investment adviser for managing the account). This method of compensation is based on the premise that superior long-term performance in managing a portfolio should be rewarded with higher compensation as a result of growth of assets through appreciation and net investment activity. The level of equity-based incentive and incentive-based variable compensation is based on an evaluation by the Adviser&#8217;s parent, GAMI, of quantitative and qualitative performance evaluation criteria. This evaluation takes into account, in a broad sense, the performance of the accounts managed by the portfolio manager, but the level of compensation is not determined with specific reference to the performance of any account against any specific benchmark. Generally, greater consideration is given to the performance of larger accounts and to longer term performance over smaller accounts and short-term performance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Portfolio Holdings Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employees of the Investment Adviser and its affiliates will often have access to information concerning the portfolio holdings of the Fund. The Fund and the Investment Adviser have adopted policies and procedures that require all employees to safeguard proprietary information of the Fund, which includes information relating to the Fund&#8217;s portfolio holdings as well as portfolio trading activity of the Investment Adviser with respect to the Fund (collectively, &#8220;Portfolio Holdings Information&#8221;). In addition, the Fund and the Investment Adviser have adopted policies and procedures providing that Portfolio Holdings Information may not be disclosed except to the extent that it is (a) made available to the general public by posting on the Fund&#8217;s website or filed as part of a required filing on Form N-PORT or N-CSR or (b) provided to a third party for legitimate business purposes or regulatory purposes, that has agreed to keep such data confidential under terms approved by the Investment Adviser&#8217;s legal department or outside counsel, as described below. The Investment Adviser will examine each situation under (b) with a view to determine that release of the information is in the best interest of the Fund and its stockholders and, if a potential conflict between the Investment Adviser&#8217;s interests and the Fund&#8217;s interests arises, to have such conflict resolved by the Chief Compliance Officer or those Directors who are not considered to be &#8220;interested persons,&#8221; as defined in the 1940 Act. These policies further provide that no officer of the Fund or employee of the Investment Adviser shall communicate with the media about the Fund without obtaining the advance consent of the Chief Executive Officer, Chief Operating Officer, or General Counsel of the Investment Adviser.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the foregoing policies, the Fund currently may disclose Portfolio Holdings Information in the circumstances outlined below. Disclosure generally may be either on a monthly or quarterly basis with no time lag in some cases and with a time lag of up to 60 days in other cases (with the exception of proxy voting services which require a regular download of data):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1) To regulatory authorities in response to requests for such information and with the approval of the Chief Compliance Officer of the Fund;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2) To fund rating and statistical agencies and to persons performing similar functions where there is a legitimate business purpose for such disclosure and such entity has agreed to keep such data confidential until at least it has been made public by the Investment Adviser;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3) To service providers of the Fund, as necessary for the performance of their services to the Fund and to the Board, where such entity has agreed to keep such data confidential until at least it has been made public by the Investment Adviser. The Fund&#8217;s current service providers that may receive such information are its administrator, sub-administrator, custodian, independent registered public accounting firm, legal counsel, and financial printers;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 163 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4) To firms providing proxy voting and other proxy services provided such entity has agreed to keep such data confidential until at least it has been made public by the Investment Adviser;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5) To certain broker dealers, investment advisers, and other financial intermediaries for purposes of their performing due diligence on the Fund and not for dissemination of this information to their clients or use of this information to conduct trading for their clients. Disclosure of Portfolio Holdings Information in these circumstances requires the broker, dealer, investment adviser, or financial intermediary to agree to keep such information confidential until it has been made public by the Investment Adviser and is further subject to prior approval of the Chief Compliance Officer of the Fund and shall be reported to the Board at the next quarterly meeting; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6) To consultants for purposes of performing analysis of the Fund, which analysis may be used by the consultant with its clients or disseminated to the public, provided that such entity shall have agreed to keep such information confidential until at least it has been made public by the Investment Adviser.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of the date of this SAI, the Fund makes information about portfolio securities available to its administrator, sub-administrator, custodian, and proxy voting services on a daily basis, with no time lag, to its typesetter on a quarterly basis with a ten day time lag, to its financial printers on a quarterly basis with a forty-five day time lag, and its independent registered public accounting firm and legal counsel on an as needed basis with no time lag. The names of the Fund&#8217;s administrator, custodian, independent registered public accounting firm, and legal counsel are set forth is this SAI. The Fund&#8217;s proxy voting service is Broadridge Investor Communication Services. The Fund selects from a number of financial printers who have agreed to keep such information confidential until at least it has been made public by the Investment Adviser. Other than these arrangements with the Fund&#8217;s service providers and proxy voting service, the Fund has no ongoing arrangements to make available information about the Fund&#8217;s portfolio securities prior to such information being disclosed in a publicly available filing with the SEC that is required to include the information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosures made pursuant to a confidentiality agreement are subject to periodic confirmation by the Chief Compliance Officer of the Fund that the recipient has utilized such information solely in accordance with the terms of the agreement. Neither the Fund, nor the Investment Adviser, nor any of the Investment Adviser&#8217;s affiliates will accept on behalf of itself, its affiliates, or the Fund any compensation or other consideration in connection with the disclosure of portfolio holdings of the Fund. The Board will review such arrangements annually with the Fund&#8217;s Chief Compliance Officer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="b_005"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DIVIDENDS AND DISTRIBUTIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund, along with other closed-end registered investment companies advised by the Investment Adviser, has obtained an exemption from Section&#160;19(b) of the 1940 Act and Rule&#160;19b-1 thereunder permitting it to make periodic distributions of long term capital gains provided that any distribution policy of the Fund with respect to its common stock calls for periodic (e.g., quarterly or semiannually, but in no event more frequently than monthly) distributions in an amount equal to a fixed percentage of the Fund&#8217;s average net asset value over a specified period of time or market price per share of common stock at or about the time of distribution or payment of a fixed dollar amount. The exemption also permits the Fund to make distributions with respect to its preferred stock in accordance with such stock&#8217;s terms. See &#8220;Automatic Dividend Reinvestment and Voluntary Cash Purchase Plans&#8221; in the Prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the total distributions required by a periodic payout policy exceed the Fund&#8217;s net investment income and net capital gain, the excess will be treated as a return of capital. Stockholders who periodically receive the payment of a dividend or other distribution consisting of a return of capital may be under the impression that they are receiving net profits when they are not. Stockholders should not assume that the source of a distribution from the Fund is net profit. Distributions sourced from paid-in-capital should not be considered the current yield or the total return from an investment in the Fund. If the Fund&#8217;s net investment income (including net short term capital gains) and net long term capital gains for any year exceed the amount required to be distributed under a periodic pay-out policy, the Fund generally intends to pay such excess once a year, but may, in its discretion, retain and not distribute net long term capital gains to the extent of such excess. The Fund reserves the right, but does not currently intend, to retain for reinvestment and pay the resulting U.S. federal income taxes on the excess of its net realized long term capital gains over its net short term capital losses, if any. See &#8220;Automatic Dividend Reinvestment and Voluntary Cash Purchase Plans&#8221; in the Prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 164 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="b_006"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PORTFOLIO TRANSACTIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject to policies established by the Board, the Investment Adviser is responsible for placing purchase and sale orders and the allocation of brokerage on behalf of the Fund. Transactions in equity securities are in most cases effected on U.S. stock exchanges and involve the payment of negotiated brokerage commissions. There may be no stated commission in the case of securities traded in OTC markets, but the prices of those securities may include undisclosed commissions or mark-ups. Principal transactions are not entered into with affiliates of the Fund. However, G.research, may execute transactions in the OTC markets on an agency basis and receive a stated commission therefrom. To the extent consistent with applicable provisions of the 1940 Act and the rules and exemptions adopted by the SEC thereunder, as well as other regulatory requirements, the Board has determined that portfolio transactions may be executed through G.research and its broker-dealer affiliates if, in the judgment of the Investment Adviser, the use of those broker-dealers is likely to result in price and execution at least as favorable as those of other qualified broker-dealers, and if, in particular transactions, the affiliated broker-dealers charge the Fund a rate consistent with that charged to comparable unaffiliated customers in similar transactions and comparable to rates charged by other broker-dealers for similar transactions. The Fund has no obligations to deal with any broker or group of brokers in executing transactions in portfolio securities. In executing transactions, the Investment Adviser seeks to obtain the best price and execution for the Fund, taking into account such factors as price, size of order, difficulty of execution and operational facilities of the firm involved and the firm&#8217;s risk in positioning a block of securities. While the Investment Adviser generally seeks reasonably competitive commission rates, the Fund does not necessarily pay the lowest commission available.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject to obtaining the best price and execution, brokers who provide supplemental research, market and statistical information, or other services (e.g., wire services) to the Investment Adviser or its affiliates may receive orders for transactions by the Fund. The term &#8220;research, market and statistical information&#8221; includes advice as to the value of securities, and advisability of investing in, purchasing or selling securities, and the availability of securities or purchasers or sellers of securities, and furnishing analyses and reports concerning issues, industries, securities, economic factors and trends, portfolio strategy and the performance of accounts. Information so received will be in addition to and not in lieu of the services required to be performed by the Investment Adviser under the Advisory Agreement and the expenses of the Investment Adviser will not necessarily be reduced as a result of the receipt of such supplemental information. Such information may be useful to the Investment Adviser and its affiliates in providing services to clients other than the Fund, and not all such information is used by the Investment Adviser in connection with the Fund. Conversely, such information provided to the Investment Adviser and its affiliates by brokers and dealers through whom other clients of the Investment Adviser and its affiliates effect securities transactions may be useful to the Investment Adviser in providing services to the Fund.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although investment decisions for the Fund are made independently from those for the other accounts managed by the Investment Adviser and its affiliates, investments of the kind made by the Fund may also be made for those other accounts. When the same securities are purchased for or sold by the Fund and any of such other accounts, it is the policy of the Investment Adviser and its affiliates to allocate such purchases and sales in a manner deemed fair and equitable over time to all of the accounts, including the Fund.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the fiscal years ended December&#160;31, 2020, December&#160;31, 2021 and December&#160;31, 2022, the Fund paid a total of $344,585, $314,754, and $298,865, respectively, in brokerage commissions, of which G.research and its affiliates received $41,765, $18,606, and $12,079, respectively. The amount received by G.research and its affiliates from the Fund in respect of brokerage commissions for the fiscal year ended December&#160;31, 2022 represented approximately 4% of the aggregate dollar amount of brokerage commissions paid by the Fund for such period and approximately 11% of the aggregate dollar amount of transactions by the Fund for such period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 165 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="b_007"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PORTFOLIO TURNOVER</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund does not engage in the trading of securities for the purpose of realizing short term profits, but adjusts its portfolio as it deems advisable in view of prevailing or anticipated market conditions to accomplish its investment objective. Portfolio turnover rate is calculated by dividing the lesser of an investment company&#8217;s annual sales or purchases of portfolio securities by the monthly average value of securities in its portfolio during the year, excluding portfolio securities the maturities of which at the time of acquisition were one year or less. A high rate of portfolio turnover involves correspondingly greater brokerage commission expense than a lower rate, which expense must be borne by the Fund and indirectly by its stockholders. The portfolio turnover rate may vary from year to year and will not be a factor when the Investment Adviser determines that portfolio changes are appropriate. A higher rate of portfolio turnover may also result in taxable gains being passed to stockholders sooner than would otherwise be the case. For the years ending December&#160;31, 2021 and 2022, the portfolio turnover rates were 12% and 9%, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="b_008"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TAXATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following discussion is a brief summary of certain federal income tax considerations affecting the Fund and the purchase, ownership and disposition of the Fund&#8217;s shares. This discussion assumes you are a U.S. person and that you hold your shares as capital assets. This discussion is based upon current provisions of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), the regulations promulgated thereunder and judicial and administrative authorities, all of which are subject to change or differing interpretations by the courts or the Internal Revenue Service (the &#8220;IRS&#8221;), possibly with retroactive effect. No ruling has been or will be sought from the IRS regarding any matter discussed herein. Counsel to the Fund has not rendered and will not render any legal opinion regarding any tax consequences relating to the Fund or an investment in the Fund. No attempt is made to present a detailed explanation of all federal tax concerns affecting the Fund and its stockholders (including stockholders owning large positions in the Fund).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The discussions set forth herein and in the Prospectus do not constitute tax advice and potential investors are urged to consult their own tax advisers to determine the tax consequences to them of investing in the Fund.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Taxation of the Fund</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund has qualified and intends to continue to qualify, as a regulated investment company under Subchapter M of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;) (a &#8220;RIC&#8221;). Accordingly, the Fund will, among other things, (i) derive in each taxable year at least 90% of its gross income from (a) dividends, interest (including tax-exempt interest), payments with respect to certain securities loans, and gains from the sale or other disposition of stock, securities or foreign currencies, or other income (including but not limited to gain from options, futures and forward contracts) derived with respect to its business of investing in such stock, securities or currencies and (b) net income derived from interests in certain publicly traded partnerships that are treated as partnerships for U.S. federal income tax purposes and that derive less than 90% of their gross income from the items described in (a) above (each a &#8220;Qualified Publicly Traded Partnership&#8221;); and (ii) diversify its holdings so that, at the end of each quarter of each taxable year (a) at least 50% of the value of its total assets is represented by cash and cash items, U.S. government securities, the securities of other regulated investment companies and other securities, with such other securities limited, in respect of any one issuer, to an amount not greater than 5% of the value of the Fund&#8217;s total assets and not more than 10% of the outstanding voting securities of such issuer and (b) not more than 25% of the value of the Fund&#8217;s total assets is invested in the securities of (I) any one issuer (other than U.S. government securities and the securities of other RICs), (II) any two or more issuers in which the Fund owns 20% or more of the voting stock and that are determined to be engaged in the same business or similar or related trades or businesses or (III) any one or more Qualified Publicly Traded Partnerships.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund may be able to cure a failure to derive 90% of its income from the sources specified above or a failure to diversify its holdings in the manner described above by paying a tax, by disposing of certain assets, or by paying a tax and disposing of assets. If, in any taxable year, the Fund fails one of these tests and does not timely cure the failure, the Fund will be taxed in the same manner as an ordinary corporation and distributions to its stockholders will not be deductible by the Fund in computing its taxable income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 166 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although in general the passive loss rules of the Code do not apply to regulated investment companies, such rules do apply to a regulated investment company with respect to items attributable to an interest in a Qualified Publicly Traded Partnership. The investments of the Fund in partnerships, including Qualified Publicly Traded Partnerships, may result in the Fund being subject to state, local, or foreign income, franchise or withholding tax liabilities, and to phantom income due to loan restructurings or other reasons.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a RIC, the Fund generally is not or will not be, as the case may be, subject to U.S. federal income tax on income and gains that it distributes each taxable year to stockholders, if it distributes at least 90% of the sum of the Fund&#8217;s (i) investment company taxable income (which includes, among other items, dividends, interest and the excess of any net short term capital gain over net long term capital loss and other taxable income, other than any net long term capital gain, reduced by deductible expenses) determined without regard to the deduction for dividends paid and (ii) its net tax-exempt interest (the excess of its gross tax-exempt interest over certain disallowed deductions). The Fund intends to distribute at least annually substantially all of such income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts not distributed on a timely basis in accordance with a calendar year distribution requirement are subject to a nondeductible 4% excise tax at the Fund level. To avoid the tax, the Fund must distribute during each calendar year an amount at least equal to the sum of (i) 98% of its ordinary income (not taking into account any capital gain or loss, and taking into account certain deferrals and elections) for the calendar year, (ii) 98.2% of its capital gain in excess of its capital loss (adjusted for certain ordinary losses) for a one-year period generally ending on October&#160;31 of the calendar year (unless an election is made to use the fund&#8217;s fiscal year), and (iii) certain undistributed amounts from previous years on which a fund paid no federal income tax. While the Fund intends to distribute any income and capital gain in the manner necessary to minimize imposition of the 4% excise tax, there can be no assurance that sufficient amounts of the Fund&#8217;s taxable income and capital gain will be distributed to avoid entirely the imposition of the tax. In that event, the Fund will be liable for the tax only on the amount by which it does not meet the foregoing distribution requirement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A distribution will be treated as paid during the calendar year if it is paid during the calendar year or declared by the Fund in October, November or December of the year, payable to stockholders of record on a date during such a month and paid by the Fund during January of the following year. Any such distributions paid during January of the following year will be deemed to be received no later than December&#160;31 of the year the distributions are declared, rather than when the distributions are received.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the Fund were unable to satisfy the 90% distribution requirement or otherwise were to fail to qualify as a RIC in any year, it would be taxed in the same manner as an ordinary corporation and distributions to the Fund&#8217;s stockholders would not be deductible by the Fund in computing its taxable income. To qualify again to be taxed as a RIC in a subsequent year, the Fund would be required to distribute to its stockholders its earnings and profits attributable to non-RIC years. In addition, if the Fund failed to qualify as a RIC for a period greater than two taxable years, then the Fund would be required to elect to recognize and pay tax on any net built-in gain (the excess of aggregate gain, including items of income, over aggregate loss that would have been realized if the Fund had been liquidated) or, alternatively, be subject to taxation on such built-in gain recognized for a period of five years, in order to qualify as a RIC in a subsequent year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gain or loss on the sales of securities by the Fund will generally be long term capital gain or loss if the securities have been held by the Fund for more than one year. Gain or loss on the sale of securities held for one year or less will be short term capital gain or loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign currency gain or loss on non-U.S. dollar-denominated securities and on any non-U.S. dollar-denominated futures contracts, options and forward contracts that are not section&#160;1256 contracts (as defined below) generally will be treated as ordinary income and loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investments by the Fund in certain &#8220;passive foreign investment companies&#8221; (&#8220;PFICs&#8221;) could subject such fund to federal income tax (including interest charges) on certain distributions or dispositions with respect to those investments which cannot be eliminated by making distributions to stockholders. Elections may be available to the Fund to mitigate the effect of this tax provided that the PFIC complies with certain reporting requirements, but such elections generally accelerate the recognition of income without the receipt of cash. Dividends paid by PFICs will not qualify for the reduced tax rates discussed below under &#8220;Taxation of Stockholders.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 167 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund may invest in debt obligations purchased at a discount with the result that the Fund may be required to accrue income for U.S. federal income tax purposes before amounts due under the obligations are paid. The Fund may also invest in securities rated in the medium to lower rating categories of nationally recognized rating organizations, and in unrated securities (&#8220;high yield securities&#8221;). A portion of the interest payments on such high yield securities may be treated as dividends for certain U.S. federal income tax purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a result of investing in stock of PFICs or securities purchased at a discount or any other investment that produces income that is not matched by a corresponding cash distribution to the Fund, the Fund could be required to include income that it has not yet received in current income. Any such income would be treated as income earned by the Fund and therefore would be subject to the distribution requirements of the Code. This might prevent the Fund from distributing 90% of its investment company taxable income as is required in order to avoid Fund-level federal income taxation on all of its income, or might prevent the Fund from distributing enough ordinary income and capital gain net income to avoid completely the imposition of the excise tax. To avoid this result, the Fund may be required to borrow money or dispose of securities to be able to make distributions to its stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the Fund does not meet the asset coverage requirements of the 1940 Act and the Articles Supplementary, the Fund will be required to suspend distributions to the holders of common stock until the asset coverage is restored. Such a suspension of distributions might prevent the Fund from distributing 90% of its investment company taxable income as is required in order to avoid fund-level federal income taxation on all of its income, or might prevent the fund from distributing enough income and capital gain net income to avoid completely imposition of the excise tax.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain of the Fund&#8217;s investment practices are subject to special and complex U.S. federal income tax provisions that may, among other things, (i) disallow, suspend or otherwise limit the allowance of certain losses or deductions, (ii) convert lower taxed long term capital gains into higher taxed short term capital gains or ordinary income, (iii) convert ordinary loss or a deduction into capital loss (the deductibility of which is more limited), (iv) cause the recognition of income or gain without a corresponding receipt of cash, (v) adversely affect the time as to when a purchase or sale of stock or securities is deemed to occur, (vi) adversely alter the characterization of certain complex financial transactions and (vii) produce income that will not qualify as good income for purposes of the 90% annual gross income requirement described above. The Fund will monitor its transactions and may make certain tax elections to mitigate the effect of these rules and prevent disqualification of the fund as a regulated investment company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Foreign Taxes</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since the Fund may invest in foreign securities, income from such securities may be subject to non-U.S. taxes. The Fund expects to invest less than 35% of its total assets in foreign securities. As long as the Fund continues to invest less than 35% of its assets in foreign securities it will not be eligible to elect to &#8220;pass-through&#8221; to stockholders of a fund the ability to use the foreign tax deduction or foreign tax credit for foreign taxes paid with respect to qualifying taxes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Taxation of Stockholders</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund will determine either to distribute or to retain for reinvestment all or part of its net capital gain. If any such gain is retained, the Fund will be subject to a tax of 21% of such amount. In that event, the Fund expects to designate the retained amount as undistributed capital gain in a notice to its stockholders, each of whom (i) will be required to include in income for tax purposes as long term capital gain its share of such undistributed amounts, (ii) will be entitled to credit its proportionate share of the tax paid by the Fund against its federal income tax liability and to claim refunds to the extent that the credit exceeds such liability and (iii) will increase its basis in its shares of the Fund by an amount equal to the amount of undistributed capital gain included in such stockholder&#8217;s gross income, reduced by the stockholder&#8217;s credit for its proportionate share of the tax paid by the Fund.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 168 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Distributions paid by the Fund from its investment company taxable income, which includes net short term capital gain, generally are taxable as ordinary income to the extent of the Fund&#8217;s earnings and profits. Such distributions, if reported by the Fund, may, however, qualify (provided holding period and other requirements are met by the Fund and its stockholders) (i) for the dividends received deduction available to corporations, but only to the extent that the Fund&#8217;s income consists of dividend income from U.S. corporations and (ii) as qualified dividend income eligible for the reduced maximum federal tax rate to individuals of 20% (plus an additional 3.8% Medicare contribution surcharge on income and net gain from investments) to the extent that the Fund receives qualified dividend income. Qualified dividend income is, in general, dividend income from taxable domestic corporations and certain qualified foreign corporations (e.g., generally, foreign corporations incorporated in a possession of the United States or in certain countries with a qualifying comprehensive tax treaty with the United States, or whose shares with respect to which such dividend is paid is readily tradable on an established securities market in the United States). A qualified foreign corporation does not include a foreign corporation which for the taxable year of the corporation in which the dividend was paid, or the preceding taxable year, is a PFIC. If the Fund engages in certain securities lending transactions, the amount received by the Fund that is the equivalent of the dividends paid by the issuer on the securities loaned will not be eligible for qualified dividend income treatment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Distributions of net capital gain designated as capital gain distributions, if any, are taxable to stockholders at rates applicable to long term capital gain, whether paid in cash or in shares, and regardless of how long the stockholder has held the Fund&#8217;s shares. Capital gain distributions are not eligible for the dividends received deduction. The federal tax rate on net long term capital gain and qualified dividend income of individuals is generally either 15% or 20% (depending on whether an individual&#8217;s income exceeds certain threshold amounts). Unrecaptured Section&#160;1250 gain distributions, if any, will be subject to a 25% tax. Distributions in excess of the Fund&#8217;s earnings and profits will first reduce the adjusted tax basis of a holder&#8217;s shares and, after such adjusted tax basis is reduced to zero, will constitute capital gain to such holder (assuming the shares are held as a capital asset). Investment company taxable income (other than qualified dividend income) will currently be taxed at a maximum rate of 37%. For corporate taxpayers, both investment company taxable income and net capital gain are taxed at a maximum rate of 21%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A 3.8% Medicare contribution surcharge is imposed on net investment income, including interest, dividends, and capital gain, of U.S. individuals with income exceeding $200,000 (or $250,000 if married filing jointly), and of estates and trusts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If an individual receives a dividend that is eligible for qualified dividend income treatment, and such dividend constitutes an &#8220;extraordinary dividend,&#8221; any loss on the sale or exchange of shares in respect of which the extraordinary dividend was paid will be long term capital loss to the extent of such extraordinary dividend. An &#8220;extraordinary dividend&#8221; for this purpose is generally a dividend (i) in an amount greater than or equal to 10% of the taxpayer&#8217;s tax basis (or trading value) in a share of common stock (5% if preferred stock), aggregating dividends with ex-dividend dates within an 85 day period or (ii) in an amount greater than 20% of the taxpayer&#8217;s tax basis (or trading value) in a share of stock, aggregating dividends with ex-dividend dates within a 365-day period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The IRS currently requires that a regulated investment company that has two or more classes of stock allocate to each such class proportionate amounts of each type of its taxable income (such as ordinary income, capital gains, dividends qualifying for the dividends received deduction (&#8220;DRD&#8221;) and qualified dividend income) based upon the percentage of total dividends paid out of current or accumulated earnings and profits to each class for the tax year. Accordingly, the Fund intends each year to allocate capital gain dividends, dividends qualifying for the DRD and dividends that constitute qualified dividend income, if any, between its common stock and preferred stock in proportion to the total dividends paid out of current or accumulated earnings and profits to each class with respect to such tax year. Distributions in excess of the Fund&#8217;s current and accumulated earnings and profits, if any, however, will not be allocated proportionately among the common stock and preferred stock. Since the Fund&#8217;s current and accumulated earnings and profits will first be used to pay dividends on its preferred stock, distributions in excess of such earnings and profits, if any, will be made disproportionately to holders of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders may be entitled to offset their capital gain distributions (but not distributions eligible for qualified dividend income treatment) with capital loss. There are a number of statutory provisions affecting when capital loss may be offset against capital gain, and limiting the use of loss from certain investments and activities. Accordingly, stockholders with capital loss are urged to consult their tax advisers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 169 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The price of stock purchased at any time may reflect the amount of a forthcoming distribution. Those purchasing stock just prior to a distribution will receive a distribution which will be taxable to them even though it represents in part a return of invested capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain types of income received by the Fund from real estate investment trusts (&#8220;REITs&#8221;), real estate mortgage investment conduits (&#8220;REMICs&#8221;), taxable mortgage pools or other investments may cause the Fund to designate some or all of its distributions as &#8220;excess inclusion income.&#8221; To Fund stockholders such excess inclusion income may (1) constitute taxable income, as &#8220;unrelated business taxable income&#8221; (&#8220;UBTI&#8221;) for those stockholders who would otherwise be tax-exempt such as individual retirement accounts, 401(k) accounts, Keogh plans, pension plans and certain charitable entities; (2) not be offset by otherwise allowable deductions for tax purposes; (3) not be eligible for reduced U.S. withholding for non-U.S. stockholders even from tax treaty countries; and (4) cause the Fund to be subject to tax if certain &#8220;disqualified organizations&#8221; as defined by the Code are Fund stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon a sale, exchange, redemption or other disposition of stock, a stockholder will generally realize a taxable gain or loss equal to the difference between the amount of cash and the fair market value of other property received and the stockholder&#8217;s adjusted tax basis in the stock. Such gain or loss will be treated as long term capital gain or loss if the shares have been held for more than one year. Any loss realized on a sale or exchange will be disallowed to the extent the shares disposed of are replaced by substantially identical shares within a 61 day period beginning 30 days before and ending 30 days after the date that the shares are disposed of. In such a case, the basis of the shares acquired will be adjusted to reflect the disallowed loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any loss realized by a stockholder on the sale of Fund shares held by the stockholder for six months or less will be treated for tax purposes as a long term capital loss to the extent of any capital gain distributions received by the stockholder (or amounts credited to the stockholder as an undistributed capital gain) with respect to such shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As with any taxable investment, stockholders may be subject to the federal alternative minimum tax on their income (including taxable income from the Fund), depending on their individual circumstances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary income distributions and capital gain distributions also may be subject to state and local taxes. Stockholders are urged to consult their own tax advisers regarding specific questions about federal (including the application of the alternative minimum tax rules), state, local or foreign tax consequences to them of investing in the Fund.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders will receive, if appropriate, various written notices after the close of each of the Fund&#8217;s taxable years regarding the U.S. federal income tax status of certain dividends, distributions and deemed distributions that were paid (or that are treated as having been paid) by the Fund to its stockholders during the preceding taxable year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If a stockholder recognizes a loss with respect to the Fund&#8217;s shares of $2 million or more for an individual stockholder or $10 million or more for a corporate stockholder, the stockholder must file with the IRS a disclosure statement on Form 8886. Direct stockholders of portfolio securities are in many cases exempted from this reporting requirement, but under current guidance, stockholders of a regulated investment company are not exempted. The fact that a loss is reportable under these regulations does not affect the legal determination of whether the taxpayer&#8217;s treatment of the loss is proper. Stockholders should consult their tax advisors to determine the applicability of these regulations in light of their individual circumstances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends paid or distributions made by the Fund to stockholders who are non-resident aliens or foreign entities (&#8220;foreign investors&#8221;) are generally subject to withholding tax at a 30% rate or a reduced rate specified by an applicable income tax treaty to the extent derived from investment income and short term capital gains. In order to obtain a reduced rate of withholding, a foreign investor will be required to provide an applicable IRS Form W-8 certifying its entitlement to benefits under a treaty. The withholding tax does not apply to regular dividends paid or distributions made to a foreign investor who provides a Form W-8ECI, certifying that the dividends or distributions are effectively connected with the foreign investor&#8217;s conduct of a trade or business within the United States. Instead, the effectively connected dividends or distributions will be subject to regular U.S. income tax as if the foreign investor were a U.S. stockholder. A non-U.S. corporation receiving effectively connected dividends or distributions may also be subject to additional &#8220;branch profits tax&#8221; imposed at a rate of 30% (or lower treaty rate). A foreign investor who fails to provide an applicable IRS Form W-8BEN or other applicable form may be subject to backup withholding at the appropriate rate. Foreign investors may also be subject to U.S. estate tax with respect to their Fund shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 170 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Properly reported dividends received by foreign investors are generally exempt from U.S. federal withholding tax when they (a) are paid in respect of the Fund&#8217;s &#8220;qualified net interest income&#8221; (generally, the Fund&#8217;s U.S. source interest income, reduced by expenses that are allocable to such income), or (b) are paid in connection with the Fund&#8217;s &#8220;qualified short term capital gains&#8221; (generally, the excess of the Fund&#8217;s net short term capital gain over the Fund&#8217;s long term capital loss for such taxable year). However, depending on the circumstances, the Fund may designate all, some or none of the Fund&#8217;s potentially eligible dividends as such qualified net interest income or as qualified short term capital gains, and a portion of the Fund&#8217;s distributions (e.g. interest from non-U.S. sources or any foreign currency gains) would be ineligible for this potential exemption from withholding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Distributions that the Fund reports as &#8220;short term capital gain dividends&#8221; or &#8220;long term capital gain dividends&#8221; will not be treated as such to a recipient non-U.S. stockholder if the distribution is attributable to a REIT&#8217;s distribution to the Fund of a gain from the sale or exchange of U.S. real property or an interest in a U.S. real property holding corporation and the Fund&#8217;s direct or indirect interests in U.S. real property exceed certain levels. Instead, if the non-U.S. stockholder has not owned more than 5% of the outstanding shares of the Fund at any time during the one-year period ending on the date of distribution, such distributions will be subject to 30% withholding by the Fund and will be treated as ordinary dividends to the non-U.S. stockholder; if the non-U.S. stockholder owned more than 5% of the outstanding shares of the Fund at any time during the one-year period ending on the date of the distribution, such distribution will be treated as real property gain subject to 21% withholding tax and could subject the non-U.S. stockholder to U.S. filing requirements. Additionally, if the Fund&#8217;s direct or indirect interests in U.S. real property were to exceed certain levels, a non-U.S. stockholder realizing gains upon redemption from the Fund could be subject to the 21% withholding tax and U.S. filing requirements unless more than 50% of the Fund&#8217;s shares were owned by U.S. persons at such time or unless the non-U.S. person had not held more than 5% of the Fund&#8217;s outstanding shares throughout either such person&#8217;s holding period for the redeemed shares or, if shorter, the previous five years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provided that 50% or more of the value of the Fund&#8217;s stock is held by U.S. stockholders, distributions of U.S. real property interests (including securities in a U.S. real property holding corporation, unless such corporation is regularly traded on an established securities market and the Fund has held 5% or less of the outstanding shares of the corporation during the five-year period ending on the date of distribution), in redemption of a non-U.S. stockholder&#8217;s shares of the Fund will cause the Fund to recognize gain. If the Fund is required to recognize gain, the amount of gain recognized will be equal to the fair market value of such interests over the Fund&#8217;s adjusted bases to the extent of the greatest non-U.S. ownership percentage of the Fund during the five-year period ending on the date of redemption. In the case of non-U.S. non-corporate stockholders, the Fund may be required to backup withhold federal income tax on distributions that are otherwise exempt from withholding tax unless such stockholders furnish the Fund with proper notification of their non-U.S. status.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Separately, a 30% withholding tax will be imposed on dividends paid to (i) foreign financial institutions including non-U.S. investment funds unless they agree to collect and disclose to the IRS information regarding their direct and indirect U.S. account holders and (ii) certain other foreign entities unless they certify certain information regarding their direct and indirect U.S. owners. To avoid withholding, a foreign financial institution will need to (i) enter into agreements with the IRS that state that they will provide the IRS information including the names, addresses and taxpayer identification numbers of direct and indirect U.S. account holders, comply with due diligence procedures with respect to the identification of U.S. accounts, report to the IRS certain information with respect to U.S. accounts maintained, agree to withhold tax on certain payments made to non-compliant foreign financial institutions or to account holders, or (ii) in the event that an applicable intergovernmental agreement and implementing legislation are adopted, provide local revenue authorities with similar account holder information, who fail to provide the required information, and determine certain other information as to their account holders. Other foreign entities will need to provide the name, address, and taxpayer identification number of each substantial U.S. owner or certifications of no substantial U.S. ownership unless certain exceptions apply.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In general, United States federal withholding tax will not apply to any gain or income realized by a foreign investor in respect of any distributions of net long term capital gains over net short term capital losses, exempt-interest dividends, or upon the sale or other disposition of shares of the Fund.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 171 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Backup Withholding</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund may be required to withhold U.S. federal income tax at a 24% rate on all taxable distributions and redemption proceeds payable to non-corporate stockholders who fail to provide the Fund with their correct taxpayer identification number or to make required certifications, or who have been notified by the IRS that they are subject to backup withholding. Backup withholding is not an additional tax. Any amounts withheld may be refunded or credited against such stockholder&#8217;s U.S. federal income tax liability, if any, provided that the required information is furnished to the IRS.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The foregoing is a general and abbreviated summary of the applicable provisions of the Code and Treasury regulations presently in effect. For the complete provisions, reference should be made to the pertinent Code sections and the Treasury regulations promulgated thereunder. The Code and the Treasury regulations are subject to change by legislative, judicial or administrative action, either prospectively or retroactively. Persons considering an investment in shares of the Fund should consult their own tax advisers regarding the purchase, ownership and disposition of shares of the Fund.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="b_009"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BENEFICIAL OWNERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of November&#160;30, 2023, no persons were known to the Fund to be beneficial owners of 5% or more of the outstanding shares of the Fund&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of November&#160;30, 2023, the Directors and officers of the Fund as a group beneficially owned less than 1% of the outstanding shares of the Fund&#8217;s common stock and less than 1% of the outstanding shares of the Fund&#8217;s preferred stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="b_010"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GENERAL INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Book-Entry-Only Issuance</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Depository Trust Company (&#8220;DTC&#8221;) will act as securities depository for the securities offered pursuant to the Prospectus. The information in this section concerning DTC and DTC&#8217;s book-entry system is based upon information obtained from DTC. The securities offered hereby initially will be issued only as fully-registered securities registered in the name of Cede &amp; Co. (as nominee for DTC). One or more fully-registered global security certificates initially will be issued, representing in the aggregate the total number of securities, and deposited with DTC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DTC is a limited-purpose trust company organized under the New York Banking Law, a &#8220;banking organization&#8221; within the meaning of the New York Banking Law, a member of the Federal Reserve System, a &#8220;clearing corporation&#8221; within the meaning of the New York Uniform Commercial Code and a &#8220;clearing agency&#8221; registered pursuant to the provisions of Section&#160;17A of the 1934 Act. DTC holds securities that its participants deposit with DTC. DTC also facilitates the settlement among participants of securities transactions, such as transfers and pledges, in deposited securities through electronic computerized book-entry changes in participants&#8217; accounts, thereby eliminating the need for physical movement of securities certificates. Direct DTC participants include securities brokers and dealers, banks, trust companies, clearing corporations and certain other organizations. Access to the DTC system is also available to others such as securities brokers and dealers, banks and trust companies that clear through or maintain a custodial relationship with a direct participant, either directly or indirectly through other entities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchases of securities within the DTC system must be made by or through direct participants, which will receive a credit for the securities on DTC&#8217;s records. The ownership interest of each actual purchaser of a security, a beneficial owner, is in turn to be recorded on the direct or indirect participants&#8217; records. Beneficial owners will not receive written confirmation from DTC of their purchases, but beneficial owners are expected to receive written confirmations providing details of the transactions, as well as periodic statements of their holdings, from the direct or indirect participants through which the beneficial owners purchased securities. Transfers of ownership interests in securities are to be accomplished by entries made on the books of participants acting on behalf of beneficial owners. Beneficial owners will not receive certificates representing their ownership interests in securities, except as provided herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 172 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DTC has no knowledge of the actual beneficial owners of the securities being offered pursuant to the Prospectus; DTC&#8217;s records reflect only the identity of the direct participants to whose accounts such securities are credited, which may or may not be the beneficial owners. The participants will remain responsible for keeping account of their holdings on behalf of their customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conveyance of notices and other communications by DTC to direct participants, by direct participants to indirect participants, and by direct participants and indirect participants to beneficial owners will be governed by arrangements among them, subject to any statutory or regulatory requirements as may be in effect from time to time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payments on the securities will be made to DTC. DTC&#8217;s practice is to credit direct participants&#8217; accounts on the relevant payment date in accordance with their respective holdings shown on DTC&#8217;s records unless DTC has reason to believe that it will not receive payments on such payment date. Payments by participants to beneficial owners will be governed by standing instructions and customary practices and will be the responsibility of such participant and not of DTC or the Fund, subject to any statutory or regulatory requirements as may be in effect from time to time. Payment of distributions to DTC is the responsibility of the Fund, disbursement of such payments to direct participants is the responsibility of DTC, and disbursement of such payments to the beneficial owners is the responsibility of direct and indirect participants. Furthermore each beneficial owner must rely on the procedures of DTC to exercise any rights under the securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DTC may discontinue providing its services as securities depository with respect to the securities at any time by giving reasonable notice to the Fund. Under such circumstances, in the event that a successor securities depository is not obtained, certificates representing the securities will be printed and delivered.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proxy Voting Procedures</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund has adopted the proxy voting procedures of the Investment Adviser and has directed the Investment Adviser to vote all proxies relating to the Fund&#8217;s voting securities in accordance with such procedures. The proxy voting procedures are attached as Appendix A to this SAI. They are also on file with the SEC and may be obtained by calling the SEC at 202-551-8090. The proxy voting procedures are also available on the EDGAR Database on the SEC&#8217;s internet site (http://www.sec.gov) and copies of the proxy voting procedures may be obtained, after paying a duplicating fee, by electronic request at the following e-mail address: publicinfo@sec.gov.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Code of Ethics</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund and the Investment Adviser have adopted a code of ethics under Rule&#160;17j-1 under the 1940 Act. The code of ethics permits personnel, subject to the code of ethics and its restrictive provisions, to invest in securities, including securities that may be purchased or held by a fund in the Fund Complex. This code of ethics sets forth restrictions on the trading activities of trustees/directors, officers and employees of the Fund, the Investment Adviser and their affiliates. For example, such persons may not purchase any security for which the Fund has a purchase or sale order pending, or for which such trade is under consideration. In addition, those trustees/directors, officers and employees that are principally involved in investment decisions for client accounts are prohibited from purchasing or selling for their own account for a period of seven days a security that has been traded for a client&#8217;s account, unless such trade is executed on more favorable terms for the client&#8217;s account and it is determined that such trade will not adversely affect the client&#8217;s account. Short term trading by such trustees/directors, officers and employees for their own accounts in securities held by a Fund client&#8217;s account is also restricted. The above examples are subject to certain exceptions and they do not represent all of the trading restrictions and policies set forth by the code of ethics. The code of ethics is on file with the SEC and may be obtained by calling the SEC at (202) 551-8090. The code of ethics is also available on the EDGAR Database on the SEC&#8217;s Internet site at http://www.sec.gov, and copies of the code of ethics may be obtained, after paying a duplicating fee, by electronic request at the following e-mail address: publicinfo@sec.gov.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Joint Code of Ethics for Chief Executive and Senior Financial Officers</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund and the Investment Adviser have adopted a joint code of ethics that serves as a code of conduct. The joint code of ethics sets forth policies to guide the chief executive and senior financial officers in the performance of their duties. The code of ethics is on file with the SEC and may be obtained by calling the SEC at 202-551-8090. The code of ethics is also available on the EDGAR Database on the SEC&#8217;s Internet site (http://www.sec.gov), and copies of the code of ethics may be obtained, after paying a duplicating fee, by electronic request at the following e-mail address: publicinfo@sec.gov.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 173 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The audited financial statements included in the <a href="https://www.sec.gov/Archives/edgar/data/794685/000138713123003229/gab-ncsr_123122.htm">annual report</a> to the Fund&#8217;s stockholders for the year ended December 31, 2022 (the &#8220;2022 Annual Report&#8221;), together with the report of PricewaterhouseCoopers LLP for the Fund&#8217;s 2022 Annual Report, and the unaudited financial statements included in the <a href="https://www.sec.gov/Archives/edgar/data/794685/000182912623005964/gab_ncsrs.htm">semi-annual report</a> to the Fund&#8217;s stockholders for the period ended June 30, 2023 (the &#8220;2023 Semiannual Report&#8221;) are incorporated herein by reference. All other portions of the 2022 Annual Report and the 2023 Semi-Annual Report are not incorporated herein by reference and are not part of the registration statement, the SAI, the Prospectus or any Prospectus Supplement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Independent Registered Public Accounting Firm</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PricewaterhouseCoopers LLP serves as the Independent Registered Public Accounting Firm of the Fund and audits the financial statements of the Fund. PricewaterhouseCoopers LLP is located at 300 Madison Avenue, New York, New York 10017.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Incorporation by Reference</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This SAI is part of a registration statement that we have filed with the SEC. We are allowed to &#8220;incorporate by reference&#8221; the information that we file with the SEC, which means that we can disclose important information to you by referring you to those documents. We incorporate by reference into this SAI the documents listed below and any future filings we make with the SEC under Sections&#160;13(a), 13(c), 14 or 15(d) of the Exchange Act, including any filings on or after the date of this SAI from the date of filing (excluding any information furnished, rather than filed), until we have sold all of the offered securities to which this SAI relates or the offering is otherwise terminated. The information incorporated by reference is an important part of this SAI. Any statement in a document incorporated by reference into this SAI will be deemed to be automatically modified or superseded to the extent a statement contained in (1) this SAI or (2) any other subsequently filed document that is incorporated by reference into this SAI modifies or supersedes such statement. The documents incorporated by reference herein include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Fund&#8217;s Prospectus, dated December 29, 2023, filed with this SAI;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our <a href="https://www.sec.gov/Archives/edgar/data/794685/000138713123003229/gab-ncsr_123122.htm">annual report</a> on Form&#160;N-CSR&#160;for the fiscal year ended&#160;December 31, 2023, filed with the SEC on March 9, 2023;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our <a href="https://www.sec.gov/Archives/edgar/data/794685/000182912623005964/gab_ncsrs.htm">semi-annual report</a> on Form N-CSR for the fiscal period ended June 30, 2023, filed with the SEC on September 6, 2023;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Fund&#8217;s <a href="https://www.sec.gov/Archives/edgar/data/794685/000113322823001747/gab-html6178_def14a.htm">definitive proxy statement dated April 12, 2023</a> on Schedule 14A, filed with the SEC on April 5, 2023;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the description of our Series G Preferred, to the extent not otherwise included in this SAI, contained in our <a href="https://www.sec.gov/Archives/edgar/data/794685/000119312512322308/d386533d8a12b.htm">Registration Statement on Form 8-A</a> (File No. 001-09234) filed with the SEC on July 30, 2012 including any amendment or report filed for the purpose of updating such description prior to the termination of the offering registered hereby;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the description of our Series H Preferred, to the extent not otherwise included in this SAI, contained in our <a href="https://www.sec.gov/Archives/edgar/data/794685/000119312512406927/d417915d8a12b.htm">Registration Statement on Form 8-A</a> (File No. 001-09234) filed with the SEC on September 27, 2012, including any amendment or report filed for the purpose of updating such description prior to the termination of the offering registered hereby; and</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the description of our Series K Preferred, to the extent not otherwise included in this SAI, contained in our <a href="https://www.sec.gov/Archives/edgar/data/794685/000119312519313789/d118280d8a12b.htm">Registration Statement on Form 8-A</a> (File No. 001-09234) filed with the SEC on December 13, 2019, including any amendment or report filed for the purpose of updating such description prior to the termination of the offering registered hereby.</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 174 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We will provide without charge to each person, including any beneficial owner, to whom this SAI is delivered, upon written or oral request, a copy of any and all of the documents that have been or may be incorporated by reference in this SAI. You should direct requests for documents by writing to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investor Relations</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Gabelli Equity Trust Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">One Corporate Center</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rye, NY 10580-1422</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(914) 921-5070</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This SAI, the Prospectus and the Fund&#8217;s annual and semi-annual reports are also available on our website at http://www.gabelli.com. Information contained in, or that can be accessed through, our website is not incorporated by reference into this SAI and should not be considered to be part of this SAI.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 175 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><span id="b_011"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>APPENDIX A</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GAMCO INVESTORS, INC. AND AFFILIATES</b><br /><b>THE VOTING OF PROXIES ON BEHALF OF CLIENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rule&#160;206(4)-6 under the Investment Advisers Act of 1940 and Rule&#160;30b1-4 under the Investment Company Act of 1940 require investment advisers to adopt written policies and procedures governing the voting of proxies on behalf of their clients.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These procedures will be used by GAMCO Asset Management Inc., Gabelli Funds, LLC, Gabelli &amp; Company Investment Advisers, Inc., and Teton Advisors, Inc. (collectively, the &#8220;Advisers&#8221;) to determine how to vote proxies relating to portfolio securities held by their clients, including the procedures that the Advisers use when a vote presents a conflict between the interests of the shareholders of an investment company managed by one of the Advisers, on the one hand, and those of the Advisers; the principal underwriter; or any affiliated person of the investment company, the Advisers, or the principal underwriter. These procedures will not apply where the Advisers do not have voting discretion or where the Advisers have agreed to with a client to vote the client&#8217;s proxies in accordance with specific guidelines or procedures supplied by the client (to the extent permitted by ERISA).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.5in"></td>
    <td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>I.</b></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proxy Voting Committee</b></span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Proxy Voting Committee was originally formed in April&#160;1989 for the purpose of formulating guidelines and reviewing proxy statements within the parameters set by the substantive proxy voting guidelines originally published in 1988 and updated periodically, a copy of which are appended as Exhibit A. The Committee will include representatives of Research, Administration, Legal, and the Advisers. Additional or replacement members of the Committee will be nominated by the Chairman and voted upon by the entire Committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Meetings are held on an as needed basis to form views on the manner in which the Advisers should vote proxies on behalf of their clients.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In general, the Director of Proxy Voting Services, using the Proxy Guidelines, and the analysts of GAMCO Investors, Inc. (&#8220;GAMI&#8221;), will determine how to vote on each issue. For non-controversial matters, the Director of Proxy Voting Services may vote the proxy if the vote is: (1) consistent with the recommendations of the issuer&#8217;s Board of Directors and not contrary to the Proxy Guidelines; (2) consistent with the recommendations of the issuer&#8217;s Board of Directors and is a non-controversial issue not covered by the Proxy Guidelines; or (3) the vote is contrary to the recommendations of the Board of Directors but is consistent with the Proxy Guidelines. In those instances, the Director of Proxy Voting Services or the Chairman of the Committee may sign and date the proxy statement indicating how each issue will be voted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All matters identified by the Chairman of the Committee, the Director of Proxy Voting Services or the Legal Department as controversial, taking into account the recommendations of the analysts of GAMI, will be presented to the Proxy Voting Committee. If the Chairman of the Committee, the Director of Proxy Voting Services or the Legal Department has identified the matter as one that (1) is controversial; (2) would benefit from deliberation by the Proxy Voting Committee; or (3) may give rise to a conflict of interest between the Advisers and their clients, the Chairman of the Committee will initially determine what vote to recommend that the Advisers should cast and the matter will go before the Committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Conflicts of Interest.</b></span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Advisers have implemented these proxy voting procedures in order to prevent conflicts of interest from influencing their proxy voting decisions. By following the Proxy Guidelines and the analysts of GAMI, the Advisers are able to avoid, wherever possible, the influence of potential conflicts of interest. Nevertheless, circumstances may arise in which one or more of the Advisers are faced with a conflict of interest or the appearance of a conflict of interest in connection with its vote. In general, a conflict of interest may arise when an Adviser knowingly does business with an issuer, and may appear to have a material conflict between its own interests and the interests of the shareholders of an investment company managed by one of the Advisers regarding how the proxy is to be voted. A conflict also may exist when an Adviser has actual knowledge of a material business arrangement between an issuer and an affiliate of the Adviser.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 176; Options: NewSection -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In practical terms, a conflict of interest may arise, for example, when a proxy is voted for a company that is a client of one of the Advisers, such as GAMCO Asset Management Inc. A conflict also may arise when a client of one of the Advisers has made a shareholder proposal in a proxy to be voted upon by one or more of the Advisers. The Director of Proxy Voting Services, together with the Legal Department, will scrutinize all proxies for these or other situations that may give rise to a conflict of interest with respect to the voting of proxies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Operation of Proxy Voting Committee</b></span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For matters submitted to the Committee, each member of the Committee will receive, prior to the meeting, a copy of the proxy statement, a summary of any views provided by the Chief Investment Officer and any recommendations by GAMI analysts. The Chief Investment Officer or the GAMI analysts may be invited to present their viewpoints. If the Director of Proxy Voting Services or the Legal Department believe that the matter before the committee is one with respect to which a conflict of interest may exist between the Advisers and their clients, counsel may provide an opinion to the Committee concerning the conflict. If the matter is one in which the interests of the clients of one or more of the Advisers may diverge, counsel may so advise and the Committee may make different recommendations as to different clients. For any matters where the recommendation may trigger appraisal rights, counsel may provide an opinion concerning the likely risks and merits of such an appraisal action.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each matter submitted to the Committee will be determined by the vote of a majority of the members present at the meeting. Should the vote concerning one or more recommendations be tied in a vote of the Committee, the Chairman of the Committee will cast the deciding vote. The Committee will notify the proxy department of its decisions and the proxies will be voted accordingly.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although the Proxy Guidelines express the normal preferences for the voting of any shares not covered by a contrary investment guideline provided by the client, the Committee is not bound by the preferences set forth in the Proxy Guidelines and will review each matter on its own merits. The Advisers subscribe to Institutional Shareholder Services Inc. (&#8220;ISS&#8221;) and Glass Lewis &amp; Co., LLC (&#8220;Glass Lewis&#8221;), which supply current information on companies, matters being voted on, regulations, trends in proxy voting and information on corporate governance issues. The information provided by ISS and GL is for informational purposes only.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the vote cast either by the analyst or as a result of the deliberations of the Proxy Voting Committee runs contrary to the recommendation of the Board of Directors of the issuer, the matter may be referred to legal counsel to determine whether an amendment to the most recently filed Schedule&#160;13D is appropriate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>II.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Social Issues and Other Client Guidelines</b></span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If a client has provided and the Advisers have accepted special instructions relating to the voting of proxies, they should be noted in the client&#8217;s account file and forwarded to the proxy department. This is the responsibility of the investment professional or sales assistant for the client. In accordance with Department of Labor guidelines, the Advisers&#8217; policy is to vote on behalf of ERISA accounts in the best interest of the plan participants with regard to social issues that carry an economic impact. Where an account is not governed by ERISA, the Advisers will vote shares held on behalf of the client in a manner consistent with any individual investment/voting guidelines provided by the client. Otherwise the Advisers may abstain with respect to those shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Specific to the Gabelli SRI Fund and the Gabelli Love Our Planet &amp; People ETF, the Proxy Voting Committee will rely on the advice of the portfolio managers of the Gabelli SRI Fund and the Gabelli Love Our Planet &amp; People ETF to provide voting recommendations on the securities held in the portfolio.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A client may always request to vote their own proxies. Clients engaged in securities lending may make additional requests related to the voting of proxies. GAMI will consider those requests on a case-by-case basis and use best efforts to comply with the request.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 177 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>III.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Client Retention of Voting Rights</b></span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If a client chooses to retain the right to vote proxies or if there is any change in voting authority, the following should be notified by the investment professional or sales assistant for the client.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operations</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proxy Department</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment professional assigned to the account</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the event that the Board of Directors (or a Committee thereof) of one or more of the investment companies managed by one of the Advisers has retained direct voting control over any security, the Proxy Voting Department will provide each Board Member (or Committee member) with a copy of the proxy statement together with any other relevant information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>IV.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proxies of Certain Non-U.S. Issuers</b></span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proxy voting in certain countries requires &#8220;share-blocking.&#8221; Shareholders wishing to vote their proxies must deposit their shares shortly before the date of the meeting with a designated depository. During the period in which the shares are held with a depository, shares that will be voted at the meeting cannot be sold until the meeting has taken place and the shares are returned to the clients&#8217; custodian. Absent a compelling reason to the contrary, the Advisers believe that the benefit to the client of exercising the vote is outweighed by the cost of voting and therefore, the Advisers will not typically vote the securities of non-U.S. issuers that require share-blocking.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition, voting proxies of issuers in non-U.S. markets may also give rise to a number of administrative issues or give rise to circumstances under which voting would impose a cost (real or implied) on its client which may cause the Advisers to abstain from voting such proxies. For example, the Advisers may receive the notices for shareholder meetings without adequate time to consider the proposals in the proxy or after the cut-off date for voting. Other markets require the Advisers to provide local agents with power of attorney prior to implementing their respective voting instructions on the proxy. Other markets may require disclosure of certain ownership information in excess of what is required to vote in the U.S. market. Although it is the Advisers&#8217; policies to vote the proxies for its clients for which they have proxy voting authority, in the case of issuers in non-U.S. markets, we vote client proxies on a best efforts basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>V.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Voting Records</b></span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Proxy Voting Department will retain a record of matters voted upon by the Advisers for their clients. The Advisers will supply information on how they voted a client&#8217;s proxy upon request from the client.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The complete voting records for each registered investment company (the &#8220;Fund&#8221;) that is managed by the Advisers will be filed on Form N-PX for the twelve months ended June&#160;30th, no later than August&#160;31st of each year. A description of the Fund&#8217;s proxy voting policies, procedures, and how the Fund voted proxies relating to portfolio securities is available without charge, upon request, by (i) calling 800-GABELLI (800-422-3554); (ii) writing to Gabelli Funds, LLC at One Corporate Center, Rye, NY 10580-1422; or (iii) visiting the SEC&#8217;s website at <span style="text-decoration: underline">www.sec.gov</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Advisers&#8217; proxy voting records will be retained in compliance with Rule&#160;204-2 under the Investment Advisers Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 178 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VI.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Voting Procedures</b></span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1. Custodian banks, outside brokerage firms and clearing firms are responsible for forwarding proxies directly to the Advisers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proxies are received in one of two forms:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholder Vote Instruction Forms (&#8220;VIFs&#8221;) - Issued by Broadridge Financial Solutions, Inc. (&#8220;Broadridge&#8221;). Broadridge is an outside service contracted by the various institutions to issue proxy materials.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proxy cards which may be voted directly.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2. Upon receipt of the proxy, the number of shares each form represents is logged into the proxy system, electronically or manually, according to security.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3. Upon receipt of instructions from the proxy committee, the votes are cast and recorded for each account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Records have been maintained on the ProxyEdge system.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ProxyEdge records include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security Name and CUSIP Number</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date and Type of Meeting (Annual, Special, Contest)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors&#8217; Recommendation (if any)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">How the Adviser voted for the client on item</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4. VIFs are kept alphabetically by security. Records for the current proxy season are located in the Proxy Voting Department office. In preparation for the upcoming season, files are transferred to an offsite storage facility during January/February.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5. If a proxy card or VIF is received too late to be voted in the conventional matter, every attempt is made to vote including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When a solicitor has been retained, the solicitor is called. At the solicitor&#8217;s direction, the proxy is faxed or sent electronically.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In some circumstances VIFs can be faxed or sent electronically to Broadridge up until the time of the meeting.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6. In the case of a proxy contest, records are maintained for each opposing entity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7. Voting in Person</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) At times it may be necessary to vote the shares in person. In this case, a &#8220;legal proxy&#8221; is obtained in the following manner:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Banks and brokerage firms using the services at Broadridge:</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Broadridge is notified that we wish to vote in person. Broadridge issues individual legal proxies and sends them back via email or overnight (or the Adviser can pay messenger charges). A lead-time of at least two weeks prior to the meeting is needed to do this. Alternatively, the procedures detailed below for banks not using Broadridge may be implemented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 179 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Banks and brokerage firms issuing proxies directly:</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The bank is called and/or faxed and a legal proxy is requested.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All legal proxies should appoint:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8220;Representative of [Adviser name] with full power of substitution.&#8221;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) The legal proxies are given to the person attending the meeting along with the limited power of attorney.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>&#160;</p>

<!-- Field: Page; Sequence: 180 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit A</b><br /><b>Proxy Guidelines</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROXY VOTING GUIDELINES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>General Policy Statement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It is the policy of GAMCO Investors, Inc., and its affiliated advisers (collectively &#8220;the Advisers&#8221;) to vote in the best economic interests of our clients. As we state in our Magna Carta of Shareholders Rights, established in May&#160;1988, we are neither <i>for</i> nor <i>against</i> management. We are for shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At our first proxy committee meeting in 1989, it was decided that each proxy statement should be evaluated on its own merits within the framework first established by our Magna Carta of Shareholders Rights. The attached guidelines serve to enhance that broad framework.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We do not consider any issue routine. We take into consideration all of our research on the company, its directors, and their short and long-term goals for the company. In cases where issues that we generally do not approve of are combined with other issues, the negative aspects of the issues will be factored into the evaluation of the overall proposals but will not necessitate a vote in opposition to the overall proposals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Board of Directors</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We do not consider the election of the Board of Directors a routine issue. Each slate of directors is evaluated on a case-by-case basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Factors taken into consideration include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Historical responsiveness to shareholders</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This may include such areas as:</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- Paying greenmail</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- Failure to adopt shareholder resolutions receiving a majority of shareholder votes</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qualifications</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nominating committee in place</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of outside directors on the board</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attendance at meetings</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Overall performance</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Selection of Auditors</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In general, we support the Board of Directors&#8217; recommendation for auditors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Blank Check Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We oppose the issuance of blank check preferred stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Blank check preferred stock allows the company to issue stock and establish dividends, voting rights, etc. without further shareholder approval.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 181 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Classified Board</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A classified board is one where the directors are divided into classes with overlapping terms. A different class is elected at each annual meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While a classified board promotes continuity of directors facilitating long range planning, we feel directors should be accountable to shareholders on an annual basis. We will look at this proposal on a case-by-case basis taking into consideration the board&#8217;s historical responsiveness to the rights of shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where a classified board is in place we will generally not support attempts to change to an annually elected board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When an annually elected board is in place, we generally will not support attempts to classify the board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Increase Authorized Common Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The request to increase the amount of outstanding shares is considered on a case-by-case basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Factors taken into consideration include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future use of additional shares</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- Stock split</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- Stock option or other executive compensation plan</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- Finance growth of company/strengthen balance sheet</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- Aid in restructuring</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- Improve credit rating</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- Implement a poison pill or other takeover defense</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount of stock currently authorized but not yet issued or reserved for stock option plans</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount of additional stock to be authorized and its dilutive effect</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We will support this proposal if a detailed and verifiable plan for the use of the additional shares is contained in the proxy statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Confidential Ballot</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We support the idea that a shareholder&#8217;s identity and vote should be treated with confidentiality.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">However, we look at this issue on a case-by-case basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In order to promote confidentiality in the voting process, we endorse the use of independent Inspectors of Election.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cumulative Voting</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In general, we support cumulative voting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cumulative voting is a process by which a shareholder may multiply the number of directors being elected by the number of shares held on record date and cast the total number for one candidate or allocate the voting among two or more candidates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 182 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where cumulative voting is in place, we will vote against any proposal to rescind this shareholder right.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cumulative voting may result in a minority block of stock gaining representation on the board. When a proposal is made to institute cumulative voting, the proposal will be reviewed on a case-by-case basis. While we feel that each board member should represent all shareholders, cumulative voting provides minority shareholders an opportunity to have their views represented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Director Liability and Indemnification</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We support efforts to attract the best possible directors by limiting the liability and increasing the indemnification of directors, except in the case of insider dealing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Equal Access to the Proxy</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The SEC&#8217;s rules provide for shareholder resolutions. However, the resolutions are limited in scope and there is a 500 word limit on proponents&#8217; written arguments. Management has no such limitations. While we support equal access to the proxy, we would look at such variables as length of time required to respond, percentage of ownership, etc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fair Price Provisions</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charter provisions requiring a bidder to pay all shareholders a fair price are intended to prevent two-tier tender offers that may be abusive. Typically, these provisions do not apply to board-approved transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We support fair price provisions because we feel all shareholders should be entitled to receive the same benefits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reviewed on a case-by-case basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Golden Parachutes</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Golden parachutes are severance payments to top executives who are terminated or demoted after a takeover.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We support any proposal that would assure management of its own welfare so that they may continue to make decisions in the best interest of the company and shareholders even if the decision results in them losing their job. We do not, however, support excessive golden parachutes. Therefore, each proposal will be decided on a case-by- case basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Anti-Greenmail Proposals</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We do not support greenmail. An offer extended to one shareholder should be extended to all shareholders equally across the board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Limit Shareholders&#8217; Rights to Call Special Meetings</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We support the right of shareholders to call a special meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reviewed on a case-by-case basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Consideration of Nonfinancial Effects of a Merger</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This proposal releases the directors from only looking at the financial effects of a merger and allows them the opportunity to consider the merger&#8217;s effects on employees, the community, and consumers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a fiduciary, we are obligated to vote in the best economic interests of our clients. In general, this proposal does not allow us to do that. Therefore, we generally cannot support this proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reviewed on a case-by-case basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 183 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Mergers, Buyouts, Spin-Offs, Restructurings</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each of the above is considered on a case-by-case basis. According to the Department of Labor, we are not required to vote for a proposal simply because the offering price is at a premium to the current market price. We may take into consideration the long term interests of the shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Military Issues</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholder proposals regarding military production must be evaluated on a purely economic set of criteria for our ERISA clients. As such, decisions will be made on a case-by-case basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In voting on this proposal for our non-ERISA clients, we will vote according to the client&#8217;s direction when applicable. Where no direction has been given, we will vote in the best economic interests of our clients. It is not our duty to impose our social judgment on others.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Northern Ireland</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholder proposals requesting the signing of the MacBride principles for the purpose of countering the discrimination of Catholics in hiring practices must be evaluated on a purely economic set of criteria for our ERISA clients. As such, decisions will be made on a case-by-case basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In voting on this proposal for our non-ERISA clients, we will vote according to client direction when applicable. Where no direction has been given, we will vote in the best economic interests of our clients. It is not our duty to impose our social judgment on others.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Opt Out of State Anti-Takeover Law</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This shareholder proposal requests that a company opt out of the coverage of the state&#8217;s takeover statutes. Example: Delaware law requires that a buyer must acquire at least 85% of the company&#8217;s stock before the buyer can exercise control unless the board approves.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We consider this on a case-by-case basis. Our decision will be based on the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">State of Incorporation</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management history of responsiveness to shareholders</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other mitigating factors</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Poison Pill</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In general, we do not endorse poison pills.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In certain cases where management has a history of being responsive to the needs of shareholders and the stock is very liquid, we will reconsider this position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reincorporation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally, we support reincorporation for well-defined business reasons. We oppose reincorporation if proposed solely for the purpose of reincorporating in a state with more stringent anti-takeover statutes that may negatively impact the value of the stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 184 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stock Incentive Plans</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director and Employee Stock incentive plans are an excellent way to attract, hold and motivate directors and employees. However, each incentive plan must be evaluated on its own merits, taking into consideration the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dilution of voting power or earnings per share by more than 10%.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kind of stock to be awarded, to whom, when and how much.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Method of payment.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount of stock already authorized but not yet issued under existing stock plans.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The successful steps taken by management to maximize shareholder value.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Supermajority Vote Requirements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Supermajority vote requirements in a company&#8217;s charter or bylaws require a level of voting approval in excess of a simple majority of the outstanding shares. In general, we oppose supermajority-voting requirements. Supermajority requirements often exceed the average level of shareholder participation. We support proposals&#8217; approvals by a simple majority of the shares voting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reviewed on a case-by-case basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Limit Shareholders Right to Act by Written Consent</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written consent allows shareholders to initiate and carry on a shareholder action without having to wait until the next annual meeting or to call a special meeting. It permits action to be taken by the written consent of the same percentage of the shares that would be required to effect proposed action at a shareholder meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reviewed on a case-by-case basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#8220;Say-on-Pay&#8221; / &#8220;Say-When-on-Pay&#8221; / &#8220;Say-on-Golden-Parachutes&#8221;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Required under the Dodd-Frank Act; these proposals are non-binding advisory votes on executive compensation. We will generally vote with the Board of Directors&#8217; recommendation(s) on advisory votes on executive compensation (&#8220;Say-on-Pay&#8221;), advisory votes on the frequency of voting on executive compensation (&#8220;Say-When-on-Pay&#8221;) and advisory votes relating to extraordinary transaction executive compensation (&#8220;Say-on-Golden-Parachutes&#8221;). In those instances when we believe that it is in our clients&#8217; best interest, we may abstain or vote against executive compensation and/or the frequency of votes on executive compensation and/or extraordinary transaction executive compensation advisory votes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Proxy Access</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proxy access is a tool used to attempt to promote board accountability by requiring that a company&#8217;s proxy materials contain not only the names of management nominees, but also any candidates nominated by long-term shareholders holding at least a certain stake in the company. We will review proposals regarding proxy access on a case-by-case basis taking into account the provisions of the proposal, the company&#8217;s current governance structure, the successful steps taken by management to maximize shareholder value, as well as other applicable factors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 185 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PART C &#8212; OTHER INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0%"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 25.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial Statements and Exhibits </b></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial Statements</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Included in Part A:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000138713123003229/gab-ncsr_123122.htm">Annual Report for the fiscal year ended December 31, 2022</a></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000182912623005964/gab_ncsrs.htm">Semi-Annual Report for the fiscal period ended June 30, 2023</a></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Included in Part B:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000138713123003229/gab-ncsr_123122.htm">Audited financial statements and financial highlights for the fiscal year ended December 31, 2022 and related Report of Independent Registered Public Accounting Firm are incorporated herein by reference to the 2022 Annual Report.</a></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000182912623005964/gab_ncsrs.htm">Audited financial statements and financial highlights for the fiscal period ended June 30, 2023 and related Report of Independent Registered Public Accounting Firm are incorporated herein by reference to the 2023 Semi-Annual Report.</a></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibits</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/0000950123-98-003497.txt">Articles of Incorporation are incorporated by reference to Exhibit (a)(1) to Pre-Effective Amendment No. 2 to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 33 3-45951 and 811-04700) as filed with the Securities and Exchange Commission on April 7, 1998.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)(ii)(a)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/0000950123-98-003497.txt">Articles Supplementary for the 7.25% Cumulative Preferred Stock are incorporated by reference to Exhibit (a)(2) to Pre-Effective Amendment No. 2 to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 33 3-45951 and 811-04700) as filed with the Securities and Exchange Commission on April 7, 1998.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)(ii)(b)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000095017201500365/gabelli.txt">Articles Supplementary for the 7.20% Tax Advantaged Series B Cumulative Preferred Stock are incorporated by reference to Exhibit (a)(3) to Pre-Effective Amendment No. 1 to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 333-47012 and 811-4700) as filed with the Securities and Exchange Commission on June 11, 2001.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)(ii)(c)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000095017201500365/gabelli.txt">Articles of Amendment dated June 15, 2001 to the Articles Supplementary for the 7.20% Tax Advantaged Series B Cumulative Preferred Stock are incorporated by reference to Exhibit (a)(2)(B) to Pre-Effective Amendment No. 1 to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 333-47012 and 811-4700) as filed with the Securities and Exchange Commission on June 11, 2001.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)(ii)(d)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000095017202001397/s649149.txt">Articles Supplementary for the Series C Auction Rate Cumulative Preferred Stock are incorporated by reference to Exhibit (a)(2)(A) to Pre-Effective Amendment No. 3 to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 333-86554 and 811-04700) as filed with the Securities and Exchange Commission on June 25, 2002.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)(iii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000095017203002928/s473948_3.txt">Articles Supplementary for the 5.875% Series D Cumulative Preferred Stock are incorporated by reference to Exhibit (a)(iv) to Pre-Effective Amendment No. 2 to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 333-106081 and 811-04700) as filed with the Securities and Exchange Commission on October 1, 2003.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)(iv)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000095017203002928/s473986_2.txt">Articles Supplementary for the Series E Auction Rate Preferred Stock are incorporated by reference to Exhibit (a)(v) to Pre-Effective Amendment No. 2 to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 333-106081 and 811-04700) as filed with the Securities and Exchange Commission on October 1, 2003.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 186; Options: NewSection -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)(v)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000095012306013535/y26698a2exv99w2wawvi.htm">Articles Supplementary for the 6.20% Series F Cumulative Preferred Stock are incorporated by reference to Exhibit (a)(vi) to Pre-Effective Amendment No. 2 to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 333-137298 and 811-04700) as filed with the Securities and Exchange Commission on November 6, 2006.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)(vi)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000095012310112512/y88235aexv3wi.htm">Articles Supplementary for election to be subject to Section 3-804(c) of the Maryland General Corporation Law are incorporated by reference to Exhibit (3)(i) the Registrant&#8217;s filing on Form 8-K (File No.&#160;811-04700) as filed with the Securities and Exchange Commission on December&#160;9, 2010.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)(vii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000095012305007742/y10046exv99w1wf.txt">Articles of Amendment dated May 12, 2004 to the Articles of Incorporation are incorporated by reference to Exhibit (f) to the Registrant&#8217;s Registration Statement on Form N-14 (File No. 333-126111) as filed with the Securities and Exchange Commission on June 24, 2005.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)(viii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000095013305004157/y11686a1exv99w2wawv.htm">Articles of Amendment dated September 12, 2005 to the Articles of Incorporation are incorporated by reference to Exhibit (a)(v) to Pre-Effective Amendment No. 1 to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 333-127724 and 811-04700) as filed with the Securities and Exchange Commission on September 15, 2005.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)(ix)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000095012311060856/y91816exv99wawix.htm">Articles of Amendment dated May 29, 2009 to the Articles Supplementary for the Series C Auction Rate Cumulative Preferred Stock are incorporated by reference to Exhibit (a)(ix) to Pre-Effective Amendment No. 1 to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 333-173819 and 811-04700) as filed with the Securities and Exchange Commission on June 22, 2011.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)(x)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000095012311060856/y91816exv99wawx.htm">Articles of Amendment dated May 29, 2009 to the Articles Supplementary for the 5.875% Series D Cumulative Preferred Stock are incorporated by reference to Exhibit (a)(x) to Pre-Effective Amendment No. 1 to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 333-173819 and 811-04700) as filed with the Securities and Exchange Commission on June 22, 2011.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)(xi)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000095012311060856/y91816exv99wawxi.htm">Articles of Amendment dated May 29, 2009 to the Articles Supplementary for the Series E Auction Rate Preferred Stock are incorporated by reference to Exhibit (a)(xi) to Pre-Effective Amendment No. 1 to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 333-173819 and 811-04700) as filed with the Securities and Exchange Commission on June 22, 2011.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)(xii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000095012311060856/y91816exv99wawxii.htm">Articles of Amendment dated May 29, 2009 to the Articles Supplementary for the 6.20% Series F Cumulative Preferred Stock are incorporated by reference to Exhibit (a)(xii) to Pre-Effective Amendment No. 1 to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 333-173819 and 811-04700) as filed with the Securities and Exchange Commission on June 22, 2011.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)(xiii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000119312512278761/d370637dex99axiii.htm">Articles Supplementary for the Series G Cumulative Preferred Stock are incorporated by reference to Exhibit (a)(xiii) to Post-Effective Amendment No. 3 to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 333-173819 and 811-04700) as filed with the Securities and Exchange Commission on June 21, 2012.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)(xiv)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000119312512404976/d415316dex99axiv.htm">Articles Supplementary for the 5.00% Series H Cumulative Preferred Stock are incorporated by reference to Exhibit (a)(xiv) to Post-Effective Amendment No. 4 to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 333-173819 and 811-04700) as filed with the Securities and Exchange Commission on September 26, 2012.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)(xv)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000119312513124461/d496290dex99axv.htm">Articles of Amendment dated November 15, 2012 to the Articles Supplementary for the Series C Auction Rate Cumulative Preferred Stock are incorporated by reference to Exhibit (a)(xv) to Post-Effective Amendment No. 5 to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 333-173819 and 811-04700) as filed with the Securities and Exchange Commission on March 25, 2013.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)(xvi)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000119312513124461/d496290dex99axvi.htm">Articles of Amendment dated November 15, 2012 to the Articles Supplementary for the 5.875% Series D Cumulative Preferred Stock are incorporated by reference to Exhibit (a)(xvi) to Post-Effective Amendment No. 5 to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 333-173819 and 811-04700) as filed with the Securities and Exchange Commission on March 25, 2013.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 187 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)(xvii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000119312513124461/d496290dex99axvii.htm">Articles of Amendment dated November 15, 2012 to the Articles Supplementary for the Series E Auction Rate Preferred Stock are incorporated by reference to Exhibit (a)(xvii) to Post-Effective Amendment No. 5 to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 333-173819 and 811-04700) as filed with the Securities and Exchange Commission on March 25, 2013.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)(xviii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000119312514142064/d710663dex99axviii.htm">Articles of Amendment dated January 23, 2014 to the Articles Supplementary for the Series C Auction Rate Cumulative Preferred Stock are incorporated by reference to Exhibit (a)(xviii) to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 333-195247 and 811-04700) as filed with the Securities and Exchange Commission on April 14, 2014.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)(xix)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000119312514142064/d710663dex99axix.htm">Articles of Amendment dated January 23, 2014 to the Articles Supplementary for the Series E Auction Rate Preferred Stock are incorporated by reference to Exhibit (a)(xix) to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 333-195247 and 811-04700) as filed with the Securities and Exchange Commission on April 14, 2014.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)(xx)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000119312514142064/d710663dex99axx.htm">Articles of Amendment dated January 23, 2014 to the Articles Supplementary for the 5.00% Series H Cumulative Preferred Stock are incorporated by reference to Exhibit (a)(xx) to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 333-195247 and 811-04700) as filed with the Securities and Exchange Commission on April 14, 2014.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)(xxi)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000119312516521615/d137835dex99axxi.htm">Articles Supplementary for the 5.45% Series J Cumulative Preferred Stock are incorporated by reference to Exhibit (a)(xxi) to Post-Effective Amendment No. 3 to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 333-195247 and 811-04700) as filed with the Securities and Exchange Commission on March 29, 2016.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)(xxii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000119312517315509/d479439dex99axxii.htm">Articles of Amendment dated October 17, 2017 to the Articles of Incorporation are incorporated by reference to Exhibit (a)(xxii) to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 333-220232 and 811-04700) as filed with the Securities and Exchange Commission on October 20, 2017.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)(xxiii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000119312519311459/d768302dex99axxiii.htm">Articles Supplementary for the 5.00% Series K Cumulative Preferred stock are incorporated by reference to Exhibit (a)(xxii) to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 333-220232 and 811-04700) as filed with the Securities and Exchange Commission on December 11, 2019.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)(xxiv)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="gabelliequitytrust_ex99axxiv.htm">Articles Supplementary Creating and Fixing the Rights of 4.25% Series M Cumulative Preferred Stock are filed herewith.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)(xxv)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="gabelliequitytrust_ex99axxv.htm">Articles Supplementary Creating and Fixing the Rights of 5.25% Series N Cumulative Preferred Stock are filed herewith.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000095012310112512/y88235aexv3wii.htm">Amended and Restated By-Laws of Registrant are incorporated by reference to Exhibit (3)(ii) to the Registrant&#8217;s filing on Form 8-K (File No. 811-04700) as filed with the Securities and Exchange Commission on December 9, 2010.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)(ii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="gabelliequitytrust_ex99bii.htm">Amendment No. 1 to Amended and Restated By-laws is filed herewith.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not applicable</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/0000950123-95-002892.txt">Form of certificate for Common Stock, par value $.001 per share is incorporated by reference to the Exhibit (d)(1) to Pre-Effective Amendment No. 1 to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 033-62323 and 811-04700) as filed with the Securities and Exchange Commission on October 13, 1995.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)(ii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000095017202001397/certificate.txt">Form of certificate for Series C Auction Rate Cumulative Preferred Stock is incorporated by reference to Exhibit (d) to Pre-Effective Amendment No. 3 to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 333-86554 and 811-04700) as filed with the Securities and Exchange Commission on June 25, 2002.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 188 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)(iii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000095017203002928/s476039.txt">Form of certificate of 5.875% Series D Cumulative Preferred Stock is incorporated by reference to Exhibit (d)(i)(C) to Pre-Effective Amendment No. 2 to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 333-106081 and 811-04700) as filed with the Securities and Exchange Commission on October 1, 2003.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)(iv)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000095017203002928/s452072a.txt">Form of certificate Series E Auction Rate Preferred Stock is incorporated by reference to Exhibit (d)(1)(D) to Pre-Effective Amendment No. 2 to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 333-106081 and 811-04700) as filed with the Securities and Exchange Commission on October 1, 2003.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/0000950123-98-003497.txt">Automatic Dividend Reinvestment and Voluntary Cash Purchase Plan of The Gabelli Equity Trust Inc. are incorporated by reference to Exhibit (e) to Pre-Effective Amendment No. 2 to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 33 3-45951 and 811-04700) as filed with the Securities and Exchange Commission on April 7, 1998.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not applicable</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/0000950123-95-002892.txt">Investment Advisory Agreement between Registrant and Gabelli Funds, LLC (the &#8220;Investment Adviser&#8221;) is incorporated by reference to the Exhibit (g) to Pre-Effective Amendment No. 1 to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 033-62323 and 811-04700) as filed with the Securities and Exchange Commission on October 13, 1995.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Underwriting Agreement to be filed by amendment.</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not applicable</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000095012311042138/y91065exv99wj.htm">Custodian Contract between Registrant and The Bank of New York Mellon is incorporated by reference to Exhibit (j) to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 333-173819 and 811-04700) as filed with the Securities and Exchange Commission on April 29, 2011.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000095012311042138/y91065exv99wkwi.htm">Transfer Agency and Service Agreement among Registrant, Computershare Trust Company, N.A. and Computershare Inc. is incorporated by reference to Exhibit (k)(i) to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 333-173819 and 811-04700) as filed with the Securities and Exchange Commission on April 29, 2011.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)(i)(a)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000119312512404976/d415316dex99kia.htm">Amendment No. 1 to Transfer Agency and Service Agreement among Registrant, Computershare Trust Company, N.A. and Computershare Inc. is incorporated by reference to Exhibit (k)(i)(a) to Post-Effective Amendment No. 4 to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 333-173819 and 811-04700) as filed with the Securities and Exchange Commission on September 26, 2012.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)(i)(b)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000119312512404976/d415316dex99kib.htm">Amendment No. 2 to Transfer Agency and Service Agreement among Registrant, Computershare Trust Company, N.A. and Computershare Inc.is incorporated by reference to Exhibit (k)(i)(b) to Post-Effective Amendment No. 4 to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 333-173819 and 811-04700) as filed with the Securities and Exchange Commission on September 26, 2012.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)(i)(c)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000119312516510238/d23122dex99kic.htm">Amendment No. 3 to Transfer Agency and Service Agreement among Registrant, Computershare Trust Company, N.A. and Computershare Inc. is incorporated by reference to Exhibit (k)(i)(c) to Post-Effective Amendment No. 2 to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 333-195247 and 811-04700) as filed with the Securities and Exchange Commission on March 18, 2016.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)(i)(d)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000119312516510238/d23122dex99kid.htm">Amendment No. 4 to Transfer Agency and Service Agreement among Registrant, Computershare Trust Company, N.A. and Computershare Inc. is incorporated by reference to Exhibit (k)(i)(d) to Post-Effective Amendment No. 2 to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 333-195247 and 811-04700) as filed with the Securities and Exchange Commission on March 18, 2016.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 189 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)(i)(e)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000119312516510238/d23122dex99kie.htm">Amendment No. 5 to Transfer Agency and Service Agreement among Registrant, Computershare Trust Company, N.A. and Computershare Inc. is incorporated by reference to Exhibit (k)(i)(e) to Post-Effective Amendment No. 2 to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 333-195247 and 811-04700) as filed with the Securities and Exchange Commission on March 18, 2016.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)(i)(f)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000119312516521615/d137835dex99kif.htm">Amendment No. 6 to Transfer Agency and Service Agreement among Registrant, Computershare Trust Company, N.A. and Computershare Inc. is incorporated by reference to Exhibit (k)(i)(f) to Post-Effective Amendment No. 3 to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 333-195247 and 811-04700) as filed with the Securities and Exchange Commission on March 29, 2016.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)(i)(g)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000119312517272059/d449457dex99kig.htm">Amendment No. 7 to Transfer Agency and Service Agreement among Registrant, Computershare Trust Company, N.A. and Computershare Inc. is incorporated by reference to Exhibit (k)(i)(g) to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 333-220232 and 811-04700) as filed with the Securities and Exchange Commission on August 29, 2017.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)(i)(h)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000119312517272059/d449457dex99kih.htm">Amendment No. 8 to Transfer Agency and Service Agreement among Registrant, Computershare Trust Company, N.A. and Computershare Inc. is incorporated by reference to Exhibit (k)(i)(h) to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 333-220232 and 811-04700) as filed with the Securities and Exchange Commission on August 29, 2017.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)(i)(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000119312517272059/d449457dex99kii.htm">Amendment No. 9 to Transfer Agency and Service Agreement among Registrant, Computershare Trust Company, N.A. and Computershare Inc. is incorporated by reference to Exhibit (k)(i)(i) to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 333-220232 and 811-04700) as filed with the Securities and Exchange Commission on August 29, 2017.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)(i)(j)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000119312517315509/d479439dex99kij.htm">Amendment No. 10 to Transfer Agency and Service Agreement among Registrant, Computershare Trust Company, N.A. and Computershare Inc. is incorporated by reference to Exhibit (k)(i)(j) to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 333-220232 and 811-04700) as filed with the Securities and Exchange Commission on October 20, 2017.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)(i)(k)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000119312517315509/d479439dex99kik.htm">Amendment No. 11 to Transfer Agency and Service Agreement among Registrant, Computershare Trust Company, N.A. and Computershare Inc. is incorporated by reference to Exhibit (k)(i)(k) to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 333-220232 and 811-04700) as filed with the Securities and Exchange Commission on October 20, 2017.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)(i)(l)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000119312519253625/d776080dex99kil.htm">Amendment No. 12 to Transfer Agency and Service Agreement among Registrant, Computershare Trust Company, N.A. and Computershare Inc. is incorporated by reference to Exhibit (k)(i)(l) to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 333-220232 and 811-04700) as filed with the Securities and Exchange Commission on September 24, 2019.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)(i)(m)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000119312519253625/d776080dex99kim.htm">Amendment No. 13 to Transfer Agency and Service Agreement among Registrant, Computershare Trust Company, N.A. and Computershare Inc. is incorporated by reference to Exhibit (k)(i)(m) to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 333-220232 and 811-04700) as filed with the Securities and Exchange Commission on September 24, 2019.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)(i)(n)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1080720/000119312520037901/d833869dex99k1xiv.htm">Amendment No. 14 to Transfer Agency and Service Agreement among Registrant, Computershare Trust Company, N.A. and Computershare Inc. is incorporated by reference to Exhibit (k)(1)(xiv) to the Registration Statement on Form N-2 of Gabelli Utility Trust (File Nos. 333-236449 and 811-09243), as filed with the Securities and Exchange Commission on February 14, 2020.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)(i)(o)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000119312519311459/d768302dex99kin.htm">Amendment No. 15 to Transfer Agency and Service Agreement among Registrant, Computershare Trust Company, N.A. and Computershare Inc. is incorporated by reference to Exhibit (k)(i)(n) to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 333-220232 and 811-04700) as filed with the Securities and Exchange Commission on December 11, 2019.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 190 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)(i)(p)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1080720/000119312520037901/d833869dex99k1xvi.htm">Amendment No. 16 to Transfer Agency and Service Agreement among Registrant, Computershare Trust Company, N.A. and Computershare Inc. is incorporated by reference to Exhibit (k)(1)(xvi) to the Registration Statement on Form N-2 of Gabelli Utility Trust (File Nos. 333-236449 and 811-09243), as filed with the Securities and Exchange Commission on February 14, 2020.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)(i)(q)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1260729/000119312521084266/d34126dex99d5xviii.htm">Amendment No. 17 to Transfer Agency and Service Agreement among Registrant, Computershare Trust Company, N.A. and Computershare Inc. is incorporated by reference to Exhibit (d)(5)(xviii) to The Gabelli Dividend &amp; Income Trust&#8217;s Tender Offer Statement on Schedule TO (File No. 005-84324), filed on March 17, 2021.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)(i)(r)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1260729/000119312521292253/d230519dex99kir.htm">Amendment No. 18 to Transfer Agency and Service Agreement among Registrant, Computershare Trust Company, N.A. and Computershare Inc. is incorporated by reference to Exhibit (k)(i)(r) to Post-Effective Amendment No. 1 to The Gabelli Dividend &amp; Income Trust&#8217;s Registration Statement on Form N-2, File Nos. 333-259726 and 811-21423, as filed with the Securities and Exchange Commission on October 5, 2021.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)(i)(s)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1260729/000119312521292253/d230519dex99kis.htm">Amendment No. 19 to Transfer Agency and Service Agreement among Registrant, Computershare Trust Company, N.A. and Computershare Inc. is incorporated by reference to Exhibit (k)(i)(s) to Post-Effective Amendment No. 1 to The Gabelli Dividend &amp; Income Trust&#8217;s Registration Statement on Form N-2, File Nos. 333-259726 and 811-21423, as filed with the Securities and Exchange Commission on October 5, 2021.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)(i)(t)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1080720/000182912623005956/gut_exd5xxi.htm">Amendment No. 20 to Transfer Agency and Service Agreement among Registrant, Computershare Trust Company, N.A. and Computershare Inc. is incorporated by reference to Exhibit (d)(5)(xxi) to The Gabelli Utility Trust&#8217;s Tender Offer Statement on Schedule TO (File No. 005-84324), filed on September 6, 2023.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)(i)(u)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1080720/000182912623005956/gut_exd5xxii.htm">Amendment No. 21 to Transfer Agency and Service Agreement among Registrant, Computershare Trust Company, N.A. and Computershare Inc. is incorporated by reference to Exhibit (d)(5)(xxii) to The Gabelli Utility Trust&#8217;s Tender Offer Statement on Schedule TO (File No. 005-84324), filed on September 6, 2023.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)(i)(v)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1080720/000182912623005956/gut_exd5xxiii.htm">Amendment No. 22 to Transfer Agency and Service Agreement among Registrant, Computershare Trust Company, N.A. and Computershare Inc. is incorporated by reference to Exhibit (d)(5)(xxiii) to The Gabelli Utility Trust&#8217;s Tender Offer Statement on Schedule TO (File No. 005-84324), filed on September 6, 2023.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)(i)(w)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1080720/000182912623005956/gut_exd5xxiv.htm">Amendment No. 23 to Transfer Agency and Service Agreement among Registrant, Computershare Trust Company, N.A. and Computershare Inc. is incorporated by reference to Exhibit (d)(5)(xxiv) to The Gabelli Utility Trust&#8217;s Tender Offer Statement on Schedule TO (File No. 005-84324), filed on September 6, 2023.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)(i)(x)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1080720/000182912623005956/gut_exd5xxv.htm">Amendment No. 24 to Transfer Agency and Service Agreement among Registrant, Computershare Trust Company, N.A. and Computershare Inc. is incorporated by reference to Exhibit (d)(5)(xxv) to The Gabelli Utility Trust&#8217;s Tender Offer Statement on Schedule TO (File No. 005-84324), filed on September 6, 2023.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)(ii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000095012311042138/y91065exv99wkwii.htm">Fee and Service Schedule for Stock Transfer Services among Registrant, Computershare Trust Company, N.A. and Computershare Inc. is incorporated by reference to Exhibit (k)(ii) to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 333-173819 and 811-04700) as filed with the Securities and Exchange Commission on April 29, 2011.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)(iii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000095017202001397/s392862.txt">Form of Auction Agency Agreement for the Series C Auction Rate Cumulative Preferred Stock is incorporated by reference to Exhibit (k)(3) to Pre-Effective Amendment No. 3 to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 333-86554 and 811-04700) as filed with the Securities and Exchange Commission on June 25, 2002.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)(iv)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000095017203002928/s476041.txt">Form of Auction Agency Agreement for the Series E Auction Rate Preferred Stock is incorporated by reference to Exhibit (k)(ii) to Pre-Effective Amendment No. 2 to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 333-106081 and 811-04700) as filed with the Securities and Exchange Commission on October 1, 2003.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 191 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)(v)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000095017202001397/s393240a.txt">Form of Broker-Dealer Agreement for the Series C Auction Rate Cumulative Preferred Stock is incorporated by reference to Exhibit (k)(4) to Pre-Effective Amendment No. 3 to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 333-86554 and 811-04700) as filed with the Securities and Exchange Commission on June 25, 2002.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)(vi)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/794685/000095017203002928/s476049.txt">Form of Broker-Dealer Agreement for the Series E Auction Rate Preferred Stock is incorporated by reference to Exhibit (k)(iii) to Pre-Effective Amendment No. 2 to the Registrant&#8217;s Registration Statement on Form N-2 (File Nos. 333-106081 and 811-04700) as filed with the Securities and Exchange Commission on October 1, 2003.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="gabelliequitytrust_ex99li.htm">Opinion and Consent of Venable LLP is filed herewith.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not applicable</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="gabelliequitytrust_ex99ni.htm">Consent of Independent Registered Public Accounting Firm is filed herewith.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0"></td>
    <td style="width: 0.75in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)(ii)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="gabelliequitytrust_ex99nii.htm">Power of Attorney is filed herewith.</a></span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not applicable</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not applicable</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not applicable</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1080720/000182912623007248/gut_exr1.htm">Code of Ethics of the Investment Adviser and of the Registrant is incorporated by reference to Exhibit (r)(1) to The Gabelli Utility Trust&#8217;s Registration Statement on Form N-2 (File Nos. 333-275448 and 811-09243) as filed with the Securities and Exchange Commission on November 9, 2023.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)(ii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1080720/000182912623007248/gut_exr2.htm">Joint Code of Ethics of the Investment Adviser and of the Registrant for Chief Executive and Senior Financial Officers of the Gabelli Funds is incorporated by reference to Exhibit (r)(2) to The Gabelli Utility Trust&#8217;s Registration Statement on Form N-2 (File Nos. 333-275448 and 811-09243) as filed with the Securities and Exchange Commission on November 9, 2023.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="gabelliequitytrust_ex99s.htm">Calculation of Filing Fee Tables is filed herewith.</a></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 26.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Marketing Arrangements </b></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The information contained under the heading &#8220;Plan of Distribution&#8221; beginning on page 45 of the Prospectus is incorporated by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0"></td>
    <td style="width: 1in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 27.</b></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other Expenses of Issuance and Distribution</b></span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth the estimated expenses to be incurred in connection with the offering described in this Registration Statement:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 68%; text-align: left">Accounting fees</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">80,000</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Legal fees</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">440,000</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">NYSE listing fees</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">49,323</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Printing expenses</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">650,000</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Rating agency fees</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">100,000</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">SEC registration fees</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">73,800</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; text-align: left">Miscellaneous</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">476,877</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Total</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">1,870,000</td>
    <td style="text-align: left">&#160;</td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Page; Sequence: 192 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0"></td>
    <td style="width: 1in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 28.</b></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Persons Controlled by or Under Common Control with Registrant</b></span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0"></td>
    <td style="width: 1in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 29.</b></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of Holders of Securities as of September 30, 2023:</b></span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">Class of Stock</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of<br /> Record Holders</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 68%; text-align: left">Common Stock</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right">65,063</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Series C Auction Rate Preferred</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">12</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Series E Auction Rate Preferred</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Series G Preferred</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,613</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Series H Preferred</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">5,236</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Series K Preferred</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,998</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Series M Preferred</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">5</td>
    <td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top">
    <td style="width: 0"></td>
    <td style="text-align: justify; width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 30.</b></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Indemnification </b></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Article VI of the Registrant&#8217;s Amended and Restated Bylaws provides as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 193 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ARTICLE VI<br /> <br /> INDEMNIFICATION, ADVANCE OF EXPENSES AND INSURANCE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 1in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 1. Indemnification of Directors and Officers. Any person who was or is a party or is threatened to be made a party in any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that such person is a current or former director or officer of the Corporation, or is or was serving while a director or officer of the Corporation at the request of the Corporation as a director, officer, partner, trustee, employee, agent or fiduciary of another corporation, partnership, joint venture, trust, enterprise or employee benefit plan, shall be indemnified by the Corporation against judgments, penalties, fines, excise taxes, settlements and reasonable expenses (including attorneys&#8217; fees) actually incurred by such person in connection with such action, suit or proceeding to the full extent permissible under the MGCL, the Securities Act of 1933, as amended, and the Investment Company Act, as those statutes are now or hereafter in force, except that such indemnity shall not protect any such person against any liability to the Corporation or any stockholder thereof to which such person would otherwise be subject by reason of willful misfeasance, bad faith, gross negligence or reckless disregard of the duties involved in the conduct of his office (&#8220;disabling conduct&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 1in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 1in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 2. Advances. Any current or former director or officer of the Corporation claiming indemnification within the scope of this Article VI shall be entitled to advances from the Corporation for payment of the reasonable expenses incurred by him or her in connection with proceedings to which he or she is a party in the manner and to the full extent permissible under the MGCL, the Securities Act of 1933, as amended, and the Investment Company Act, as those statutes are now or hereafter in force; provided, however, that the person seeking indemnification shall provide to the Corporation a written affirmation of his good faith belief that the standard of conduct necessary for indemnification by the Corporation has been met and a written undertaking to repay any such advance, if it should ultimately be determined that the standard of conduct has not been met, and provided further that at least one of the following additional conditions is met: (a) the person seeking indemnification shall provide a security in form and amount acceptable to the Corporation for his undertaking; (b) the Corporation is insured against losses arising by reason of the advance; or (c) a majority of a quorum of directors of the Corporation who are neither &#8220;interested persons&#8221; as defined in Section 2(a)(19) of the Investment Company Act, nor parties to the proceeding (&#8220;disinterested non-party directors&#8221;), or independent legal counsel, in a written opinion, shall determine, based on a review of facts readily available to the Corporation at the time the advance is proposed to be made, that there is reason to believe that the person seeking indemnification will ultimately be found to be entitled to indemnification.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 1in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 1in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 3. Procedure. At the request of any current or former director or officer, or any employee or agent whom the Corporation proposes to indemnify, the Board of Directors shall determine, or cause to be determined, in a manner consistent with the MGCL, the Securities Act of 1933, as amended, and the Investment Company Act, as those statutes are now or hereafter in force, whether the standards required by this Article V have been met; provided, however, that indemnification shall be made only following: (a) a final decision on the merits by a court or other body before whom the proceeding was brought that the person to be indemnified was not liable by reason of disabling conduct or (b) in the absence of such a decision, a reasonable determination, based upon a review of the facts, that the person to be indemnified was not liable by reason of disabling conduct, by (i) the vote of a majority of a quorum of disinterested non-party directors or (ii) an independent legal counsel in a written opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 1in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 1in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 4. Indemnification of Employees and Agents. Employees and agents who are not officers or directors of the Corporation may be indemnified, and reasonable expenses may be advanced to such employees or agents, in accordance with the procedures set forth in this Article V to the extent permissible under the MGCL, the Securities Act of 1933, as amended, and the Investment Company Act, as those statutes are now or hereafter in force, and to such further extent, consistent with the foregoing, as may be provided by action of the Board of Directors or by contract.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 1in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 1in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 5. General; Other Rights. The rights to indemnification and advance of expenses provided by the Charter and these Bylaws shall vest immediately upon election of a director or officer. Neither the amendment nor repeal of this Article, nor the adoption or amendment of any other provision of the Charter or these Bylaws inconsistent with this Article, shall apply to or affect in any respect the applicability of the preceding paragraph with respect to any act or failure to act which occurred prior to such amendment, repeal or adoption. The indemnification provided by this Article VI shall not be deemed exclusive of any other right, with respect to indemnification or otherwise, to which those seeking such indemnification may be entitled under any insurance or other agreement, vote of stockholders or disinterested directors or otherwise, both as to action by a director or officer of the Corporation in his official capacity and as to action by such person in another capacity while holding such office or position, and shall continue as to a person who has ceased to be a director or officer and shall inure to the benefit of the heirs, executors and administrators of such a person.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 1in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 194 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 1in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 1in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 6. Insurance. The Corporation shall have the power to purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or agent of the Corporation, or who, while a director, officer, employee or agent of the Corporation, is or was serving at the request of the Corporation as a director, officer, partner, trustee, employee, agent or fiduciary of another corporation, partnership, joint venture, trust, enterprise or employee benefit plan, against any liability asserted against and incurred by him or her in any such capacity, or arising out of his or her status as such, and reasonable expenses incurred by him or her in connection with proceedings to which he or she is made a party, provided that no insurance may be obtained by the Corporation for liabilities against which the Corporation is specifically prohibited from indemnifying him or her under this Article VI or applicable law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section 5 of the Registrant&#8217;s Investment Advisory Agreement provides as follows: </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Standard of Care</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Advisor shall exercise its best judgment in rendering the services described in paragraphs 2 and 3 above. The Advisor shall not be liable for any error of judgment or mistake of law or for any loss suffered by the Fund in connection with the matters of which this Agreement relates, provided that nothing in this paragraph shall be deemed to protect or purport to protect the Advisor against any liability to the Fund or to its shareholders to which the Advisor would otherwise be subject by reason of willful misfeasance, bad faith or gross negligence on its part in the performance of its duties or by reason of the Advisor&#8217;s reckless disregard of its obligations and duties under this Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top">
    <td style="width: 0"></td>
    <td style="text-align: justify; width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 31.</b></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Business and Other Connections of Investment Adviser </b></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Investment Adviser, a limited liability company organized under the laws of the State of New York, acts as investment adviser to the Registrant. The Registrant is fulfilling the requirement of this Item 31 to provide a list of the officers and directors of the Investment Adviser, together with information as to any other business, profession, vocation or employment of a substantial nature engaged in by the Investment Adviser or those officers and directors during the past two years, by incorporating by reference the information contained in the Form ADV of the Investment Adviser filed with the SEC pursuant to the Investment Advisers Act of 1940 (Commission File No. 801-37706).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top">
    <td style="width: 0"></td>
    <td style="text-align: justify; width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 32.</b></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Location of Accounts and Records </b></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Omitted pursuant to the Instruction of Item 32 of Form N-2.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top">
    <td style="width: 0"></td>
    <td style="text-align: justify; width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 33.</b></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Management Services </b></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top">
    <td style="width: 0"></td>
    <td style="text-align: justify; width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 34.</b></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Undertakings </b></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1. Not applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2. Not applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3. Registrant undertakes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) to file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1) to include any prospectus required by Section 10(a)(3) of the Securities Act;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 195 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2) to reflect in the prospectus any facts or events after the effective date of the Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration statement; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3) to include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration Statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4) if (i)&#160;it determines to conduct one or more offerings of the Fund&#8217;s common shares (including rights to purchase its common shares) at a price below its net asset value per common share at the date the offering is commenced, and (ii)&#160;such offering or offerings will result in greater than a 15% dilution to the Fund&#8217;s net asset value per common share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) that, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of those securities at that time shall be deemed to be the initial bona fide offering thereof;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) to remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) that, for the purpose of determining liability under the Securities Act to any purchaser:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1) if the Registrant is relying on Rule 430B:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 1in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A) Each prospectus filed by the Registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 1in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 1in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B) Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (x), or (xi) for the purpose of providing the information required by Section 10(a) of the Securities Act shall be deemed to be part of and included in the registration<b>&#160;</b>statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date; or</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2) if the Registrant is relying on Rule 430C: each prospectus filed pursuant to Rule 424(b) under the Securities Act as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A,&#160;shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 196 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) that for the purpose of determining liability of the Registrant under the Securities Act to any purchaser in the initial distribution of securities:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The undersigned Registrant undertakes that in a primary offering of securities of the undersigned Registrant pursuant to this Registration Statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned Registrant will be a seller to the purchaser and will be considered to offer or sell such securities to the purchaser:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any preliminary prospectus or prospectus of the undersigned Registrant relating to the offering required to be filed pursuant to Rule 424 under the Securities Act;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">free writing prospectus relating to the offering prepared by or on behalf of the undersigned Registrant or used or referred to by the undersigned Registrants;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the portion of any other free writing prospectus or advertisement pursuant to Rule 482 under the Securities Act relating to the offering containing material information about the undersigned Registrant or its securities provided by or on behalf of the undersigned Registrant; and</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any other communication that is an offer in the offering made by the undersigned Registrant to the purchaser.</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4. Registrant undertakes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) that, for the purpose of determining any liability under the Securities Act the information omitted from the form of prospectus filed as part of the Registration Statement in reliance upon Rule 430A and contained in a form of prospectus filed by the Registrant under Rule 424(b)(1) under the Securities Act will be deemed to be a part of the Registration Statement as of the time it was declared effective.</span></p>

<p style="margin: 0; text-align: justify">&#160;</p>

<p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) that, for the purpose of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus will be deemed to be a new Registration Statement relating to the securities offered therein, and the offering of the securities at that time will be deemed to be the initial bona fide offering thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5. The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the Registrant&#8217;s annual report pursuant to Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 that is incorporated by reference into the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6. Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7. Registrant undertakes to send by first class mail or other means designed to ensure equally prompt delivery, within two business days of receipt of a written or oral request, any prospectus or Statement of Additional Information constituting Part B of this Registration Statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8. Registrant undertakes to only offer rights to purchase a combination of common stock and preferred stock together after a post-effective amendment to the Registration Statement relating to such rights has been declared effective.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 197 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As required by the Securities Act of 1933, as amended, and the Investment Company Act of 1940, as amended, <span style="background-color: white">the Registrant </span>has duly caused this Registration Statement on Form N-2 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Rye, State of New York, on the 29th day of December, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="text-align: left">&#160;</td>
    <td colspan="2" style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE GABELLI EQUITY TRUST INC.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: left; width: 50%">&#160;</td>
    <td style="text-align: left; width: 4%">&#160;</td>
    <td style="text-align: left; width: 46%">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ John C. Ball</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">John C. Ball</span> </td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">President and Principal Executive Officer</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As required by the Securities Act of 1933, as amended, this Form N-2 has been signed below by the following persons in the capacities set forth below on the 29th day of December, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NAME</b></span></td>
    <td style="text-align: center; padding-bottom: 1pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TITLE</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; text-align: center">*</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Elizabeth C. Bogan</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; text-align: center">*</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">James P. Conn</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; text-align: center">*</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Frank J. Fahrenkopf, Jr.</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; text-align: center">*</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael J. Ferrantino</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; text-align: center">*</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leslie F. Foley</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; text-align: center">*</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">William F. Heitmann</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; text-align: center">*</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agnes Mullady</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; text-align: center">*</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salvatore J. Zizza</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; text-align: center">/s/ <span style="font: small-caps 10pt Times New Roman, Times, Serif"> John C. Ball</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">President, Treasurer and Principal Financial and Accounting Officer</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">John C. Ball</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font: small-caps 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; text-align: center">/s/<span style="font: small-caps 10pt Times New Roman, Times, Serif"> John C. Ball</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attorney-in-Fact</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">John C. Ball</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to a Power of Attorney</span></td> </tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Page; Sequence: 198 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EXHIBIT INDEX</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 9%">
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit Number</b></span></p></td>
    <td style="text-align: justify; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 90%">
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)(xxiv)</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="gabelliequitytrust_ex99axxiv.htm">Articles Supplementary Creating and Fixing the Rights of 4.25% Series M Cumulative Preferred Stock</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)(xxv)</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="gabelliequitytrust_ex99axxv.htm">Articles Supplementary Creating and Fixing the Rights of 5.25% Series N Cumulative Preferred Stock</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)(ii)</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="gabelliequitytrust_ex99bii.htm">Amendment No. 1 to Amended and Restated By-laws</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)(i)</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="gabelliequitytrust_ex99li.htm">Opinion and Consent of Venable LLP</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)(i)</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="gabelliequitytrust_ex99ni.htm">Consent of Independent Registered Public Accounting Firm</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)(ii)</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="gabelliequitytrust_ex99nii.htm">Power of Attorney</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="gabelliequitytrust_ex99s.htm">Calculation of Filing Fee Tables</a></span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Page; Sequence: 199 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div>

    <!-- Field: /Page -->

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!--   -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.(A)(XXIV)
<SEQUENCE>2
<FILENAME>gabelliequitytrust_ex99axxiv.htm
<DESCRIPTION>EXHIBIT (A)(XXIV)
<TEXT>
<HTML>
   <HEAD>
      <TITLE></TITLE>
   </HEAD>
   <BODY STYLE="font: 10pt Times New Roman, Times, Serif">
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Exhibit (a)(xxiv)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>THE GABELLI EQUITY TRUST INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>ARTICLES SUPPLEMENTARY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CREATING
AND FIXING THE RIGHTS OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>4.25% SERIES M CUMULATIVE PREFERRED STOCK</B></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The Gabelli Equity Trust Inc., a Maryland corporation, having its principal office
         in Baltimore City, Maryland (hereinafter called the &ldquo;<U>Corporation</U>&rdquo;), hereby certifies to the State Department of Assessments and Taxation of Maryland
         (the &ldquo;<U>SDAT</U>&rdquo;) that:</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">FIRST: The Board of Directors, at a meeting duly convened and held on December&nbsp;15, 2021, pursuant to authority expressly vested in it by Article V of the Charter of the Corporation, adopted resolutions classifying 1,000,000 authorized and unissued shares of preferred stock of the Corporation, par value $0.001 per share, without further designation as to class or series, as shares of 4.25% Series M Cumulative Preferred Stock having the preferences, conversion and other rights, voting powers, restrictions,
         limitations as to dividends and other distributions, qualifications, and terms and
         conditions of redemption set forth herein.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">SECOND: The preferences, conversion and other rights, voting powers, restrictions, limitations as to dividends and other distributions, qualifications, and terms and conditions of redemption of the Corporation&rsquo;s 4.25% Series M Cumulative Preferred Stock, par value $0.001 per share, as fixed by the Board of Directors are as follows:</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>DESIGNATION</B></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">4.25% Series M Cumulative Preferred Stock: A series of 1,000,000 shares of preferred stock, par value $0.001 per share, is hereby designated &ldquo;4.25% Series M Cumulative Preferred Stock&rdquo; (the &ldquo;<U>Series M Preferred Stock</U>&rdquo;). The Series M Preferred Stock shall constitute a separate series of Preferred Stock.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>ARTICLE I</B></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>DEFINITIONS</B></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Unless the context or use indicates another or different meaning or intent, each of
         the following terms when used in these Articles Supplementary shall have the meaning ascribed to it below, whether such term is used
         in the singular or plural and regardless of tense or gender:</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>1940 Act</U>&rdquo; means the Investment Company Act of 1940, as amended, or any successor statute.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>Adjusted Value</U>&rdquo; of each Rating Agency Eligible Asset shall be computed as follows:</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(a) cash shall be valued at 100% of the face value thereof; and</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(b) all other Rating Agency Eligible Assets shall be valued at the Discounted Value thereof; and</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(c) each asset that is not a Rating Agency Eligible Asset shall be valued at zero.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>Administrator</U>&rdquo; means the other party to the Administration Agreement with the Corporation, which
         shall initially be Gabelli Funds, LLC, a New York limited liability company, and will
         include, as appropriate, any sub-administrator appointed by the Administrator.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>Adviser</U>&rdquo; means Gabelli Funds, LLC, a New York limited liability company, or such other person
         as shall be serving as the investment adviser of the Corporation.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>Annual Valuation Date</U>&rdquo; means the Valuation Date each calendar year so designated by the Corporation, commencing in the calendar year 2021.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>Asset Coverage</U>&rdquo; means asset coverage, as determined in accordance with Section&nbsp;18(h) of the 1940 Act, of at least 200% with respect to all outstanding senior securities
         of the Corporation which are stock, including all Outstanding shares of Series M Preferred Stock (or such other asset coverage as may in the future be specified in
         or under the 1940 Act as the minimum asset coverage for senior securities which are
         stock of a closed-end investment company as a condition of declaring dividends on
         its common stock), determined on the basis of values calculated as of a time within
         48 hours (not including Saturdays, Sundays or holidays) next preceding the time of such
         determination.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>Basic Maintenance Amount</U>&rdquo; has the meaning set forth in the Moody&rsquo;s Guidelines or, if any Other Rating Agency is rating the Series M Preferred Stock at the Corporation&rsquo;s request, the meaning set forth in the guidelines of the Other Rating Agency.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>Basic Maintenance Amount Cure Date</U>&rdquo; means, with respect to the Series M Preferred Stock, 10 Business Days following a Valuation Date, such date being the
         last day upon which the Corporation&rsquo;s failure to comply with paragraph 6(a)(ii)(A) of Article II hereof could be cured, and for the purposes of these Articles Supplementary shall
         have a correlative meaning with respect to any other class or series of Preferred
         Stock.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>Basic Maintenance Report</U>&rdquo; or &ldquo;<U>Report</U>&rdquo; means, with respect to the Series M Preferred Stock, a report prepared by the Administrator (if requested by any Rating
         Agency) which sets forth, as of the related Valuation Date, Rating Agency Eligible
         Assets sufficient to meet or exceed the Basic Maintenance Amount, the Market Value
         and Discounted Value thereof (seriatim and in the aggregate), and the Basic Maintenance
         Amount, and for the purposes of these Articles Supplementary shall have a correlative
         meaning with respect to any other class or series of Preferred Stock.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>Board of Directors</U>&rdquo; means the Board of Directors of the Corporation or any duly authorized committee
         thereof as permitted by applicable law.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>Business Day</U>&rdquo; means a day on which the New York Stock Exchange is open for trading and that is
         neither a Saturday, Sunday nor any other day on which banks in the city of New York,
         New York are authorized or obligated by law to close.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>By-Laws</U>&rdquo; means the By-Laws of the Corporation, as amended from time to time.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>Charter</U>&rdquo; means the Articles of Incorporation of the Corporation, as amended and supplemented
         (including by these Articles Supplementary), as filed with the State Department of Assessments and Taxation of
         Maryland.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>Code</U>&rdquo; means the Internal Revenue Code of 1986, as amended.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>Common Stock</U>&rdquo; means the Common Stock, par value $0.001 per share, of the Corporation.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>Corporation</U>&rdquo; means The Gabelli Equity Trust Inc., a Maryland corporation.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>Cure Date</U>&rdquo; shall have the meaning set forth in paragraph 4(a)(ii) of Article II hereof.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>Date of Original Issue</U>&rdquo; means, with respect to the Series M Preferred Stock, December&nbsp;17, 2021, and for the purposes of these Articles Supplementary shall mean with respect to any other class or series of Preferred Stock
         the date upon which shares of such class or series are first issued.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>Deposit Assets</U>&rdquo; means cash, Short-Term Money Market Instruments and U.S. Government Obligations. Except for determining whether the Corporation has Rating
         Agency Eligible Assets with an Adjusted Value equal to or greater than the Basic Maintenance
         Amount, each Deposit Asset shall be deemed to have a value equal to its principal
         or face amount payable at maturity plus any interest payable thereon after delivery
         of such Deposit Asset but only if payable on or prior to the applicable payment date
         in advance of which the relevant deposit is made.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>Discount Factor</U>&rdquo; means (a) if a Rating Agency is rating the Series M Preferred Stock at the Corporation&rsquo;s request, the Rating Agency Discount Factor, or (b) any applicable discount factor
         established by any other Rating Agency, whichever is applicable.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>Discounted Value</U>&rdquo; means, as applicable, (a) the quotient of the Market Value of an Eligible Asset divided by the applicable Rating
         Agency Discount Factor or (b) such other formula for determining the discounted value of an Eligible Asset as may
         be established by an applicable Rating Agency, provided, in either case that with
         respect to an Eligible Asset that is currently callable, Discounted Value will be
         equal to the applicable quotient or product as calculated above or the call price,
         whichever is lower, and that with respect to an Eligible Asset that is prepayable,
         Discounted Value will be equal to the applicable quotient or product as calculated
         above or the par value, whichever is lower.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>Dividend-Disbursing Agent</U>&rdquo; means, with respect to the Series M Preferred Stock, Computershare Trust Company, N.A. and its successors or any other
         dividend-disbursing agent appointed by the Corporation and, with respect to any other
         class or series of Preferred Stock, the Person appointed by the Corporation as dividend-disbursing
         or paying agent with respect to such class or series.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>Dividend Payment Date</U>&rdquo; means with respect to the Series M Preferred Stock, any date on which dividends and distributions declared by, or under authority granted by, the Board of Directors thereon are payable pursuant to the provisions of paragraph 2(a) of Article II of these Articles Supplementary and shall for the purposes of these Articles Supplementary have a correlative meaning with respect to any other class or series
         of Preferred Stock.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>Dividend Period</U>&rdquo; shall have the meaning set forth in paragraph 2(a) of Article II hereof, and for the purposes of these Articles Supplementary shall have a correlative meaning with respect to any other class or
         series of Preferred Stock.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>Eligible Assets</U>&rdquo; means Rating Agency Eligible Assets (if a Rating Agency is then rating the Series M Preferred Stock at the request of the Corporation) and/or Other Rating Agency Eligible
         Assets if any Other Rating Agency is then rating the Series M Preferred Stock or any other outstanding series of Preferred Stock, whichever is
         applicable.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>Fitch</U>&rdquo; means Fitch Ratings.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>Governing Documents</U>&rdquo; means the Charter and the By-Laws.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>Liquidation Preference</U>&rdquo; shall, with respect to the Series M Preferred Stock, have the meaning set forth in paragraph 3(a) of Article II hereof, and for the purposes of these Articles Supplementary shall have a correlative meaning with respect to any other class or
         series of Preferred Stock.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>Mandatory Redemption Date</U>&rdquo; means March&nbsp;26, 2032.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>Market Value</U>&rdquo; means the amount determined by the Corporation with respect to specific Eligible Assets in accordance with valuation policies adopted
         from time to time by the Board of Directors as being in compliance with the requirements
         of the 1940 Act.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>Monthly Valuation Date</U>&rdquo; means the last Valuation Date of each calendar month.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>Moody&rsquo;s</U>&rdquo; means Moody&rsquo;s Investors Service, Inc. and its successors at law.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>Moody&rsquo;s Discount Factor</U>&rdquo; means the discount factors set forth in the Moody&rsquo;s Guidelines as eligible for inclusion in calculating the Discounted Value of the Corporation&rsquo;s assets in connection with Moody&rsquo;s ratings of Preferred Stock.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>Moody&rsquo;s Eligible Assets</U>&rdquo; means the assets of the Corporation set forth in the Moody&rsquo;s Guidelines as eligible for inclusion in calculating the Discounted Value of the Corporation&rsquo;s assets in connection with Moody&rsquo;s ratings of the Series M Preferred Stock.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>Moody&rsquo;s Guidelines</U>&rdquo; means the guidelines provided by Moody&rsquo;s, as may be amended from time to time, in connection with Moody&rsquo;s ratings of the Series M Preferred Stock at the rating then assigned.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>Notice of Redemption</U>&rdquo; shall have the meaning set forth in paragraph 4(d)(i) of Article II hereof.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>Other Rating Agency</U>&rdquo; means any rating agency other than a Rating Agency then providing a rating for the
         Series M Preferred Stock at the request of the Corporation.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>Outstanding</U>&rdquo; means, as of any date, Preferred Stock theretofore issued by the Corporation except:</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(a) any such share of Preferred Stock theretofore redeemed, repurchased, cancelled or otherwise reacquired by the Corporation or delivered to the Corporation for redemption, repurchase, cancellation or other acquisition by the Corporation;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(b) any such share of Preferred Stock, other than auction rate Preferred Stock, as to
         which a notice of redemption shall have been given and for whose payment at the redemption
         thereof Deposit Assets in the necessary amount are held by the Corporation in trust
         for, or have been irrevocably deposited with the relevant disbursing agent for payment
         to, the holder of such share pursuant to these Articles Supplementary with respect thereto;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(c) in the case of auction rate Preferred Stock, any such shares theretofore delivered
         to the applicable auction agent for redemption, repurchase, cancellation or other acquisition by the Corporation or with respect to which the Corporation has given notice of redemption and irrevocably
         deposited with the paying agent sufficient funds to redeem such shares; and</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(d) any such share in exchange for or in lieu of which other shares have been issued and
         delivered.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Notwithstanding the foregoing, (i) for purposes of voting rights (including the determination of the number of shares
         required to constitute a quorum), any shares of Preferred Stock as to which any subsidiary
         of the Corporation is the holder will be disregarded and deemed not Outstanding, and
         (ii) in connection with any auction of shares of auction rate Preferred Stock as to which
         the Corporation or any Person known to the auction agent to be a subsidiary of the
         Corporation is the holder will be disregarded and not deemed Outstanding.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>Person</U>&rdquo; means and includes an individual, a partnership, the Corporation, a trust, a corporation,
         a limited liability company, an unincorporated association, a joint venture or other
         entity or a government or any agency or political subdivision thereof.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>Preferred Stock</U>&rdquo; means the preferred stock, par value $0.001 per share, of the Corporation, and includes the Series M Preferred Stock.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>Rating Agency</U>&rdquo; means Moody&rsquo;s as long as such rating agency is then rating the Series M Preferred Stock at the Corporation&rsquo;s request or any other rating agency then rating the Series M Preferred Stock at the Corporation&rsquo;s request.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>Rating Agency Discount Factor</U>&rdquo; means the Moody&rsquo;s Discount Factor as long as such Rating Agency is then rating the Series M Preferred Stock at the Corporation&rsquo;s request or the discount factor of any Other Rating Agency then rating the Series M Preferred Stock at the Corporation&rsquo;s request.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>Rating Agency Eligible Assets</U>&rdquo; means the Moody&rsquo;s Eligible Assets as long as such Rating Agency is then rating the Series M Preferred Stock at the Corporation&rsquo;s request or the eligible assets of any Other Rating Agency then rating the Series M Preferred Stock at the Corporation&rsquo;s request.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>Redemption Price</U>&rdquo; has the meaning set forth in paragraph 4(a)(ii) of Article II hereof, and for the purposes of these Articles Supplementary shall have a correlative meaning with respect to any other class or
         series of Preferred Stock.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>S&amp;P</U>&rdquo; means S&amp;P Global Ratings, or its successors at law.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>Series M Preferred Stock</U>&rdquo; means the 4.25% Series M Cumulative Preferred Stock, par value $0.001 per share, of the Corporation.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>Series M Asset Coverage Cure Date</U>&rdquo; means, with respect to the failure by the Corporation to maintain Asset Coverage
         (as required by paragraph 6(a) of Article II hereof) as of the last Business Day of each March, June, September and December
         of each year, 60 days following such Business Day.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>Short-Term Money Market Instruments</U>&rdquo; means the following types of instruments if, on the date of purchase or other acquisition
         thereof by the Corporation, the remaining term to maturity thereof is not in excess
         of 180 days or 360 days for purposes of determining Rating Agency Eligible Assets:</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(i)</TD><TD STYLE="text-align: justify">commercial paper rated either F-1 by Fitch or A-1 by S&amp;P
if such commercial paper matures in 30 days or P-1 by Moody&rsquo;s and either F-1+ by Fitch or A-1+ by S&amp;P if such commercial paper
matures in over 30 days;</TD>
</TR></TABLE>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(ii)</TD><TD STYLE="text-align: justify">demand or time deposits in, and banker&rsquo;s acceptances and
certificates of deposit of, (A) a depository institution or trust company incorporated under the laws of the United States of America
or any state thereof or the District of Columbia or (B) a United States branch office or agency of a foreign depository institution (provided
that such branch office or agency is subject to banking regulation under the laws of the United States, any state thereof or the District
of Columbia);</TD>
</TR></TABLE>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(iii)</TD><TD STYLE="text-align: justify">overnight funds;</TD>
</TR></TABLE>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(iv)</TD><TD STYLE="text-align: justify">U.S. Government Obligations and U.S. Government Securities;
and</TD>
</TR></TABLE>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(v)</TD><TD STYLE="text-align: justify">Eurodollar demand or time deposits in, or certificates of deposit
of, the head office or the London branch office of a depository institution or trust company if the certificates of deposit, if any,
and the long-term unsecured debt obligations (other than such obligations the ratings of which are based on the credit of a person or
entity other than such depository institution or trust company) of such depository institution or trust company that have (1) credit
ratings on each Valuation Date of at least P-1 from Moody&rsquo;s and either F-1+ from Fitch or A-1+ from S&amp;P, in the case of commercial
paper or certificates of deposit, and (2) credit ratings on each Valuation Date of at least Aa3 from Moody&rsquo;s and either AA from
Fitch or AA- from S&amp;P, in the case of long-term unsecured debt obligations; provided, however, that in the case of any such investment
that matures in no more than one Business Day from the date of purchase or other acquisition by the Corporation, all of the foregoing
requirements shall be applicable except that the required long-term unsecured debt credit rating of such depository institution or trust
company from Moody&rsquo;s, Fitch and S&amp;P shall be at least A2, A-2 and A, respectively; and provided further, however, that the
foregoing credit rating requirements shall be deemed to be met with respect to a depository institution or trust company if (1) such
depository institution or trust company is the principal depository institution in a holding company system, (2) the certificates of
deposit, if any, of such depository institution or trust company are not rated on any Valuation Date below P-1 by Moody&rsquo;s, F-1+
by Fitch or A-1+ by S&amp;P and there is no long-term rating, and (3) the holding company shall meet all of the foregoing credit rating
requirements (including the preceding proviso in the case of investments that mature in no more than one Business Day from the date of
purchase or other acquisition by the Corporation); and provided further, that the interest receivable by the Corporation shall not be
subject to any withholding or similar taxes.</TD>
</TR></TABLE>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>U.S. Government Obligations</U>&rdquo; means direct obligations of the United States or by its agencies or instrumentalities
         that are entitled to the full faith and credit of the United States and that, other
         than United States Treasury Bills, provide for the periodic payment of interest and
         the full payment of principal at maturity or call for redemption.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>U.S. Government Securities</U>&rdquo; mean securities that are direct obligations of, and obligations the timely payment
         of principal and interest on which is fully guaranteed by, the United States or any
         agency or instrumentality of the United States, the obligations of which are backed
         by the full faith and credit of the United States and in the form of conventional
         bills, bonds and notes.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>Valuation Date</U>&rdquo; means the last Business Day of each month, or for purposes of determining whether
         the Corporation is maintaining the Basic Maintenance Amount, each Business Day commencing with the Date of Original Issue.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&ldquo;<U>Voting Period</U>&rdquo; shall have the meaning set forth in paragraph 5(b) of Article II hereof.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>ARTICLE II</B></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>4.25% SERIES M CUMULATIVE PREFERRED STOCK</B></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">1. Number of Shares; Ranking.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(a) The initial number of authorized shares constituting the Series M Preferred Stock to be issued is 1,000,000. No fractional shares of Series M Preferred Stock shall be issued.</P>
      <P STYLE="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(b) Shares of Series M Preferred Stock which at any time have been redeemed or purchased by the Corporation
         shall, after such redemption or purchase, have the status of authorized but unissued
         shares of Preferred Stock without further designation as to class or series.</P>
      <P STYLE="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(c) The Series M Preferred Stock shall rank on a parity with any other series of Preferred Stock as
         to the payment of dividends, distributions and liquidation preference to which such
         stock is entitled.</P>
      <P STYLE="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(d) No holder of Series M Preferred Stock shall have, solely by reason of being such a holder, any preemptive
         or other right to acquire, purchase or subscribe for any shares of any Preferred Stock
         or Common Stock or other securities of the Corporation which it may hereafter issue
         or sell.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">2. Dividends and Distributions.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(a) Holders of shares of Series M Preferred Stock shall be entitled to receive, when, as and if authorized by, or under authority granted by, the Board of Directors and declared by the Corporation, out of funds legally available therefor, cumulative cash dividends and distributions
         at the rate of 4.25% per annum (computed on the basis of a 360-day year consisting of twelve 30-day months)
         of the Liquidation Preference on the Series M Preferred Stock and no more, payable quarterly on March&nbsp;26, June&nbsp;26, September&nbsp;26 and December&nbsp;26 in each year (each a &ldquo;<U>Dividend Payment Date</U>&rdquo;) commencing on March&nbsp;26, 2022 (or, if any such day is not a Business Day, then on the next succeeding Business Day).
         Dividends and distributions will be payable to holders of record of Series M Preferred Stock as they appear on the stock register of the Corporation at the close
         of business on the fifth Business Day prior to the Dividend Payment Date in preference
         to dividends and distributions on shares of Common Stock and any other capital stock
         of the Corporation ranking junior to the Series M Preferred Stock in payment of dividends and distributions. Dividends and distributions
         on shares of Series M Preferred Stock shall accumulate from, and including, the Date of Original Issue or, in the case of shares of Series M Preferred Stock issued after the end of the
         first Dividend Period, from, and including, the first day of the most recent Dividend
         Period with respect to which full, cumulative cash dividends have not been paid in
         full. Each period beginning on and including a Dividend Payment Date (or the Date of Original
         Issue, in the case of the first dividend period after the issuance of such shares) and ending on but excluding the next succeeding Dividend
         Payment Date is referred to herein as a &ldquo;<U>Dividend Period</U>.&rdquo; Dividends and distributions on account of arrears for any past Dividend Period or
         in connection with the redemption of Series M Preferred Stock may be declared and paid at any time, without reference to any Dividend
         Payment Date, to holders of record on such date not exceeding 30 days preceding the payment date thereof as shall be fixed by the Board of Directors.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(b) (i) No dividends or distributions shall be declared or paid on shares of Series M Preferred Stock for any Dividend Period or part thereof unless all accumulated and unpaid dividends and distributions on all Outstanding shares of all series of Preferred Stock ranking on a parity with the Series M Preferred Stock as to the payment of dividends and distributions for all applicable past Dividend Periods (whether or not earned or declared by the
         Corporation) shall have been or contemporaneously are declared and paid for declared and Deposit Assets for the payment of such dividends and distributions shall have
         been deposited with the Dividend-Disbursing Agent as set forth in paragraph 2(c) of
         Article II hereof, provided, however, that the foregoing shall not prevent the purchase or acquisition of Outstanding shares of Preferred Stock pursuant to the successful completion of an otherwise
         lawful purchase or exchange offer made on the same terms to holders of all Outstanding
         shares of Series M Preferred Stock. If full cumulative dividends and distributions due have not been paid on all Outstanding
         shares of such Preferred Stock, any dividends and distributions being declared and paid on such shares of Preferred Stock (including the Series M Preferred Stock) will be paid as nearly pro rata as possible in proportion to the
         respective amounts of dividends and distributions accumulated but unpaid on each such
         series of Preferred Stock on the relevant Dividend Payment Date. No holders of shares
         of Series M Preferred Stock shall be entitled to any dividends or distributions, whether payable
         in cash, property or stock, in excess of full cumulative dividends and distributions
         as provided in this paragraph 2(b)(i) on shares of Series M Preferred Stock. No interest or sum of money in lieu of interest shall be payable
         in respect of any dividend payments on any shares of Series M Preferred Stock that may be in arrears.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in">(ii) For so long as shares of Series M Preferred Stock are Outstanding, the Corporation shall not pay any dividend or other
         distribution (other than a dividend or distribution paid in shares of, or options,
         warrants or rights to subscribe for or purchase, Common Stock or other stock, if any,
         ranking junior to the Series M Preferred Stock as to payment of dividends and the distribution of assets upon liquidation)
         in respect of the Common Stock or any other stock of the Corporation ranking junior
         to the Series M Preferred Stock as to payment of dividends and the distribution of assets upon liquidation,
         or call for redemption, redeem, purchase or otherwise acquire for consideration any
         shares of Common Stock or any other stock of the Corporation ranking junior to the
         Series M Preferred Stock as to payment of dividends and the distribution of assets upon liquidation
         (except by conversion into or exchange for stock of the Corporation ranking junior
         to the Series M Preferred Stock as to payment of dividends and the distribution of assets upon liquidation),
         unless, in each case, (A) immediately thereafter, the aggregate Adjusted Value of the Corporation&rsquo;s Rating Agency Eligible Assets shall equal or exceed the Basic Maintenance Amount
         and the Corporation shall have Asset Coverage, (B) all cumulative dividends and distributions on all shares of Series M Preferred Stock due on or prior to the date of the transaction have been declared
         and paid (or shall have been declared and sufficient funds for the payment thereof
         deposited with the applicable Dividend-Disbursing Agent) and (C) the Corporation has redeemed the full number of shares of Series M Preferred Stock to be redeemed mandatorily pursuant to any provision contained herein
         for mandatory redemption.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in">(iii) Any dividend payment made on the shares of Series M Preferred Stock shall first be credited against the dividends and distributions accumulated
         with respect to the earliest Dividend Period for which dividends and distributions
         have not been paid.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(c) Not later than the Business Day immediately preceding each Dividend Payment Date,
         the Corporation shall deposit with the Dividend-Disbursing Agent Deposit Assets having
         an initial combined value sufficient to pay the dividends and distributions that are
         payable on such Dividend Payment Date, which Deposit Assets shall mature (if such
         assets constitute debt securities) on or prior to such Dividend Payment Date. The
         Corporation may direct the Dividend-Disbursing Agent with respect to the investment
         of any such Deposit Assets, provided that such investment consists exclusively of
         Deposit Assets and provided further that the proceeds of any such investment will
         be available at the opening of business on such Dividend Payment Date.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">3. Liquidation Rights.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(a) In the event of any liquidation, dissolution or winding up of the affairs of the Corporation,
         whether voluntary or involuntary, the holders of shares of Series M Preferred Stock shall be entitled to receive out of the assets of the Corporation
         available for distribution to stockholders, after satisfying claims of creditors but
         before any distribution or payment shall be made in respect of the Common Stock or
         any other stock of the Corporation ranking junior to the Series M Preferred Stock as to liquidation payments, a liquidation distribution in the amount
         of $100.00 per share (the &ldquo;<U>Liquidation Preference</U>&rdquo;), plus an amount equal to all unpaid dividends and distributions accumulated to and
         including the date fixed for such distribution or payment (whether or not earned or
         declared by the Corporation, but excluding interest thereon), and such holders shall
         be entitled to no further participation in any distribution or payment in connection
         with any such liquidation, dissolution or winding up of the Corporation.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(b) If, upon any liquidation, dissolution or winding up of the affairs of the Corporation,
         whether voluntary or involuntary, the assets of the Corporation available for distribution
         among the holders of all Outstanding shares of Series M Preferred Stock, and any other Outstanding shares of a class or series of Preferred Stock ranking
         on a parity with the Series M Preferred Stock as to payment upon liquidation, shall be insufficient to permit the payment in full to such holders of Series M Preferred Stock of the Liquidation Preference plus all accumulated and unpaid dividends and distributions and the amounts due upon liquidation
         with respect to such other series of Preferred Stock, then such available assets shall be distributed among the holders
         of shares of Series M Preferred Stock and such other series of Preferred Stock ratably in proportion to the respective preferential liquidation
         amounts to which they are entitled. Unless and until the Liquidation Preference plus
         accumulated and unpaid dividends and distributions has been paid in full to the holders
         of shares of Series M Preferred Stock, no dividends or distributions will be made to holders of the Common
         Stock or any other stock of the Corporation ranking junior to the Series M Preferred Stock as to liquidation.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">4. Redemption and Puts.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Shares of the Series M Preferred Stock shall be redeemed by the Corporation as provided below:</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(a) Mandatory Redemptions.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in">(i) The Corporation is required to redeem all Outstanding shares of Series M Preferred Stock on the Mandatory Redemption Date at the Redemption Price.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in">(ii) If the Corporation is required to redeem any shares of Preferred Stock (which may
         include shares of Series M Preferred Stock) prior to the Mandatory Redemption Date pursuant to paragraphs 6(b) or 6(c) of Article II hereof or pursuant to the Charter, then the Corporation shall, to the extent permitted
         by the 1940 Act and Maryland law, by the close of business on such Series M Asset Coverage Cure Date or Basic Maintenance Amount Cure Date (herein collectively
         referred to as a &ldquo;<U>Cure Date</U>&rdquo;), as the case may be, fix a redemption date and proceed to redeem shares as set forth
         in paragraph 4(d) hereof. On such redemption date, the Corporation shall redeem, out of funds legally
         available therefor, the number of shares of Preferred Stock, which, to the extent
         permitted by the 1940 Act and Maryland law, at the option of the Corporation may include
         any proportion of Series M Preferred Stock or any other series of Preferred Stock, equal to the minimum number
         of shares the redemption of which, if such redemption had occurred immediately prior
         to the opening of business on such Cure Date, would have resulted in the Corporation
         having Asset Coverage or an Adjusted Value of its Rating Agency Eligible Assets equal
         to or greater than the Basic Maintenance Amount, as the case may be, immediately prior
         to the opening of business on such Cure Date or, if such Asset Coverage or an Adjusted
         Value of its Eligible Assets equal to or greater than the Basic Maintenance Amount,
         as the case may be, cannot be so restored, all of the Outstanding shares of Series M Preferred Stock, at a price equal to the Liquidation Preference per share plus all accumulated but unpaid dividends and distributions (whether or not earned or declared
         by the Corporation) through and including the date of redemption (the &ldquo;<U>Redemption Price</U>&rdquo;). In the event that, prior to the Mandatory Redemption Date, shares of Preferred Stock are redeemed pursuant to paragraphs 6(b) or 6(c) of Article II hereof, the Corporation may, but is not required to, redeem a sufficient number
         of shares of Series M Preferred Stock pursuant to this paragraph 4(a)(ii) which, when aggregated with other shares of Preferred Stock redeemed by the Corporation, permits the Corporation to have with respect to the shares of
         Preferred Stock (including the Series M Preferred Stock) remaining Outstanding after such redemption (i) Asset Coverage of as much as 210% and (ii) Rating Agency Eligible Assets with Adjusted Value of as great as 110% of the Basic
         Maintenance Amount. In the event that all of the shares of Series M Preferred Stock then Outstanding are required to be redeemed pursuant to paragraph 6 of Article II hereof prior to the Mandatory Redemption Date, the Corporation shall redeem such shares at the Redemption Price and proceed to do so as set forth in paragraph 4(d) hereof.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(b) Optional Redemptions.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Corporation may redeem all or any part of the shares of Series M Preferred Stock, upon not less than 30 nor more than 60 days&rsquo; prior written notice, at the Redemption Price, at any time commencing on March&nbsp;26, 2027 and thereafter, to the extent permitted by the 1940 Act and Maryland law. The Series M Preferred Stock is not otherwise subject to optional redemption by the Corporation unless such redemption is necessary, in the judgment of the Board of Directors, to maintain the Corporation&rsquo;s status as a regulated investment company under Subchapter M of the Internal Revenue
         Code of 1986, as amended.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(c) Puts.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Corporation will accept for redemption all or any part of the outstanding shares of Series M
         Preferred Stock that holders have properly submitted for redemption during the 60-day period prior to March&nbsp;26, 2027 at the Redemption Price.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(d) Procedures for Redemption.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in">(i) If the Corporation shall determine or be required to redeem shares of Series M Preferred Stock pursuant to this paragraph 4, it shall mail a written notice of redemption (&ldquo;<U>Notice of Redemption</U>&rdquo;) with respect to such redemption by first class mail, postage prepaid, to each holder
         of the shares to be redeemed at such holder&rsquo;s address as the same appears on the stock books of the Corporation on the close of
         business on such date as the Board of Directors or its delegatee may determine, which
         date shall not be earlier than the second Business Day prior to the date upon which
         such Notice of Redemption is mailed to the holders of Series M Preferred Stock. Each such Notice of Redemption shall state: (A) the redemption date as established by the Board of Directors or its delegate (which, in the case of a redemption pursuant to paragraph 4(a)(i) hereof,
         shall be the Mandatory Redemption Date); (B) the number or percentage of shares of Series M Preferred Stock to be redeemed; (C) the CUSIP number(s) of such shares; (D) the Redemption Price (specifying the amount of accumulated dividends to be included therein); (E) the place or places where the certificate(s) for such shares (properly endorsed or
         assigned for transfer, if the Board of Directors or its delegatee shall so require
         and the Notice of Redemption shall so state), if any, are to be surrendered for payment
         in respect of such redemption; (F) that dividends and distributions on the shares to be redeemed will cease to accrue
         on such redemption date; (G) the provisions of this paragraph 4 under which such redemption is made; and (H) in the case of a redemption pursuant to paragraph 4(b), any conditions precedent to such redemption. If fewer than all shares of Series M Preferred Stock held by any holder are to be redeemed, the Notice of Redemption mailed
         to such holder also shall specify the number or percentage of shares to be redeemed
         from such holder. No defect in the Notice of Redemption or the mailing thereof shall
         affect the validity of the redemption proceedings, except as required by applicable
         law.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in">(ii) If the Corporation shall give a Notice of Redemption, then by the close of business
         on the Business Day preceding the redemption date specified in the Notice of Redemption
         (so long as any conditions precedent to such redemption have been met) or, if the
         Dividend-Disbursing Agent so agrees, another date not later than the redemption date,
         the Corporation shall (A) deposit with the Dividend-Disbursing Agent Deposit Assets that shall mature (if such
         assets constitute debt securities) on or prior to such redemption date having an initial
         combined value sufficient to effect the redemption of the shares of Series M Preferred Stock to be redeemed and (B) give the Dividend-Disbursing Agent irrevocable instructions and authority to pay the
         Redemption Price to the holders of the shares of Series M Preferred Stock called for redemption on the redemption date. The Corporation may
         direct the Dividend-Disbursing Agent with respect to the investment of any Deposit
         Assets so deposited provided that the proceeds of any such investment will be available
         at the opening of business on such redemption date. Upon the date of such deposit
         (unless the Corporation shall default in making payment of the Redemption Price), all rights of the holders of the shares of Series M Preferred Stock so called for redemption shall cease and terminate except the right
         of the holders thereof to receive the Redemption Price thereof and such shares shall no longer be deemed Outstanding for any purpose.
         The Corporation shall be entitled to receive, promptly after the date fixed for redemption,
         any cash in excess of the aggregate Redemption Price of the shares of Series M Preferred Stock called for redemption on such date and any remaining Deposit Assets.
         Any assets so deposited that are unclaimed at the end of two years from such redemption
         date shall, to the extent permitted by law, be repaid to the Corporation, after which
         the holders of the shares of Series M Preferred Stock so called for redemption shall look only to the Corporation for payment
         of the Redemption Price thereof. The Corporation shall be entitled to receive, from time to time after
         the date fixed for redemption, any interest on the Deposit Assets so deposited.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in">(iii) On or after the redemption date, each holder of shares of Series M Preferred Stock that are subject to redemption shall surrender such shares to the
         Corporation as instructed in the Notice of Redemption and shall then be entitled to
         receive the cash Redemption Price, without interest.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in">(iv) In the case of any redemption of less than all of the shares of Series M Preferred Stock pursuant to these Articles Supplementary, such redemption shall be made pro rata from each holder of shares of Series M Preferred Stock in accordance with the respective number of shares held by each such
         holder on the record date for such redemption.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in">(v) Notwithstanding the other provisions of this paragraph 4, the Corporation shall not redeem shares of Series M Preferred Stock unless all accumulated and unpaid dividends and distributions on
         all Outstanding shares of Series M Preferred Stock and other Preferred Stock ranking on a parity with the Series M Preferred Stock with respect to dividends and distributions for all applicable past
         Dividend Periods (whether or not earned or declared by the Corporation) shall have
         been or are contemporaneously paid or declared and Deposit Assets for the payment
         of such dividends and distributions shall have been deposited with the Dividend-Disbursing
         Agent as set forth in paragraph 2(c) of Article II hereof, provided, however, that the foregoing shall not prevent the purchase or acquisition of Outstanding shares of Preferred Stock pursuant to the successful completion of an otherwise
         lawful purchase or exchange offer made on the same terms to holders of all Outstanding
         shares of Series M Preferred Stock.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">If the Corporation shall not have funds legally available for the redemption of, or
         is otherwise unable to redeem, all the shares of the Series M Preferred Stock or other Preferred Stock designated to be redeemed on any redemption
         date, the Corporation shall redeem on such redemption date the number of shares of
         Series M Preferred Stock and other Preferred Stock so designated as it shall have legally
         available funds, or is otherwise able, to redeem ratably on the basis of the Redemption Price from each holder whose shares are to be redeemed, and the remainder of the shares
         of the Series M Preferred Stock and other Preferred Stock designated to be redeemed shall be redeemed
         on the earliest practicable date on which the Corporation shall have funds legally
         available for the redemption of, or is otherwise able to redeem, such shares upon
         Notice of Redemption.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">5. Voting Rights.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(a) General.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Except as otherwise provided by law or as specified in the Governing Documents or
         a resolution of the Board of Directors, each holder of shares of Series M Preferred Stock and any other Preferred Stock shall be entitled to one vote for each
         share held on each matter submitted to a vote of stockholders of the Corporation,
         and the holders of Outstanding shares of Preferred Stock, including Series M Preferred Stock, and of Outstanding shares of Common Stock shall vote together as a single class; provided, however, that at any meeting of the stockholders of the Corporation held for the election
         of directors, the holders of Outstanding shares of Preferred Stock, including Series M Preferred Stock, shall be entitled, as a single class, to the exclusion of the holders of all other securities and classes of capital
         stock of the Corporation, to elect a number of the Corporation&rsquo;s directors, such that following the election of directors at the meeting of the stockholders,
         the Corporation&rsquo;s Board of Directors shall contain two directors elected exclusively by the holders of the Outstanding shares of Preferred Stock, including the Series M Preferred Stock. Subject to paragraph 5(b) of Article II hereof, the holders of outstanding shares of capital stock of the Corporation,
         including the holders of Outstanding shares of Preferred Stock, including the Series M Preferred Stock, voting together as a single class, shall elect the balance of the directors.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(b) Right to Elect Majority of Board of Directors.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During any period in which any one or more of the conditions described below shall
         exist (such period being referred to herein as a &ldquo;<U>Voting Period</U>&rdquo;), the number of directors constituting the Board of Directors shall be automatically
         increased by the smallest number that, when added to the two directors elected exclusively
         by the holders of shares of Preferred Stock pursuant to paragraph 5(a) above, would constitute a majority of the Board of Directors as so increased
         by such smallest number; and the holders of shares of Preferred Stock shall be entitled,
         voting together as a single class (to the exclusion of the holders of all other securities and classes of capital
         stock of the Corporation), to elect such smallest number of additional directors,
         together with the two directors that such holders are in any event entitled to elect
         pursuant to paragraph 5(a) above. The Corporation and the Board of Directors shall take all necessary action,
         including amending the By-Laws, to effect an increase in the number of directors as
         described in the preceding sentence. A Voting Period shall commence:</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in">(i) if at any time accumulated dividends and distributions (whether or not earned or declared,
         and whether or not funds are then legally available in an amount sufficient therefor)
         on the Outstanding shares of Series M Preferred Stock equal to at least two full years&rsquo; dividends and distributions shall be due and unpaid and sufficient cash or specified
         securities shall not have been deposited with the Dividend-Disbursing Agent for the
         payment of such accumulated dividends and distributions; or</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in">(ii) if at any time holders of any other shares of Preferred Stock are entitled to elect
         a majority of the Directors of the Corporation under the 1940 Act or Articles Supplementary creating such shares.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Upon the termination of a Voting Period, the voting rights described in this paragraph 5(b) shall cease, subject always, however, to the reverting of such voting rights
         in the holders of Preferred Stock upon the further occurrence of any of the events
         described in this paragraph 5(b).</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(c) Voting Procedures.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in">(i) As soon as practicable after the accrual of any right of the holders of shares of
         Preferred Stock to elect additional directors as described in paragraph 5(b) above, the Corporation shall call a special meeting of such holders and shall
         mail a notice of such special meeting to such holders, such meeting to be held not
         less than 10 nor more than 20 days after the date of mailing of such notice. If the Corporation fails to send such
         notice or if the Corporation does not call such a special meeting, it may be called
         by any such holder on like notice. The record date for determining the holders entitled
         to notice of and to vote at such special meeting shall be the close of business on
         the day on which such notice is mailed or such other date as the Board of Directors
         shall determine. At any such special meeting and at each meeting held during a Voting
         Period, such holders of Preferred Stock, voting together as a single class (to the exclusion of the holders of all other securities and classes of capital
         stock of the Corporation), shall be entitled to elect the number of directors prescribed
         in paragraph 5(b) above on a one-vote-per-share basis. At any such meeting or adjournment thereof
         in the absence of a quorum, a majority of such holders present in person or by proxy
         shall have the power to adjourn the meeting without notice, other than by an announcement
         at the meeting, to a date not more than 120 days after the original record date.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in">(ii) For purposes of determining any rights of the holders of Series M Preferred Stock to vote on any matter or the number of shares required to constitute
         a quorum, whether such right is created by these Articles Supplementary, by the other
         provisions of the Governing Documents, by statute or otherwise, a share of Series M Preferred Stock which is not Outstanding shall not be counted.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in">(iii) The terms of office of all persons who are directors of the Corporation at the time
         of a special meeting of holders of Preferred Stock, including Series M Preferred Stock, to elect directors, shall continue following such meeting, notwithstanding
         the election at such meeting by such holders of the number of directors that they
         are entitled to elect, and the persons so elected by such holders, together with the
         two incumbent directors elected by the holders of Preferred Stock, including Series M Preferred Stock, and the remaining incumbent directors elected by the holders of
         the Common Stock and Preferred Stock, shall constitute the duly elected directors
         of the Corporation.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in">(iv) Upon the expiration of a Voting Period, the terms of office of the additional directors
         elected by the holders of Preferred Stock pursuant to paragraph 5(b) above shall expire at the earliest time permitted by law and the remaining directors
         shall constitute the directors of the Corporation and the voting rights of such holders
         of Preferred Stock, including Series M Preferred Stock, to elect additional directors pursuant to paragraph 5(b) above shall cease, subject to the provisions of the last sentence of paragraph 5(b). Upon the expiration of the terms of the directors elected by the holders of
         Preferred Stock pursuant to paragraph 5(b) above, the number of directors shall be automatically reduced to eliminate the directorships of the additional directors elected by the holders
         of Preferred Stock pursuant to Section&nbsp;5(b) above.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(d) Exclusive Remedy.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Unless otherwise required by law, the holders of shares of Series M Preferred Stock shall not have any rights or preferences other than those specifically
         set forth herein. The holders of shares of Series M Preferred Stock shall have no preemptive rights or rights to cumulative voting. In
         the event that the Corporation fails to pay any dividends and distributions on the
         shares of Series M Preferred Stock, the exclusive remedy of the holders shall be the right to vote for
         directors pursuant to the provisions of this paragraph 5.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(e) Notification to a Rating Agency.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In the event a vote of holders of Series M Preferred Stock is required pursuant to the provisions of Section&nbsp;13(a) of the 1940 Act, if the Series M Preferred Stock is then rated by a Rating Agency at the Corporation&rsquo;s request, the Corporation shall, not later than ten Business Days prior to the date
         on which such vote is to be taken, notify the Rating Agency that such vote is to be
         taken and the nature of the action with respect to which such vote is to be taken
         and, not later than ten Business Days after the date on which such vote is taken,
         notify the Rating Agency of the result of such vote.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">6. Coverage Tests.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(a) Determination of Compliance.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">For so long as any shares of Series M Preferred Stock are Outstanding, the Corporation shall make the following determinations:</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in">(i) Asset Coverage. The Corporation shall have Asset Coverage as of the last Business
         Day of each March, June, September and December of each year in which any share of
         Series M Preferred Stock is Outstanding.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in">(ii) Basic Maintenance Amount Requirement.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(A) If any shares of Series M Preferred Stock are Outstanding and are rated by a Rating Agency at the Corporation&rsquo;s request, the Corporation shall maintain, on each Valuation Date, Rating Agency Eligible
         Assets having an Adjusted Value at least equal to the Basic Maintenance Amount, each
         as of such Valuation Date. Upon any failure to maintain Rating Agency Eligible Assets
         having an Adjusted Value at least equal to the Basic Maintenance Amount, the Corporation
         shall use all commercially reasonable efforts to retain Rating Agency Eligible Assets
         having an Adjusted Value at least equal to the Basic Maintenance Amount on or prior
         to the Basic Maintenance Amount Cure Date, by altering the composition of its portfolio
         or otherwise.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(B) The Administrator shall prepare a Basic Maintenance Report relating to each Valuation
         Date. On or before 5:00 P.M., New York City time, on the tenth Business Day after the first Valuation Date
         following the Date of Original Issue of the Series M Preferred Stock and after each (1) Annual Valuation Date, (2) Valuation Date on which the Corporation fails to satisfy the requirements of paragraph 6(a)(ii)(A) above, (3) Basic Maintenance Amount Cure Date following a Valuation Date on which the Corporation
         fails to satisfy the requirements of paragraph 6(a)(ii)(A) above and (4) Valuation Date and any immediately succeeding Business Day on which the Adjusted Value
         of the Corporation&rsquo;s Rating Agency Eligible Assets exceeds the Basic Maintenance Amount by 5% or less,
         the Corporation shall complete and deliver to the applicable Rating Agency a Basic
         Maintenance Report, which will be deemed to have been delivered to the applicable
         Rating Agency if the Rating Agency receives a copy or telecopy, telex or other electronic
         transcription or transmission of the Basic Maintenance Report and on the same day
         the Corporation mails to the Rating Agency for delivery on the next Business Day the
         Basic Maintenance Report. A failure by the Corporation to deliver a Basic Maintenance
         Report under this paragraph 6(a)(ii)(B) shall be deemed to be delivery of a Basic Maintenance Report indicating
         an Adjusted Value of the Corporation&rsquo;s Rating Agency Eligible Assets less than the Basic Maintenance Amount, as of the
         relevant Valuation Date.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(C) In the event the Adjusted Value of the Corporation&rsquo;s Rating Agency Eligible Assets shown in any Basic Maintenance Report prepared pursuant
         to paragraph 6(a)(ii)(B) above is less than the applicable Basic Maintenance Amount, the Corporation
         shall have until the Basic Maintenance Amount Cure Date to achieve an Adjusted Value
         of the Corporation&rsquo;s Rating Agency Eligible Assets at least equal to the Basic Maintenance Amount, and
         upon such achievement (and not later than such Basic Maintenance Amount Cure Date)
         the Corporation shall inform a Rating Agency of such achievement in writing by delivery
         of a revised Basic Maintenance Report showing an Adjusted Value of the Corporation&rsquo;s Rating Agency Eligible Assets at least equal to the Basic Maintenance Amount as
         of the date of such revised Basic Maintenance Report.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(D) On or before 5:00 P.M., New York City time, on no later than the tenth Business Day after the next Valuation
         Date following each date on which the Corporation has repurchased more than 1% of
         its Common Stock since the most recent date of delivery of a Basic Maintenance Report,
         the Corporation shall complete and deliver to the applicable Rating Agency a Basic
         Maintenance Report. A Basic Maintenance Report delivered as provided in paragraph 6(a)(ii)(B) above also shall be deemed to have been delivered pursuant to this paragraph 6(a)(ii)(D).</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(b) Failure to Meet Asset Coverage.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">If the Corporation fails to have Asset Coverage as provided in paragraph 6(a)(i) hereof and such failure is not cured as of the Series M Asset Coverage Cure Date, (i) the Corporation shall give a Notice of Redemption as described in paragraph 4 of Article II hereof with respect to the redemption of a sufficient number of shares of Preferred
         Stock, which at the Corporation&rsquo;s determination (to the extent permitted by the 1940 Act and Maryland law) may include
         any proportion of shares of Series M Preferred Stock, to enable it to meet the requirements of paragraph 6(a)(i) above, and, at the Corporation&rsquo;s discretion, such additional number of shares of Series M Preferred Stock or other Preferred Stock in order that the Corporation shall have
         Asset Coverage with respect to the shares of Series M Preferred Stock and any other Preferred Stock remaining Outstanding after such redemption
         as great as 210%, and (ii) deposit with the Dividend-Disbursing Agent Deposit Assets having an initial combined
         value sufficient to effect the redemption of the shares of Series M Preferred Stock or other Preferred Stock to be redeemed, as contemplated by paragraph 4(a)(ii) of Article II hereof.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(c) Failure to Maintain Rating Agency Eligible Assets having an Adjusted Value at Least
         Equal to the Basic Maintenance Amount.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">If the Corporation fails to have Rating Agency Eligible Assets having an Adjusted
         Value at least equal to the Basic Maintenance Amount as provided in paragraph 6(a)(ii)(A) above and such failure is not cured, the Corporation shall, on or prior
         to the Basic Maintenance Amount Cure Date, (i) give a Notice of Redemption as described in paragraph 4 of Article II hereof with respect to the redemption of a sufficient number of shares of Series M Preferred Stock or other Preferred Stock to enable it to meet the requirements of
         paragraph 6(a)(ii)(A) above, and, at the Corporation&rsquo;s discretion, such additional number of shares of Series M Preferred Stock or other Preferred Stock in order that the Corporation have Adjusted
         Assets with respect to the remaining shares of Series M Preferred Stock and any other Preferred Stock remaining Outstanding after such redemption
         as great as 110% of the Basic Maintenance Amount, and (ii) deposit with the Dividend-Disbursing Agent Deposit Assets having an initial combined
         value sufficient to effect the redemption of the shares of Series M Preferred Stock or other Preferred Stock to be redeemed, as contemplated by paragraph 4 of Article II hereof.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(d) Status of Shares Called for Redemption.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">For purposes of determining whether the requirements of paragraphs 6(a)(i) and 6(a)(ii)(A) hereof are satisfied, (i) no share of the Series M Preferred Stock shall be deemed to be Outstanding for purposes of any computation
         if, prior to or concurrently with such determination, sufficient Deposit Assets to
         pay the full Redemption Price for such share shall have been deposited in trust with the Dividend-Disbursing
         Agent (or applicable paying agent) and the requisite Notice of Redemption shall have
         been given, and (ii) such Deposit Assets deposited with the Dividend-Disbursing Agent (or paying agent)
         shall not be included.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">7. Certain Other Restrictions.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(a) If the Series M Preferred Stock is rated by a Rating Agency at the request of the Corporation, the
         Corporation will not, and will cause the Adviser not to, (i) knowingly and willfully purchase or sell any asset for the specific purpose of causing,
         and with the actual knowledge that the effect of such purchase or sale will be to
         cause, the Corporation to have Rating Agency Eligible Assets having an Adjusted Value
         as of the date of such purchase or sale to be less than the Basic Maintenance Amount
         as of such date, (ii) in the event that, as of the immediately preceding Valuation Date, the Adjusted Value
         of the Corporation&rsquo;s Rating Agency Eligible Assets exceeded the Basic Maintenance Amount by 5% or less,
         alter the composition of the Corporation&rsquo;s assets in a manner reasonably expected to reduce the Adjusted Value of the Corporation&rsquo;s Rating Agency Eligible Assets, unless the Corporation shall have confirmed that,
         after giving effect to such alteration, the Adjusted Value of the Corporation&rsquo;s Rating Agency Eligible Assets exceeded the Basic Maintenance Amount or (iii) declare or pay any dividend or other distribution on any shares of Common Stock or
         repurchase any shares of Common Stock, unless the Corporation shall have confirmed
         that, after giving effect to such dividend, other distribution or repurchase, the Corporation continued to satisfy the requirements
         of paragraph 6(a)(ii)(A) of Article II hereof.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(b) If the Series M Preferred Stock is rated by a Rating Agency at the request of the Corporation, unless
         the Corporation shall have received written confirmation from the Rating Agency, the
         Corporation may engage in the lending of its portfolio securities only in an amount
         of up to 20% of the Corporation&rsquo;s total assets, provided that the Corporation receives cash collateral for such loaned
         securities which is maintained at all times in an amount equal to at least 100% of
         the current market value of the loaned securities and, if invested, is invested only
         in Short-Term Money Market Investments or in money market mutual funds meeting the
         requirements of Rule&nbsp;2a-7 under the 1940 Act that maintain a constant $1.00 per share net asset value and treat the loaned securities rather than the collateral
         as the assets of the Corporation for purposes of determining compliance with paragraph 6 of Article II hereof.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(c) If the Series M Preferred Stock is rated by a Rating Agency at the request of the Corporation, the
         Corporation shall not consolidate the Corporation with, merge the Corporation into,
         sell or otherwise transfer all or substantially all of the Corporation&rsquo;s assets to another Person or adopt a plan of liquidation of the Corporation, in each
         case without providing prior written notification to the Rating Agency.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">8. Limitation on Incurrence of Additional Indebtedness and Issuance of Additional Preferred
         Stock</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(a) So long as any shares of Series M Preferred Stock are Outstanding and the Corporation is permitted to issue indebtedness
         under its fundamental investment restrictions, the Corporation may issue and sell
         one or more series of a class of senior securities of the Corporation representing
         indebtedness under Section&nbsp;18 of the 1940 Act and/or otherwise create or incur indebtedness, provided that, immediately after giving effect to the incurrence of such indebtedness and to its
         receipt and application of the proceeds thereof, the Corporation shall have an &ldquo;asset coverage&rdquo; for all senior securities representing indebtedness, as defined in Section&nbsp;18(h) of the 1940 Act, of at least 300% of the amount of all indebtedness of the Corporation
         then Outstanding and no such additional indebtedness shall have any preference or
         priority over any other indebtedness of the Corporation upon the distribution of the
         assets of the Corporation or in respect of the payment of interest. Any possible liability
         resulting from lending and/or borrowing portfolio securities, entering into reverse
         repurchase agreements, entering into futures contracts and writing options or the
         use of any other financial instrument that may have the effect of creating leverage,
         to the extent such transactions are made in accordance with the investment restrictions
         of the Corporation then in effect, shall not be considered to be indebtedness limited
         by this paragraph 8(a).</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(b) So long as any shares of Series M Preferred Stock are Outstanding, the Corporation may issue and sell shares of one
         or more other series of Preferred Stock constituting a series of a class of senior
         securities of the Corporation representing stock under Section&nbsp;18 of the 1940 Act in addition to the shares of Series M Preferred Stock or shares of other Preferred Stock Outstanding, provided that (i) the Corporation shall, immediately after giving effect to the issuance of such additional
         Preferred Stock and to its receipt and application of the proceeds thereof, including,
         without limitation, to the redemption of Preferred Stock for which a Redemption Notice has been mailed prior to such issuance, have an &ldquo;asset coverage&rdquo; for all senior securities which are stock, as defined in Section&nbsp;18(h) of the 1940 Act, of at least 200% of the sum of the Liquidation Preference of
         the shares of Series M Preferred Stock and all other Preferred Stock then Outstanding, and (ii) no such additional Preferred Stock shall have any preference or priority over any
         other Preferred Stock upon the distribution of the assets of the Corporation or in
         respect of the payment of dividends.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>ARTICLE III</B></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>ABILITY OF BOARD OF DIRECTORS TO MODIFY THESE<BR>
ARTICLES SUPPLEMENTARY</B></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">1. Modification to Prevent Ratings Reduction or Withdrawal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">The Board of Directors, without the vote or consent of any holders of Series M Preferred Stock or the holders of any other shares of Preferred Stock of the Corporation,
         or any other stockholder of the Corporation, may from time to time amend, alter or
         repeal the provisions of paragraph 7 of </P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Article II of these Articles Supplementary, as well as any or all of the definitions contained within these Articles Supplementary (and any terms defined within, or related to, such definitions), add
         covenants and other obligations of the Corporation, or confirm the applicability of
         covenants and other obligations set forth herein, all in connection with obtaining
         or maintaining the rating of any Rating Agency then rating the Series M Preferred Stock, and any such amendment, alteration or repeal will be deemed not
         to affect the preferences, rights or powers of the holders of Series M Preferred Stock or the holders of any other shares of Preferred Stock expressly set
         forth in the Charter, provided that the Board of Directors shall have obtained written
         confirmation from any Rating Agency then rating the Series M Preferred Stock (with such confirmation in no event being required to be obtained
         from a particular Rating Agency with respect to definitions or other provisions relevant
         only to and adopted in connection with another Rating Agency&rsquo;s rating of the Series M Preferred Stock) that any such amendment, alteration or repeal would not adversely
         affect the rating then assigned by such Rating Agency.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">2. Other Modification.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(a) The affirmative vote of the holders of a majority, as defined in the 1940 Act, of
         shares of Series M Preferred Stock (or of any other series of Preferred Stock), voting separately from
         any other series of Preferred Stock (to the extent its rights are affected differently),
         shall be required with respect to any matter that materially and adversely affects
         the rights, preferences or powers of that series in a manner different from that of
         other series or classes of the Corporation&rsquo;s capital stock. For purposes of the foregoing, no matter shall be deemed to adversely
         affect any rights, preferences or powers unless such matter (i) adversely alters or abolishes any preferential right of such series; (ii) creates, adversely alters or abolishes any right in respect of redemption of such
         series; or (iii) creates or adversely alters (other than to abolish) any restriction on transfer applicable
         to such series. An increase in the number of authorized shares of Preferred Stock
         pursuant to the Charter or the issuance of additional shares of any series of Preferred
         Stock (including the Series M Preferred Stock) pursuant to the Charter shall not in and of itself be considered
         to adversely affect the contract rights of the holders of Preferred Stock. The vote
         of holders of any series described in this paragraph 2(a) of Article III will in each case be in addition to a separate vote of the requisite percentage
         of Common Stock and Preferred Stock, if any, necessary to authorize the action in
         question. The holders of the Series M Preferred Stock shall not be entitled to vote on any matter that affects the rights
         or interests of only one or more series of Preferred Stock other than the Series M Preferred Stock.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(b) The affirmative vote of the holders of a majority, as defined in the 1940 Act, of
         the shares of Outstanding Preferred Stock (including the Series M Preferred Stock), voting together as a single class, shall be required to amend, alter or repeal the provisions of the Governing Documents,
         whether by merger, consolidation or otherwise, if such amendment, alteration or repeal
         would affect adversely the rights, preferences or powers expressly set forth in any
         Articles Supplementary of the Preferred Stock, including the Series M Preferred Stock, unless, in each case, the Corporation obtains written confirmation from any Rating
         Agency then rating the Series M Preferred Stock that such amendment, alteration or repeal would not impair the rating
         then assigned by such rating agency to the Series M Preferred Stock, in which case the vote or consent of the holders of the Series M Preferred Stock is not required. For purposes of the foregoing, no matter shall be
         deemed to adversely affect any rights, preferences or powers unless such matter (i) adversely alters or abolishes any preferential right of the Series M Preferred Stock; (ii) creates, adversely alters or abolishes any right in respect of redemption of the Series M Preferred Stock; or (iii) creates or adversely alters (other than to abolish) any restriction on transfer applicable
         to the Series M Preferred Stock. An increase in the number of authorized shares of Preferred Stock
         pursuant to the Charter or the issuance of additional shares of any series of Preferred
         Stock (including the Series M Preferred Stock) pursuant to the Charter shall not in and of itself be considered
         to adversely affect the rights, preferences or powers of the Series M Preferred Stock. The vote of holders of any Series M Preferred Stock described in this paragraph 2(b) of Article III will in each case be in addition to a separate vote of the requisite percentage,
         if any, of Common Stock and Preferred Stock necessary to authorize the action in question.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(c) Notwithstanding the provisions of Article III, to the extent permitted by law, the Board of Directors, without the vote of the
         holders of the Series M Preferred Stock or any other capital stock of the Corporation, may amend the provisions
         of these Articles Supplementary to resolve any inconsistency or ambiguity or to remedy any formal defect
         so long as the amendment does not in the aggregate adversely affect the rights and
         preferences of the Series M Preferred Stock.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(d) Unless a higher percentage is required under the Governing Documents or applicable
         provisions of Maryland law or the 1940 Act, the affirmative vote of the holders of
         a majority, as defined in the 1940 Act, of the shares of Outstanding Preferred Stock,
         including the Series M Preferred Stock, voting together as a single class, will be required to approve any
         plan of reorganization adversely affecting the Preferred Stock or any action requiring
         a vote of security holders under Section&nbsp;13(a) of the 1940 Act. The vote of holders of any series described in this paragraph 2(d) of Article III will in each case be in addition to a separate vote of the requisite percentage
         of Common Stock and Preferred Stock, if any, necessary to authorize the action in
         question.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(e) For purposes of these Article III, the phrase &ldquo;vote of the Holders of a majority of the Outstanding shares of Preferred Stock&rdquo; (or any like phrase) shall mean, in accordance with Section&nbsp;2(a)(42) of the 1940 Act, the affirmative vote, at the annual or a special meeting of the stockholders of the Corporation duly
         called, of the Holders (A) of 67 percent or more of the shares of Preferred Stock present at such meeting, if the Holders
         of more than 50 percent of the Outstanding shares of Preferred Stock are present or represented by
         proxy at such meeting; or (B) of more than 50 percent of the Outstanding shares of Preferred Stock, whichever is less.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(f) The provisions of this Article III are subject to the provisions of paragraph 7 of Article II of these Articles Supplementary.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">3. Notice.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">In the event of any modification of these Articles Supplementary pursuant to paragraph 2 of this Article III, the Corporation shall provide notice of such modification to the Rating Agencies
         10 Business Days prior to the date such modification takes effect.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">4. No Modification of Existing Preferred Stock.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Nothing contained in these Articles Supplementary creating the Series M Preferred Stock shall be understood to modify the rights, obligations or privileges
         of any other series of the Corporation&rsquo;s Preferred Stock Outstanding. To the extent permitted by law, the Board of Directors, without the vote of the holders
         of the Series M Preferred Stock or any other capital stock of the Corporation, may amend the provisions
         of these Articles Supplementary to resolve any inconsistency or ambiguity or to remedy any formal defect
         so as to negate the effect of any such modification of the rights, obligations or
         privileges of any other series of the Corporation&rsquo;s Preferred Stock Outstanding.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.25in">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">IN WITNESS WHEREOF, the Corporation has caused these Articles Supplementary to be signed in its name and on its behalf by its duly authorized President, and attested by its Secretary, and the undersigned President of the Corporation further acknowledges said instrument to be the corporate act of the Corporation, and states that, to the best of such officer&rsquo;s knowledge, information and belief under penalty of perjury, the matters and facts set forth herein required to be verified under oath are true in all material respects, as of December&nbsp;15, 2021.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE GABELLI EQUITY TRUST INC.</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; text-align: left; font-size: 10pt; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left; font-size: 10pt; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Bruce N. Alpert</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left; width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bruce N. Alpert</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attest:</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Peter
D. Goldstein</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peter D. Goldstein</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Secretary</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Signature
Page to Articles Supplementary for Series M Preferred Stock of The Gabelli Equity Trust Inc.]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>

    <!-- Field: /Page -->


   </BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.(A)(XXV)
<SEQUENCE>3
<FILENAME>gabelliequitytrust_ex99axxv.htm
<DESCRIPTION>EXHIBIT (A)(XXV)
<TEXT>
<HTML>
   <HEAD>
      <TITLE></TITLE>
   </HEAD>
   <BODY STYLE="font: 10pt Times New Roman, Times, Serif">
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
(a)(xxv)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
      GABELLI EQUITY TRUST INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLES
SUPPLEMENTARY</B><BR><B>CREATING AND FIXING THE RIGHTS OF </B><BR><B>5.25% SERIES N CUMULATIVE PREFERRED STOCK</B></FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
      Gabelli Equity Trust Inc., a Maryland corporation, having its principal office in Baltimore City, Maryland (hereinafter called
      the &ldquo;<U>Corporation</U>&rdquo;), hereby certifies to the State Department of Assessments and Taxation of Maryland (the &ldquo;<U>SDAT</U>&rdquo;)
      that:</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FIRST:
      The Board of Directors, and a duly authorized committee thereof, pursuant to authority expressly vested in it by Article V of the
      Charter of the Corporation, adopted resolutions classifying 350,000 authorized and unissued shares of preferred stock of the Corporation,
      par value $0.001 per share, without further designation as to class or series, as shares of 5.25% Series N Cumulative Preferred
      Stock having the preferences, conversion and other rights, voting powers, restrictions, limitations as to dividends and other distributions,
      qualifications, and terms and conditions of redemption set forth herein.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECOND:
      The preferences, conversion and other rights, voting powers, restrictions, limitations as to dividends and other distributions,
      qualifications, and terms and conditions of redemption of the Corporation&rsquo;s 5.25% Series N Cumulative Preferred Stock, par
      value $0.001 per share, as fixed by the Board of Directors, and a duly authorized committee thereof, are as follows:</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DESIGNATION</B></FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.25%
      Series N Cumulative Preferred Stock: A series of 350,000 shares of preferred stock, par value $0.001 per share, is hereby designated
      &ldquo;5.25% Series N Cumulative Preferred Stock&rdquo; (the &ldquo;<U>Series N Preferred Stock</U>&rdquo;). The Series N Preferred
      Stock shall constitute a separate series of Preferred Stock.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
      I</B></FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DEFINITIONS</B></FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
      the context or use indicates another or different meaning or intent, each of the following terms when used in these Articles Supplementary
      shall have the meaning ascribed to it below, whether such term is used in the singular or plural and regardless of tense or gender:</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>1940
      Act</U>&rdquo; means the Investment Company Act of 1940, as amended, or any successor statute.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Administrator</U>&rdquo;
      means the other party to the Administration Agreement with the Corporation, which shall initially be Gabelli Funds, LLC, a New
      York limited liability company, and will include, as appropriate, any sub-administrator appointed by the Administrator.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Adviser</U>&rdquo;
      means Gabelli Funds, LLC, a New York limited liability company, or such other person as shall be serving as the investment adviser
      of the Corporation.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Asset
      Coverage</U>&rdquo; means asset coverage, as determined in accordance with Section&nbsp;18(h) of the 1940 Act, of at least 200%
      with respect to all outstanding senior securities of the Corporation which are stock, including all Outstanding shares of Series
      N Preferred Stock (or such other asset coverage as may in the future be specified in or under the 1940 Act as the minimum asset
      coverage for senior securities which are stock of a closed-end investment company as a condition of declaring dividends on its
      common stock), determined on the basis of values calculated as of a time within 48 hours (not including Saturdays, Sundays or holidays)
      next preceding the time of such determination.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Board
      of Directors</U>&rdquo; means the Board of Directors of the Corporation or any duly authorized committee thereof as permitted by
      applicable law.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
      Day</U>&rdquo; means a day on which the New York Stock Exchange is open for trading and that is neither a Saturday, Sunday nor
      any other day on which banks in the city of New York, New York are authorized or obligated by law to close.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>By-Laws</U>&rdquo;
      means the By-Laws of the Corporation, as amended from time to time.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Charter</U>&rdquo;
      means the Articles of Incorporation of the Corporation, as amended and supplemented (including by these Articles Supplementary),
      as accepted for record by the SDAT.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Code</U>&rdquo;
      means the Internal Revenue Code of 1986, as amended.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
      Stock</U>&rdquo; means the Common Stock, par value $0.001 per share, of the Corporation.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Corporation</U>&rdquo;
      means The Gabelli Equity Trust Inc., a Maryland corporation.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Cure
      Date</U>&rdquo; shall have the meaning set forth in paragraph 4(a)(ii) of Article II hereof.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Date
      of Original Issue</U>&rdquo; means, with respect to the Series N Preferred Stock, the date on which any shares of the Series N
      Preferred Stock are first issued, and for the purposes of these Articles Supplementary shall mean with respect to any other class
      or series of Preferred Stock the date upon which shares of such class or series are first issued.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Deposit
      Assets</U>&rdquo; means cash, Short-Term Money Market Instruments and U.S. Government Obligations. Each Deposit Asset shall be
      deemed to have a value equal to its principal or face amount payable at maturity plus any interest payable thereon after delivery
      of such Deposit Asset but only if payable on or prior to the applicable payment date in advance of which the relevant deposit is
      made.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Dividend-Disbursing
      Agent</U>&rdquo; means, with respect to the Series N Preferred Stock, Computershare Trust Company, N.A. and its successors or any
      other dividend-disbursing agent appointed by the Corporation and, with respect to any other class or series of Preferred Stock,
      the Person appointed by the Corporation as dividend-disbursing or paying agent with respect to such class or series.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Dividend
      Payment Date</U>&rdquo; means with respect to the Series N Preferred Stock, any date on which dividends and distributions declared
      by, or under authority granted by, the Board of Directors thereon are payable pursuant to the provisions of paragraph 2(a) of Article
      II of these Articles Supplementary and shall for the purposes of these Articles Supplementary have a correlative meaning with respect
      to any other class or series of Preferred Stock.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Dividend
      Period</U>&rdquo; shall have the meaning set forth in paragraph 2(a) of Article II hereof, and for the purposes of these Articles
      Supplementary shall have a correlative meaning with respect to any other class or series of Preferred Stock.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Fitch</U>&rdquo;
      means Fitch Ratings.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Governing
      Documents</U>&rdquo; means the Charter and the By-Laws.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Liquidation
      Preference</U>&rdquo; shall, with respect to the Series N Preferred Stock, have the meaning set forth in paragraph 3(a) of Article
      II hereof, and for the purposes of these Articles Supplementary shall have a correlative meaning with respect to any other class
      or series of Preferred Stock.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Mandatory
      Redemption Date</U>&rdquo; means December&nbsp;26, 2025.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Moody&rsquo;s</U>&rdquo;
      means Moody&rsquo;s Investors Service, Inc. and its successors at law.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Notice
      of Redemption</U>&rdquo; shall have the meaning set forth in paragraph 4(d)(i) of Article II hereof.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Outstanding</U>&rdquo;
      means, as of any date, Preferred Stock theretofore issued by the Corporation except:</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
      any such share of Preferred Stock theretofore redeemed, repurchased, cancelled or otherwise reacquired by the Corporation or delivered
      to the Corporation for redemption, repurchase, cancellation or other acquisition by the Corporation;</FONT></P>
      <P STYLE="text-indent: -0.25in; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
any such share of Preferred Stock, other than auction rate Preferred Stock, as to which a notice of redemption shall have been given
and for whose payment at the redemption thereof Deposit Assets in the necessary amount are held by the Corporation in trust for, or have
been irrevocably deposited with the relevant disbursing agent for payment to, the holder of such share pursuant to these Articles Supplementary
with respect thereto;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
      in the case of auction rate Preferred Stock, any such shares theretofore delivered to the applicable auction agent for redemption,
      repurchase, cancellation or other acquisition by the Corporation or with respect to which the Corporation has given notice of redemption
      and irrevocably deposited with the paying agent sufficient funds to redeem such shares; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
      any such share in exchange for or in lieu of which other shares have been issued and delivered.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
      the foregoing, (i) for purposes of voting rights (including the determination of the number of shares required to constitute a
      quorum), any shares of Preferred Stock as to which any subsidiary of the Corporation is the holder will be disregarded and deemed
      not Outstanding, and (ii) in connection with any auction of shares of auction rate Preferred Stock as to which the Corporation
      or any Person known to the auction agent to be a subsidiary of the Corporation is the holder will be disregarded and not deemed
      Outstanding.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
      means and includes an individual, a partnership, the Corporation, a trust, a corporation, a limited liability company, an unincorporated
      association, a joint venture or other entity or a government or any agency or political subdivision thereof.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Preferred
      Stock</U>&rdquo; means the preferred stock, par value $0.001 per share, of the Corporation, and includes the Series N Preferred
      Stock.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Redemption
      Price</U>&rdquo; has the meaning set forth in paragraph 4(a)(ii) of Article II hereof, and for the purposes of these Articles Supplementary
      shall have a correlative meaning with respect to any other class or series of Preferred Stock.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>S&amp;P</U>&rdquo;
      means S&amp;P Global Ratings, or its successors at law.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Series
      N Preferred Stock</U>&rdquo; means the 5.25% Series N Cumulative Preferred Stock, par value $0.001 per share, of the Corporation.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Series
      N Asset Coverage Cure Date</U>&rdquo; means, with respect to the failure by the Corporation to maintain Asset Coverage (as required
      by paragraph 6(a) of Article II hereof) as of the last Business Day of each March, June, September and December of each year, 60
      days following such Business Day.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Short-Term
      Money Market Instruments</U>&rdquo; means the following types of instruments if, on the date of purchase or other acquisition thereof
      by the Corporation, the remaining term to maturity thereof is not in excess of 360 days:</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">commercial
paper rated either F-1 by Fitch or A-1 by S&amp;P if such commercial paper matures in 30 days or P-1 by Moody&rsquo;s and either F-1+
by Fitch or A-1+ by S&amp;P if such commercial paper matures in over 30 days;</FONT></TD>
</TR></TABLE>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">demand
or time deposits in, and banker&rsquo;s acceptances and certificates of deposit of, (A) a depository institution or trust company incorporated
under the laws of the United States of America or any state thereof or the District of Columbia or (B) a United States branch office
or agency of a foreign depository institution (provided that such branch office or agency is subject to banking regulation under the
laws of the United States, any state thereof or the District of Columbia);</FONT></TD>
</TR></TABLE>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">overnight
funds;</FONT></TD>
</TR></TABLE>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
Government Obligations and U.S. Government Securities; and</FONT></TD>
</TR></TABLE>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eurodollar
demand or time deposits in, or certificates of deposit of, the head office or the London branch office of a depository institution or
trust company if the certificates of deposit, if any, and the long-term unsecured debt obligations (other than such obligations the ratings
of which are based on the credit of a person or entity other than such depository institution or trust company) of such depository institution
or trust company that have (1) credit ratings on each Valuation Date of at least P-1 from Moody&rsquo;s and either F-1+ from Fitch or
A-1+ from S&amp;P, in the case of commercial paper or certificates of deposit, and (2) credit ratings on each Valuation Date of at least
Aa3 from Moody&rsquo;s and either AA from Fitch or AA- from S&amp;P, in the case of long-term unsecured debt obligations; provided, however,
that in the case of any such investment that matures in no more than one Business Day from the date of purchase or other acquisition
by the Corporation, all of the foregoing requirements shall be applicable except that the required long-term unsecured debt credit rating
of such depository institution or trust company from Moody&rsquo;s, Fitch and S&amp;P shall be at least A2, A-2 and A, respectively;
and provided further, however, that the foregoing credit rating requirements shall be deemed to be met with respect to a depository institution
or trust company if (1) such depository institution or trust company is the principal depository institution in a holding company system,
(2) the certificates of deposit, if any, of such depository institution or trust company are not rated on any Valuation Date below P-1
by Moody&rsquo;s, F-1+ by Fitch or A-1+ by S&amp;P and there is no long-term rating, and (3) the holding company shall meet all of the
foregoing credit rating requirements (including the preceding proviso in the case of investments that mature in no more than one Business
Day from the date of purchase or other acquisition by the Corporation); and provided further, that the interest receivable by the Corporation
shall not be subject to any withholding or similar taxes.</FONT></TD>
</TR></TABLE>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>U.S.
      Government Obligations</U>&rdquo; means direct obligations of the United States or by its agencies or instrumentalities that are
      entitled to the full faith and credit of the United States and that, other than United States Treasury Bills, provide for the periodic
      payment of interest and the full payment of principal at maturity or call for redemption.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>U.S.
      Government Securities</U>&rdquo; mean securities that are direct obligations of, and obligations the timely payment of principal
      and interest on which is fully guaranteed by, the United States or any agency or instrumentality of the United States, the obligations
      of which are backed by the full faith and credit of the United States and in the form of conventional bills, bonds and notes.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Valuation
      Date</U>&rdquo; means the last Business Day of each month.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Voting
      Period</U>&rdquo; shall have the meaning set forth in paragraph 5(b) of Article II hereof.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
      II</B></FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.25%
      SERIES N CUMULATIVE PREFERRED STOCK</B></FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
      Number of Shares; Ranking.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
      The initial number of authorized shares constituting the Series N Preferred Stock to be issued is 350,000. No fractional shares
      of Series N Preferred Stock shall be issued.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
      Shares of Series N Preferred Stock which at any time have been redeemed or purchased by the Corporation shall, after such redemption
      or purchase, have the status of authorized but unissued shares of Preferred Stock without further designation as to class or series.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
      The Series N Preferred Stock shall rank on a parity with any other series of Preferred Stock as to the payment of dividends, distributions
      and liquidation preference to which such stock is entitled.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
      No holder of Series N Preferred Stock shall have, solely by reason of being such a holder, any preemptive or other right to acquire,
      purchase or subscribe for any shares of any Preferred Stock or Common Stock or other securities of the Corporation which it may
      hereafter issue or sell.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
      Dividends and Distributions.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
      Holders of shares of Series N Preferred Stock shall be entitled to receive, when, as and if authorized by, or under authority granted
      by, the Board of Directors and declared by the Corporation, out of funds legally available therefor, cumulative cash dividends
      and distributions at the rate of 5.25% per annum (computed on the basis of a 360-day year consisting of twelve 30-day months) of
      the Liquidation Preference on the Series N Preferred Stock and no more, which shall become due and be payable semiannually on June&nbsp;26
      and December&nbsp;26 in each year (each a &ldquo;<U>Dividend Payment Date</U>&rdquo;) commencing on June&nbsp;26, 2024 (or, if
      any such day is not a Business Day, then on the next succeeding Business Day). Dividends and distributions will be payable to holders
      of record of Series N Preferred Stock as they appear on the stock register of the Corporation at the close of business on the fifth
      Business Day prior to the Dividend Payment Date in preference to dividends and distributions on shares of Common Stock and any
      other capital stock of the Corporation ranking junior to the Series N Preferred Stock in payment of dividends and distributions.
      Dividends and distributions on shares of Series N Preferred Stock shall accumulate from, and including, the Date of Original Issue
      or, if later, from, and including, the first day of the most recent Dividend Period with respect to which full, cumulative cash
      dividends have been neither (i) paid in full nor (ii) declared in full and the record date for determining stockholders entitled
      to payment of thereof has passed. Each period beginning on and including a Dividend Payment Date (or the Date of Original Issue,
      in the case of the first dividend period after the issuance of such shares) and ending on but excluding the next succeeding Dividend
      Payment Date is referred to herein as a &ldquo;<U>Dividend Period</U>.&rdquo; Dividends and distributions on account of arrears
      for any past Dividend Period or in connection with the redemption of Series N Preferred Stock may be declared and paid at any time,
      without reference to any Dividend Payment Date, to holders of record on such date not exceeding 30 days preceding the payment date
      thereof as shall be fixed by the Board of Directors.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
      (i) No dividends or distributions shall be declared or paid on shares of Series N Preferred Stock for any Dividend Period or part
      thereof unless all accumulated and unpaid dividends and distributions on all Outstanding shares of all series of Preferred Stock
      ranking on a parity with the Series N Preferred Stock as to the payment of dividends and distributions for all applicable past
      Dividend Periods (whether or not earned or declared by the Corporation) shall have been or contemporaneously are declared and paid
      for and Deposit Assets for the payment of such dividends and distributions shall have been deposited with the Dividend-Disbursing
      Agent as set forth in paragraph 2(c) of Article II hereof, provided, however, that the foregoing shall not prevent the purchase
      or acquisition of Outstanding shares of Preferred Stock pursuant to the successful completion of an otherwise lawful purchase or
      exchange offer made on the same terms to holders of all Outstanding shares of Series N Preferred Stock. If full cumulative dividends
      and distributions due have not been paid on all Outstanding shares of such Preferred Stock, any dividends and distributions being
      declared and paid on such shares of Preferred Stock (including the Series N Preferred Stock) will be paid as nearly pro rata as
      possible in proportion to the respective amounts of dividends and distributions accumulated but unpaid on each such series of Preferred
      Stock on the relevant Dividend Payment Date. No holders of shares of Series N Preferred Stock shall be entitled to any dividends
      or distributions, whether payable in cash, property or stock, in excess of full cumulative dividends and distributions as provided
      in this paragraph 2(b)(i) on shares of Series N Preferred Stock. No interest or sum of money in lieu of interest shall be payable
      in respect of any dividend payments on any shares of Series N Preferred Stock that may be in arrears.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
      For so long as shares of Series N Preferred Stock are Outstanding, the Corporation shall not pay any dividend or other distribution
      (other than a dividend or distribution paid in shares of, or options, warrants or rights to subscribe for or purchase, Common Stock
      or other stock, if any, ranking junior to the Series N Preferred Stock as to payment of dividends and the distribution of assets
      upon liquidation) in respect of the Common Stock or any other stock of the Corporation ranking junior to the Series N Preferred
      Stock as to payment of dividends and the distribution of assets upon liquidation, or call for redemption, redeem, purchase or otherwise
      acquire for consideration any shares of Common Stock or any other stock of the Corporation ranking junior to the Series N Preferred
      Stock as to payment of dividends and the distribution of assets upon liquidation (except by conversion into or exchange for stock
      of the Corporation ranking junior to the Series N Preferred Stock as to payment of dividends and the distribution of assets upon
      liquidation), unless, in each case, (A) immediately thereafter, the Corporation shall have Asset Coverage, (B) all cumulative dividends
      and distributions on all shares of Series N Preferred Stock due on or prior to the date of the transaction have been declared and
      paid (or shall have been declared and sufficient funds for the payment thereof deposited with the applicable Dividend-Disbursing
      Agent) and (C) the Corporation has redeemed the full number of shares of Series N Preferred Stock to be redeemed mandatorily pursuant
      to any provision contained herein for mandatory redemption.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
      Any dividend payment made on the shares of Series N Preferred Stock shall first be credited against the dividends and distributions
      accumulated with respect to the earliest Dividend Period for which dividends and distributions have not been paid.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>



<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
      Not later than the Business Day immediately preceding each Dividend Payment Date, the Corporation shall deposit with the Dividend-Disbursing
      Agent Deposit Assets having an initial combined value sufficient to pay the dividends and distributions that are payable on such
      Dividend Payment Date, which Deposit Assets shall mature (if such assets constitute debt securities) on or prior to such Dividend
      Payment Date. The Corporation may direct the Dividend-Disbursing Agent with respect to the investment of any such Deposit Assets,
      provided that such investment consists exclusively of Deposit Assets and provided further that the proceeds of any such investment
      will be available at the opening of business on such Dividend Payment Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
      Liquidation Rights.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
      In the event of any liquidation, dissolution or winding up of the affairs of the Corporation, whether voluntary or involuntary,
      the holders of shares of Series N Preferred Stock shall be entitled to receive out of the assets of the Corporation available for
      distribution to stockholders, after satisfying claims of creditors but before any distribution or payment shall be made in respect
      of the Common Stock or any other stock of the Corporation ranking junior to the Series N Preferred Stock as to liquidation payments,
      a liquidation distribution in the amount of $100.00 per share (the &ldquo;<U>Liquidation Preference</U>&rdquo;), plus an amount
      equal to all unpaid dividends and distributions accumulated to and including the date fixed for such distribution or payment (whether
      or not earned or declared by the Corporation, but excluding interest thereon), and such holders shall be entitled to no further
      participation in any distribution or payment in connection with any such liquidation, dissolution or winding up of the Corporation.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
      If, upon any liquidation, dissolution or winding up of the affairs of the Corporation, whether voluntary or involuntary, the assets
      of the Corporation available for distribution among the holders of all Outstanding shares of Series N Preferred Stock, and any
      other Outstanding shares of a class or series of Preferred Stock ranking on a parity with the Series N Preferred Stock as to payment
      upon liquidation, shall be insufficient to permit the payment in full to such holders of Series N Preferred Stock of the Liquidation
      Preference plus all accumulated and unpaid dividends and distributions and the amounts due upon liquidation with respect to such
      other series of Preferred Stock, then such available assets shall be distributed among the holders of shares of Series N Preferred
      Stock and such other series of Preferred Stock ratably in proportion to the respective preferential liquidation amounts to which
      they are entitled. Unless and until the Liquidation Preference plus accumulated and unpaid dividends and distributions has been
      paid in full to the holders of shares of Series N Preferred Stock, no dividends or distributions will be made to holders of the
      Common Stock or any other stock of the Corporation ranking junior to the Series N Preferred Stock as to liquidation.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
      Redemption and Puts.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
      of the Series N Preferred Stock shall be redeemed by the Corporation as provided below:</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
      Mandatory Redemptions.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
      The Corporation is required to redeem all Outstanding shares of Series N Preferred Stock on the Mandatory Redemption Date at the
      Redemption Price.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
      If the Corporation is required to redeem any shares of Preferred Stock (which may include shares of Series N Preferred Stock) prior
      to the Mandatory Redemption Date pursuant to paragraph 6(b) of Article II hereof or pursuant to the Charter, then the Corporation
      shall, to the extent permitted by the 1940 Act and Maryland law, by the close of business on such Series N Asset Coverage Cure
      Date (a &ldquo;<U>Cure Date</U>&rdquo;), as the case may be, fix a redemption date and proceed to redeem shares as set forth in
      paragraph 4(d) hereof. On such redemption date, the Corporation shall redeem, out of funds legally available therefor, the number
      of shares of Preferred Stock, which, to the extent permitted by the 1940 Act and Maryland law, at the option of the Corporation
      may include any proportion of Series N Preferred Stock or any other series of Preferred Stock, equal to the minimum number of shares
      the redemption of which, if such redemption had occurred immediately prior to the opening of business on such Cure Date, would
      have resulted in the Corporation having Asset Coverage immediately prior to the opening of business on such Cure Date or, if Asset
      Coverage cannot be so restored, all of the Outstanding shares of Series N Preferred Stock, at a price equal to the Liquidation
      Preference per share plus all accumulated but unpaid dividends and distributions (whether or not earned or declared by the Corporation)
      through and including the date of redemption (the &ldquo;<U>Redemption Price</U>&rdquo;). In the event that, prior to the Mandatory
      Redemption Date, shares of Preferred Stock are redeemed pursuant to paragraph 6(b) of Article II hereof, the Corporation may, but
      is not required to, redeem a sufficient number of shares of Series N Preferred Stock pursuant to this paragraph 4(a)(ii) which,
      when aggregated with other shares of Preferred Stock redeemed by the Corporation, permits the Corporation to have with respect
      to the shares of Preferred Stock (including the Series N Preferred Stock) remaining Outstanding after such redemption Asset Coverage
      of as much as 210%. In the event that all of the shares of Series N Preferred Stock then Outstanding are required to be redeemed
      pursuant to paragraph 6 of Article II hereof prior to the Mandatory Redemption Date, the Corporation shall redeem such shares at
      the Redemption Price and proceed to do so as set forth in paragraph 4(d) hereof.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
      Optional Redemptions.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
      Corporation may redeem all or any part of the shares of Series N Preferred Stock, upon 30 days&rsquo; prior written notice, at
      the Redemption Price, at any time commencing on December&nbsp;26, 2024 and thereafter, to the extent permitted by the 1940 Act
      and Maryland law. The Series N Preferred Stock is not otherwise subject to optional redemption by the Corporation unless such redemption
      is necessary, in the judgment of the Board of Directors, to maintain the Corporation&rsquo;s status as a regulated investment company
      under Subchapter M of the Code.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
      Puts.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
      Corporation will accept for redemption all or any part of the outstanding shares of Series N Preferred Stock that holders have
      properly submitted for redemption during the 60-day period prior to each of June&nbsp;26, 2024 and December&nbsp;26, 2024 at the
      Redemption Price.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
      Procedures for Redemption.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
      If the Corporation shall determine or be required to redeem shares of Series N Preferred Stock pursuant to this paragraph 4, it
      shall mail a written notice of redemption (&ldquo;<U>Notice of Redemption</U>&rdquo;) with respect to such redemption by first
      class mail, postage prepaid, to each holder of the shares to be redeemed at such holder&rsquo;s address as the same appears on
      the stock books of the Corporation on the close of business on such date as the Board of Directors or its delegatee may determine,
      which date shall not be earlier than the second Business Day prior to the date upon which such Notice of Redemption is mailed to
      the holders of Series N Preferred Stock. Each such Notice of Redemption shall state: (A) the redemption date as established by
      the Board of Directors or its delegatee (which, in the case of a redemption pursuant to paragraph 4(a)(i) hereof, shall be the
      Mandatory Redemption Date); (B) the number or percentage of shares of Series N Preferred Stock to be redeemed; (C) the CUSIP number(s)
      of such shares; (D) the Redemption Price (specifying the amount of accumulated dividends to be included therein); (E) the place
      or places where the certificate(s) for such shares (properly endorsed or assigned for transfer, if the Board of Directors or its
      delegatee shall so require and the Notice of Redemption shall so state), if any, are to be surrendered for payment in respect of
      such redemption; (F) that dividends and distributions on the shares to be redeemed will cease to accrue on such redemption date;
      (G) the provisions of this paragraph 4 under which such redemption is made; and (H) in the case of a redemption pursuant to paragraph
      4(b), any conditions precedent to such redemption. If fewer than all shares of Series N Preferred Stock held by any holder are
      to be redeemed, the Notice of Redemption mailed to such holder also shall specify the number or percentage of shares to be redeemed
      from such holder. No defect in the Notice of Redemption or the mailing thereof shall affect the validity of the redemption proceedings,
      except as required by applicable law.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
      If the Corporation shall give a Notice of Redemption, then by the close of business on the Business Day preceding the redemption
      date specified in the Notice of Redemption (so long as any conditions precedent to such redemption have been met) or, if the Dividend-Disbursing
      Agent so agrees, another date not later than the redemption date, the Corporation shall (A) deposit with the Dividend-Disbursing
      Agent Deposit Assets that shall mature (if such assets constitute debt securities) on or prior to such redemption date having an
      initial combined value sufficient to effect the redemption of the shares of Series N Preferred Stock to be redeemed and (B) give
      the Dividend-Disbursing Agent irrevocable instructions and authority to pay the Redemption Price to the holders of the shares of
      Series N Preferred Stock called for redemption on the redemption date. The Corporation may direct the Dividend-Disbursing Agent
      with respect to the investment of any Deposit Assets so deposited provided that the proceeds of any such investment will be available
      at the opening of business on such redemption date. Upon the date</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">of such deposit (unless the Corporation shall default in making
      payment of the Redemption Price), all rights of the holders of the shares of Series N Preferred Stock so called for redemption
      shall cease and terminate except the right of the holders thereof to receive the Redemption Price thereof and such shares shall
      no longer be deemed Outstanding for any purpose. The Corporation shall be entitled to receive, promptly after the date fixed for
      redemption, any cash in excess of the aggregate Redemption Price of the shares of Series N Preferred Stock called for redemption
      on such date and any remaining Deposit Assets. Any assets so deposited that are unclaimed at the end of two years from such redemption
      date shall, to the extent permitted by law, be repaid to the Corporation, after which the holders of the shares of Series N Preferred
      Stock so called for redemption shall look only to the Corporation for payment of the Redemption Price thereof. The Corporation
      shall be entitled to receive, from time to time after the date fixed for redemption, any interest on the Deposit Assets so deposited.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
      On or after the redemption date, each holder of shares of Series N Preferred Stock that are subject to redemption shall surrender
      such shares to the Corporation as instructed in the Notice of Redemption and shall then be entitled to receive the cash Redemption
      Price, without interest.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
      In the case of any redemption of less than all of the then-Outstanding shares of Series N Preferred Stock pursuant to these Articles
      Supplementary, such redemption shall be made pro rata from each holder of shares of Series N Preferred Stock in accordance with
      the respective number of shares held by each such holder on the record date for such redemption.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
      Notwithstanding the other provisions of this paragraph 4, the Corporation shall not redeem shares of Series N Preferred Stock unless
      all accumulated and unpaid dividends and distributions on all Outstanding shares of Series N Preferred Stock and other Preferred
      Stock ranking on a parity with the Series N Preferred Stock with respect to dividends and distributions for all applicable past
      Dividend Periods (whether or not earned or declared by the Corporation) shall have been or are contemporaneously paid or declared
      and Deposit Assets for the payment of such dividends and distributions shall have been deposited with the Dividend-Disbursing Agent
      as set forth in paragraph 2(c) of Article II hereof, provided, however, that the foregoing shall not prevent the purchase or acquisition
      of Outstanding shares of Preferred Stock pursuant to the successful completion of an otherwise lawful purchase or exchange offer
      made on the same terms to holders of all Outstanding shares of Series N Preferred Stock.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
      the Corporation shall not have funds legally available for the redemption of, or is otherwise unable to redeem, all the then-Outstanding
      shares of the Series N Preferred Stock or other Preferred Stock designated to be redeemed on any redemption date, the Corporation
      shall redeem on such redemption date the number of shares of Series N Preferred Stock and other Preferred Stock so designated as
      it shall have legally available funds, or is otherwise able, to redeem ratably on the basis of the Redemption Price from each holder
      whose shares are to be redeemed, and the remainder of the shares of the Series N Preferred Stock and other Preferred Stock designated
      to be redeemed shall be redeemed on the earliest practicable date on which the Corporation shall have funds legally available for
      the redemption of, or is otherwise able to redeem, such shares upon Notice of Redemption.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
      Voting Rights.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
      General.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
      as otherwise provided by law or as specified in the Governing Documents or a resolution of the Board of Directors, each holder
      of shares of Series N Preferred Stock and any other Preferred Stock shall be entitled to one vote for each share held on each matter
      submitted to a vote of stockholders of the Corporation, and the holders of Outstanding shares of Preferred Stock, including Series
      N Preferred Stock, and of Outstanding shares of Common Stock shall vote together as a single class; provided, however, that at
      any meeting of the stockholders of the Corporation held for the election of directors, the holders of Outstanding shares of Preferred
      Stock, including Series N Preferred Stock, shall be entitled, as a single class, to the exclusion of the holders of all other securities
      and classes of capital stock of the Corporation, to elect a number of the Corporation&rsquo;s directors, such that following the
      election of directors at the meeting of the stockholders, the Corporation&rsquo;s Board of Directors shall contain two directors
      elected exclusively by the holders of the Outstanding shares of Preferred Stock, including the Series N Preferred Stock. Subject
      to paragraph 5(b) of Article II hereof, the holders of outstanding shares of capital stock of the Corporation, including the holders
      of Outstanding shares of Preferred Stock, including the Series N Preferred Stock, voting together as a single class, shall elect
      the balance of the directors.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
      Right to Elect Majority of Board of Directors.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
      any period in which any one or more of the conditions described below shall exist (such period being referred to herein as a &ldquo;<U>Voting
      Period</U>&rdquo;), the number of directors constituting the Board of Directors shall be automatically increased by the smallest
      number that, when added to the two directors elected exclusively by the holders of shares of Preferred Stock pursuant to paragraph
      5(a) above, would constitute a majority of the Board of Directors as so increased by such smallest number; and the holders of shares
      of Preferred Stock shall be entitled, voting together as a single class (to the exclusion of the holders of all other securities
      and classes of capital stock of the Corporation), to elect such smallest number of additional directors, together with the two
      directors that such holders are in any event entitled to elect pursuant to paragraph 5(a) above. The Corporation and the Board
      of Directors shall take all necessary action, including amending the By-Laws, to effect an increase in the number of directors
      as described in the preceding sentence. A Voting Period shall commence:</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
      if at any time accumulated dividends and distributions (whether or not earned or declared, and whether or not funds are then legally
      available in an amount sufficient therefor) on the Outstanding shares of Series N Preferred Stock equal to at least two full years&rsquo;
      dividends and distributions shall be due and unpaid and sufficient cash or specified securities shall not have been deposited with
      the Dividend-Disbursing Agent for the payment of such accumulated dividends and distributions; or</FONT></P>
      <P STYLE="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
      if at any time holders of any other shares of Preferred Stock are entitled to elect a majority of the Directors of the Corporation
      under the 1940 Act or Articles Supplementary creating such shares.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
      the termination of a Voting Period, the voting rights described in this paragraph 5(b) shall cease, subject always, however, to
      the reverting of such voting rights in the holders of Preferred Stock upon the further occurrence of any of the events described
      in this paragraph 5(b).</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
      Voting Procedures.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
      As soon as practicable after the accrual of any right of the holders of shares of Preferred Stock to elect additional directors
      as described in paragraph 5(b) above, the Corporation shall call a special meeting of such holders and shall mail a notice of such
      special meeting to such holders, such meeting to be held not less than 10 nor more than 20 days after the date of mailing of such
      notice. If the Corporation fails to send such notice or if the Corporation does not call such a special meeting, it may be called
      by any such holder on like notice. The record date for determining the holders entitled to notice of and to vote at such special
      meeting shall be the close of business on the day on which such notice is mailed or such other date as the Board of Directors shall
      determine. At any such special meeting and at each meeting held during a Voting Period, such holders of Preferred Stock, voting
      together as a single class (to the exclusion of the holders of all other securities and classes of capital stock of the Corporation),
      shall be entitled to elect the number of directors prescribed in paragraph 5(b) above on a one-vote-per-share basis. At any such
      meeting or adjournment thereof in the absence of a quorum, a majority of such holders present in person or by proxy shall have
      the power to adjourn the meeting without notice, other than by an announcement at the meeting, to a date not more than 120 days
      after the original record date.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
      For purposes of determining any rights of the holders of Series N Preferred Stock to vote on any matter or the number of shares
      required to constitute a quorum, whether such right is created by these Articles Supplementary, by the other provisions of the
      Governing Documents, by statute or otherwise, a share of Series N Preferred Stock which is not Outstanding shall not be counted.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
      The terms of office of all persons who are directors of the Corporation at the time of a special meeting of holders of Preferred
      Stock, including Series N Preferred Stock, to elect directors, shall continue following such meeting, notwithstanding the election
      at such meeting by such holders of the number of directors that they are entitled to elect, and the persons so elected by such
      holders, together with the two incumbent directors elected by the holders of Preferred Stock, including Series N Preferred Stock,
      and the remaining incumbent directors elected by the holders of the Common Stock and Preferred Stock, shall constitute the duly
      elected directors of the Corporation.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
      Upon the expiration of a Voting Period, the terms of office of the additional directors elected by the holders of Preferred Stock
      pursuant to paragraph 5(b) above shall expire at the earliest time permitted by law and the remaining directors shall constitute
      the directors of the Corporation and the voting rights of such holders of Preferred Stock, including Series N Preferred Stock,
      to elect additional directors pursuant to paragraph 5(b) above shall cease, subject to the provisions of the last sentence of paragraph
      5(b). Upon the expiration of the terms of the directors elected by the holders of Preferred Stock pursuant to paragraph 5(b) above,
      the number of directors shall be automatically reduced to eliminate the directorships of the additional directors elected by the
      holders of Preferred Stock pursuant to Section&nbsp;5(b) above.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
      Exclusive Remedy.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
      otherwise required by law, the holders of shares of Series N Preferred Stock shall not have any rights or preferences other than
      those specifically set forth herein. The holders of shares of Series N Preferred Stock shall have no preemptive rights or rights
      to cumulative voting. In the event that the Corporation fails to pay any dividends and distributions on the shares of Series N
      Preferred Stock, the exclusive remedy of the holders shall be the right to vote for directors pursuant to the provisions of this
      paragraph 5.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
      Asset Coverage Test.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
      Determination of Compliance.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
      so long as any shares of Series N Preferred Stock are Outstanding, the Corporation shall have Asset Coverage as of the last Business
      Day of each March, June, September and December of each year in which any share of Series N Preferred Stock is Outstanding.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
      Failure to Meet Asset Coverage.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
      the Corporation fails to have Asset Coverage as provided in paragraph 6(a) hereof and such failure is not cured as of the Series
      N Asset Coverage Cure Date, (i) the Corporation shall give a Notice of Redemption as described in paragraph 4 of Article II hereof
      with respect to the redemption of a sufficient number of shares of Preferred Stock, which at the Corporation&rsquo;s determination
      (to the extent permitted by the 1940 Act and Maryland law) may include any proportion of shares of Series N Preferred Stock, to
      enable it to meet the requirements of paragraph 6(a) above, and, at the Corporation&rsquo;s discretion, such additional number
      of shares of Series N Preferred Stock or other Preferred Stock in order that the Corporation shall have Asset Coverage with respect
      to the shares of Series N Preferred Stock and any other Preferred Stock remaining Outstanding after such redemption as great as
      210%, and (ii) deposit with the Dividend-Disbursing Agent Deposit Assets having an initial combined value sufficient to effect
      the redemption of the shares of Series N Preferred Stock or other Preferred Stock to be redeemed, as contemplated by paragraph
      4(a)(ii) of Article II hereof.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
      Status of Shares Called for Redemption.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
      purposes of determining whether the requirements of paragraph 6(a) hereof are satisfied, (i) no share of the Series N Preferred
      Stock shall be deemed to be Outstanding for purposes of any computation if, prior to or concurrently with such determination, sufficient
      Deposit Assets to pay the full Redemption Price for such share shall have been deposited in trust with the Dividend-Disbursing
      Agent (or applicable paying agent) and the requisite Notice of Redemption shall have been given, and (ii) such Deposit Assets deposited
      with the Dividend-Disbursing Agent (or paying agent) shall not be included.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
      Limitation on Incurrence of Additional Indebtedness and Issuance of Additional Preferred Stock.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
      So long as any shares of Series N Preferred Stock are Outstanding and the Corporation is permitted to issue indebtedness under
      its fundamental investment restrictions, the Corporation may issue and sell one or more series of a class of senior securities
      of the Corporation representing indebtedness under Section&nbsp;18 of the 1940 Act and/or otherwise create or incur indebtedness,
      provided that, immediately after giving effect to the incurrence of such indebtedness and to its receipt and application of the
      proceeds thereof, the Corporation shall have an &ldquo;asset coverage&rdquo; for all senior securities representing indebtedness,
      as defined in Section&nbsp;18(h) of the 1940 Act, of at least 300% of the amount of all indebtedness of the Corporation then Outstanding
      and no such additional indebtedness shall have any preference or priority over any other indebtedness of the Corporation upon the
      distribution of the assets of the Corporation or in respect of the payment of interest. Any possible liability resulting from lending
      and/or borrowing portfolio securities, entering into reverse repurchase agreements, entering into futures contracts and writing
      options or the use of any other financial instrument that may have the effect of creating leverage, to the extent such transactions
      are made in accordance with the investment restrictions of the Corporation then in effect, shall not be considered to be indebtedness
      limited by this paragraph 7(a).</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
      So long as any shares of Series N Preferred Stock are Outstanding, the Corporation may issue and sell shares of one or more other
      series of Preferred Stock constituting a series of a class of senior securities of the Corporation representing stock under Section&nbsp;18
      of the 1940 Act in addition to the shares of Series N Preferred Stock or shares of other Preferred Stock Outstanding, provided
      that (i) the Corporation shall, immediately after giving effect to the issuance of such additional Preferred Stock and to its receipt
      and application of the proceeds thereof, including, without limitation, to the redemption of Preferred Stock for which a Redemption
      Notice has been mailed prior to such issuance, have an &ldquo;asset coverage&rdquo; for all senior securities which are stock,
      as defined in Section&nbsp;18(h) of the 1940 Act, of at least 200% of the sum of the Liquidation Preference of the shares of Series
      N Preferred Stock and all other Preferred Stock then Outstanding, and (ii) no such additional Preferred Stock shall have any preference
      or priority over any other Preferred Stock upon the distribution of the assets of the Corporation or in respect of the payment
      of dividends.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
      III</B></FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ABILITY
      OF BOARD OF DIRECTORS TO MODIFY THESE<BR>
ARTICLES SUPPLEMENTARY</B></FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
      Modification.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
      The affirmative vote of the holders of a majority, as defined in the 1940 Act, of shares of Series N Preferred Stock (or of any
      other series of Preferred Stock), voting separately from any other series of Preferred Stock (to the extent its rights are affected
      differently), shall be required with respect to any matter that materially and adversely affects the rights, preferences or powers
      of that series in a manner different from that of other series or classes of the Corporation&rsquo;s capital stock. For purposes
      of the foregoing, no matter shall be deemed to adversely affect any rights, preferences or powers unless such matter (i) adversely
      alters or abolishes any preferential right of such series; (ii) creates, adversely alters or abolishes any right in respect of
      redemption of such series; or (iii) creates or adversely alters (other than to abolish) any restriction on transfer applicable
      to such series. An increase in the number of authorized shares of Preferred Stock pursuant to the Charter or the issuance of additional
      shares of any series of Preferred Stock</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(including the Series N Preferred Stock) pursuant to the Charter shall not in and of itself
      be considered to adversely affect the contract rights of the holders of Preferred Stock. The vote of holders of any series described
      in this paragraph 1(a) of Article III will in each case be in addition to a separate vote of the requisite percentage of Common
      Stock and Preferred Stock, if any, necessary to authorize the action in question. The holders of the Series N Preferred Stock shall
      not be entitled to vote on any matter that affects the rights or interests of only one or more series of Preferred Stock other
      than the Series N Preferred Stock.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
      Notwithstanding the provisions of Article III, to the extent permitted by law, the Board of Directors, without the vote of the
      holders of the Series N Preferred Stock or any other capital stock of the Corporation, may amend the provisions of these Articles
      Supplementary to resolve any inconsistency or ambiguity or to remedy any formal defect so long as the amendment does not in the
      aggregate adversely affect the rights and preferences of the Series N Preferred Stock.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
      Unless a higher percentage is required under the Governing Documents or applicable provisions of Maryland law or the 1940 Act,
      the affirmative vote of the holders of a majority, as defined in the 1940 Act, of the shares of Outstanding Preferred Stock, including
      the Series N Preferred Stock, voting together as a single class, will be required to approve any plan of reorganization adversely
      affecting the Preferred Stock or any action requiring a vote of security holders under Section&nbsp;13(a) of the 1940 Act. The
      vote of holders of any series described in this paragraph 1(c) of Article III will in each case be in addition to a separate vote
      of the requisite percentage of Common Stock and Preferred Stock, if any, necessary to authorize the action in question.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
      For purposes of this Article III, the phrase &ldquo;vote of the Holders of a majority of the Outstanding shares of Preferred Stock&rdquo;
      (or any like phrase) shall mean, in accordance with Section&nbsp;2(a)(42) of the 1940 Act, the affirmative vote, at the annual
      or a special meeting of the stockholders of the Corporation duly called, of the Holders (A) of 67 percent or more of the shares
      of Preferred Stock present at such meeting, if the Holders of more than 50 percent of the Outstanding shares of Preferred Stock
      are present or represented by proxy at such meeting; or (B) of more than 50 percent of the Outstanding shares of Preferred Stock,
      whichever is less.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
      No Modification of Existing Preferred Stock.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nothing
      contained in these Articles Supplementary creating the Series N Preferred Stock shall be understood to modify the rights, obligations
      or privileges of any other series of the Corporation&rsquo;s Preferred Stock Outstanding. To the extent permitted by law, the Board
      of Directors, without the vote of the holders of the Series N Preferred Stock or any other capital stock of the Corporation, may
      amend the provisions of these Articles Supplementary to resolve any inconsistency or ambiguity or to remedy any formal defect so
      as to negate the effect of any such modification of the rights, obligations or privileges of any other series of the Corporation&rsquo;s
      Preferred Stock Outstanding.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[REMAINDER
      OF PAGE INTENTIONALLY LEFT BLANK]</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
      WITNESS WHEREOF, the Corporation has caused these Articles Supplementary to be signed in its name and on its behalf by its duly
      authorized President, and attested by its Secretary, and the undersigned President of the Corporation further acknowledges said
      instrument to be the corporate act of the Corporation, and states that, to the best of such officer&rsquo;s knowledge, information
      and belief under penalty of perjury, the matters and facts set forth herein required to be verified under oath are true in all
      material respects, as of December&nbsp;11, 2023.</FONT></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE GABELLI EQUITY TRUST INC.</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 5%">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 45%">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ John C. Ball</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">John C. Ball&nbsp;</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attest:</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Peter D. Goldstein</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peter D. Goldstein</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Secretary</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Signature Page to Articles Supplementary for Series N Preferred Stock of The Gabelli Equity Trust Inc.]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>

    <!-- Field: /Page -->


   </BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.(B)(II)
<SEQUENCE>4
<FILENAME>gabelliequitytrust_ex99bii.htm
<DESCRIPTION>EXHIBIT (B)(II)
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit (b)(ii)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AMENDMENT
NO. 1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TO</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AMENDED
AND RESTATED BYLAWS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OF</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
GABELLI EQUITY TRUST, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Effective:
February 15, 2023</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 15, 2023, the Board of Directors (the &ldquo;Board&rdquo;) of The Gabelli Equity Trust, Inc. (the &ldquo;Corporation&rdquo;),
in accordance with the Corporation&rsquo;s Amended and Restated Bylaws (the &ldquo;Bylaws&rdquo;), as amended, and the Maryland General
Corporation Law (the &ldquo;MGCL&rdquo;), approved and adopted the following amendment to the Bylaws, to be effective immediately:</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Article V, Section 7., is hereby added to the Bylaws as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
V</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
7. <U>CONTROL SHARE ACQUISITION ACT</U>. <FONT STYLE="background-color: white">Pursuant to </FONT>Section 3-702(c)(4) <FONT STYLE="background-color: white">of
the MGCL, the Board of Directors has adopted a resolution that the Corporation shall be subject to Title 3, Subtitle 7 of the MGCL (the
&ldquo;Maryland Control Share Acquisition Act&rdquo; or the &ldquo;Act&rdquo;). Notwithstanding the Board of Directors&rsquo; election
or any prior provision of these Bylaws to the contrary, (a) no holder of stock of the Corporation shall be entitled to exercise the rights
of an objecting stockholder under </FONT>Section 3-708 <FONT STYLE="background-color: white">of the MGCL; (b) the Act shall not apply
to the voting rights of any person acquiring (i) shares of any class or series of stock of the Corporation other than common stock or
(ii) shares of stock of the Corporation in a control share acquisition (as defined in the Act) if, prior to the acquisition, the person
obtains approval of the Board of Directors exempting the acquisition from the Act specifically, generally, or generally by type, which
exemption may include the person and the person&rsquo;s affiliates or associates or other persons; and (c) to the extent that any provisions
of the Act are determined to be inconsistent with the Investment Company Act, then any such provisions shall not apply. This section
may be amended or repealed, in whole or in part, at any time, whether before or after an acquisition of control shares and, upon effectiveness
of such amendment or repeal, may, subject to any successor bylaw provision, apply to any subsequent control share acquisition.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>

    <!-- Field: /Page -->



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.(L)(I)
<SEQUENCE>5
<FILENAME>gabelliequitytrust_ex99li.htm
<DESCRIPTION>EXHIBIT (L)(I)
<TEXT>
<HTML>
   <HEAD>
      <TITLE></TITLE>
   </HEAD>
   <BODY STYLE="font: 10pt Times New Roman, Times, Serif">
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Exhibit (l)(i)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">LETTERHEAD OF VENABLE LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">December&nbsp;29, 2023</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Gabelli Equity Trust Inc.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">One Corporate Center</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Rye, NY 10580-1422</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">Re:</TD><TD STYLE="text-align: justify">Registration Statement on Form N-2:</TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify"><U>Investment Company Act File No.: 811-04700</U></TD></TR>
     </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Ladies and Gentlemen:</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify">We have served as Maryland counsel to The Gabelli Equity Trust Inc., a Maryland corporation
         registered under the Investment Company Act of 1940, as amended (the &ldquo;Investment Company Act&rdquo;), as a closed-end management investment company (the &ldquo;Company&rdquo;), in connection with certain matters of Maryland law arising out of the registration of
         the offering and sale of the following securities of the Company having an aggregate initial offering price of up to $500,000,000 (collectively, the &ldquo;Securities&rdquo;): (a) shares of common stock, $0.001 par value per share (&ldquo;Common Stock&rdquo;), (b) shares of preferred stock, $0.001 par value per share (the &ldquo;Preferred Stock&rdquo;), and (c) subscription rights to purchase shares of Common Stock and/or Preferred Stock (&ldquo;Subscription Rights&rdquo;), covered by the above-referenced Registration Statement, and all amendments thereto
         (the &ldquo;Registration Statement&rdquo;), filed by the Company with the Securities and Exchange
         Commission (the &ldquo;Commission&rdquo;) under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), and the Investment Company Act.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"> In connection with our representation of the Company, and as a basis for the opinion
         hereinafter set forth, we have examined originals, or copies certified or otherwise
         identified to our satisfaction, of the following documents (collectively, the &ldquo;Documents&rdquo;):</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"> 1.&nbsp;The Registration Statement and the related form of prospectus included therein, substantially
         in the form in which it was transmitted to the Commission under the Securities Act and the Investment Company Act;   </P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"> 2.&nbsp;The charter of the Company (the &ldquo;Charter&rdquo;), certified by the State Department of Assessments and Taxation of Maryland (the &ldquo;SDAT&rdquo;);</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"> 3.&nbsp;The Amended and Restated Bylaws of the Company, as amended (the &ldquo;Bylaws&rdquo;), certified as of the date hereof by an officer of the Company;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in; text-align: justify"> 4.&nbsp;Resolutions adopted by the Board of Directors (the &ldquo;Board of Directors&rdquo;) of the Company
         (the &ldquo;Resolutions&rdquo;) relating to, among other matters, the registration of the offering and sale of the Securities, certified as of the date hereof by an officer of the Company;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The Gabelli Equity Trust Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">December 29, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Page 2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">5.&nbsp;A certificate executed by an officer of the Company, dated as of the date hereof;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">6.&nbsp;A certificate of the SDAT as to the good standing of the Company, dated as of a recent date; and</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">7.&nbsp;Such other documents and matters as we have deemed necessary or appropriate to express
         the opinion set forth below, subject to the assumptions, limitations and qualifications
         stated herein.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">In expressing the opinions set forth below, we have assumed the following:</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">1.&nbsp;Each individual executing any of the Documents, whether on behalf of such individual
         or any other person, is legally competent to do so.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">2.&nbsp;Each individual executing any of the Documents on behalf of a party (other than the
         Company) is duly authorized to do so.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">3.&nbsp;Each of the parties (other than the Company) executing any of the Documents has duly
         and validly executed and delivered each of the Documents to which such party is a
         signatory, and such party&rsquo;s obligations set forth therein are legal, valid and binding and are enforceable in
         accordance with all stated terms.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">4.&nbsp;All Documents submitted to us as originals are authentic. The form and content of all Documents submitted to us as unexecuted drafts do not
         differ in any respect relevant to this opinion from the form and content of such Documents,
         as executed and delivered. All Documents submitted to us as certified or photostatic copies conform to the original
         documents. All signatures on all such Documents are genuine. All public records reviewed or relied upon by us or on our behalf are true and complete. All representations, warranties, statements and information contained in the Documents
         are true and complete. There has been no oral or written modification of or amendment to any of the Documents,
         and there has been no waiver of any provision of any of the Documents, by action or
         omission of the parties or otherwise.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">5.&nbsp;The issuance of, and certain terms of, the Securities to be issued by the Company
         from time to time will be authorized and approved by the Board of Directors, or a
         duly authorized committee thereof, in accordance with the Maryland General Corporation
         Law, the Charter, the Bylaws and the Resolutions (such approval referred to herein
         as the &ldquo;Corporate Proceedings&rdquo;).</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The Gabelli Equity Trust Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">December 29, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Page 3</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">6.&nbsp;Upon the issuance of any Securities that are shares of Common Stock (&ldquo;Common Securities&rdquo;),
         including Common Securities which may be issued in respect of the Securities, the total number of shares of Common Stock issued and outstanding will not exceed
         the total number of shares of Common Stock that the Company is then authorized to
         issue under the Charter.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">7.&nbsp;Upon the issuance of any Securities that are shares of Preferred Stock (&ldquo;Preferred Securities&rdquo;), including Preferred Securities which may be issued in respect of the Securities, the total number of shares of Preferred Stock issued and outstanding, and the total number of issued and outstanding shares of
         the applicable class or series of Preferred Stock designated pursuant to the Charter, will not exceed the total number of shares of Preferred Stock or the number of shares of such class or series of Preferred Stock that the Company is then authorized to issue under the Charter.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">8.&nbsp;Articles Supplementary setting forth the designation, number of shares and the terms of any series of Preferred Securities to be issued
         by the Company will be filed with and accepted for record by the SDAT prior to the
         issuance of such Preferred Securities.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">9.&nbsp;None of the Securities will be issued to a Principal Shareholder (as defined in the
         Charter).</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">10.&nbsp;Any Securities convertible into or exchangeable for any other Securities will be duly
         converted or exchanged in accordance with their terms.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">Based upon the foregoing, and subject to the assumptions, limitations and qualifications
         stated herein, it is our opinion that:</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">1.&nbsp;The Company is a corporation duly incorporated and validly existing under and by virtues of the laws of the State of Maryland and is in good
         standing with the SDAT.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">2.&nbsp;Upon the completion of all Corporate Proceedings relating to the Common Securities,
         the issuance of the Common Securities will be duly authorized and, when and if issued
         and delivered against payment therefor in accordance with the Registration Statement,
         the Resolutions and the Corporate Proceedings, the Common Securities will be validly
         issued, fully paid and nonassessable.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">3.&nbsp;Upon the completion of all Corporate Proceedings relating to the Preferred Securities,
         the issuance of the Preferred Securities will be duly authorized and, when and if
         delivered against payment therefor in accordance with the Registration Statement,
         the Resolutions and the Corporate Proceedings, the Preferred Securities will be validly
         issued, fully paid and nonassessable.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The Gabelli Equity Trust Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">December 29, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Page 4</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">4.&nbsp;Upon completion of all Corporate Proceedings relating to the Subscription Rights,
         the issuance of the Subscription Rights will be duly authorized.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">The foregoing opinion is limited to the laws of the State of Maryland and we do not
         express any opinion herein concerning federal law or any other state law. We express no opinion as to compliance with, or the applicability of, federal or state
         securities laws, including the securities laws of the State of Maryland. The opinion expressed herein is subject to the effect of judicial decisions which
         may permit the introduction of parol evidence to modify the terms or the interpretation
         of agreements.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">The opinion expressed herein is limited to the matters specifically set forth herein
         and no other opinion shall be inferred beyond the matters expressly stated. We assume no obligation to supplement this opinion if any applicable law changes after
         the date hereof or if we become aware of any fact that might change the opinion expressed
         herein after the date hereof.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">This opinion is being furnished to you for submission to the Commission as an exhibit
         to the Registration Statement. We hereby consent to the filing of this opinion as an exhibit to the Registration
         Statement and to the use of the name of our firm therein. In giving this consent, we do not admit that we are within the category of persons
         whose consent is required by Section&nbsp;7 of the Securities Act.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: left; width: 50%">&nbsp;</TD>
  <TD STYLE="text-align: left; width: 50%">Very truly yours,</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: left">&nbsp;</TD>
  <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: left">&nbsp;</TD>
  <TD STYLE="border-bottom: Black 1pt solid; text-align: left">/s/ Venable LLP</TD></TR>
</TABLE>


      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"> </P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"> </P>




<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> -</P></DIV>

    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
   </BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.(N)(I)
<SEQUENCE>6
<FILENAME>gabelliequitytrust_ex99ni.htm
<DESCRIPTION>EXHIBIT (N)(I)
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
(n)(i)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0pt 0"><IMG SRC="exni_001.jpg" ALT="" STYLE="width: 140px; height: 119px"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</U></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
hereby consent to the incorporation by reference in this Registration Statement on Form N-2 of our report dated March 1, 2023, relating
to the financial statements and financial highlights, which appears in the Gabelli Equity Trust Inc.&rsquo;s Annual Report on Form N-CSR
for the year ended December 31, 2022. We also consent to the references to us under the headings &ldquo;Financial Highlights&rdquo;,
&ldquo;Financial Statements&rdquo; and &ldquo;Independent Registered Public Accounting Firm&rdquo; in such Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: left; border-bottom: Black 1pt solid; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
PricewaterhouseCoopers LLP</FONT></TD>
  <TD STYLE="text-align: left; width: 50%">&nbsp;</TD>
  </TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York</FONT></TD>
  <TD STYLE="text-align: left">&nbsp;</TD>
  </TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
28, 2023</FONT></TD>
  <TD STYLE="text-align: left">&nbsp;</TD>
  </TR>
</TABLE>





<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="exni_002.jpg" ALT=""></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>PricewaterhouseCoopers
LLP, PricewaterhouseCoopers Center, 300 Madison Avenue, New York, NY 10017</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>T: (646) 471 3000, F: (813) 286 6000, www.pwc.com/us</I></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>

    <!-- Field: /Page -->





</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.(N)(II)
<SEQUENCE>7
<FILENAME>gabelliequitytrust_ex99nii.htm
<DESCRIPTION>EXHIBIT (N)(II)
<TEXT>
<HTML>
   <HEAD>
      <TITLE></TITLE>
   </HEAD>
   <BODY STYLE="font: 10pt Times New Roman, Times, Serif">
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Exhibit (n)(ii)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>POWER OF ATTORNEY</U></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">KNOW ALL MEN BY THESE PRESENTS, that each person whose name appears below nominates,
         constitutes and appoints John C. Ball as his or her true and lawful attorney-in-fact to execute and sign the Registration
         Statement on Form N-2 under the Securities Act of 1933 and the Investment Company
         Act of 1940 of The Gabelli Equity Trust (the &ldquo;Fund&rdquo;), and all amendments and supplements thereto, and to file with
         the Securities and Exchange Commission, and any other regulatory authority having
         jurisdiction over the offer and sale of shares of the Fund, par value $0.001 per share,
         any and all exhibits and other documents requisite in connection therewith, granting
         unto said attorney full power and authority to do and perform each and every act and
         thing requisite and necessary to be done and about the premises as fully to all intents
         and purposes as the Trustees themselves might or could do.</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">December&nbsp;29, 2023</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">IN WITNESS WHEREOF, each of the undersigned Directors have hereunto set their hand on the date first written above. </P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
         <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; width: 50%">&nbsp;</TD>
            <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-bottom: Black 1pt solid; width: 50%">&nbsp;</TD>
         </TR>
         <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left">&nbsp;</TD>
            <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.25in; padding-left: 0.25in">Mario J. Gabelli</TD>
         </TR>
         <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left">&nbsp;</TD>
            <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: middle">&nbsp;</TD>
         </TR>
         <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left">&nbsp;</TD>
            <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-bottom: Black 1pt solid">/s/ Elizabeth C. Bogan</TD>
         </TR>
         <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left">&nbsp;</TD>
            <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.25in; padding-left: 0.25in">Elizabeth C. Bogan</TD>
         </TR>
         <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left">&nbsp;</TD>
            <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: middle">&nbsp;</TD>
         </TR>
         <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left">&nbsp;</TD>
            <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-bottom: Black 1pt solid">/s/ James P. Conn</TD>
         </TR>
         <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left">&nbsp;</TD>
            <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.25in; padding-left: 0.25in">James P. Conn</TD>
         </TR>
         <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left">&nbsp;</TD>
            <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: middle">&nbsp;</TD>
         </TR>
         <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left">&nbsp;</TD>
            <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-bottom: Black 1pt solid">/s/ Frank J. Fahrenkopf, Jr.</TD>
         </TR>
         <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left">&nbsp;</TD>
            <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.25in; padding-left: 0.25in">Frank J. Fahrenkopf, Jr.</TD>
         </TR>
         <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left">&nbsp;</TD>
            <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: middle">&nbsp;</TD>
         </TR>
         <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left">&nbsp;</TD>
            <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-bottom: Black 1pt solid">/s/ Michael J. Ferrantino</TD>
         </TR>
         <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left">&nbsp;</TD>
            <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.25in; padding-left: 0.25in">Michael J. Ferrantino</TD>
         </TR>
         <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left">&nbsp;</TD>
            <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: middle">&nbsp;</TD>
         </TR>
         <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left">&nbsp;</TD>
            <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-bottom: Black 1pt solid">/s/ Leslie F. Foley</TD>
         </TR>
         <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left">&nbsp;</TD>
            <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.25in; padding-left: 0.25in">Leslie F. Foley</TD>
         </TR>
         <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left">&nbsp;</TD>
            <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: middle">&nbsp;</TD>
         </TR>
         <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left">&nbsp;</TD>
            <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-bottom: Black 1pt solid">/s/ William F. Heitmann</TD>
         </TR>
         <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left">&nbsp;</TD>
            <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.25in; padding-left: 0.25in">William F. Heitmann</TD>
         </TR>
         <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left">&nbsp;</TD>
            <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: middle">&nbsp;</TD>
         </TR>
         <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left">&nbsp;</TD>
            <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: middle">&nbsp;</TD></TR>
         <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left">&nbsp;</TD>
            <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: middle">Laura Linehan</TD></TR>
         <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left">&nbsp;</TD>
            <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: middle">&nbsp;</TD></TR>
         <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left">&nbsp;</TD>
            <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-bottom: Black 1pt solid">/s/ Agnes Mullady</TD>
         </TR>
         <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left">&nbsp;</TD>
            <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.25in; padding-left: 0.25in">Agnes Mullady</TD>
         </TR>
         <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left">&nbsp;</TD>
            <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: middle">&nbsp;</TD>
         </TR>
         <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left">&nbsp;</TD>
            <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-bottom: Black 1pt solid">/s/ Salvatore J. Zizza</TD>
         </TR>
         <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left">&nbsp;</TD>
            <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.25in; padding-left: 0.25in">Salvatore J. Zizza</TD>
         </TR>
      </TABLE>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">[Signature Page to Power of Attorney for
      Registration Statement on Form N-2 of The Gabelli Equity Trust Inc.]</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>

    <!-- Field: /Page -->


   </BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>8
<FILENAME>gabelliequitytrust_ex99s.htm
<DESCRIPTION>EXHIBIT (S)
<TEXT>
<HTML>
   <HEAD>
      <TITLE></TITLE>
   </HEAD>
   <BODY STYLE="font: 10pt Times New Roman, Times, Serif">
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Exhibit (s)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin: 0"><B>Calculation of Filing Fee Tables</B></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin: 0"><B>Form N-2</B></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin: 0">(Form Type)</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin: 0"><B>The Gabelli Equity Trust Inc.</B></P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin: 0">(Exact Name of Registrant as Specified in its Charter)</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin: 0"><U>Table 1: Newly Registered and Carry Forward
Securities</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="3" STYLE="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="border: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Security
    Type</B></FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; width: 20%"><P STYLE="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Security</B></FONT></P>
    <P STYLE="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Class</B></FONT></P>
    <P STYLE="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Title</B></FONT></P></TD>
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; width: 15%"><P STYLE="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Fee</B></FONT></P>
    <P STYLE="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Calculation</B></FONT></P>
    <P STYLE="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>or
    Carry<BR>
    Forward</B></FONT></P>
    <P STYLE="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Rule</B></FONT></P></TD>
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Amount<BR>
    Registered </B></FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Proposed<BR>
    Maximum<BR>
    Offering<BR>
    Price Per<BR>
    Share </B></FONT></TD>
    <TD STYLE="border: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Maximum<BR>
    Aggregate<BR>
    Offering<BR>
    Price </B></FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Fee<BR>
    Rate</B></FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Amount
    of<BR>
    Registration<BR>
    Fee </B></FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Carry<BR>
    Forward<BR>
    Form<BR>
    Type</B></FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Carry<BR>
    Forward<BR>
    File<BR>
    Number</B></FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Carry<BR>
    Forward<BR>
    Initial<BR>
    effective<BR>
    date</B></FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Filing
    Fee<BR>
    Previously Paid<BR>
    In Connection<BR>
    with Unsold<BR>
    Securities to be<BR>
    Carried<BR>
    Forward</B></FONT></TD></TR>
  <TR STYLE="font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Fees
    to Be Paid</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Equity</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Common
    Stock </FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Rule
    456(b) and Rule 457(r)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1)</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Fees
    to Be Paid</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Equity</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Preferred
    Stock </FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Rule
    456(b) and Rule 457(r)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1)</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Fees
    to Be Paid</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Other</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Subscription
    Rights to Purchase Common Stock </FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Rule
    456(b) and Rule 457(r)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1)</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Fees
    to Be Paid</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Other</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Subscription
    Rights to Purchase Preferred Stock </FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Rule
    456(b) and Rule 457(r)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1)</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 8pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Fees
    to Be Paid</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Other</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Subscription
    Rights to Purchase Common Stock and Preferred Stock </FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Rule
    456(b) and Rule 457(r)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1)</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 8pt Times New Roman, Times, Serif">
    <TD COLSPAN="4" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Total
    Offering Amounts </B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&mdash;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 8pt Times New Roman, Times, Serif">
    <TD COLSPAN="4" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Total
    Fees Previously Paid </B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&mdash;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 8pt Times New Roman, Times, Serif">
    <TD COLSPAN="4" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Total
    Fee Offsets </B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&mdash;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 8pt Times New Roman, Times, Serif">
    <TD COLSPAN="4" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Net
    Fee Due </B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&mdash;</FONT></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(1)</TD><TD STYLE="text-align: justify">An indeterminate aggregate initial offering price or number
of the securities of each identified class is being registered as may from time to time be offered hereunder by The Gabelli Equity Trust
Inc. (the &ldquo;Registrant&rdquo;).</TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(2)</TD><TD STYLE="text-align: justify">In reliance on Rules&nbsp;456(b) and 457(r) under the Securities
Act of 1933, as amended, the Registrant hereby defers payment of the registration fee required in connection with this Registration Statement.
Any registration fees will be paid subsequently on a pay-as-you-go basis.</TD>
</TR></TABLE>
      <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>

    <!-- Field: /Page -->


   </BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>exni_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exni_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !^ '\# 2(  A$! Q$!_\0
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MAKU=/AYX5C.5TM1_VU?_ .*J<>!?#IX&G@?]M'_QKG>63YD]#2>=X63OR/\
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MHL9D"[F ]1D@#  QR>E>@? [Q?KGB?0]0CUMWN/L4B+#>/C+Y!)4GN1@'/\
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A44 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>exni_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exni_002.jpg
M_]C_X1 317AI9@  34T *@    @ !P$2  ,    !  $   $:  4    !
M8@$;  4    !    :@$H  ,    !  (   $Q  (    @    <@$R  (    4
M    DH=I  0    !    J    -0 #J8    G$  .I@   "<0061O8F4@4&AO
M=&]S:&]P($-3-B H36%C:6YT;W-H*0 R,#(S.C$R.C(X(#$S.C Q.C4V
M  .@ 0 #     0 !  "@ @ $     0   H.@ P $     0    0
M!@$#  ,    !  8   $:  4    !   !(@$;  4    !   !*@$H  ,    !
M  (   (!  0    !   !,@("  0    !   .V0        !(     0   $@
M   !_]C_X@Q824-#7U!23T9)3$4  0$   Q(3&EN;P(0  !M;G1R4D="(%A9
M6B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@<U)'0@
M    ]M8  0    #3+4A0("
M                         !%C<')T   !4    #-D97-C   !A    &QW
M='!T   !\    !1B:W!T   "!    !1R6%E:   "&    !1G6%E:   "+
M !1B6%E:   "0    !1D;6YD   "5    '!D;61D   "Q    (AV=65D   #
M3    (9V:65W   #U    "1L=6UI   #^    !1M96%S   $#    "1T96-H
M   $,     QR5%)#   $/   " QG5%)#   $/   " QB5%)#   $/   " QT
M97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L971T+5!A8VMA<F0@0V]M
M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV-BTR+C$
M !)S4D="($E%0S8Q.38V+3(N,0
M                                6%E:(        /-1  $    !%LQ8
M65H@                     %A96B        !OH@  ./4   .06%E:(
M     &*9  "WA0  &-I865H@        )*    ^$  "VSV1E<V,
M%DE%0R!H='1P.B\O=W=W+FEE8RYC:               %DE%0R!H='1P.B\O
M=W=W+FEE8RYC:
M              !D97-C         "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@
M4D="(&-O;&]U<B!S<&%C92 M('-21T(              "Y)14,@-C$Y-C8M
M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M                9&5S8P         L4F5F97)E;F-E(%9I97=I;F<@0V]N
M9&ET:6]N(&EN($E%0S8Q.38V+3(N,0              +%)E9F5R96YC92!6
M:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$
M                 '9I97<      !.D_@ 47RX $,\4  /MS  $$PL  UR>
M     5A96B       $P)5@!0    5Q_G;65A<P         !
M             H\    "<VEG(     !#4E0@8W5R=@        0     !0 *
M  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4 %D 7@!C &@ ;0!R '<
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M=_P'_)C]*?VZ_DO^W/]M____[0 ,061O8F5?0TT  ?_N  Y!9&]B90!D@
M  '_VP"$  P(" @)" P)"0P1"PH+$14/# P/%1@3$Q43$Q@1# P,# P,$0P,
M# P,# P,# P,# P,# P,# P,# P,# P,# P!#0L+#0X-$ X.$!0.#@X4% X.
M#@X4$0P,# P,$1$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,
M#/_  !$(  $ H ,!(@ "$0$#$0'_W0 $  K_Q $_   !!0$! 0$! 0
M   #  $"! 4&!P@)"@L!  $% 0$! 0$!          $  @,$!08'" D*"Q
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M    #W!R:6YT4VEX=&5E;D)I=&)O;VP     "W!R:6YT97).86UE5$585
M  $       ]P<FEN=%!R;V]F4V5T=7!/8FIC    # !0 '( ;P!O &8 ( !3
M &4 = !U '        IP<F]O9E-E='5P     0    !";'1N96YU;0    QB
M=6EL=&EN4')O;V8    )<')O;V9#35E+ #A"24T$.P     "+0   !     !
M       2<')I;G1/=71P=71/<'1I;VYS    %P    !#<'1N8F]O;
M0VQB<F)O;VP      %)G<TUB;V]L      !#<FY#8F]O;       0VYT0V)O
M;VP      $QB;'-B;V]L      !.9W1V8F]O;       16UL1&)O;VP
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M9G15;G1&(U)L=                %1O<"!5;G1&(U)L=
M %-C;"!5;G1&(U!R8T!9            $&-R;W!7:&5N4')I;G1I;F=B;V]L
M      YC<F]P4F5C=$)O='1O;6QO;F<         #&-R;W!296-T3&5F=&QO
M;F<         #6-R;W!296-T4FEG:'1L;VYG          MC<F]P4F5C=%1O
M<&QO;F<      #A"24T#[0      $ !@     0 ! &     !  $X0DE-!"8
M      X             /X   #A"24T$#0      !    '@X0DE-!!D
M  0    >.$))30/S       )           ! #A"24TG$       "@ !
M      $X0DE- _4      $@ +V9F  $ ;&9F  8       $ +V9F  $ H9F:
M  8       $ ,@    $ 6@    8       $ -0    $ +0    8       $X
M0DE- _@      '   /____________________________\#Z     #_____
M________________________ ^@     ____________________________
M_P/H     /____________________________\#Z   .$))300(       0
M     0   D    )      #A"24T$'@      !      X0DE-!!H      X,
M   &               $   "@P   "< 10!X "X * !N "D * !I "D (  M
M "  1P!! $( (  M "  0P!O &X 9@!O '( ;0!E &0 ( !0 %< 0P @ $,
M;P!N ', 90!N '0    !                          $
M H,    $                      $                         $
M  $       !N=6QL     @    9B;W5N9'-/8FIC     0       %)C=#$
M   $     %1O<"!L;VYG          !,969T;&]N9P          0G1O;6QO
M;F<    $     %)G:'1L;VYG   "@P    9S;&EC97-6;$QS     4]B:F,
M   !       %<VQI8V4    2    !W-L:6-E241L;VYG          =G<F]U
M<$E$;&]N9P         &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -
M875T;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI8V54>7!E     $EM
M9R     &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG    !     !29VAT
M;&]N9P   H,    #=7)L5$585     $       !N=6QL5$585     $
M  !-<V=E5$585     $       9A;'1486=415A4     0      #F-E;&Q4
M97AT27-(5$U,8F]O; $    (8V5L;%1E>'1415A4     0      "6AO<GI!
M;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R
M=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX    '9&5F875L=     MB
M9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO<E1Y<&4     3F]N90
M  ET;W!/=71S971L;VYG          IL969T3W5T<V5T;&]N9P         ,
M8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/=71S971L;VYG       X
M0DE-!"@       P    "/_         X0DE-!!0       0    ".$))300,
M      [U     0   *     !   !X    >    [9 !@  ?_8_^(,6$E#0U]0
M4D]&24Q%  $!   ,2$QI;F\"$   ;6YT<E)'0B!865H@!\X  @ )  8 ,0
M86-S<$U31E0     245#('-21T(                  /;6  $     TRU(
M4" @
M       18W!R=    5     S9&5S8P   80   !L=W1P=    ?     48FMP
M=    @0    4<EA96@   A@    49UA96@   BP    48EA96@   D     4
M9&UN9    E0   !P9&UD9    L0   "(=G5E9    TP   "&=FEE=P   ]0
M   D;'5M:0   _@    4;65A<P  ! P    D=&5C:   !#     ,<E120P
M!#P   @,9U120P  !#P   @,8E120P  !#P   @,=&5X=     !#;W!Y<FEG
M:'0@*&,I(#$Y.3@@2&5W;&5T="U086-K87)D($-O;7!A;GD  &1E<V,
M    $G-21T(@245#-C$Y-C8M,BXQ               2<U)'0B!)14,V,3DV
M-BTR+C$
M             %A96B        #S40 !     1;,6%E:(
M      !865H@        ;Z(  #CU   #D%A96B        !BF0  MX4  !C:
M6%E:(        "2@   /A   ML]D97-C         !9)14,@:'1T<#HO+W=W
M=RYI96,N8V@              !9)14,@:'1T<#HO+W=W=RYI96,N8V@
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M"58 4    %<?YVUE87,          0                        */
M G-I9R      0U)4(&-U<G8        $      4 "@ / !0 &0 > ", *  M
M #( -P [ $  10!* $\ 5 !9 %X 8P!H &T <@!W 'P @0"& (L D "5 )H
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M# P,$0P,# P,# P,# P,# P,# P,# P,# P,# P,# S_P  1"  ! * # 2(
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M %_(OEM))3__V0 X0DE-!"$      %4    ! 0    \ 00!D &\ 8@!E "
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M  #VU@ !     -,M2% @(
M                        $6-P<G0   %0    ,V1E<V,   &$    ;'=T
M<'0   'P    %&)K<'0   ($    %')865H   (8    %&=865H   (L
M%&)865H   )     %&1M;F0   )4    <&1M9&0   +$    B'9U960   -,
M    AG9I97<   /4    )&QU;6D   /X    %&UE87,   0,    )'1E8V@
M  0P    #')44D,   0\   (#&=44D,   0\   (#&)44D,   0\   (#'1E
M>'0     0V]P>7)I9VAT("AC*2 Q.3DX($AE=VQE='0M4&%C:V%R9"!#;VUP
M86YY  !D97-C         !)S4D="($E%0S8Q.38V+3(N,0
M$G-21T(@245#-C$Y-C8M,BXQ
M                              !865H@        \U$  0    $6S%A9
M6B                      6%E:(        &^B   X]0   Y!865H@
M    8ID  +>%   8VEA96B         DH   #X0  +;/9&5S8P         6
M245#(&AT=' Z+R]W=W<N:65C+F-H               6245#(&AT=' Z+R]W
M=W<N:65C+F-H
M             &1E<V,         +DE%0R V,3DV-BTR+C$@1&5F875L="!2
M1T(@8V]L;W5R('-P86-E("T@<U)'0@              +DE%0R V,3DV-BTR
M+C$@1&5F875L="!21T(@8V]L;W5R('-P86-E("T@<U)'0@
M              !D97-C         "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD
M:71I;VX@:6X@245#-C$Y-C8M,BXQ               L4F5F97)E;F-E(%9I
M97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M                =FEE=P      $Z3^ !1?+@ 0SQ0  ^W,  03"P #7)X
M   !6%E:(       3 E6 %    !7'^=M96%S          $
M           "CP    )S:6<@     $-25"!C=7)V        !      %  H
M#P 4 !D '@ C "@ +0 R #< .P!  $4 2@!/ %0 60!> &, : !M '( =P!\
M ($ A@"+ )  E0": )\ I "I *X L@"W +P P0#& ,L T #5 -L X #E .L
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MMGFV\+=HM^"X6;C1N4JYPKH[NK6[+KNGO"&\F[T5O8^^"KZ$OO^_>K_UP'#
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M_ ?\F/TI_;K^2_[<_VW____N "%!9&]B90!D      $# ! # @,&
M        _]L A  &! 0$!00&!04&"08%!@D+" 8&" L,"@H+"@H,$ P,# P,
M#! ,# P,# P,# P,# P,# P,# P,# P,# P,# P, 0<'!PT,#1@0$!@4#@X.
M%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,
M# P,# S_P@ 1"  $ H,# 1$  A$! Q$!_\0 EP ! 0$
M  ,( 0$  P$                  @,$!1   @,! 0$! 0            (2
M$Q0!$0,C(A$  0(& P$! 0 " P      $1(3  $",D)2(F)#88)3D2-C@Q02
M   #!0<% 0$  P$      !)"$P#P4J)3 1%! B(C,S)R@L)#46*2LF.#_]H
M# ,! 0(1 Q$   #3/(U4MB
M!2Z'_]H " $"  $% /G&#U#U#U#U#U#U#U#U#U#U#U#U#U#U#U#U#U#U#U#U
M#U#U#U#U#U#U#U#U#U#U#U#U#U#U#U#U#U#U#U#U#U#U#U#U#U#U#U#U#U#5
M#5#5#5#5#5#5#5#5#5#5#5#5#5#5#5#5#5#5#5#5#5#5#5#5#5#5#5#5#5'Y
MQ__:  @! P !!0!O?5D+(61R1R1R1R1R1R1R1R1R1R1R1R1R1R1R1R1R1R1R
M1R1R1R1R1R1R1R1R1R1R1R1R1R1R1R1R1R1R1R1R1R1R1R1R1R1R1R1R1R1R
M1R1R1R1R1R1R1R1R1R1R1R1R1R1R1R1R1R1R1R1R1R1R1R1R1R1R1R1_7O\
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9'OZ24!VM&%O"/1+O_(5K_P H5_UIZ1__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>cover_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 cover_001.jpg
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MK5?%WA[6H(XE@TK>\B/(0S[U&,84CBKOC#2I[C5?#WB:W,6-*E9I878C>D@
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J0-,>Q:1Q(WS&,C?CY?1>/KVKK8M&TR%-B:?;@9+',0)))R22>I))-?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>13
<FILENAME>gab-20231229.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.21a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +KIpo7xRiXgen8uAZHZcOauICbPtxZ97KekhsmR1bTk6fygowYSWlyQ2Qid2wSsC -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:cef="http://xbrl.sec.gov/cef/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:gab="http://gabelli.com/20231229" elementFormDefault="qualified" targetNamespace="http://gabelli.com/20231229">
    <annotation>
      <appinfo>
        <link:linkbaseRef xlink:type="simple" xlink:href="gab-20231229_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="gab-20231229_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="gab-20231229_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/cef/2023" schemaLocation="https://xbrl.sec.gov/cef/2023/cef-2023.xsd" />
    <import namespace="http://xbrl.sec.gov/cef-pre/2023" schemaLocation="https://xbrl.sec.gov/cef/2023/cef-2023_pre.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
    <element id="gab_PurchaseTransactionFeeMember" name="PurchaseTransactionFeeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="gab_SaleTransactionFeeMember" name="SaleTransactionFeeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="gab_CommonSharesMember" name="CommonSharesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="gab_PreferredSharesMember" name="PreferredSharesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="gab_CumulativePreferredSharesAuctionRateSeriesCPreferredMember" name="CumulativePreferredSharesAuctionRateSeriesCPreferredMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="gab_CumulativePreferredShares5.875SerieAPreferredMember" name="CumulativePreferredShares5.875SerieAPreferredMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="gab_CumulativePreferredSharesAuctionRateSeriesEPreferredMember" name="CumulativePreferredSharesAuctionRateSeriesEPreferredMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="gab_CumulativePreferredShares5.000SerieGPreferredMember" name="CumulativePreferredShares5.000SerieGPreferredMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="gab_CumulativePreferredShares5.000SerieHPreferredMember" name="CumulativePreferredShares5.000SerieHPreferredMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="gab_CumulativePreferredShares5.450SerieJPreferredMember" name="CumulativePreferredShares5.450SerieJPreferredMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="gab_CumulativePreferredShares5.000SerieKPreferredMember" name="CumulativePreferredShares5.000SerieKPreferredMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="gab_CumulativePreferredShares4.250SerieMCumulativePreferredMember" name="CumulativePreferredShares4.250SerieMCumulativePreferredMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="gab_CumulativePreferredShares5.875SerieDPreferredMember" name="CumulativePreferredShares5.875SerieDPreferredMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="gab_HowTheFundManagesRiskMember" name="HowTheFundManagesRiskMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="gab_CommonShareMember" name="CommonShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="gab_SeriesCPreferredSharesMember" name="SeriesCPreferredSharesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="gab_SeriesDPreferredSharesMember" name="SeriesDPreferredSharesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="gab_SeriesEPreferredSharesMember" name="SeriesEPreferredSharesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="gab_SeriesGPreferredSharesMember" name="SeriesGPreferredSharesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="gab_SeriesHPreferredSharesMember" name="SeriesHPreferredSharesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="gab_SeriesJPreferredSharesMember" name="SeriesJPreferredSharesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="gab_SeriesKPreferredSharesMember" name="SeriesKPreferredSharesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="gab_SeriesMPreferredSharesMember" name="SeriesMPreferredSharesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="gab_SeriesNPreferredSharesMember" name="SeriesNPreferredSharesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="gab_PreferredShareMember" name="PreferredShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="gab_SubscriptionRightsMember" name="SubscriptionRightsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>14
<FILENAME>gab-20231229_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.21a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://xbrl.sec.gov/cef/role/SecurityOnly" xlink:href="https://xbrl.sec.gov/cef/2023/cef-2023.xsd#SecurityOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/cef/role/AddressTypeOnly" xlink:href="https://xbrl.sec.gov/cef/2023/cef-2023.xsd#AddressTypeOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/cef/role/RiskOnly" xlink:href="https://xbrl.sec.gov/cef/2023/cef-2023.xsd#RiskOnly" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/SecurityOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/SecurityOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/SecurityOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/AddressTypeOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/RiskOnly">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2023/cef-2023.xsd#cef_AllRisksMember" xlink:label="loc_cefAllRisksMember" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_PurchaseTransactionFeeMember" xlink:label="loc_gabPurchaseTransactionFeeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabPurchaseTransactionFeeMember" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_SaleTransactionFeeMember" xlink:label="loc_gabSaleTransactionFeeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabSaleTransactionFeeMember" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_CommonSharesMember" xlink:label="loc_gabCommonSharesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabCommonSharesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_PreferredSharesMember" xlink:label="loc_gabPreferredSharesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabPreferredSharesMember" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_CumulativePreferredSharesAuctionRateSeriesCPreferredMember" xlink:label="loc_gabCumulativePreferredSharesAuctionRateSeriesCPreferredMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabCumulativePreferredSharesAuctionRateSeriesCPreferredMember" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_CumulativePreferredShares5.875SerieAPreferredMember" xlink:label="loc_gabCumulativePreferredShares5.875SerieAPreferredMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabCumulativePreferredShares5.875SerieAPreferredMember" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_CumulativePreferredSharesAuctionRateSeriesEPreferredMember" xlink:label="loc_gabCumulativePreferredSharesAuctionRateSeriesEPreferredMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabCumulativePreferredSharesAuctionRateSeriesEPreferredMember" xlink:type="arc" order="60" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_CumulativePreferredShares5.000SerieGPreferredMember" xlink:label="loc_gabCumulativePreferredShares5.000SerieGPreferredMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabCumulativePreferredShares5.000SerieGPreferredMember" xlink:type="arc" order="70" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_CumulativePreferredShares5.000SerieHPreferredMember" xlink:label="loc_gabCumulativePreferredShares5.000SerieHPreferredMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabCumulativePreferredShares5.000SerieHPreferredMember" xlink:type="arc" order="80" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_CumulativePreferredShares5.450SerieJPreferredMember" xlink:label="loc_gabCumulativePreferredShares5.450SerieJPreferredMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabCumulativePreferredShares5.450SerieJPreferredMember" xlink:type="arc" order="90" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_CumulativePreferredShares5.000SerieKPreferredMember" xlink:label="loc_gabCumulativePreferredShares5.000SerieKPreferredMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabCumulativePreferredShares5.000SerieKPreferredMember" xlink:type="arc" order="100" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_CumulativePreferredShares4.250SerieMCumulativePreferredMember" xlink:label="loc_gabCumulativePreferredShares4.250SerieMCumulativePreferredMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabCumulativePreferredShares4.250SerieMCumulativePreferredMember" xlink:type="arc" order="110" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_CumulativePreferredShares5.875SerieDPreferredMember" xlink:label="loc_gabCumulativePreferredShares5.875SerieDPreferredMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabCumulativePreferredShares5.875SerieDPreferredMember" xlink:type="arc" order="120" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_HowTheFundManagesRiskMember" xlink:label="loc_gabHowTheFundManagesRiskMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabHowTheFundManagesRiskMember" xlink:type="arc" order="130" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_CommonShareMember" xlink:label="loc_gabCommonShareMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabCommonShareMember" xlink:type="arc" order="140" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_SeriesCPreferredSharesMember" xlink:label="loc_gabSeriesCPreferredSharesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabSeriesCPreferredSharesMember" xlink:type="arc" order="150" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_SeriesDPreferredSharesMember" xlink:label="loc_gabSeriesDPreferredSharesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabSeriesDPreferredSharesMember" xlink:type="arc" order="160" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_SeriesEPreferredSharesMember" xlink:label="loc_gabSeriesEPreferredSharesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabSeriesEPreferredSharesMember" xlink:type="arc" order="170" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_SeriesGPreferredSharesMember" xlink:label="loc_gabSeriesGPreferredSharesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabSeriesGPreferredSharesMember" xlink:type="arc" order="180" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_SeriesHPreferredSharesMember" xlink:label="loc_gabSeriesHPreferredSharesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabSeriesHPreferredSharesMember" xlink:type="arc" order="190" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_SeriesJPreferredSharesMember" xlink:label="loc_gabSeriesJPreferredSharesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabSeriesJPreferredSharesMember" xlink:type="arc" order="200" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_SeriesKPreferredSharesMember" xlink:label="loc_gabSeriesKPreferredSharesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabSeriesKPreferredSharesMember" xlink:type="arc" order="210" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_SeriesMPreferredSharesMember" xlink:label="loc_gabSeriesMPreferredSharesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabSeriesMPreferredSharesMember" xlink:type="arc" order="220" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_SeriesNPreferredSharesMember" xlink:label="loc_gabSeriesNPreferredSharesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabSeriesNPreferredSharesMember" xlink:type="arc" order="230" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_PreferredShareMember" xlink:label="loc_gabPreferredShareMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabPreferredShareMember" xlink:type="arc" order="240" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_SubscriptionRightsMember" xlink:label="loc_gabSubscriptionRightsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabSubscriptionRightsMember" xlink:type="arc" order="250" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>15
<FILENAME>gab-20231229_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.21a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_PurchaseTransactionFeeMember" xlink:label="gab_PurchaseTransactionFeeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gab_PurchaseTransactionFeeMember" xlink:to="gab_PurchaseTransactionFeeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="gab_PurchaseTransactionFeeMember_lbl" xml:lang="en-US">Purchase Transaction Fee [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_SaleTransactionFeeMember" xlink:label="gab_SaleTransactionFeeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gab_SaleTransactionFeeMember" xlink:to="gab_SaleTransactionFeeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="gab_SaleTransactionFeeMember_lbl" xml:lang="en-US">Sale Transaction Fee [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_CommonSharesMember" xlink:label="gab_CommonSharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gab_CommonSharesMember" xlink:to="gab_CommonSharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="gab_CommonSharesMember_lbl" xml:lang="en-US">Common Shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_PreferredSharesMember" xlink:label="gab_PreferredSharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gab_PreferredSharesMember" xlink:to="gab_PreferredSharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="gab_PreferredSharesMember_lbl" xml:lang="en-US">Preferred Shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_CumulativePreferredSharesAuctionRateSeriesCPreferredMember" xlink:label="gab_CumulativePreferredSharesAuctionRateSeriesCPreferredMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gab_CumulativePreferredSharesAuctionRateSeriesCPreferredMember" xlink:to="gab_CumulativePreferredSharesAuctionRateSeriesCPreferredMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="gab_CumulativePreferredSharesAuctionRateSeriesCPreferredMember_lbl" xml:lang="en-US">Cumulative Preferred Shares Auction Rate Series C Preferred [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_CumulativePreferredShares5.875SerieAPreferredMember" xlink:label="gab_CumulativePreferredShares5.875SerieAPreferredMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gab_CumulativePreferredShares5.875SerieAPreferredMember" xlink:to="gab_CumulativePreferredShares5.875SerieAPreferredMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="gab_CumulativePreferredShares5.875SerieAPreferredMember_lbl" xml:lang="en-US">Cumulative Preferred Shares 5. 875 Serie A Preferred [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_CumulativePreferredSharesAuctionRateSeriesEPreferredMember" xlink:label="gab_CumulativePreferredSharesAuctionRateSeriesEPreferredMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gab_CumulativePreferredSharesAuctionRateSeriesEPreferredMember" xlink:to="gab_CumulativePreferredSharesAuctionRateSeriesEPreferredMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="gab_CumulativePreferredSharesAuctionRateSeriesEPreferredMember_lbl" xml:lang="en-US">Cumulative Preferred Shares Auction Rate Series E Preferred [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_CumulativePreferredShares5.000SerieGPreferredMember" xlink:label="gab_CumulativePreferredShares5.000SerieGPreferredMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gab_CumulativePreferredShares5.000SerieGPreferredMember" xlink:to="gab_CumulativePreferredShares5.000SerieGPreferredMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="gab_CumulativePreferredShares5.000SerieGPreferredMember_lbl" xml:lang="en-US">Cumulative Preferred Shares 5. 000 Serie G Preferred [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_CumulativePreferredShares5.000SerieHPreferredMember" xlink:label="gab_CumulativePreferredShares5.000SerieHPreferredMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gab_CumulativePreferredShares5.000SerieHPreferredMember" xlink:to="gab_CumulativePreferredShares5.000SerieHPreferredMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="gab_CumulativePreferredShares5.000SerieHPreferredMember_lbl" xml:lang="en-US">Cumulative Preferred Shares 5. 000 Serie H Preferred [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_CumulativePreferredShares5.450SerieJPreferredMember" xlink:label="gab_CumulativePreferredShares5.450SerieJPreferredMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gab_CumulativePreferredShares5.450SerieJPreferredMember" xlink:to="gab_CumulativePreferredShares5.450SerieJPreferredMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="gab_CumulativePreferredShares5.450SerieJPreferredMember_lbl" xml:lang="en-US">Cumulative Preferred Shares 5. 450 Serie J Preferred [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_CumulativePreferredShares5.000SerieKPreferredMember" xlink:label="gab_CumulativePreferredShares5.000SerieKPreferredMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gab_CumulativePreferredShares5.000SerieKPreferredMember" xlink:to="gab_CumulativePreferredShares5.000SerieKPreferredMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="gab_CumulativePreferredShares5.000SerieKPreferredMember_lbl" xml:lang="en-US">Cumulative Preferred Shares 5. 000 Serie K Preferred [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_CumulativePreferredShares4.250SerieMCumulativePreferredMember" xlink:label="gab_CumulativePreferredShares4.250SerieMCumulativePreferredMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gab_CumulativePreferredShares4.250SerieMCumulativePreferredMember" xlink:to="gab_CumulativePreferredShares4.250SerieMCumulativePreferredMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="gab_CumulativePreferredShares4.250SerieMCumulativePreferredMember_lbl" xml:lang="en-US">Cumulative Preferred Shares 4. 250 Serie M Cumulative Preferred [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_CumulativePreferredShares5.875SerieDPreferredMember" xlink:label="gab_CumulativePreferredShares5.875SerieDPreferredMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gab_CumulativePreferredShares5.875SerieDPreferredMember" xlink:to="gab_CumulativePreferredShares5.875SerieDPreferredMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="gab_CumulativePreferredShares5.875SerieDPreferredMember_lbl" xml:lang="en-US">Cumulative Preferred Shares 5. 875 Serie D Preferred [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_HowTheFundManagesRiskMember" xlink:label="gab_HowTheFundManagesRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gab_HowTheFundManagesRiskMember" xlink:to="gab_HowTheFundManagesRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="gab_HowTheFundManagesRiskMember_lbl" xml:lang="en-US">How The Fund Manages Risk [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_CommonShareMember" xlink:label="gab_CommonShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gab_CommonShareMember" xlink:to="gab_CommonShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="gab_CommonShareMember_lbl" xml:lang="en-US">Common Share [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_SeriesCPreferredSharesMember" xlink:label="gab_SeriesCPreferredSharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gab_SeriesCPreferredSharesMember" xlink:to="gab_SeriesCPreferredSharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="gab_SeriesCPreferredSharesMember_lbl" xml:lang="en-US">Series C Preferred Shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_SeriesDPreferredSharesMember" xlink:label="gab_SeriesDPreferredSharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gab_SeriesDPreferredSharesMember" xlink:to="gab_SeriesDPreferredSharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="gab_SeriesDPreferredSharesMember_lbl" xml:lang="en-US">Series D Preferred Shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_SeriesEPreferredSharesMember" xlink:label="gab_SeriesEPreferredSharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gab_SeriesEPreferredSharesMember" xlink:to="gab_SeriesEPreferredSharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="gab_SeriesEPreferredSharesMember_lbl" xml:lang="en-US">Series E Preferred Shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_SeriesGPreferredSharesMember" xlink:label="gab_SeriesGPreferredSharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gab_SeriesGPreferredSharesMember" xlink:to="gab_SeriesGPreferredSharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="gab_SeriesGPreferredSharesMember_lbl" xml:lang="en-US">Series G Preferred Shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_SeriesHPreferredSharesMember" xlink:label="gab_SeriesHPreferredSharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gab_SeriesHPreferredSharesMember" xlink:to="gab_SeriesHPreferredSharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="gab_SeriesHPreferredSharesMember_lbl" xml:lang="en-US">Series H Preferred Shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_SeriesJPreferredSharesMember" xlink:label="gab_SeriesJPreferredSharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gab_SeriesJPreferredSharesMember" xlink:to="gab_SeriesJPreferredSharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="gab_SeriesJPreferredSharesMember_lbl" xml:lang="en-US">Series J Preferred Shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_SeriesKPreferredSharesMember" xlink:label="gab_SeriesKPreferredSharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gab_SeriesKPreferredSharesMember" xlink:to="gab_SeriesKPreferredSharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="gab_SeriesKPreferredSharesMember_lbl" xml:lang="en-US">Series K Preferred Shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_SeriesMPreferredSharesMember" xlink:label="gab_SeriesMPreferredSharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gab_SeriesMPreferredSharesMember" xlink:to="gab_SeriesMPreferredSharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="gab_SeriesMPreferredSharesMember_lbl" xml:lang="en-US">Series M Preferred Shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_SeriesNPreferredSharesMember" xlink:label="gab_SeriesNPreferredSharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gab_SeriesNPreferredSharesMember" xlink:to="gab_SeriesNPreferredSharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="gab_SeriesNPreferredSharesMember_lbl" xml:lang="en-US">Series N Preferred Shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_PreferredShareMember" xlink:label="gab_PreferredShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gab_PreferredShareMember" xlink:to="gab_PreferredShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="gab_PreferredShareMember_lbl" xml:lang="en-US">Preferred Share [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_SubscriptionRightsMember" xlink:label="gab_SubscriptionRightsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gab_SubscriptionRightsMember" xlink:to="gab_SubscriptionRightsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="gab_SubscriptionRightsMember_lbl" xml:lang="en-US">Subscription Rights [Member]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>16
<FILENAME>gab-20231229_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.21a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://xbrl.sec.gov/cef/role/N2Cover" xlink:href="https://xbrl.sec.gov/cef/2023/cef-2023.xsd#N2Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/cef/role/N2" xlink:href="https://xbrl.sec.gov/cef/2023/cef-2023.xsd#N2" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2" xlink:title="995470 - Disclosure - N-2">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2023/cef-2023.xsd#cef_ProspectusLineItems" xlink:label="loc_cefProspectusLineItems" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2023/cef-2023.xsd#cef_AllRisksMember" xlink:label="loc_cefAllRisksMember" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_PurchaseTransactionFeeMember" xlink:label="loc_gabPurchaseTransactionFeeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabPurchaseTransactionFeeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_SaleTransactionFeeMember" xlink:label="loc_gabSaleTransactionFeeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabSaleTransactionFeeMember" order="100" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_CommonSharesMember" xlink:label="loc_gabCommonSharesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabCommonSharesMember" order="200" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_PreferredSharesMember" xlink:label="loc_gabPreferredSharesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabPreferredSharesMember" order="300" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_CumulativePreferredSharesAuctionRateSeriesCPreferredMember" xlink:label="loc_gabCumulativePreferredSharesAuctionRateSeriesCPreferredMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabCumulativePreferredSharesAuctionRateSeriesCPreferredMember" order="400" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_CumulativePreferredShares5.875SerieAPreferredMember" xlink:label="loc_gabCumulativePreferredShares5.875SerieAPreferredMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabCumulativePreferredShares5.875SerieAPreferredMember" order="500" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_CumulativePreferredSharesAuctionRateSeriesEPreferredMember" xlink:label="loc_gabCumulativePreferredSharesAuctionRateSeriesEPreferredMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabCumulativePreferredSharesAuctionRateSeriesEPreferredMember" order="600" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_CumulativePreferredShares5.000SerieGPreferredMember" xlink:label="loc_gabCumulativePreferredShares5.000SerieGPreferredMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabCumulativePreferredShares5.000SerieGPreferredMember" order="700" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_CumulativePreferredShares5.000SerieHPreferredMember" xlink:label="loc_gabCumulativePreferredShares5.000SerieHPreferredMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabCumulativePreferredShares5.000SerieHPreferredMember" order="800" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_CumulativePreferredShares5.450SerieJPreferredMember" xlink:label="loc_gabCumulativePreferredShares5.450SerieJPreferredMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabCumulativePreferredShares5.450SerieJPreferredMember" order="900" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_CumulativePreferredShares5.000SerieKPreferredMember" xlink:label="loc_gabCumulativePreferredShares5.000SerieKPreferredMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabCumulativePreferredShares5.000SerieKPreferredMember" order="1000" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_CumulativePreferredShares4.250SerieMCumulativePreferredMember" xlink:label="loc_gabCumulativePreferredShares4.250SerieMCumulativePreferredMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabCumulativePreferredShares4.250SerieMCumulativePreferredMember" order="1100" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_CumulativePreferredShares5.875SerieDPreferredMember" xlink:label="loc_gabCumulativePreferredShares5.875SerieDPreferredMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabCumulativePreferredShares5.875SerieDPreferredMember" order="1200" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_HowTheFundManagesRiskMember" xlink:label="loc_gabHowTheFundManagesRiskMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabHowTheFundManagesRiskMember" order="1300" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_CommonShareMember" xlink:label="loc_gabCommonShareMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabCommonShareMember" order="1400" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_SeriesCPreferredSharesMember" xlink:label="loc_gabSeriesCPreferredSharesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabSeriesCPreferredSharesMember" order="1500" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_SeriesDPreferredSharesMember" xlink:label="loc_gabSeriesDPreferredSharesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabSeriesDPreferredSharesMember" order="1600" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_SeriesEPreferredSharesMember" xlink:label="loc_gabSeriesEPreferredSharesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabSeriesEPreferredSharesMember" order="1700" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_SeriesGPreferredSharesMember" xlink:label="loc_gabSeriesGPreferredSharesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabSeriesGPreferredSharesMember" order="1800" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_SeriesHPreferredSharesMember" xlink:label="loc_gabSeriesHPreferredSharesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabSeriesHPreferredSharesMember" order="1900" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_SeriesJPreferredSharesMember" xlink:label="loc_gabSeriesJPreferredSharesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabSeriesJPreferredSharesMember" order="2000" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_SeriesKPreferredSharesMember" xlink:label="loc_gabSeriesKPreferredSharesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabSeriesKPreferredSharesMember" order="2100" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_SeriesMPreferredSharesMember" xlink:label="loc_gabSeriesMPreferredSharesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabSeriesMPreferredSharesMember" order="2200" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_SeriesNPreferredSharesMember" xlink:label="loc_gabSeriesNPreferredSharesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabSeriesNPreferredSharesMember" order="2300" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_PreferredShareMember" xlink:label="loc_gabPreferredShareMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabPreferredShareMember" order="2400" />
      <link:loc xlink:type="locator" xlink:href="gab-20231229.xsd#gab_SubscriptionRightsMember" xlink:label="loc_gabSubscriptionRightsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cefAllRisksMember" xlink:to="loc_gabSubscriptionRightsMember" order="2500" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140099575327296">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>N-2 - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="11">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 29, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">0000794685<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInvCompanyType', window );">Entity Inv Company Type</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">N-2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_InvestmentCompanyActFileNumber', window );">Investment Company Act File Number</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">811-04700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">N-2ASR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_InvestmentCompanyActRegistration', window );">Investment Company Act Registration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_InvestmentCompanyRegistrationAmendment', window );">Investment Company Registration Amendment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_InvestmentCompanyRegistrationAmendmentNumber', window );">Investment Company Registration Amendment Number</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">THE GABELLI EQUITY TRUST INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">One Corporate Center<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Rye<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">10580-1422<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">(800)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">422-3554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ApproximateDateOfCommencementOfProposedSaleToThePublic', window );">Approximate Date of Commencement of Proposed Sale to Public</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">As soon as practicable after the effective date of this Registration Statement.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DividendOrInterestReinvestmentPlanOnly', window );">Dividend or Interest Reinvestment Plan Only</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DelayedOrContinuousOffering', window );">Delayed or Continuous Offering</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_PrimaryShelfFlag', window );">Primary Shelf [Flag]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EffectiveUponFiling462e', window );">Effective Upon Filing, 462(e)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AdditionalSecuritiesEffective413b', window );">Additional Securities Effective, 413(b)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EffectiveWhenDeclaredSection8c', window );">Effective when Declared, Section 8(c)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_NewEffectiveDateForPreviousFiling', window );">New Effective Date for Previous Filing</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AdditionalSecurities462b', window );">Additional Securities. 462(b)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_NoSubstantiveChanges462c', window );">No Substantive Changes, 462(c)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ExhibitsOnly462d', window );">Exhibits Only, 462(d)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RegisteredClosedEndFundFlag', window );">Registered Closed-End Fund [Flag]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_BusinessDevelopmentCompanyFlag', window );">Business Development Company [Flag]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_IntervalFundFlag', window );">Interval Fund [Flag]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_PrimaryShelfQualifiedFlag', window );">Primary Shelf Qualified [Flag]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_NewCefOrBdcRegistrantFlag', window );">New CEF or BDC Registrant [Flag]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_FeeTableAbstract', window );"><strong>Fee Table [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ShareholderTransactionExpensesTableTextBlock', window );">Shareholder Transaction Expenses [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_80F_ecef--ShareholderTransactionExpensesTableTextBlock_z0COtgujwqFk" style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 68%; text-align: left">Sales Load (as a percentage of offering price)</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right"><span id="xdx_90C_ecef--SalesLoadPercent_dp_c20231229__20231229_fKDEp_zILxwfGXDf01" title="Sales Load (as a percentage of offering price)">1.86</span></td>
    <td style="white-space: nowrap; width: 1%; text-align: left">%(1)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Offering Expenses (excluding Preferred Stock Offering Expenses) (as a percentage of offering price)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_908_ecef--OtherTransactionExpensesPercent_dp_c20231229__20231229_fKDEp_zmKdEQnPv1y" title="Offering Expenses (excluding Preferred Share Offering Expenses) (as a percentage of offering price)">0.23</span></td>
    <td style="white-space: nowrap; text-align: left">%(1)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Dividend Reinvestment Plan Fees</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_90E_ecef--DividendReinvestmentAndCashPurchaseFees_dn_c20231229__20231229_fKDIp_ztmWUdSZnKxg" title="Dividend Reinvestment Plan Fees">None</span></td>
    <td style="white-space: nowrap; text-align: left">(2)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Voluntary Cash Purchase Plan Purchase Transaction Fee</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_909_ecef--SeniorSecuritiesCvgPerUnit_iI_c20231229__cef--RiskAxis__custom--PurchaseTransactionFeeMember_fKDIp_zALBRjMMeF37" title="Voluntary Cash Purchase Plan Purchase Transaction Fee">0.75</span></td>
    <td style="white-space: nowrap; text-align: left">(2)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Voluntary Cash Purchase Plan Sale Transaction Fee</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_909_ecef--SeniorSecuritiesCvgPerUnit_iI_c20231229__cef--RiskAxis__custom--SaleTransactionFeeMember_fKDIp_zYEjCvehWdy" title="Voluntary Cash Purchase Plan Sale Transaction Fee">2.50</span></td>
    <td style="white-space: nowrap; text-align: left">(2)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Preferred Stock Offering Expenses (as a percentage of net assets attributable to common stock)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_90B_ecef--OtherTransactionExpense1Percent_dp_c20231229__20231229_fKDMp_zaNINUF1T07g" title="Preferred Share Offering Expenses (as a percentage of net assets attributable to common shares)">0.04</span></td>
    <td style="white-space: nowrap; text-align: left">%(3)</td></tr>
  </table>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SalesLoadPercent', window );">Sales Load [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1.86%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_DividendReinvestmentAndCashPurchaseFees', window );">Dividend Reinvestment and Cash Purchase Fees</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherTransactionExpensesAbstract', window );"><strong>Other Transaction Expenses [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherTransactionExpense1Percent', window );">Other Transaction Expense 1 [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">0.04%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherTransactionExpensesPercent', window );">Other Transaction Expenses [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0.23%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_AnnualExpensesTableTextBlock', window );">Annual Expenses [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_809_ecef--AnnualExpensesTableTextBlock_zpl5YWSdHXh5" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Percentage&#160;of<br/> Net Assets<br/> Attributable&#160;to<br/> Common Stock</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Annual Expenses</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 68%; text-align: left">Management Fees</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right"><span id="xdx_903_ecef--ManagementFeesPercent_dp_c20231229__20231229_fKDQp_zS28PLRjUBzj" title="Management Fees">1.37</span></td>
    <td style="white-space: nowrap; width: 1%; text-align: left">%(4)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Interest on Borrowed Funds</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_907_ecef--InterestExpensesOnBorrowingsPercent_dpn_c20231229__20231229_zWjbgkkTQZ59" title="Interest on Borrowed Funds">None</span></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Other Expenses</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_900_ecef--OtherAnnualExpensesPercent_dp_c20231229__20231229_fKDUp_ziGetCgtXND2" title="Other Expenses">0.16</span></td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">%(5)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Total Annual Expenses</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_90B_ecef--TotalAnnualExpensesPercent_dp_c20231229__20231229_zUtRN3hSM2r7" title="Total Annual Expenses">1.53</span></td>
    <td style="white-space: nowrap; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Dividends on Preferred Stock</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_903_ecef--WaiversAndReimbursementsOfFeesPercent_dp_c20231229__20231229_fKDYp_znf7R5y6bcF9" title="Dividends on Preferred Stock">2.17</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">%(6)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Total Annual Expenses and Dividends on Preferred Stock</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90F_ecef--NetExpenseOverAssetsPercent_dp_c20231229__20231229_zN2fCQMjGJSh" title="Total Annual Expenses and Dividends on Preferred Stock">3.70</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in"></td>
    <td style="width: 0.25in; text-align: left"><span id="xdx_F0B_zdPHy79JEOpj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span id="xdx_F18_zfwBx6Eu71Yd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated maximum amount based on offering of $300 million in shares of common stock and $200 million in shares of preferred stock. The estimates assume a 1.00% sales load on common stock and $1,150,000 in common offering expenses, and 3.15% sales load on preferred stock and $720,000 in preferred offering expenses. The sales load on preferred stock is an expense borne by the Fund and indirectly by the holders of its common stock. Actual sales loads and offering expenses may be higher or lower than these estimates and will be set forth in the Prospectus Supplement if applicable.</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span id="xdx_F03_z2l2S1YoK6F9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span id="xdx_F10_zIM4p7k5Ysv3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There are no fees charged to stockholders for participating in the Fund&#8217;s Automatic Dividend Reinvestment and Voluntary Cash Purchase Plan. However, stockholders participating in the Plan that elect to make additional cash purchases under the Plan would pay $0.75 per transaction plus a per share fee (which includes any applicable brokerage commissions) to purchase shares and $2.50 per transaction plus a per share fee (which includes any applicable brokerage commissions) to sell shares. See &#8220;Automatic Dividend Reinvestment and Voluntary Cash Purchase Plans.&#8221;</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span id="xdx_F0C_zLBKaybG7Rp6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span id="xdx_F19_zVUHVGYRd7F5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumes issuance of $200 million in liquidation preference of fixed rate preferred stock, net assets attributable to common stock of approximately $1.77 billion (which includes the issuance of $300 million in common stock) and $720,000 in preferred offering expenses. The actual amounts in connection with any offering will be set forth in the Prospectus Supplement if applicable.</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span id="xdx_F0F_zvPcJ9HEmkti" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span id="xdx_F1F_zPVtcQyy3XKh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Investment Adviser&#8217;s fee is 1.00% annually of the Fund&#8217;s average weekly net assets. The Fund&#8217;s average weekly net assets will be deemed to be the average weekly value of the Fund&#8217;s total assets minus the sum of the Fund&#8217;s liabilities (such liabilities exclude (i) the aggregate liquidation preference of outstanding shares of preferred stock and accumulated dividends, if any, on those shares and (ii) the liabilities for any money borrowed). Consequently, because the Fund has preferred stock outstanding, the investment management fees and other expenses as a percentage of net assets attributable to common stock will be higher than if the Fund did not utilize a leveraged capital structure.</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span id="xdx_F00_zQr0XxwS3RVj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span id="xdx_F13_z7yBtLwBHrPl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Other Expenses&#8221; are based on estimated amounts for the current year assuming completion of the proposed issuances.</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span id="xdx_F0A_z3A0psgKBOs6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span id="xdx_F12_zHcHRSuTde45" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends on Preferred Stock represent the aggregate of (1) the estimated annual distributions on the existing preferred stock outstanding and (2) the distributions that would be made assuming $200 million of preferred stock is issued with a fixed dividend rate of 6.00%. There can, of course, be no guarantee that any preferred stock would be issued or, if issued, the terms thereof.</span></td> </tr>
  </table>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ManagementFeesPercent', window );">Management Fees [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">1.37%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_InterestExpensesOnBorrowingsPercent', window );">Interest Expenses on Borrowings [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherAnnualExpensesAbstract', window );"><strong>Other Annual Expenses [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherAnnualExpensesPercent', window );">Other Annual Expenses [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">0.16%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_TotalAnnualExpensesPercent', window );">Total Annual Expenses [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1.53%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_WaiversAndReimbursementsOfFeesPercent', window );">Waivers and Reimbursements of Fees [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="nump">2.17%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_NetExpenseOverAssetsPercent', window );">Net Expense over Assets [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleTableTextBlock', window );">Expense Example [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_80B_ecef--ExpenseExampleTableTextBlock_zUN4xkLdPXHc" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">1 Year</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">3 Years</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">5 Years</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">10 Years</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 52%; text-align: left">Total Expenses Incurred</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><span id="xdx_903_ecef--ExpenseExampleYear01_c20231229__20231229__cef--RiskAxis__custom--CommonSharesMember_zVs3TSFehnb4">60</span></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><span id="xdx_907_ecef--ExpenseExampleYears1to3_c20231229__20231229__cef--RiskAxis__custom--CommonSharesMember_zuZkudbdaLfk">136</span></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><span id="xdx_90D_ecef--ExpenseExampleYears1to5_c20231229__20231229__cef--RiskAxis__custom--CommonSharesMember_zC9r06c1oij6">214</span></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><span id="xdx_908_ecef--ExpenseExampleYears1to10_c20231229__20231229__cef--RiskAxis__custom--CommonSharesMember_zn7irLysb8n">417</span></td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The example should not be considered a representation of future expenses</b>. The example is based on Total Annual Expenses and Dividends on Preferred Stock shown in the table above and assumes that the amounts set forth in the table do not change and that all distributions are reinvested at net asset value. Actual expenses may be greater or less than those assumed. Moreover, the Fund&#8217;s actual rate of return may be greater or less than the hypothetical 5% return shown in the example.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The above example includes Dividends on Preferred Stock. If Dividends on Preferred Stock were not included in the example calculation, the expenses would be as follows (based on the same assumptions as above).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">1 Year</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">3 Years</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">5 Years</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">10 Years</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 52%; text-align: left">Total Expenses Incurred</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><span id="xdx_90C_ecef--ExpenseExampleYear01_c20231229__20231229__cef--RiskAxis__custom--PreferredSharesMember_zwuHuqdYxBk3">38</span></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><span id="xdx_907_ecef--ExpenseExampleYears1to3_c20231229__20231229__cef--RiskAxis__custom--PreferredSharesMember_zVt8JUa61Zyb">69</span></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><span id="xdx_908_ecef--ExpenseExampleYears1to5_c20231229__20231229__cef--RiskAxis__custom--PreferredSharesMember_zpcZHLuWZgkf">104</span></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><span id="xdx_906_ecef--ExpenseExampleYears1to10_c20231229__20231229__cef--RiskAxis__custom--PreferredSharesMember_zD7O0HntnEyf">200</span></td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_InvestmentObjectivesAndPracticesTextBlock', window );">Investment Objectives and Practices [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_A8B_ecef--InvestmentObjectivesAndPracticesTextBlock_zU5jS1NbMAMj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_006"></span>INVESTMENT OBJECTIVES AND POLICIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">Please refer to the <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000794685/000138713123003229/gab-ncsr_123122.htm">section of the Fund&#8217;s most recent annual report on Form N-CSR entitled &#8220;Additional Fund Information &#8211; Summary of Updated Information Regarding the Fund &#8211; Investment Objective and Strategies,&#8221;</a> which is incorporated by reference herein, for a discussion of the Fund&#8217;s investment objectives and policies.</p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskFactorsTableTextBlock', window );">Risk Factors [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_A8C_ecef--RiskFactorsTableTextBlock_zhbvpeBFAS4b" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_007"></span>RISK FACTORS AND SPECIAL CONSIDERATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Risk is inherent in all investing. Please refer to the <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000794685/000138713123003229/gab-ncsr_123122.htm">section of the Fund&#8217;s most recent annual report on Form N-CSR entitled &#8220;Additional Information &#8211; Summary of Updated Information Regarding the Fund &#8211; Principal Risk Factors,&#8221;</a> which is incorporated by reference herein, for a discussion of investing in the Fund. You should carefully consider those risks and the risk described below. As of the date of this Prospectus, the Fund is classified as a &#8220;diversified&#8221; investment company under the 1940 Act. Accordingly, the risk factor entitled &#8220;Non-Diversified Status&#8221; included in the Fund&#8217;s most recent annual report referenced above is no longer applicable.</p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SharePriceTableTextBlock', window );">Share Price [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_891_ecef--SharePriceTableTextBlock_zczBTBcvccLb" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund&#8217;s outstanding common stock is listed and traded on the NYSE under the symbol &#8220;GAB.&#8221; The average weekly trading volume of the common stock on the NYSE during the period from January&#160;1, 2022 through December&#160;31, 2022 was 2,642,587 shares. The Fund determines its NAV on a daily basis. The following table sets forth, for the quarters indicated, the highest and lowest daily closing prices on the NYSE per common share, and the NAV per common share and the premium to or discount from NAV, on the date of each of the high and low market prices. The table also sets forth the number of common shares traded on the NYSE during the respective quarters.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Market Price</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Corresponding<br/>Net Asset Value<br/>(&#8220;NAV&#8221;) Per<br/>Share</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Corresponding<br/>Premium or<br/>Discount<br/>as a %<br/>of NAV</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: left">Quarter Ended</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">High</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Low</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">High</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Low</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">High</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Low</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March&#160;31, 2021</span></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 7%; text-align: right"><span id="xdx_909_ecef--HighestPriceOrBid_c20210101__20210331_zPQn2Ykwikbf">7.05</span></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 7%; text-align: right"><span id="xdx_903_ecef--LowestPriceOrBid_c20210101__20210331_z0X0WYhy0GJ2">6.07</span></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 7%; text-align: right"><span id="xdx_908_ecef--HighestPriceOrBidNav_c20210101__20210331_z8Oox7IO7Zy8">6.67</span></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 7%; text-align: right"><span id="xdx_908_ecef--LowestPriceOrBidNav_c20210101__20210331_zFPZu6PGhdAd">5.78</span></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 7%; text-align: right"><span id="xdx_906_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20210101__20210331_zIJIFvq2SpH">5.70</span></td>
    <td style="width: 1%; text-align: left">%</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 7%; text-align: right"><span id="xdx_909_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20210101__20210331_zr79rJHXn1vl">5.02</span></td>
    <td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June&#160;30, 2021</span></td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_906_ecef--HighestPriceOrBid_c20210401__20210630_zPQuQX4DpsI8">7.54</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_904_ecef--LowestPriceOrBid_c20210401__20210630_zdKgIBEaWiod">6.67</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_90E_ecef--HighestPriceOrBidNav_c20210401__20210630_zmDs2s6AMPZ7">6.83</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_90F_ecef--LowestPriceOrBidNav_c20210401__20210630_zCCZghoylbIe">6.48</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_90F_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20210401__20210630_zTw4BtNgRaEi">10.40</span></td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_90E_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20210401__20210630_zMN7j9sZH8j2">2.93</span></td>
    <td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September&#160;30, 2021</span></td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_90B_ecef--HighestPriceOrBid_c20210701__20210930_zzvr1ezylsvc">7.07</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_902_ecef--LowestPriceOrBid_c20210701__20210930_zY58DLFzoE1h">6.52</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_907_ecef--HighestPriceOrBidNav_c20210701__20210930_zPd6uAzbLlC2">6.62</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_907_ecef--LowestPriceOrBidNav_c20210701__20210930_zw7HUFGq64Cf">6.26</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_901_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20210701__20210930_zLJwf5KEk0ab">6.80</span></td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_90B_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20210701__20210930_z4UoR2cFdBT5">4.15</span></td>
    <td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December&#160;31, 2021</span></td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_902_ecef--HighestPriceOrBid_c20211001__20211231_zGLSoRbSM8lc">7.37</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_909_ecef--LowestPriceOrBid_c20211001__20211231_zBLAut2UyUmh">6.64</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_90A_ecef--HighestPriceOrBidNav_c20211001__20211231_zDs7lTSCKwZ3">6.46</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_90E_ecef--LowestPriceOrBidNav_c20211001__20211231_z8I9QEE7a1r7">6.28</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_90E_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20211001__20211231_z0yVQnbUpBve">14.09</span></td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_901_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20211001__20211231_zTo6Yc4VZWwa">5.73</span></td>
    <td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March&#160;31, 2022</span></td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_909_ecef--HighestPriceOrBid_c20220101__20220331_zv4HL5aEACve">7.24</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_902_ecef--LowestPriceOrBid_c20220101__20220331_zxR7zHk2CYp2">6.76</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_90A_ecef--HighestPriceOrBidNav_c20220101__20220331_z6lMWfqijXi1">6.45</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_907_ecef--LowestPriceOrBidNav_c20220101__20220331_zN9OL4WO8H2b">5.79</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_906_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20220101__20220331_zlPFJwupSjKl">12.25</span></td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_90D_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20220101__20220331_zfWHgDEsTlX1">16.75</span></td>
    <td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June&#160;30, 2022</span></td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_901_ecef--HighestPriceOrBid_c20220401__20220630_zlkJuqKDvDw5">7.05</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_901_ecef--LowestPriceOrBid_c20220401__20220630_zPg6jvxDP6p4">5.54</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_90A_ecef--HighestPriceOrBidNav_c20220401__20220630_zGhosLxVmCI8">5.95</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_902_ecef--LowestPriceOrBidNav_c20220401__20220630_zhWE3h6l1TF1">4.73</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_904_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20220401__20220630_zNIQD6Tynh21">18.49</span></td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_904_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20220401__20220630_zrzXcHRCTF3i">17.12</span></td>
    <td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September&#160;30, 2022</span></td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_90D_ecef--HighestPriceOrBid_c20220701__20220930_zTtzoUDASF0e">6.53</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_90A_ecef--LowestPriceOrBid_c20220701__20220930_zR3OmP299GXh">5.50</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_905_ecef--HighestPriceOrBidNav_c20220701__20220930_zEOGYutkZT0b">5.37</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_900_ecef--LowestPriceOrBidNav_c20220701__20220930_zbSAdU003rdf">4.47</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_905_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20220701__20220930_z1aOixqVsh29">21.60</span></td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_90B_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20220701__20220930_zxdTuOLQ1m89">23.04</span></td>
    <td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December&#160;31, 2022</span></td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_90C_ecef--HighestPriceOrBid_c20221001__20221231_zmVYoSoZ8YXd">6.16</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_906_ecef--LowestPriceOrBid_c20221001__20221231_zXbn6q1z8lz2">4.97</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_908_ecef--HighestPriceOrBidNav_c20221001__20221231_z0TJgXXgSpjb">5.53</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_909_ecef--LowestPriceOrBidNav_c20221001__20221231_zyCzlA3ua6K5">4.54</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_909_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20221001__20221231_z0hXHkWwbEib">11.39</span></td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_906_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20221001__20221231_zWKaFtTUWLqi">9.47</span></td>
    <td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March&#160;31, 2023</span></td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_907_ecef--HighestPriceOrBid_c20230101__20230331_zYunadAE1eLd">5.99</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_901_ecef--LowestPriceOrBid_c20230101__20230331_zspe6oXWVOI8">5.41</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_908_ecef--HighestPriceOrBidNav_c20230101__20230331_zlEkpfytnkk">5.53</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_90F_ecef--LowestPriceOrBidNav_c20230101__20230331_znwXeeucRXJh">4.93</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_90C_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20230101__20230331_zVtAhkL5VTCa">8.32</span></td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_900_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20230101__20230331_zuIaNK8n2NBa">9.74</span></td>
    <td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June&#160;30, 2023</span></td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_901_ecef--HighestPriceOrBid_c20230401__20230630_z5puDW6SZ4s3">5.80</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_90B_ecef--LowestPriceOrBid_c20230401__20230630_zRotsob4VTD5">5.33</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_90D_ecef--HighestPriceOrBidNav_c20230401__20230630_zCj0qKPeBH5">5.30</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_907_ecef--LowestPriceOrBidNav_c20230401__20230630_zLCXSYO6Dn75">5.02</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_908_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20230401__20230630_zAMyRtXxfAOl">9.43</span></td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_907_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20230401__20230630_zRGVi5tAyWF4">6.18</span></td>
    <td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September&#160;30, 2023</span></td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_90E_ecef--HighestPriceOrBid_c20230701__20230930_za93zKGKdmQ3">5.87</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_908_ecef--LowestPriceOrBid_c20230701__20230930_zB6c0sskB8H6">5.13</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_904_ecef--HighestPriceOrBidNav_c20230701__20230930_zbLscm2TjPD1">5.30</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_909_ecef--LowestPriceOrBidNav_c20230701__20230930_zdo5Iufyj94i">4.79</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_906_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20230701__20230930_zr9mrRNBlbOh">10.75</span></td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_905_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20230701__20230930_zUipaRuFO9qa">7.10</span></td>
    <td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December&#160;28, 2023, the last reported price for our common shares was $5.13 and the net asset value per share on December&#160;28, 2023 was $5.21 per share. Accordingly, our common stock traded at a discount to net asset value of -1.54% on December&#160;28, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund&#8217;s net asset value per share will be reduced immediately following the offering of common stock by the amount of the sales load and offering expenses paid by the Fund. See &#8220;Use of Proceeds.&#8221; Unlike open-end funds, closed-end funds like the Fund do not continuously offer shares and do not provide daily redemptions. Rather, if a stockholder determines to buy additional shares of common stock or sell shares already held, the stockholder may do so by trading through a broker on the NYSE or otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares of closed-end investment companies often trade on an exchange at prices lower than net asset value. The Fund&#8217;s shares of common stock have traded in the market at both premiums to and discounts from net asset value. Over the Fund&#8217;s thirty-seven year history, the range fluctuated from a 38% premium in 2002 to a 27% discount in 1987. Beginning in early 2001, the market price of the Fund exceeded the net asset value and this premium continued through September&#160;2005. The previous extended period over which the premium existed occurred during the twenty month period from August&#160;1993 to March&#160;1995. As of September&#160;30, 2023, the market price of the Fund closed at an approximate 7.1% premium to its net asset value. Because the market value of the common stock may be influenced by such factors as dividend and distribution levels (which are in turn affected by expenses), dividend and distribution stability, net asset value, market liquidity, relative demand for and supply of such shares in the market, unrealized gains, general market and economic conditions and other factors beyond the control of the Fund, the Fund cannot assure you that shares of common stock will trade at a price equal to or higher than net asset value in the future. The common stock is designed primarily for long term investors and you should not purchase the shares of the common stock if you intend to sell them soon after purchase.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund&#8217;s common stockholders vote together with the holders of preferred stock, as a single class, to elect the Fund&#8217;s Board (other than two directors elected exclusively by holders of the Fund&#8217;s preferred stock) and, except as described below, on additional matters with respect to which the 1940 Act, the Governing Documents or resolutions adopted by the Directors provide for a vote of the Fund&#8217;s common stockholders. Holders of the Fund&#8217;s preferred stock vote together as a single class to elect two of the directors of the Fund and vote together as a single class, separately from holders of the Fund&#8217;s common stock, to approve any plan of reorganization adversely affecting the preferred stock and to approve certain amendments to the Charter, whether by merger, consolidation or otherwise, that materially and adversely affect the contract rights of the existing preferred stock as set forth in the Charter. In addition, the affirmative vote of the holders of 66 &#8532;% of the outstanding shares of each class of stock of the Fund normally entitled to vote in the election of directors, each such class voting as a separate class, is required to authorize the conversion of the Fund from a closed-end to an open-end investment company. See &#8220;Anti-Takeover Provisions of the Fund&#8217;s Governing Documents.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund may repurchase its shares of common stock from time to time as and when it deems such repurchase advisable from legally available funds, subject to rights of holders of the Fund&#8217;s outstanding preferred stock and maintaining required asset coverage for each series of outstanding preferred stock. The Board has adopted a policy to authorize such repurchases when the shares are trading at a discount of 10% or more (or such other percentage as the Board may determine from time to time) from the net asset value of the shares. Although the Board has authorized such repurchases, the Fund is not required to repurchase its shares. The policy does not limit the amount of common stock that can be repurchased. The percentage of the discount from net asset value at which share repurchases will be authorized may be changed at any time by the Board. Through December&#160;31, 2022, the Fund has not repurchased shares of its common stock under this authorization.</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_LowestPriceOrBid', window );">Lowest Price or Bid</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.13<span></span>
</td>
<td class="nump">$ 5.33<span></span>
</td>
<td class="nump">$ 5.41<span></span>
</td>
<td class="nump">$ 4.97<span></span>
</td>
<td class="nump">$ 5.50<span></span>
</td>
<td class="nump">$ 5.54<span></span>
</td>
<td class="nump">$ 6.76<span></span>
</td>
<td class="nump">$ 6.64<span></span>
</td>
<td class="nump">$ 6.52<span></span>
</td>
<td class="nump">$ 6.67<span></span>
</td>
<td class="nump">$ 6.07<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_HighestPriceOrBid', window );">Highest Price or Bid</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.87<span></span>
</td>
<td class="nump">5.80<span></span>
</td>
<td class="nump">5.99<span></span>
</td>
<td class="nump">6.16<span></span>
</td>
<td class="nump">6.53<span></span>
</td>
<td class="nump">7.05<span></span>
</td>
<td class="nump">7.24<span></span>
</td>
<td class="nump">7.37<span></span>
</td>
<td class="nump">7.07<span></span>
</td>
<td class="nump">7.54<span></span>
</td>
<td class="nump">7.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_LowestPriceOrBidNav', window );">Lowest Price or Bid, NAV</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.79<span></span>
</td>
<td class="nump">5.02<span></span>
</td>
<td class="nump">4.93<span></span>
</td>
<td class="nump">4.54<span></span>
</td>
<td class="nump">4.47<span></span>
</td>
<td class="nump">4.73<span></span>
</td>
<td class="nump">5.79<span></span>
</td>
<td class="nump">6.28<span></span>
</td>
<td class="nump">6.26<span></span>
</td>
<td class="nump">6.48<span></span>
</td>
<td class="nump">5.78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_HighestPriceOrBidNav', window );">Highest Price or Bid, NAV</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.30<span></span>
</td>
<td class="nump">$ 5.30<span></span>
</td>
<td class="nump">$ 5.53<span></span>
</td>
<td class="nump">$ 5.53<span></span>
</td>
<td class="nump">$ 5.37<span></span>
</td>
<td class="nump">$ 5.95<span></span>
</td>
<td class="nump">$ 6.45<span></span>
</td>
<td class="nump">$ 6.46<span></span>
</td>
<td class="nump">$ 6.62<span></span>
</td>
<td class="nump">$ 6.83<span></span>
</td>
<td class="nump">$ 6.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_HighestPriceOrBidPremiumDiscountToNavPercent', window );">Highest Price or Bid, Premium (Discount) to NAV [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.75%<span></span>
</td>
<td class="nump">9.43%<span></span>
</td>
<td class="nump">8.32%<span></span>
</td>
<td class="nump">11.39%<span></span>
</td>
<td class="nump">21.60%<span></span>
</td>
<td class="nump">18.49%<span></span>
</td>
<td class="nump">12.25%<span></span>
</td>
<td class="nump">14.09%<span></span>
</td>
<td class="nump">6.80%<span></span>
</td>
<td class="nump">10.40%<span></span>
</td>
<td class="nump">5.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_LowestPriceOrBidPremiumDiscountToNavPercent', window );">Lowest Price or Bid, Premium (Discount) to NAV [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.10%<span></span>
</td>
<td class="nump">6.18%<span></span>
</td>
<td class="nump">9.74%<span></span>
</td>
<td class="nump">9.47%<span></span>
</td>
<td class="nump">23.04%<span></span>
</td>
<td class="nump">17.12%<span></span>
</td>
<td class="nump">16.75%<span></span>
</td>
<td class="nump">5.73%<span></span>
</td>
<td class="nump">4.15%<span></span>
</td>
<td class="nump">2.93%<span></span>
</td>
<td class="nump">5.02%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SecurityTitleTextBlock', window );">Security Title [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_80E_ecef--SecurityTitleTextBlock_zjTfPbCN6asl" style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; width: 40%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td>
    <td id="xdx_495_20230630_z7tgzvwZFrnk" style="text-align: right; width: 7%">&#160;</td>
    <td style="white-space: nowrap; text-align: left; width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td>
    <td id="xdx_496_20221231_zyBtHqkqKHYe" style="text-align: right; width: 7%">&#160;</td>
    <td style="white-space: nowrap; text-align: left; width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td>
    <td id="xdx_49B_20211231_zJCsKvxBe2vb" style="text-align: right; width: 7%">&#160;</td>
    <td style="white-space: nowrap; text-align: left; width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td>
    <td id="xdx_49E_20201231_z1cNGZ9tYkdi" style="text-align: right; width: 7%">&#160;</td>
    <td style="white-space: nowrap; text-align: left; width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td>
    <td id="xdx_497_20191231_z2bwPciCV3zk" style="text-align: right; width: 7%">&#160;</td>
    <td style="white-space: nowrap; text-align: left; width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td>
    <td id="xdx_493_20181231_zyt2fZN0mah8" style="text-align: right; width: 7%">&#160;</td>
    <td style="white-space: nowrap; text-align: left; width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Cumulative Preferred Stock:</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">Auction Rate Series C Preferred</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredSharesAuctionRateSeriesCPreferredMember_ziznl8LjOuXl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation value, end of period (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">62,300</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">62,300</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">62,300</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">62,300</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">72,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">72,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total shares outstanding (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation preference per share</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation value (h)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredSharesAuctionRateSeriesCPreferredMember_zRaHmKzIbtsg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Asset coverage per share (i)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">118,342</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">113,590</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">116,432</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">111,456</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">108,305</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">105,562</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">5.875% Series D Preferred (j)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.875SerieAPreferredMember_zQjVFda9Kltf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation value, end of period (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0110">&#8212;</span></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0111">&#8212;</span></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0112">&#8212;</span></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0113">&#8212;</span></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0114">&#8212;</span></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">59,097</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total shares outstanding (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,364</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation preference per share</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Average market value (k)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.62</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.875SerieAPreferredMember_zBAciZw3cXth" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Asset coverage per share (i)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0117">&#8212;</span></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0118">&#8212;</span></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0119">&#8212;</span></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0120">&#8212;</span></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0121">&#8212;</span></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">105.56</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">Auction Rate Series E Preferred</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredSharesAuctionRateSeriesEPreferredMember_z04eiOXEQOdk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation value, end of period (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">27,700</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">27,700</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">27,700</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">27,700</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">28,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">28,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total shares outstanding (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation preference per share</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation value (h)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredSharesAuctionRateSeriesEPreferredMember_zS2rlYq1vEXg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Asset coverage per share (i)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">118,342</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">113,590</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">116,432</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">111,456</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">108,305</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">105,562</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  </table>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">
        <p style="margin-top: 0; margin-bottom: 0">Six Months Ended June&#160;30,</p>
        <p style="margin-top: 0; margin-bottom: 0">2023</p></td>
    <td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="18" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December&#160;31,</td>
    <td style="white-space: nowrap; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">(Unaudited)</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2018</td>
    <td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left; width: 40%">5.000% Series G Preferred</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td>
    <td style="text-align: right; width: 7%">&#160;</td>
    <td style="white-space: nowrap; text-align: left; width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td>
    <td style="text-align: right; width: 7%">&#160;</td>
    <td style="white-space: nowrap; text-align: left; width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td>
    <td style="text-align: right; width: 7%">&#160;</td>
    <td style="white-space: nowrap; text-align: left; width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td>
    <td style="text-align: right; width: 7%">&#160;</td>
    <td style="white-space: nowrap; text-align: left; width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td>
    <td style="text-align: right; width: 7%">&#160;</td>
    <td style="white-space: nowrap; text-align: left; width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td>
    <td style="text-align: right; width: 7%">&#160;</td>
    <td style="white-space: nowrap; text-align: left; width: 1%">&#160;</td></tr>
  <tr id="xdx_40D_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.000SerieGPreferredMember_z5KK79wW9Z8i" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation value, end of period (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">64,647</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">65,060</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">69,491</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">69,491</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">69,495</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">69,495</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total shares outstanding (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,586</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,602</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,780</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,780</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,780</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,780</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation preference per share</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Average market value (k)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">22.59</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">23.59</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.66</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.25</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">24.57</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">23.92</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.000SerieGPreferredMember_zohtagmRw4S3" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Asset coverage per share (i)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">118.34</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">113.59</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">116.43</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">111.46</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">108.30</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">105.56</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">5.000% Series H Preferred</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.000SerieHPreferredMember_zf0fugCsjixg" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation value, end of period (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">102,910</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">103,195</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">104,322</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">104,322</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">104,322</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">104,322</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total shares outstanding (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">4,116</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">4,128</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">4,173</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">4,173</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">4,173</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">4,173</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation preference per share</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Average market value (k)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">22.64</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">23.58</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.55</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.30</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">24.68</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">24.18</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.000SerieHPreferredMember_zcCLyYyn5rO4" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Asset coverage per share (i)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">118.34</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">113.59</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">116.43</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">111.46</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">108.30</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">105.56</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">5.450% Series J Preferred (l)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.450SerieJPreferredMember_zYlG1f8QJ8fh" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation value, end of period (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0166">&#8212;</span></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0167">&#8212;</span></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">80,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">80,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">80,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">80,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total shares outstanding (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3,200</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3,200</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3,200</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3,200</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation preference per share</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Average market value (k)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">26.03</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">26.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.98</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.14</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.450SerieJPreferredMember_zuzfh1jDXbyc" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Asset coverage per share (i)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0173">&#8212;</span></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0174">&#8212;</span></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">116.43</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">111.46</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">108.30</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">105.56</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">5.000% Series K Preferred</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.000SerieKPreferredMember_zpojXgxxxhU3" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation value, end of period (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">98,243</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">98,243</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">99,825</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">99,825</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">100,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0185">&#8212;</span></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total shares outstanding (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3,930</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3,930</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3,993</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3,993</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">4,000</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation preference per share</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">25.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Average market value (k)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">22.74</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">23.70</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">26.40</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.86</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.24</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.000SerieKPreferredMember_zqBbxIMEX4V9" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Asset coverage per share (i)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">118.34</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">113.59</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">116.43</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">111.46</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">108.30</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0192">&#8212;</span></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">4.250% Series M Cumulative Preferred Shares</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredShares4.250SerieMCumulativePreferredMember_zyegUutqQJ12" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation value, end of period (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">68,550</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">68,550</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">67,850</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0197">&#8212;</span></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0198">&#8212;</span></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0199">&#8212;</span></td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total shares outstanding (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">686</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">686</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">679</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation preference per share</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">100.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">100.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">100.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Average market value (k)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">100.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">100.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">100.00</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredShares4.250SerieMCumulativePreferredMember_zB882vMWthMf" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Asset coverage per share (i)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">473.37</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">113.59</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">116.43</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">Asset Coverage (m)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">473</td>
    <td style="white-space: nowrap; text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">454</td>
    <td style="white-space: nowrap; text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">466</td>
    <td style="white-space: nowrap; text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">446</td>
    <td style="white-space: nowrap; text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">433</td>
    <td style="white-space: nowrap; text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">422</td>
    <td style="white-space: nowrap; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8224;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on net asset value per share, adjusted for reinvestment of distributions at net asset value on the ex-dividend dates and adjustments for the rights offering. Total return for a period of less than one year is not annualized.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8224;&#8224;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Based on market value per share, adjusted for reinvestment of distributions at prices determined under the Fund&#8217;s dividend reinvestment plan. Total return for a period of less than one year is not annualized.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on year to date book income. Amounts are subject to change and recharacterization at year end.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Calculated based on average common shares outstanding on the record dates throughout the periods.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount represents less than $0.005 per share.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annualized.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund received credits from a designated broker who agreed to pay certain Fund operating expenses. For all years presented there was no impact on the expense ratios.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ratio of operating expenses to average net assets including liquidation value of preferred shares before fee reductions for the six months ended June&#160;30, 2023 and the years ended December&#160;31, 2022, 2021, 2020, 2019, and 2018 would have been 1.26%, 1.24%, 1.10%, 1.10%, 1.03%, and 1.09%, respectively.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In 2019, due to failed auctions relating to previous fiscal years, the Fund reversed accumulated auction fees. The 2019 ratio of operating expenses to average net assets attributable to common shares and the ratio of operating expenses to average net assets including liquidation value of preferred shares, excluding the reversal of auction agent fees, were 1.39% and 1.08%, respectively.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ratio of operating expenses to average net assets including liquidation value of preferred shares net of fee reductions for the six months ended June&#160;30, 2023 and the years ended December&#160;31, 2022, 2021, 2020, 2019, and 2018 would have been 1.22%, 1.20%, 1.10%, 1.10%, 1.03%, and 1.01%, respectively.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since February&#160;2008, the weekly auctions have failed. Holders that have submitted orders have not been able to sell any or all of their shares in the auction.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asset coverage per share is calculated by combining all series of preferred stock.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund redeemed and retired all of the 2,363,860 shares of Series D Preferred on December&#160;26, 2019.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on weekly prices.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund redeemed and retired all of the 3,200,000 shares of Series J Preferred on January&#160;31, 2022.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asset coverage is calculated by combining all series of preferred stock.</span></td> </tr>
  </table>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherSecuritiesTableTextBlock', window );">Other Securities [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_80B_ecef--OtherSecuritiesTableTextBlock_zw1RGBmoDIGf" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_497_20171231_zTtgvQ06Wg4j" style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_497_20161231_zgmT6FlJdRMi" style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_49F_20151231_zVfd6ZxFSv64" style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_490_20141231_zFeUNFmmRfHh" style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_496_20131231_zqMxG7jjrpUe" style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="18" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December&#160;31,</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2017</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2016</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2015</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2014</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2013</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Cumulative Preferred Stock:</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">Auction Rate Series C Preferred</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredSharesAuctionRateSeriesCPreferredMember_zDa3Suzhj5B7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 50%; text-align: left">Liquidation value, end of year (in 000&#8217;s)</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 7%; text-align: right">72,000</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 7%; text-align: right">72,000</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 7%; text-align: right">72,000</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 7%; text-align: right">72,000</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 7%; text-align: right">72,000</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total shares outstanding (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation preference per share</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation value(d)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredSharesAuctionRateSeriesCPreferredMember_zlobUkONpU9f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Asset coverage per share(e)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">123,830</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">102,426</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">118,593</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">136,308</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">128,106</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">5.875% Series D Preferred</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.875SerieAPreferredMember_zUJfJw8IW7uk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation value, end of year (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">59,097</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">59,097</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">59,097</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">59,097</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">59,097</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total shares outstanding (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,364</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,364</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,364</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,364</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,364</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation preference per share</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Average market value(f)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">26.16</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">26.22</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.69</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.21</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.27</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.875SerieAPreferredMember_zH14xhzjzOP9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Asset coverage per share(e)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">123.83</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">102.43</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">118.59</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">136.31</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">128.11</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">Auction Rate Series E Preferred</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredSharesAuctionRateSeriesEPreferredMember_zmkLD8nFbdY" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation value, end of year (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">28,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">28,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">28,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">28,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">28,000</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total shares outstanding (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation preference per share</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation value(d)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredSharesAuctionRateSeriesEPreferredMember_zkcPOtk5rHr4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Asset coverage per share(e)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">123,830</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">102,426</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">118,593</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">136,308</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">128,106</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">5.000% Series G Preferred</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.000SerieGPreferredMember_zHcuZDVqyih5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation value, end of year (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">69,495</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">69,743</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">69,925</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">70,099</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">70,373</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total shares outstanding (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,780</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,791</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,797</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,804</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,815</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation preference per share</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Average market value(f)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">24.50</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">24.67</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">23.78</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">23.32</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">23.91</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.000SerieGPreferredMember_z31W2Zfh5rW" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Asset coverage per share(e)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">123.83</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">102.43</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">118.59</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">136.31</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">128.11</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">5.000% Series H Preferred</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.000SerieHPreferredMember_z1RPRsXtzmSd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation value, end of year (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">104,322</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">104,494</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">104,644</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">104,674</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">104,757</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total shares outstanding (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">4,173</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">4,180</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">4,186</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">4,187</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">4,190</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation preference per share</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Average market value(f)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">24.64</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">24.33</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">22.82</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">23.85</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.000SerieHPreferredMember_zvoU9oaDF8ie" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Asset coverage per share(e)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">123.83</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">102.43</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">118.59</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">136.31</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">128.11</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">5.450% Series J Preferred</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.450SerieJPreferredMember_z1mYjValdsh4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation value, end of period (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">80,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">80,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0272">&#8212;</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0273">&#8212;</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0274">&#8212;</span></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total shares outstanding (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3,200</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3,200</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation preference per share</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Average market value(f)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.36</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.43</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#8212;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.450SerieJPreferredMember_z7qt99O2yjag" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Asset coverage per share(e)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">123.83</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">102.43</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0278">&#8212;</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0279">&#8212;</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0280">&#8212;</span></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">Asset Coverage(g)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">495</td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">410</td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">474</td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">545</td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">512</td>
    <td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: center"><b>&#160;</b></td>
    <td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="18" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year Ended December&#160;31,</b></span></td>
    <td style="padding-bottom: 1pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2017</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2016</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2015</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2014</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2013</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Cumulative Preferred Stock:</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">Auction Rate Series C</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredSharesAuctionRateSeriesCPreferredMember_zieGgcOK9s7f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; width: 50%; text-align: left">Liquidation value, end of year (in 000&#8217;s)</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 7%; text-align: right">72,000</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 7%; text-align: right">72,000</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 7%; text-align: right">72,000</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 7%; text-align: right">72,000</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 7%; text-align: right">72,000</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total shares outstanding (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">3</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation preference per share</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation value(c)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredSharesAuctionRateSeriesCPreferredMember_zrlfaIX7czv" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Asset coverage per share</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">123,830</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">102,426</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">118,593</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">136,308</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">128,106</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">5.875% Series D</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.875SerieDPreferredMember_zSzoJNjRvAF7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation value, end of year (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">59,097</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">59,097</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">59,097</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">59,097</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">59,097</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total shares outstanding (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,364</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,364</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,364</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,364</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,364</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation preference per share</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Average market value(d)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">26.16</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">26.22</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.69</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.21</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.27</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.875SerieDPreferredMember_z0u8A9dwo5ob" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Asset coverage per share</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">123.83</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">102.43</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">118.59</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">136.31</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">128.11</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">Auction Rate Series E</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredSharesAuctionRateSeriesEPreferredMember_zMirsp0Kdbob" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation value, end of year (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">28,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">28,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">28,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">28,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">28,000</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total shares outstanding (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">1</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation preference per share</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation value(c)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25,000</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredSharesAuctionRateSeriesEPreferredMember_zwM5TvAOPjWf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Asset coverage per share</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">123,830</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">102,426</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">118,593</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">136,308</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">128,106</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">5.000% Series G</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.000SerieGPreferredMember_zdvuzgbzNke4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation value, end of year (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">69,495</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">69,743</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">69,925</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">70,099</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">70,373</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total shares outstanding (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,780</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,791</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,797</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,804</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,815</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation preference per share.</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Average market value(d)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">24.50</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">24.67</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">23.78</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">23.32</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">23.92</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.000SerieGPreferredMember_zvEadDiIWxWe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Asset coverage per share</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">123.83</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">102.43</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">118.59</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">136.31</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">128.11</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">5.000% Series H</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.000SerieHPreferredMember_z0hnwJfYAyyi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation value, end of year (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">104,322</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">104,494</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">104,644</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">104,674</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">104,757</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total shares outstanding (in 000&#8217;s)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">4,173</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">4,180</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">4,186</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">4,187</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">4,190</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Liquidation preference per share.</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Average market value(d)</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">24.64</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">25.00</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">24.33</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">22.82</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">23.85</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.000SerieHPreferredMember_zb7YKWk7uJQd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Asset coverage per share</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">123.83</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">102.43</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right">118.59</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">136.31</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">128.11</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">Asset Coverage(e)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">495</td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">410</td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">474</td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">545</td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">512</td>
    <td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8224;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on net asset value per share, adjusted for reinvestment of distributions at net asset value on the ex-dividend dates and adjustments for the rights offering.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8224;&#8224;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Based on market value per share, adjusted for reinvestment of distributions at prices determined under the Fund&#8217;s dividend reinvestment plan and adjustments for the rights offering.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Calculated based on average common shares outstanding on the record dates throughout the years.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount represents less than $0.005 per share.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund received credits from a designated broker who agreed to pay certain Fund operating expenses. For the years ended December&#160;31, 2017, 2016, and 2015, there was no impact on the expense ratios.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since February&#160;2008, the weekly auctions have failed. Holders that have submitted orders have not been able to sell any or all of their shares in the auction.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asset coverage per share is calculated by combining all series of preferred stock.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on weekly prices.</span></td> </tr>
  <tr style="vertical-align: top; text-align: justify">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asset coverage is calculated by combining all series of preferred stock.</span></td> </tr>
  </table>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecuritiesTableTextBlock', window );">Outstanding Securities [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_898_ecef--OutstandingSecuritiesTableTextBlock_zO0dEgMIKJJh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table shows (i) the classes of capital stock authorized, (ii) the number of shares outstanding in each class, and (iii) the number of shares authorized in each class as of December&#160;18, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: left">Title of Class</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount<br/> Outstanding</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount<br/> Authorized</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td id="xdx_987_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--CommonSharesMember_zKVbTqM1GdG3" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left">Common Stock</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td id="xdx_982_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--CommonSharesMember_zcv9EQE2V2N3" style="width: 9%; text-align: right">300,659,233</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td id="xdx_98B_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--CommonSharesMember_z7rW8DmoFDNb" style="width: 9%; text-align: right">337,024,900</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_985_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--SeriesCPreferredSharesMember_fKDEp_zr5cmvWrTL49" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series C Auction Rate Preferred<sup>(1)</sup></span></td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_98E_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--SeriesCPreferredSharesMember_fKDEp_zt1dQ1BB79r2" style="text-align: right">2,492</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_98A_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--SeriesCPreferredSharesMember_fKDEp_z1mvkGKtneRe" style="text-align: right">4,812</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td id="xdx_989_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--SeriesDPreferredSharesMember_fKDIp_zy6XRIylzwf2" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.875% Series D Cumulative Preferred Stock (the &#8220;Series D Preferred&#8221;)<sup>(2)</sup></span></td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_981_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--SeriesDPreferredSharesMember_fKDIp_zgppFgOEUkz7" style="text-align: right">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_985_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--SeriesDPreferredSharesMember_fKDIp_zxOfKDmTMaJh" style="text-align: right">636,140</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_98E_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--SeriesEPreferredSharesMember_fKDEp_zbqKO6rCTlLg" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series E Auction Rate Preferred<sup>(1)</sup></span></td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_981_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--SeriesEPreferredSharesMember_fKDEp_zYQIY8RwemW1" style="text-align: right">1,108</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_98F_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--SeriesEPreferredSharesMember_fKDEp_zVQJpILax6a4" style="text-align: right">1,988</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td id="xdx_980_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--SeriesGPreferredSharesMember_zuokzI2UEO35" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Series G Preferred</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_98F_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--SeriesGPreferredSharesMember_zZQYulGfeP08" style="text-align: right">2,520,627</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_98C_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--SeriesGPreferredSharesMember_zQvVudRpnmLh" style="text-align: right">2,959,830</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_983_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--SeriesHPreferredSharesMember_z8kju9w66ue9" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Series H Preferred</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_989_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--SeriesHPreferredSharesMember_zZPRfpRck7m8" style="text-align: right">4,083,160</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_985_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--SeriesHPreferredSharesMember_zY3FrYEZN685" style="text-align: right">4,109,167</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td id="xdx_98C_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--SeriesJPreferredSharesMember_fKDMp_zti0TaJNrMp3" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.45% Series J Cumulative Preferred Stock (the &#8220;Series J Preferred&#8221;)<sup>(3)</sup></span></td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_98D_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--SeriesJPreferredSharesMember_fKDMp_zJIDGKAacer4" style="text-align: right">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_98D_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--SeriesJPreferredSharesMember_fKDMp_zp6hcx1szaY3" style="text-align: right">1,300,000</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_983_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--SeriesKPreferredSharesMember_zsVvgQAlAHR" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Series K Preferred</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_981_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--SeriesKPreferredSharesMember_zhucs1J6Nf5l" style="text-align: right">3,813,640</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_981_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--SeriesKPreferredSharesMember_zfJMUPLjDnxc" style="text-align: right">3,813,640</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td id="xdx_981_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--SeriesMPreferredSharesMember_ze9EHkEuyjoh" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Series M Preferred</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_989_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--SeriesMPreferredSharesMember_zLXgIyIT3Bfj" style="text-align: right">685,500</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_986_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--SeriesMPreferredSharesMember_zOlp3NekX1Xa" style="text-align: right">1,000,000</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_988_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--SeriesNPreferredSharesMember_fKDQp_zcVA0VGv5dj" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series N Preferred<sup>(4)</sup></span></td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_988_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--SeriesNPreferredSharesMember_fKDQp_z7bJ0UCCnRB1" style="text-align: right">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_984_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--SeriesNPreferredSharesMember_fKDQp_zambtTnL1GK3" style="text-align: right">350,000</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td id="xdx_981_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--PreferredShareMember_fKDUp_zOhGvNFx41He" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred Stock<sup>(5)</sup></span></td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_981_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--PreferredSharesMember_fKDUp_zQnRN00lu7H4" style="text-align: right">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_98B_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--PreferredSharesMember_fKDUp_znXyVFL7CTCf" style="text-align: right">18,799,523</td>
    <td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F06_zC8C67MHA0l8">(1)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span id="xdx_F16_zTt5jbBZjG64" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund commenced a tender offer for all of its outstanding Series C Auction Rate Preferred and Series E Auction Rate Preferred on November&#160;16, 2023. The tender offer is scheduled to expire on January&#160;5, 2024.</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F01_zFaEaP71LMtf">(2)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span id="xdx_F10_zebcZKHFTBtj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund redeemed all of its outstanding Series D Preferred on December&#160;26, 2019.</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F00_zKUL6PUiZT1j">(3)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span id="xdx_F1C_zy4U0XwRlpqb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund redeemed all of its outstanding Series J Preferred on January&#160;31, 2022.</span></td> </tr>
  </table>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left; text-indent: 0in; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F0A_znGbxbrpUrph">(4)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span id="xdx_F13_zEZPV1JdEGt3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December&#160;1, 2023, the Fund&#8217;s Board approved an offering of up to 350,000 shares of the Series N Preferred for an aggregate maximum offering amount of up to $35,000,000. On December&#160;12, 2023, the Fund filed Articles Supplementary with the State Department of Assessments and Taxation of Maryland classifying and designating 350,000 shares of preferred stock, without further designation as to class or series, as shares of Series N Preferred. The Series N Preferred are not registered under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), or listed on a securities exchange. The Fund issued 147,750 Series N Preferred in an initial closing for the offering of the Series N Preferred on December&#160;28, 2023.</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F04_zWBR6q3wGmIh">(5)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span id="xdx_F1C_zHGrLoGacqd2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Preferred Stock&#8221; refers to the Fund&#8217;s authorized and unissued shares of preferred stock without further designation as to class or series.</span></td> </tr>
  </table>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=gab_PurchaseTransactionFeeMember', window );">Purchase Transaction Fee [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_FinancialHighlightsAbstract', window );"><strong>Financial Highlights [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SeniorSecuritiesCvgPerUnit', window );">Senior Securities Coverage per Unit</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 0.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=gab_SaleTransactionFeeMember', window );">Sale Transaction Fee [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_FinancialHighlightsAbstract', window );"><strong>Financial Highlights [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SeniorSecuritiesCvgPerUnit', window );">Senior Securities Coverage per Unit</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 2.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=gab_CommonSharesMember', window );">Common Shares [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherAnnualExpensesAbstract', window );"><strong>Other Annual Expenses [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYear01', window );">Expense Example, Year 01</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYears1to3', window );">Expense Example, Years 1 to 3</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYears1to5', window );">Expense Example, Years 1 to 5</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYears1to10', window );">Expense Example, Years 1 to 10</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 417<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityTitleTextBlock', window );">Outstanding Security, Title [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Common Stock<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityAuthorizedShares', window );">Outstanding Security, Authorized [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">337,024,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityHeldShares', window );">Outstanding Security, Held [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">300,659,233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=gab_PreferredSharesMember', window );">Preferred Shares [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherAnnualExpensesAbstract', window );"><strong>Other Annual Expenses [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYear01', window );">Expense Example, Year 01</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYears1to3', window );">Expense Example, Years 1 to 3</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYears1to5', window );">Expense Example, Years 1 to 5</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYears1to10', window );">Expense Example, Years 1 to 10</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityTitleTextBlock', window );">Outstanding Security, Title [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_80F_ecef--OutstandingSecurityTitleTextBlock_hcef--RiskAxis__custom--PreferredSharesMember_zk9q2j9Kjwu" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Preferred Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently, 32,975,100 shares of the Fund&#8217;s capital stock have been classified by the Board as preferred stock, par value $0.001 per share. The Fund&#8217;s Board may reclassify authorized and unissued shares of the Fund, including shares of capital stock previously classified as common stock, as preferred stock prior to the completion of any offering. The terms of each series of preferred stock may be fixed by the Board and may materially limit and/or qualify the rights of the holders of the Fund&#8217;s common stock. As of September&#160;30, 2023, the Fund had 2,492 outstanding shares of Series C Auction Rate Preferred, 1,108 outstanding shares of Series E Auction Rate Preferred, 2,572,905 outstanding shares of Series G Preferred, 4,116,414 outstanding shares of Series H Preferred, 3,887,650 outstanding shares of Series K Preferred and 685,500 outstanding shares of Series M Preferred. On December&#160;28, 2023, the Fund issued 147,750 shares of Series N Preferred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November&#160;16, 2023, the Fund commenced a tender offer for all of its outstanding Series C Auction Rate Preferred and Series E Auction Rate Preferred. The tender offer is scheduled to expire on January&#160;5, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Distributions on the Series C Auction Rate Preferred accumulate at a variable maximum rate based on short term rates. At present, the maximum rate is equal to 175% of the &#8220;AA&#8221; Financial Composite Commercial Paper Rate determined on each calculation date. Prior to the failing of auctions for the Fund&#8217;s Series C Auction Rate Preferred, these securities paid dividends set at a weekly auction. The liquidation preference of the Series C Auction Rate Preferred is $25,000 per share plus accumulated but unpaid dividends (whether or not earned or declared). The Fund generally may redeem the outstanding Series C Auction Rate Preferred, in whole or in part, at any time other than during a non-call period. The Series C Auction Rate Preferred is not traded on any public exchange.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Distributions on the Series E Auction Rate Preferred accumulate at a variable maximum rate based on short term rates. At present, the maximum rate is equal to 175% of the &#8220;AA&#8221; Financial Composite Commercial Paper Rate determined on each calculation date. Prior to the failing of auctions for the Fund&#8217;s Series E Auction Rate Preferred, these securities paid dividends set at a weekly auction. The liquidation preference of the Series E Auction Rate Preferred is $25,000 per share plus accumulated but unpaid dividends (whether or not earned or declared). The Fund generally may redeem the outstanding Series E Auction Rate Preferred, in whole or in part, at any time other than during a non-call period. The Series E Auction Rate Preferred is not traded on any public exchange.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Distributions on the Series G Preferred accumulate at an annual rate of 5.00% of the liquidation preference of $25 per share plus accumulated but unpaid dividends (whether or not earned or declared), are cumulative from the date of original issuance thereof, and are payable quarterly on March&#160;26, June&#160;26, September&#160;26 and December&#160;26 of each year. The Fund&#8217;s outstanding Series G Preferred is redeemable at the liquidation preference plus accumulated but unpaid dividends (whether or not earned or declared) through the date of redemption at the option of the Fund at any time. The Series G Preferred is listed and traded on the NYSE under the symbol &#8220;GAB PrG.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Distributions on the Series H Preferred accumulate at an annual rate of 5.00% of the liquidation preference of $25 per share plus accumulated but unpaid dividends (whether or not earned or declared), are cumulative from the date of original issuance thereof, and are payable quarterly on March&#160;26, June&#160;26, September&#160;26 and December&#160;26 of each year. The Fund&#8217;s outstanding Series H Preferred is redeemable at the liquidation preference plus accumulated but unpaid dividends (whether or not earned or declared) through the date of redemption at the option of the Fund at any time. The Series H Preferred is listed and traded on the NYSE under the symbol &#8220;GAB PrH.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Distributions on the Series K Preferred accumulate at an annual rate of 5.00% of the liquidation preference of $25 per share plus accumulated but unpaid dividends (whether or not earned or declared), are cumulative from the date of original issuance thereof, and are payable quarterly on March&#160;26, June&#160;26, September&#160;26 and December&#160;26 of each year. The Fund&#8217;s outstanding Series K Preferred is redeemable at the liquidation preference plus accumulated but unpaid dividends (whether or not earned or declared) through the date of redemption at the option of the Fund following the expiration of the five year call protection on December&#160;16, 2024. The Series K Preferred is listed and traded on the NYSE under the symbol &#8220;GAB PrK.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Distributions on the Series M Preferred accumulate at an annual rate of 4.25% of the liquidation preference of $100 per share plus accumulated but unpaid dividends (whether or not earned or declared), are cumulative from the date of original issuance thereof, and are payable quarterly on March&#160;26, June&#160;26, September&#160;26 and December&#160;26 of each year. The Fund&#8217;s outstanding Series M Preferred is puttable during the 60-day period prior to March&#160;26, 2027, is callable at our option upon not less than 30 nor more than 60 days&#8217; prior notice at any time commencing on December&#160;26, 2027 and thereafter, and is subject to mandatory redemption by the Fund on March&#160;26, 2032, in each case at the liquidation preference, plus any accumulated and unpaid dividends. The Series M Preferred is not traded on any public exchange.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Distributions
on the Series N Preferred accumulate at an annual rate of 5.25% of the liquidation preference of $100 per share plus accumulated but
unpaid dividends (whether or not earned or declared), are  cumulative from the date of original issuance thereof, and are
payable semiannually June&#160;26 and December&#160;26 of each year, commencing on June&#160;26, 2024. The Fund&#8217;s outstanding
Series N Preferred is puttable during the 60-day period prior to each of June&#160;26, 2024 and December&#160;26, 2024, and is
callable at our option upon 30 days&#8217; prior notice at any time commencing on December&#160;26, 2024 and thereafter, and is
subject to mandatory redemption by the Fund on December&#160;26, 2025, in each case at the liquidation preference, plus any
accumulated and unpaid dividends. The Series N Preferred is not traded on any public exchange.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the Fund issues any additional series of preferred stock, it will pay dividends to the holders at either a fixed rate or a rate that will be reset, as described in the Prospectus Supplement accompanying each preferred stock offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_898_ecef--OutstandingSecuritiesTableTextBlock_zO0dEgMIKJJh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table shows (i) the classes of capital stock authorized, (ii) the number of shares outstanding in each class, and (iii) the number of shares authorized in each class as of December&#160;18, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: left">Title of Class</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount<br/> Outstanding</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount<br/> Authorized</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td id="xdx_987_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--CommonSharesMember_zKVbTqM1GdG3" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left">Common Stock</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td id="xdx_982_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--CommonSharesMember_zcv9EQE2V2N3" style="width: 9%; text-align: right">300,659,233</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td id="xdx_98B_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--CommonSharesMember_z7rW8DmoFDNb" style="width: 9%; text-align: right">337,024,900</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_985_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--SeriesCPreferredSharesMember_fKDEp_zr5cmvWrTL49" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series C Auction Rate Preferred<sup>(1)</sup></span></td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_98E_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--SeriesCPreferredSharesMember_fKDEp_zt1dQ1BB79r2" style="text-align: right">2,492</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_98A_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--SeriesCPreferredSharesMember_fKDEp_z1mvkGKtneRe" style="text-align: right">4,812</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td id="xdx_989_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--SeriesDPreferredSharesMember_fKDIp_zy6XRIylzwf2" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.875% Series D Cumulative Preferred Stock (the &#8220;Series D Preferred&#8221;)<sup>(2)</sup></span></td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_981_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--SeriesDPreferredSharesMember_fKDIp_zgppFgOEUkz7" style="text-align: right">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_985_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--SeriesDPreferredSharesMember_fKDIp_zxOfKDmTMaJh" style="text-align: right">636,140</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_98E_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--SeriesEPreferredSharesMember_fKDEp_zbqKO6rCTlLg" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series E Auction Rate Preferred<sup>(1)</sup></span></td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_981_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--SeriesEPreferredSharesMember_fKDEp_zYQIY8RwemW1" style="text-align: right">1,108</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_98F_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--SeriesEPreferredSharesMember_fKDEp_zVQJpILax6a4" style="text-align: right">1,988</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td id="xdx_980_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--SeriesGPreferredSharesMember_zuokzI2UEO35" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Series G Preferred</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_98F_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--SeriesGPreferredSharesMember_zZQYulGfeP08" style="text-align: right">2,520,627</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_98C_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--SeriesGPreferredSharesMember_zQvVudRpnmLh" style="text-align: right">2,959,830</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_983_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--SeriesHPreferredSharesMember_z8kju9w66ue9" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Series H Preferred</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_989_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--SeriesHPreferredSharesMember_zZPRfpRck7m8" style="text-align: right">4,083,160</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_985_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--SeriesHPreferredSharesMember_zY3FrYEZN685" style="text-align: right">4,109,167</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td id="xdx_98C_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--SeriesJPreferredSharesMember_fKDMp_zti0TaJNrMp3" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.45% Series J Cumulative Preferred Stock (the &#8220;Series J Preferred&#8221;)<sup>(3)</sup></span></td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_98D_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--SeriesJPreferredSharesMember_fKDMp_zJIDGKAacer4" style="text-align: right">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_98D_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--SeriesJPreferredSharesMember_fKDMp_zp6hcx1szaY3" style="text-align: right">1,300,000</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_983_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--SeriesKPreferredSharesMember_zsVvgQAlAHR" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Series K Preferred</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_981_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--SeriesKPreferredSharesMember_zhucs1J6Nf5l" style="text-align: right">3,813,640</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_981_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--SeriesKPreferredSharesMember_zfJMUPLjDnxc" style="text-align: right">3,813,640</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td id="xdx_981_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--SeriesMPreferredSharesMember_ze9EHkEuyjoh" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Series M Preferred</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_989_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--SeriesMPreferredSharesMember_zLXgIyIT3Bfj" style="text-align: right">685,500</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_986_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--SeriesMPreferredSharesMember_zOlp3NekX1Xa" style="text-align: right">1,000,000</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_988_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--SeriesNPreferredSharesMember_fKDQp_zcVA0VGv5dj" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series N Preferred<sup>(4)</sup></span></td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_988_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--SeriesNPreferredSharesMember_fKDQp_z7bJ0UCCnRB1" style="text-align: right">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_984_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--SeriesNPreferredSharesMember_fKDQp_zambtTnL1GK3" style="text-align: right">350,000</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td id="xdx_981_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--PreferredShareMember_fKDUp_zOhGvNFx41He" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred Stock<sup>(5)</sup></span></td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_981_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--PreferredSharesMember_fKDUp_zQnRN00lu7H4" style="text-align: right">0</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_98B_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--PreferredSharesMember_fKDUp_znXyVFL7CTCf" style="text-align: right">18,799,523</td>
    <td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F06_zC8C67MHA0l8">(1)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span id="xdx_F16_zTt5jbBZjG64" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund commenced a tender offer for all of its outstanding Series C Auction Rate Preferred and Series E Auction Rate Preferred on November&#160;16, 2023. The tender offer is scheduled to expire on January&#160;5, 2024.</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F01_zFaEaP71LMtf">(2)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span id="xdx_F10_zebcZKHFTBtj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund redeemed all of its outstanding Series D Preferred on December&#160;26, 2019.</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F00_zKUL6PUiZT1j">(3)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span id="xdx_F1C_zy4U0XwRlpqb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund redeemed all of its outstanding Series J Preferred on January&#160;31, 2022.</span></td> </tr>
  </table>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left; text-indent: 0in; vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F0A_znGbxbrpUrph">(4)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span id="xdx_F13_zEZPV1JdEGt3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December&#160;1, 2023, the Fund&#8217;s Board approved an offering of up to 350,000 shares of the Series N Preferred for an aggregate maximum offering amount of up to $35,000,000. On December&#160;12, 2023, the Fund filed Articles Supplementary with the State Department of Assessments and Taxation of Maryland classifying and designating 350,000 shares of preferred stock, without further designation as to class or series, as shares of Series N Preferred. The Series N Preferred are not registered under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), or listed on a securities exchange. The Fund issued 147,750 Series N Preferred in an initial closing for the offering of the Series N Preferred on December&#160;28, 2023.</span></td> </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F04_zWBR6q3wGmIh">(5)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span id="xdx_F1C_zHGrLoGacqd2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Preferred Stock&#8221; refers to the Fund&#8217;s authorized and unissued shares of preferred stock without further designation as to class or series.</span></td> </tr>
  </table>

<p id="xdx_8AB_zPCX9UiFHhP8" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of October&#160;31, 2023, the Fund did not hold any shares of capital stock for its account. Upon a liquidation, each holder of preferred stock will be entitled to receive out of the assets of the Fund available for distribution to stockholders (after payment of claims of the Fund&#8217;s creditors but before any distributions with respect to the Fund&#8217;s common stock or any other class of capital stock of the Fund ranking junior to the preferred stock as to liquidation payments) an amount per share equal to such share&#8217;s liquidation preference plus any accumulated but unpaid distributions (whether or not earned or declared, excluding interest thereon) to the date of distribution, and such stockholders shall be entitled to no further participation in any distribution or payment in connection with such liquidation. Each series of preferred stock ranks on a parity with all other series of preferred stock of the Fund as to the payment of distributions and the distribution of assets upon liquidation, and is junior to the Fund&#8217;s obligations with respect to any outstanding senior securities representing debt. The preferred stock carries one vote per share on all matters on which such shares are entitled to vote. The issued and outstanding preferred stock is fully paid and non-assessable and has no preemptive, exchange or conversion rights. The Board may by resolution classify or reclassify any authorized but unissued shares of stock of the Fund from time to time by setting or changing the preferences, conversion or other rights, voting powers, restrictions, limitations as to dividends or other distributions and terms and conditions of redemption. The Fund will not issue any class of capital stock senior to the preferred stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Rating Agency Guidelines</i>. New issuances of shares of preferred stock may, but are not required to, be issued with a specified rating by a nationally recognized statistical rating organization. To the extent the Fund seeks a rating agency for its shares of preferred stock, the Fund expects that it will be required under Moody&#8217;s and Fitch guidelines to maintain assets having in the aggregate a discounted value at least equal to the Basic Maintenance Amount (as defined below) for its outstanding preferred stock with respect to the separate guidelines Moody&#8217;s and Fitch has each established for determining discounted value. To the extent any particular portfolio holding does not satisfy the applicable rating agency&#8217;s guidelines, all or a portion of such holding&#8217;s value will not be included in the calculation of discounted value (as defined by such rating agency). The Moody&#8217;s and Fitch guidelines also impose certain diversification requirements and industry concentration limitations on the Fund&#8217;s overall portfolio, and apply specified discounts to securities held by the Fund (except certain money market securities). The &#8220;Basic Maintenance Amount&#8221; is calculated as set out in the organizational documents for each series of preferred stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the Fund does not cure in a timely manner a failure to maintain a discounted value of its portfolio equal to the Basic Maintenance Amount in accordance with the requirements of the applicable rating agency or agencies then rating the preferred stock at the request of the Fund, the Fund may, and in certain circumstances will be required to, mandatorily redeem preferred stock, as described below under &#8220;&#8212;Redemption.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund may, but is not required to, adopt any modifications to the rating agency guidelines that may hereafter be established by Moody&#8217;s and Fitch. Failure to adopt any such modifications, however, may result in a change in the relevant rating agency&#8217;s ratings or a withdrawal of such ratings altogether. In addition, any rating agency providing a rating for the preferred stock at the request of the Fund may, at any time, change or withdraw any such rating. The Board, without further action by the stockholders, may amend, alter, add to or repeal certain of the definitions and related provisions that have been adopted by the Fund pursuant to the rating agency guidelines if the Board determines that such modification is necessary to prevent a reduction in rating of the preferred stock by Moody&#8217;s and Fitch, as the case may be, is in the best interests of the holders of common stock and is not adverse to the holders of preferred stock in view of advice to the Fund by Moody&#8217;s and Fitch (or such other rating agency then rating the preferred stock at the request of the Fund) that such modification would not adversely affect, as the case may be, its then current rating of the preferred stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As described by Moody&#8217;s and Fitch, the ratings assigned to each series of preferred stock are assessments of the capacity and willingness of the Fund to pay the obligations of each such series. The ratings on these series of preferred stock are not recommendations to purchase, hold or sell shares of any series, inasmuch as the ratings do not comment as to market price or suitability for a particular investor. The rating agency guidelines also do not address the likelihood that an owner of preferred stock will be able to sell such shares on an exchange, in an auction or otherwise. The ratings are based on current information furnished to Moody&#8217;s and Fitch by the Fund and the Investment Adviser and information obtained from other sources. The ratings may be changed, suspended or withdrawn as a result of changes in, or the unavailability of, such information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The rating agency guidelines apply to each series of preferred stock only so long as such rating agency is rating such series at the request of the Fund. The Fund pays fees to Moody&#8217;s and Fitch for rating the preferred stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Asset Maintenance Requirements</i>. In addition to the requirements summarized under &#8220;&#8212;Rating Agency Guidelines&#8221; above, the Fund must also satisfy asset maintenance requirements under the 1940 Act with respect to its preferred stock. Under the 1940 Act, debt or additional preferred stock may be issued only if immediately after such issuance the value of the Fund&#8217;s total assets (less ordinary course liabilities) is at least 300% of the amount of any debt outstanding and at least 200% of the amount of any preferred stock and debt outstanding. The Fund is required under the applicable Articles Supplementary to determine whether it has, as of the last business day of each March, June, September and December of each year (for its Series E Auction Rate Preferred, Series H Preferred, Series K Preferred, Series M Preferred and Series N Preferred), at the time the Fund declares or pays any dividend or distribution on its common stock (other than a dividend payable solely in shares of common stock) and at the time the Fund purchases any of its common stock (for its Series G Preferred), and as of the last business day of each week (for its Series C Auction Rate Preferred), an &#8220;asset coverage&#8221; (as defined in the 1940 Act) of at least 200% (or such higher or lower percentage as may be required at the time under the 1940 Act) with respect to all outstanding senior securities of the Fund that are debt or stock, including any outstanding preferred stock. If the Fund fails to maintain the asset coverage required under the 1940 Act on such dates and such failure is not cured on or before 60 days, in the case of the Fixed Rate Preferred Stock, or 10 business days, in the case of the Auction Rate Preferred Stock, the Fund may, and in certain circumstances will be required to, mandatorily redeem the minimum number of shares of preferred stock sufficient to satisfy such asset coverage. See &#8220;&#8212;Redemption&#8221; below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Distributions</i>. In connection with the offering of one or more additional series of preferred stock, an accompanying Prospectus Supplement will specify whether dividends on such preferred stock will be based on a constant fixed rate or on a fixed rate that changes after an initial period (e.g., one year). Holders of additional shares of such &#8220;Fixed Rate Preferred Stock&#8221; will be entitled to receive, out of funds legally available therefor, cumulative cash distributions, at an annual rate set forth in the applicable Prospectus Supplement, payable with such frequency as set forth in the applicable Prospectus Supplement. Such distributions will accumulate from the date on which such shares are issued.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Restrictions on Dividends and Other Distributions for the Preferred Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">So long as any preferred stock is outstanding, the Fund may not pay any dividend or other distribution (other than a dividend or other distribution paid in common stock or in options, warrants or rights to subscribe for or purchase common stock) in respect of the common stock or call for redemption, redeem, purchase or otherwise acquire for consideration any common stock (except by conversion into or exchange for shares of the Fund ranking junior to the preferred stock as to the payment of dividends or distributions and the distribution of assets upon liquidation), unless:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in"></td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Fund has declared and paid (or provided to the relevant dividend paying agent) all cumulative distributions on the Fund&#8217;s outstanding preferred stock due on or prior to the date of such common stock dividend or distribution;</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Fund has redeemed the full number of shares of preferred stock to be redeemed pursuant to any mandatory redemption provision in the Fund&#8217;s Governing Documents; and</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">after making the distribution, the Fund meets applicable asset coverage requirements described under &#8220;&#8212;Rating Agency Guidelines&#8221; and &#8220;&#8212;Asset Maintenance Requirements.&#8221;</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No full distribution will be declared or made on any series of preferred stock for any dividend period, or part thereof, unless full cumulative distributions due through the most recent dividend payment dates therefor for all outstanding series of preferred stock of the Fund ranking on a parity with such series as to distributions have been or contemporaneously are declared and made. If full cumulative distributions due have not been made on all outstanding preferred stock of the Fund ranking on a parity with such series of preferred stock as to the payment of distributions, any distributions being paid on the preferred stock will be paid as nearly pro rata as possible in proportion to the respective amounts of distributions accumulated but unmade on each such series of preferred stock on the relevant dividend payment date. The Fund&#8217;s obligation to make distributions on the preferred stock will be subordinate to its obligations to pay interest and principal, when due, on any senior securities representing debt.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Redemption</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Mandatory Redemption Relating to Asset Coverage Requirements.</i> The Fund may, at its option, consistent with its Governing Documents and the 1940 Act, and in certain circumstances will be required to, mandatorily redeem preferred stock in the event that:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Fund fails to maintain the asset coverage requirements specified under the 1940 Act on a quarterly valuation date and such failure is not cured on or before 60 days, in the case of the existing Fixed Rate Preferred Stock, following such failure; or</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Fund fails to maintain the asset coverage requirements as calculated in accordance with the applicable rating agency guidelines as of any monthly valuation date, and such failure is not cured on or before 10 business days after such valuation date.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The redemption price for preferred stock subject to mandatory redemption will be the liquidation preference, as stated in the Articles Supplementary of each existing series of preferred stock or the Prospectus Supplement accompanying the issuance of any additional series of preferred stock, including an amount equal to any accumulated but unpaid distributions (whether or not earned or declared) to the date fixed for redemption.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The number of shares of preferred stock that will be redeemed in the case of a mandatory redemption will equal the minimum number of outstanding shares of preferred stock, the redemption of which, if such redemption had occurred immediately prior to the opening of business on the applicable cure date, would have resulted in the relevant asset coverage requirement having been met or, if the required asset coverage cannot be so restored, all of the shares of preferred stock. In the event that shares of preferred stock are redeemed due to a failure to satisfy the 1940 Act asset coverage requirements, the Fund may, but is not required to, redeem a sufficient number of shares of preferred stock so that the Fund&#8217;s assets exceed the asset coverage requirements under the 1940 Act after the redemption by 10% (that is, 210% asset coverage). In the event that shares of preferred stock are redeemed due to a failure to satisfy applicable rating agency guidelines, the Fund may, but is not required to, redeem a sufficient number of shares of preferred stock so that the Fund&#8217;s discounted portfolio value (as determined in accordance with the applicable rating agency guidelines) after redemption exceeds the asset coverage requirements of each applicable rating agency by up to 10% (that is, 110% rating agency asset coverage).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the Fund does not have funds legally available for the redemption of, or is otherwise unable to redeem, all the shares of preferred stock to be redeemed on any redemption date, the Fund will redeem on such redemption date that number of shares for which it has legally available funds, or is otherwise able to redeem, from the holders whose shares are to be redeemed ratably on the basis of the redemption price of such shares, and the remainder of those shares to be redeemed will be redeemed on the earliest practicable date on which the Fund will have funds legally available for the redemption of, or is otherwise able to redeem, such shares upon written notice of redemption.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If fewer than all shares of the Fund&#8217;s outstanding preferred stock are to be redeemed, the Fund, at its discretion and subject to the limitations of the Charter, the 1940 Act, and Maryland law, will select one or more series of preferred stock from which shares will be redeemed and the amount of preferred stock to be redeemed from each such series. If fewer than all shares of a series of preferred stock are to be redeemed, such redemption will be made as among the holders of that series pro rata in accordance with the respective number of shares of such series held by each such holder on the record date for such redemption. If fewer than all shares of preferred stock held by any holder are to be redeemed, the notice of redemption mailed to such holder will specify the number of shares to be redeemed from such holder, which may be expressed as a percentage of shares held on the applicable record date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Optional Redemption of Fixed Rate Preferred Stock</i>. Shares of any additional series of Fixed Rate Preferred Stock will not be subject to optional redemption by the Fund until the date, if any, specified in the applicable Prospectus or Prospectus Supplement, unless such redemption is necessary, in the judgment of the Fund, to maintain the Fund&#8217;s status as a regulated investment company under the Code. Commencing on such date and thereafter, the Fund may at any time redeem such Fixed Rate Preferred Stock in whole or in part for cash at a redemption price per share equal to the liquidation preference per share plus accumulated and unpaid distributions (whether or not earned or declared) to the redemption date. Such redemptions are subject to the notice requirements set forth under &#8220;&#8212;Redemption Procedures&#8221; and the limitations of the Charter, the 1940 Act and Maryland law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Redemption Procedures</i>. A notice of redemption with respect to an optional redemption will be given to the holders of record of preferred stock selected for redemption not less than (a) 15 days (subject to NYSE requirements), nor more than 40 days prior (in the case of the Series H Preferred, Series K Preferred, Series G Preferred, Series C Auction Rate Preferred, Series J Preferred, Series D Preferred, and Series F Preferred), (b) not less than 7 days, not more than 40 days prior (in the case of the Series E Auction Rate Preferred), (c) not less than 30 days, nor more than 60 days prior (in the case of the Series M Preferred) or (d) 30 days prior (in the case of the Series N Preferred) to the date fixed for redemption. Preferred stockholders may receive shorter notice in the event of a mandatory redemption. Each notice of redemption will state (i) the redemption date, (ii) the number or percentage of shares of preferred stock to be redeemed (which may be expressed as a percentage of such shares outstanding), (iii) the CUSIP number(s) of such shares, (iv) the redemption price (specifying the amount of accumulated distributions to be included therein), (v) the place or places where such shares are to be redeemed, (vi) that distributions on the shares to be redeemed will cease to accrue on such redemption date, (vii) the provision of the Articles Supplementary for the applicable series of preferred stock under which the redemption is being made and (viii) (except in the case of the Series C Auction Rate Preferred) any conditions precedent to such redemption. No defect in the notice of redemption or in the mailing thereof will affect the validity of the redemption proceedings, except as required by applicable law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The holders of preferred stock, whether subject to a variable or fixed rate, will not have the right to redeem any of their shares at their option, unless specifically provided in the Charter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liquidation Preference</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Fund, the holders of preferred stock then outstanding will be entitled to receive a preferential liquidating distribution, which is expected to equal the original purchase price per share of preferred stock plus accumulated and unpaid dividends, whether or not earned or declared, before any distribution of assets is made to holders of common stock. After payment of the full amount of the liquidating distribution to which they are entitled, the holders of preferred stock will not be entitled to any further participation in any distribution of assets by the Fund.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Voting Rights</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except as otherwise stated in this Prospectus, specified in the Charter or resolved by the Board or as otherwise required by applicable law, holders of preferred stock shall be entitled to one vote per share held on each matter submitted to a vote of the stockholders of the Fund and will vote together with holders of common stock and of any other preferred stock then outstanding as a single class.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the election of the Fund&#8217;s Directors, holders of the outstanding shares of preferred stock, voting together as a separate class, will be entitled at all times to elect two of the Fund&#8217;s Directors, and the remaining Directors will be elected by holders of common stock and holders of preferred stock, voting together as a single class. In addition, if (i) at any time dividends and distributions on outstanding shares of preferred stock are unpaid in an amount equal to at least two full years&#8217; dividends and distributions thereon and sufficient cash or specified securities have not been deposited with the applicable paying agent for the payment of such accumulated dividends and distributions or (ii) at any time holders of any other series of preferred stock are entitled to elect a majority of the Directors of the Fund under the 1940 Act or the applicable Articles Supplementary creating such shares, then the number of Directors constituting the Board automatically will be increased by the smallest number that, when added to the two Directors elected exclusively by the holders of preferred stock as described above, would then constitute a simple majority of the Board as so increased by such smallest number. Such additional Directors will be elected by</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the holders of the outstanding shares of preferred stock, voting together as a separate class, at a special meeting of stockholders which will be called as soon as practicable and will be held not less than ten nor more than twenty days after the mailing date of the meeting notice. If the Fund fails to send such meeting notice or to call such a special meeting, the meeting may be called by any preferred stockholder on like notice. The terms of office of the persons who are Directors at the time of that election will continue. If the Fund thereafter pays, or declares and sets apart for payment in full, all dividends and distributions payable on all outstanding shares of preferred stock for all past dividend periods or the holders of other series of preferred stock are no longer entitled to elect such additional Directors, the additional voting rights of the holders of the preferred stock as described above will cease, and the terms of office of all of the additional Directors elected by the holders of the preferred stock (but not of the Directors with respect to whose election the holders of common stock were entitled to vote or the two Directors the holders of preferred stock have the right to elect as a separate class in any event) will terminate at the earliest time permitted by law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">So long as shares of preferred stock are outstanding, the Fund will not, without the affirmative vote of the holders of a majority (as defined in the 1940 Act) of the shares of preferred stock outstanding at the time, and present and voting on such matter, voting together as a separate class, amend, alter or repeal the provisions of the Charter whether by merger, consolidation or otherwise, so as to materially and adversely affect any of the rights, preferences or powers expressly set forth in the Charter with respect to such shares of preferred stock, unless the Fund obtains written confirmation from Moody&#8217;s, Fitch or any such other rating agency then rating the preferred stock that such amendment, alteration or repeal would not impair the rating then assigned by such rating agency to the preferred stock, in which case the vote or consent of the holders of the preferred stock is not required. Also, to the extent permitted under the 1940 Act, in the event shares of more than one series of preferred stock are outstanding, the Fund will not approve any action that materially and adversely affects the rights, preferences or powers expressly set forth in the Charter with respect to such shares of a series of preferred stock differently than those of shares of any other series of preferred stock without the affirmative vote of the holders of at least a majority, as defined in the 1940 Act, of the outstanding shares of preferred stock of each series materially adversely affected and outstanding at such time (each such materially adversely affected series voting as a separate class to the extent its rights are affected differently). For purposes of this paragraph, no matter shall be deemed to adversely affect any right, preference or power unless such matter (i) adversely alters or abolishes any preferential right of such series; (ii) creates, adversely alters or abolishes any right in respect of redemption of such series; or (iii) creates or adversely alters (other than to abolish) any restriction on transfer applicable to such series.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the Charter and applicable provisions of the 1940 Act and Maryland law, the affirmative vote of the holders of a majority, as defined under the 1940 Act, of the outstanding shares of the preferred stock, voting together as a separate class, will be required to approve any plan of reorganization adversely affecting the preferred stock or any action requiring a vote of security holders under Section&#160;13(a) of the 1940 Act (other than a conversion of the Fund from a closed-end to an open-end investment company), including, among other things, changes in the Fund&#8217;s investment objectives or changes in the investment restrictions described as fundamental policies under &#8220;Investment Objectives and Policies&#8221; in this Prospectus and the SAI, &#8220;How the Fund Manages Risk&#8212;Investment Restrictions&#8221; in this Prospectus and &#8220;Investment Restrictions&#8221; in the SAI. Under the Charter, the affirmative vote of the holders of 66 &#8532;% of the outstanding shares of each class of stock of the Fund normally entitled to vote in the election of directors, each such class voting as a separate class, is required to authorize the conversion of the Fund from a closed-end to an open-end investment company. For purposes of this paragraph, except as otherwise required under the 1940 Act, the vote of the holders of a majority of the outstanding shares of preferred stock means, in accordance with Section&#160;2(a)(42) of the 1940 Act, the vote, at the annual or a special meeting of the stockholders of the Fund duly called (i) of 67% or more of the shares of preferred stock present at such meeting, if the holders of more than 50% of the outstanding shares of preferred stock are present or represented by proxy, or (ii) more than 50% of the outstanding shares of preferred stock, whichever is less. The class vote of holders of preferred stock described above will in each case be in addition to any other approvals by shareholders that may be required under the 1940 Act to authorize the action in question.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The calculation of the elements and definitions of certain terms of the rating agency guidelines may be modified by action of the Board without further action by the stockholders if the Board determines that such modification is necessary to prevent a reduction in rating of the shares of preferred stock by Moody&#8217;s and/or Fitch (or such other rating agency then rating the preferred stock at the request of the Fund), as the case may be, or is in the best interests of the holders of common stock and is not adverse to the holders of preferred stock in view of advice to the Fund by the relevant rating agencies that such modification would not adversely affect its then-current rating of the preferred stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The foregoing voting provisions will not apply to any series of preferred stock if, at or prior to the time when the act with respect to which such vote otherwise would be required will be effected, such stock will have been redeemed or called for redemption and sufficient cash or cash equivalents provided to the applicable paying agent to effect such redemption. The holders of preferred stock will have no preemptive rights or rights to cumulative voting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Limitation on Issuance of Preferred Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">So long as the Fund has preferred stock outstanding, subject to receipt of approval from the rating agencies of each series of preferred stock outstanding, and subject to compliance with the Fund&#8217;s investment objectives, policies and restrictions, the Fund may issue and sell shares of one or more other series of additional preferred stock provided that the Fund will, immediately after giving effect to the issuance of such additional preferred stock and to its receipt and application of the proceeds thereof (including, without limitation, to the redemption of preferred stock to be redeemed out of such proceeds), have an &#8220;asset coverage&#8221; for all senior securities of the Fund which are stock, as defined in the 1940 Act, of at least 200% of the sum of the liquidation preference of the shares of preferred stock of the Fund then outstanding and all indebtedness of the Fund constituting senior securities, and no such additional preferred stock will have any preference or priority over any other preferred stock of the Fund upon the distribution of the assets of the Fund or in respect of the payment of dividends or distributions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund will consider from time to time whether to offer additional preferred stock or securities representing indebtedness and may issue such additional securities if the Board concludes that such an offering would be consistent with the Charter and applicable law, and in the best interest of the Fund.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Book Entry</i>. Shares of Fixed Rate Preferred Stock sold through this offering will initially be held in the name of Cede &amp; Co. as nominee for DTC. The Fund will treat Cede &amp; Co. as the holder of record of such shares for all purposes. In accordance with the procedures of DTC, however, purchasers of Fixed Rate Preferred Stock will be deemed the beneficial owners of shares purchased for purposes of dividends, voting and liquidation rights.</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityAuthorizedShares', window );">Outstanding Security, Authorized [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="nump">18,799,523<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityHeldShares', window );">Outstanding Security, Held [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=gab_CumulativePreferredSharesAuctionRateSeriesCPreferredMember', window );">Cumulative Preferred Shares Auction Rate Series C Preferred [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_FinancialHighlightsAbstract', window );"><strong>Financial Highlights [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SeniorSecuritiesAmt', window );">Senior Securities Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 62,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 62,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 62,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 62,300<span></span>
</td>
<td class="nump">$ 72,000<span></span>
</td>
<td class="nump">$ 72,000<span></span>
</td>
<td class="nump">$ 72,000<span></span>
</td>
<td class="nump">$ 72,000<span></span>
</td>
<td class="nump">$ 72,000<span></span>
</td>
<td class="nump">$ 72,000<span></span>
</td>
<td class="nump">$ 72,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SeniorSecuritiesCvgPerUnit', window );">Senior Securities Coverage per Unit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 118,342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 113,590<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 116,432<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 111,456<span></span>
</td>
<td class="nump">$ 108,305<span></span>
</td>
<td class="nump">$ 105,562<span></span>
</td>
<td class="nump">$ 123,830<span></span>
</td>
<td class="nump">$ 102,426<span></span>
</td>
<td class="nump">$ 118,593<span></span>
</td>
<td class="nump">$ 136,308<span></span>
</td>
<td class="nump">$ 128,106<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=gab_CumulativePreferredShares5.875SerieAPreferredMember', window );">Cumulative Preferred Shares 5. 875 Serie A Preferred [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_FinancialHighlightsAbstract', window );"><strong>Financial Highlights [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SeniorSecuritiesAmt', window );">Senior Securities Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 59,097<span></span>
</td>
<td class="nump">$ 59,097<span></span>
</td>
<td class="nump">$ 59,097<span></span>
</td>
<td class="nump">$ 59,097<span></span>
</td>
<td class="nump">$ 59,097<span></span>
</td>
<td class="nump">$ 59,097<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SeniorSecuritiesCvgPerUnit', window );">Senior Securities Coverage per Unit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 105.56<span></span>
</td>
<td class="nump">$ 123.83<span></span>
</td>
<td class="nump">$ 102.43<span></span>
</td>
<td class="nump">$ 118.59<span></span>
</td>
<td class="nump">$ 136.31<span></span>
</td>
<td class="nump">$ 128.11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=gab_CumulativePreferredSharesAuctionRateSeriesEPreferredMember', window );">Cumulative Preferred Shares Auction Rate Series E Preferred [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_FinancialHighlightsAbstract', window );"><strong>Financial Highlights [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SeniorSecuritiesAmt', window );">Senior Securities Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,700<span></span>
</td>
<td class="nump">$ 28,000<span></span>
</td>
<td class="nump">$ 28,000<span></span>
</td>
<td class="nump">$ 28,000<span></span>
</td>
<td class="nump">$ 28,000<span></span>
</td>
<td class="nump">$ 28,000<span></span>
</td>
<td class="nump">$ 28,000<span></span>
</td>
<td class="nump">$ 28,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SeniorSecuritiesCvgPerUnit', window );">Senior Securities Coverage per Unit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 118,342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 113,590<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 116,432<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 111,456<span></span>
</td>
<td class="nump">$ 108,305<span></span>
</td>
<td class="nump">$ 105,562<span></span>
</td>
<td class="nump">$ 123,830<span></span>
</td>
<td class="nump">$ 102,426<span></span>
</td>
<td class="nump">$ 118,593<span></span>
</td>
<td class="nump">$ 136,308<span></span>
</td>
<td class="nump">$ 128,106<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=gab_CumulativePreferredShares5.000SerieGPreferredMember', window );">Cumulative Preferred Shares 5. 000 Serie G Preferred [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_FinancialHighlightsAbstract', window );"><strong>Financial Highlights [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SeniorSecuritiesAmt', window );">Senior Securities Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64,647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 65,060<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69,491<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69,491<span></span>
</td>
<td class="nump">$ 69,495<span></span>
</td>
<td class="nump">$ 69,495<span></span>
</td>
<td class="nump">$ 69,495<span></span>
</td>
<td class="nump">$ 69,743<span></span>
</td>
<td class="nump">$ 69,925<span></span>
</td>
<td class="nump">$ 70,099<span></span>
</td>
<td class="nump">$ 70,373<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SeniorSecuritiesCvgPerUnit', window );">Senior Securities Coverage per Unit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 118.34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 113.59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 116.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 111.46<span></span>
</td>
<td class="nump">$ 108.30<span></span>
</td>
<td class="nump">$ 105.56<span></span>
</td>
<td class="nump">$ 123.83<span></span>
</td>
<td class="nump">$ 102.43<span></span>
</td>
<td class="nump">$ 118.59<span></span>
</td>
<td class="nump">$ 136.31<span></span>
</td>
<td class="nump">$ 128.11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=gab_CumulativePreferredShares5.000SerieHPreferredMember', window );">Cumulative Preferred Shares 5. 000 Serie H Preferred [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_FinancialHighlightsAbstract', window );"><strong>Financial Highlights [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SeniorSecuritiesAmt', window );">Senior Securities Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 102,910<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 103,195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 104,322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 104,322<span></span>
</td>
<td class="nump">$ 104,322<span></span>
</td>
<td class="nump">$ 104,322<span></span>
</td>
<td class="nump">$ 104,322<span></span>
</td>
<td class="nump">$ 104,494<span></span>
</td>
<td class="nump">$ 104,644<span></span>
</td>
<td class="nump">$ 104,674<span></span>
</td>
<td class="nump">$ 104,757<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SeniorSecuritiesCvgPerUnit', window );">Senior Securities Coverage per Unit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 118.34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 113.59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 116.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 111.46<span></span>
</td>
<td class="nump">$ 108.30<span></span>
</td>
<td class="nump">$ 105.56<span></span>
</td>
<td class="nump">$ 123.83<span></span>
</td>
<td class="nump">$ 102.43<span></span>
</td>
<td class="nump">$ 118.59<span></span>
</td>
<td class="nump">$ 136.31<span></span>
</td>
<td class="nump">$ 128.11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=gab_CumulativePreferredShares5.450SerieJPreferredMember', window );">Cumulative Preferred Shares 5. 450 Serie J Preferred [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_FinancialHighlightsAbstract', window );"><strong>Financial Highlights [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SeniorSecuritiesAmt', window );">Senior Securities Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80,000<span></span>
</td>
<td class="nump">$ 80,000<span></span>
</td>
<td class="nump">$ 80,000<span></span>
</td>
<td class="nump">$ 80,000<span></span>
</td>
<td class="nump">$ 80,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SeniorSecuritiesCvgPerUnit', window );">Senior Securities Coverage per Unit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 116.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 111.46<span></span>
</td>
<td class="nump">$ 108.30<span></span>
</td>
<td class="nump">$ 105.56<span></span>
</td>
<td class="nump">$ 123.83<span></span>
</td>
<td class="nump">$ 102.43<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=gab_CumulativePreferredShares5.000SerieKPreferredMember', window );">Cumulative Preferred Shares 5. 000 Serie K Preferred [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_FinancialHighlightsAbstract', window );"><strong>Financial Highlights [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SeniorSecuritiesAmt', window );">Senior Securities Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 98,243<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 98,243<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 99,825<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 99,825<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SeniorSecuritiesCvgPerUnit', window );">Senior Securities Coverage per Unit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 118.34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 113.59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 116.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 111.46<span></span>
</td>
<td class="nump">$ 108.30<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=gab_CumulativePreferredShares4.250SerieMCumulativePreferredMember', window );">Cumulative Preferred Shares 4. 250 Serie M Cumulative Preferred [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_FinancialHighlightsAbstract', window );"><strong>Financial Highlights [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SeniorSecuritiesAmt', window );">Senior Securities Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 68,550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 68,550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SeniorSecuritiesCvgPerUnit', window );">Senior Securities Coverage per Unit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 473.37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 113.59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 116.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=gab_CumulativePreferredShares5.875SerieDPreferredMember', window );">Cumulative Preferred Shares 5. 875 Serie D Preferred [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_FinancialHighlightsAbstract', window );"><strong>Financial Highlights [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SeniorSecuritiesAmt', window );">Senior Securities Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 59,097<span></span>
</td>
<td class="nump">$ 59,097<span></span>
</td>
<td class="nump">$ 59,097<span></span>
</td>
<td class="nump">$ 59,097<span></span>
</td>
<td class="nump">$ 59,097<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SeniorSecuritiesCvgPerUnit', window );">Senior Securities Coverage per Unit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 123.83<span></span>
</td>
<td class="nump">$ 102.43<span></span>
</td>
<td class="nump">$ 118.59<span></span>
</td>
<td class="nump">$ 136.31<span></span>
</td>
<td class="nump">$ 128.11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=gab_HowTheFundManagesRiskMember', window );">How The Fund Manages Risk [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_008"></span>HOW THE FUND MANAGES RISK</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investment Restrictions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund has adopted certain investment limitations, some of which are fundamental policies of the Fund, designed to limit investment risk and maintain portfolio diversification. Under the 1940 Act, a fundamental policy may not be changed without the vote of a majority, as defined in the 1940 Act, of the outstanding voting securities of the Fund (voting together as a single class). The Fund may become subject to guidelines that are more limiting than its current investment restrictions in order to obtain and maintain ratings from Moody&#8217;s and Fitch Ratings, Inc. (&#8220;Fitch&#8221;) on certain series of its preferred stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Interest Rate Transactions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund may enter into interest rate swap or cap transactions. The use of interest rate swaps and caps is a highly specialized activity that involves investment techniques and risks different from those associated with ordinary portfolio security transactions. In an interest rate swap, the Fund would agree to pay to the other party to the interest rate swap (which is known as the &#8220;counterparty&#8221;) periodically a fixed rate payment in exchange for the counterparty agreeing to pay to the Fund periodically a variable rate payment that is intended to approximate the Fund&#8217;s variable rate payment obligation on its outstanding Series C Auction Rate Preferred and Series E Auction Rate Preferred (together, the &#8220;Auction Rate Preferred Stock&#8221;). In an interest rate cap, the Fund would pay a premium to the counterparty to the interest rate cap and, to the extent that a specified variable rate index exceeds a predetermined fixed rate, would receive from the counterparty payments of the difference based on the notional amount of such cap. Interest rate swap and cap transactions introduce additional risk because the Fund would remain obligated to pay preferred stock dividends or distributions when due in accordance with the Articles Supplementary of the relevant series of the Auction Rate Preferred Stock even if the counterparty defaulted. Depending on the general state of short term interest rates and the returns on the Fund&#8217;s portfolio securities at that point in time, such a default could negatively affect the Fund&#8217;s ability to make dividend or distribution payments on the Auction Rate Preferred Stock. In addition, at the time an interest rate swap or cap transaction reaches its scheduled termination date, there is a risk that the Fund will not be able to obtain a replacement transaction or that the terms of the replacement will not be as favorable as on the expiring transaction. If this occurs, it could have a negative impact on the Fund&#8217;s ability to make dividend or distribution payments on the Auction Rate Preferred Stock. To the extent there is a decline in interest rates, the value of the interest rate swap or cap could decline, resulting in a decline in the asset coverage for the Auction Rate Preferred Stock. A sudden and dramatic decline in interest rates may result in a significant decline in the asset coverage. Under the Articles Supplementary for each series of preferred stock, if the Fund fails to maintain the required asset coverage on the outstanding preferred stock or fails to comply with other covenants, the Fund may be required to redeem some or all of these shares. The Fund generally may redeem any series of Auction Rate Preferred Stock, in whole or in part, at its option at any time (usually on a dividend or distribution payment date), other than during a non-call period. Such redemption would likely result in the Fund seeking to terminate early all or a portion of any swap or cap transactions. Early termination of a swap could result in a termination payment by the Fund to the counterparty, while early termination of a cap could result in a termination payment to the Fund.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund will usually enter into swaps or caps on a net basis; that is, the two payment streams will be netted out in a cash settlement on the payment date or dates specified in the instrument, with the Fund receiving or paying, as the case may be, only the net amount of the two payments. The Fund will monitor any such swap with a view to ensuring that the Fund remains in compliance with all applicable regulatory investment policy and tax requirements.</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=gab_CommonShareMember', window );">Common Share [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityTitleTextBlock', window );">Outstanding Security, Title [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_805_ecef--OutstandingSecurityTitleTextBlock_hcef--RiskAxis__custom--CommonShareMember_zKmgR8jxX1wj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to an amendment to the Fund&#8217;s Charter that was approved by stockholders in 2004, the Board may increase or decrease the aggregate number of shares of stock of the Fund or the number of shares of any class or series that the Fund has authority to issue without stockholder approval. The Fund is currently authorized to issue 337,024,900 shares of common stock, par value $0.001 per share. Holders of the common stock are entitled to one vote per share held. Holders of the common stock are entitled to share equally in distributions authorized by the Board and payable to the holders of such shares and in the net assets of the Fund available on liquidation for distribution to holders of such shares. The shares of common stock have noncumulative voting rights and no conversion, preemptive or other subscription rights, and are not redeemable. In the event of liquidation, each share of the Fund&#8217;s common stock is entitled to its proportion of the Fund&#8217;s assets after payment of debts and expenses and the amounts payable to holders of the Fund&#8217;s preferred stock ranking senior to the shares of common stock of the Fund as described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offerings of stock require approval by the Board. Any additional offering of common stock will be subject to the requirements of the 1940 Act, which provides that common stock may not be issued at a price below the then current net asset value, exclusive of sales load, except in connection with an offering to existing holders of common stock or with the consent of a majority of the Fund&#8217;s outstanding voting securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p id="xdx_891_ecef--SharePriceTableTextBlock_zczBTBcvccLb" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund&#8217;s outstanding common stock is listed and traded on the NYSE under the symbol &#8220;GAB.&#8221; The average weekly trading volume of the common stock on the NYSE during the period from January&#160;1, 2022 through December&#160;31, 2022 was 2,642,587 shares. The Fund determines its NAV on a daily basis. The following table sets forth, for the quarters indicated, the highest and lowest daily closing prices on the NYSE per common share, and the NAV per common share and the premium to or discount from NAV, on the date of each of the high and low market prices. The table also sets forth the number of common shares traded on the NYSE during the respective quarters.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Market Price</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Corresponding<br/>Net Asset Value<br/>(&#8220;NAV&#8221;) Per<br/>Share</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Corresponding<br/>Premium or<br/>Discount<br/>as a %<br/>of NAV</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: left">Quarter Ended</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">High</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Low</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">High</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Low</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">High</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Low</td>
    <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March&#160;31, 2021</span></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 7%; text-align: right"><span id="xdx_909_ecef--HighestPriceOrBid_c20210101__20210331_zPQn2Ykwikbf">7.05</span></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 7%; text-align: right"><span id="xdx_903_ecef--LowestPriceOrBid_c20210101__20210331_z0X0WYhy0GJ2">6.07</span></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 7%; text-align: right"><span id="xdx_908_ecef--HighestPriceOrBidNav_c20210101__20210331_z8Oox7IO7Zy8">6.67</span></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 7%; text-align: right"><span id="xdx_908_ecef--LowestPriceOrBidNav_c20210101__20210331_zFPZu6PGhdAd">5.78</span></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 7%; text-align: right"><span id="xdx_906_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20210101__20210331_zIJIFvq2SpH">5.70</span></td>
    <td style="width: 1%; text-align: left">%</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 7%; text-align: right"><span id="xdx_909_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20210101__20210331_zr79rJHXn1vl">5.02</span></td>
    <td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June&#160;30, 2021</span></td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_906_ecef--HighestPriceOrBid_c20210401__20210630_zPQuQX4DpsI8">7.54</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_904_ecef--LowestPriceOrBid_c20210401__20210630_zdKgIBEaWiod">6.67</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_90E_ecef--HighestPriceOrBidNav_c20210401__20210630_zmDs2s6AMPZ7">6.83</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_90F_ecef--LowestPriceOrBidNav_c20210401__20210630_zCCZghoylbIe">6.48</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_90F_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20210401__20210630_zTw4BtNgRaEi">10.40</span></td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_90E_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20210401__20210630_zMN7j9sZH8j2">2.93</span></td>
    <td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September&#160;30, 2021</span></td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_90B_ecef--HighestPriceOrBid_c20210701__20210930_zzvr1ezylsvc">7.07</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_902_ecef--LowestPriceOrBid_c20210701__20210930_zY58DLFzoE1h">6.52</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_907_ecef--HighestPriceOrBidNav_c20210701__20210930_zPd6uAzbLlC2">6.62</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_907_ecef--LowestPriceOrBidNav_c20210701__20210930_zw7HUFGq64Cf">6.26</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_901_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20210701__20210930_zLJwf5KEk0ab">6.80</span></td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_90B_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20210701__20210930_z4UoR2cFdBT5">4.15</span></td>
    <td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December&#160;31, 2021</span></td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_902_ecef--HighestPriceOrBid_c20211001__20211231_zGLSoRbSM8lc">7.37</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_909_ecef--LowestPriceOrBid_c20211001__20211231_zBLAut2UyUmh">6.64</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_90A_ecef--HighestPriceOrBidNav_c20211001__20211231_zDs7lTSCKwZ3">6.46</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_90E_ecef--LowestPriceOrBidNav_c20211001__20211231_z8I9QEE7a1r7">6.28</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_90E_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20211001__20211231_z0yVQnbUpBve">14.09</span></td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_901_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20211001__20211231_zTo6Yc4VZWwa">5.73</span></td>
    <td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March&#160;31, 2022</span></td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_909_ecef--HighestPriceOrBid_c20220101__20220331_zv4HL5aEACve">7.24</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_902_ecef--LowestPriceOrBid_c20220101__20220331_zxR7zHk2CYp2">6.76</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_90A_ecef--HighestPriceOrBidNav_c20220101__20220331_z6lMWfqijXi1">6.45</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_907_ecef--LowestPriceOrBidNav_c20220101__20220331_zN9OL4WO8H2b">5.79</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_906_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20220101__20220331_zlPFJwupSjKl">12.25</span></td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_90D_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20220101__20220331_zfWHgDEsTlX1">16.75</span></td>
    <td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June&#160;30, 2022</span></td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_901_ecef--HighestPriceOrBid_c20220401__20220630_zlkJuqKDvDw5">7.05</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_901_ecef--LowestPriceOrBid_c20220401__20220630_zPg6jvxDP6p4">5.54</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_90A_ecef--HighestPriceOrBidNav_c20220401__20220630_zGhosLxVmCI8">5.95</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_902_ecef--LowestPriceOrBidNav_c20220401__20220630_zhWE3h6l1TF1">4.73</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_904_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20220401__20220630_zNIQD6Tynh21">18.49</span></td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_904_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20220401__20220630_zrzXcHRCTF3i">17.12</span></td>
    <td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September&#160;30, 2022</span></td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_90D_ecef--HighestPriceOrBid_c20220701__20220930_zTtzoUDASF0e">6.53</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_90A_ecef--LowestPriceOrBid_c20220701__20220930_zR3OmP299GXh">5.50</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_905_ecef--HighestPriceOrBidNav_c20220701__20220930_zEOGYutkZT0b">5.37</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_900_ecef--LowestPriceOrBidNav_c20220701__20220930_zbSAdU003rdf">4.47</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_905_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20220701__20220930_z1aOixqVsh29">21.60</span></td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_90B_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20220701__20220930_zxdTuOLQ1m89">23.04</span></td>
    <td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December&#160;31, 2022</span></td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_90C_ecef--HighestPriceOrBid_c20221001__20221231_zmVYoSoZ8YXd">6.16</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_906_ecef--LowestPriceOrBid_c20221001__20221231_zXbn6q1z8lz2">4.97</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_908_ecef--HighestPriceOrBidNav_c20221001__20221231_z0TJgXXgSpjb">5.53</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_909_ecef--LowestPriceOrBidNav_c20221001__20221231_zyCzlA3ua6K5">4.54</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_909_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20221001__20221231_z0hXHkWwbEib">11.39</span></td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_906_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20221001__20221231_zWKaFtTUWLqi">9.47</span></td>
    <td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March&#160;31, 2023</span></td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_907_ecef--HighestPriceOrBid_c20230101__20230331_zYunadAE1eLd">5.99</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_901_ecef--LowestPriceOrBid_c20230101__20230331_zspe6oXWVOI8">5.41</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_908_ecef--HighestPriceOrBidNav_c20230101__20230331_zlEkpfytnkk">5.53</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_90F_ecef--LowestPriceOrBidNav_c20230101__20230331_znwXeeucRXJh">4.93</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_90C_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20230101__20230331_zVtAhkL5VTCa">8.32</span></td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_900_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20230101__20230331_zuIaNK8n2NBa">9.74</span></td>
    <td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June&#160;30, 2023</span></td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_901_ecef--HighestPriceOrBid_c20230401__20230630_z5puDW6SZ4s3">5.80</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_90B_ecef--LowestPriceOrBid_c20230401__20230630_zRotsob4VTD5">5.33</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_90D_ecef--HighestPriceOrBidNav_c20230401__20230630_zCj0qKPeBH5">5.30</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_907_ecef--LowestPriceOrBidNav_c20230401__20230630_zLCXSYO6Dn75">5.02</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_908_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20230401__20230630_zAMyRtXxfAOl">9.43</span></td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_907_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20230401__20230630_zRGVi5tAyWF4">6.18</span></td>
    <td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September&#160;30, 2023</span></td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_90E_ecef--HighestPriceOrBid_c20230701__20230930_za93zKGKdmQ3">5.87</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_908_ecef--LowestPriceOrBid_c20230701__20230930_zB6c0sskB8H6">5.13</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_904_ecef--HighestPriceOrBidNav_c20230701__20230930_zbLscm2TjPD1">5.30</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td>
    <td style="text-align: right"><span id="xdx_909_ecef--LowestPriceOrBidNav_c20230701__20230930_zdo5Iufyj94i">4.79</span></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_906_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20230701__20230930_zr9mrRNBlbOh">10.75</span></td>
    <td style="text-align: left">%</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><span id="xdx_905_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20230701__20230930_zUipaRuFO9qa">7.10</span></td>
    <td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December&#160;28, 2023, the last reported price for our common shares was $5.13 and the net asset value per share on December&#160;28, 2023 was $5.21 per share. Accordingly, our common stock traded at a discount to net asset value of -1.54% on December&#160;28, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund&#8217;s net asset value per share will be reduced immediately following the offering of common stock by the amount of the sales load and offering expenses paid by the Fund. See &#8220;Use of Proceeds.&#8221; Unlike open-end funds, closed-end funds like the Fund do not continuously offer shares and do not provide daily redemptions. Rather, if a stockholder determines to buy additional shares of common stock or sell shares already held, the stockholder may do so by trading through a broker on the NYSE or otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares of closed-end investment companies often trade on an exchange at prices lower than net asset value. The Fund&#8217;s shares of common stock have traded in the market at both premiums to and discounts from net asset value. Over the Fund&#8217;s thirty-seven year history, the range fluctuated from a 38% premium in 2002 to a 27% discount in 1987. Beginning in early 2001, the market price of the Fund exceeded the net asset value and this premium continued through September&#160;2005. The previous extended period over which the premium existed occurred during the twenty month period from August&#160;1993 to March&#160;1995. As of September&#160;30, 2023, the market price of the Fund closed at an approximate 7.1% premium to its net asset value. Because the market value of the common stock may be influenced by such factors as dividend and distribution levels (which are in turn affected by expenses), dividend and distribution stability, net asset value, market liquidity, relative demand for and supply of such shares in the market, unrealized gains, general market and economic conditions and other factors beyond the control of the Fund, the Fund cannot assure you that shares of common stock will trade at a price equal to or higher than net asset value in the future. The common stock is designed primarily for long term investors and you should not purchase the shares of the common stock if you intend to sell them soon after purchase.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund&#8217;s common stockholders vote together with the holders of preferred stock, as a single class, to elect the Fund&#8217;s Board (other than two directors elected exclusively by holders of the Fund&#8217;s preferred stock) and, except as described below, on additional matters with respect to which the 1940 Act, the Governing Documents or resolutions adopted by the Directors provide for a vote of the Fund&#8217;s common stockholders. Holders of the Fund&#8217;s preferred stock vote together as a single class to elect two of the directors of the Fund and vote together as a single class, separately from holders of the Fund&#8217;s common stock, to approve any plan of reorganization adversely affecting the preferred stock and to approve certain amendments to the Charter, whether by merger, consolidation or otherwise, that materially and adversely affect the contract rights of the existing preferred stock as set forth in the Charter. In addition, the affirmative vote of the holders of 66 &#8532;% of the outstanding shares of each class of stock of the Fund normally entitled to vote in the election of directors, each such class voting as a separate class, is required to authorize the conversion of the Fund from a closed-end to an open-end investment company. See &#8220;Anti-Takeover Provisions of the Fund&#8217;s Governing Documents.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund may repurchase its shares of common stock from time to time as and when it deems such repurchase advisable from legally available funds, subject to rights of holders of the Fund&#8217;s outstanding preferred stock and maintaining required asset coverage for each series of outstanding preferred stock. The Board has adopted a policy to authorize such repurchases when the shares are trading at a discount of 10% or more (or such other percentage as the Board may determine from time to time) from the net asset value of the shares. Although the Board has authorized such repurchases, the Fund is not required to repurchase its shares. The policy does not limit the amount of common stock that can be repurchased. The percentage of the discount from net asset value at which share repurchases will be authorized may be changed at any time by the Board. Through December&#160;31, 2022, the Fund has not repurchased shares of its common stock under this authorization.</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=gab_SeriesCPreferredSharesMember', window );">Series C Preferred Shares [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityTitleTextBlock', window );">Outstanding Security, Title [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[8]</sup></td>
<td class="text"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series C Auction Rate Preferred<sup>(1)</sup></span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityAuthorizedShares', window );">Outstanding Security, Authorized [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[8]</sup></td>
<td class="nump">4,812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityHeldShares', window );">Outstanding Security, Held [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[8]</sup></td>
<td class="nump">2,492<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=gab_SeriesDPreferredSharesMember', window );">Series D Preferred Shares [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityTitleTextBlock', window );">Outstanding Security, Title [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="text"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.875% Series D Cumulative Preferred Stock (the &#8220;Series D Preferred&#8221;)<sup>(2)</sup></span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityAuthorizedShares', window );">Outstanding Security, Authorized [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="nump">636,140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityHeldShares', window );">Outstanding Security, Held [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=gab_SeriesEPreferredSharesMember', window );">Series E Preferred Shares [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityTitleTextBlock', window );">Outstanding Security, Title [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[8]</sup></td>
<td class="text"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series E Auction Rate Preferred<sup>(1)</sup></span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityAuthorizedShares', window );">Outstanding Security, Authorized [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[8]</sup></td>
<td class="nump">1,988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityHeldShares', window );">Outstanding Security, Held [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[8]</sup></td>
<td class="nump">1,108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=gab_SeriesGPreferredSharesMember', window );">Series G Preferred Shares [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityTitleTextBlock', window );">Outstanding Security, Title [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Series G Preferred<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityAuthorizedShares', window );">Outstanding Security, Authorized [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,959,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityHeldShares', window );">Outstanding Security, Held [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,520,627<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=gab_SeriesHPreferredSharesMember', window );">Series H Preferred Shares [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityTitleTextBlock', window );">Outstanding Security, Title [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Series H Preferred<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityAuthorizedShares', window );">Outstanding Security, Authorized [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,109,167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityHeldShares', window );">Outstanding Security, Held [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,083,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=gab_SeriesJPreferredSharesMember', window );">Series J Preferred Shares [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityTitleTextBlock', window );">Outstanding Security, Title [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[10]</sup></td>
<td class="text"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.45% Series J Cumulative Preferred Stock (the &#8220;Series J Preferred&#8221;)<sup>(3)</sup></span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityAuthorizedShares', window );">Outstanding Security, Authorized [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[10]</sup></td>
<td class="nump">1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityHeldShares', window );">Outstanding Security, Held [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[10]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=gab_SeriesKPreferredSharesMember', window );">Series K Preferred Shares [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityTitleTextBlock', window );">Outstanding Security, Title [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Series K Preferred<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityAuthorizedShares', window );">Outstanding Security, Authorized [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,813,640<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityHeldShares', window );">Outstanding Security, Held [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,813,640<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=gab_SeriesMPreferredSharesMember', window );">Series M Preferred Shares [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityTitleTextBlock', window );">Outstanding Security, Title [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Series M Preferred<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityAuthorizedShares', window );">Outstanding Security, Authorized [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityHeldShares', window );">Outstanding Security, Held [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">685,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=gab_SeriesNPreferredSharesMember', window );">Series N Preferred Shares [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityTitleTextBlock', window );">Outstanding Security, Title [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[11]</sup></td>
<td class="text"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series N Preferred<sup>(4)</sup></span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityAuthorizedShares', window );">Outstanding Security, Authorized [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[11]</sup></td>
<td class="nump">350,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityHeldShares', window );">Outstanding Security, Held [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[11]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=gab_PreferredShareMember', window );">Preferred Share [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityTitleTextBlock', window );">Outstanding Security, Title [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="text"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred Stock<sup>(5)</sup></span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=gab_SubscriptionRightsMember', window );">Subscription Rights [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityTitleTextBlock', window );">Outstanding Security, Title [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_808_ecef--OutstandingSecurityTitleTextBlock_hcef--RiskAxis__custom--SubscriptionRightsMember_zfCDS9xErOT7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Subscription Rights</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>General</i>. We may issue subscription rights to holders of our (i) common stock to purchase common and/or preferred stock or (ii) preferred stock to purchase preferred stock (subject to applicable law). Subscription rights may be issued independently or together with any other offered security and may or may not be transferable by the person purchasing or receiving the subscription rights. In connection with a subscription rights offering to holders of our common stock or preferred stock, we would distribute certificates or other documentation evidencing the subscription rights and a prospectus supplement to our common or preferred stockholders as of the record date that we set for determining the stockholders eligible to receive subscription rights in such subscription rights offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The applicable prospectus supplement would describe the following terms of the subscription rights in respect of which this prospectus is being delivered:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the period of time the offering would remain open (which will be open a minimum number of days such that all record holders would be eligible to participate in the offering and will not be open longer than 120 days);</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the underwriter or distributor, if any, of the subscription rights and any associated underwriting fees or discounts applicable to purchases of the rights;</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the title of such subscription rights;</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the exercise price for such subscription rights (or method of calculation thereof);</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the number of such subscription rights issued in respect of each share of common stock or each share of preferred stock;</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the number of rights required to purchase a single share of common stock or share of preferred stock;</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the terms of the preferred stock, if any, for which a holder of such rights may subscribe;</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the extent to which such subscription rights are transferable and the market on which they may be traded if they are transferable;</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if applicable, a discussion of the material U.S. federal income tax considerations applicable to the issuance or exercise of such subscription rights;</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the date on which the right to exercise such subscription rights will commence, and the date on which such right will expire (subject to any extension);</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the extent to which such subscription rights include an over-subscription privilege with respect to unsubscribed securities and the terms of such over-subscription privilege;</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any termination right we may have in connection with such subscription rights offering; and</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any other terms of such subscription rights, including exercise, settlement and other procedures and limitations relating to the transfer and exercise of such subscription rights.</span></td> </tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Exercise of Subscription Rights</i>. A certain number of subscription rights would entitle the holder of the subscription right(s) to purchase for cash such number of shares of common stock or shares of preferred stock at such exercise price as in each case is set forth in, or be determinable as set forth in, the prospectus supplement relating to the subscription rights offered thereby. Subscription rights would be exercisable at any time up to the close of business on the expiration date for such subscription rights set forth in the prospectus supplement. After the close of business on the expiration date, all unexercised subscription rights would become void. Upon expiration of the rights offering and the receipt of payment and the subscription rights certificate or other appropriate documentation properly executed and completed and duly executed at the corporate trust office of the subscription rights agent, or any other office indicated in the prospectus supplement, the shares of common stock or shares of preferred stock purchased as a result of such exercise will be issued as soon as practicable. To the extent permissible under applicable law, we may determine to offer any unsubscribed offered securities directly to persons other than stockholders, to or through agents, underwriters or dealers or through a combination of such methods, as set forth in the applicable prospectus supplement.</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">The Gabelli Equity Trust Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">One Corporate Center<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Rye<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">10580-1422<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">(914)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">921-5100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">John C. Ball<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="21"></td></tr>
<tr><td colspan="21"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Estimated maximum amount based on offering of $300 million in shares of common stock and $200 million in shares of preferred stock. The estimates assume a 1.00% sales load on common stock and $1,150,000 in common offering expenses, and 3.15% sales load on preferred stock and $720,000 in preferred offering expenses. The sales load on preferred stock is an expense borne by the Fund and indirectly by the holders of its common stock. Actual sales loads and offering expenses may be higher or lower than these estimates and will be set forth in the Prospectus Supplement if applicable.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">There are no fees charged to stockholders for participating in the Fund&#8217;s Automatic Dividend Reinvestment and Voluntary Cash Purchase Plan. However, stockholders participating in the Plan that elect to make additional cash purchases under the Plan would pay $0.75 per transaction plus a per share fee (which includes any applicable brokerage commissions) to purchase shares and $2.50 per transaction plus a per share fee (which includes any applicable brokerage commissions) to sell shares. See &#8220;Automatic Dividend Reinvestment and Voluntary Cash Purchase Plans.&#8221;</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Assumes issuance of $200 million in liquidation preference of fixed rate preferred stock, net assets attributable to common stock of approximately $1.77 billion (which includes the issuance of $300 million in common stock) and $720,000 in preferred offering expenses. The actual amounts in connection with any offering will be set forth in the Prospectus Supplement if applicable.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">The Investment Adviser&#8217;s fee is 1.00% annually of the Fund&#8217;s average weekly net assets. The Fund&#8217;s average weekly net assets will be deemed to be the average weekly value of the Fund&#8217;s total assets minus the sum of the Fund&#8217;s liabilities (such liabilities exclude (i) the aggregate liquidation preference of outstanding shares of preferred stock and accumulated dividends, if any, on those shares and (ii) the liabilities for any money borrowed). Consequently, because the Fund has preferred stock outstanding, the investment management fees and other expenses as a percentage of net assets attributable to common stock will be higher than if the Fund did not utilize a leveraged capital structure.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">&#8220;Other Expenses&#8221; are based on estimated amounts for the current year assuming completion of the proposed issuances.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[6]</td>
<td style="vertical-align: top;" valign="top">Dividends on Preferred Stock represent the aggregate of (1) the estimated annual distributions on the existing preferred stock outstanding and (2) the distributions that would be made assuming $200 million of preferred stock is issued with a fixed dividend rate of 6.00%. There can, of course, be no guarantee that any preferred stock would be issued or, if issued, the terms thereof.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[7]</td>
<td style="vertical-align: top;" valign="top">&#8220;Preferred Stock&#8221; refers to the Fund&#8217;s authorized and unissued shares of preferred stock without further designation as to class or series.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[8]</td>
<td style="vertical-align: top;" valign="top">The Fund commenced a tender offer for all of its outstanding Series C Auction Rate Preferred and Series E Auction Rate Preferred on November&#160;16, 2023. The tender offer is scheduled to expire on January&#160;5, 2024.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[9]</td>
<td style="vertical-align: top;" valign="top">The Fund redeemed all of its outstanding Series D Preferred on December&#160;26, 2019.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[10]</td>
<td style="vertical-align: top;" valign="top">The Fund redeemed all of its outstanding Series J Preferred on January&#160;31, 2022.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[11]</td>
<td style="vertical-align: top;" valign="top">On December&#160;1, 2023, the Fund&#8217;s Board approved an offering of up to 350,000 shares of the Series N Preferred for an aggregate maximum offering amount of up to $35,000,000. On December&#160;12, 2023, the Fund filed Articles Supplementary with the State Department of Assessments and Taxation of Maryland classifying and designating 350,000 shares of preferred stock, without further designation as to class or series, as shares of Series N Preferred. The Series N Preferred are not registered under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), or listed on a securities exchange. The Fund issued 147,750 Series N Preferred in an initial closing for the offering of the Series N Preferred on December&#160;28, 2023.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_AnnualExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_AnnualExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_BusinessDevelopmentCompanyFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_BusinessDevelopmentCompanyFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_DividendReinvestmentAndCashPurchaseFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_DividendReinvestmentAndCashPurchaseFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYear01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYear01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYears1to10">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYears1to10</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYears1to3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYears1to3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYears1to5">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYears1to5</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_FeeTableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_FeeTableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_FinancialHighlightsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_FinancialHighlightsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_GeneralDescriptionOfRegistrantAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_GeneralDescriptionOfRegistrantAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_HighestPriceOrBid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_HighestPriceOrBid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_HighestPriceOrBidNav">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph Instruction 4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_HighestPriceOrBidNav</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_HighestPriceOrBidPremiumDiscountToNavPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph Instructions 4, 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_HighestPriceOrBidPremiumDiscountToNavPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_InterestExpensesOnBorrowingsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_InterestExpensesOnBorrowingsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_IntervalFundFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_IntervalFundFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_InvestmentObjectivesAndPracticesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 2<br> -Paragraph b, d<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_InvestmentObjectivesAndPracticesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_LowestPriceOrBid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_LowestPriceOrBid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_LowestPriceOrBidNav">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph Instruction 4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_LowestPriceOrBidNav</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_LowestPriceOrBidPremiumDiscountToNavPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph Instructions 4, 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_LowestPriceOrBidPremiumDiscountToNavPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ManagementFeesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 7<br> -Subparagraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ManagementFeesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_NetExpenseOverAssetsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_NetExpenseOverAssetsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_NewCefOrBdcRegistrantFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_NewCefOrBdcRegistrantFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherAnnualExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherAnnualExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherAnnualExpensesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherAnnualExpensesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherSecuritiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherSecuritiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherTransactionExpense1Percent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherTransactionExpense1Percent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherTransactionExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherTransactionExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherTransactionExpensesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherTransactionExpensesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OutstandingSecuritiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OutstandingSecuritiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OutstandingSecurityAuthorizedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 5<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OutstandingSecurityAuthorizedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OutstandingSecurityHeldShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 5<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OutstandingSecurityHeldShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OutstandingSecurityTitleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 5<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OutstandingSecurityTitleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_PrimaryShelfFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_PrimaryShelfFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_PrimaryShelfQualifiedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_PrimaryShelfQualifiedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RegisteredClosedEndFundFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RegisteredClosedEndFundFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskFactorsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 3<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskFactorsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SalesLoadPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SalesLoadPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SecurityTitleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 1<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SecurityTitleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SeniorSecuritiesAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 4<br> -Subsection 3<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SeniorSecuritiesAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SeniorSecuritiesCvgPerUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 4<br> -Subsection 3<br> -Paragraph 3<br> -Subparagraph Instruction 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SeniorSecuritiesCvgPerUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SharePriceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph 4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SharePriceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ShareholderTransactionExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ShareholderTransactionExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_TotalAnnualExpensesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_TotalAnnualExpensesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_WaiversAndReimbursementsOfFeesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_WaiversAndReimbursementsOfFeesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AdditionalSecurities462b">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 462<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AdditionalSecurities462b</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AdditionalSecuritiesEffective413b">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 413<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AdditionalSecuritiesEffective413b</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ApproximateDateOfCommencementOfProposedSaleToThePublic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ApproximateDateOfCommencementOfProposedSaleToThePublic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:dateOrAsapItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DelayedOrContinuousOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form S-3<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form F-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DelayedOrContinuousOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DividendOrInterestReinvestmentPlanOnly">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form S-3<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form F-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DividendOrInterestReinvestmentPlanOnly</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EffectiveUponFiling462e">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 462<br> -Subsection e<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EffectiveUponFiling462e</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EffectiveWhenDeclaredSection8c">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Section 8<br> -Subsection c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EffectiveWhenDeclaredSection8c</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInvCompanyType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInvCompanyType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:invCompanyType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ExhibitsOnly462d">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 462<br> -Subsection d<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ExhibitsOnly462d</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_InvestmentCompanyActFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-3<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-4<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_InvestmentCompanyActFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_InvestmentCompanyActRegistration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Investment Company Act<br> -Number 270<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_InvestmentCompanyActRegistration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_InvestmentCompanyRegistrationAmendment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Investment Company Act<br> -Number 270<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_InvestmentCompanyRegistrationAmendment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_InvestmentCompanyRegistrationAmendmentNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Investment Company Act<br> -Number 270<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_InvestmentCompanyRegistrationAmendmentNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:sequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_NewEffectiveDateForPreviousFiling">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-3<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-4<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_NewEffectiveDateForPreviousFiling</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_NoSubstantiveChanges462c">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 462<br> -Subsection c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_NoSubstantiveChanges462c</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=gab_PurchaseTransactionFeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=gab_PurchaseTransactionFeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=gab_SaleTransactionFeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=gab_SaleTransactionFeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=gab_CommonSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=gab_CommonSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=gab_PreferredSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=gab_PreferredSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=gab_CumulativePreferredSharesAuctionRateSeriesCPreferredMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=gab_CumulativePreferredSharesAuctionRateSeriesCPreferredMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=gab_CumulativePreferredShares5.875SerieAPreferredMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=gab_CumulativePreferredShares5.875SerieAPreferredMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=gab_CumulativePreferredSharesAuctionRateSeriesEPreferredMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=gab_CumulativePreferredSharesAuctionRateSeriesEPreferredMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=gab_CumulativePreferredShares5.000SerieGPreferredMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=gab_CumulativePreferredShares5.000SerieGPreferredMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=gab_CumulativePreferredShares5.000SerieHPreferredMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=gab_CumulativePreferredShares5.000SerieHPreferredMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=gab_CumulativePreferredShares5.450SerieJPreferredMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=gab_CumulativePreferredShares5.450SerieJPreferredMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=gab_CumulativePreferredShares5.000SerieKPreferredMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=gab_CumulativePreferredShares5.000SerieKPreferredMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=gab_CumulativePreferredShares4.250SerieMCumulativePreferredMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=gab_CumulativePreferredShares4.250SerieMCumulativePreferredMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=gab_CumulativePreferredShares5.875SerieDPreferredMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=gab_CumulativePreferredShares5.875SerieDPreferredMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=gab_HowTheFundManagesRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=gab_HowTheFundManagesRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=gab_CommonShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=gab_CommonShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=gab_SeriesCPreferredSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=gab_SeriesCPreferredSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=gab_SeriesDPreferredSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=gab_SeriesDPreferredSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=gab_SeriesEPreferredSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=gab_SeriesEPreferredSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=gab_SeriesGPreferredSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=gab_SeriesGPreferredSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=gab_SeriesHPreferredSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=gab_SeriesHPreferredSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=gab_SeriesJPreferredSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=gab_SeriesJPreferredSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=gab_SeriesKPreferredSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=gab_SeriesKPreferredSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=gab_SeriesMPreferredSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=gab_SeriesMPreferredSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=gab_SeriesNPreferredSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=gab_SeriesNPreferredSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=gab_PreferredShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=gab_PreferredShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=gab_SubscriptionRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=gab_SubscriptionRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>gabelliequitytrust_n2asr_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cef="http://xbrl.sec.gov/cef/2023"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:gab="http://gabelli.com/20231229"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="gab-20231229.xsd" xlink:type="simple"/>
    <context id="AsOf2023-12-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2023-12-29</endDate>
        </period>
    </context>
    <context id="From2023-12-292023-12-29_dei_BusinessContactMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2023-12-29</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-29_custom_PurchaseTransactionFeeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:PurchaseTransactionFeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-29</instant>
        </period>
    </context>
    <context id="AsOf2023-12-29_custom_SaleTransactionFeeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:SaleTransactionFeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-29</instant>
        </period>
    </context>
    <context id="From2023-12-292023-12-29_custom_CommonSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CommonSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2023-12-29</endDate>
        </period>
    </context>
    <context id="From2023-12-292023-12-29_custom_PreferredSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:PreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2023-12-29</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredSharesAuctionRateSeriesCPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredSharesAuctionRateSeriesCPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredSharesAuctionRateSeriesCPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredSharesAuctionRateSeriesCPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredSharesAuctionRateSeriesCPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredSharesAuctionRateSeriesCPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_CumulativePreferredShares5.875SerieAPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.875SerieAPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.875SerieAPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.875SerieAPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.875SerieAPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.875SerieAPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.875SerieAPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredSharesAuctionRateSeriesEPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredSharesAuctionRateSeriesEPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredSharesAuctionRateSeriesEPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredSharesAuctionRateSeriesEPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredSharesAuctionRateSeriesEPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredSharesAuctionRateSeriesEPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_CumulativePreferredShares5.000SerieGPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieGPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieGPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieGPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieGPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieGPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieGPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_CumulativePreferredShares5.000SerieHPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieHPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieHPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieHPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieHPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieHPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieHPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_CumulativePreferredShares5.450SerieJPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.450SerieJPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.450SerieJPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.450SerieJPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.450SerieJPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.450SerieJPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.450SerieJPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_CumulativePreferredShares5.000SerieKPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieKPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_CumulativePreferredShares5.000SerieKPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieKPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_CumulativePreferredShares5.000SerieKPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieKPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_CumulativePreferredShares5.000SerieKPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieKPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_CumulativePreferredShares5.000SerieKPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieKPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_custom_CumulativePreferredShares5.000SerieKPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieKPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_CumulativePreferredShares4.250SerieMCumulativePreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares4.250SerieMCumulativePreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_CumulativePreferredShares4.250SerieMCumulativePreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares4.250SerieMCumulativePreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_CumulativePreferredShares4.250SerieMCumulativePreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares4.250SerieMCumulativePreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_CumulativePreferredShares4.250SerieMCumulativePreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares4.250SerieMCumulativePreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_CumulativePreferredShares4.250SerieMCumulativePreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares4.250SerieMCumulativePreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_custom_CumulativePreferredShares4.250SerieMCumulativePreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares4.250SerieMCumulativePreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2017-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredSharesAuctionRateSeriesCPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="AsOf2016-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredSharesAuctionRateSeriesCPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="AsOf2015-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredSharesAuctionRateSeriesCPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-12-31</instant>
        </period>
    </context>
    <context id="AsOf2014-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredSharesAuctionRateSeriesCPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-12-31</instant>
        </period>
    </context>
    <context id="AsOf2013-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredSharesAuctionRateSeriesCPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-12-31</instant>
        </period>
    </context>
    <context id="AsOf2017-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.875SerieAPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="AsOf2016-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.875SerieAPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="AsOf2015-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.875SerieAPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-12-31</instant>
        </period>
    </context>
    <context id="AsOf2014-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.875SerieAPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-12-31</instant>
        </period>
    </context>
    <context id="AsOf2013-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.875SerieAPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-12-31</instant>
        </period>
    </context>
    <context id="AsOf2017-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredSharesAuctionRateSeriesEPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="AsOf2016-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredSharesAuctionRateSeriesEPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="AsOf2015-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredSharesAuctionRateSeriesEPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-12-31</instant>
        </period>
    </context>
    <context id="AsOf2014-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredSharesAuctionRateSeriesEPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-12-31</instant>
        </period>
    </context>
    <context id="AsOf2013-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredSharesAuctionRateSeriesEPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-12-31</instant>
        </period>
    </context>
    <context id="AsOf2017-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieGPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="AsOf2016-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieGPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="AsOf2015-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieGPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-12-31</instant>
        </period>
    </context>
    <context id="AsOf2014-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieGPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-12-31</instant>
        </period>
    </context>
    <context id="AsOf2013-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieGPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-12-31</instant>
        </period>
    </context>
    <context id="AsOf2017-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieHPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="AsOf2016-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieHPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="AsOf2015-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieHPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-12-31</instant>
        </period>
    </context>
    <context id="AsOf2014-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieHPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-12-31</instant>
        </period>
    </context>
    <context id="AsOf2013-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.000SerieHPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-12-31</instant>
        </period>
    </context>
    <context id="AsOf2017-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.450SerieJPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="AsOf2016-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.450SerieJPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="AsOf2015-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.450SerieJPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-12-31</instant>
        </period>
    </context>
    <context id="AsOf2014-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.450SerieJPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-12-31</instant>
        </period>
    </context>
    <context id="AsOf2013-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.450SerieJPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-12-31</instant>
        </period>
    </context>
    <context id="AsOf2017-12-31_custom_CumulativePreferredShares5.875SerieDPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.875SerieDPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="AsOf2016-12-31_custom_CumulativePreferredShares5.875SerieDPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.875SerieDPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="AsOf2015-12-31_custom_CumulativePreferredShares5.875SerieDPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.875SerieDPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-12-31</instant>
        </period>
    </context>
    <context id="AsOf2014-12-31_custom_CumulativePreferredShares5.875SerieDPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.875SerieDPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-12-31</instant>
        </period>
    </context>
    <context id="AsOf2013-12-31_custom_CumulativePreferredShares5.875SerieDPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CumulativePreferredShares5.875SerieDPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-12-31</instant>
        </period>
    </context>
    <context id="From2023-12-292023-12-29_custom_HowTheFundManagesRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:HowTheFundManagesRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2023-12-29</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-10-012021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2022-10-012022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-12-292023-12-29_custom_CommonShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:CommonShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2023-12-29</endDate>
        </period>
    </context>
    <context id="From2023-12-292023-12-29_custom_SeriesCPreferredSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:SeriesCPreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2023-12-29</endDate>
        </period>
    </context>
    <context id="From2023-12-292023-12-29_custom_SeriesDPreferredSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:SeriesDPreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2023-12-29</endDate>
        </period>
    </context>
    <context id="From2023-12-292023-12-29_custom_SeriesEPreferredSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:SeriesEPreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2023-12-29</endDate>
        </period>
    </context>
    <context id="From2023-12-292023-12-29_custom_SeriesGPreferredSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:SeriesGPreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2023-12-29</endDate>
        </period>
    </context>
    <context id="From2023-12-292023-12-29_custom_SeriesHPreferredSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:SeriesHPreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2023-12-29</endDate>
        </period>
    </context>
    <context id="From2023-12-292023-12-29_custom_SeriesJPreferredSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:SeriesJPreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2023-12-29</endDate>
        </period>
    </context>
    <context id="From2023-12-292023-12-29_custom_SeriesKPreferredSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:SeriesKPreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2023-12-29</endDate>
        </period>
    </context>
    <context id="From2023-12-292023-12-29_custom_SeriesMPreferredSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:SeriesMPreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2023-12-29</endDate>
        </period>
    </context>
    <context id="From2023-12-292023-12-29_custom_SeriesNPreferredSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:SeriesNPreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2023-12-29</endDate>
        </period>
    </context>
    <context id="From2023-12-292023-12-29_custom_PreferredShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:PreferredShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2023-12-29</endDate>
        </period>
    </context>
    <context id="From2023-12-292023-12-29_custom_SubscriptionRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000794685</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">gab:SubscriptionRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2023-12-29</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Ratio">
        <measure>pure</measure>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2023-12-29">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="AsOf2023-12-29">N-2ASR</dei:DocumentType>
    <dei:EntityCentralIndexKey contextRef="AsOf2023-12-29">0000794685</dei:EntityCentralIndexKey>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2023-06-30_custom_CumulativePreferredShares5.875SerieAPreferredMember"
      id="xdx2ixbrl0110"
      unitRef="USD"
      xsi:nil="true"/>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2022-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember"
      id="xdx2ixbrl0111"
      unitRef="USD"
      xsi:nil="true"/>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2021-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember"
      id="xdx2ixbrl0112"
      unitRef="USD"
      xsi:nil="true"/>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2020-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember"
      id="xdx2ixbrl0113"
      unitRef="USD"
      xsi:nil="true"/>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2019-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember"
      id="xdx2ixbrl0114"
      unitRef="USD"
      xsi:nil="true"/>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2023-06-30_custom_CumulativePreferredShares5.875SerieAPreferredMember"
      id="xdx2ixbrl0117"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2022-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember"
      id="xdx2ixbrl0118"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2021-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember"
      id="xdx2ixbrl0119"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2020-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember"
      id="xdx2ixbrl0120"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2019-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember"
      id="xdx2ixbrl0121"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2023-06-30_custom_CumulativePreferredShares5.450SerieJPreferredMember"
      id="xdx2ixbrl0166"
      unitRef="USD"
      xsi:nil="true"/>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2022-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember"
      id="xdx2ixbrl0167"
      unitRef="USD"
      xsi:nil="true"/>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2023-06-30_custom_CumulativePreferredShares5.450SerieJPreferredMember"
      id="xdx2ixbrl0173"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2022-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember"
      id="xdx2ixbrl0174"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2018-12-31_custom_CumulativePreferredShares5.000SerieKPreferredMember"
      id="xdx2ixbrl0185"
      unitRef="USD"
      xsi:nil="true"/>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2018-12-31_custom_CumulativePreferredShares5.000SerieKPreferredMember"
      id="xdx2ixbrl0192"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2020-12-31_custom_CumulativePreferredShares4.250SerieMCumulativePreferredMember"
      id="xdx2ixbrl0197"
      unitRef="USD"
      xsi:nil="true"/>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2019-12-31_custom_CumulativePreferredShares4.250SerieMCumulativePreferredMember"
      id="xdx2ixbrl0198"
      unitRef="USD"
      xsi:nil="true"/>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2018-12-31_custom_CumulativePreferredShares4.250SerieMCumulativePreferredMember"
      id="xdx2ixbrl0199"
      unitRef="USD"
      xsi:nil="true"/>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2015-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember"
      id="xdx2ixbrl0272"
      unitRef="USD"
      xsi:nil="true"/>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2014-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember"
      id="xdx2ixbrl0273"
      unitRef="USD"
      xsi:nil="true"/>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2013-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember"
      id="xdx2ixbrl0274"
      unitRef="USD"
      xsi:nil="true"/>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2015-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember"
      id="xdx2ixbrl0278"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2014-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember"
      id="xdx2ixbrl0279"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2013-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember"
      id="xdx2ixbrl0280"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <dei:InvestmentCompanyActFileNumber contextRef="AsOf2023-12-29">811-04700</dei:InvestmentCompanyActFileNumber>
    <dei:EntityInvCompanyType contextRef="AsOf2023-12-29">N-2</dei:EntityInvCompanyType>
    <dei:InvestmentCompanyActRegistration contextRef="AsOf2023-12-29">true</dei:InvestmentCompanyActRegistration>
    <dei:InvestmentCompanyRegistrationAmendment contextRef="AsOf2023-12-29">true</dei:InvestmentCompanyRegistrationAmendment>
    <dei:InvestmentCompanyRegistrationAmendmentNumber contextRef="AsOf2023-12-29">68</dei:InvestmentCompanyRegistrationAmendmentNumber>
    <dei:EntityRegistrantName contextRef="AsOf2023-12-29">THE GABELLI EQUITY TRUST INC.</dei:EntityRegistrantName>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2023-12-29">One Corporate Center</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2023-12-29">Rye</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2023-12-29">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2023-12-29">10580-1422</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2023-12-29">(800)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2023-12-29">422-3554</dei:LocalPhoneNumber>
    <dei:ContactPersonnelName contextRef="From2023-12-292023-12-29_dei_BusinessContactMember">John C. Ball</dei:ContactPersonnelName>
    <dei:EntityAddressAddressLine1 contextRef="From2023-12-292023-12-29_dei_BusinessContactMember">The Gabelli Equity Trust Inc.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2023-12-292023-12-29_dei_BusinessContactMember">One Corporate Center</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2023-12-292023-12-29_dei_BusinessContactMember">Rye</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2023-12-292023-12-29_dei_BusinessContactMember">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2023-12-292023-12-29_dei_BusinessContactMember">10580-1422</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2023-12-292023-12-29_dei_BusinessContactMember">(914)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2023-12-292023-12-29_dei_BusinessContactMember">921-5100</dei:LocalPhoneNumber>
    <dei:ApproximateDateOfCommencementOfProposedSaleToThePublic contextRef="AsOf2023-12-29">As soon as practicable after the effective date of this Registration Statement.</dei:ApproximateDateOfCommencementOfProposedSaleToThePublic>
    <dei:DividendOrInterestReinvestmentPlanOnly contextRef="AsOf2023-12-29">false</dei:DividendOrInterestReinvestmentPlanOnly>
    <dei:DelayedOrContinuousOffering contextRef="AsOf2023-12-29">true</dei:DelayedOrContinuousOffering>
    <cef:PrimaryShelfFlag contextRef="AsOf2023-12-29">true</cef:PrimaryShelfFlag>
    <dei:EffectiveUponFiling462e contextRef="AsOf2023-12-29">true</dei:EffectiveUponFiling462e>
    <dei:AdditionalSecuritiesEffective413b contextRef="AsOf2023-12-29">false</dei:AdditionalSecuritiesEffective413b>
    <dei:EffectiveWhenDeclaredSection8c contextRef="AsOf2023-12-29">false</dei:EffectiveWhenDeclaredSection8c>
    <dei:NewEffectiveDateForPreviousFiling contextRef="AsOf2023-12-29">false</dei:NewEffectiveDateForPreviousFiling>
    <dei:AdditionalSecurities462b contextRef="AsOf2023-12-29">false</dei:AdditionalSecurities462b>
    <dei:NoSubstantiveChanges462c contextRef="AsOf2023-12-29">false</dei:NoSubstantiveChanges462c>
    <dei:ExhibitsOnly462d contextRef="AsOf2023-12-29">false</dei:ExhibitsOnly462d>
    <cef:RegisteredClosedEndFundFlag contextRef="AsOf2023-12-29">true</cef:RegisteredClosedEndFundFlag>
    <cef:BusinessDevelopmentCompanyFlag contextRef="AsOf2023-12-29">false</cef:BusinessDevelopmentCompanyFlag>
    <cef:IntervalFundFlag contextRef="AsOf2023-12-29">false</cef:IntervalFundFlag>
    <cef:PrimaryShelfQualifiedFlag contextRef="AsOf2023-12-29">true</cef:PrimaryShelfQualifiedFlag>
    <dei:EntityWellKnownSeasonedIssuer contextRef="AsOf2023-12-29">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2023-12-29">false</dei:EntityEmergingGrowthCompany>
    <cef:NewCefOrBdcRegistrantFlag contextRef="AsOf2023-12-29">false</cef:NewCefOrBdcRegistrantFlag>
    <cef:ShareholderTransactionExpensesTableTextBlock contextRef="AsOf2023-12-29">&lt;p id="xdx_80F_ecef--ShareholderTransactionExpensesTableTextBlock_z0COtgujwqFk" style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 68%; text-align: left"&gt;Sales Load (as a percentage of offering price)&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90C_ecef--SalesLoadPercent_dp_c20231229__20231229_fKDEp_zILxwfGXDf01" title="Sales Load (as a percentage of offering price)"&gt;1.86&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;%(1)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Offering Expenses (excluding Preferred Stock Offering Expenses) (as a percentage of offering price)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecef--OtherTransactionExpensesPercent_dp_c20231229__20231229_fKDEp_zmKdEQnPv1y" title="Offering Expenses (excluding Preferred Share Offering Expenses) (as a percentage of offering price)"&gt;0.23&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;%(1)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Dividend Reinvestment Plan Fees&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecef--DividendReinvestmentAndCashPurchaseFees_dn_c20231229__20231229_fKDIp_ztmWUdSZnKxg" title="Dividend Reinvestment Plan Fees"&gt;None&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;(2)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Voluntary Cash Purchase Plan Purchase Transaction Fee&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecef--SeniorSecuritiesCvgPerUnit_iI_c20231229__cef--RiskAxis__custom--PurchaseTransactionFeeMember_fKDIp_zALBRjMMeF37" title="Voluntary Cash Purchase Plan Purchase Transaction Fee"&gt;0.75&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;(2)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Voluntary Cash Purchase Plan Sale Transaction Fee&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecef--SeniorSecuritiesCvgPerUnit_iI_c20231229__cef--RiskAxis__custom--SaleTransactionFeeMember_fKDIp_zYEjCvehWdy" title="Voluntary Cash Purchase Plan Sale Transaction Fee"&gt;2.50&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;(2)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Preferred Stock Offering Expenses (as a percentage of net assets attributable to common stock)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecef--OtherTransactionExpense1Percent_dp_c20231229__20231229_fKDMp_zaNINUF1T07g" title="Preferred Share Offering Expenses (as a percentage of net assets attributable to common shares)"&gt;0.04&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;%(3)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</cef:ShareholderTransactionExpensesTableTextBlock>
    <cef:SalesLoadPercent
      contextRef="AsOf2023-12-29"
      decimals="INF"
      id="Fact000052"
      unitRef="Ratio">0.0186</cef:SalesLoadPercent>
    <cef:OtherTransactionExpensesPercent
      contextRef="AsOf2023-12-29"
      decimals="INF"
      id="Fact000054"
      unitRef="Ratio">0.0023</cef:OtherTransactionExpensesPercent>
    <cef:DividendReinvestmentAndCashPurchaseFees
      contextRef="AsOf2023-12-29"
      decimals="0"
      id="Fact000056"
      unitRef="USD">0</cef:DividendReinvestmentAndCashPurchaseFees>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2023-12-29_custom_PurchaseTransactionFeeMember"
      decimals="INF"
      id="Fact000058"
      unitRef="USDPShares">0.75</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2023-12-29_custom_SaleTransactionFeeMember"
      decimals="INF"
      id="Fact000060"
      unitRef="USDPShares">2.50</cef:SeniorSecuritiesCvgPerUnit>
    <cef:OtherTransactionExpense1Percent
      contextRef="AsOf2023-12-29"
      decimals="INF"
      id="Fact000062"
      unitRef="Ratio">0.0004</cef:OtherTransactionExpense1Percent>
    <cef:AnnualExpensesTableTextBlock contextRef="AsOf2023-12-29">&lt;p id="xdx_809_ecef--AnnualExpensesTableTextBlock_zpl5YWSdHXh5" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Percentage&#160;of&lt;br/&gt; Net Assets&lt;br/&gt; Attributable&#160;to&lt;br/&gt; Common Stock&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;Annual Expenses&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 68%; text-align: left"&gt;Management Fees&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_903_ecef--ManagementFeesPercent_dp_c20231229__20231229_fKDQp_zS28PLRjUBzj" title="Management Fees"&gt;1.37&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;%(4)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Interest on Borrowed Funds&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecef--InterestExpensesOnBorrowingsPercent_dpn_c20231229__20231229_zWjbgkkTQZ59" title="Interest on Borrowed Funds"&gt;None&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;Other Expenses&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_ecef--OtherAnnualExpensesPercent_dp_c20231229__20231229_fKDUp_ziGetCgtXND2" title="Other Expenses"&gt;0.16&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"&gt;%(5)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Total Annual Expenses&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecef--TotalAnnualExpensesPercent_dp_c20231229__20231229_zUtRN3hSM2r7" title="Total Annual Expenses"&gt;1.53&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"&gt;Dividends on Preferred Stock&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_903_ecef--WaiversAndReimbursementsOfFeesPercent_dp_c20231229__20231229_fKDYp_znf7R5y6bcF9" title="Dividends on Preferred Stock"&gt;2.17&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"&gt;%(6)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"&gt;Total Annual Expenses and Dividends on Preferred Stock&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90F_ecef--NetExpenseOverAssetsPercent_dp_c20231229__20231229_zN2fCQMjGJSh" title="Total Annual Expenses and Dividends on Preferred Stock"&gt;3.70&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;div style="width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F0B_zdPHy79JEOpj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_F18_zfwBx6Eu71Yd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Estimated maximum amount based on offering of $300 million in shares of common stock and $200 million in shares of preferred stock. The estimates assume a 1.00% sales load on common stock and $1,150,000 in common offering expenses, and 3.15% sales load on preferred stock and $720,000 in preferred offering expenses. The sales load on preferred stock is an expense borne by the Fund and indirectly by the holders of its common stock. Actual sales loads and offering expenses may be higher or lower than these estimates and will be set forth in the Prospectus Supplement if applicable.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0in; text-align: right; vertical-align: top"&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"&gt;&lt;span id="xdx_F03_z2l2S1YoK6F9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;&lt;span id="xdx_F10_zIM4p7k5Ysv3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There are no fees charged to stockholders for participating in the Fund&#x2019;s Automatic Dividend Reinvestment and Voluntary Cash Purchase Plan. However, stockholders participating in the Plan that elect to make additional cash purchases under the Plan would pay $0.75 per transaction plus a per share fee (which includes any applicable brokerage commissions) to purchase shares and $2.50 per transaction plus a per share fee (which includes any applicable brokerage commissions) to sell shares. See &#x201c;Automatic Dividend Reinvestment and Voluntary Cash Purchase Plans.&#x201d;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0in; text-align: right; vertical-align: top"&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"&gt;&lt;span id="xdx_F0C_zLBKaybG7Rp6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;&lt;span id="xdx_F19_zVUHVGYRd7F5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Assumes issuance of $200 million in liquidation preference of fixed rate preferred stock, net assets attributable to common stock of approximately $1.77 billion (which includes the issuance of $300 million in common stock) and $720,000 in preferred offering expenses. The actual amounts in connection with any offering will be set forth in the Prospectus Supplement if applicable.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0in; text-align: right; vertical-align: top"&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"&gt;&lt;span id="xdx_F0F_zvPcJ9HEmkti" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(4)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;&lt;span id="xdx_F1F_zPVtcQyy3XKh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Investment Adviser&#x2019;s fee is 1.00% annually of the Fund&#x2019;s average weekly net assets. The Fund&#x2019;s average weekly net assets will be deemed to be the average weekly value of the Fund&#x2019;s total assets minus the sum of the Fund&#x2019;s liabilities (such liabilities exclude (i) the aggregate liquidation preference of outstanding shares of preferred stock and accumulated dividends, if any, on those shares and (ii) the liabilities for any money borrowed). Consequently, because the Fund has preferred stock outstanding, the investment management fees and other expenses as a percentage of net assets attributable to common stock will be higher than if the Fund did not utilize a leveraged capital structure.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0in; text-align: right; vertical-align: top"&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"&gt;&lt;span id="xdx_F00_zQr0XxwS3RVj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(5)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;&lt;span id="xdx_F13_z7yBtLwBHrPl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x201c;Other Expenses&#x201d; are based on estimated amounts for the current year assuming completion of the proposed issuances.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0in; text-align: right; vertical-align: top"&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"&gt;&lt;span id="xdx_F0A_z3A0psgKBOs6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(6)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;&lt;span id="xdx_F12_zHcHRSuTde45" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Dividends on Preferred Stock represent the aggregate of (1) the estimated annual distributions on the existing preferred stock outstanding and (2) the distributions that would be made assuming $200 million of preferred stock is issued with a fixed dividend rate of 6.00%. There can, of course, be no guarantee that any preferred stock would be issued or, if issued, the terms thereof.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cef:AnnualExpensesTableTextBlock>
    <cef:ManagementFeesPercent
      contextRef="AsOf2023-12-29"
      decimals="INF"
      id="Fact000066"
      unitRef="Ratio">0.0137</cef:ManagementFeesPercent>
    <cef:InterestExpensesOnBorrowingsPercent contextRef="AsOf2023-12-29" decimals="INF" unitRef="Ratio">0</cef:InterestExpensesOnBorrowingsPercent>
    <cef:OtherAnnualExpensesPercent
      contextRef="AsOf2023-12-29"
      decimals="INF"
      id="Fact000070"
      unitRef="Ratio">0.0016</cef:OtherAnnualExpensesPercent>
    <cef:TotalAnnualExpensesPercent contextRef="AsOf2023-12-29" decimals="INF" unitRef="Ratio">0.0153</cef:TotalAnnualExpensesPercent>
    <cef:WaiversAndReimbursementsOfFeesPercent
      contextRef="AsOf2023-12-29"
      decimals="INF"
      id="Fact000074"
      unitRef="Ratio">0.0217</cef:WaiversAndReimbursementsOfFeesPercent>
    <cef:NetExpenseOverAssetsPercent contextRef="AsOf2023-12-29" decimals="INF" unitRef="Ratio">0.0370</cef:NetExpenseOverAssetsPercent>
    <cef:ExpenseExampleTableTextBlock contextRef="AsOf2023-12-29">&lt;p id="xdx_80B_ecef--ExpenseExampleTableTextBlock_zUN4xkLdPXHc" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;1 Year&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;3 Years&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;5 Years&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;10 Years&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 52%; text-align: left"&gt;Total Expenses Incurred&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_903_ecef--ExpenseExampleYear01_c20231229__20231229__cef--RiskAxis__custom--CommonSharesMember_zVs3TSFehnb4"&gt;60&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_907_ecef--ExpenseExampleYears1to3_c20231229__20231229__cef--RiskAxis__custom--CommonSharesMember_zuZkudbdaLfk"&gt;136&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90D_ecef--ExpenseExampleYears1to5_c20231229__20231229__cef--RiskAxis__custom--CommonSharesMember_zC9r06c1oij6"&gt;214&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_908_ecef--ExpenseExampleYears1to10_c20231229__20231229__cef--RiskAxis__custom--CommonSharesMember_zn7irLysb8n"&gt;417&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;div style="width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;The example should not be considered a representation of future expenses&lt;/b&gt;. The example is based on Total Annual Expenses and Dividends on Preferred Stock shown in the table above and assumes that the amounts set forth in the table do not change and that all distributions are reinvested at net asset value. Actual expenses may be greater or less than those assumed. Moreover, the Fund&#x2019;s actual rate of return may be greater or less than the hypothetical 5% return shown in the example.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The above example includes Dividends on Preferred Stock. If Dividends on Preferred Stock were not included in the example calculation, the expenses would be as follows (based on the same assumptions as above).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;1 Year&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;3 Years&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;5 Years&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;10 Years&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 52%; text-align: left"&gt;Total Expenses Incurred&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90C_ecef--ExpenseExampleYear01_c20231229__20231229__cef--RiskAxis__custom--PreferredSharesMember_zwuHuqdYxBk3"&gt;38&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_907_ecef--ExpenseExampleYears1to3_c20231229__20231229__cef--RiskAxis__custom--PreferredSharesMember_zVt8JUa61Zyb"&gt;69&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_908_ecef--ExpenseExampleYears1to5_c20231229__20231229__cef--RiskAxis__custom--PreferredSharesMember_zpcZHLuWZgkf"&gt;104&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_906_ecef--ExpenseExampleYears1to10_c20231229__20231229__cef--RiskAxis__custom--PreferredSharesMember_zD7O0HntnEyf"&gt;200&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</cef:ExpenseExampleTableTextBlock>
    <cef:ExpenseExampleYear01
      contextRef="From2023-12-292023-12-29_custom_CommonSharesMember"
      decimals="0"
      unitRef="USD">60</cef:ExpenseExampleYear01>
    <cef:ExpenseExampleYears1to3
      contextRef="From2023-12-292023-12-29_custom_CommonSharesMember"
      decimals="0"
      unitRef="USD">136</cef:ExpenseExampleYears1to3>
    <cef:ExpenseExampleYears1to5
      contextRef="From2023-12-292023-12-29_custom_CommonSharesMember"
      decimals="0"
      unitRef="USD">214</cef:ExpenseExampleYears1to5>
    <cef:ExpenseExampleYears1to10
      contextRef="From2023-12-292023-12-29_custom_CommonSharesMember"
      decimals="0"
      unitRef="USD">417</cef:ExpenseExampleYears1to10>
    <cef:ExpenseExampleYear01
      contextRef="From2023-12-292023-12-29_custom_PreferredSharesMember"
      decimals="0"
      unitRef="USD">38</cef:ExpenseExampleYear01>
    <cef:ExpenseExampleYears1to3
      contextRef="From2023-12-292023-12-29_custom_PreferredSharesMember"
      decimals="0"
      unitRef="USD">69</cef:ExpenseExampleYears1to3>
    <cef:ExpenseExampleYears1to5
      contextRef="From2023-12-292023-12-29_custom_PreferredSharesMember"
      decimals="0"
      unitRef="USD">104</cef:ExpenseExampleYears1to5>
    <cef:ExpenseExampleYears1to10
      contextRef="From2023-12-292023-12-29_custom_PreferredSharesMember"
      decimals="0"
      unitRef="USD">200</cef:ExpenseExampleYears1to10>
    <cef:SecurityTitleTextBlock contextRef="AsOf2023-12-29">&lt;p id="xdx_80E_ecef--SecurityTitleTextBlock_zjTfPbCN6asl" style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; width: 40%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_495_20230630_z7tgzvwZFrnk" style="text-align: right; width: 7%"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_496_20221231_zyBtHqkqKHYe" style="text-align: right; width: 7%"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20211231_zJCsKvxBe2vb" style="text-align: right; width: 7%"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49E_20201231_z1cNGZ9tYkdi" style="text-align: right; width: 7%"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20191231_z2bwPciCV3zk" style="text-align: right; width: 7%"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_493_20181231_zyt2fZN0mah8" style="text-align: right; width: 7%"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;Cumulative Preferred Stock:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left"&gt;Auction Rate Series C Preferred&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredSharesAuctionRateSeriesCPreferredMember_ziznl8LjOuXl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Liquidation value, end of period (in 000&#x2019;s)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;62,300&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;62,300&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;62,300&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;62,300&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;72,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;72,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Total shares outstanding (in 000&#x2019;s)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;3&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;3&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Liquidation preference per share&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Liquidation value (h)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredSharesAuctionRateSeriesCPreferredMember_zRaHmKzIbtsg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Asset coverage per share (i)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;118,342&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;113,590&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;116,432&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;111,456&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;108,305&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;105,562&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left"&gt;5.875% Series D Preferred (j)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.875SerieAPreferredMember_zQjVFda9Kltf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Liquidation value, end of period (in 000&#x2019;s)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0110"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0111"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0112"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0113"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0114"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;59,097&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Total shares outstanding (in 000&#x2019;s)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,364&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Liquidation preference per share&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Average market value (k)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.62&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.875SerieAPreferredMember_zBAciZw3cXth" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Asset coverage per share (i)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0117"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0118"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0119"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0120"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0121"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;105.56&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left"&gt;Auction Rate Series E Preferred&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredSharesAuctionRateSeriesEPreferredMember_z04eiOXEQOdk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Liquidation value, end of period (in 000&#x2019;s)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;27,700&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;27,700&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;27,700&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;27,700&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;28,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;28,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Total shares outstanding (in 000&#x2019;s)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Liquidation preference per share&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Liquidation value (h)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredSharesAuctionRateSeriesEPreferredMember_zS2rlYq1vEXg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Asset coverage per share (i)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;118,342&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;113,590&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;116,432&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;111,456&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;108,305&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;105,562&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;
        &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Six Months Ended June&#160;30,&lt;/p&gt;
        &lt;p style="margin-top: 0; margin-bottom: 0"&gt;2023&lt;/p&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="18" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended December&#160;31,&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;(Unaudited)&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2018&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left; width: 40%"&gt;5.000% Series G Preferred&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 7%"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 7%"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 7%"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 7%"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 7%"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 7%"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.000SerieGPreferredMember_z5KK79wW9Z8i" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Liquidation value, end of period (in 000&#x2019;s)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;64,647&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;65,060&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;69,491&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;69,491&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;69,495&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;69,495&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Total shares outstanding (in 000&#x2019;s)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,586&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,602&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,780&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,780&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,780&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,780&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Liquidation preference per share&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Average market value (k)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;22.59&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;23.59&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.66&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.25&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;24.57&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;23.92&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.000SerieGPreferredMember_zohtagmRw4S3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Asset coverage per share (i)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;118.34&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;113.59&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;116.43&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;111.46&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;108.30&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;105.56&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left"&gt;5.000% Series H Preferred&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.000SerieHPreferredMember_zf0fugCsjixg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Liquidation value, end of period (in 000&#x2019;s)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;102,910&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;103,195&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;104,322&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;104,322&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;104,322&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;104,322&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Total shares outstanding (in 000&#x2019;s)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;4,116&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;4,128&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;4,173&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;4,173&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;4,173&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;4,173&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Liquidation preference per share&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Average market value (k)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;22.64&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;23.58&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.55&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.30&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;24.68&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;24.18&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.000SerieHPreferredMember_zcCLyYyn5rO4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Asset coverage per share (i)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;118.34&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;113.59&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;116.43&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;111.46&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;108.30&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;105.56&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left"&gt;5.450% Series J Preferred (l)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.450SerieJPreferredMember_zYlG1f8QJ8fh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Liquidation value, end of period (in 000&#x2019;s)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0166"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0167"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;80,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;80,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;80,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;80,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Total shares outstanding (in 000&#x2019;s)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;3,200&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;3,200&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;3,200&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;3,200&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Liquidation preference per share&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Average market value (k)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;26.03&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;26.00&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.98&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.14&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.450SerieJPreferredMember_zuzfh1jDXbyc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Asset coverage per share (i)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0173"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0174"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;116.43&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;111.46&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;108.30&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;105.56&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left"&gt;5.000% Series K Preferred&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.000SerieKPreferredMember_zpojXgxxxhU3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Liquidation value, end of period (in 000&#x2019;s)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;98,243&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;98,243&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;99,825&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;99,825&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;100,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0185"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Total shares outstanding (in 000&#x2019;s)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;3,930&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;3,930&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;3,993&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;3,993&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;4,000&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Liquidation preference per share&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Average market value (k)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;22.74&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;23.70&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;26.40&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.86&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.24&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.000SerieKPreferredMember_zqBbxIMEX4V9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Asset coverage per share (i)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;118.34&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;113.59&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;116.43&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;111.46&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;108.30&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0192"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left"&gt;4.250% Series M Cumulative Preferred Shares&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredShares4.250SerieMCumulativePreferredMember_zyegUutqQJ12" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Liquidation value, end of period (in 000&#x2019;s)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;68,550&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;68,550&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;67,850&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0197"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0198"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0199"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Total shares outstanding (in 000&#x2019;s)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;686&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;686&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;679&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Liquidation preference per share&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;100.00&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;100.00&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;100.00&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Average market value (k)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;100.00&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;100.00&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;100.00&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredShares4.250SerieMCumulativePreferredMember_zB882vMWthMf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Asset coverage per share (i)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;473.37&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;113.59&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;116.43&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left"&gt;Asset Coverage (m)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;473&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;454&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;466&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;446&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;433&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;422&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;div style="width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2020;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Based on net asset value per share, adjusted for reinvestment of distributions at net asset value on the ex-dividend dates and adjustments for the rights offering. Total return for a period of less than one year is not annualized.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2020;&#x2020;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt; Based on market value per share, adjusted for reinvestment of distributions at prices determined under the Fund&#x2019;s dividend reinvestment plan. Total return for a period of less than one year is not annualized.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Based on year to date book income. Amounts are subject to change and recharacterization at year end.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Calculated based on average common shares outstanding on the record dates throughout the periods.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amount represents less than $0.005 per share.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(c)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Annualized.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(d)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Fund received credits from a designated broker who agreed to pay certain Fund operating expenses. For all years presented there was no impact on the expense ratios.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(e)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Ratio of operating expenses to average net assets including liquidation value of preferred shares before fee reductions for the six months ended June&#160;30, 2023 and the years ended December&#160;31, 2022, 2021, 2020, 2019, and 2018 would have been 1.26%, 1.24%, 1.10%, 1.10%, 1.03%, and 1.09%, respectively.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(f)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In 2019, due to failed auctions relating to previous fiscal years, the Fund reversed accumulated auction fees. The 2019 ratio of operating expenses to average net assets attributable to common shares and the ratio of operating expenses to average net assets including liquidation value of preferred shares, excluding the reversal of auction agent fees, were 1.39% and 1.08%, respectively.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(g)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Ratio of operating expenses to average net assets including liquidation value of preferred shares net of fee reductions for the six months ended June&#160;30, 2023 and the years ended December&#160;31, 2022, 2021, 2020, 2019, and 2018 would have been 1.22%, 1.20%, 1.10%, 1.10%, 1.03%, and 1.01%, respectively.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(h)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Since February&#160;2008, the weekly auctions have failed. Holders that have submitted orders have not been able to sell any or all of their shares in the auction.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Asset coverage per share is calculated by combining all series of preferred stock.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(j)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Fund redeemed and retired all of the 2,363,860 shares of Series D Preferred on December&#160;26, 2019.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(k)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Based on weekly prices.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(l)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Fund redeemed and retired all of the 3,200,000 shares of Series J Preferred on January&#160;31, 2022.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(m)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Asset coverage is calculated by combining all series of preferred stock.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cef:SecurityTitleTextBlock>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2023-06-30_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember"
      decimals="0"
      unitRef="USD">62300</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2022-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember"
      decimals="0"
      unitRef="USD">62300</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2021-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember"
      decimals="0"
      unitRef="USD">62300</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2020-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember"
      decimals="0"
      unitRef="USD">62300</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2019-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember"
      decimals="0"
      unitRef="USD">72000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2018-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember"
      decimals="0"
      unitRef="USD">72000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2023-06-30_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember"
      decimals="INF"
      unitRef="USDPShares">118342</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2022-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember"
      decimals="INF"
      unitRef="USDPShares">113590</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2021-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember"
      decimals="INF"
      unitRef="USDPShares">116432</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2020-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember"
      decimals="INF"
      unitRef="USDPShares">111456</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2019-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember"
      decimals="INF"
      unitRef="USDPShares">108305</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2018-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember"
      decimals="INF"
      unitRef="USDPShares">105562</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2018-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember"
      decimals="0"
      unitRef="USD">59097</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2018-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember"
      decimals="INF"
      unitRef="USDPShares">105.56</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2023-06-30_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember"
      decimals="0"
      unitRef="USD">27700</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2022-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember"
      decimals="0"
      unitRef="USD">27700</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2021-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember"
      decimals="0"
      unitRef="USD">27700</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2020-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember"
      decimals="0"
      unitRef="USD">27700</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2019-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember"
      decimals="0"
      unitRef="USD">28000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2018-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember"
      decimals="0"
      unitRef="USD">28000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2023-06-30_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember"
      decimals="INF"
      unitRef="USDPShares">118342</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2022-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember"
      decimals="INF"
      unitRef="USDPShares">113590</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2021-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember"
      decimals="INF"
      unitRef="USDPShares">116432</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2020-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember"
      decimals="INF"
      unitRef="USDPShares">111456</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2019-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember"
      decimals="INF"
      unitRef="USDPShares">108305</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2018-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember"
      decimals="INF"
      unitRef="USDPShares">105562</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2023-06-30_custom_CumulativePreferredShares5.000SerieGPreferredMember"
      decimals="0"
      unitRef="USD">64647</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2022-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember"
      decimals="0"
      unitRef="USD">65060</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2021-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember"
      decimals="0"
      unitRef="USD">69491</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2020-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember"
      decimals="0"
      unitRef="USD">69491</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2019-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember"
      decimals="0"
      unitRef="USD">69495</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2018-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember"
      decimals="0"
      unitRef="USD">69495</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2023-06-30_custom_CumulativePreferredShares5.000SerieGPreferredMember"
      decimals="INF"
      unitRef="USDPShares">118.34</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2022-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember"
      decimals="INF"
      unitRef="USDPShares">113.59</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2021-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember"
      decimals="INF"
      unitRef="USDPShares">116.43</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2020-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember"
      decimals="INF"
      unitRef="USDPShares">111.46</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2019-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember"
      decimals="INF"
      unitRef="USDPShares">108.30</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2018-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember"
      decimals="INF"
      unitRef="USDPShares">105.56</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2023-06-30_custom_CumulativePreferredShares5.000SerieHPreferredMember"
      decimals="0"
      unitRef="USD">102910</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2022-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember"
      decimals="0"
      unitRef="USD">103195</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2021-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember"
      decimals="0"
      unitRef="USD">104322</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2020-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember"
      decimals="0"
      unitRef="USD">104322</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2019-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember"
      decimals="0"
      unitRef="USD">104322</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2018-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember"
      decimals="0"
      unitRef="USD">104322</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2023-06-30_custom_CumulativePreferredShares5.000SerieHPreferredMember"
      decimals="INF"
      unitRef="USDPShares">118.34</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2022-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember"
      decimals="INF"
      unitRef="USDPShares">113.59</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2021-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember"
      decimals="INF"
      unitRef="USDPShares">116.43</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2020-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember"
      decimals="INF"
      unitRef="USDPShares">111.46</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2019-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember"
      decimals="INF"
      unitRef="USDPShares">108.30</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2018-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember"
      decimals="INF"
      unitRef="USDPShares">105.56</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2021-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember"
      decimals="0"
      unitRef="USD">80000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2020-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember"
      decimals="0"
      unitRef="USD">80000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2019-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember"
      decimals="0"
      unitRef="USD">80000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2018-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember"
      decimals="0"
      unitRef="USD">80000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2021-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember"
      decimals="INF"
      unitRef="USDPShares">116.43</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2020-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember"
      decimals="INF"
      unitRef="USDPShares">111.46</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2019-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember"
      decimals="INF"
      unitRef="USDPShares">108.30</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2018-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember"
      decimals="INF"
      unitRef="USDPShares">105.56</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2023-06-30_custom_CumulativePreferredShares5.000SerieKPreferredMember"
      decimals="0"
      unitRef="USD">98243</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2022-12-31_custom_CumulativePreferredShares5.000SerieKPreferredMember"
      decimals="0"
      unitRef="USD">98243</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2021-12-31_custom_CumulativePreferredShares5.000SerieKPreferredMember"
      decimals="0"
      unitRef="USD">99825</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2020-12-31_custom_CumulativePreferredShares5.000SerieKPreferredMember"
      decimals="0"
      unitRef="USD">99825</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2019-12-31_custom_CumulativePreferredShares5.000SerieKPreferredMember"
      decimals="0"
      unitRef="USD">100000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2023-06-30_custom_CumulativePreferredShares5.000SerieKPreferredMember"
      decimals="INF"
      unitRef="USDPShares">118.34</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2022-12-31_custom_CumulativePreferredShares5.000SerieKPreferredMember"
      decimals="INF"
      unitRef="USDPShares">113.59</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2021-12-31_custom_CumulativePreferredShares5.000SerieKPreferredMember"
      decimals="INF"
      unitRef="USDPShares">116.43</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2020-12-31_custom_CumulativePreferredShares5.000SerieKPreferredMember"
      decimals="INF"
      unitRef="USDPShares">111.46</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2019-12-31_custom_CumulativePreferredShares5.000SerieKPreferredMember"
      decimals="INF"
      unitRef="USDPShares">108.30</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2023-06-30_custom_CumulativePreferredShares4.250SerieMCumulativePreferredMember"
      decimals="0"
      unitRef="USD">68550</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2022-12-31_custom_CumulativePreferredShares4.250SerieMCumulativePreferredMember"
      decimals="0"
      unitRef="USD">68550</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2021-12-31_custom_CumulativePreferredShares4.250SerieMCumulativePreferredMember"
      decimals="0"
      unitRef="USD">67850</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2023-06-30_custom_CumulativePreferredShares4.250SerieMCumulativePreferredMember"
      decimals="INF"
      unitRef="USDPShares">473.37</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2022-12-31_custom_CumulativePreferredShares4.250SerieMCumulativePreferredMember"
      decimals="INF"
      unitRef="USDPShares">113.59</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2021-12-31_custom_CumulativePreferredShares4.250SerieMCumulativePreferredMember"
      decimals="INF"
      unitRef="USDPShares">116.43</cef:SeniorSecuritiesCvgPerUnit>
    <cef:OtherSecuritiesTableTextBlock contextRef="AsOf2023-12-29">&lt;p id="xdx_80B_ecef--OtherSecuritiesTableTextBlock_zw1RGBmoDIGf" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20171231_zTtgvQ06Wg4j" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20161231_zgmT6FlJdRMi" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49F_20151231_zVfd6ZxFSv64" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_490_20141231_zFeUNFmmRfHh" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_496_20131231_zqMxG7jjrpUe" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="18" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended December&#160;31,&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2017&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2016&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2015&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2014&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2013&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;Cumulative Preferred Stock:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left"&gt;Auction Rate Series C Preferred&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredSharesAuctionRateSeriesCPreferredMember_zDa3Suzhj5B7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 50%; text-align: left"&gt;Liquidation value, end of year (in 000&#x2019;s)&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 7%; text-align: right"&gt;72,000&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 7%; text-align: right"&gt;72,000&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 7%; text-align: right"&gt;72,000&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 7%; text-align: right"&gt;72,000&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 7%; text-align: right"&gt;72,000&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Total shares outstanding (in 000&#x2019;s)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;3&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;3&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;3&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;3&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;3&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Liquidation preference per share&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Liquidation value(d)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredSharesAuctionRateSeriesCPreferredMember_zlobUkONpU9f" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Asset coverage per share(e)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;123,830&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;102,426&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;118,593&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;136,308&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;128,106&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left"&gt;5.875% Series D Preferred&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.875SerieAPreferredMember_zUJfJw8IW7uk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Liquidation value, end of year (in 000&#x2019;s)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;59,097&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;59,097&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;59,097&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;59,097&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;59,097&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Total shares outstanding (in 000&#x2019;s)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,364&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,364&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,364&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,364&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,364&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Liquidation preference per share&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Average market value(f)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;26.16&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;26.22&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.69&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.21&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.27&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.875SerieAPreferredMember_zH14xhzjzOP9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Asset coverage per share(e)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;123.83&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;102.43&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;118.59&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;136.31&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;128.11&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left"&gt;Auction Rate Series E Preferred&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredSharesAuctionRateSeriesEPreferredMember_zmkLD8nFbdY" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Liquidation value, end of year (in 000&#x2019;s)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;28,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;28,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;28,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;28,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;28,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Total shares outstanding (in 000&#x2019;s)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Liquidation preference per share&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Liquidation value(d)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredSharesAuctionRateSeriesEPreferredMember_zkcPOtk5rHr4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Asset coverage per share(e)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;123,830&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;102,426&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;118,593&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;136,308&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;128,106&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left"&gt;5.000% Series G Preferred&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.000SerieGPreferredMember_zHcuZDVqyih5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Liquidation value, end of year (in 000&#x2019;s)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;69,495&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;69,743&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;69,925&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;70,099&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;70,373&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Total shares outstanding (in 000&#x2019;s)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,780&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,791&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,797&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,804&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,815&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Liquidation preference per share&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Average market value(f)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;24.50&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;24.67&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;23.78&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;23.32&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;23.91&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.000SerieGPreferredMember_z31W2Zfh5rW" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Asset coverage per share(e)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;123.83&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;102.43&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;118.59&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;136.31&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;128.11&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left"&gt;5.000% Series H Preferred&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.000SerieHPreferredMember_z1RPRsXtzmSd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Liquidation value, end of year (in 000&#x2019;s)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;104,322&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;104,494&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;104,644&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;104,674&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;104,757&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Total shares outstanding (in 000&#x2019;s)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;4,173&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;4,180&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;4,186&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;4,187&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;4,190&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Liquidation preference per share&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Average market value(f)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;24.64&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;24.33&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;22.82&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;23.85&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.000SerieHPreferredMember_zvoU9oaDF8ie" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Asset coverage per share(e)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;123.83&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;102.43&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;118.59&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;136.31&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;128.11&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left"&gt;5.450% Series J Preferred&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.450SerieJPreferredMember_z1mYjValdsh4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Liquidation value, end of period (in 000&#x2019;s)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;80,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;80,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0272"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0273"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0274"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Total shares outstanding (in 000&#x2019;s)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;3,200&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;3,200&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Liquidation preference per share&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Average market value(f)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.36&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.43&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.450SerieJPreferredMember_z7qt99O2yjag" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Asset coverage per share(e)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;123.83&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;102.43&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0278"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0279"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0280"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left"&gt;Asset Coverage(g)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;495&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;410&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;474&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;545&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;512&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="18" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year Ended December&#160;31,&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2017&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2016&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2015&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2014&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2013&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;Cumulative Preferred Stock:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left"&gt;Auction Rate Series C&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredSharesAuctionRateSeriesCPreferredMember_zieGgcOK9s7f" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; width: 50%; text-align: left"&gt;Liquidation value, end of year (in 000&#x2019;s)&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 7%; text-align: right"&gt;72,000&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 7%; text-align: right"&gt;72,000&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 7%; text-align: right"&gt;72,000&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 7%; text-align: right"&gt;72,000&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 7%; text-align: right"&gt;72,000&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Total shares outstanding (in 000&#x2019;s)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;3&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;3&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;3&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;3&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;3&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Liquidation preference per share&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Liquidation value(c)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredSharesAuctionRateSeriesCPreferredMember_zrlfaIX7czv" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Asset coverage per share&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;123,830&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;102,426&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;118,593&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;136,308&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;128,106&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left"&gt;5.875% Series D&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.875SerieDPreferredMember_zSzoJNjRvAF7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Liquidation value, end of year (in 000&#x2019;s)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;59,097&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;59,097&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;59,097&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;59,097&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;59,097&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Total shares outstanding (in 000&#x2019;s)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,364&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,364&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,364&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,364&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,364&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Liquidation preference per share&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Average market value(d)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;26.16&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;26.22&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.69&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.21&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.27&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.875SerieDPreferredMember_z0u8A9dwo5ob" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Asset coverage per share&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;123.83&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;102.43&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;118.59&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;136.31&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;128.11&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left"&gt;Auction Rate Series E&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredSharesAuctionRateSeriesEPreferredMember_zMirsp0Kdbob" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Liquidation value, end of year (in 000&#x2019;s)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;28,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;28,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;28,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;28,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;28,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Total shares outstanding (in 000&#x2019;s)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;1&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Liquidation preference per share&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Liquidation value(c)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredSharesAuctionRateSeriesEPreferredMember_zwM5TvAOPjWf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Asset coverage per share&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;123,830&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;102,426&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;118,593&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;136,308&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;128,106&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left"&gt;5.000% Series G&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.000SerieGPreferredMember_zdvuzgbzNke4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Liquidation value, end of year (in 000&#x2019;s)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;69,495&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;69,743&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;69,925&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;70,099&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;70,373&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Total shares outstanding (in 000&#x2019;s)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,780&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,791&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,797&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,804&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,815&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Liquidation preference per share.&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Average market value(d)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;24.50&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;24.67&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;23.78&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;23.32&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;23.92&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.000SerieGPreferredMember_zvEadDiIWxWe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Asset coverage per share&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;123.83&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;102.43&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;118.59&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;136.31&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;128.11&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left"&gt;5.000% Series H&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecef--SeniorSecuritiesAmt_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.000SerieHPreferredMember_z0hnwJfYAyyi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Liquidation value, end of year (in 000&#x2019;s)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;104,322&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;104,494&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;104,644&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;104,674&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;104,757&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Total shares outstanding (in 000&#x2019;s)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;4,173&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;4,180&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;4,186&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;4,187&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;4,190&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Liquidation preference per share.&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Average market value(d)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;24.64&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;25.00&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;24.33&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;22.82&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;23.85&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecef--SeniorSecuritiesCvgPerUnit_iI_hcef--RiskAxis__custom--CumulativePreferredShares5.000SerieHPreferredMember_zb7YKWk7uJQd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Asset coverage per share&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;123.83&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;102.43&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;118.59&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;136.31&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;128.11&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left"&gt;Asset Coverage(e)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;495&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;410&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;474&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;545&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;512&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;div style="width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2020;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Based on net asset value per share, adjusted for reinvestment of distributions at net asset value on the ex-dividend dates and adjustments for the rights offering.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2020;&#x2020;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt; Based on market value per share, adjusted for reinvestment of distributions at prices determined under the Fund&#x2019;s dividend reinvestment plan and adjustments for the rights offering.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Calculated based on average common shares outstanding on the record dates throughout the years.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amount represents less than $0.005 per share.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(c)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Fund received credits from a designated broker who agreed to pay certain Fund operating expenses. For the years ended December&#160;31, 2017, 2016, and 2015, there was no impact on the expense ratios.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(d)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Since February&#160;2008, the weekly auctions have failed. Holders that have submitted orders have not been able to sell any or all of their shares in the auction.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(e)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Asset coverage per share is calculated by combining all series of preferred stock.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(f)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Based on weekly prices.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(g)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Asset coverage is calculated by combining all series of preferred stock.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cef:OtherSecuritiesTableTextBlock>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2017-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember"
      decimals="0"
      unitRef="USD">72000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2016-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember"
      decimals="0"
      unitRef="USD">72000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2015-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember"
      decimals="0"
      unitRef="USD">72000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2014-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember"
      decimals="0"
      unitRef="USD">72000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2013-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember"
      decimals="0"
      unitRef="USD">72000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2017-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember"
      decimals="INF"
      unitRef="USDPShares">123830</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2016-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember"
      decimals="INF"
      unitRef="USDPShares">102426</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2015-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember"
      decimals="INF"
      unitRef="USDPShares">118593</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2014-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember"
      decimals="INF"
      unitRef="USDPShares">136308</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2013-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember"
      decimals="INF"
      unitRef="USDPShares">128106</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2017-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember"
      decimals="0"
      unitRef="USD">59097</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2016-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember"
      decimals="0"
      unitRef="USD">59097</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2015-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember"
      decimals="0"
      unitRef="USD">59097</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2014-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember"
      decimals="0"
      unitRef="USD">59097</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2013-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember"
      decimals="0"
      unitRef="USD">59097</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2017-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember"
      decimals="INF"
      unitRef="USDPShares">123.83</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2016-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember"
      decimals="INF"
      unitRef="USDPShares">102.43</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2015-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember"
      decimals="INF"
      unitRef="USDPShares">118.59</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2014-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember"
      decimals="INF"
      unitRef="USDPShares">136.31</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2013-12-31_custom_CumulativePreferredShares5.875SerieAPreferredMember"
      decimals="INF"
      unitRef="USDPShares">128.11</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2017-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember"
      decimals="0"
      unitRef="USD">28000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2016-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember"
      decimals="0"
      unitRef="USD">28000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2015-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember"
      decimals="0"
      unitRef="USD">28000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2014-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember"
      decimals="0"
      unitRef="USD">28000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2013-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember"
      decimals="0"
      unitRef="USD">28000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2017-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember"
      decimals="INF"
      unitRef="USDPShares">123830</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2016-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember"
      decimals="INF"
      unitRef="USDPShares">102426</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2015-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember"
      decimals="INF"
      unitRef="USDPShares">118593</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2014-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember"
      decimals="INF"
      unitRef="USDPShares">136308</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2013-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember"
      decimals="INF"
      unitRef="USDPShares">128106</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2017-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember"
      decimals="0"
      unitRef="USD">69495</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2016-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember"
      decimals="0"
      unitRef="USD">69743</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2015-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember"
      decimals="0"
      unitRef="USD">69925</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2014-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember"
      decimals="0"
      unitRef="USD">70099</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2013-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember"
      decimals="0"
      unitRef="USD">70373</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2017-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember"
      decimals="INF"
      unitRef="USDPShares">123.83</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2016-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember"
      decimals="INF"
      unitRef="USDPShares">102.43</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2015-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember"
      decimals="INF"
      unitRef="USDPShares">118.59</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2014-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember"
      decimals="INF"
      unitRef="USDPShares">136.31</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2013-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember"
      decimals="INF"
      unitRef="USDPShares">128.11</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2017-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember"
      decimals="0"
      unitRef="USD">104322</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2016-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember"
      decimals="0"
      unitRef="USD">104494</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2015-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember"
      decimals="0"
      unitRef="USD">104644</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2014-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember"
      decimals="0"
      unitRef="USD">104674</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2013-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember"
      decimals="0"
      unitRef="USD">104757</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2017-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember"
      decimals="INF"
      unitRef="USDPShares">123.83</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2016-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember"
      decimals="INF"
      unitRef="USDPShares">102.43</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2015-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember"
      decimals="INF"
      unitRef="USDPShares">118.59</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2014-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember"
      decimals="INF"
      unitRef="USDPShares">136.31</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2013-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember"
      decimals="INF"
      unitRef="USDPShares">128.11</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2017-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember"
      decimals="0"
      unitRef="USD">80000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2016-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember"
      decimals="0"
      unitRef="USD">80000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2017-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember"
      decimals="INF"
      unitRef="USDPShares">123.83</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2016-12-31_custom_CumulativePreferredShares5.450SerieJPreferredMember"
      decimals="INF"
      unitRef="USDPShares">102.43</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2017-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember"
      decimals="0"
      unitRef="USD">72000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2016-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember"
      decimals="0"
      unitRef="USD">72000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2015-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember"
      decimals="0"
      unitRef="USD">72000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2014-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember"
      decimals="0"
      unitRef="USD">72000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2013-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember"
      decimals="0"
      unitRef="USD">72000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2017-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember"
      decimals="INF"
      unitRef="USDPShares">123830</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2016-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember"
      decimals="INF"
      unitRef="USDPShares">102426</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2015-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember"
      decimals="INF"
      unitRef="USDPShares">118593</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2014-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember"
      decimals="INF"
      unitRef="USDPShares">136308</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2013-12-31_custom_CumulativePreferredSharesAuctionRateSeriesCPreferredMember"
      decimals="INF"
      unitRef="USDPShares">128106</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2017-12-31_custom_CumulativePreferredShares5.875SerieDPreferredMember"
      decimals="0"
      unitRef="USD">59097</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2016-12-31_custom_CumulativePreferredShares5.875SerieDPreferredMember"
      decimals="0"
      unitRef="USD">59097</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2015-12-31_custom_CumulativePreferredShares5.875SerieDPreferredMember"
      decimals="0"
      unitRef="USD">59097</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2014-12-31_custom_CumulativePreferredShares5.875SerieDPreferredMember"
      decimals="0"
      unitRef="USD">59097</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2013-12-31_custom_CumulativePreferredShares5.875SerieDPreferredMember"
      decimals="0"
      unitRef="USD">59097</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2017-12-31_custom_CumulativePreferredShares5.875SerieDPreferredMember"
      decimals="INF"
      unitRef="USDPShares">123.83</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2016-12-31_custom_CumulativePreferredShares5.875SerieDPreferredMember"
      decimals="INF"
      unitRef="USDPShares">102.43</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2015-12-31_custom_CumulativePreferredShares5.875SerieDPreferredMember"
      decimals="INF"
      unitRef="USDPShares">118.59</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2014-12-31_custom_CumulativePreferredShares5.875SerieDPreferredMember"
      decimals="INF"
      unitRef="USDPShares">136.31</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2013-12-31_custom_CumulativePreferredShares5.875SerieDPreferredMember"
      decimals="INF"
      unitRef="USDPShares">128.11</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2017-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember"
      decimals="0"
      unitRef="USD">28000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2016-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember"
      decimals="0"
      unitRef="USD">28000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2015-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember"
      decimals="0"
      unitRef="USD">28000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2014-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember"
      decimals="0"
      unitRef="USD">28000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2013-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember"
      decimals="0"
      unitRef="USD">28000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2017-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember"
      decimals="INF"
      unitRef="USDPShares">123830</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2016-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember"
      decimals="INF"
      unitRef="USDPShares">102426</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2015-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember"
      decimals="INF"
      unitRef="USDPShares">118593</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2014-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember"
      decimals="INF"
      unitRef="USDPShares">136308</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2013-12-31_custom_CumulativePreferredSharesAuctionRateSeriesEPreferredMember"
      decimals="INF"
      unitRef="USDPShares">128106</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2017-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember"
      decimals="0"
      unitRef="USD">69495</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2016-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember"
      decimals="0"
      unitRef="USD">69743</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2015-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember"
      decimals="0"
      unitRef="USD">69925</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2014-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember"
      decimals="0"
      unitRef="USD">70099</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2013-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember"
      decimals="0"
      unitRef="USD">70373</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2017-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember"
      decimals="INF"
      unitRef="USDPShares">123.83</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2016-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember"
      decimals="INF"
      unitRef="USDPShares">102.43</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2015-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember"
      decimals="INF"
      unitRef="USDPShares">118.59</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2014-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember"
      decimals="INF"
      unitRef="USDPShares">136.31</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2013-12-31_custom_CumulativePreferredShares5.000SerieGPreferredMember"
      decimals="INF"
      unitRef="USDPShares">128.11</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2017-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember"
      decimals="0"
      unitRef="USD">104322</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2016-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember"
      decimals="0"
      unitRef="USD">104494</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2015-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember"
      decimals="0"
      unitRef="USD">104644</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2014-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember"
      decimals="0"
      unitRef="USD">104674</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2013-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember"
      decimals="0"
      unitRef="USD">104757</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2017-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember"
      decimals="INF"
      unitRef="USDPShares">123.83</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2016-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember"
      decimals="INF"
      unitRef="USDPShares">102.43</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2015-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember"
      decimals="INF"
      unitRef="USDPShares">118.59</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2014-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember"
      decimals="INF"
      unitRef="USDPShares">136.31</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="AsOf2013-12-31_custom_CumulativePreferredShares5.000SerieHPreferredMember"
      decimals="INF"
      unitRef="USDPShares">128.11</cef:SeniorSecuritiesCvgPerUnit>
    <cef:InvestmentObjectivesAndPracticesTextBlock contextRef="AsOf2023-12-29">&lt;p id="xdx_A8B_ecef--InvestmentObjectivesAndPracticesTextBlock_zU5jS1NbMAMj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="a_006"&gt;&lt;/span&gt;INVESTMENT OBJECTIVES AND POLICIES&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"&gt;Please refer to the &lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000794685/000138713123003229/gab-ncsr_123122.htm"&gt;section of the Fund&#x2019;s most recent annual report on Form N-CSR entitled &#x201c;Additional Fund Information &#x2013; Summary of Updated Information Regarding the Fund &#x2013; Investment Objective and Strategies,&#x201d;&lt;/a&gt; which is incorporated by reference herein, for a discussion of the Fund&#x2019;s investment objectives and policies.&lt;/p&gt;

</cef:InvestmentObjectivesAndPracticesTextBlock>
    <cef:RiskFactorsTableTextBlock contextRef="AsOf2023-12-29">&lt;p id="xdx_A8C_ecef--RiskFactorsTableTextBlock_zhbvpeBFAS4b" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="a_007"&gt;&lt;/span&gt;RISK FACTORS AND SPECIAL CONSIDERATIONS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Risk is inherent in all investing. Please refer to the &lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000794685/000138713123003229/gab-ncsr_123122.htm"&gt;section of the Fund&#x2019;s most recent annual report on Form N-CSR entitled &#x201c;Additional Information &#x2013; Summary of Updated Information Regarding the Fund &#x2013; Principal Risk Factors,&#x201d;&lt;/a&gt; which is incorporated by reference herein, for a discussion of investing in the Fund. You should carefully consider those risks and the risk described below. As of the date of this Prospectus, the Fund is classified as a &#x201c;diversified&#x201d; investment company under the 1940 Act. Accordingly, the risk factor entitled &#x201c;Non-Diversified Status&#x201d; included in the Fund&#x2019;s most recent annual report referenced above is no longer applicable.&lt;/p&gt;

</cef:RiskFactorsTableTextBlock>
    <cef:RiskTextBlock contextRef="From2023-12-292023-12-29_custom_HowTheFundManagesRiskMember">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="a_008"&gt;&lt;/span&gt;HOW THE FUND MANAGES RISK&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Investment Restrictions&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Fund has adopted certain investment limitations, some of which are fundamental policies of the Fund, designed to limit investment risk and maintain portfolio diversification. Under the 1940 Act, a fundamental policy may not be changed without the vote of a majority, as defined in the 1940 Act, of the outstanding voting securities of the Fund (voting together as a single class). The Fund may become subject to guidelines that are more limiting than its current investment restrictions in order to obtain and maintain ratings from Moody&#x2019;s and Fitch Ratings, Inc. (&#x201c;Fitch&#x201d;) on certain series of its preferred stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Interest Rate Transactions&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Fund may enter into interest rate swap or cap transactions. The use of interest rate swaps and caps is a highly specialized activity that involves investment techniques and risks different from those associated with ordinary portfolio security transactions. In an interest rate swap, the Fund would agree to pay to the other party to the interest rate swap (which is known as the &#x201c;counterparty&#x201d;) periodically a fixed rate payment in exchange for the counterparty agreeing to pay to the Fund periodically a variable rate payment that is intended to approximate the Fund&#x2019;s variable rate payment obligation on its outstanding Series C Auction Rate Preferred and Series E Auction Rate Preferred (together, the &#x201c;Auction Rate Preferred Stock&#x201d;). In an interest rate cap, the Fund would pay a premium to the counterparty to the interest rate cap and, to the extent that a specified variable rate index exceeds a predetermined fixed rate, would receive from the counterparty payments of the difference based on the notional amount of such cap. Interest rate swap and cap transactions introduce additional risk because the Fund would remain obligated to pay preferred stock dividends or distributions when due in accordance with the Articles Supplementary of the relevant series of the Auction Rate Preferred Stock even if the counterparty defaulted. Depending on the general state of short term interest rates and the returns on the Fund&#x2019;s portfolio securities at that point in time, such a default could negatively affect the Fund&#x2019;s ability to make dividend or distribution payments on the Auction Rate Preferred Stock. In addition, at the time an interest rate swap or cap transaction reaches its scheduled termination date, there is a risk that the Fund will not be able to obtain a replacement transaction or that the terms of the replacement will not be as favorable as on the expiring transaction. If this occurs, it could have a negative impact on the Fund&#x2019;s ability to make dividend or distribution payments on the Auction Rate Preferred Stock. To the extent there is a decline in interest rates, the value of the interest rate swap or cap could decline, resulting in a decline in the asset coverage for the Auction Rate Preferred Stock. A sudden and dramatic decline in interest rates may result in a significant decline in the asset coverage. Under the Articles Supplementary for each series of preferred stock, if the Fund fails to maintain the required asset coverage on the outstanding preferred stock or fails to comply with other covenants, the Fund may be required to redeem some or all of these shares. The Fund generally may redeem any series of Auction Rate Preferred Stock, in whole or in part, at its option at any time (usually on a dividend or distribution payment date), other than during a non-call period. Such redemption would likely result in the Fund seeking to terminate early all or a portion of any swap or cap transactions. Early termination of a swap could result in a termination payment by the Fund to the counterparty, while early termination of a cap could result in a termination payment to the Fund.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Fund will usually enter into swaps or caps on a net basis; that is, the two payment streams will be netted out in a cash settlement on the payment date or dates specified in the instrument, with the Fund receiving or paying, as the case may be, only the net amount of the two payments. The Fund will monitor any such swap with a view to ensuring that the Fund remains in compliance with all applicable regulatory investment policy and tax requirements.&lt;/span&gt;&lt;/p&gt;

</cef:RiskTextBlock>
    <cef:OutstandingSecurityTitleTextBlock contextRef="From2023-12-292023-12-29_custom_CommonShareMember">&lt;p id="xdx_805_ecef--OutstandingSecurityTitleTextBlock_hcef--RiskAxis__custom--CommonShareMember_zKmgR8jxX1wj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Common Stock&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant to an amendment to the Fund&#x2019;s Charter that was approved by stockholders in 2004, the Board may increase or decrease the aggregate number of shares of stock of the Fund or the number of shares of any class or series that the Fund has authority to issue without stockholder approval. The Fund is currently authorized to issue 337,024,900 shares of common stock, par value $0.001 per share. Holders of the common stock are entitled to one vote per share held. Holders of the common stock are entitled to share equally in distributions authorized by the Board and payable to the holders of such shares and in the net assets of the Fund available on liquidation for distribution to holders of such shares. The shares of common stock have noncumulative voting rights and no conversion, preemptive or other subscription rights, and are not redeemable. In the event of liquidation, each share of the Fund&#x2019;s common stock is entitled to its proportion of the Fund&#x2019;s assets after payment of debts and expenses and the amounts payable to holders of the Fund&#x2019;s preferred stock ranking senior to the shares of common stock of the Fund as described below.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Offerings of stock require approval by the Board. Any additional offering of common stock will be subject to the requirements of the 1940 Act, which provides that common stock may not be issued at a price below the then current net asset value, exclusive of sales load, except in connection with an offering to existing holders of common stock or with the consent of a majority of the Fund&#x2019;s outstanding voting securities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p id="xdx_891_ecef--SharePriceTableTextBlock_zczBTBcvccLb" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Fund&#x2019;s outstanding common stock is listed and traded on the NYSE under the symbol &#x201c;GAB.&#x201d; The average weekly trading volume of the common stock on the NYSE during the period from January&#160;1, 2022 through December&#160;31, 2022 was 2,642,587 shares. The Fund determines its NAV on a daily basis. The following table sets forth, for the quarters indicated, the highest and lowest daily closing prices on the NYSE per common share, and the NAV per common share and the premium to or discount from NAV, on the date of each of the high and low market prices. The table also sets forth the number of common shares traded on the NYSE during the respective quarters.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Market Price&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Corresponding&lt;br/&gt;Net Asset Value&lt;br/&gt;(&#x201c;NAV&#x201d;) Per&lt;br/&gt;Share&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Corresponding&lt;br/&gt;Premium or&lt;br/&gt;Discount&lt;br/&gt;as a %&lt;br/&gt;of NAV&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: left"&gt;Quarter Ended&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;High&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Low&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;High&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Low&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;High&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Low&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 40%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;March&#160;31, 2021&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 7%; text-align: right"&gt;&lt;span id="xdx_909_ecef--HighestPriceOrBid_c20210101__20210331_zPQn2Ykwikbf"&gt;7.05&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 7%; text-align: right"&gt;&lt;span id="xdx_903_ecef--LowestPriceOrBid_c20210101__20210331_z0X0WYhy0GJ2"&gt;6.07&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 7%; text-align: right"&gt;&lt;span id="xdx_908_ecef--HighestPriceOrBidNav_c20210101__20210331_z8Oox7IO7Zy8"&gt;6.67&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 7%; text-align: right"&gt;&lt;span id="xdx_908_ecef--LowestPriceOrBidNav_c20210101__20210331_zFPZu6PGhdAd"&gt;5.78&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 7%; text-align: right"&gt;&lt;span id="xdx_906_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20210101__20210331_zIJIFvq2SpH"&gt;5.70&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 7%; text-align: right"&gt;&lt;span id="xdx_909_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20210101__20210331_zr79rJHXn1vl"&gt;5.02&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June&#160;30, 2021&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecef--HighestPriceOrBid_c20210401__20210630_zPQuQX4DpsI8"&gt;7.54&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecef--LowestPriceOrBid_c20210401__20210630_zdKgIBEaWiod"&gt;6.67&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecef--HighestPriceOrBidNav_c20210401__20210630_zmDs2s6AMPZ7"&gt;6.83&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecef--LowestPriceOrBidNav_c20210401__20210630_zCCZghoylbIe"&gt;6.48&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20210401__20210630_zTw4BtNgRaEi"&gt;10.40&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20210401__20210630_zMN7j9sZH8j2"&gt;2.93&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September&#160;30, 2021&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecef--HighestPriceOrBid_c20210701__20210930_zzvr1ezylsvc"&gt;7.07&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecef--LowestPriceOrBid_c20210701__20210930_zY58DLFzoE1h"&gt;6.52&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecef--HighestPriceOrBidNav_c20210701__20210930_zPd6uAzbLlC2"&gt;6.62&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecef--LowestPriceOrBidNav_c20210701__20210930_zw7HUFGq64Cf"&gt;6.26&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20210701__20210930_zLJwf5KEk0ab"&gt;6.80&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20210701__20210930_z4UoR2cFdBT5"&gt;4.15&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecef--HighestPriceOrBid_c20211001__20211231_zGLSoRbSM8lc"&gt;7.37&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecef--LowestPriceOrBid_c20211001__20211231_zBLAut2UyUmh"&gt;6.64&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecef--HighestPriceOrBidNav_c20211001__20211231_zDs7lTSCKwZ3"&gt;6.46&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecef--LowestPriceOrBidNav_c20211001__20211231_z8I9QEE7a1r7"&gt;6.28&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20211001__20211231_z0yVQnbUpBve"&gt;14.09&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20211001__20211231_zTo6Yc4VZWwa"&gt;5.73&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;March&#160;31, 2022&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecef--HighestPriceOrBid_c20220101__20220331_zv4HL5aEACve"&gt;7.24&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecef--LowestPriceOrBid_c20220101__20220331_zxR7zHk2CYp2"&gt;6.76&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecef--HighestPriceOrBidNav_c20220101__20220331_z6lMWfqijXi1"&gt;6.45&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecef--LowestPriceOrBidNav_c20220101__20220331_zN9OL4WO8H2b"&gt;5.79&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20220101__20220331_zlPFJwupSjKl"&gt;12.25&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20220101__20220331_zfWHgDEsTlX1"&gt;16.75&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June&#160;30, 2022&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecef--HighestPriceOrBid_c20220401__20220630_zlkJuqKDvDw5"&gt;7.05&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecef--LowestPriceOrBid_c20220401__20220630_zPg6jvxDP6p4"&gt;5.54&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecef--HighestPriceOrBidNav_c20220401__20220630_zGhosLxVmCI8"&gt;5.95&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecef--LowestPriceOrBidNav_c20220401__20220630_zhWE3h6l1TF1"&gt;4.73&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20220401__20220630_zNIQD6Tynh21"&gt;18.49&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20220401__20220630_zrzXcHRCTF3i"&gt;17.12&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September&#160;30, 2022&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecef--HighestPriceOrBid_c20220701__20220930_zTtzoUDASF0e"&gt;6.53&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecef--LowestPriceOrBid_c20220701__20220930_zR3OmP299GXh"&gt;5.50&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecef--HighestPriceOrBidNav_c20220701__20220930_zEOGYutkZT0b"&gt;5.37&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecef--LowestPriceOrBidNav_c20220701__20220930_zbSAdU003rdf"&gt;4.47&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20220701__20220930_z1aOixqVsh29"&gt;21.60&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20220701__20220930_zxdTuOLQ1m89"&gt;23.04&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December&#160;31, 2022&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecef--HighestPriceOrBid_c20221001__20221231_zmVYoSoZ8YXd"&gt;6.16&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecef--LowestPriceOrBid_c20221001__20221231_zXbn6q1z8lz2"&gt;4.97&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecef--HighestPriceOrBidNav_c20221001__20221231_z0TJgXXgSpjb"&gt;5.53&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecef--LowestPriceOrBidNav_c20221001__20221231_zyCzlA3ua6K5"&gt;4.54&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20221001__20221231_z0hXHkWwbEib"&gt;11.39&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20221001__20221231_zWKaFtTUWLqi"&gt;9.47&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;March&#160;31, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecef--HighestPriceOrBid_c20230101__20230331_zYunadAE1eLd"&gt;5.99&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecef--LowestPriceOrBid_c20230101__20230331_zspe6oXWVOI8"&gt;5.41&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecef--HighestPriceOrBidNav_c20230101__20230331_zlEkpfytnkk"&gt;5.53&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecef--LowestPriceOrBidNav_c20230101__20230331_znwXeeucRXJh"&gt;4.93&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20230101__20230331_zVtAhkL5VTCa"&gt;8.32&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20230101__20230331_zuIaNK8n2NBa"&gt;9.74&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June&#160;30, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecef--HighestPriceOrBid_c20230401__20230630_z5puDW6SZ4s3"&gt;5.80&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecef--LowestPriceOrBid_c20230401__20230630_zRotsob4VTD5"&gt;5.33&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecef--HighestPriceOrBidNav_c20230401__20230630_zCj0qKPeBH5"&gt;5.30&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecef--LowestPriceOrBidNav_c20230401__20230630_zLCXSYO6Dn75"&gt;5.02&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20230401__20230630_zAMyRtXxfAOl"&gt;9.43&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20230401__20230630_zRGVi5tAyWF4"&gt;6.18&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September&#160;30, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecef--HighestPriceOrBid_c20230701__20230930_za93zKGKdmQ3"&gt;5.87&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecef--LowestPriceOrBid_c20230701__20230930_zB6c0sskB8H6"&gt;5.13&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecef--HighestPriceOrBidNav_c20230701__20230930_zbLscm2TjPD1"&gt;5.30&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecef--LowestPriceOrBidNav_c20230701__20230930_zdo5Iufyj94i"&gt;4.79&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20230701__20230930_zr9mrRNBlbOh"&gt;10.75&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20230701__20230930_zUipaRuFO9qa"&gt;7.10&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On December&#160;28, 2023, the last reported price for our common shares was $5.13 and the net asset value per share on December&#160;28, 2023 was $5.21 per share. Accordingly, our common stock traded at a discount to net asset value of -1.54% on December&#160;28, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Fund&#x2019;s net asset value per share will be reduced immediately following the offering of common stock by the amount of the sales load and offering expenses paid by the Fund. See &#x201c;Use of Proceeds.&#x201d; Unlike open-end funds, closed-end funds like the Fund do not continuously offer shares and do not provide daily redemptions. Rather, if a stockholder determines to buy additional shares of common stock or sell shares already held, the stockholder may do so by trading through a broker on the NYSE or otherwise.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Shares of closed-end investment companies often trade on an exchange at prices lower than net asset value. The Fund&#x2019;s shares of common stock have traded in the market at both premiums to and discounts from net asset value. Over the Fund&#x2019;s thirty-seven year history, the range fluctuated from a 38% premium in 2002 to a 27% discount in 1987. Beginning in early 2001, the market price of the Fund exceeded the net asset value and this premium continued through September&#160;2005. The previous extended period over which the premium existed occurred during the twenty month period from August&#160;1993 to March&#160;1995. As of September&#160;30, 2023, the market price of the Fund closed at an approximate 7.1% premium to its net asset value. Because the market value of the common stock may be influenced by such factors as dividend and distribution levels (which are in turn affected by expenses), dividend and distribution stability, net asset value, market liquidity, relative demand for and supply of such shares in the market, unrealized gains, general market and economic conditions and other factors beyond the control of the Fund, the Fund cannot assure you that shares of common stock will trade at a price equal to or higher than net asset value in the future. The common stock is designed primarily for long term investors and you should not purchase the shares of the common stock if you intend to sell them soon after purchase.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Fund&#x2019;s common stockholders vote together with the holders of preferred stock, as a single class, to elect the Fund&#x2019;s Board (other than two directors elected exclusively by holders of the Fund&#x2019;s preferred stock) and, except as described below, on additional matters with respect to which the 1940 Act, the Governing Documents or resolutions adopted by the Directors provide for a vote of the Fund&#x2019;s common stockholders. Holders of the Fund&#x2019;s preferred stock vote together as a single class to elect two of the directors of the Fund and vote together as a single class, separately from holders of the Fund&#x2019;s common stock, to approve any plan of reorganization adversely affecting the preferred stock and to approve certain amendments to the Charter, whether by merger, consolidation or otherwise, that materially and adversely affect the contract rights of the existing preferred stock as set forth in the Charter. In addition, the affirmative vote of the holders of 66 &#x2154;% of the outstanding shares of each class of stock of the Fund normally entitled to vote in the election of directors, each such class voting as a separate class, is required to authorize the conversion of the Fund from a closed-end to an open-end investment company. See &#x201c;Anti-Takeover Provisions of the Fund&#x2019;s Governing Documents.&#x201d;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Fund may repurchase its shares of common stock from time to time as and when it deems such repurchase advisable from legally available funds, subject to rights of holders of the Fund&#x2019;s outstanding preferred stock and maintaining required asset coverage for each series of outstanding preferred stock. The Board has adopted a policy to authorize such repurchases when the shares are trading at a discount of 10% or more (or such other percentage as the Board may determine from time to time) from the net asset value of the shares. Although the Board has authorized such repurchases, the Fund is not required to repurchase its shares. The policy does not limit the amount of common stock that can be repurchased. The percentage of the discount from net asset value at which share repurchases will be authorized may be changed at any time by the Board. Through December&#160;31, 2022, the Fund has not repurchased shares of its common stock under this authorization.&lt;/span&gt;&lt;/p&gt;

</cef:OutstandingSecurityTitleTextBlock>
    <cef:SharePriceTableTextBlock contextRef="AsOf2023-12-29">&lt;p id="xdx_891_ecef--SharePriceTableTextBlock_zczBTBcvccLb" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Fund&#x2019;s outstanding common stock is listed and traded on the NYSE under the symbol &#x201c;GAB.&#x201d; The average weekly trading volume of the common stock on the NYSE during the period from January&#160;1, 2022 through December&#160;31, 2022 was 2,642,587 shares. The Fund determines its NAV on a daily basis. The following table sets forth, for the quarters indicated, the highest and lowest daily closing prices on the NYSE per common share, and the NAV per common share and the premium to or discount from NAV, on the date of each of the high and low market prices. The table also sets forth the number of common shares traded on the NYSE during the respective quarters.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Market Price&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Corresponding&lt;br/&gt;Net Asset Value&lt;br/&gt;(&#x201c;NAV&#x201d;) Per&lt;br/&gt;Share&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Corresponding&lt;br/&gt;Premium or&lt;br/&gt;Discount&lt;br/&gt;as a %&lt;br/&gt;of NAV&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: left"&gt;Quarter Ended&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;High&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Low&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;High&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Low&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;High&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Low&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 40%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;March&#160;31, 2021&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 7%; text-align: right"&gt;&lt;span id="xdx_909_ecef--HighestPriceOrBid_c20210101__20210331_zPQn2Ykwikbf"&gt;7.05&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 7%; text-align: right"&gt;&lt;span id="xdx_903_ecef--LowestPriceOrBid_c20210101__20210331_z0X0WYhy0GJ2"&gt;6.07&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 7%; text-align: right"&gt;&lt;span id="xdx_908_ecef--HighestPriceOrBidNav_c20210101__20210331_z8Oox7IO7Zy8"&gt;6.67&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 7%; text-align: right"&gt;&lt;span id="xdx_908_ecef--LowestPriceOrBidNav_c20210101__20210331_zFPZu6PGhdAd"&gt;5.78&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 7%; text-align: right"&gt;&lt;span id="xdx_906_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20210101__20210331_zIJIFvq2SpH"&gt;5.70&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 7%; text-align: right"&gt;&lt;span id="xdx_909_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20210101__20210331_zr79rJHXn1vl"&gt;5.02&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June&#160;30, 2021&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecef--HighestPriceOrBid_c20210401__20210630_zPQuQX4DpsI8"&gt;7.54&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecef--LowestPriceOrBid_c20210401__20210630_zdKgIBEaWiod"&gt;6.67&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecef--HighestPriceOrBidNav_c20210401__20210630_zmDs2s6AMPZ7"&gt;6.83&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecef--LowestPriceOrBidNav_c20210401__20210630_zCCZghoylbIe"&gt;6.48&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20210401__20210630_zTw4BtNgRaEi"&gt;10.40&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20210401__20210630_zMN7j9sZH8j2"&gt;2.93&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September&#160;30, 2021&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecef--HighestPriceOrBid_c20210701__20210930_zzvr1ezylsvc"&gt;7.07&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecef--LowestPriceOrBid_c20210701__20210930_zY58DLFzoE1h"&gt;6.52&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecef--HighestPriceOrBidNav_c20210701__20210930_zPd6uAzbLlC2"&gt;6.62&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecef--LowestPriceOrBidNav_c20210701__20210930_zw7HUFGq64Cf"&gt;6.26&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20210701__20210930_zLJwf5KEk0ab"&gt;6.80&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20210701__20210930_z4UoR2cFdBT5"&gt;4.15&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecef--HighestPriceOrBid_c20211001__20211231_zGLSoRbSM8lc"&gt;7.37&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecef--LowestPriceOrBid_c20211001__20211231_zBLAut2UyUmh"&gt;6.64&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecef--HighestPriceOrBidNav_c20211001__20211231_zDs7lTSCKwZ3"&gt;6.46&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecef--LowestPriceOrBidNav_c20211001__20211231_z8I9QEE7a1r7"&gt;6.28&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20211001__20211231_z0yVQnbUpBve"&gt;14.09&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20211001__20211231_zTo6Yc4VZWwa"&gt;5.73&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;March&#160;31, 2022&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecef--HighestPriceOrBid_c20220101__20220331_zv4HL5aEACve"&gt;7.24&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecef--LowestPriceOrBid_c20220101__20220331_zxR7zHk2CYp2"&gt;6.76&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecef--HighestPriceOrBidNav_c20220101__20220331_z6lMWfqijXi1"&gt;6.45&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecef--LowestPriceOrBidNav_c20220101__20220331_zN9OL4WO8H2b"&gt;5.79&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20220101__20220331_zlPFJwupSjKl"&gt;12.25&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20220101__20220331_zfWHgDEsTlX1"&gt;16.75&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June&#160;30, 2022&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecef--HighestPriceOrBid_c20220401__20220630_zlkJuqKDvDw5"&gt;7.05&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecef--LowestPriceOrBid_c20220401__20220630_zPg6jvxDP6p4"&gt;5.54&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecef--HighestPriceOrBidNav_c20220401__20220630_zGhosLxVmCI8"&gt;5.95&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecef--LowestPriceOrBidNav_c20220401__20220630_zhWE3h6l1TF1"&gt;4.73&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20220401__20220630_zNIQD6Tynh21"&gt;18.49&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20220401__20220630_zrzXcHRCTF3i"&gt;17.12&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September&#160;30, 2022&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecef--HighestPriceOrBid_c20220701__20220930_zTtzoUDASF0e"&gt;6.53&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecef--LowestPriceOrBid_c20220701__20220930_zR3OmP299GXh"&gt;5.50&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecef--HighestPriceOrBidNav_c20220701__20220930_zEOGYutkZT0b"&gt;5.37&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecef--LowestPriceOrBidNav_c20220701__20220930_zbSAdU003rdf"&gt;4.47&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20220701__20220930_z1aOixqVsh29"&gt;21.60&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20220701__20220930_zxdTuOLQ1m89"&gt;23.04&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December&#160;31, 2022&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecef--HighestPriceOrBid_c20221001__20221231_zmVYoSoZ8YXd"&gt;6.16&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecef--LowestPriceOrBid_c20221001__20221231_zXbn6q1z8lz2"&gt;4.97&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecef--HighestPriceOrBidNav_c20221001__20221231_z0TJgXXgSpjb"&gt;5.53&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecef--LowestPriceOrBidNav_c20221001__20221231_zyCzlA3ua6K5"&gt;4.54&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20221001__20221231_z0hXHkWwbEib"&gt;11.39&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20221001__20221231_zWKaFtTUWLqi"&gt;9.47&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;March&#160;31, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecef--HighestPriceOrBid_c20230101__20230331_zYunadAE1eLd"&gt;5.99&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecef--LowestPriceOrBid_c20230101__20230331_zspe6oXWVOI8"&gt;5.41&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecef--HighestPriceOrBidNav_c20230101__20230331_zlEkpfytnkk"&gt;5.53&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecef--LowestPriceOrBidNav_c20230101__20230331_znwXeeucRXJh"&gt;4.93&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20230101__20230331_zVtAhkL5VTCa"&gt;8.32&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20230101__20230331_zuIaNK8n2NBa"&gt;9.74&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June&#160;30, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecef--HighestPriceOrBid_c20230401__20230630_z5puDW6SZ4s3"&gt;5.80&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecef--LowestPriceOrBid_c20230401__20230630_zRotsob4VTD5"&gt;5.33&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecef--HighestPriceOrBidNav_c20230401__20230630_zCj0qKPeBH5"&gt;5.30&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecef--LowestPriceOrBidNav_c20230401__20230630_zLCXSYO6Dn75"&gt;5.02&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20230401__20230630_zAMyRtXxfAOl"&gt;9.43&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20230401__20230630_zRGVi5tAyWF4"&gt;6.18&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September&#160;30, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecef--HighestPriceOrBid_c20230701__20230930_za93zKGKdmQ3"&gt;5.87&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecef--LowestPriceOrBid_c20230701__20230930_zB6c0sskB8H6"&gt;5.13&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecef--HighestPriceOrBidNav_c20230701__20230930_zbLscm2TjPD1"&gt;5.30&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecef--LowestPriceOrBidNav_c20230701__20230930_zdo5Iufyj94i"&gt;4.79&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_c20230701__20230930_zr9mrRNBlbOh"&gt;10.75&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_c20230701__20230930_zUipaRuFO9qa"&gt;7.10&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On December&#160;28, 2023, the last reported price for our common shares was $5.13 and the net asset value per share on December&#160;28, 2023 was $5.21 per share. Accordingly, our common stock traded at a discount to net asset value of -1.54% on December&#160;28, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Fund&#x2019;s net asset value per share will be reduced immediately following the offering of common stock by the amount of the sales load and offering expenses paid by the Fund. See &#x201c;Use of Proceeds.&#x201d; Unlike open-end funds, closed-end funds like the Fund do not continuously offer shares and do not provide daily redemptions. Rather, if a stockholder determines to buy additional shares of common stock or sell shares already held, the stockholder may do so by trading through a broker on the NYSE or otherwise.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Shares of closed-end investment companies often trade on an exchange at prices lower than net asset value. The Fund&#x2019;s shares of common stock have traded in the market at both premiums to and discounts from net asset value. Over the Fund&#x2019;s thirty-seven year history, the range fluctuated from a 38% premium in 2002 to a 27% discount in 1987. Beginning in early 2001, the market price of the Fund exceeded the net asset value and this premium continued through September&#160;2005. The previous extended period over which the premium existed occurred during the twenty month period from August&#160;1993 to March&#160;1995. As of September&#160;30, 2023, the market price of the Fund closed at an approximate 7.1% premium to its net asset value. Because the market value of the common stock may be influenced by such factors as dividend and distribution levels (which are in turn affected by expenses), dividend and distribution stability, net asset value, market liquidity, relative demand for and supply of such shares in the market, unrealized gains, general market and economic conditions and other factors beyond the control of the Fund, the Fund cannot assure you that shares of common stock will trade at a price equal to or higher than net asset value in the future. The common stock is designed primarily for long term investors and you should not purchase the shares of the common stock if you intend to sell them soon after purchase.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Fund&#x2019;s common stockholders vote together with the holders of preferred stock, as a single class, to elect the Fund&#x2019;s Board (other than two directors elected exclusively by holders of the Fund&#x2019;s preferred stock) and, except as described below, on additional matters with respect to which the 1940 Act, the Governing Documents or resolutions adopted by the Directors provide for a vote of the Fund&#x2019;s common stockholders. Holders of the Fund&#x2019;s preferred stock vote together as a single class to elect two of the directors of the Fund and vote together as a single class, separately from holders of the Fund&#x2019;s common stock, to approve any plan of reorganization adversely affecting the preferred stock and to approve certain amendments to the Charter, whether by merger, consolidation or otherwise, that materially and adversely affect the contract rights of the existing preferred stock as set forth in the Charter. In addition, the affirmative vote of the holders of 66 &#x2154;% of the outstanding shares of each class of stock of the Fund normally entitled to vote in the election of directors, each such class voting as a separate class, is required to authorize the conversion of the Fund from a closed-end to an open-end investment company. See &#x201c;Anti-Takeover Provisions of the Fund&#x2019;s Governing Documents.&#x201d;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Fund may repurchase its shares of common stock from time to time as and when it deems such repurchase advisable from legally available funds, subject to rights of holders of the Fund&#x2019;s outstanding preferred stock and maintaining required asset coverage for each series of outstanding preferred stock. The Board has adopted a policy to authorize such repurchases when the shares are trading at a discount of 10% or more (or such other percentage as the Board may determine from time to time) from the net asset value of the shares. Although the Board has authorized such repurchases, the Fund is not required to repurchase its shares. The policy does not limit the amount of common stock that can be repurchased. The percentage of the discount from net asset value at which share repurchases will be authorized may be changed at any time by the Board. Through December&#160;31, 2022, the Fund has not repurchased shares of its common stock under this authorization.&lt;/span&gt;&lt;/p&gt;

</cef:SharePriceTableTextBlock>
    <cef:HighestPriceOrBid
      contextRef="From2021-01-012021-03-31"
      decimals="INF"
      unitRef="USDPShares">7.05</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2021-01-012021-03-31"
      decimals="INF"
      unitRef="USDPShares">6.07</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2021-01-012021-03-31"
      decimals="INF"
      unitRef="USDPShares">6.67</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2021-01-012021-03-31"
      decimals="INF"
      unitRef="USDPShares">5.78</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2021-01-012021-03-31"
      decimals="INF"
      unitRef="Ratio">0.0570</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2021-01-012021-03-31"
      decimals="INF"
      unitRef="Ratio">0.0502</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2021-04-012021-06-30"
      decimals="INF"
      unitRef="USDPShares">7.54</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2021-04-012021-06-30"
      decimals="INF"
      unitRef="USDPShares">6.67</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2021-04-012021-06-30"
      decimals="INF"
      unitRef="USDPShares">6.83</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2021-04-012021-06-30"
      decimals="INF"
      unitRef="USDPShares">6.48</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2021-04-012021-06-30"
      decimals="INF"
      unitRef="Ratio">0.1040</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2021-04-012021-06-30"
      decimals="INF"
      unitRef="Ratio">0.0293</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2021-07-012021-09-30"
      decimals="INF"
      unitRef="USDPShares">7.07</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2021-07-012021-09-30"
      decimals="INF"
      unitRef="USDPShares">6.52</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2021-07-012021-09-30"
      decimals="INF"
      unitRef="USDPShares">6.62</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2021-07-012021-09-30"
      decimals="INF"
      unitRef="USDPShares">6.26</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2021-07-012021-09-30"
      decimals="INF"
      unitRef="Ratio">0.0680</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2021-07-012021-09-30"
      decimals="INF"
      unitRef="Ratio">0.0415</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2021-10-012021-12-31"
      decimals="INF"
      unitRef="USDPShares">7.37</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2021-10-012021-12-31"
      decimals="INF"
      unitRef="USDPShares">6.64</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2021-10-012021-12-31"
      decimals="INF"
      unitRef="USDPShares">6.46</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2021-10-012021-12-31"
      decimals="INF"
      unitRef="USDPShares">6.28</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2021-10-012021-12-31"
      decimals="INF"
      unitRef="Ratio">0.1409</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2021-10-012021-12-31"
      decimals="INF"
      unitRef="Ratio">0.0573</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2022-01-012022-03-31"
      decimals="INF"
      unitRef="USDPShares">7.24</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2022-01-012022-03-31"
      decimals="INF"
      unitRef="USDPShares">6.76</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2022-01-012022-03-31"
      decimals="INF"
      unitRef="USDPShares">6.45</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2022-01-012022-03-31"
      decimals="INF"
      unitRef="USDPShares">5.79</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2022-01-012022-03-31"
      decimals="INF"
      unitRef="Ratio">0.1225</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2022-01-012022-03-31"
      decimals="INF"
      unitRef="Ratio">0.1675</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2022-04-012022-06-30"
      decimals="INF"
      unitRef="USDPShares">7.05</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2022-04-012022-06-30"
      decimals="INF"
      unitRef="USDPShares">5.54</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2022-04-012022-06-30"
      decimals="INF"
      unitRef="USDPShares">5.95</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2022-04-012022-06-30"
      decimals="INF"
      unitRef="USDPShares">4.73</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2022-04-012022-06-30"
      decimals="INF"
      unitRef="Ratio">0.1849</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2022-04-012022-06-30"
      decimals="INF"
      unitRef="Ratio">0.1712</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2022-07-012022-09-30"
      decimals="INF"
      unitRef="USDPShares">6.53</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2022-07-012022-09-30"
      decimals="INF"
      unitRef="USDPShares">5.50</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2022-07-012022-09-30"
      decimals="INF"
      unitRef="USDPShares">5.37</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2022-07-012022-09-30"
      decimals="INF"
      unitRef="USDPShares">4.47</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2022-07-012022-09-30"
      decimals="INF"
      unitRef="Ratio">0.2160</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2022-07-012022-09-30"
      decimals="INF"
      unitRef="Ratio">0.2304</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2022-10-012022-12-31"
      decimals="INF"
      unitRef="USDPShares">6.16</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2022-10-012022-12-31"
      decimals="INF"
      unitRef="USDPShares">4.97</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2022-10-012022-12-31"
      decimals="INF"
      unitRef="USDPShares">5.53</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2022-10-012022-12-31"
      decimals="INF"
      unitRef="USDPShares">4.54</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2022-10-012022-12-31"
      decimals="INF"
      unitRef="Ratio">0.1139</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2022-10-012022-12-31"
      decimals="INF"
      unitRef="Ratio">0.0947</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2023-01-012023-03-31"
      decimals="INF"
      unitRef="USDPShares">5.99</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2023-01-012023-03-31"
      decimals="INF"
      unitRef="USDPShares">5.41</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2023-01-012023-03-31"
      decimals="INF"
      unitRef="USDPShares">5.53</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2023-01-012023-03-31"
      decimals="INF"
      unitRef="USDPShares">4.93</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-01-012023-03-31"
      decimals="INF"
      unitRef="Ratio">0.0832</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-01-012023-03-31"
      decimals="INF"
      unitRef="Ratio">0.0974</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2023-04-012023-06-30"
      decimals="INF"
      unitRef="USDPShares">5.80</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2023-04-012023-06-30"
      decimals="INF"
      unitRef="USDPShares">5.33</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2023-04-012023-06-30"
      decimals="INF"
      unitRef="USDPShares">5.30</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2023-04-012023-06-30"
      decimals="INF"
      unitRef="USDPShares">5.02</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-04-012023-06-30"
      decimals="INF"
      unitRef="Ratio">0.0943</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-04-012023-06-30"
      decimals="INF"
      unitRef="Ratio">0.0618</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2023-07-012023-09-30"
      decimals="INF"
      unitRef="USDPShares">5.87</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2023-07-012023-09-30"
      decimals="INF"
      unitRef="USDPShares">5.13</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2023-07-012023-09-30"
      decimals="INF"
      unitRef="USDPShares">5.30</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2023-07-012023-09-30"
      decimals="INF"
      unitRef="USDPShares">4.79</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-07-012023-09-30"
      decimals="INF"
      unitRef="Ratio">0.1075</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-07-012023-09-30"
      decimals="INF"
      unitRef="Ratio">0.0710</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:OutstandingSecurityTitleTextBlock contextRef="From2023-12-292023-12-29_custom_PreferredSharesMember">&lt;p id="xdx_80F_ecef--OutstandingSecurityTitleTextBlock_hcef--RiskAxis__custom--PreferredSharesMember_zk9q2j9Kjwu" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Preferred Stock&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Currently, 32,975,100 shares of the Fund&#x2019;s capital stock have been classified by the Board as preferred stock, par value $0.001 per share. The Fund&#x2019;s Board may reclassify authorized and unissued shares of the Fund, including shares of capital stock previously classified as common stock, as preferred stock prior to the completion of any offering. The terms of each series of preferred stock may be fixed by the Board and may materially limit and/or qualify the rights of the holders of the Fund&#x2019;s common stock. As of September&#160;30, 2023, the Fund had 2,492 outstanding shares of Series C Auction Rate Preferred, 1,108 outstanding shares of Series E Auction Rate Preferred, 2,572,905 outstanding shares of Series G Preferred, 4,116,414 outstanding shares of Series H Preferred, 3,887,650 outstanding shares of Series K Preferred and 685,500 outstanding shares of Series M Preferred. On December&#160;28, 2023, the Fund issued 147,750 shares of Series N Preferred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On November&#160;16, 2023, the Fund commenced a tender offer for all of its outstanding Series C Auction Rate Preferred and Series E Auction Rate Preferred. The tender offer is scheduled to expire on January&#160;5, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Distributions on the Series C Auction Rate Preferred accumulate at a variable maximum rate based on short term rates. At present, the maximum rate is equal to 175% of the &#x201c;AA&#x201d; Financial Composite Commercial Paper Rate determined on each calculation date. Prior to the failing of auctions for the Fund&#x2019;s Series C Auction Rate Preferred, these securities paid dividends set at a weekly auction. The liquidation preference of the Series C Auction Rate Preferred is $25,000 per share plus accumulated but unpaid dividends (whether or not earned or declared). The Fund generally may redeem the outstanding Series C Auction Rate Preferred, in whole or in part, at any time other than during a non-call period. The Series C Auction Rate Preferred is not traded on any public exchange.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Distributions on the Series E Auction Rate Preferred accumulate at a variable maximum rate based on short term rates. At present, the maximum rate is equal to 175% of the &#x201c;AA&#x201d; Financial Composite Commercial Paper Rate determined on each calculation date. Prior to the failing of auctions for the Fund&#x2019;s Series E Auction Rate Preferred, these securities paid dividends set at a weekly auction. The liquidation preference of the Series E Auction Rate Preferred is $25,000 per share plus accumulated but unpaid dividends (whether or not earned or declared). The Fund generally may redeem the outstanding Series E Auction Rate Preferred, in whole or in part, at any time other than during a non-call period. The Series E Auction Rate Preferred is not traded on any public exchange.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Distributions on the Series G Preferred accumulate at an annual rate of 5.00% of the liquidation preference of $25 per share plus accumulated but unpaid dividends (whether or not earned or declared), are cumulative from the date of original issuance thereof, and are payable quarterly on March&#160;26, June&#160;26, September&#160;26 and December&#160;26 of each year. The Fund&#x2019;s outstanding Series G Preferred is redeemable at the liquidation preference plus accumulated but unpaid dividends (whether or not earned or declared) through the date of redemption at the option of the Fund at any time. The Series G Preferred is listed and traded on the NYSE under the symbol &#x201c;GAB PrG.&#x201d;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Distributions on the Series H Preferred accumulate at an annual rate of 5.00% of the liquidation preference of $25 per share plus accumulated but unpaid dividends (whether or not earned or declared), are cumulative from the date of original issuance thereof, and are payable quarterly on March&#160;26, June&#160;26, September&#160;26 and December&#160;26 of each year. The Fund&#x2019;s outstanding Series H Preferred is redeemable at the liquidation preference plus accumulated but unpaid dividends (whether or not earned or declared) through the date of redemption at the option of the Fund at any time. The Series H Preferred is listed and traded on the NYSE under the symbol &#x201c;GAB PrH.&#x201d;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Distributions on the Series K Preferred accumulate at an annual rate of 5.00% of the liquidation preference of $25 per share plus accumulated but unpaid dividends (whether or not earned or declared), are cumulative from the date of original issuance thereof, and are payable quarterly on March&#160;26, June&#160;26, September&#160;26 and December&#160;26 of each year. The Fund&#x2019;s outstanding Series K Preferred is redeemable at the liquidation preference plus accumulated but unpaid dividends (whether or not earned or declared) through the date of redemption at the option of the Fund following the expiration of the five year call protection on December&#160;16, 2024. The Series K Preferred is listed and traded on the NYSE under the symbol &#x201c;GAB PrK.&#x201d;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Distributions on the Series M Preferred accumulate at an annual rate of 4.25% of the liquidation preference of $100 per share plus accumulated but unpaid dividends (whether or not earned or declared), are cumulative from the date of original issuance thereof, and are payable quarterly on March&#160;26, June&#160;26, September&#160;26 and December&#160;26 of each year. The Fund&#x2019;s outstanding Series M Preferred is puttable during the 60-day period prior to March&#160;26, 2027, is callable at our option upon not less than 30 nor more than 60 days&#x2019; prior notice at any time commencing on December&#160;26, 2027 and thereafter, and is subject to mandatory redemption by the Fund on March&#160;26, 2032, in each case at the liquidation preference, plus any accumulated and unpaid dividends. The Series M Preferred is not traded on any public exchange.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Distributions
on the Series N Preferred accumulate at an annual rate of 5.25% of the liquidation preference of $100 per share plus accumulated but
unpaid dividends (whether or not earned or declared), are  cumulative from the date of original issuance thereof, and are
payable semiannually June&#160;26 and December&#160;26 of each year, commencing on June&#160;26, 2024. The Fund&#x2019;s outstanding
Series N Preferred is puttable during the 60-day period prior to each of June&#160;26, 2024 and December&#160;26, 2024, and is
callable at our option upon 30 days&#x2019; prior notice at any time commencing on December&#160;26, 2024 and thereafter, and is
subject to mandatory redemption by the Fund on December&#160;26, 2025, in each case at the liquidation preference, plus any
accumulated and unpaid dividends. The Series N Preferred is not traded on any public exchange.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If the Fund issues any additional series of preferred stock, it will pay dividends to the holders at either a fixed rate or a rate that will be reset, as described in the Prospectus Supplement accompanying each preferred stock offering.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_898_ecef--OutstandingSecuritiesTableTextBlock_zO0dEgMIKJJh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The following table shows (i) the classes of capital stock authorized, (ii) the number of shares outstanding in each class, and (iii) the number of shares authorized in each class as of December&#160;18, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: left"&gt;Title of Class&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;br/&gt; Outstanding&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;br/&gt; Authorized&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td id="xdx_987_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--CommonSharesMember_zKVbTqM1GdG3" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"&gt;Common Stock&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--CommonSharesMember_zcv9EQE2V2N3" style="width: 9%; text-align: right"&gt;300,659,233&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--CommonSharesMember_z7rW8DmoFDNb" style="width: 9%; text-align: right"&gt;337,024,900&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td id="xdx_985_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--SeriesCPreferredSharesMember_fKDEp_zr5cmvWrTL49" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Series C Auction Rate Preferred&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--SeriesCPreferredSharesMember_fKDEp_zt1dQ1BB79r2" style="text-align: right"&gt;2,492&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--SeriesCPreferredSharesMember_fKDEp_z1mvkGKtneRe" style="text-align: right"&gt;4,812&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td id="xdx_989_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--SeriesDPreferredSharesMember_fKDIp_zy6XRIylzwf2" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5.875% Series D Cumulative Preferred Stock (the &#x201c;Series D Preferred&#x201d;)&lt;sup&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--SeriesDPreferredSharesMember_fKDIp_zgppFgOEUkz7" style="text-align: right"&gt;0&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--SeriesDPreferredSharesMember_fKDIp_zxOfKDmTMaJh" style="text-align: right"&gt;636,140&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td id="xdx_98E_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--SeriesEPreferredSharesMember_fKDEp_zbqKO6rCTlLg" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Series E Auction Rate Preferred&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--SeriesEPreferredSharesMember_fKDEp_zYQIY8RwemW1" style="text-align: right"&gt;1,108&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--SeriesEPreferredSharesMember_fKDEp_zVQJpILax6a4" style="text-align: right"&gt;1,988&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td id="xdx_980_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--SeriesGPreferredSharesMember_zuokzI2UEO35" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Series G Preferred&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--SeriesGPreferredSharesMember_zZQYulGfeP08" style="text-align: right"&gt;2,520,627&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--SeriesGPreferredSharesMember_zQvVudRpnmLh" style="text-align: right"&gt;2,959,830&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td id="xdx_983_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--SeriesHPreferredSharesMember_z8kju9w66ue9" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Series H Preferred&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--SeriesHPreferredSharesMember_zZPRfpRck7m8" style="text-align: right"&gt;4,083,160&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--SeriesHPreferredSharesMember_zY3FrYEZN685" style="text-align: right"&gt;4,109,167&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td id="xdx_98C_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--SeriesJPreferredSharesMember_fKDMp_zti0TaJNrMp3" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5.45% Series J Cumulative Preferred Stock (the &#x201c;Series J Preferred&#x201d;)&lt;sup&gt;(3)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--SeriesJPreferredSharesMember_fKDMp_zJIDGKAacer4" style="text-align: right"&gt;0&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--SeriesJPreferredSharesMember_fKDMp_zp6hcx1szaY3" style="text-align: right"&gt;1,300,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td id="xdx_983_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--SeriesKPreferredSharesMember_zsVvgQAlAHR" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Series K Preferred&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--SeriesKPreferredSharesMember_zhucs1J6Nf5l" style="text-align: right"&gt;3,813,640&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--SeriesKPreferredSharesMember_zfJMUPLjDnxc" style="text-align: right"&gt;3,813,640&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td id="xdx_981_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--SeriesMPreferredSharesMember_ze9EHkEuyjoh" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Series M Preferred&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--SeriesMPreferredSharesMember_zLXgIyIT3Bfj" style="text-align: right"&gt;685,500&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--SeriesMPreferredSharesMember_zOlp3NekX1Xa" style="text-align: right"&gt;1,000,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td id="xdx_988_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--SeriesNPreferredSharesMember_fKDQp_zcVA0VGv5dj" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Series N Preferred&lt;sup&gt;(4)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--SeriesNPreferredSharesMember_fKDQp_z7bJ0UCCnRB1" style="text-align: right"&gt;0&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--SeriesNPreferredSharesMember_fKDQp_zambtTnL1GK3" style="text-align: right"&gt;350,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td id="xdx_981_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--PreferredShareMember_fKDUp_zOhGvNFx41He" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Preferred Stock&lt;sup&gt;(5)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--PreferredSharesMember_fKDUp_zQnRN00lu7H4" style="text-align: right"&gt;0&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--PreferredSharesMember_fKDUp_znXyVFL7CTCf" style="text-align: right"&gt;18,799,523&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;div style="width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;sup id="xdx_F06_zC8C67MHA0l8"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;&lt;span id="xdx_F16_zTt5jbBZjG64" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Fund commenced a tender offer for all of its outstanding Series C Auction Rate Preferred and Series E Auction Rate Preferred on November&#160;16, 2023. The tender offer is scheduled to expire on January&#160;5, 2024.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left; text-indent: 0in; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;sup id="xdx_F01_zFaEaP71LMtf"&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;&lt;span id="xdx_F10_zebcZKHFTBtj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Fund redeemed all of its outstanding Series D Preferred on December&#160;26, 2019.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left; text-indent: 0in; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;sup id="xdx_F00_zKUL6PUiZT1j"&gt;(3)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;&lt;span id="xdx_F1C_zy4U0XwRlpqb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Fund redeemed all of its outstanding Series J Preferred on January&#160;31, 2022.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left; text-indent: 0in; vertical-align: top; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;sup id="xdx_F0A_znGbxbrpUrph"&gt;(4)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;&lt;span id="xdx_F13_zEZPV1JdEGt3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On December&#160;1, 2023, the Fund&#x2019;s Board approved an offering of up to 350,000 shares of the Series N Preferred for an aggregate maximum offering amount of up to $35,000,000. On December&#160;12, 2023, the Fund filed Articles Supplementary with the State Department of Assessments and Taxation of Maryland classifying and designating 350,000 shares of preferred stock, without further designation as to class or series, as shares of Series N Preferred. The Series N Preferred are not registered under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;), or listed on a securities exchange. The Fund issued 147,750 Series N Preferred in an initial closing for the offering of the Series N Preferred on December&#160;28, 2023.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left; text-indent: 0in; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;sup id="xdx_F04_zWBR6q3wGmIh"&gt;(5)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;&lt;span id="xdx_F1C_zHGrLoGacqd2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x201c;Preferred Stock&#x201d; refers to the Fund&#x2019;s authorized and unissued shares of preferred stock without further designation as to class or series.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AB_zPCX9UiFHhP8" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As of October&#160;31, 2023, the Fund did not hold any shares of capital stock for its account. Upon a liquidation, each holder of preferred stock will be entitled to receive out of the assets of the Fund available for distribution to stockholders (after payment of claims of the Fund&#x2019;s creditors but before any distributions with respect to the Fund&#x2019;s common stock or any other class of capital stock of the Fund ranking junior to the preferred stock as to liquidation payments) an amount per share equal to such share&#x2019;s liquidation preference plus any accumulated but unpaid distributions (whether or not earned or declared, excluding interest thereon) to the date of distribution, and such stockholders shall be entitled to no further participation in any distribution or payment in connection with such liquidation. Each series of preferred stock ranks on a parity with all other series of preferred stock of the Fund as to the payment of distributions and the distribution of assets upon liquidation, and is junior to the Fund&#x2019;s obligations with respect to any outstanding senior securities representing debt. The preferred stock carries one vote per share on all matters on which such shares are entitled to vote. The issued and outstanding preferred stock is fully paid and non-assessable and has no preemptive, exchange or conversion rights. The Board may by resolution classify or reclassify any authorized but unissued shares of stock of the Fund from time to time by setting or changing the preferences, conversion or other rights, voting powers, restrictions, limitations as to dividends or other distributions and terms and conditions of redemption. The Fund will not issue any class of capital stock senior to the preferred stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Rating Agency Guidelines&lt;/i&gt;. New issuances of shares of preferred stock may, but are not required to, be issued with a specified rating by a nationally recognized statistical rating organization. To the extent the Fund seeks a rating agency for its shares of preferred stock, the Fund expects that it will be required under Moody&#x2019;s and Fitch guidelines to maintain assets having in the aggregate a discounted value at least equal to the Basic Maintenance Amount (as defined below) for its outstanding preferred stock with respect to the separate guidelines Moody&#x2019;s and Fitch has each established for determining discounted value. To the extent any particular portfolio holding does not satisfy the applicable rating agency&#x2019;s guidelines, all or a portion of such holding&#x2019;s value will not be included in the calculation of discounted value (as defined by such rating agency). The Moody&#x2019;s and Fitch guidelines also impose certain diversification requirements and industry concentration limitations on the Fund&#x2019;s overall portfolio, and apply specified discounts to securities held by the Fund (except certain money market securities). The &#x201c;Basic Maintenance Amount&#x201d; is calculated as set out in the organizational documents for each series of preferred stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If the Fund does not cure in a timely manner a failure to maintain a discounted value of its portfolio equal to the Basic Maintenance Amount in accordance with the requirements of the applicable rating agency or agencies then rating the preferred stock at the request of the Fund, the Fund may, and in certain circumstances will be required to, mandatorily redeem preferred stock, as described below under &#x201c;&#x2014;Redemption.&#x201d;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Fund may, but is not required to, adopt any modifications to the rating agency guidelines that may hereafter be established by Moody&#x2019;s and Fitch. Failure to adopt any such modifications, however, may result in a change in the relevant rating agency&#x2019;s ratings or a withdrawal of such ratings altogether. In addition, any rating agency providing a rating for the preferred stock at the request of the Fund may, at any time, change or withdraw any such rating. The Board, without further action by the stockholders, may amend, alter, add to or repeal certain of the definitions and related provisions that have been adopted by the Fund pursuant to the rating agency guidelines if the Board determines that such modification is necessary to prevent a reduction in rating of the preferred stock by Moody&#x2019;s and Fitch, as the case may be, is in the best interests of the holders of common stock and is not adverse to the holders of preferred stock in view of advice to the Fund by Moody&#x2019;s and Fitch (or such other rating agency then rating the preferred stock at the request of the Fund) that such modification would not adversely affect, as the case may be, its then current rating of the preferred stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As described by Moody&#x2019;s and Fitch, the ratings assigned to each series of preferred stock are assessments of the capacity and willingness of the Fund to pay the obligations of each such series. The ratings on these series of preferred stock are not recommendations to purchase, hold or sell shares of any series, inasmuch as the ratings do not comment as to market price or suitability for a particular investor. The rating agency guidelines also do not address the likelihood that an owner of preferred stock will be able to sell such shares on an exchange, in an auction or otherwise. The ratings are based on current information furnished to Moody&#x2019;s and Fitch by the Fund and the Investment Adviser and information obtained from other sources. The ratings may be changed, suspended or withdrawn as a result of changes in, or the unavailability of, such information.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The rating agency guidelines apply to each series of preferred stock only so long as such rating agency is rating such series at the request of the Fund. The Fund pays fees to Moody&#x2019;s and Fitch for rating the preferred stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Asset Maintenance Requirements&lt;/i&gt;. In addition to the requirements summarized under &#x201c;&#x2014;Rating Agency Guidelines&#x201d; above, the Fund must also satisfy asset maintenance requirements under the 1940 Act with respect to its preferred stock. Under the 1940 Act, debt or additional preferred stock may be issued only if immediately after such issuance the value of the Fund&#x2019;s total assets (less ordinary course liabilities) is at least 300% of the amount of any debt outstanding and at least 200% of the amount of any preferred stock and debt outstanding. The Fund is required under the applicable Articles Supplementary to determine whether it has, as of the last business day of each March, June, September and December of each year (for its Series E Auction Rate Preferred, Series H Preferred, Series K Preferred, Series M Preferred and Series N Preferred), at the time the Fund declares or pays any dividend or distribution on its common stock (other than a dividend payable solely in shares of common stock) and at the time the Fund purchases any of its common stock (for its Series G Preferred), and as of the last business day of each week (for its Series C Auction Rate Preferred), an &#x201c;asset coverage&#x201d; (as defined in the 1940 Act) of at least 200% (or such higher or lower percentage as may be required at the time under the 1940 Act) with respect to all outstanding senior securities of the Fund that are debt or stock, including any outstanding preferred stock. If the Fund fails to maintain the asset coverage required under the 1940 Act on such dates and such failure is not cured on or before 60 days, in the case of the Fixed Rate Preferred Stock, or 10 business days, in the case of the Auction Rate Preferred Stock, the Fund may, and in certain circumstances will be required to, mandatorily redeem the minimum number of shares of preferred stock sufficient to satisfy such asset coverage. See &#x201c;&#x2014;Redemption&#x201d; below.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Distributions&lt;/i&gt;. In connection with the offering of one or more additional series of preferred stock, an accompanying Prospectus Supplement will specify whether dividends on such preferred stock will be based on a constant fixed rate or on a fixed rate that changes after an initial period (e.g., one year). Holders of additional shares of such &#x201c;Fixed Rate Preferred Stock&#x201d; will be entitled to receive, out of funds legally available therefor, cumulative cash distributions, at an annual rate set forth in the applicable Prospectus Supplement, payable with such frequency as set forth in the applicable Prospectus Supplement. Such distributions will accumulate from the date on which such shares are issued.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Restrictions on Dividends and Other Distributions for the Preferred Stock&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;So long as any preferred stock is outstanding, the Fund may not pay any dividend or other distribution (other than a dividend or other distribution paid in common stock or in options, warrants or rights to subscribe for or purchase common stock) in respect of the common stock or call for redemption, redeem, purchase or otherwise acquire for consideration any common stock (except by conversion into or exchange for shares of the Fund ranking junior to the preferred stock as to the payment of dividends or distributions and the distribution of assets upon liquidation), unless:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="vertical-align: top; text-align: justify"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the Fund has declared and paid (or provided to the relevant dividend paying agent) all cumulative distributions on the Fund&#x2019;s outstanding preferred stock due on or prior to the date of such common stock dividend or distribution;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the Fund has redeemed the full number of shares of preferred stock to be redeemed pursuant to any mandatory redemption provision in the Fund&#x2019;s Governing Documents; and&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;after making the distribution, the Fund meets applicable asset coverage requirements described under &#x201c;&#x2014;Rating Agency Guidelines&#x201d; and &#x201c;&#x2014;Asset Maintenance Requirements.&#x201d;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;No full distribution will be declared or made on any series of preferred stock for any dividend period, or part thereof, unless full cumulative distributions due through the most recent dividend payment dates therefor for all outstanding series of preferred stock of the Fund ranking on a parity with such series as to distributions have been or contemporaneously are declared and made. If full cumulative distributions due have not been made on all outstanding preferred stock of the Fund ranking on a parity with such series of preferred stock as to the payment of distributions, any distributions being paid on the preferred stock will be paid as nearly pro rata as possible in proportion to the respective amounts of distributions accumulated but unmade on each such series of preferred stock on the relevant dividend payment date. The Fund&#x2019;s obligation to make distributions on the preferred stock will be subordinate to its obligations to pay interest and principal, when due, on any senior securities representing debt.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Redemption&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Mandatory Redemption Relating to Asset Coverage Requirements.&lt;/i&gt; The Fund may, at its option, consistent with its Governing Documents and the 1940 Act, and in certain circumstances will be required to, mandatorily redeem preferred stock in the event that:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the Fund fails to maintain the asset coverage requirements specified under the 1940 Act on a quarterly valuation date and such failure is not cured on or before 60 days, in the case of the existing Fixed Rate Preferred Stock, following such failure; or&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the Fund fails to maintain the asset coverage requirements as calculated in accordance with the applicable rating agency guidelines as of any monthly valuation date, and such failure is not cured on or before 10 business days after such valuation date.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The redemption price for preferred stock subject to mandatory redemption will be the liquidation preference, as stated in the Articles Supplementary of each existing series of preferred stock or the Prospectus Supplement accompanying the issuance of any additional series of preferred stock, including an amount equal to any accumulated but unpaid distributions (whether or not earned or declared) to the date fixed for redemption.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The number of shares of preferred stock that will be redeemed in the case of a mandatory redemption will equal the minimum number of outstanding shares of preferred stock, the redemption of which, if such redemption had occurred immediately prior to the opening of business on the applicable cure date, would have resulted in the relevant asset coverage requirement having been met or, if the required asset coverage cannot be so restored, all of the shares of preferred stock. In the event that shares of preferred stock are redeemed due to a failure to satisfy the 1940 Act asset coverage requirements, the Fund may, but is not required to, redeem a sufficient number of shares of preferred stock so that the Fund&#x2019;s assets exceed the asset coverage requirements under the 1940 Act after the redemption by 10% (that is, 210% asset coverage). In the event that shares of preferred stock are redeemed due to a failure to satisfy applicable rating agency guidelines, the Fund may, but is not required to, redeem a sufficient number of shares of preferred stock so that the Fund&#x2019;s discounted portfolio value (as determined in accordance with the applicable rating agency guidelines) after redemption exceeds the asset coverage requirements of each applicable rating agency by up to 10% (that is, 110% rating agency asset coverage).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If the Fund does not have funds legally available for the redemption of, or is otherwise unable to redeem, all the shares of preferred stock to be redeemed on any redemption date, the Fund will redeem on such redemption date that number of shares for which it has legally available funds, or is otherwise able to redeem, from the holders whose shares are to be redeemed ratably on the basis of the redemption price of such shares, and the remainder of those shares to be redeemed will be redeemed on the earliest practicable date on which the Fund will have funds legally available for the redemption of, or is otherwise able to redeem, such shares upon written notice of redemption.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If fewer than all shares of the Fund&#x2019;s outstanding preferred stock are to be redeemed, the Fund, at its discretion and subject to the limitations of the Charter, the 1940 Act, and Maryland law, will select one or more series of preferred stock from which shares will be redeemed and the amount of preferred stock to be redeemed from each such series. If fewer than all shares of a series of preferred stock are to be redeemed, such redemption will be made as among the holders of that series pro rata in accordance with the respective number of shares of such series held by each such holder on the record date for such redemption. If fewer than all shares of preferred stock held by any holder are to be redeemed, the notice of redemption mailed to such holder will specify the number of shares to be redeemed from such holder, which may be expressed as a percentage of shares held on the applicable record date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Optional Redemption of Fixed Rate Preferred Stock&lt;/i&gt;. Shares of any additional series of Fixed Rate Preferred Stock will not be subject to optional redemption by the Fund until the date, if any, specified in the applicable Prospectus or Prospectus Supplement, unless such redemption is necessary, in the judgment of the Fund, to maintain the Fund&#x2019;s status as a regulated investment company under the Code. Commencing on such date and thereafter, the Fund may at any time redeem such Fixed Rate Preferred Stock in whole or in part for cash at a redemption price per share equal to the liquidation preference per share plus accumulated and unpaid distributions (whether or not earned or declared) to the redemption date. Such redemptions are subject to the notice requirements set forth under &#x201c;&#x2014;Redemption Procedures&#x201d; and the limitations of the Charter, the 1940 Act and Maryland law.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Redemption Procedures&lt;/i&gt;. A notice of redemption with respect to an optional redemption will be given to the holders of record of preferred stock selected for redemption not less than (a) 15 days (subject to NYSE requirements), nor more than 40 days prior (in the case of the Series H Preferred, Series K Preferred, Series G Preferred, Series C Auction Rate Preferred, Series J Preferred, Series D Preferred, and Series F Preferred), (b) not less than 7 days, not more than 40 days prior (in the case of the Series E Auction Rate Preferred), (c) not less than 30 days, nor more than 60 days prior (in the case of the Series M Preferred) or (d) 30 days prior (in the case of the Series N Preferred) to the date fixed for redemption. Preferred stockholders may receive shorter notice in the event of a mandatory redemption. Each notice of redemption will state (i) the redemption date, (ii) the number or percentage of shares of preferred stock to be redeemed (which may be expressed as a percentage of such shares outstanding), (iii) the CUSIP number(s) of such shares, (iv) the redemption price (specifying the amount of accumulated distributions to be included therein), (v) the place or places where such shares are to be redeemed, (vi) that distributions on the shares to be redeemed will cease to accrue on such redemption date, (vii) the provision of the Articles Supplementary for the applicable series of preferred stock under which the redemption is being made and (viii) (except in the case of the Series C Auction Rate Preferred) any conditions precedent to such redemption. No defect in the notice of redemption or in the mailing thereof will affect the validity of the redemption proceedings, except as required by applicable law.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The holders of preferred stock, whether subject to a variable or fixed rate, will not have the right to redeem any of their shares at their option, unless specifically provided in the Charter.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Liquidation Preference&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Fund, the holders of preferred stock then outstanding will be entitled to receive a preferential liquidating distribution, which is expected to equal the original purchase price per share of preferred stock plus accumulated and unpaid dividends, whether or not earned or declared, before any distribution of assets is made to holders of common stock. After payment of the full amount of the liquidating distribution to which they are entitled, the holders of preferred stock will not be entitled to any further participation in any distribution of assets by the Fund.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Voting Rights&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Except as otherwise stated in this Prospectus, specified in the Charter or resolved by the Board or as otherwise required by applicable law, holders of preferred stock shall be entitled to one vote per share held on each matter submitted to a vote of the stockholders of the Fund and will vote together with holders of common stock and of any other preferred stock then outstanding as a single class.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In connection with the election of the Fund&#x2019;s Directors, holders of the outstanding shares of preferred stock, voting together as a separate class, will be entitled at all times to elect two of the Fund&#x2019;s Directors, and the remaining Directors will be elected by holders of common stock and holders of preferred stock, voting together as a single class. In addition, if (i) at any time dividends and distributions on outstanding shares of preferred stock are unpaid in an amount equal to at least two full years&#x2019; dividends and distributions thereon and sufficient cash or specified securities have not been deposited with the applicable paying agent for the payment of such accumulated dividends and distributions or (ii) at any time holders of any other series of preferred stock are entitled to elect a majority of the Directors of the Fund under the 1940 Act or the applicable Articles Supplementary creating such shares, then the number of Directors constituting the Board automatically will be increased by the smallest number that, when added to the two Directors elected exclusively by the holders of preferred stock as described above, would then constitute a simple majority of the Board as so increased by such smallest number. Such additional Directors will be elected by&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the holders of the outstanding shares of preferred stock, voting together as a separate class, at a special meeting of stockholders which will be called as soon as practicable and will be held not less than ten nor more than twenty days after the mailing date of the meeting notice. If the Fund fails to send such meeting notice or to call such a special meeting, the meeting may be called by any preferred stockholder on like notice. The terms of office of the persons who are Directors at the time of that election will continue. If the Fund thereafter pays, or declares and sets apart for payment in full, all dividends and distributions payable on all outstanding shares of preferred stock for all past dividend periods or the holders of other series of preferred stock are no longer entitled to elect such additional Directors, the additional voting rights of the holders of the preferred stock as described above will cease, and the terms of office of all of the additional Directors elected by the holders of the preferred stock (but not of the Directors with respect to whose election the holders of common stock were entitled to vote or the two Directors the holders of preferred stock have the right to elect as a separate class in any event) will terminate at the earliest time permitted by law.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;So long as shares of preferred stock are outstanding, the Fund will not, without the affirmative vote of the holders of a majority (as defined in the 1940 Act) of the shares of preferred stock outstanding at the time, and present and voting on such matter, voting together as a separate class, amend, alter or repeal the provisions of the Charter whether by merger, consolidation or otherwise, so as to materially and adversely affect any of the rights, preferences or powers expressly set forth in the Charter with respect to such shares of preferred stock, unless the Fund obtains written confirmation from Moody&#x2019;s, Fitch or any such other rating agency then rating the preferred stock that such amendment, alteration or repeal would not impair the rating then assigned by such rating agency to the preferred stock, in which case the vote or consent of the holders of the preferred stock is not required. Also, to the extent permitted under the 1940 Act, in the event shares of more than one series of preferred stock are outstanding, the Fund will not approve any action that materially and adversely affects the rights, preferences or powers expressly set forth in the Charter with respect to such shares of a series of preferred stock differently than those of shares of any other series of preferred stock without the affirmative vote of the holders of at least a majority, as defined in the 1940 Act, of the outstanding shares of preferred stock of each series materially adversely affected and outstanding at such time (each such materially adversely affected series voting as a separate class to the extent its rights are affected differently). For purposes of this paragraph, no matter shall be deemed to adversely affect any right, preference or power unless such matter (i) adversely alters or abolishes any preferential right of such series; (ii) creates, adversely alters or abolishes any right in respect of redemption of such series; or (iii) creates or adversely alters (other than to abolish) any restriction on transfer applicable to such series.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under the Charter and applicable provisions of the 1940 Act and Maryland law, the affirmative vote of the holders of a majority, as defined under the 1940 Act, of the outstanding shares of the preferred stock, voting together as a separate class, will be required to approve any plan of reorganization adversely affecting the preferred stock or any action requiring a vote of security holders under Section&#160;13(a) of the 1940 Act (other than a conversion of the Fund from a closed-end to an open-end investment company), including, among other things, changes in the Fund&#x2019;s investment objectives or changes in the investment restrictions described as fundamental policies under &#x201c;Investment Objectives and Policies&#x201d; in this Prospectus and the SAI, &#x201c;How the Fund Manages Risk&#x2014;Investment Restrictions&#x201d; in this Prospectus and &#x201c;Investment Restrictions&#x201d; in the SAI. Under the Charter, the affirmative vote of the holders of 66 &#x2154;% of the outstanding shares of each class of stock of the Fund normally entitled to vote in the election of directors, each such class voting as a separate class, is required to authorize the conversion of the Fund from a closed-end to an open-end investment company. For purposes of this paragraph, except as otherwise required under the 1940 Act, the vote of the holders of a majority of the outstanding shares of preferred stock means, in accordance with Section&#160;2(a)(42) of the 1940 Act, the vote, at the annual or a special meeting of the stockholders of the Fund duly called (i) of 67% or more of the shares of preferred stock present at such meeting, if the holders of more than 50% of the outstanding shares of preferred stock are present or represented by proxy, or (ii) more than 50% of the outstanding shares of preferred stock, whichever is less. The class vote of holders of preferred stock described above will in each case be in addition to any other approvals by shareholders that may be required under the 1940 Act to authorize the action in question.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The calculation of the elements and definitions of certain terms of the rating agency guidelines may be modified by action of the Board without further action by the stockholders if the Board determines that such modification is necessary to prevent a reduction in rating of the shares of preferred stock by Moody&#x2019;s and/or Fitch (or such other rating agency then rating the preferred stock at the request of the Fund), as the case may be, or is in the best interests of the holders of common stock and is not adverse to the holders of preferred stock in view of advice to the Fund by the relevant rating agencies that such modification would not adversely affect its then-current rating of the preferred stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The foregoing voting provisions will not apply to any series of preferred stock if, at or prior to the time when the act with respect to which such vote otherwise would be required will be effected, such stock will have been redeemed or called for redemption and sufficient cash or cash equivalents provided to the applicable paying agent to effect such redemption. The holders of preferred stock will have no preemptive rights or rights to cumulative voting.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Limitation on Issuance of Preferred Stock&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;So long as the Fund has preferred stock outstanding, subject to receipt of approval from the rating agencies of each series of preferred stock outstanding, and subject to compliance with the Fund&#x2019;s investment objectives, policies and restrictions, the Fund may issue and sell shares of one or more other series of additional preferred stock provided that the Fund will, immediately after giving effect to the issuance of such additional preferred stock and to its receipt and application of the proceeds thereof (including, without limitation, to the redemption of preferred stock to be redeemed out of such proceeds), have an &#x201c;asset coverage&#x201d; for all senior securities of the Fund which are stock, as defined in the 1940 Act, of at least 200% of the sum of the liquidation preference of the shares of preferred stock of the Fund then outstanding and all indebtedness of the Fund constituting senior securities, and no such additional preferred stock will have any preference or priority over any other preferred stock of the Fund upon the distribution of the assets of the Fund or in respect of the payment of dividends or distributions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Fund will consider from time to time whether to offer additional preferred stock or securities representing indebtedness and may issue such additional securities if the Board concludes that such an offering would be consistent with the Charter and applicable law, and in the best interest of the Fund.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Book Entry&lt;/i&gt;. Shares of Fixed Rate Preferred Stock sold through this offering will initially be held in the name of Cede &amp;amp; Co. as nominee for DTC. The Fund will treat Cede &amp;amp; Co. as the holder of record of such shares for all purposes. In accordance with the procedures of DTC, however, purchasers of Fixed Rate Preferred Stock will be deemed the beneficial owners of shares purchased for purposes of dividends, voting and liquidation rights.&lt;/span&gt;&lt;/p&gt;

</cef:OutstandingSecurityTitleTextBlock>
    <cef:OutstandingSecuritiesTableTextBlock contextRef="AsOf2023-12-29">&lt;p id="xdx_898_ecef--OutstandingSecuritiesTableTextBlock_zO0dEgMIKJJh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The following table shows (i) the classes of capital stock authorized, (ii) the number of shares outstanding in each class, and (iii) the number of shares authorized in each class as of December&#160;18, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: left"&gt;Title of Class&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;br/&gt; Outstanding&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;br/&gt; Authorized&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td id="xdx_987_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--CommonSharesMember_zKVbTqM1GdG3" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"&gt;Common Stock&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--CommonSharesMember_zcv9EQE2V2N3" style="width: 9%; text-align: right"&gt;300,659,233&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--CommonSharesMember_z7rW8DmoFDNb" style="width: 9%; text-align: right"&gt;337,024,900&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td id="xdx_985_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--SeriesCPreferredSharesMember_fKDEp_zr5cmvWrTL49" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Series C Auction Rate Preferred&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--SeriesCPreferredSharesMember_fKDEp_zt1dQ1BB79r2" style="text-align: right"&gt;2,492&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--SeriesCPreferredSharesMember_fKDEp_z1mvkGKtneRe" style="text-align: right"&gt;4,812&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td id="xdx_989_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--SeriesDPreferredSharesMember_fKDIp_zy6XRIylzwf2" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5.875% Series D Cumulative Preferred Stock (the &#x201c;Series D Preferred&#x201d;)&lt;sup&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--SeriesDPreferredSharesMember_fKDIp_zgppFgOEUkz7" style="text-align: right"&gt;0&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--SeriesDPreferredSharesMember_fKDIp_zxOfKDmTMaJh" style="text-align: right"&gt;636,140&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td id="xdx_98E_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--SeriesEPreferredSharesMember_fKDEp_zbqKO6rCTlLg" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Series E Auction Rate Preferred&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--SeriesEPreferredSharesMember_fKDEp_zYQIY8RwemW1" style="text-align: right"&gt;1,108&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--SeriesEPreferredSharesMember_fKDEp_zVQJpILax6a4" style="text-align: right"&gt;1,988&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td id="xdx_980_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--SeriesGPreferredSharesMember_zuokzI2UEO35" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Series G Preferred&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--SeriesGPreferredSharesMember_zZQYulGfeP08" style="text-align: right"&gt;2,520,627&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--SeriesGPreferredSharesMember_zQvVudRpnmLh" style="text-align: right"&gt;2,959,830&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td id="xdx_983_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--SeriesHPreferredSharesMember_z8kju9w66ue9" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Series H Preferred&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--SeriesHPreferredSharesMember_zZPRfpRck7m8" style="text-align: right"&gt;4,083,160&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--SeriesHPreferredSharesMember_zY3FrYEZN685" style="text-align: right"&gt;4,109,167&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td id="xdx_98C_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--SeriesJPreferredSharesMember_fKDMp_zti0TaJNrMp3" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5.45% Series J Cumulative Preferred Stock (the &#x201c;Series J Preferred&#x201d;)&lt;sup&gt;(3)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--SeriesJPreferredSharesMember_fKDMp_zJIDGKAacer4" style="text-align: right"&gt;0&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--SeriesJPreferredSharesMember_fKDMp_zp6hcx1szaY3" style="text-align: right"&gt;1,300,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td id="xdx_983_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--SeriesKPreferredSharesMember_zsVvgQAlAHR" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Series K Preferred&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--SeriesKPreferredSharesMember_zhucs1J6Nf5l" style="text-align: right"&gt;3,813,640&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--SeriesKPreferredSharesMember_zfJMUPLjDnxc" style="text-align: right"&gt;3,813,640&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td id="xdx_981_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--SeriesMPreferredSharesMember_ze9EHkEuyjoh" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Series M Preferred&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--SeriesMPreferredSharesMember_zLXgIyIT3Bfj" style="text-align: right"&gt;685,500&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--SeriesMPreferredSharesMember_zOlp3NekX1Xa" style="text-align: right"&gt;1,000,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td id="xdx_988_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--SeriesNPreferredSharesMember_fKDQp_zcVA0VGv5dj" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Series N Preferred&lt;sup&gt;(4)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--SeriesNPreferredSharesMember_fKDQp_z7bJ0UCCnRB1" style="text-align: right"&gt;0&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--SeriesNPreferredSharesMember_fKDQp_zambtTnL1GK3" style="text-align: right"&gt;350,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td id="xdx_981_ecef--OutstandingSecurityTitleTextBlock_c20231229__20231229__cef--RiskAxis__custom--PreferredShareMember_fKDUp_zOhGvNFx41He" style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Preferred Stock&lt;sup&gt;(5)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_ecef--OutstandingSecurityHeldShares_c20231229__20231229__cef--RiskAxis__custom--PreferredSharesMember_fKDUp_zQnRN00lu7H4" style="text-align: right"&gt;0&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_ecef--OutstandingSecurityAuthorizedShares_c20231229__20231229__cef--RiskAxis__custom--PreferredSharesMember_fKDUp_znXyVFL7CTCf" style="text-align: right"&gt;18,799,523&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;div style="width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;sup id="xdx_F06_zC8C67MHA0l8"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;&lt;span id="xdx_F16_zTt5jbBZjG64" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Fund commenced a tender offer for all of its outstanding Series C Auction Rate Preferred and Series E Auction Rate Preferred on November&#160;16, 2023. The tender offer is scheduled to expire on January&#160;5, 2024.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left; text-indent: 0in; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;sup id="xdx_F01_zFaEaP71LMtf"&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;&lt;span id="xdx_F10_zebcZKHFTBtj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Fund redeemed all of its outstanding Series D Preferred on December&#160;26, 2019.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left; text-indent: 0in; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;sup id="xdx_F00_zKUL6PUiZT1j"&gt;(3)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;&lt;span id="xdx_F1C_zy4U0XwRlpqb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Fund redeemed all of its outstanding Series J Preferred on January&#160;31, 2022.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left; text-indent: 0in; vertical-align: top; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;sup id="xdx_F0A_znGbxbrpUrph"&gt;(4)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;&lt;span id="xdx_F13_zEZPV1JdEGt3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On December&#160;1, 2023, the Fund&#x2019;s Board approved an offering of up to 350,000 shares of the Series N Preferred for an aggregate maximum offering amount of up to $35,000,000. On December&#160;12, 2023, the Fund filed Articles Supplementary with the State Department of Assessments and Taxation of Maryland classifying and designating 350,000 shares of preferred stock, without further designation as to class or series, as shares of Series N Preferred. The Series N Preferred are not registered under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;), or listed on a securities exchange. The Fund issued 147,750 Series N Preferred in an initial closing for the offering of the Series N Preferred on December&#160;28, 2023.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left; text-indent: 0in; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;sup id="xdx_F04_zWBR6q3wGmIh"&gt;(5)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;&lt;span id="xdx_F1C_zHGrLoGacqd2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x201c;Preferred Stock&#x201d; refers to the Fund&#x2019;s authorized and unissued shares of preferred stock without further designation as to class or series.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

</cef:OutstandingSecuritiesTableTextBlock>
    <cef:OutstandingSecurityTitleTextBlock contextRef="From2023-12-292023-12-29_custom_CommonSharesMember">Common Stock</cef:OutstandingSecurityTitleTextBlock>
    <cef:OutstandingSecurityHeldShares
      contextRef="From2023-12-292023-12-29_custom_CommonSharesMember"
      decimals="INF"
      unitRef="Shares">300659233</cef:OutstandingSecurityHeldShares>
    <cef:OutstandingSecurityAuthorizedShares
      contextRef="From2023-12-292023-12-29_custom_CommonSharesMember"
      decimals="INF"
      unitRef="Shares">337024900</cef:OutstandingSecurityAuthorizedShares>
    <cef:OutstandingSecurityTitleTextBlock
      contextRef="From2023-12-292023-12-29_custom_SeriesCPreferredSharesMember"
      id="Fact000421">&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Series C Auction Rate Preferred&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;</cef:OutstandingSecurityTitleTextBlock>
    <cef:OutstandingSecurityHeldShares
      contextRef="From2023-12-292023-12-29_custom_SeriesCPreferredSharesMember"
      decimals="INF"
      id="Fact000422"
      unitRef="Shares">2492</cef:OutstandingSecurityHeldShares>
    <cef:OutstandingSecurityAuthorizedShares
      contextRef="From2023-12-292023-12-29_custom_SeriesCPreferredSharesMember"
      decimals="INF"
      id="Fact000423"
      unitRef="Shares">4812</cef:OutstandingSecurityAuthorizedShares>
    <cef:OutstandingSecurityTitleTextBlock
      contextRef="From2023-12-292023-12-29_custom_SeriesDPreferredSharesMember"
      id="Fact000424">&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5.875% Series D Cumulative Preferred Stock (the &#x201c;Series D Preferred&#x201d;)&lt;sup&gt;(2)&lt;/sup&gt;&lt;/span&gt;</cef:OutstandingSecurityTitleTextBlock>
    <cef:OutstandingSecurityHeldShares
      contextRef="From2023-12-292023-12-29_custom_SeriesDPreferredSharesMember"
      decimals="INF"
      id="Fact000425"
      unitRef="Shares">0</cef:OutstandingSecurityHeldShares>
    <cef:OutstandingSecurityAuthorizedShares
      contextRef="From2023-12-292023-12-29_custom_SeriesDPreferredSharesMember"
      decimals="INF"
      id="Fact000426"
      unitRef="Shares">636140</cef:OutstandingSecurityAuthorizedShares>
    <cef:OutstandingSecurityTitleTextBlock
      contextRef="From2023-12-292023-12-29_custom_SeriesEPreferredSharesMember"
      id="Fact000427">&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Series E Auction Rate Preferred&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;</cef:OutstandingSecurityTitleTextBlock>
    <cef:OutstandingSecurityHeldShares
      contextRef="From2023-12-292023-12-29_custom_SeriesEPreferredSharesMember"
      decimals="INF"
      id="Fact000428"
      unitRef="Shares">1108</cef:OutstandingSecurityHeldShares>
    <cef:OutstandingSecurityAuthorizedShares
      contextRef="From2023-12-292023-12-29_custom_SeriesEPreferredSharesMember"
      decimals="INF"
      id="Fact000429"
      unitRef="Shares">1988</cef:OutstandingSecurityAuthorizedShares>
    <cef:OutstandingSecurityTitleTextBlock contextRef="From2023-12-292023-12-29_custom_SeriesGPreferredSharesMember">Series G Preferred</cef:OutstandingSecurityTitleTextBlock>
    <cef:OutstandingSecurityHeldShares
      contextRef="From2023-12-292023-12-29_custom_SeriesGPreferredSharesMember"
      decimals="INF"
      unitRef="Shares">2520627</cef:OutstandingSecurityHeldShares>
    <cef:OutstandingSecurityAuthorizedShares
      contextRef="From2023-12-292023-12-29_custom_SeriesGPreferredSharesMember"
      decimals="INF"
      unitRef="Shares">2959830</cef:OutstandingSecurityAuthorizedShares>
    <cef:OutstandingSecurityTitleTextBlock contextRef="From2023-12-292023-12-29_custom_SeriesHPreferredSharesMember">Series H Preferred</cef:OutstandingSecurityTitleTextBlock>
    <cef:OutstandingSecurityHeldShares
      contextRef="From2023-12-292023-12-29_custom_SeriesHPreferredSharesMember"
      decimals="INF"
      unitRef="Shares">4083160</cef:OutstandingSecurityHeldShares>
    <cef:OutstandingSecurityAuthorizedShares
      contextRef="From2023-12-292023-12-29_custom_SeriesHPreferredSharesMember"
      decimals="INF"
      unitRef="Shares">4109167</cef:OutstandingSecurityAuthorizedShares>
    <cef:OutstandingSecurityTitleTextBlock
      contextRef="From2023-12-292023-12-29_custom_SeriesJPreferredSharesMember"
      id="Fact000436">&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5.45% Series J Cumulative Preferred Stock (the &#x201c;Series J Preferred&#x201d;)&lt;sup&gt;(3)&lt;/sup&gt;&lt;/span&gt;</cef:OutstandingSecurityTitleTextBlock>
    <cef:OutstandingSecurityHeldShares
      contextRef="From2023-12-292023-12-29_custom_SeriesJPreferredSharesMember"
      decimals="INF"
      id="Fact000437"
      unitRef="Shares">0</cef:OutstandingSecurityHeldShares>
    <cef:OutstandingSecurityAuthorizedShares
      contextRef="From2023-12-292023-12-29_custom_SeriesJPreferredSharesMember"
      decimals="INF"
      id="Fact000438"
      unitRef="Shares">1300000</cef:OutstandingSecurityAuthorizedShares>
    <cef:OutstandingSecurityTitleTextBlock contextRef="From2023-12-292023-12-29_custom_SeriesKPreferredSharesMember">Series K Preferred</cef:OutstandingSecurityTitleTextBlock>
    <cef:OutstandingSecurityHeldShares
      contextRef="From2023-12-292023-12-29_custom_SeriesKPreferredSharesMember"
      decimals="INF"
      unitRef="Shares">3813640</cef:OutstandingSecurityHeldShares>
    <cef:OutstandingSecurityAuthorizedShares
      contextRef="From2023-12-292023-12-29_custom_SeriesKPreferredSharesMember"
      decimals="INF"
      unitRef="Shares">3813640</cef:OutstandingSecurityAuthorizedShares>
    <cef:OutstandingSecurityTitleTextBlock contextRef="From2023-12-292023-12-29_custom_SeriesMPreferredSharesMember">Series M Preferred</cef:OutstandingSecurityTitleTextBlock>
    <cef:OutstandingSecurityHeldShares
      contextRef="From2023-12-292023-12-29_custom_SeriesMPreferredSharesMember"
      decimals="INF"
      unitRef="Shares">685500</cef:OutstandingSecurityHeldShares>
    <cef:OutstandingSecurityAuthorizedShares
      contextRef="From2023-12-292023-12-29_custom_SeriesMPreferredSharesMember"
      decimals="INF"
      unitRef="Shares">1000000</cef:OutstandingSecurityAuthorizedShares>
    <cef:OutstandingSecurityTitleTextBlock
      contextRef="From2023-12-292023-12-29_custom_SeriesNPreferredSharesMember"
      id="Fact000445">&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Series N Preferred&lt;sup&gt;(4)&lt;/sup&gt;&lt;/span&gt;</cef:OutstandingSecurityTitleTextBlock>
    <cef:OutstandingSecurityHeldShares
      contextRef="From2023-12-292023-12-29_custom_SeriesNPreferredSharesMember"
      decimals="INF"
      id="Fact000446"
      unitRef="Shares">0</cef:OutstandingSecurityHeldShares>
    <cef:OutstandingSecurityAuthorizedShares
      contextRef="From2023-12-292023-12-29_custom_SeriesNPreferredSharesMember"
      decimals="INF"
      id="Fact000447"
      unitRef="Shares">350000</cef:OutstandingSecurityAuthorizedShares>
    <cef:OutstandingSecurityTitleTextBlock
      contextRef="From2023-12-292023-12-29_custom_PreferredShareMember"
      id="Fact000448">&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Preferred Stock&lt;sup&gt;(5)&lt;/sup&gt;&lt;/span&gt;</cef:OutstandingSecurityTitleTextBlock>
    <cef:OutstandingSecurityHeldShares
      contextRef="From2023-12-292023-12-29_custom_PreferredSharesMember"
      decimals="INF"
      id="Fact000449"
      unitRef="Shares">0</cef:OutstandingSecurityHeldShares>
    <cef:OutstandingSecurityAuthorizedShares
      contextRef="From2023-12-292023-12-29_custom_PreferredSharesMember"
      decimals="INF"
      id="Fact000450"
      unitRef="Shares">18799523</cef:OutstandingSecurityAuthorizedShares>
    <cef:OutstandingSecurityTitleTextBlock contextRef="From2023-12-292023-12-29_custom_SubscriptionRightsMember">&lt;p id="xdx_808_ecef--OutstandingSecurityTitleTextBlock_hcef--RiskAxis__custom--SubscriptionRightsMember_zfCDS9xErOT7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Subscription Rights&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;General&lt;/i&gt;. We may issue subscription rights to holders of our (i) common stock to purchase common and/or preferred stock or (ii) preferred stock to purchase preferred stock (subject to applicable law). Subscription rights may be issued independently or together with any other offered security and may or may not be transferable by the person purchasing or receiving the subscription rights. In connection with a subscription rights offering to holders of our common stock or preferred stock, we would distribute certificates or other documentation evidencing the subscription rights and a prospectus supplement to our common or preferred stockholders as of the record date that we set for determining the stockholders eligible to receive subscription rights in such subscription rights offering.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The applicable prospectus supplement would describe the following terms of the subscription rights in respect of which this prospectus is being delivered:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the period of time the offering would remain open (which will be open a minimum number of days such that all record holders would be eligible to participate in the offering and will not be open longer than 120 days);&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the underwriter or distributor, if any, of the subscription rights and any associated underwriting fees or discounts applicable to purchases of the rights;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the title of such subscription rights;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the exercise price for such subscription rights (or method of calculation thereof);&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the number of such subscription rights issued in respect of each share of common stock or each share of preferred stock;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the number of rights required to purchase a single share of common stock or share of preferred stock;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the terms of the preferred stock, if any, for which a holder of such rights may subscribe;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the extent to which such subscription rights are transferable and the market on which they may be traded if they are transferable;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;if applicable, a discussion of the material U.S. federal income tax considerations applicable to the issuance or exercise of such subscription rights;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the date on which the right to exercise such subscription rights will commence, and the date on which such right will expire (subject to any extension);&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the extent to which such subscription rights include an over-subscription privilege with respect to unsubscribed securities and the terms of such over-subscription privilege;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;any termination right we may have in connection with such subscription rights offering; and&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;any other terms of such subscription rights, including exercise, settlement and other procedures and limitations relating to the transfer and exercise of such subscription rights.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Exercise of Subscription Rights&lt;/i&gt;. A certain number of subscription rights would entitle the holder of the subscription right(s) to purchase for cash such number of shares of common stock or shares of preferred stock at such exercise price as in each case is set forth in, or be determinable as set forth in, the prospectus supplement relating to the subscription rights offered thereby. Subscription rights would be exercisable at any time up to the close of business on the expiration date for such subscription rights set forth in the prospectus supplement. After the close of business on the expiration date, all unexercised subscription rights would become void. Upon expiration of the rights offering and the receipt of payment and the subscription rights certificate or other appropriate documentation properly executed and completed and duly executed at the corporate trust office of the subscription rights agent, or any other office indicated in the prospectus supplement, the shares of common stock or shares of preferred stock purchased as a result of such exercise will be issued as soon as practicable. To the extent permissible under applicable law, we may determine to offer any unsubscribed offered securities directly to persons other than stockholders, to or through agents, underwriters or dealers or through a combination of such methods, as set forth in the applicable prospectus supplement.&lt;/span&gt;&lt;/p&gt;

</cef:OutstandingSecurityTitleTextBlock>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact000052"
          xlink:label="Fact000052"
          xlink:type="locator"/>
        <link:footnote id="Footnote000077" xlink:label="Footnote000077" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Estimated maximum amount based on offering of $300 million in shares of common stock and $200 million in shares of preferred stock. The estimates assume a 1.00% sales load on common stock and $1,150,000 in common offering expenses, and 3.15% sales load on preferred stock and $720,000 in preferred offering expenses. The sales load on preferred stock is an expense borne by the Fund and indirectly by the holders of its common stock. Actual sales loads and offering expenses may be higher or lower than these estimates and will be set forth in the Prospectus Supplement if applicable.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000052"
          xlink:to="Footnote000077"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000054"
          xlink:label="Fact000054"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000054"
          xlink:to="Footnote000077"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000056"
          xlink:label="Fact000056"
          xlink:type="locator"/>
        <link:footnote id="Footnote000078" xlink:label="Footnote000078" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">There are no fees charged to stockholders for participating in the Fund&#x2019;s Automatic Dividend Reinvestment and Voluntary Cash Purchase Plan. However, stockholders participating in the Plan that elect to make additional cash purchases under the Plan would pay $0.75 per transaction plus a per share fee (which includes any applicable brokerage commissions) to purchase shares and $2.50 per transaction plus a per share fee (which includes any applicable brokerage commissions) to sell shares. See &#x201c;Automatic Dividend Reinvestment and Voluntary Cash Purchase Plans.&#x201d;</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000056"
          xlink:to="Footnote000078"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000058"
          xlink:label="Fact000058"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000058"
          xlink:to="Footnote000078"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000060"
          xlink:label="Fact000060"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000060"
          xlink:to="Footnote000078"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000062"
          xlink:label="Fact000062"
          xlink:type="locator"/>
        <link:footnote id="Footnote000079" xlink:label="Footnote000079" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Assumes issuance of $200 million in liquidation preference of fixed rate preferred stock, net assets attributable to common stock of approximately $1.77 billion (which includes the issuance of $300 million in common stock) and $720,000 in preferred offering expenses. The actual amounts in connection with any offering will be set forth in the Prospectus Supplement if applicable.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000062"
          xlink:to="Footnote000079"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000066"
          xlink:label="Fact000066"
          xlink:type="locator"/>
        <link:footnote id="Footnote000080" xlink:label="Footnote000080" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Investment Adviser&#x2019;s fee is 1.00% annually of the Fund&#x2019;s average weekly net assets. The Fund&#x2019;s average weekly net assets will be deemed to be the average weekly value of the Fund&#x2019;s total assets minus the sum of the Fund&#x2019;s liabilities (such liabilities exclude (i) the aggregate liquidation preference of outstanding shares of preferred stock and accumulated dividends, if any, on those shares and (ii) the liabilities for any money borrowed). Consequently, because the Fund has preferred stock outstanding, the investment management fees and other expenses as a percentage of net assets attributable to common stock will be higher than if the Fund did not utilize a leveraged capital structure.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000066"
          xlink:to="Footnote000080"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000070"
          xlink:label="Fact000070"
          xlink:type="locator"/>
        <link:footnote id="Footnote000081" xlink:label="Footnote000081" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">&#x201c;Other Expenses&#x201d; are based on estimated amounts for the current year assuming completion of the proposed issuances.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000070"
          xlink:to="Footnote000081"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000074"
          xlink:label="Fact000074"
          xlink:type="locator"/>
        <link:footnote id="Footnote000082" xlink:label="Footnote000082" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Dividends on Preferred Stock represent the aggregate of (1) the estimated annual distributions on the existing preferred stock outstanding and (2) the distributions that would be made assuming $200 million of preferred stock is issued with a fixed dividend rate of 6.00%. There can, of course, be no guarantee that any preferred stock would be issued or, if issued, the terms thereof.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000074"
          xlink:to="Footnote000082"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000421"
          xlink:label="Fact000421"
          xlink:type="locator"/>
        <link:footnote id="Footnote000451" xlink:label="Footnote000451" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Fund commenced a tender offer for all of its outstanding Series C Auction Rate Preferred and Series E Auction Rate Preferred on November&#160;16, 2023. The tender offer is scheduled to expire on January&#160;5, 2024.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000421"
          xlink:to="Footnote000451"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000422"
          xlink:label="Fact000422"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000422"
          xlink:to="Footnote000451"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000423"
          xlink:label="Fact000423"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000423"
          xlink:to="Footnote000451"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000427"
          xlink:label="Fact000427"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000427"
          xlink:to="Footnote000451"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000428"
          xlink:label="Fact000428"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000428"
          xlink:to="Footnote000451"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000429"
          xlink:label="Fact000429"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000429"
          xlink:to="Footnote000451"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000424"
          xlink:label="Fact000424"
          xlink:type="locator"/>
        <link:footnote id="Footnote000452" xlink:label="Footnote000452" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Fund redeemed all of its outstanding Series D Preferred on December&#160;26, 2019.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000424"
          xlink:to="Footnote000452"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000425"
          xlink:label="Fact000425"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000425"
          xlink:to="Footnote000452"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000426"
          xlink:label="Fact000426"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000426"
          xlink:to="Footnote000452"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000436"
          xlink:label="Fact000436"
          xlink:type="locator"/>
        <link:footnote id="Footnote000453" xlink:label="Footnote000453" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Fund redeemed all of its outstanding Series J Preferred on January&#160;31, 2022.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000436"
          xlink:to="Footnote000453"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000437"
          xlink:label="Fact000437"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000437"
          xlink:to="Footnote000453"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000438"
          xlink:label="Fact000438"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000438"
          xlink:to="Footnote000453"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000445"
          xlink:label="Fact000445"
          xlink:type="locator"/>
        <link:footnote id="Footnote000454" xlink:label="Footnote000454" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">On December&#160;1, 2023, the Fund&#x2019;s Board approved an offering of up to 350,000 shares of the Series N Preferred for an aggregate maximum offering amount of up to $35,000,000. On December&#160;12, 2023, the Fund filed Articles Supplementary with the State Department of Assessments and Taxation of Maryland classifying and designating 350,000 shares of preferred stock, without further designation as to class or series, as shares of Series N Preferred. The Series N Preferred are not registered under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;), or listed on a securities exchange. The Fund issued 147,750 Series N Preferred in an initial closing for the offering of the Series N Preferred on December&#160;28, 2023.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000445"
          xlink:to="Footnote000454"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000446"
          xlink:label="Fact000446"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000446"
          xlink:to="Footnote000454"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000447"
          xlink:label="Fact000447"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000447"
          xlink:to="Footnote000454"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000448"
          xlink:label="Fact000448"
          xlink:type="locator"/>
        <link:footnote id="Footnote000455" xlink:label="Footnote000455" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">&#x201c;Preferred Stock&#x201d; refers to the Fund&#x2019;s authorized and unissued shares of preferred stock without further designation as to class or series.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000448"
          xlink:to="Footnote000455"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000449"
          xlink:label="Fact000449"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000449"
          xlink:to="Footnote000455"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000450"
          xlink:label="Fact000450"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000450"
          xlink:to="Footnote000455"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>113</ContextCount>
  <ElementCount>70</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>27</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="gabelliequitytrust_n2asr.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995470 - Disclosure - N-2</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cef/role/N2</Role>
      <ShortName>N-2</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>gab-20231229.xsd</File>
    <File>gab-20231229_def.xml</File>
    <File>gab-20231229_lab.xml</File>
    <File>gab-20231229_pre.xml</File>
    <File doctype="N-2ASR" isN2Prospectus="true" isUsgaap="true" original="gabelliequitytrust_n2asr.htm">gabelliequitytrust_n2asr.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="341">http://xbrl.sec.gov/cef/2023</BaseTaxonomy>
    <BaseTaxonomy items="35">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>23
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "gabelliequitytrust_n2asr.htm": {
   "nsprefix": "gab",
   "nsuri": "http://gabelli.com/20231229",
   "dts": {
    "schema": {
     "local": [
      "gab-20231229.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/2006/xbrldi-2006.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/cef/2023/cef-2023.xsd",
      "https://xbrl.sec.gov/cef/2023/cef-2023_pre.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023_lab.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "gab-20231229_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "gab-20231229_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "gab-20231229_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "gabelliequitytrust_n2asr.htm"
     ]
    }
   },
   "keyStandard": 70,
   "keyCustom": 0,
   "axisStandard": 2,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 26,
   "hidden": {
    "total": 28,
    "http://xbrl.sec.gov/cef/2023": 25,
    "http://xbrl.sec.gov/dei/2023": 3
   },
   "contextCount": 113,
   "entityCount": 1,
   "segmentCount": 27,
   "elementCount": 223,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/cef/2023": 341,
    "http://xbrl.sec.gov/dei/2023": 35
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/cef/role/N2",
     "longName": "995470 - Disclosure - N-2",
     "shortName": "N-2",
     "isDefault": "true",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-29",
      "name": "dei:EntityInvCompanyType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gabelliequitytrust_n2asr.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-29",
      "name": "dei:EntityInvCompanyType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gabelliequitytrust_n2asr.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "cef_IncentiveAllocationMaximumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "IncentiveAllocationMaximumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation Maximum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "gab_SeriesGPreferredSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://gabelli.com/20231229",
     "localname": "SeriesGPreferredSharesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series G Preferred Shares [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "gab_SeriesHPreferredSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://gabelli.com/20231229",
     "localname": "SeriesHPreferredSharesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series H Preferred Shares [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "gab_SeriesJPreferredSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://gabelli.com/20231229",
     "localname": "SeriesJPreferredSharesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series J Preferred Shares [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AdditionalSecurities462bFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "gab_SeriesKPreferredSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://gabelli.com/20231229",
     "localname": "SeriesKPreferredSharesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series K Preferred Shares [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoSubstantiveChanges462cFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "auth_ref": []
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NewEffectiveDateForPreviousFiling",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "auth_ref": [
      "r5",
      "r72",
      "r73",
      "r74"
     ]
    },
    "gab_SeriesMPreferredSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://gabelli.com/20231229",
     "localname": "SeriesMPreferredSharesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series M Preferred Shares [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "gab_SeriesNPreferredSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://gabelli.com/20231229",
     "localname": "SeriesNPreferredSharesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series N Preferred Shares [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoSubstantiveChanges462c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoSubstantiveChanges462c",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "gab_PreferredShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://gabelli.com/20231229",
     "localname": "PreferredShareMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Share [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "cef_AcquiredFundFeesEstimatedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AcquiredFundFeesEstimatedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees Estimated, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "gab_SubscriptionRightsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://gabelli.com/20231229",
     "localname": "SubscriptionRightsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subscription Rights [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "cef_IncentiveAllocationMinimumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "IncentiveAllocationMinimumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation Minimum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "us-gaap_PreferredStockLiquidationPreference": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockLiquidationPreference",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Liquidating Preference"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_ExpenseExampleYears1to10": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ExpenseExampleYears1to10",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 10"
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "cef_AcquiredFundTotalAnnualExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AcquiredFundTotalAnnualExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Total Annual Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "cef_ExpenseExampleYears1to5": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ExpenseExampleYears1to5",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 5"
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "dei_AdditionalSecurities462b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AdditionalSecurities462b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "cef_LowestPriceOrBid": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LowestPriceOrBid",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid"
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "cef_FeeTableAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "FeeTableAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Table [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "cef_DividendReinvestmentAndCashPurchaseFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "DividendReinvestmentAndCashPurchaseFees",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend Reinvestment and Cash Purchase Fees"
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "cef_EffectsOfLeveragePurposeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "EffectsOfLeveragePurposeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage, Purpose [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "cef_ShareholderTransactionExpensesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ShareholderTransactionExpensesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholder Transaction Expenses [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "cef_LatestSharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LatestSharePrice",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest Share Price (Deprecated 2023-01-31)"
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "cef_HighestPriceOrBid": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "HighestPriceOrBid",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid"
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "cef_GeneralDescriptionOfRegistrantAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "GeneralDescriptionOfRegistrantAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Description of Registrant [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "auth_ref": [
      "r4",
      "r5",
      "r75"
     ]
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r2",
      "r3"
     ]
    },
    "cef_OtherMasterFundExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherMasterFundExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Master Fund Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_SharePriceTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SharePriceTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_DelayedOrContinuousOffering": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DelayedOrContinuousOffering",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "auth_ref": [
      "r4",
      "r5",
      "r75"
     ]
    },
    "cef_InterestExpensesOnBorrowingsPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "InterestExpensesOnBorrowingsPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Expenses on Borrowings [Percent]"
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "dei_EffectiveOnSetDate486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnSetDate486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "cef_SalesLoadPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SalesLoadPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales Load [Percent]"
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "cef_OtherTransactionExpense3Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionExpense3Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 3 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_LowestPriceOrBidNav": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LowestPriceOrBidNav",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid, NAV"
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "auth_ref": []
    },
    "us-gaap_InterestRateRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestRateRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Rate Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_UnderwritersCompensationPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "UnderwritersCompensationPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underwriters Compensation [Percent]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionExpensesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expenses [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_HighestPriceOrBidNav": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "HighestPriceOrBidNav",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid, NAV"
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_OtherTransactionExpense1Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionExpense1Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 1 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionExpense2Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionExpense2Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 2 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_NetAssetValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetAssetValuePerShare",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NAV Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "cef_HighestPriceOrBidPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "HighestPriceOrBidPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid, Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "cef_OtherTransactionExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionExpensesPercent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "dei_EffectiveUponFiling486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveUponFiling486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "cef_SecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "cef_AnnualExpensesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualExpensesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Expenses [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveWhenDeclaredSection8c",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "cef_LatestNav": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LatestNav",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest NAV (Deprecated 2023-01-31)"
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "cef_SharePricesNotActualTransactionsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SharePricesNotActualTransactionsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Prices Not Actual Transactions [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "cef_LowestPriceOrBidPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LowestPriceOrBidPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid, Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "cef_ExpenseExampleYears1to3": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ExpenseExampleYears1to3",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 3"
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "cef_ManagementFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ManagementFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "cef_NoPublicTradingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "NoPublicTradingTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Public Trading [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AdditionalSecuritiesEffective413b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "cef_DividendAndInterestExpensesOnShortSalesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "DividendAndInterestExpensesOnShortSalesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend and Interest Expenses on Short Sales [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "CapitalStockLongTermDebtAndOtherSecuritiesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock, Long-Term Debt, and Other Securities [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "cef_IncentiveFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "IncentiveFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_DistributionServicingFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "DistributionServicingFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distribution/Servicing Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_NoTradingHistoryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "NoTradingHistoryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading History [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "cef_LatestPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LatestPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "cef_SecurityDividendsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityDividendsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Dividends [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "cef_LoanServicingFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LoanServicingFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loan Servicing Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_CapitalStockTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "CapitalStockTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "cef_AcquiredFundFeesAndExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AcquiredFundFeesAndExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees and Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "cef_OtherFeederFundExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherFeederFundExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Feeder Fund Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "dei_EffectiveUponFiling462e": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveUponFiling462e",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "cef_OtherSecurityDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherSecurityDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Security, Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "cef_OtherTransactionFeesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionFeesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyRegistrationAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "cef_SecurityVotingRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityVotingRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Voting Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "cef_ProspectusTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ProspectusTable",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_BdcFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "BdcFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "BDC File Number"
       }
      }
     },
     "auth_ref": []
    },
    "cef_AcquiredFundFeesAndExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AcquiredFundFeesAndExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees and Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "cef_OutstandingSecurityAuthorizedShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OutstandingSecurityAuthorizedShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Authorized [Shares]"
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "cef_OutstandingSecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OutstandingSecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "cef_LongTermDebtTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "cef_OutstandingSecurityNotHeldShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OutstandingSecurityNotHeldShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Not Held [Shares]"
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "cef_OutstandingSecurityHeldShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OutstandingSecurityHeldShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Held [Shares]"
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "cef_SecurityLiquidationRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityLiquidationRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Liquidation Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities Act File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_InvestmentCompanyActRegistration": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyActRegistration",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "dei_EffectiveOnDate486a": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnDate486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "cef_LongTermDebtPrincipal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtPrincipal",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Principal"
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_InvestmentCompanyActFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyActFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "auth_ref": [
      "r5",
      "r72",
      "r73",
      "r74"
     ]
    },
    "cef_ProspectusLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ProspectusLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Prospectus [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_TotalAnnualExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "TotalAnnualExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Annual Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "dei_PostEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PostEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "cef_SecurityLiabilitiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityLiabilitiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Liabilities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "cef_SecurityPreemptiveAndOtherRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityPreemptiveAndOtherRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Preemptive and Other Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "cef_DistributionsMayReducePrincipalTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "DistributionsMayReducePrincipalTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distributions May Reduce Principal [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "cef_SecurityObligationsOfOwnershipTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityObligationsOfOwnershipTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Obligations of Ownership [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "cef_PreferredStockRestrictionsArrearageTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "PreferredStockRestrictionsArrearageTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Restrictions, Arrearage [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "cef_PreferredStockRestrictionsOtherTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "PreferredStockRestrictionsOtherTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Restrictions, Other [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "cef_RightsSubjectToOtherThanMajorityVoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "RightsSubjectToOtherThanMajorityVoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights Subject to Other than Majority Vote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "cef_RightsLimitedByOtherSecuritiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "RightsLimitedByOtherSecuritiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights Limited by Other Securities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "cef_LongTermDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EffectiveOnSetDate486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnSetDate486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "cef_BasisOfTransactionFeesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "BasisOfTransactionFeesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Transaction Fees, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "dei_PostEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PostEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "cef_LongTermDebtStructuringTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtStructuringTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Structuring [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "cef_ExpenseExampleYear01": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ExpenseExampleYear01",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Year 01"
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "cef_OtherTransactionFeesBasisMaximum": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionFeesBasisMaximum",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Maximum"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OutstandingSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OutstandingSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "cef_NetExpenseOverAssetsPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "NetExpenseOverAssetsPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Expense over Assets [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherSecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherSecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Security, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "dei_EffectiveAfter60Days486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveAfter60Days486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "cef_LongTermDebtIssuanceAndSubstitutionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtIssuanceAndSubstitutionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Issuance and Substitution [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ExhibitsOnly462dFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "cef_LongTermDebtDividendsAndCovenantsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtDividendsAndCovenantsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Dividends and Covenants [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "dei_ExhibitsOnly462d": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ExhibitsOnly462d",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "cef_LongTermDebtRightsLimitedByOtherSecuritiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtRightsLimitedByOtherSecuritiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Rights Limited by Other Securities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "cef_OtherSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "cef_PurposeOfFeeTableNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "PurposeOfFeeTableNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purpose of Fee Table , Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "cef_WaiversAndReimbursementsOfFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "WaiversAndReimbursementsOfFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Waivers and Reimbursements of Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_WarrantsOrRightsCalledPeriodDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "WarrantsOrRightsCalledPeriodDate",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Period [Date]"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "cef_OtherTransactionFeesBasisNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionFeesBasisNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_WarrantsOrRightsCalledAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "WarrantsOrRightsCalledAmount",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Amount"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "cef_WarrantsOrRightsCalledTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "WarrantsOrRightsCalledTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Title"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "cef_ExpenseExampleTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ExpenseExampleTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "cef_OtherAnnualExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherAnnualExpensesPercent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "dei_PreEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "cef_WarrantsOrRightsExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "WarrantsOrRightsExercisePrice",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "dei_EffectiveOnDate486b": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnDate486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "cef_FinancialHighlightsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "FinancialHighlightsAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Highlights [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "cef_RiskTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "RiskTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_OtherAnnualExpense1Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherAnnualExpense1Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 1 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "dei_PreEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "cef_AnnualDividendPaymentInitial": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualDividendPaymentInitial",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment, Initial"
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "cef_DividendExpenseOnPreferredSharesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "DividendExpenseOnPreferredSharesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend Expenses on Preferred Shares [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherAnnualExpense2Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherAnnualExpense2Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 2 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_AllRisksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AllRisksMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Risks:"
       }
      }
     },
     "auth_ref": []
    },
    "cef_RiskAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "RiskAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_OtherAnnualExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherAnnualExpensesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expenses [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_AcquiredFundIncentiveAllocationNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AcquiredFundIncentiveAllocationNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Incentive Allocation, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "cef_AnnualDividendPayment": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualDividendPayment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment"
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "gab_PurchaseTransactionFeeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://gabelli.com/20231229",
     "localname": "PurchaseTransactionFeeMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase Transaction Fee [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_ManagementFeeNotBasedOnNetAssetsNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ManagementFeeNotBasedOnNetAssetsNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Fee not based on Net Assets, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "cef_EffectsOfLeverageTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "EffectsOfLeverageTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "cef_OtherAnnualExpense3Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherAnnualExpense3Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 3 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "cef_AnnualInterestRateInitialPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualInterestRateInitialPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate, Initial [Percent]"
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "cef_OtherTransactionFeesBasisMaximumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionFeesBasisMaximumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Maximum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_SeniorSecuritiesAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesAmount",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Amount (Deprecated 2023-01-31)"
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "cef_AnnualDividendPaymentCurrent": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualDividendPaymentCurrent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment, Current"
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "gab_SaleTransactionFeeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://gabelli.com/20231229",
     "localname": "SaleTransactionFeeMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale Transaction Fee [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_SeniorSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "cef_AnnualInterestRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualInterestRatePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate [Percent]"
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "cef_SeniorSecuritiesAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "gab_CommonSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://gabelli.com/20231229",
     "localname": "CommonSharesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Shares [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityInvCompanyType": {
     "xbrltype": "invCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInvCompanyType",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Inv Company Type",
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "gab_PreferredSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://gabelli.com/20231229",
     "localname": "PreferredSharesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Shares [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_ReturnAtMinusFivePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ReturnAtMinusFivePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Minus Five [Percent]"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "cef_SeniorSecuritiesCvgPerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesCvgPerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Coverage per Unit"
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "cef_PrimaryShelfFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "PrimaryShelfFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Primary Shelf [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_EffectsOfLeverageTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "EffectsOfLeverageTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "cef_IncentiveAllocationPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "IncentiveAllocationPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation [Percent]"
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "cef_OtherExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "cef_AnnualCoverageReturnRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualCoverageReturnRatePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Coverage Return Rate [Percent]"
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "gab_CumulativePreferredShares5.000SerieGPreferredMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://gabelli.com/20231229",
     "localname": "CumulativePreferredShares5.000SerieGPreferredMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Preferred Shares 5. 000 Serie G Preferred [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_AnnualInterestRateCurrentPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualInterestRateCurrentPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate, Current [Percent]"
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "gab_CumulativePreferredSharesAuctionRateSeriesCPreferredMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://gabelli.com/20231229",
     "localname": "CumulativePreferredSharesAuctionRateSeriesCPreferredMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Preferred Shares Auction Rate Series C Preferred [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_ReturnAtMinusTenPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ReturnAtMinusTenPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Minus Ten [Percent]"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "cef_RegisteredClosedEndFundFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "RegisteredClosedEndFundFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registered Closed-End Fund [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "gab_CumulativePreferredShares5.875SerieAPreferredMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://gabelli.com/20231229",
     "localname": "CumulativePreferredShares5.875SerieAPreferredMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Preferred Shares 5. 875 Serie A Preferred [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_SeniorSecuritiesCoveragePerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesCoveragePerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Coverage per Unit (Deprecated 2023-01-31)"
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "cef_PrimaryShelfQualifiedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "PrimaryShelfQualifiedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Primary Shelf Qualified [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "gab_CumulativePreferredSharesAuctionRateSeriesEPreferredMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://gabelli.com/20231229",
     "localname": "CumulativePreferredSharesAuctionRateSeriesEPreferredMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Preferred Shares Auction Rate Series E Preferred [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_BusinessDevelopmentCompanyFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "BusinessDevelopmentCompanyFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Development Company [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "gab_CumulativePreferredShares5.000SerieHPreferredMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://gabelli.com/20231229",
     "localname": "CumulativePreferredShares5.000SerieHPreferredMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Preferred Shares 5. 000 Serie H Preferred [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "gab_CumulativePreferredShares5.450SerieJPreferredMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://gabelli.com/20231229",
     "localname": "CumulativePreferredShares5.450SerieJPreferredMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Preferred Shares 5. 450 Serie J Preferred [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "gab_CumulativePreferredShares5.000SerieKPreferredMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://gabelli.com/20231229",
     "localname": "CumulativePreferredShares5.000SerieKPreferredMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Preferred Shares 5. 000 Serie K Preferred [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "gab_CumulativePreferredShares4.250SerieMCumulativePreferredMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://gabelli.com/20231229",
     "localname": "CumulativePreferredShares4.250SerieMCumulativePreferredMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Preferred Shares 4. 250 Serie M Cumulative Preferred [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_SeniorSecuritiesInvoluntaryLiquidatingPreferencePerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesInvoluntaryLiquidatingPreferencePerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Involuntary Liquidating Preference per Unit (Deprecated 2023-01-31)"
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "gab_CumulativePreferredShares5.875SerieDPreferredMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://gabelli.com/20231229",
     "localname": "CumulativePreferredShares5.875SerieDPreferredMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Preferred Shares 5. 875 Serie D Preferred [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_IntervalFundFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "IntervalFundFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interval Fund [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "gab_HowTheFundManagesRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://gabelli.com/20231229",
     "localname": "HowTheFundManagesRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "How The Fund Manages Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_ReturnAtZeroPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ReturnAtZeroPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Zero [Percent]"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "cef_SeniorSecuritiesHighlightsAnnualizedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesHighlightsAnnualizedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Highlights Annualized, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r47",
      "r54"
     ]
    },
    "cef_SeniorSecuritiesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r46",
      "r54"
     ]
    },
    "cef_SeniorSecuritiesAverageMarketValuePerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesAverageMarketValuePerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Average Market Value per Unit"
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharePrice",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price"
       }
      }
     },
     "auth_ref": []
    },
    "cef_RiskFactorsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "RiskFactorsTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk Factors [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "cef_ReturnAtPlusFivePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ReturnAtPlusFivePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Plus Five [Percent]"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "gab_CommonShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://gabelli.com/20231229",
     "localname": "CommonShareMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Share [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_NewCefOrBdcRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "NewCefOrBdcRegistrantFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New CEF or BDC Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "gab_SeriesEPreferredSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://gabelli.com/20231229",
     "localname": "SeriesEPreferredSharesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series E Preferred Shares [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_SeniorSecuritiesHeadingsNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesHeadingsNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Headings, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "xbrltype": "dateOrAsapItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Approximate Date of Commencement of Proposed Sale to Public",
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings."
       }
      }
     },
     "auth_ref": []
    },
    "cef_SeniorSecuritiesAveragingMethodNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesAveragingMethodNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Averaging Method, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "cef_ReturnAtPlusTenPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ReturnAtPlusTenPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Plus Ten [Percent]"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "cef_InvestmentObjectivesAndPracticesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "InvestmentObjectivesAndPracticesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Objectives and Practices [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "gab_SeriesCPreferredSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://gabelli.com/20231229",
     "localname": "SeriesCPreferredSharesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series C Preferred Shares [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "cef_SeniorSecuritiesHighlightsAuditedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesHighlightsAuditedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Highlights Audited, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r48",
      "r54"
     ]
    },
    "gab_SeriesDPreferredSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://gabelli.com/20231229",
     "localname": "SeriesDPreferredSharesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series D Preferred Shares [Member]"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form F-3"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "4"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "5"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "6"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "Instruction 2"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "b",
   "Subparagraph": "1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "b",
   "Subparagraph": "2"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "c"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "d"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "a"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "b"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "c"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "e"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "3"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "1"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "2"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "3"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "4"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 1"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "a"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "a, g, h"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "f"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "g"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "i"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 11"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 4"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 5"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 6"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 7",
   "Subparagraph": "a"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 7",
   "Subparagraph": "b"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 8"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 9"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 2"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 3"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 8"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "2"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "3",
   "Subparagraph": "Instruction 2"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "4",
   "Subparagraph": "Instruction 3"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "5"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 1"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 4"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 5"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "2",
   "Paragraph": "b, d"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "a"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "1"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "2"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "3"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "4"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 2"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 3"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 4"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instructions 4, 5"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "c"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "e"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-3"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-4"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-6"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form S-3"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Investment Company Act",
   "Number": "270"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "313"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "413",
   "Subsection": "b"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "b"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "c"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "d"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "e"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "a"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "b"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Section": "8",
   "Subsection": "c"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>24
<FILENAME>0001829126-23-008312-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001829126-23-008312-xbrl.zip
M4$L#!!0    ( )%[G5>C=RKP; 0  ,\@   0    9V%B+3(P,C,Q,C(Y+GAS
M9-58;7/:.!#^?C/W'WS^>F.;E](T%*Z3@9+0A%X*::^7+QUA+Z#!EEQ)#N3?
MGV1CPHOMV.1RH^,3UCZ[^SS:]4K0^; .?.,!&,>4=,VZ73,-("[U,)EWS:\3
MZV+2&PY-X\,?O_YBR$_G-\LR!AA\KVWTJ6L-R8R^-SZC -K&)1!@2%#VWOB&
M_$BMT 'V@1D]&H0^")"&)%/;:-F-.C(LJT3<;T \RKZ.A]NX"R%"WG:<U6IE
M$_J 5I0MN>W2H%S B4 BXMMHM75M\RGG/L+<W3K_?CT,Z=EZC+_/@;R++NZO
M[MT_433L36_%^O[\[!J6"QZ,Z].[Y=O9XYRN_I[\Y3]^:7S!7F,UX;TD98>[
M"PB0(8M!>-=4^C;R5DV;LKG3J-7JSO?1S23&F0FPO?8Q66;!Z^?GYTYL3:%'
MR/64^6GHIJ/,4\1A&UE:<0$>$RX0<??PGM@Z[();3F+<@^),Z-L$BE.H!P<X
M#JX]IP^.-$A\HYD"79AE Z5A#^@)9HG'$'BV-FEVE%GY-*Q:TVK64\\YFFY]
MY'?P?:PZ+HY>;S3.Y7OC0P!$#"@+^C!#D2_WXV>$?#S#X)F&0&P.0K40#Y$+
MQ<'2-D2$4-FM\I79K*BU,,2R';<+<DF5KYW6< PS(ZY]6TGIFARKM\_<K"V8
MVBN9U$J3_0@9V%)DBF#4AX+2*[,C7;C4&C.[><J;AD#,/8IRU)HR" V!"0Q\
MM_\2YE@H]]N=-(;*PTW#^?>$^VA:5;BOJO6*BF]4_%>0ZL&LJE3I@@E^Y0KW
MMTF.17><_5:7SX>O0T?JIDP8Y.BU*II9R;2]H6X<JL!%/5FIGZ66K'I##@5[
MS;TGIE5(/&U#-1*IWPDD<B9G5GZ>!U=?XF8JFW2&^#26$/%DX);)NNLT1RA,
M4H,O^#9,)1+/S_8\.L]YQL_\I H\'4FE*I#"U9=*X@^C6')FORAQ<DY4+#]G
MHE+E4WQ2=?ET6M<IQ^IM=YP\M^<VA[V!O7C0_KB-F+N0[^<=0X0C5V49 (P@
MF (S8Z;R-"O&8%\>+FHF"A:I,:FN8&TY/C'U[N(A[T4LIB_O$LES>IEI>S1
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MBQT81MLNG09P%>PW,Y69;,CL]LR#KK4)9D:Z^-$*$NRA!_0,HC*'X;^O%*7
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M4HH,'4A)HDE>@OG^".A7<@_%BXCE6S\T/C%-)V#44\C)^+<=]H011[PB&#W
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MV1GF5^RH*"+.9</8 .SUC1L<)$)V)SUN01DK\AN,:>A7L8<$9H@7DV^V<'?
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MI'FPA=49QWV!-J.!5JE1)64&/N>, _.O=;ZO-;+W4$JZ!O8R*Y"\E:1RKVU
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M5_X&NO(%KN\=YEZN7-QWQ<(>#X#-+WJ<9W]+YHMG[[H217T1O<K+,99$8I
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M.QU3#>Q?)N5 ?^2D'I@/L\(F'D1;],\D6KTUUDBZ>[I3VMO9VXNV\-PR@1'
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M;'];Y"C77/;+!-06--X2@85/OI6-MZRI!-_TF]9:,'7L\F&]JQXRPP,SI'W
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MMX+7_:<'K[OTNO_TX'6_]UYWD8-UAAGK?*_YAA\DIL'H!O7.,(C0OD(&NG+
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MK,9A,8/AP.8O'PTQ ^1]ED9+%$9_1BB;BC*O;#'*I[WSO> =NG%3\L-^8/\
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MF?>?WG\Z.1@._M4//I[UW_;/SOH8!OAP])_=06R/F3TQML.IJ; ^5R@@9YQ
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MWQR[LZB;)+*F)Q$W7E88L?HJ?HZ+,M@A/J[&'$5XB\WE1K<O]P"E^VR+]]A
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M[T7X#9T'H0JD"".W-A]V[!WNWLH\C/"B*#HF,*'$1&G:<8PMN3J>[EDCP8E
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MUCGW*(/AHEHIE*.RE*T12Y@L([[EZ8;;NN&&-K,X%@E13)L53(X,-R.7 +=
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MLFIQ6<,LI<%$-M1(&HN;-J?+EE2?/6E>M[\:BC]9GWOU_P!02P,$%     @
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MELL^7RXO/U\NOX8OEQ? E\L^7RXO/U\NOX8OEQ? E\L^7RXO/U\NOX8OEQ?
ME\L^7RXO/U\NOX8OEQ? ERL^7ZXL/U^NO(8O5Q; ERL^7ZXL/U^NO(8O5Q;
MERL^7ZXL/U^NO(8O5Q; EQ,-,@=VKV=;9*Y:-3/,T-(RX\M$I!&M0<IMFJM&
M):-6F1',*PCF\%T03/PJ,X)Y!<$<O0N"B5]E1C"O()@O[X)@XE>9$<PK".;K
MNR"8^%5F!/,*@OG]71!,_"HS@GD%P7Q[%P03O\J,8%Y!,&?O@F#B5YD1S"L(
MYOQ=$$S\*C."F8A@PCA<-4*)6UU&()-QE$'3;3EFGVJ?FG<=;_6X2<(*,T+9
M'5@FIY*;QN'0AO>8[@X<MF>Z=K5<VMJ%9^1@\J?P%#A:POB<@R=.(9! #[UZ
M#H#O,F$>PWP 2AO&+;Y[/N@Q1_=L9YC0)L!!%,:X495)#YEE]TSKI6E?QDMT
MWKB!Y>\A+(R!T"L=CLP+>]:'CV/NV&?S:==A&!QO6V['[&MM8$U7K.T"D]);
M'C*'6CFG>;;XSK8]R_88,8VMW-[GC<C[8P]:G<>@FPF#;D\SZ/8<!MTLSF/0
MI(W:F6;0!)QN%Z<8="MA^=NE:09-(*GM\NL'!?X2.VBU-@6DU7+\1DTY:&4>
M@V[-8]#X$S7EH#OS&#2>I*JUJ4BJ-H]!XX_I=(-6D@:M3#-H$DE--6@224TS
M:#5IHZK3#)J$TZD&3<+I5(,FX;0VS:!)QW2:06OQU\FH0?FWKCUP6LS%K^B;
M#M,-4C8^;X!<!O_&_W[N:Z[WW 45J@WB^JY6*O8][1J4&U<[9X_:E=W3K3S_
M(J^AE:3]2>OISIUI[6IX2;I]W5)'*+3UGME]WGUI#'K6-7\R/F5N[W_^N[19
M_/1Y P>$=?7WIH;NDX;J1T'OFG?P9PM4)]0Q9P?QY^9>W=7:9I<9VJ/I=32O
MP^#AUL Q/1-&TBU#.WIJ=73KCFD8#F:ZJ#!J\+]#UB+-CR^ZO)/74-?ZO-'<
MFR4"EFE['%239[P[RE[46YYV##NEG=OK6J52*?#UO.Z?L]ZG^6/BQ'I@KH<6
M!21$&/@YC!$^&6I@3\;3[4YQZY89S"P4@O?$:_ 6O@2Z)E#O;0NIME0N[]S>
M^I]^/IP>MZ\.-MM?JRV8&_B.95NDFYHM39@$@)G)5&YI8<AIEHZ&')AV=_2L
MN;WM$N;?;16+Q-:"X8--&=Z?_RH48+FL:^QJ5X,N*USJ<"@+A;W/P HEEA]-
MP^L@UHH?<J$?FK8#G+/@V?U=;;^KM^ZU,FRO:W=-XY,F?FS:GF?WY.^EX'=U
M/]23A#Q8_%,!;B,$W;MB 7/AT#?G)]='AUKCNGY]U)COP9T+_(VC@YNKD^N3
MHX96/S_4COXZ^%H__W*D'5R<G9TT&B<7YTNXJ#]UD%6L.\^&IP_7#];A]JM5
M=V:TD&'HY>+X 2[Z?\HCNX!3,@[[$5!U61M6J@\\VP>4K@3YG>!2Y=J+3.J-
MF5 J-R*E)Z,J3L;QQ=79T&U\(&[C(S+^P^THKL7KYSZ+OX-KQM>M\H_+G]=_
MF*^\@^/FRNV=%\H3W+FK0C/9X4W)1J3T\,IK;>V@PV#GZOV^8_<=4_>8MF\_
M:;:#_V+NQ\7<U!)U2X"S__GOG:WJYB<-<'?%[DS7<\B0H34\P!UI*P,+CD54
ML4;5Q6YKI9W*S%7F))0"G-5/,R46[=)AA:-VF[6P=)-6A^4:M&30QQ:Z*FVF
MR[JT7>]MES73Y>B6L6$[BP0\N/;+(Y1P];C$BP"G[LW]3?];_^;BGXE$@+;M
M]'3OMYSYY.TV;;O+=,MS!NPE_5P%R#_8";+";"GN1<Z18/P@#E(MOLW>EI+V
M5EV-?WCB=_CQZH]VQSVV*U\F,[2\9H=CP5KL/H=8R9",7)T(H:/L5\6J5?.^
M;CUYSJS,5R- R.UM;H^2J)N.MI')U9E<_2[E:JD41\_Z84@?EJ<+CA0<P?@S
M?52_:U6__;O]SV-U*GTX/%=N[_KKD?:EOG]T>GJB'?UQ<W+]0[N^NFE<:R?G
M!^OSU907JM@</>EP8^*:\=H,L*#IKM;HLQ;&4QJ::6D''=V!^6>EZJ3RM&1L
M*R4;D?)3DR3S<592-PR'N:[XUZEIL5(\[_K+N"P]5/ZZ/C_J3,6[8B;,[5U8
MZ)IV^K:#UHH#0D,"W\H/R5SEN 4=P,<+Y]I^3-!+JOL_6M<-[^;Y^W2FR:'I
M<GM7SVQLV.MQL)/V<.%<.O:#:;42[I+.[YMFY:Z\];T]V5VBB-T%E[4P -MC
M?9@*5\:LQ!5&@,KM(1'^L)W[T5)WL-3CN*6BGJYW_S;[![:1L-#2X=^#ZZ/O
MA]_.FK/8J=",N;U2L;9=+)2JY3E;E!=Z3XJEXB5YZ<!NF7V]JQT]L=: K"$7
M[;;9FH,A\-VSVD B^9__WBZ7MCZYVC7KLG['!O[&-:V\=F*UN@/#M.ZTNL-T
M#<EP=^BP;(O#@GP%'TL^'N5*LU\[/OEQ^GWGE<=#G2.WM[9=+'X<]TQ+E]"I
MW=*[E[C,42KM9>]LWZ[_>W_Z;^F5H$;GR>W!P2U4:K7J@D[ONR?Q* 74)*'"
MLR"<7S+'M2V+=1.5H-OA2X!):0"]>YB^)![:'[@@'L#ERL?F64JW/_]X?FJW
M_[BK#<ZV1I)18@(8#'X;.W;H5,0L*+?WN]T![6)=V]>[W=6Y,,:2J%X4$:??
MV7_/O.\_ZM^<6J\\QYT=(8=>=YCV16^R;M?4COX=P&/:M3-P/63:*Z1(C[9D
M#&.F/*?]/C*OC8-+]OO??V^_P7Z7)]([5F";#UZA*$V_R9OZZ7EQ\//RH3?:
M/S##37ZM-A;+]\;1QJ;'TK7>\<P_ZD=6<[0^^AHL+9O*-STVG=;.7Y?GYZ=_
M5_5%T=P[T"M?K:1,OZ'ZU_K%7=,Y;_PS^^.1J GME*IC:T([DVA"T^/#?:K=
M?_UZ_^? GB>!#ZM;.^52H5::*.0]Y42]1NX$3))1K";U.W3P M_$-Q_,%GM3
M3T(DE"HS_&>&_['8M;EW8/<Q4LVS=^' +J$QQ-.;72926W[+%7. J&X7'FF9
MUIW_=U\W#/GWQ(M1DFW\')J6W>WJ?1=@DY]X+8C/GC/I!+*(Q&?/F W1/S#'
M,X$KR^^!^OU%5'<^!$4K8,Y7[VWBF5H U5XR&%/[8G<-UV,FO'+D_CL<LK?<
M:WS!S+!2:XU7L5=JB:!BYC6I&VFJY+]2RR1Y6 LDP-#BM,\;GC',[.)8F!0Z
M/@1</^[5C$^.YI/KVN_ZL];HFY;=U14VR6/UFGO[F.?-M&_KVCX:L)V5Y*1_
MFMWN/:SR6'<<[7_T'FSR%QWN[+L.7"*GIY<KMMRM[2WX^0&&[FAU^-> K=@"
M)1<-\=-B::>P6=P9SLQ<[K6NE4OEC]I6>;NP74S@I_A/1Q33(%EXM12H3)--
MR4;,3I/]!\18L_T\XZ-"N6Q/9@]%2*S\R"-;[+[M,D.['#2[9@NC6F  ZPX/
MTG! 1478YY21<*"+-E9$85:+LC4NVG+0AMYEUS;(Z7SP^'B&/^Y+6T_/%XV3
MZ]>&Q+T.FAP6?'%MV\*XU[ZCMU#20459;WLBV83YJ4^&0)?7,5TM/DDEV;.9
M1<Z^:[:3;'A$<#[!V/\.D%H!! X;7<;#: @7)5&*EJ@0;/:](1@VZ?Q'EFNA
M.ZL[&9-2T=S?DY6GAL!UF'Y?:+*V[<":^K3&5X$X*]A4,L@NGD5?/"=MXJ6V
MU7W6W"#OM\DP>,\A5LH<N(" EQ)W/0;"U'2'B2=LO)#@Y_[ <0>8I>#9&J]$
M:QF8C6WB'C#7@Z',(#>PW]4M@*E%.=PX?=ON=NU''+!I/PDL)D01'XK1+YP3
M,?:5,O0EC'P!:XF_S%IGY9V37O'J_GYT+,88:7QMO>N&\OC&@RM(<)[;=;0X
MVEE.<L>DU+$I_1%T;WC$IW.41S2#=?5G1O2-5&-: WL  ^DNO&5:,%;7U.'&
MP(?Q7N-HJI9J+Z;8:VL84ULN?@K_3%^6/GW,:[;7H0$0&\$C$CB8NX5FD!:)
M/E0G3P].X] )3#R Z_$G4.9]'O+E7S@'_N*E7!I_["RK_^?V:?6I_SCUL8MF
MSXZ Y:64V:6BV^4\:L$Y@G_KXI )R=SUT\?5N^,+LY@#@L^)!0\.."'7U\MX
MU'2MCP4/ JE?][.4\50PSY[P1BG>LA9K%PJ7#B@GSG.CP[KMXZZ>0,273]5N
MLUK]VSB;++#[!2+&C@91 #+*71'*W1^/;I&A>_*J:=D]5;4=]&&<MME%2O8K
MGRH53E40E,MFL[S&/B;>-Q,>%!G_[M<:N0&@C@DFF"@A9Z-Y8=C?&IN77G?F
M13$2X,B.3=J.33+AV\F'BE?Y??EHP0]2:M,P.@*_AH=4N2CT0ZNK8P@:REK*
M,PGGIU19:\[L_$C5I>X#$PSGTS),V8P_21??^INU\F&_59^YTO(B1)F^\L9G
MRL.3U)=F8+HHZ)#Y5T+<I;'&R5-7JJ,!<7[<7:JE9]%2H^U; N6CPP"*Z^6:
M:<W44Y$4_RZI[\\.LPX9<%OLW,9UT>T$YT*?=?Z\[&TUKL\F<RZ,P]I&PS,V
M7YM=U,:H_9KE!CW">C5#+%AA"NI-)_# C]CV6NLC]YY$[SD5"[-ST[XU"TDU
MR&B@"MAVHJ"1L?)WSLJ'I4N8R>=YZ&@%,?S280^F/7"YCA3/@YWZ9:N\^?S'
MZ6-EYCSX19!>9L/+QW^O43S[OV'5Y_\INH_!7)@6L($:D@7#1OS8;6XS$'CJ
M/@N%Z/\F*5/_3_N_\9K4_UM?3?Z=\8V9\(VM$5II=;.<H(P6+W]>/AU<WE\=
M3U93Z+7:*$*RLEQ"6DKX"7_9H$&LP>+^'A0$DHU_(XT7F @6XX1*L,=8E!8G
M!42F.UWL!APPHB0SCLTG=WDE.P&QZ>YJM_2?C#EES&D1^JED<^<VMHKVX+0
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M<\UI9M/"P)E=K2#2A3YI D<BIMW_.C;=6J!@AQ)UFS[>FU,G=TO<?@@V,V[
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M*H?U  IB4(K%DR.>=ENI5D;PHO1+QL-@L'7M:HA2T(B)IMIA[H*K]0W0C.\
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M=X75W-76_'-)46%Z3Y!G7]"_RU?Q<<D\09D!.#, KXA!,#, OZ]U9P;@%3$
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M6&O5<837]QSDP%E<W_-0YB<)3#D,MQ^QHP5^1%?>76U-C[#>9?*29T!G0&=
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M+\<:\VS(K*L%.;@YN#FXVZH#;CX;LE';HO-2+=8WKN@M=+SKVY1>6*=0]=:
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M0_P]VQ,?T\\8B.O?<+P5<=L<OAR^#.8-)"4XI]:_X7C* /FBV\ZH]$GK9M0
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M>@X50 R:Z7V=:06PY_3> *4H1RTWZT"/1S^'P&J7W" C@^%?$4#2S\$$5(9
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MRQ=0'\Z_*]*OH7SIG'7>@XZ/4BL72:DZ.8 $(27WDJ%GE"</Y8A>C3=I@$)
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MDW_ZE"&[7O"EI$-AH+-^.'8E$(#&+P^V!ZBRHP4+?H6!0%.$DOR;-F_$._G
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MMXJ3+)YC4<ES+-Y52GF.1=;.;*9!#L4(N)?&#E5BJUADAF>6ZOCZ,^2,:)M
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MZ/3;Z='QV=&5TCD[4HY.KZXO3P^^YLQC-;:><.>Z.)R.IJRJV%[U7T^U79I
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M\TY7AH_WPCL(Z^' B^FMBJ2O4J6FW.DJN@6'(![;[?VCTV^YLI%BF6J_X,_
MBOA$"B$V$.\D2E0&I"$;. HF;5AEQDC-D)TJ1^,]S7!07HYD40Z^H6J(ON#H
M^<_2Z"_@M/88\Q@%LU/XNXB)5P4AIDF>TQT(I$U4"JATQON8ZC_-K;R1[&P;
M\J HL<-?81&N@PDV2P_!-35C*(!_#VE(@B"4'!'%+T^D""R>6;"*FTX#H.>
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M5"(Q4NY*)#^'ST_\X',7;$O,.R'_,!]C7 @/:9SYI'2>C";F1?LNUG! 6HB
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M6 S.&*PO EH,S3B8B?#%O1(4 H>'N2=] 5BNOF4<1']X8UKF&3;1 0&(N1C
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M_ H^ I<07BD7POOBHE P&KKA@%K@$RQ>]G&9J#L^&((1T./\#DUXO>"+=4X
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MZJ=^-(_A5[B?O_P(&].V1Z!)?K@_B.$RPW SVMG/VI=KD8X^\MK<]")P=;P
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M,:71M)K$QOY#'FX"A;PLE*#.SG2:07U0D0?CY&-C,T6Q4G8W"S;XXD>8"'I
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M.!L<,L[&(4>T<3;1G%@E<#@,0F/^5*HSVC;!&G#@*_A7/0%OE\:JF7>[UA.
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MIJWUO@W3X\V'?1NFJYI,[M6]'?'EPJ)F@-R@[-A[_RE]/O@XR&?O\MG9O9;
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M<B'D(I7K,">(!D4LY73^PDV907W7(GO91Y&K(YZ@S[Z;S;:XL"4TU<4YL>+
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M24'5*" Z25>T?0/Y*X%7H+:X%M>@]HXI:'3 ]NB!55;SP  <UM_BGL?.S+Y
M(A=&'I%^B:JHZ(_6*. L6K(TQ$]3+Q,JSSQT<:_.551=$S# %M+C8)Y5H+L4
M9[;P"#[0>7V-G:,G*!*#,R7I/75)AE2*-$D^B#N+O02L'_/D.@J7^&O\'Z 2
MLCDBO:$66\,KYH5IJXHIO^,-/T63<L-PM9]L'5H]U3P8H,C3KHC2Y%*GL;1R
M9Y>%*=T)]D"9";WC5H?*E5(ID+W+CF9_?I)6607&2U1P(13^AFF86RYC FPW
ML?"QLQM%C9:DXTEV49@H#_]!@)K4>"JI[6,PC%*.,8!-HJJO,KE8=NM:6M>
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MUY+IB_/-;(Y9P5VXV=@2DB(WD*\]M(HVU&@_2[(AURXGL6FB%T]3!Y$\F)-
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M*Q11;2:M. 6V!072+E;U%V]L$,V&ONO?+0048M30<ISY/6.FRU(ZWA0I';
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M@)3KE4N1Q>.G#1*1ZJCI,4KL%FU#%"IK]?W9%.OI&#=8D0N-L[2\4F); MB
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MW4:K:7RL=8U:N]UI?3(O#'C_HM%5OT([W=AW^'>S9W9N&DWX<^,2WFATC=0
M2P/^T.O<]CY>WE[C=R(2W"S3B#IFNP-M-WM4S@,CQ7',]5:SUZEUON"W-:/>
M:4 _-?CZ\M)L=N'+_:.8+15>%<KKP'==:Q+"&.1/ZY5<E>7?TZN6YJXJOK*2
M*[Z?6EM]>9WC-!69UOW1YOB=ON\.UZQTG]K?!DO<IXQOZZ%>;9!RB/5OMNQ]
MSJD4._CC.]A#7^3/WKVH2NTJC@$,"!;S#E17;W@DDG^"N_Y!M7):JIZ<EZIG
M9X=97"7&$M;C,X*UO7WS.I7GO'K?3JL&6I1:+\K0;Z ,_5/.Q.=[4.]2#D+V
MA9G[+"P.^#97(=OX2N1FWDLW]>?OY$K2_M4GNG7>O162;8LZIR5IK)+EE$LQ
M9.:#X\.7M9LO9J(1V?Y.FM(^J'1KP'\\<TK!EI3-F%=RT2>YGLJYH!LJ2TC6
M]5QQO%?++_!*.8O!;##]\O@P-X5O*;K-NKL+[#OT1:BJ\\F2Y@?V=VF@S%?7
MGJ-YHL+V[%S[+248'B9M[.-QW6F;'6[KK8[WGPSV&-JN\Z <EJO-UG#)^]^.
MX#X.Y@S?+!V,V-.%/?%#AR+D.5]&QC>+&'MRCA1Y$-O1\+70F^7P+XNUR/;-
MZ+DD1.=-I8C&@06H%M$XOP2KV(X;)Q8$0$$D422)[LT6SG,,D0V6UB[X@3""
M,@S=$=$H0AWST@K54/D^:S:]]P.8#-:(F/L>1;F(NE04'$%84T-G1$.+^?HU
M5"L1?#&VON%05D-("32H_\#OX= 1!3?R@D+I$1<RDF-L1U$<Z>O]0TM*0:!8
M/@^O UEU9"YNAWAIAQPWQHK.2HD@^=8L4.''):UTA,JGH0]F+I?4\"?2X4O]
M3$2S',M%6RY R0QH$4-2[S'"&4=-*3ZKQBT\X)E#GWDN14GCHCPZH:W7+UZ2
MX0N?)IY$V;QZ.L&C'242" I;FEI<,JRH8I(\;8)VL^>),>VB;DO(,?,8Z@6S
M>O3XI/*>PTJ'L,Y[>-WONN15^W MZI W>R^]T-)V_(]IA+]_JQR93W1S2=*<
MLO8,-.O($L=]'L/)%EQJJ;VD&1V76B)7N5H7#)#9WETD)Y DF7IR&K;3ER;I
M%3V93-.B$I[D@GQ7R7)!;O!@6<8]W$O_>/5_)O];J1R_>E^OW6*P#,;'-%N]
M1MTT.N95K7/1:%X9EZW.9_CQZ+K5^A-_U\O*66BX66*Z2ETHS0>XM7/W(S[N
MA=T4=*4<C)L<=_OH5!_TCM'DL])A]=7[[NW-#1)AZY*"MC <K"M_Z9H=C!/3
M;%0=\]+L=,P+H_NQUC&)'->EQKTBP<W2W5E!=TQW)Z_>7YC=>J?1IH#!@MRV
M0FYO"W)C<CM]]?ZV2UI#N].JF^9%04GK4=)Y04E,26<HN+4;O=IUXW\HV+D@
MI(*0GD)(;UZ]KW6[9L^HMSZ9G=H5B/](3P4Y%>3T%')Z"X)\VZ0:Y'40E6IU
MD.,;75 KNT:M>6' SW\64OV6B/!=081,A.<@9I6[9>/2O "6=HT ^*T;4"EK
M_T9K;=?\UZW9K)N*#C$1J--H7A7DMA:Y'9\4],;T]@Z$,;/3JS6:AGG3OFY]
M,4WC@]DT+QL]HWU=:Q+K:W1J1'T-I$F4V KV5M#;D^CMN +\K0ED]!GS)PN^
M]9/H:*](YOC5^VOS"N["FUH/1+)LWK,;=/&32.!EQ)_"J\_KO]VTT_8Y)O"L
MB==IH>X_FCZ=REI3X^9U[V-Z&)IB)1;[#&.I^>2V87[R%#_@,@]PKCE(GK$\
M"?!T@=L_WP+G6-2X ^P2KG?#_'<;\0FZ:RWM!M<S91&/*[N]BB>OWE\VFK4F
MV1\^-JX^7L/_>SNU@M7=7L$L#\5N+-[Y;B_>V2LJPH>GMUBUW*OVYM7[1O.3
MV>T1ODN+BGPVX'?2FMNMZT:]L5M,<,?7\^VK]VAF-2YK]5ZKP\NH;+(I!HAB
M47,LZOFK]Q];GPUYO$&-:M:N@$9QI8MES+V,[UZ]YY7CLWYI["*_?+?3:XC6
MGW:KT[L$SM@R>IU:LPL'?<>.<W6WQ6TTAUPT/@$G;%XP@[QH='N=QH?;8B'7
M6TC06QK=[BV(W"(8_N:FU32ZO59]E]AB]6RW5Q'TEMIMKW4#UW+=D(1I=$Q-
M+D(B_=2ZOFWV4$>LU[H?C?9MI_ZQ!M(Z^AAVBFAW?+E/4Z/^1#Q-0;QKKB9H
M/;5FKW'4J_UI8@P):HZ?&H@"V=5O>(%9VS6N\*4FAI-?M.JW*II\1U;[9,=7
M&[2E^G6K:UX<(8L@611NKMMZ[[9C[M(R[K@0A4J2J1CH[MY<N[Z.YZALHHU-
M15'LTF$^W6U[Y3&H0TT3[G8*P/M4N[[=I2.\XXM7!3WHNG'3$%B_\+^+1L<D
MDX>X:DAF K)LU,WHV76C]J%QW>BMY['8\DH?[_9*@[;4J_U;"S,N5BW'JH%J
M5+^%^^2B46N66%$'#FG4KJ0XKP1]4#X_W':Z*!+17W=ID7=;'*J"YD015G"#
MZRI\L8*Y5_ T-3)D-Y;N[6XOW1EZ+B[,-IQA/-,=\PI(T,3XY?;MAVM0Y6OU
M>@LT=DJE;71NBJ7-O;28EG!QT:#,9 S@O6QU;G;N MKQ-7R+Y%EO==HM]O<8
M'[!" MQ!&/W\:Z_C4Y?L'&-;&I]J]2\&_+=9;[2OS>YR/\72I5EG%9*N&Q6,
MMJ>Q4LOPVHX+O#98@),"KVU/0RB?(7R2&W.&P%\YZ$Z,_ZEX'?N&F[/3<'K9
MR%REI1AM$E:M.[6F#.3ECXS:D#'2@$DU-%RX6)G(6D/5=Y/%[<2?X(-'*Q@>
MN;Y/R':A;#I4)>0O,U^1%>L<O%>=D</08=CQ([#B4/8QMN9)[#,L,IA\YL Q
M6,1-8^#9A:<"'#CY'&?G>+.%YQ,7MB7QS()7!\Y$;P47.'1@4ZT :" 81TON
M(<@QUB;'"MNSP3W_N0Q;!S]G+Z*L+YH;I2\T'A%/T I7X-#I4'6PO67C RV\
M$QB>Q<7=L"[DDH&):G*B9ARV-O-$83D$,"S1(PNZ KJ2X'L#0B1DJ$1C+*H?
MNG-9>Q!A]G"B]GCB2L1''-\2&H,C@O7I8*2BNAMA''(_6@<6](CE4&=!<DB6
M0%2<V '1OC>P)0 U%F\<P<WOTYY%T(R/MG'ONZ+4-9=@ASX?[QW82>Q!%% _
MB.KJY0(Z/N3*F02F)W=FPK5?N(QJJ-5_E--%#.Q9&#)=4*5;Z,8?PC<C!PL^
MAHQ.20,PZR\6_7@;=59=(%@$H09RZ-LNECJ- #:9Z5@,,@F_P/9J>[3D5%E4
M@]0*@1V#]%UZP@&:!/Y_&&D;T:\)^#-'QXRA*8J@I@!HBHJI*1B:)9WG(.1G
M=B<EFEXXHUJQ5/6=*XL2IXC_Q?'N&4TUD[T0$[5"B<X)Y\#UPX4"E$^L_+B\
MR*,.M[GY"I=+&7S9J"UGRQN!SQ58N)D0IM2TO#IHZZCZLZ4FFP/B-4<?T'B)
MMQAK$H>VN S+6)/6GG#=7B1KW[OS\7,?F.6=.'112>R1/:0;0N/@KO4(/<#!
M'?J$CRLD!]JT1X$!/+6^P:WM:XU2_9;9A.:VE- 9]C?7)BW=AYS"G-@"KI(@
MR_[B7T)K!%>5%8!>BVQA*HA;8!<3173Y&?/?ZMM:1*T;J"->7#>;&W)]%B _
M!%[_S?,?N79OFM SL&:AG;PVL.9"^IV!QR=V60E0WY+1GW%I7SP?+HBT7+N!
M25))'QEE?[?$=1=DVY];99AJI<^".U$BW8?E?G!@0P?0TFB&2\QWDV@LY&KK
MQI@+F ,#<.VA%."TZ0=RQ%9:)?>54]BS0[?,3%<MS'2P *>%F>Z7N!2>P4Q7
M56:Z'X0S+:QUF]PF9XG!#FZ'*=T,H*4+_498CA)WUM]_=][+JG3.^Y0Z220$
M@/2*EW94+'86A#/+FW+IP2<7=Z"VL<+#=&H-[KF*$[Z/51=779(T=W6ASJ8N
MEFE0<\4OG)$S,%S[#O@O#B12/W]@(4@IP9OVSO90_(?;.))6(N7@WK;(0O-4
M26+58*1 @=JLX^6H#Y$]M@L:_D27E"*Q6QE;Z];$F0(M8[D27KY9F*NV!\IY
M44V*H3TB_22\1S,@%<7 #L>VY9%5R9)+R80P7C6K2&.LH4O2M?7^K6!NW/D/
M=H!MTV! Z+% [PKOI?7L2910QA?VBY'M%EQ_W@Y2X&GRCVT1R&893$3U[49!
MT$41,RRXLK)2N1C!R0K4B*?-7-P[RR?_MK+1R3^I+DR)[@'06V"@(?EL2@:;
MWHYL#XWN'@AW0F-1RHM@"J AW0%'M8,8#SY^=UI!LT%4+4E$RX9H71\C=]":
M\LE&B)X4AQ1;N(_(]NKZR"J 31AW@?\(MRDPBP$S0S1T< L.UT^'-F'!J,92
MW,IO\RIHIJ(!:JS\(3;HC\<^+KX_^%:"EB2_$0_@9=H^/,,^*M9LX*0S';4I
M[$Q6$%BR>"4%8=!TX,*&CU!K1/MF]!%6'H+>;5Y]>.Y[PZR5*:M=Q<6$_JZO
MZ_!) &^R\JP^L88/P.T#O3!QF6LW2H6(70^1(3@L136SR%_!K:$'Q+4M^.&\
M\EKRZ0?+G9$9T*&YX4Y8(<D[L/(+2ZT5RWJD46JV2WA?T:*//\^%Q:I2 O(Y
M?Z,J@*)J-*3^](6)"C[!Q[79'="X^/Z8OR]+V4&,/$:$^J:SOPA=-$-9O*SY
MI6MJU!S.QWW?E9?V5>V#O)HSBH[N(K=]0K64S7.]V"!V?;TV>B-IUM06597+
MOIN>?4\V7V/[:PZ;UNI7F!DAMYXZTQE:Z(&U3"PJ1Q?RQW"V$QQ;/^[,?E;W
MHV3AT!J3^]</D(^1FU54I2,^;LUE@,40[@\0EF=1R3G7 >8WM(0U7CEEA*M#
MC*$.G(J5I@Y.0@VD)%\P5[UPE?+L8\JS/U.>W6@S)PLN/VY&C[.J*._F 2T8
MVD]D:!<..IQ0AP9"_15YF9P@'^_X@8?SN9JKH%@QF(UG+@<)21>>@T4^'5 ^
M071RPG F/*LBRL#R//+R"&>K:EX)8%')<XP+.:+ E"SFXZ_M7RB.?7'L\QW[
MMK@,+W[1X__1=X=8+QB.W>JCSB:UOFU@S./491M:8 ]L./@EK/'KL9L=384C
MO?IP?TY1$:QJB.<@>=RA&BG^C"?X@V\%0QS*A0.M*A?LT!ZX5A %U5&-6;3'
MXJLCU!/9!(O1<@^6XY+2BO9 ="&5=.8TL$*L=YS)\<K&,G9(<AK,?F(Y0[TL
MO-#>2-'VHC\4[*9@-SG9S;5VL;75Q?8K\IOXO<X!I\5!*0Y*SH-R&Y*\V [\
M@6T/PU_QA/RE;(D<W42V58R,XIAMGK@4DY6W-&^8$-_80]OF.#NX1,,IW'04
MY:?LB&B$U$3RU8W& ^JRWE;!=49M[,\\84S]/J":\B*""(8V9D>A1>]PY!'<
MN_I(EPQ()!V0YS":*K01V,H^S7'H]G=A',]E8RGA6!_O?3:/P\\3*YC20_0;
M!D.*OE<!Z\KGAYX#80[/[(2"FW6C+PQTXH>1!1^?J:;3K.8QXV_YJ]'J&!$5
M#7WX.[I(F9QR45/6RJU>L_+7@ID7S/S':ESL,?/&4]>(3FA-.*FB?"L9X^'%
M_5^C^'F4FL98)-2D\9B8HR>=*Z *,_%=Z)K=9]8$>I@$#EI=8DXF]"3./+;;
MHZ$ERFHKB>P@)Q3\@_EJGU(>D"%/.207W:2NC7_% >*0L:_OE*E&X:2!C5$M
MWO1><9O(*O2'<>\_8C84JX&R]X$E(T9R#3P>,)2]0+3/R-C8Q4FWT(*OD"X2
MCDA.<%U.4\).@+[01  +2QY<^&_H?)>35*'LT31%0!%'._N#P2R =8SZ2*&;
MD>^Z_B.Z3<DA>01JL^VQ5U&;#EK1[H"VI<H+NOCB?+A7#JN6 2TI/0YMUYK+
MT)4XA2KJ=%!"D)E#;/CG.!-\BZ*[:44I=<"*4C2CUD(D)[R21M:#'Y"Z#E^X
MZ$F6XL?J^:)G10D=VDQ:<?IO"_HG2JCJ+][8TWM_Z+O^W3SI/%7)+)EA05DZ
M2VHAG!T)2CXI@I)A <Y>2E!R$?OUTP6F;<5^Y2@0]LN%?+5MH::B.J7KB=[P
M]YC^5-J0IBR%L'LX9'@;W,/]9/QW!C/%X)][D#PX:&MH]Z=ZW)6>2>]X<%W-
M5,*WNJ\2=HPBT*;0G=8SA#5][ZB.=I$VB:._=]2!^&5M8JM/;!0PC](["IB(
M/P$/,+64+!D1UV _M!\+2B=["<7%H'@?.7*B\#[HA8,1.=T-!-:2IKO$3&LY
M/.>L!TX=C(TDF1K%8AOM858P+TD)]#^SX9VN)2YZR:CK,>:78UX"BL^8L<MY
MAQ9&KLY<*R%%R[!6=LEU9WU0AB; SHP;V4T#)3&4VSLP.P]4F+H_M#F=]OQ-
M9CHMOA39^=2Z66[H2]M<@/&341RM3*<8.,%@-D:5<A S4ZY<QY+!8AFA!HQP
M#IIO#I628,AQHF,;52+1G5@5/YB3C<LBLQ;(4=Y@SJ&>L$2(SW&G!LQ<O&#1
M!8M^L>:M>N3IULZ82,$"#0E/7TG:7\@\0O:2L3/5,'%DT#Q]IV*C7>M1B\]&
M5J&QQY(QFP";!H[N,,A-Q,E+Z_'<%"N^O LRHHN4F]*8N,A2!R*>@!@8A0(L
M"2@P#A[O;7(W^ $;X:U (%S(J(9#-(X1' NG6.G(.Q*,(IIN85\O&%#N8&SR
M+YDBE<.X9M_-KR@?UB835YJ+_Q)ZVU?CKWL04OJV[7UE0SKP)1?6(">G$%&%
MFA38EI*AKD^6F/49LB\$7HEA7Y'DF2-.O"$@)+2I.,)D_X!V>!8/(T_"4& V
M!9QJF1RN5%_1+"M,\M'?AM9<LU"OAKPI&Q]8Q,HIV%*L9CB-,DVTVP)_)<GO
M$?1E##U#C+P89H? K1&H'6-$L['D8N;&DB# #C+N3=UYUNJ5(FF?D'I$&HZ2
MMC/6MO1$@ ME4H#_T&532),%,\^;ZVE]MWY5]7XQX@4Y6UR0(@Z>-]([2JE!
M?@\G^< YU-(L97+E'2J"!_2OACSE$C.TU%NL#9(5$)N@9#F8N._9QAS$N<,2
MM [-DV60@$"E/$B)@*#;'R0?4&=2$1W"$TS59P !8+*PPGK6:EB*8*_D-PCB
M2 FA[(N,P!5U596!!&#H('?W?<UKK# 3*&+CGB* #UF,AYG 5%+L!%,@/_;3
M\92X.UJ(S(F7-&D6<<H"S+:4?](,J+'ML#*6Z=X>WLD<>]48Y0\ E_9"BX&*
M#C&"5R<;$M )E0^GA!'%6A Q]Y!(N<R8L7"#,\94*!0<&;KDP2IG3 C^_H Y
MJ?#&(@&Z?AA2^)1_9XO]$W0,0V;@!;9H6 I1U@]@/3E]EL:EE \%<VO%H"/D
M-&)K@'!WB7;B2INP :&VPJ )9!CS1\XT'FO$(+ )E<=!A04]\_&0[4.^Z96Y
MC.EF;APH\HZ3=;B"K@_I5(\$&E^DA(F =(P;'XHL,W%!$Q(?Y4*+]%S]!(2)
M)5"(F&*!=!NAX"PAY\BE'.[;<K><.,3B>!WBXF?SBFCC;&"UE(XM9QC@="C$
M[;LSGHT5.B#LL#@(N,74(#0?2DE2;'XZ 1*%)L^,%)8C>J$Y65Z"XC.:BP@^
MY4A(BI>@Q?K17R!EG8&DOVD,8%4$P)M^QD&:#&P!5!C+&J DZ(PCD34?AW9^
MSOF3).-C-(H=,# +L&MKFNPFL.^L8.AJD8VN[=UQ:C_;>U7'U*K_*"!+1 1F
M1HYG<NOEV944@#:2S(VAT J-/AS=8&X[=,Z.SUZC;:):>0U3FPB/FX\V$^9/
M)/?*)K3@&AH&4@=ZW!08T#W,!@^7B.4D)  5$5)2[]%AB9W$QWN?XY"BX98(
M604#J/ X(-8#\X=' JI;-8)(]%;69\YTA7O^I'S^VK@!,AHPDBO&.B(T'@L;
M#I-R3-K'O@A";V!YJ+ @5FU 6'H:>[.(H3PB%P%:P< &M"53Q@I!U6Y2O,G8
M<%R?3%83\T?^W7E/NW I"$L@-H#0&>E1@RC.M"64WS+CV!2^RT*564.5,3N-
M;NU7U&/@%&EGJBZ8D#F>N/X<GG\ ;@L2E-%V+3Z;C4XM@2L:!0(X[XL#51RH
M];-5\<*NP;T^_14/V,K<RM3PRR<$WOW<0,W3(E 3%N#-2PG4W$GZW"OTV!.%
M'GMA=NN=1ILK&Q>@L2LW9RLEGFR1N$"&/PQ!ZH-",Q(HIK&(JU1PS"5.'4J@
MP/]1V0.5BV*!VC8FN#W1E 2+9]-IR&@F*0!I&9">4JV7!L>1\UVZY 7>7>XH
M4CTX2O86!4AU'61IY'@3=4!0-730^XAH!G):)<)I!TV6<SA&$>Z=F@ CM,LT
MG+2UUFM,Z,8LG. <T?1Y:FQI4.VB3JRP<PG< ;3L>Z?O,%:4'TZ/;"I1A/@*
M%!%&2K(W&_?U2*S4I!S&5&31U]!J4-3]":ZJB!?S^\*08X4+0+AR85,+@>7,
MY#!JWESJS1KXK,2=E?B_TFC^<Y'[#041C(8'B76;1+E%BP00\"+(K=S6/8/:
MWWE^%T==A&U%HWTL+I*?149Z"8X2DO\A!?F$H55<W,G1G"*A=$"5V11. *66
MZ6;#A1,FS4$"Y?.W2KE2.<:H)X%PJ8*;2A0D@)@J(@@!^"9\EP .%?:Y)(N0
MXU+Y;K(6V6P2"Z3-P^%KKIO7 $94;V6B0HV,5+ )8V.0-^L@R\@@LQ3$JPG9
M58%A&@?(H&9:V$3?"AW.(S=.WE2.AL 0T>68@':=/MI8SNZ$7^#\P\.M FDM
MA<G)A1I&&QC%TJ4%HRQ"B&G)J"F:8,')-L')<H1;(]"3(7B/[DTE)R'Z6U$6
M26;C:I+>4['\2\J(SS5JJ"\&@/>.T$L?AN37L23 +S$(C,<*; J?1)0JB6Q,
M"< $>DP5;*3L@[+ :NJ5@ A#0V05V./$6D3N!L'"'2$^13R<*\,M\/ E(!2*
M1X]F ;ECE)R*\@E=&=0;CHH1&IA3I]PN)%LAJG7HNW1N#775T)2R+I[8H%<O
M%!]K1_B7\;]]!$Z>,NL2*=A2M(XX45C2]P9KI;$7F#:I9#SX#(?M/]J8_("A
M ($S$'Y6JO@DQ%Q+%)#*9%;2"RTB[MBYQ)0:Z-G3L1A<50@U5%J)C74Z'9([
M@>1@?,I??!_=-AC$]A]"/BNQ+#N*"JE%8=$E):_G0SR1>H8?:$2$N\9K%B%U
M+ @'"4H[5 LKX6>C\HSQ>3RA<8QQT+WK*/0(58HT#%(A;%D@DH+V#DN+3KLD
M5BT.!19]RK$HTUCA5.1(0Z0A6Y51U?)VPI).;[C=3$X\&6LJYT9(Z\ \/3QN
M<G!R62SROL77(N"3E$<@>P[*62(<+H# B^U7T2A6J&,1,VM9NS9L*9*A=-\K
MJ8I8JG?*P?&!/;$QF(%3-Y?I[$*4QH_Z<U$/4;BG@;F,[> .W:\H(J%9E)FC
M9"%8(:2$#GVNP2G553$.]:X8S"/IVZ(";T1+JVE(U$UUB=>)$CGDCP5"E%)S
M&+,XY-J?^-)+^;L$#!DC#2C9R09%G>)<M&0*5J!!Y@HP#P.#RSQ!<;XG0SOF
MB12H*=[QXM%R */DL'(($$(63M@"_CNS0Z'?KK$[5 03A 4GD/*U&(@7*<%]
M <*4F**?=[R4-.*(A:6/^)RR(*[%2VE'=N.+)B SY!DJ&TU?LCYUP(0@@L<K
MP?EXBU<SOCPF+28WGJ$8 49B:5VZ%-B-%JF^C[5P;*ZO*_M%S!@>3&*E_N (
MJ4%@8Z1'*4>3W KE\_&ED'%3B^;]0(0XBBZHP60G>G C+B5W>,C]1;(&J4L8
M>XCFN'BPE=8GBI2XV5@:617'%M8Q/P:2FD\$3,K5&C=,:M\:]DI<,L@DRUA/
MZU<!SQH;TR>7J^6@/@)YL=V1*!!/'O ,PN7 ?&^*5K:$]54[;OGTUD)7W&QI
M.%NW6L>N.M+R4NM^K4P>\399Y6QUS>H?<B;D,)5H)OXGK<<.. /V?I,C68LU
M@)0%27+":*+1.$%XIT^RR]J)&G8&I]Z1< /=:\/"Y_G\$B6]Y!ZFX$O;/UVD
M@A 7ZQCO_5XY'$\:1[[$2>N;EBA#OF01?XDU86LIT#"KM4#.>$<.[05B7@E:
MMF]5!9>%R9P583*P &^+,)E?0D9[AC"94Q4F<]LU,3RFW6G53?.BB(#9CD<8
M4Q8( 96E#JXCB-D$RX"7^S&?79^]#,S615YY5"(Y<+(=G6P I>RQ*!%*]*?R
MK[$5O!T9CEN6(@0E4A7\DE,81MUBEJ:'!LZ)-2>-5W-\%"K6+X $G\=-OS4$
M=S&Z LA]9X#<BY-<P((7L. %+'@!"[X&+'C!-%\\X.]+I85GT&3/E"9;K[4;
MO=IUXW]JF/-1*+(;UD#H3I< '2]7)GP&DGZC2+K6[9H]H][Z9'9J5Z;10<HN
M"'NS=TM"*(Q"J)0G+,+&H'M!H$E':*886,@0GNR=$$&&)0W;4XN4TZ,.!9HI
M_3$U4DL/N:?VE-ZFU-#X*WH $,C+\AT* T+5.SNT("6,E\/JV?%.(9L(<D,3
MB@1O.0R%*>''ITAQ%?$FU#?:9))(R_C:U'!M*YP:U4KEM<*)49BQ-?J@+C_H
M1+A 46J%;O,2(JLP1<APD&BSXONB+S49UTJRLCU%_K!-H@R#D$+%:NA$WH"T
M\*[TO4]N$)*1KF+Q[B26S8L-1H\!R2?Y2%U**691>L*+E6*VP'4T])LDXUE"
MV!I/PG2T&2DR%.NMH,RC^&?#]^(:U1@M4'3 [V9 \Z[C\7XC?!V0^QA1/?6X
M.(<C_%&Y)U(3#()?X<@"V:\@KR6T*Y"<6=>U9#\2T"J'F?$O39G;K%L5E#[Z
M2/Q<)QPIH\,CQ+_$%+Y,8-0]DXB6N5/?%.Y46(#SPIWZ2[#O9Y#8WRJ)O=LV
MZXW:M5'_6.O4ZCT$..HUZEVCUKPPX.<_NP46P4^*4HS <<)B:3>ZM$4:;9%&
M6YR,M"$OVU5I8Y:A$_^=48@\J%R^#M!_0'D\EHHTU0"^R$EQ =NK%-Y!5)4E
MWH@?4*Y3I*V3+$ZF#,OHST+4!4)\6N*$&4&X'BP/?H#F=&Q4?_.0=-#HZ,,9
M]CFW-$?0)*G2<U0U\?2)WEA58"@0SHF(@I%%]+_K,VZO&HCX=.2,IO=X\@:+
M ]W X6*FE7VZ9%90SI!1JE#%Y] 5.M&P;)BXT<)Y2-4:/+&/\6HPEI%* Y3V
MJ9_WY$E/(!_SJ@7A-++<2 SQT51$L_+?US8B''*XD(*,18@*^[N>09*DJ_09
M.6$*"C:G(BZ<!AJZQ$Q<M>'HLA-&( M:MP(1)X_QU&AP2C0KPD/@CO $,(OR
ML<<3C'+'LLB*/U&B?*S$D4SNCBX2D>":NDZEC(/HR:,^M<GU+"_>D?,]LO.E
MP8U@_(%@#F,N]0'L\*3"M4)$A36VWXE1D.^ZN#8V-F30/Q'70!-_$D;5Z/90
ME(0&2R2D7/Q,4GL*H5,=+ H40-06SN^CP6BRV3*Q;#A#@N$R5N3X]Q&=WQX0
MM::1;ZC"$NAH)L+#GI*N%EC>-\DZ<3[HM%4G-M_EQ"8Y2=_^:.F4(S1PS@.=
M DOP81"V/\/$7V3WBP?^B6M$U8'6W0^!?C$5D.6"3+*7>L% +19Q(755=W>D
M==ZW*3A5=*@A):1MX?I9AI$(Y5"4C0>LW*6<&%0++'PT\</0$?$C&"+D![K-
M5:2*,F 9AS&NV&N]Z!M#+\G9D9RV*C#0$]VZ]H.5M=D%)]VHUM])V,0OE,>G
M$XLD,5KDGA,[4=@(-KL1MRI%*L7!*H2-F$>5/04+/(+Q ,*\'$)<8 ZH14.'
M'5HLWE([2K)5(]'0Q'*X)'W1#CMV-6Q_BR4](7(+F'\,B43'!0$ 435:+7$L
M*H4IXN4<C^H[),8P(CP?SZ'_J+"CP$:0"32H(!N7]Z'%ZM+PB)'^%\K:D""M
M @ CWZ[(!-"A<:0K-)0H1WQL0AF,QZ@Q5-1!.,M+*FA:RNKQF4A)G3U 3B@C
MI FW,)26'<?7%"O&J1/7$V=04)NQ*ZMDT(;CW>8Z5M]QH\ LQ\-P+7M(>B$#
M*(AE$\ 0R77%<L)65 W&NKO#8A[3F ]Y^5[$NHSE[F,!T7BC,NC5>_#=&4.!
M9./9I>2I<H)NCL_IIVA6/)>IOM+)4\?X&KK-3EQD6;WI4W5BG:,B(Y=K#HS&
MBXKNC9-5HM/8@AY/$3,11MA0\>@#KH*M!TG$?/L+?Y0!%(F8!5:E]-B'J!&-
MDX7PQW#DD, &PR<VD5U#>D6 @DA8C852I 0E1( 3A>2P%0]]HAIQWV9D,>;B
M2$#,9^89])E"C3KTTQ/DW@4"_L'V?HSF[QD+>#$2A<NI11Q0FB!+L:OTA,Y(
MGDB==4X"L1)UJ8HD\5!6KA+UHK6D DORF5 3_SF/0>EN*E8K1^C4^IO@I.A=
ML?LC8YV34LF2>*T\[(;G7ESE>:_R/>.YR\(^WA9A'[  [XJPCT(FR$[>T_E@
MG&7,)2-4Z9FB1J@$:L%L:A\D94] QHFD5>*X+-;'F(R "22'S2-5%F?EUW!]
MBRJ"$\-E6R.TJE),&2.()6]+Y=YRNJATN&!QOU%^5AR[5 CT%W^3X\ DQ+)1
M4[\CUYPA^ER*>LM7:L;(.6^,W#YD51.9@F^$Z\&*3 6<62=1=SW[T09&I' =
M12MJ'/C%LH[+QB4+%&(!\=;$?7;( R<A)7$>?,/".$Z62_9Z?0*K[S_8 K,E
MQ8VTQ,@?%W32E.^5<@5?WO&!*C?4P'('PI:9C(\@L@CU-RP1-\$TP#MS>@XR
MU R!\B)RIZ1NV'G<,1CP/4%OSD' (:=?Y*+5A10:8X2;)U>?I)8]NV!WFH']
MO?_^DR_B6A'4JS!R;OQ^4,AK(E6*=(N2T#KH$"DNI:H="SMA*K;M03K4*RF!
MEH[:+8[1HD.7DAFL,,+<[<_UP^9:CR7=?9PW&D)!JB-F*+)71D+U="1F,6O^
MC2+6(TN.%8,XCD,C:P89KA0;-;FDC00(9#PQAMPS_,8/!*IAK#QUB1<)-;FJ
M(<XAE7CV.I)SIOMM"4)L#GZO2KJG)A&):=$<$NC.T+XKL)W_4+295))%G,+8
MME6PW'VB>+8N-]#D992_[49U;881=:9LW=KKDDO'+BWN:2ZDZU)4#QSZ"[7#
MEMQ.:D$#_8X;9F*Z+<(#N 3'JV' +IP$;9E(^*,]B$IJ9:ZJ%-B6[%,I*_Y#
MEA3FNLF/OM8J]159.IYEUXK[?X/QB+. "YG-9;"7 K2F'$0M$T@Q4040$4FT
M?1OH3QPFPH\1?CD5O(:=K C=$G((!YY$9=XI.DR=AXCR,$ 7CNQ,V:U2"%>=
M;FL&^K5%Y4=)YF;(946VX1B>(\*X!KX<H5 ,8X%0HL8)_-V6);0RSH1@#@_H
M8UP\'SG/!GM:U&1M#>\_^X*GZ"X_/D\.1(A/M)1V#6V+U>:J(+!QOGJ8?FTS
MITU;D\S-ETL5W^S$X#:Y8!05JF3#A='KSC$QM-A-D7D>IM8WFU81M$ZLBP-Z
MKR4KI&A1I6,1K[G0L*RL@ .1 /)+8,R'.E4N8-)&ZA\9:[T!&0YBO$ ,6X0R
MVW_;+_9/58>-@>VZ\!P#L?_QJO**?I\@F8G?UY[!HS.<WN.KE==_&,(@.P Q
MP)J$,"#YTZN?4N<ZI=*S&G"E?.9X\6N-X*2SZD/_8"7JY4.I+HR%RW+3$S2]
M83<5?&?+Q:L/G,/4>MP;FG!J/>[D)#<Y'V>DQR_'8N26Q=(=2,L:R!QDU+,"
MCTUZTN7&-U;BM=&,FJ/ 9+B:7?N.KGGKP7)<"145V3W#V6B$^$[>5,50'DIK
MUWHXA#8" )'6*?UM>#=0+";F$(6"8RZ=<E2?8V8+Z&A5NTP;*7F.T;*LXH4T
MMU140R$*/!W:$S]T)+J:4>>TIX"3DWH!$ $](^=KLUPK"TCQ:<A1^&B7Y@H8
M&DP%S^(()M"?!:%,"Y^B[<!W/$T-8(5&:GE:T"S;J_-1 U;DV/M2[@7W+[A_
M#N[_:[/_]/IPRV%-%F3U1;TGDFMU U.*BPG96'II+5G*4!;SUHM[ZV7\]IX/
M[;01@F*RI1>K\$!LNA;/#5"V-44_L[[*SONRP3'8$K-EX 1P,:/\,Y!NPIQ9
MQHSM*K%GQJH_+1E.#X7"3#9_),2V16E-2F59,+91<6E4?6-^BSTS#2Z+O3DO
M8F]@ 8XK1?!-P=HR G*U6W\$S"/,P$ 3=5$Y@H M3TFVTF6/"2_"\?G!O0)W
MB!50C<=5+A2<3?KO%N('=3E%&-D#>]$^F&QH-1=.))XDPE">.?DD,;,?SSQ1
MX3"+H?N'):$I0X]( S@S$1$$XU%!*N2XP+]1[G-LWOJ-4J)BE5'L/NG5=Y0,
MB$V*BAK:K98D 0IMC66 6[H6'QE%(^D79[1H]><E3*F%&HN$259.CA(CQ'4;
M[2-,YP8D7A=_@(OR4%!$+!Q-YD+F#","R=QC\PI?^[8]38DMB@5!T6ZE%WG%
M4B.!S6'8;":(C/#1NN7 *UQ5ZWI9HC"=@Z$=*-L%/<V 5DS;_!S)Q&2O7V]8
ML'H6AY[I;$'+6],AL$/C#@N8X@_5X\IK/B!4.U78A#1;V$^S#<%ZLLX%2^Y0
MS5<XU7UBSQQ_J%OIE)]A\7CE6W,56IEON3DRD(MCV/L6S[W35W9+Y'PK7EQ*
M<EM>]5)>'2'I'\[#5[7HC36YIN)<?HP 52+0#_#3'^);5 %:6:/U"WMA91:/
MD%@36?A<^^.])8I.8*=ZQNPDB)+T8"UL3T24Z" \R7UF1S;Q42XI$0]S4QPA
MSF-_K%>.KAV#AAC7(#7+$*<@Q3L=6)Z = Y]0E#UV?/@*K#>M:0SHAI+5.12
MNY1:EXNR0#,0!7[,<:*S7Q1Q&&LB#B2$?Y=@01$9Q*IFK*IK*B!34ZJ:(JBJ
M:C-1,4/#3^7RM"@,S$(] ("JJ;/R)P!IF*! 1D2G<YHJ@'<FARPM%TKPIM3"
MFC.L#IJA(5XK7L/.3500U4T5ZE@3>!Q0,UYS+,058#D;-WFU)D)R3%J\VI*'
MJ-.7U]"%QQ./EF;H\F4O&78N@3608+FHGLC "P7"]9_9\$ZOZY06M)LDZ9CX
M#.P(CP\I4H%]IVAY0=5B):\[ZP_NK0D*D#?J(/N8M5&/$..BU1 !)B!7HLSY
M(Q=H[+[4G0242RF4+#%!V&P/81024='J4&DEZE;O7TIIMU2^C*UEY,FORZ=7
M<^4U.7'!)#;I<[B.=KEP.FPZ59[8PX/@:'C(M3-%I16B-(4 +ED6I683E?LS
M@FL\[MDKJ;"/"&*":SW)7Q<BQY\8TR_!9X4.HL2'1 :<4D9&R0H7T$8\L%JH
MZA9B09"S$8Z_P]4C!X0NCQHU\A !IL<P6HGT=A%&H88L2_U)$\2JQ(FXRIZ-
MDA;#X,@-CQ;CF0(RJ82YB=KSV)2D8*;RK5,EX@-\1PB?VH$5HT"V'(4*,U=6
MQHTH/ ?6*X<0K?-S@E=,Y<@,ECB2!M>L75I/(B\E(#'18H**!U^ZOJ>;.25]
MIY*NA_%' 74\(9\WEI 4J[V,J%+2$!4T['HG=P]3X'>;EXZTFD#/QD37XW=P
MX,0169+.E-,TFID$E6836>!W22/)1I ?Y2&A;=#YF8-B9=Q2R;)P+.X-SA;%
M!.*MH!_@?&8AGF0ZZUN40[4(PJ6L3@2,2XQ###Y<F-U*_Y8:H>9Z4GM36FZP
MHDA-MO,KNA)$%X5$RC'CQ-)(+!])I8UN!5PHQO7,5R)$2M6 [-?ZRLEEU3&T
MYK&X)HR]8# 3VK"IXVYCFQ$@)D+XU.APW74LX<62 WR61)(X^/!NB"1[=B,M
M"PQY5P2&8&#(<1$84HA,F;H]F9T-\SL7[ :^2J4\"C5_H^M<8Y.X$!;B-X#K
ML/:21\1A13"J-V(T8@ @4M2B,H0/]G =BZU>'E$FD!G3P)*5"&(=2Q"3Z %C
MEL3K.4J,V#V[4G::DC "&"ON%0=TH\N*:\I*RCW)J60%@'/*;@$X I1#2HYT
MNR1M3^J/TD*S^J3-_1D609>9RHX,(PNH].( WD'!<Q[S)-+8+JTHMU;5<!0M
MT+D/$YY"],R1'X/20Y7;D!P[8U1FN4O0)/R!8ZGT)TNO?)E_7L*?O]&,TZUO
M^A[2*06I!]_L*6XC,&BD#?;7]<@-1']B/TWN J'J1G*\D4NR(5G<6" @=Y R
MLF$"N@AX)\ANT.V&PBZ+19A<+><DG\;)ZLS($HX[6>L4!G/OW FCH,LH.5A)
M98G+*6^WXB#C8:=X#6_J(JR<7+O\957WBF[VD]19R4>BBNB\+C>MQ"9?#F(U
M)K,^2$#K[R*6H49008$U5R*K^+:DM8\2#V@HP4144)_ _U UY1BI+Q+)&'\P
M*7!%]::4S(7 P4+N6BLS1<3QX/P8TXZ+QJA895MH"&7C ]]^^47+J,W8>O#P
MR,O^")V@%62,5=30P"]C"'S8U3OA9RC!G[\QK =M<M[+J6R (@SWW"R@?!T,
M6J+*)])93C$RKBQAF#EQ@G?AGF$<5"EMOC@#6DL.VXJ<\XHF5Z\7 \ PC].]
M_@6[V3Z[T8J:Q._5U# ,$5.Q>DOC(2 1E(B,!!=!*)@&MBSVBA LM=^UHN3B
M!DY4(&=H3ON[-9ZX=DE&?L5 2Q.(V4KN0TONR'<=!F7'B"W!;?N4JC8;* CL
MQ32'7&=R$1<^.NE1<@4&\.<O2,X.:=J4T!_3>=4"$7.PB1AN_2 END<;M;P7
M.,;6Q[ X-R]+S(J,Q1$\4! EIZ$(EBR[0!RH!^'J1.Z%%X+R]^AA4UY"BF=.
M)[<LM,3:2!%+E8$@>"$A9UG3-1:NYF+1O;M[C.-ROMEX-R-:C3-QIOXL5#0D
M&6(V"0J_QH 4I#@7U4-?8ZXD\4VT^>MLNJ)8LO=KBT@R=,%TM\]TNS.TQ\LT
M'>2[962\Q'?SQQI:!J(_2R:R<*[R-R;\)_%@D4678(82(FI-)K"H15QX+(K!
M\D2(MSJ2%+2MO*Z:-S%62B_G0.)EGNI&;<;Q"AT\XFKB)?F"N>J%JY1G'U.>
M_9GR[";E65-;_;QY/L248M<&%8\H#NF6A_P7G-(Z2Q@=2R @+TA'#L9TV]^X
MRFY<'LE?R;OF)64965!5E G)VY2X03@W:3;@<"(\5\/ >B381M>.+DF&VH:[
M-,\0N<4HE(3;M-25$Q\_A][SI1@51QN"N(1 =9RKY<?4A-CEN*[0DEQZ!:=O
M8]D=SV+P_#&\?<=WO;0\HN:XMC6S_'6OZ'@/CQZ<O L]?"A#+:%RPSF22@U"
M7@X\/6<0KB<4EJDJ-U<=DG*C2 WY9AL+T/J%A6P7A@S4T9"66;JWX^2QFDN"
M9*%'Q: 8Q4&;J G\)9.KL9#/5-J:%DQ67\MLBB8>PE\+DHI1DLW9H@^H^.(?
M@/^Y0M31#,V"!\[1S1_&;-K\B!+7(M,,>3@"J1_ENQE$]B%!<,H9QKATI'98
M4G-)55SR7!8J,1M5(BS1$3.D(^^%,6Q@0KB1:=H<RXB)&*-\32:43]BN]?1;
M)\B432E/.TV7M:9RNVGP!0-Y!LE.U5$F#E(;8C>D;L292=Q(D-_'$X.3MJCU
MD,L/R(;4UZ\IF-WR/(3/8&8CS>+Z:YP7&.H&&G$C#:5,DT_5&SE!.!62)452
MI)Q.::FGXFQH]ENSW@.>))DD80GP;T'B\15E1H2O#ZQ9:.L2(;OSUK&"";:U
M$?DL%1(O%JZV&*SV4\/^WE:*L#\,^ZL687_[0<M/7KC,,:<1VX:#D+@Q9_B/
M5Y/_K53.7\E@I-MRMVQ<FA=FIW9M-)KUUHUI]&K_-NJM9M?\UZW9K)M=HW5I
M]#Z:\)]+L]-H7A6Q3)N]U7N^[M_<K):^3VO[#(3_3A%^W>ST:HVF8=ZTKUM?
M3-/X8#;-RT;/:%_7FD:M>6$T.C4Z!@T\'+T&_%00?D'X^TGXQY6(XS>!GC]W
M&KV"DQ<$O;\$?:P(^MJ\ MGEIM;KF9V"16^6HNL"09EPR@Q9W% &4TS0=DU>
MGO[<^ P/OSFV<6D%@?%_K?'D#^/*<EV+K%S7UVT,T9AYH:W2]"0N83(]FX(M
M1J D:]7<<ACOTH>:VC[5?14=).9"N:(RR" 6*093U$(#5\V6K&::#83L"NY<
MY.])8&HY2IBE#B:CBG9,'$_XQC\)1$IH^L6F9VR%JUPVFK5FO0$<I-NK]<P;
ML]DKF,BFK\5DW-#,LV9#JN$R<CS+H^P(Q'F*8,LH3"JJIQDZWZ4=D8MA_W/F
MV;P4)Y624:U4H[,F\C7(F6Q)#O.?F9=@,4M'$(,'$"GE31^MC!16-_5E!D6$
MW>1Y,X+EPE@\G<5%0%;(J*0U4L4Q.>' XJHZ8F87]L!&:$,QN^/X[,I?R;PK
M!V]QKROG\-3NC+_D[*,M"^VQLVZ_:^S?5S+VHD\JP-KE GPK<D<X'BTN\' -
M7*^KBE^4EF73J+WLUAIEH\WY[^G)W&*& >\G+8,V<7[\5<3 J%R'=&HF_PFG
MMX]\?^K%Z$A&1,4FC'/DF*.ASX6@_&#,. ]30B!XZOQEO"=,?[\8W#(#\G%A
M0$8#\DEA0-X- NW,7/M(#EU?:ZVXU:OW*:1*"[Y IZET?!S]71^@/CY<4_&O
MOJ:QT6U@8:-M+!K["8UM440^%2(RVOZO:A_,Z^N&8?[KMM'[8O0ZM]T>^@O*
M+UE6WHI"$LE>K-D6"[RM!7Z]:%9(-3!@-'.Q"QO>A8,,1*C?M#U08(F'+VOY
M%RZ(/,*%D-&PTN/?*(Y'B6U4B%(^$S)(]6RE"/)+BAA;I.RJH.QVI]5MF_7>
M;=?HWK;;UV13VC\"+FCNI<E[DC7S://\JV5:5BO5D_TC\F)TQ>AVE;FN82TX
M7F$MJ.X,6_V9=L+J;MH)\QC%"H/=3C&(+;O,_L!"]W[P-RSRPA:8>T)[0IJ*
M$.:S/ "J3"36A[*GMH[2Q+D[PY1\-)DP$MIZ@DL$X!O8=YA5QOTK[X8Q<EP)
M1<9^>O4I]JI@*K'VBL-EC["@%R52.@\VCF/5-"R/G?5Z5DM\D!;GL](LX,@.
M'$YCQ8_(V]Z?S1<_$K#Q-!.$#A<(.=P58N!;KBJXJ<K %-:N#<J:"U3>O?WP
M3]";C%[+J+=N0''"H,N2<5'KF1?&BQ8UXQM!NM4F!WQ)A[@]"Q"'BIS7>.WS
M-$ZKIP?]PP.U_(=_[P?&[^\[.COH*G;0],O&R<G)D7J]V*/-&18*._RSXK8^
MBQUGZQ,YZ/GZ_3JD^(($,SU\J82S90=.!YD Q_HDO3H8<U+G>@&%?V$;N]"=
M]:."GF(CX&*K#0A>X9?9A1=NI=T?(M\":T<=[LKJ@T[D&":0]70N:IPWO$$Y
M5E],1K95C_\HR6>/=O+)3&%2 \,2S_Q9(,N025P?JI"CGZZ 3Y?>(1\X]266
M%)T%L0(I,A!2_TH>12U04F]B,@M G00USE(X#5JIGECUE0/;P@(\:0W+.:+6
M" J(RYJHP*=-^T"-8<]"YG:>=B40%59%1H019^0@Y-C 19S,(YN,$Q[P"@%M
MOE#PE4T2=A##H&Q$[]7%>S5&A</:K26J(SOF&%2=]&1A5[77RD*B5>!B('9M
M)#Y5S$6P (=1$@;WC@V_N532R0[&QEW@/T[OB3Y%->G^7(-NXC8=+LED:3B>
M\('-1SH&-^*%$O<V3O +-:DPVP)A6Z9.GRO#2EA<RB*(VN0HTT<K""P5JZHN
M2W7@J-!4]!&B6#%D#&X>//>]8=;*8#THW!MA$!48"?@%'>$PB=$I<$80XM>V
MX(?SRFL9GZO@7!P:'BZF ).$Q5M8K90=U,9G#1^<$(8%,Y L%%^%X5Q?UV.4
MH1%4C3\J^,%V^$&,Z:8@46-K7_S@FY&H@7,@=JKYI6NJ^R+B".%\W/==N9V@
M0)?E%=#RDIH0[[R+A"=KJ1!*R230JG3%QRG?L[\?\:UWR"1-C7"<.$S!LP7R
MJ:#BJ ZHJE&M-_H(;$JK&BK#UN-MHHDR%' CL?;B;<G5@]5)M%L0\.:&'"D4
M*.F(P+(KH\Z5[?"*2$24Q9B,>C^9UQ;5@,5FS\J5BHI:^[AFXQ\S&^?2#LGV
M_URS_3^7M!]P;2+M+",U+CFCT-9529[3V../N@ 7^\N?\B]1)4,LS;)XRM,.
MJ':8POAIRMR;DI&YLESW)6M=XD<270^_:2/4?\9F]-\3,XLH+0$9N][.9>'-
M1L0G7LS"G<UN.NN+J.G3,FB<LH.;I2./-WVSV!JMUYG>8'.-!IMI#8KTG(AZ
M+:%BJ (+!1/=V)!K:=6,I)I SD"LE :'E.I5"\!X"0H+$M]G&ZM%T(M8/\*F
M^DTQ'.(T65#)JE%FLQ#DAV40.%0%*$HG7.)W5;5G,Y*O1!FJH3U@='=9L)BR
M"4GJ%3-."$*4/T;YP@Z7I1C-IC@Y%33+HN[3!@62.#<]1D9HT;)'CF:KCZ7B
ML0S5#2QY@)EMM)RJ_FIFGEXI46(\GER7(WWQ+RX%NRQ-4S!(3L)+&[:L'>+W
M<8[82N"/\3D680#:P<&=5RI'TJMR<%JM'IV<G9T>HLI$+^?S:JN9*99BUA4/
M>;3[(<S!.+B?3B=_^_WWQ\?',N@IY3O_X9"+/F@&C=@T@!@U^#IAQ8SJD4VM
M@8:PC7CEMFM/[GW/1OTI>V+OCD^/WE6/C\XJ;T$CA@?P*::Y3VV/\&<)Z-$W
MEMJ72G"OX@J(S3?J9,0M&9TY;+V2U(\K9^>5HV/H?<_8Y+(XHA/0',CR%?X-
M^^D*<(&=#"YZ<A)BYVE)B$4.8G&W9_ID&CID>4*+O@^H(HG@<7 ?^BY>R!(I
M@V#/]3N%<=!E7C4AE+HV8V@/E:TMG 8@?<X"*JUE<9FJH8V6ZWZ4N2\YMJS2
M" ,"O@JS@*$.F.-W).@ZOB^&V!(((E+I" 4;Z-NPH)Z .45:-CI'Q^?\<9;H
M4'CO-U\G^6.M8WYL75^8G:[Q^6/+N&@9S5;/N+R]OOYBF/\V._4&:%^]CV:C
M8W0:5Q][7>.F]J5DU'H$=AA%("7A#^'F^]PT:D;WIG9];7:,=J?5;G7P38)0
M[)D=DV(RZ*/+V^8%_%!K&@UJ)>KZ(M9WV:AUH4WX]/:ZE^S1^-*ZQ<'!MVUX
M@*",1O?V0[=7:_80N>2B<7U+(_VKU3%J]7J'QOU5-E.[NNJ85[6>:33-'O33
MA7\_U:YOL0-LNH.3O8'/:<VZQH79-IL7V.]M&YY^_FA"*QTU'2'K=!=:@['%
M6C(:,*4/K4\FC0L$D=;GK]0*CKW>:;1IS.U. Z;3XN6""388;(_"OHISL?%S
M\5>M^26QWXUN]Q;(,84 Q;E0=/BY<7U-I^@#_,VLMSH7M$VRH<M6"I7\Z[;6
M@3,!A^ZBT>UU&A^85'LM;*1=:US@WB?-L(B_J'=F J'WKO',M+!CL_$)J:C^
M,=8FXJT5Y+)9<FF:#77X0:>!_0 . Q1$8$GXY!:1!&'OD:2 D'!K/R(EM8$M
M?H(-@_=AC]2OT$XW]AW^W03ZN&DTX<_$)(%MI,9>(3_I=6Y['X&'XW>"19ME
M&E''; ,-PFLU25_,QIN]3JWSA7B1 4P'^@&.B13=[!;\90O\I=G2MQ<NGMOK
M6J\%.U"#G6MU,&H1[L9ZK5F[J!&I ,^'C<,+$6[)5KO1Q.V#>^.VMT@MA,M*
MA(#O\B92O/!UK7%CM)!4/\/=6F8J2N5;-[4+$T> -(-$V<#;%/B=&!'<=GAS
M41_X11M)LX<1R!^^&->US_O(9*;D]!V (C]!2X-W]X]7E5?T.[PWD+^O/0.A
MVV(0A?7_L_>NS6T;:9OP][?J_0\H;[(E;5$<2;82.\FXBJ8HFT]D20]))9-U
MN;9 $I0P!@$.0$CF_OJ]3]WHQH&D%$H697R8C"4!C3[>?1^O:Y9 ']2_="X1
MURZA4?7;/%8?H*CTR W4/F2+[H6RO>;CJ@?!%K1W,&8T96.>CXM-Y)_^U:GZ
M>FDK,""<R7^^.'RQU* W$J+*VY>ENO4XX6H8!>-'R(&[\&*VKZPM6S9/]^QU
M]0(\R_D<4,[!SL'NO>=3SI\>[@%Z-NXZR?"?>+U#!6<4IO,*3.MPO"?5%O'5
M<.=P_U7C\.7KQN'1T6[)P:.O(RDB2H*]_>;!X9$?9IWG1$+]Z])C*@+@YY]^
M+!N,E9RI^3)R'H'(1LSSOGKQR$^8SPXM\'5/O))%/RX7%?JQL@YO;AO]L'3?
M2"?>_/C %1]*WUZG,^4S\GG%._5D;WRR_]ZY__/:GWL/<]B+';Y4R+F40>,G
M"/TKZ64C'319\P3?[8:G15_UX+=9XI6'Z+D/=!LNKF+?+X3NK*$"N-[7F1<F
M.$LFDO7.X>[#[.?'$H=/=]_<]X#4,Y>=N'^0$;@-UNH=L#$>N5;E@>QH*QZ+
M@BD?C\7?W<6B+@@R[>JI4CO@$R^6*R;[31::#WG*R+):<Y<_@/?JG9NH%*]C
MSPW >/Y(]0>Q@A7@K(R)1];*#S9.G6F\-,U1..O<>EN[8H??=,4("OWJ*O:(
M'EO=RRI0JSD>=KRO*FR<KJ68<MX?QJJG*KP\-),T!;="/:# X+$:0NH2IMAN
M;IM,J PCZZ,1]" Z3-YS4]ES"CI=PLUJ,$8D.TDI<0U[%WO^=)C&">=\#1=:
M+6G"W.D0M\5-W<*2#RZN251&?,6^W9Z[XTE[Q\MK''!'C+)-ADF&"UK\L1=@
M6125!@VCZ,L>K%2\8"AXE2Z!RWSLS:+$GT>Q2L]2=4],><^Y<+D &_&G9G@G
MN)>_SJDJJE&6@?C-NKE=?O8G7A(]4)R[2W-1<#,4EV';0A[+\O=>U:EZ, $U
MW^SS$!4/$\:UTMX#%-+T'Y+D9HJRI(^CWAPO)6WY&XGS!EH9YIU3>G\ZOXYB
MZ#+FD"\PX1G+59EWCY+^"9%L[$^H U9.N]&:%!5,W2_XP=5 8X(9]F_X.1G[
MPB>T+G2864F@*A2F7E:=4#ZK?VOBJ#YW!-U'H:](E19R!]C,-6O<"RL^5E:<
M-$P3&$4"?\O2]W7I+[V0!LP8%,%$N<S&@]^92;/,R'[MWFCH.@=:'.&T10GW
MFJJ15_5;4CTKNYZ& 723)^46>>1]Z.0(]W'#Q%#(5Z3!J[G?9'@)9GV:QEK@
M([%&<KV;$<*I,R5[MWJ<01)EE@@5+&&U-8SJ-N3SR&L.,YW /&_AI?[4]:O6
MNU-.)3D_&WSO/'(/D]!0MO&W;Y8S/Z+I-\S[%>\\ L-%N"0Y9QWOX9V2<=:.
MMZAXZ_Z/%1K,6A'CY8_=-YUD12P8MA[HEKS3U@QDE4]C/@'DY:PD)^D><_O0
M&J'K7,/5]<\7_R/^/_O[!R_>MEN4<HN9E6?G \S@QA3S'F6-GYSW_H1_[IV>
MG_^./YO$FN[RO)F2Z5F^WNLFVM \/VB<IK?WRAS:=[Y%#E^\[5]^_(C[0W+)
M,<>W7Y%8_KSWQ5&]+_2^>/GB[7$G*_Z [?!=;877]5;06^'5BTQC/NE(<C=6
M.)WU.\_\ICCXJ=X'>A\<O7A[V:==<-$[;W<ZQ\]]\7^N%U\O_D^H2EYT!ZW3
M[O^FPIUGOO;U!9"M_<\OWG+Q9Z]U]EX<)T9=8KT3OIN=\!JLA8M.&VN9V[#V
MK388"]T^F)6L%,"_?_\^38=ZEQB[Y TH"LU^$Y3%XTZ/:NU!7H!AV?H7>ES[
MG?^^Q,KX?KYZ_GGOD,/]>H>H'7*P#]:E663>ZM'5\AWXG@X/-K,-2I;KKBM>
M^J&'6O&#%V]/.^]!&'QL#>#2J%[E>ZWD0R_:8?FB?8_Y=@\<+]KF(-%&D\W+
M\LC_;B'-^G?'RA!0=KI=#C182!#D4.8COJ8$7[O\<ZTQK!<M>E60P8\WP6M,
MJNV:)X BV^NVD<OQ3O-9,HD'^T][%E^^>'O2/6N=D='R 6R24[)+GM(,'C[M
M&7Q5X?=[&I/W^FE/WM&+MPIIJ9ZUM6?MIQ=ONV=_=/H#@A,Z)[K)[A\2>K@X
M/^VVNT]+"#[Q^?P9M-AN_W?GI-4>G/=X&K4C!TSR+AKJ:(G5D[K^I+Y^\?;#
M^9\9>N#'UEGK/4(IP4S7T[CV-+YY\99GCL_ZB?,4Y>6;)SV'Z$]!:,L3D(SG
MSJ#7.NO#07]BQ_GP::O;Z*$X[OX!DO#LF 6DZ:&J)W+]B02[!9$J6PJO36)%
M@_/V4Q*+AT=/>Q;!;FE=#LX_PK7<=M3&='H=0R_"3?K'^>GEV0!MQ':K_\&Y
MN.RU/[1 6[\X;3VM3?O$I_M5(=^)4"DYY%UOWCO.)E@]"'F\-VC]WCG_@[&7
M_^@BZ&C?O.$U]NQ[?.@,<U"/S]N71AC@2<SVRR<^VYB;<7K>[QSOH8@@711N
MKLOVX++7>4K3^,25*#22.EJ /MV;ZZG/XVLT-JW8_U,ZS*^>MK_R ,RA'%Y[
M/7GK3MXAV$&GW8]=@99&</INKT,N#[EJ2&>";=EM=[+?G79;[[JGW<'=(A8/
M/-,'3WNF#S I^%]&)F ]:VO,&IA&[4NX3XZ[K;,&&^H@(9W6>Z7.:T4?C,]W
ME[T^JD3TUZ<TR4];'3H$RPFM'[S!31.^GL&U9_!5:;+&TYBZGY_VU!UAY(*)
M6?!,]SKO80MV>IUC,,W?G8(IWVJWS\%BI_J[;N]C/;5K3RV8.:WCXZXF\#DY
M[WU\<A?0$Y_#GW%[ML][%^?"WO,."3G@#L*,S.<]C_>=LM>4_?Y'JXTT%#!Y
MW8O33G]YG&)3.6RO\J$;G7#VQ'.BEJ$Z'=6H3C !+VM4ISH=LBH=DAOSQ_]\
M(57\TO_[%O-O6TKEDP;=JD;V:2S%>%*P3'U%BXQP2JVQ)A3N&KA2%D%[JZL9
MBA4)M/P)7KAUX_%>$$6$C)4Q+BN@4&0MKGA$<2[[>'_Z$Y^AA_##MR"*$_6-
MJ;O(8R<A^7;^=WZ(L)3YWS(89>&W L>:_SV.S@_3PN]G 2Q+[G<N/#KR9V8K
M.,&)#XOJQK 'XFDVY2'BSB*Q/,QXDHZN^<]-6#KX=_4D$J85S-#:*%^)<XMX
M9&ZR L?*A+J"Y6TZ[VCB_=@)769!14;I)1T3VE4A5V4";F%@10 TIMMVX5.P
MKQ1XUX@0S1AJS9D*2WBP4.S9"-.% _6FLT#APF'_ENPQ.")(Y H]A4]%<<(8
M:?P=XP,N?'$$NSV-\UUR!9%MYL6T]\.1IS"!D>1\ C=_1&N60;O=>L2TS4>-
M&6G@F[?7/JPD?B%A)%3BAR=H+37/LW08^".4$U\\ 1)FF"W5>0093I.$5QF;
M@E[YT1C>F?A(0)XP5AVM6:?]W2*>/H!$;06P_1!^%A9WZ 4^[*H,;H]%B$#.
MP0^PNL8:+3DCN+E 74I N(+.W+C'<9C%T;\92Q=Q;PD&<(T/,Z+>),6#7 :G
M1UNO%%&O84H0! "L_D@C#RPM3/=T[NV_^.$U8RM6"@L2B6ZBL/K@' 114N!=
M1FYEYT0."[:BB9BAZW")R"#R-,MRGI=)P@T1.R\5SDVGM5RD;@0@4Z# *^$+
MJ6DE]GD-IRBC7#VV-? =U_@(MY[0<R,W\>0F:SJ=KR,/CC[B0>,NCL*K"%^/
M0#9>R1DCY'46_=Z8Q+LA?@/W%KX YW0<$3BF7/NT1O!;>G?N?H$K-S(:)0*6
M=$9C6[JO&?-SK55:NA!K:F*MKD!F$Q;C6)U].#[N!.X9-P:C%*7 7/:R )?2
MENCS[UC<'O[<4@O8SR:K-2(=[^#-RY>T&F "(G*WK=U9CRM%K[Y=-M?E=AJC
M^ /1_B6,;IFAODQC&;EIXN5O"=BW%5<$'A_K;A)$SX8S3!GV'\]' /HH@['S
MEM3*1@6Y_0,)V8)BNB&1:WV_6O3^"9(AOF+ 7R)!N/%A^48P29,4)Y0O'FDL
M(>GD.E.D<!I[<-P#;ZRT,V.PL>H?FLKA#1@5C(H>%H'QM^PX+?.>_51[SV "
M7M7>LV<A[A_!>W:HO6=WPCG<-I?9TX*J7?<#)< &Z_?M_O@6Y0S39N'SX<\_
M;AITFCQ2<G?1/;J2G%CZ\G)%1?0=9RP/&K&4%GA_H].042S-8S=,8 YHUR8F
MRS"%OIP=-].(X&?M "6_#CHMP1I'A1V9FERP7LGM@[,[XGL_F4=P <IL,^TC
M/H=X[=*NJ2!8+D3<U H=OV$J2Y9*H7MT#>+;L-_(=,8?%*2^(F.(/3 IQV3?
M-94ZE>?K88>5O&"16&D-C"8 M-#H5@_5)%]&2@2>S2'944X(BV.3!!F3TLP^
M4OT0]3)*YV"%A7BP9+ %HJ*L*;.K1$'TG]2/>82S-!Y=HT&*5! 6%9OSJ06J
M'6S&O21'.GT#"B#<C:HYHF] O/]/AI.#%4+<.=+S=Q%8D/C#,7R:U6EK-QCK
M2H_J]83&/-3:0S16B2ZBND_-SY_7FL'<KO4GY-^U-@%Q9B/[Q"<C)&"W6&QE
M1?>8+DJU_-ED&/O-MP523K__[1_^6QU"^ 32JP56N]T;Z06:M6(MY=K2K&[4
M;S2&AM8I4*Y:Q9^&,R49F8GSG]2-03, VV!L<J$QI]7,]8G^+[<%V0EA? SC
M&O. -QY\V,,( /FZS#:)7N'S2B+ ;;W1RJ^.1[Y/K$X\K]G=J([08C;"U@W8
MO'0SXMFXB'W0(Q=@4&=GO%)U>/2%W6 48#:+HZ\4&(1C_T/N^IL)N?-2(4,"
M9IR.LNA5%=6D1;=XR3>VXH]>0;+X''9M+1.V1B8,\ I[CN?=E&?J.,-%W1J1
MMFBH44KO0)6^/I/UF?SV9]+:NA>8A/ <#VC!H)-T&&U28.:%*TD8RXFV[9!7
M8?9TV.N>)DHM%6JI\.VE0H]MVV-08)^C.,AY=<3^AQM;^9[@G(IY;_@^M$6?
M8ZI>[C#+6_:F^#"FN98;M=S8?KEQEDZ'2$@[45NU2T?K.<J0G$KQ*?E<\&J&
MBIX6)X1\^Y8B8;I5BT[II1YX0W#4 J,6&,](8/2,",N%BK"<YR(LSU&>M$3Y
M,.8"C10=92H/SJ#8,>4(11&AIXMB#,L(S* 7,LS// <D,EW(-<-Q=Q1*F0\S
M2BE/,)VIT%;HH=8T+WX?NAU2D.3&3WST& \79N"PEG*UE-M6*7>.@<V\KX #
MF\]1E'WZD)E1=[*5\E)DIV@G<4MBIV6Y%->1P_F72LJ986D_].><[II)-_C4
ME./51F1UF*H$3JO;#4Z:EUO)U?5D,PEG%>/6' _6N1B4FGOK22*M$ND4V>'"
M'>FH,C^E7B1QIYY3=#$UG2ZHDR&5F:SJ @W154$X+L:BN#%F,H 8SHS@ZRB,
M8M9:<2;I(YSL(0].*(%\Q>>\KQAW4A5-*[J6=8LR?G6H<.6;JL^8/#*BPH99
M'#FQ.W<=%Y;M2A;1VA&H65?M(]H_YM>@[2&MD&S*PF45Q?Z5'Y;M*8G6<4Y*
M;O>/1+>!'9"D;JC3/98E/N1*8'#(E!W<K*^V^FK[QE=;+G_SN5Q?W=!Q)7.I
MH9+P43N=9Z5\EC\00P2<M1=Z6#J;P']OW"#UE"#W0NU(M,4YE64Z.UD)Q= +
MHMM=RG;Z#Q9OP(D'L1O@_0C?#DN:P!NAH?M$_?5!0"51P/5OL<?C0&-B[&&U
M,%RW5$R'<DL/M)"BY6-U'XK3E,N[68/7"OF/:D")E4.5EVQ*E)O"K>HZ33PL
M+%PF^'4>5_^:ZERTV5,RL"2"RQ.K+^"J4%U=^0&:R$7)_1*A:<)WR])+!-J<
M^G-ZH_ )=9.B+;.J(]MRQ8$IUD1[Z[,#_U)9@.J:DZ.333M7+--6)$7(C57E
MNWIV688B?J?BTBME+WLB92X_UV4N, %'WTN92UTHL64*T4,52BQ1CIY8501_
MD#[ZI,M?SZ(YXE;H0 E9C4.X,AI&GORUU(IS"KUH0^X0I&HZ-S6B.V7',UZ&
MBN:@'N3Y9+AK4S5&\+-U['%$=E$7XN?JY_P)=!QKQ*E4-L$?Q$'+%^40?:A8
MLD[.5-,%C'6^H(A$[.;E2<$;=XJU[*3 *FW)90R'.16RSV'N&S3.*)WC.+#B
M(IIC0@RTF'-08,T]CA\6B_5"1H'!JF&U,)G_>>QBF3S6>:B_=;[.?"[_%3^/
MBV7$$RJ&9PVX^=D2=MNQ/TND]'9TO/OP-@Y8-%=PF<\)CT$,F?Q9@ZVVXS>]
M9F-YM8B1JD6;I=A9^$7HC+A8/M_?W4;%8;<-&4/'S0HQI#A$CB#MX*HD;G:$
M$2!%Z%'I$L^>+O.:7\>>>BT?W5CJ+\Z"&^89<6H_4.T'^I:YW5(%F1F0SS&R
MD:]>!*%DEG_>-4J91X*#5_IN #T"Z2./MZY@S?%9LZXS>_RC!_<U"=X^J/TD
M;F)'K04)(K48=4RT%AA/26"4* G/7&*4YIR+YNVX$U2-4/D@Z$ \Y:R#HYF2
MJ<NV+*E.1:?Y5.'1AH **I%U],O^OG/QT>FX"7PTI"&L2E7-J>Q9TVE(WFDR
M!VXQ\ J33-A0=Q6&JP1<1T5VC1NF%FJU4'M*0DWM9[1PJ5CSN8JTJF+4 @X$
MAC JJF&S(G>,141Q2"E?1@K^\L3[O'S)E;[6PJ$6#D]+.'SJ1X$_\AEDSSGQ
MGF7NU[+*.10'<?3%B_?&'I@Y"K/PVKTAK6B4HLQP*9P;^#>(C())J#QI*%OX
M+<>]BCU!J0['_+8\))E'7D%3R,N*8Q.)HQ7'"#A+J)RUU*BEQM.2&N@0^&Z<
M*B0E3#PM4T5PQY):03 [L2O>U5RT(</\31;3812H4Z^?D-.-*,J"U1U&!(D=
MD^4E5 )7((!"ED^NREM0\#ZF!VCLW7A!-&OH#HES6/F#\]TC'"-3/;JB%] 7
M_$YEPAZ[BR2S_O))L3@E&9K_.*6FTG#N!W9B;6Z& C#V' NUC/Z*P1GK4SE#
MKXFT"YC6,XNTNE<-5:PAR<RQ:(35:\S%F7J85@1F+WX9/L*FJ9Z]Q!A4 3VL
MELBU1*Y3'A](!',TS_+/- C?+5PT#$RB2<#":ZAX/D0X"G9" ?#/=GZ!HD:O
MP@+[-_X84QR-F+)Z2"?1F1F'=N6TX1W750 HGQ,7W?"(\2:/6(T9DIE>U:\X
M4YAI075#<#4= +2>UH)2/&@-RX76*/&A-8S^+Y'OA8!X%#<4*IX=)=715.5F
M:ZS3*_L.,CMB]T,UFN_0;BUZ:]%;B]X'Q*)@33,6":DS#D 9PJ JZDN<T(2Y
M-@(KY1:!+%FS^F1D)2W--=+Y3<*RA%*S/'^8DYLQTY"?,C1@A5 )LT-EFPB-
M6DSLO4^?^/*I14\M>FK1\R!:G[(0)TM-5J7[68:9"Q+!"_=4MI2;^(D8H<54
M0"8"TJ9>/D.LC:.<^%CED)2D @JUD"\UFI4%#AEFCY#BQ!X'52OZ'WM7:>#&
M>[>H="[M_[JF,S*6!)X9IRT)RG):IE&=6>(.D ]X7_=D3<IU-RS^KW(35$G-
MIUPI\;JNE( )^*FNE*@K)39TH]:U#X_'"-&=%!T&XDU(U&^UNP$U=4K\"3 Q
M/PP]M/?G?%4A=Q<6+5"*OS>!=QB=!=7O91>U1:[ WQ>*A02,ACG2H<YU.X86
M#W^B6)@KVGM2?JO>4L$A'!>BK4PTEX(_YO*)RY "<,0)G!!U']H,%)Z#&6Y=
MG..O3N#_I DK)G<"8@L6"&XP#,PQ>=:*.-RWOLF^5YE25U\]50F$7D]D4O&)
M7"Y+42:2"?%G)I(F;!?T-.$K7-"DBQY".]AER!/RDB8S+$W"$^!;<F\$PHP=
M N3(0&4ZE*:Q,NLJ=6,75"B/O0U3/_2GZ91D8B(N9#O*IG%(LO95XPUYC77M
MI)"9/<8L 8;U1"$T]+P0Q2DKVU*U<NOA._@STC]?*1[FI5Y@D;NH_A.4BA&[
MY&Y10B0.SYW- EA[ K.BQ ?\@K%"#6?N?O5,!F>55U4[/6JG1^WT>(A163X#
M/+-(YTE2(AHB'R]Y!D94""=F>)E8*GI)%.&N'\M9;SA#-_S2,'BSW?&-GV#I
MI' 2ZS\0$WA]Y.LC7Q_YAQC5.SB'\.=<[B%Y"6,,^S+3,/)6<SXB*BXY1B^D
M(TY#8;FGRF=&5L,3S=(#:Z4G"CYN!@^@!D;M:0A/#4=7#HM"#YL:A0ZOY.(I
MJ%HL THQ#:ME51<E%1>EY6=U0F0MH)Z(@/IM6,SS?YX9D62$>?"]*<5%&#IW
M7B /TX47RVLMT#?D@SCSK]*8R!0M[*<BHE@Q>=MF1:%P<9*D."[,ZL,"]SQI
MY(0SN&/#%-38 KI^)/8"UTC.R>KG9>1<)5=901*S=5OK3K5H^M:BZ7GJ3BB*
MNN$-'$>JN&B1PH,)*4HA2;)#[6?/B732TDKY9*;("HPJS A]RI1P3= ZA5(O
MLRT"/R4W.I7%4JV'1V#")!A \6'%*'MC-HOB>8JPO^*H]G'7^!,?\^4X#%U(
MQ*9$NSD.S$7,.PGF,HR=+8 X71MDW?PZ^174Q5M$7&=8$?6=D:O"P&MU,0^;
M6#45M*)H/X)"&5YQQH]HCZA,$I(CYUJ.7 PCY%9%L@>II!@3_7 *@X@I)Q+_
MJPQ)[HH102Q&HU$*%JV7M5>R&QC=!^ES*8ET+XI]C)..[:[', 57BU\Y-(]Q
MRD9)W_FK-M!*R1?'<&TL5'S>WG=ZSS&$TM +?.]&;E .#U!0PT^^\.Q]H;+%
M# 8S:PW!8$C_GK@W$=<CP!N!XF;&&,WJ\5K:N#&2<WM77\BNIE4_-!_D"N@H
MB*X6^:)(5-YECO! H15#DY)EYS>="X_!LLBPR/K7*#^?1 $.35[#()&Y./#G
M"["%8*LZB!D%\SZ<H^62QG*V*%D"QIK2A#6=4O!4 W7+Y+3.]2&OT4@V<)HH
MVF-TZ"+T#_3&:,HZ*R:/RDS#C IZZ&?GV)O)=$1E!X?\L'!(Z/ FC>*W1FYR
MS7-DX ,UC'01-,WT@&*7C$/E&=(C:^2'-G-M<NAD+1%IT4F35%S47+"UJK0%
MJA+B!;E?Z93]HP/7;+3 \B<O]"8@L"\"5XYBM]=ZEN8=GM'?!/ "CFFSWW1.
M0+C%</ETPQ'B%L/L@#D%!A(G_VC9F//<8+4JS536&B;3H1>[=%K5K%+;B"OH
MY@+ME0"[SV'_UM)A:Z2##7[U_"3 IP%9'* IW/@(E?.Y/G;UL?OVQZXUQH0,
MLES ,*F/7VF*V3W29+]M6O6;.JT:)N#G[R6M^DGNS\W!'_-6V;#@X\;\\3]?
MQ/]G?__E"R7QCCO]=J][,>B>GSGG)\[@0\?I==]_&/3AIY-.KWOVWA*/&QCL
M-BW% R!1HV6X%">PGNV'B#/ZC'LM<<01!_(J\L S#C^S%"O6)*(9OPPF3^2#
M@MJ-U70Z"(-=56^:?0^#E1YC@U"MF56(E2'%T$[)X+7MV.5MF 4[+>YD(V->
MB #I&>F$46R+#?]0CD50C)YJ1 *%_6WU1O>Q0-&*GL6F<Q*[(_%%FV1 DE8K
MLY#.9#@FV)69-MLB]R',6[#(XZF+]S'C(21VHWP,HHBB16P*('VOT%,Q38.Y
M/Y/\VUP-PAK<LJO7??,4L@)S/W)Y4/:DD%<W^SJ\V?;&L,;N=/8K/-K49)3X
MZPS^U,4( 3)/91F"Q]XL2OQY%"^< >47M=DSKULX'K2S!B*N[N;TWW'V*M$O
M4,/L)B\,-IM-ZBA6EJ"+?TE#!I(2"A/Q/2,5Q)QG&4\93//.WYKGW9SLYK4W
M,ZJ'Y)*BS$<\F3&G6=U>1U,,V/B)>02S%:%-ZD_6'ZVH]XD95$,A@%P=I-#9
M>$DF$6D>"?<V1@@1I/#"5$V0%*X9%2C,3ZQ(K">JGVIZ\W@HY6# XS16L2T)
MV:V)]"NQ313@XC<L021!)Z 7CHEF]!-BAGQ^##!@E L%"(,H1^R]0C::$U-*
MI">'B;Z:^"PA8R^:[*I\_Y),%P/:1I/2*88';^KZH6S#:MPK1RAG2M9',]:5
MTW=;-Z*NJ%(!+->6K;P0ZS65H\Q )(4@,"L5##;PC+F-WB*T:8WDDT>FR=56
M*RJWH=5BJXA,(=0=":574W"W@CC#O.O,2R*7D&E%POZ3NC'T)K"C:")YJ/JE
M9$-K:#G5?X,(6*05GUVS39N$KM9 -X1^HJ0ARFN06W1+6,FM(PLCH$P0FB@"
MF?ZE,:72T&B"D]&LK_%%8B9KC*,1!;5I\U?H-=D=3$)+8:7(X4OF[KPBR<[H
MK8%V*A<5-\.?G#+^.?2017OE]0$#LH\<[7L\+B"V$D8OG%\+8P[(-YG#9?CJ
M)?G!%^YBJG"S^C8G9\NXLDUY0L57890)?WAIY*.XRS*C69@4*JVP8DPK#C/^
MM!7B+G9']8;&"2H?Z1-9MI*1@E@JH$PE&+9XB0ZL%C?PD^48A;5P^-MN6H-'
M7LW^=4375R4*2)[2W;9&*]ENES.NWX6PNV&R=8\D&HL\<W.=5:(HO-5E*D?#
M3(VY$SN==226<$?99^-SO5,WUN4\1JIBV%/*ZM3]2G6NV05B;S\22B+3JUGB
M447*E[$T\C4L7'9F4/1)X;Z!.%-AZJ)=M%AEC)94UPY-GTG><Z=QS536U-KF
M&TM6+*?SKMU@4@O69X"XC!4#9-FHY#OO*URCF5:O8$>-#51P5A&#9D3LWS'!
M-Z<)PH@:!=;7"*@1< X1@5]8C^>UC!H(>DT@Z#7APHJ)U8\"'/9W4<)6=EOP
MPIS-X8459WBEPJ^.*M&K%_5Z/HH%U7XY-YS6X <%K?CA\,D<PGGC6U(.-2)'
MI,H>P\?/_NIW:K&_2?YDNEE9B[YFF;B,82=?_9H5OS;X^G835C8JE!+\5&1<
M[[XTF>6/-S"W'!/^=?6LIUB6?8+LR#N*H0?T9:7-P!&(\'2"F(R21.&/NHE2
MO.GA0C,R7 IFA%GJ=X8!P"GM#$-4X'XVHRP"3I+_ O1*MR'7F5)K9,"JO&2Y
M:X#N.@*P%@+H@HE,G4.G!9)1*PO9RL$OG<2B 0SK8GI:U6W)ZUSL?3AW1W-K
M8-A7='QCQ,#\/5HRA+K"PLL=56:XERZ640:3K<F6284EV3FO]^OL')B UW5V
M3GUK57B!+A3Z09B!)UB75BN%E04]:N0<^^33'8.F891BH63Z(PK@!D.TA3;6
M\%PHSR.EQ9NQ+?Q%%DZSPRA9&%Q=!Z6B5!51L?FJH2.DZ_B!IF,-ZM9/KB7W
M0GL<YR:D%;$3F'\RNE)6)T0E2.,4.Y.IB _@]/W>?4BYI-Y]/]QP,E0[*TZK
M,Z*^R2+HN+41H]0I2<O*F0_>O-IW6B-6T:(4*T*CT1>)D5"@Z<8-! UZ[DXF
M&C.ZTZ; !RJG\2SV%*N=;L_EHE1.,J#2SI*&J?38]NSD1X')'TH,)CJ$K)*_
ML$U*2A#\*S8PL2/PO] !#3Y&F8"8%&Z"0H;Y8T#Q517%2@<W"RQC,G"-BLE?
MG!U_%SYR%8% FK@X><HL9,L879+.Q!3W0W:0:[2<+'2<JQUVJ7=#*8 BX>HG
M\]R,);]"#Z +5NGI),42<)C).0CYQ'I<V0XS)"&<D9DB$TO,A9''JT,EK\I_
M[TZCW$>='>_KR)MEKB1MOHBN#"N!S60]RI+"^'.[U&_H.&QBE]D+L9XT*86.
M]<(D)<8(L M@VU!,08QX<6FIC(<,IQ;KO3$,:_8:#<<Q81UEMQ'GM]![?&OL
M^#<\G>3;6&,CZDG#.2%W"V?-)0IXA#>CS@UA+UELY,Q]YQ)PPY=.=XIESQAY
M.&: !_2G33T,7=37S89UV\!#\0N;W\LBTV.:=3F1##/,TI> '0CY0:&NEMQ,
M.N5JRY2S!\)3%O./JZM<L!0T^NY/2Q&6]9LTQ?SJ)E&72PW\@\S OU\%U1HX
MRV\VBCD,XJ+S1^=L4%DFIKZBRMS4@ _0-E=]6@'!_#!SI=P:CSM;QZU!)S]9
M?ZOB$_8P3,<599CB/H[B7YSX:KASN/^J<?CR=>/PZ&AWPTP"=ZMD?&@"K2RH
M\%AUBDMVSD9O!SMC\4%WS)_7_MQ[SMND)%_X?SWO_:)]^+G?_\__\17^SX8J
MJR70W\G^\=$LHZBF>&?^1+\AQLN?N4AZE*WT[$53+@_@F8NE6OQL>'Z+[GER
MPU0&E>&QLVA.;,T3YWVJ"3F..0]]X1RG]1ZLY=;J2>TFF)\*^^CYZ]ZUT-KP
M_+:C<.+'T^S6^Z[WSU8"S?32P-M360YF6H;RG1RA[Z28TT*I&:4^'/5]\_.8
M72'_-;,KK(_G_(>FOS#O3[RO_Y"37O!@Y)->\'<&:5O!1UCJ7BKU*U<QE'%$
M<QF'V7ZS'#1JD_NA7"5033^PH[QEHE&HV)/!8T8)$E)(AU$K+&M>JZJYLF)Y
MUQ':LAT7XY-+4_1FA@96R*K;&>Y2 IW2N P*M+'2N#[E6^%X[.?5N/;/97>5
M"<C'WF27O!=T)-B*IFR]Y'[2@;#?AF^7%*[54<>-E_]PE>&U(!=P 2(F/F,>
MPQ"NY'1NP7;?I1RQD##]220I%IA%E*[L3S$3K]@&Y3LK7J3/)0](G@I#NX\$
MQ3:1Y.BAIX*FE/] "33X#Q,884X)#$G$B3<\"QA6G;I?) )KIY\8L!P-G<G#
M10TBTC$Z;I%I9J5W#0&M*9:(9 436!7"^/GJ;X6RD*XB4ZB:MFSJ!;!>K]4X
MHQ5F8',JO,B5C=3I$QL'-# 39I;7*X?$K"P91V:*IQ];>!U/N:99U2FH1W2%
M<[VS'B3.:6^ADNUC@+WX2#'BXE\SL I8[FEA5PU3Q5YG;:.&!8P#PD.2@JNE
M$<OHADHD)J%Z"Y*8J>QT':<&W;@N5/DOW[DD$+V00ENK>L$L?3>N'Z":1K7W
MDK#&E2H&\T441C&SO>!D:JFK'\2SMO)SDL&V7%RKKF7=HB(K]>/J-W5]+IPS
MQC.9Q1&FV[F2:LCK:&T*,I:6;2'S:]"V11!6 #Z)0&/ J%=Q6QG$&,V\0*JL
M;%]RHQ%_V/:+EF4E0 =U"1!,P)NZ!*B^^BJ<J66D0@A".,^2)JV*(*R&Y.SA
M?'ZZXA\,QSK?O@1(#@U_9#^BDM#8$;> 6\66V- ]:"@C"LZH:4 QY8\N>":,
M.92;U=H;\;RB.)?"6[8DM-WPH^I^4HE?9%Y"IG"MNM$S0MJJBT=7BO>Y#%1;
M524#2Y#'!-73(-!=7?D!FLA%R?U&X(]\MRV]Q+A8EMXH?$+=Y B7LZHC6W/%
M?C;@^_3]6L4PK-#Z<GS"J^"%:LR[QU/D"00SOZDL:W %!J94:/OAF/S3C97P
M<TJ"+E2E>5F]>SG*<&YC-I +$>M1\NB/U#J.#$^5E!XI"- [Z();IO(]Z4TX
M4.LZ)[+"=((U]_C/(@ (2HS,.)F3L3E!\4BBO5+,(AJLEG5Y<$(;37:$]ZN%
MW[>[K@#>G+Q=9L>@KU ZPCLRHBZC//7#FRBX@3^#N"6$BVAB/$KW..GQ?-=2
M&9;66>;1'.[]*E"P;,[1]"Q,-+%3:FQ2A5*C)XD@:NH3LUFO.2S$- U<<383
M?2/J:;+<VG]K[&>"GTP40^HOV[4>SS"D7EH_+-\ZVM]LL8?9$GUWC,**Y,(O
M#-4$EZ'WXJTAM[0%8\JU"X3/@9?T\BP)D:II6U%1LVP:#C8Z"_]:I[O[S2.,
M0M^QQYO-P34/;8^ OZF\_N'B[_?G ]-M#N@"*=LK>)VTX 8UHZIPRR1WR*\J
M_>*=V=Q6M5*'TC>\D]^M0.0BDF-RO"N$IJ(#/L/$%XM2XCZ$T55$H6HH0@4"
M#UWBS"W 5N=M#>)/)NN4L/;R8%#$MR$=<*^N8N\*]WR1GT*WO\)84@"\52J8
MH;].&.)U;;\U(9B7X%G)-Q5X027<E=7LK6L.2H<HSJP%+.D.ZBN\XH5N9'#H
MV8,:V]70*E'5V<B.FJ] <-3#290-2]B=@@RG6I3XD9'Z5>7LR.;8@%"\E_=C
MFU2V)RV:!A8]A<:W(#A@#PW*$L^!P ?CP[G3N.)LW^V\ULN\67?](WCH0?R[
M3!L@COG\RHX\9\=O>LT\_U4.U:L4Y,;J[#+$F]U&Q=:R'?.&.R';_1E4C067
M8ERO&MB! \L,XVNBH^1 44PBL2W#?WC26QI143C9+$-NHU6&M:L1N1[ESL!<
MQ:'G823PAM0@+5BZ&=1?B_X6:\7..L;'H,J.YI%D747H\D25@MH!I:B$)2\#
M.2I&LU;DUS0T/K<"1:T,]=WEFG):8<$9OXX:"O(V83!;&($?CF+"G>'  L+'
M1C%U#52BFX@\6;/H5N91PS 5)I3$8.UDW&"7/[IPNSG_U73>NT,$[89=I+>M
MS146,@IO' 6RMNK/Q=- )(/(7N;"E@]\<J93YA<A,#_1??XQ;O+ZZ9E8-0@R
M%UBAQ"1)>*FA4W&IM$.!D#7N,4S*![M;G[ '27D/DGM-=/[SC%\]3M1P'69I
MH"]8ED\%0B&LB<N,#_\PWZP"#UU"@)=10%Q[!"NGDPJ.O6QURQ$LZ<F#PU^=
MOHMLHB"P3-=""1SI'9I<%P)?,U04IECIBO,RE&^3G4]:^BU)9V\/0.; _^F3
ML=ZFE%QQWA#&\I5NO2SEHGSYB_N*KKEKS^@0DA\,%PW\I0Q3C0\V'UZ(H4YM
MSPBZ!+A<3S[LB9RN6C*+2)H9WWAFL4%9I[/O$9&CD?UBCL$WR[6RU)SBB(N[
M%TQ_]RIV9]=;=F?559??:]6E*4^^96U<I6 L\$"-25U92U@*,3>_ 3('9'_Q
MBJUXB7%A:33DT4-F@VM_)E3"R)Q2Z++((+ CX&;QD,1:7F0=IOI#K22)1GR]
MM]V9CS&7]W&4SAJ@;(V:**RH;DHI <G#%PMFR:<KLXL/Z^QBF("#_3J]N#:Z
MUI1MH"FTKUV$I] :)E<*P@_:B8"F&9K-$S@OD: P%VVT]K7O34R;[)S=#N:#
M)0J3T8.&M-'YZHU2PIN6)AK+/Z!TX#_(JWJA>DI!F?>MC^US>8F&0G),\>K"
M7[L&PWTH[DXU1/SJQ _!ED#ACD+51ZIQ9B!<-)T/5(9(UAB.<-D,E/5MB4>'
MN]VBWGS,8*_SG6^?9[VG@E-HE:\$J@8R!C/EY+=AXH]]5V5OX?!S'#KEZU.Q
M*E4#Q@TS5K:\<E")#4^VB0EQ@/UXW[[(KPS\RE@9LI?19R-S+SH^M) 06=V_
MH]B?+[)"6%"#<7 -_75SEW_\K_?912=;HJ'F#5'0D;P;'9YZ7,:>OT&_19J8
M?T7,=C,VJ'@PK V239_9E>7W+0T\'0;^R!XW M_[8[S@ \1\<*E98YVY"A>D
MQSQ52.I@EK@QTDG))N:9\<W9VV,M0&^2A5J:+3,AGK0$_FWXMM3ZKWWI&YWF
M:C[E-"0[#J.J#.^/E#06'PVE=IA^A2PCG=-@F9VKD!NB#7UL( VS+ ;EW!@L
M2PJ (SK#4QKJ[$KE"2![@X@]);1F?93P8"B!1;&'*QY"089I6- PC1)LF$8%
MJV&.D3-7K>_L1"#H!9W=]FUFI46"*=(H]*K8*1LLP.R'W0W59KX_NTWG<B;M
MS*'18,%S,M.P"";GO<5[IQ:NA)15<<_!7Y$FHHQRPB*X4WY&?B7VL,Q@KGB*
MO#'S^KE8"8O15<R@ALV"3"1^DC!IM@Q3TD!XUQ0[0W>*.Y\C,X>U\71A,>>U
MJ$SVQ,P8SZA!F3$9KG_8>HEDP4?I'.-_U(O+T,>[J3^G+4K@/6VX9\;N9W+N
M$;TBLM[#L6U=G..O3N#_I#VA?!%_I(47P(.8D2_;8K3-9@)C-RG5;I5L^Z;S
MZ7U376H-Y_2T_=G*M#^FU!U1G6)3D8B]*^2SIW;--!_#LXY\?\C'0FS,.%FX
MZJ, BP82BTM&97/8^3G1S M5:@XG)-$6\<+$50S#5#>GU$F*RF<#STK@?LB.
M R81T%<:ZO+GJ* ^@$I8(!(OM\@Y!M#8#_O-_0-=W*<2\OVIEW%,NE*:38Y0
MHRO*]0'#C:\\*0^PYY9U"-@(05"N070M1:2O1HT2&MWGM'A*^\(93$$H&&TZ
M96VN5)O"S$>Q+%HD7TT:ZLL-*B<2)TU.,4*?32YHA43/M*<HNX$_E* L#K@F
MXMJ?)>4ZM:MVJJD6<WA+!0*DW_9TU[K8@Y"#FY)5<>Q1<*!,Q!;O=E;+8\JE
MAC^/ M='5Z%K;X[JNY\YMF(/MV F\&91@CL;.G0=,8LLMH@1* )38Q)S;4FN
M<W>6\3 G?&EER4)$]26WDWTSN5\E!Y)4)+)UD#,YQ)MCYOIC6VI2NFG$DX'#
M*Z1*-C'&QK?B)(ZF4N=D=X88!F$^/K5!A*9S='WB'37 C$P,NJ)1U'#.FJUF
MX[.J2!ZYZ) '<U PG^P,)QTWXGS>$N;?\HX;NF1&/:ZO=<(88? GM?J8KY2,
MKC%UBR5GK*G6+?IUG=U1W(M8%287>%'+$.5!2QUU\\/ZA-(5[: );1YW_@3F
MF1@8?=@8C->?IE-9!$X5LSG@FY1LG_^HZBVIJ3(<N0)G7#?N4V_QEF&H?A>S
M.X3B!SZ@4EF%J\O\7M>ZX60&\4,-Z:8="RNZZTE#H80:IASS=!=O/7P'?[YA
M_8-'K'7I,H5;5$Q$LS(CSX3>09WB:Q8F$_1-,-V9U:A,PS%/E'V:FD[1@!%)
M)$6ERX11B1ZB9]U6>N2S.J\P=[5G',B<$"914:VAD7\,TYA%/U#S97]#2R"E
M"5HF553H;'W%;9 +Q$+@0O.7UBGC_W9ILX?9R2L[\T7S3.0UKB,O=H-RYQN&
MNY22UR)*><9WLS_,R#:H%WF3/J5UTS]J-]-F9]X7;U[^@!"2A&FZX]FSJ"&U
MCP#O^+% >4PX1T2RGW-G+DL]2A;3810H"T(_H7-[6@&B-X*XM_0,N3FOX&8+
MI=Q 70^YXT[]&GLW7A#-&KI#<JU4B01R]\SX>B6?%:S!>HXELZI/)1*1T1R.
M4VHNT[=&0239H/8L!2ZH@]G'U%_'JQ3@[3H+RX+?+^O@-P:_#^K@=RVLJ\U]
M[13+)%EFFF2UH). Y9CHLZ8ETS1C 89C'OU&-_X8H;0,=%SUD 9K*JDI91AT
MN$8PY5T[<-=[I>C^+S-9+.?[>A$!+K)YK&A HP!?3S[*:Q^NA?M$ K9+K#_I
M4_/)]' I(S<K[()+FIPIL'%UMJL"/"H6.1+4V\+YI'$_X^4@V 8NKW([5<#@
M,"8:Y:$;41#=32S%ABGRQ9E24AA[GSZQX*C+SS8II)5>-UFJ;.K A-81"1/H
M]MH+]U0=(L("B>I8A"4?4V0@E C ?&ED=L=-0!L& Q9;Q;K)73H(4]<70.&E
MF-?H8?$XJ[RBU[%WA1@ >[=X62SM]7W57+)$BGA717U=M>A]W9.I+]?@/R6?
M*W7X6OINU, \)Q>=LN43-"RMH+"'T4#0<251& $#@B4@>**1*%M40!0QUD8E
M='"A1K&"XJMN96(6,U04W>#OR#_/QF,6;P<]QY$RO-PYO^-8=H;IG,3[)'9'
M$F#DEG;+QCE<*!X:<:(6%*4E[#>8.N#%@9JAS%B7FA8:=CZK0 6;)9RS?,AS
MKE)1%U+H3K6FJCX#*MF.R]P. JI*!=+5B(=1_G7YG%I@<WIDYB@AD&I(J*J]
ML>H;N1:';D#;H-PI;Q5ZY5("# 72_D,2Z8GE_ @W-$OOLM'5DF?S&528'J6.
MBU5R%4M6<+:E,Z?^LH,I004X3],91ME+Z_@P'RO4$(*_.#O^KK5?[9.6&6YB
M!!')%$,7EIM$#6C1WUVUM?/P"7CRL .V86:<+D,B>%Y2Q!<MG#9)4+4;PL2:
MW)NQA]YZXS5EL^+K,!29GC(Q2K)DR2BU)9O%D5 %-O+-8%K]F62_H(R"U5ZN
M;9RM%7Y,KG$?2?K0P@E\=^@'&+;%$UXQJY&%8[DLI*Z@5/2>0+&*QB7A2.BZ
M<C&CGY&3\$E+%02?FV7^YHGG%?.A<L%$:\_LL+ZN#B8E'9B (Z2I*^@<UM69
M"L,*NTYL+">=P["3:=OE*6E: E"5*P9O=[,T-=A@H-B'WHB!K)0:I++%&BK-
M2KUO[<,"(%E%7H)]$$PO%L7]$3)%Q^:+8XZ,P:H/#:,X]*Q)+#FL]1EX )P/
M-U1.B*20!*)61WLM+(U;POFJO$$!"95#5ROQKG(?],MT MT1"ETI"#D>M)V=
M K2<2A[ OZ)8+0?5Q[]V<JD(*O&RWCX;C?;6A0./EQ/H&RZ0JF1LT3%T5H0Z
MWJJLWX-N3EWM:#$2>QN4UQ6SUC6IOA-5&5/L^=-A"N:GYD]5)&5:KE/R:<'&
MTI %]5[9+%06NKI!>M;'<*-3>V+3_?DAPG:R2DY&0R$[+DM5F[NC#(6/]!HO
M\&;7J!G!/?EZ?W_O?>M=Y_2TZ^R\.CS<>WET]&H759XW!Z_VWAP>[!WM_[Q/
MQ0WPZFV,EIY&^L<SA1) Y7%W8/'!7N%D5,X\/P_1T1K/(F*@;%/$N^'T%J#X
MX>C_BN(O,,2CU_M[!_#U^C1N]#2VQIB_FLS1> -Q7-^/#Q .-/-]Z'H"8PGS
MW.VI=W64NAPW)Q?)F7DQ'O!\*_KZJS"M<LTVC&@)YJRFP=S59+NSV$-,' 5E
M6-:<E,A&$]:K-3:P>+CP!H]]-T#OE,((%LAAA@TNH ,GA8%2?9$:K50+YV:.
MVAM]$=0^JTRHD,PNI0'_-QNFX1=K.B<Y-:*1[XY27%S2.K!6J)CB*6Q?LR!-
M<NJ'5$9%Z7POFNS-HA$F2>@4YNTZ=,M2JU[5J5686G58IU;5M\(:&<B=@E.K
MOH,?@GF[X+8?+C1F'5[*"&@*75@9R^646Y^RQGV-T>R%E/[KZ7K3')J?&4F]
MUF!Y$B7![V+9\(JXI!V1F4=7'MV(="'/W,4TTR$*V0L%/Z^D1XLSZL)XNV\S
M.AJS1[>Q-87*U955L5"95:$$K$'Y1M@&>ZOIA4*=F"LW+TX27K E>@<%O=3W
MM^S.?-*'I*TWY)(8$>J%LE/NGDA9B6)02(U,0ZH)4Y_"T+IRQL)7IIX;,ID:
M44!P[-RHRY.3MKC'IM?^5S \TWRI#K%::& 9=;@90V?J<:TU 5Y,9P02 !]W
MQ\CC9(;0C,I^T)X#7U6358-/5.8G+150:N[$SA]J 521("O:,K.1D3AD3((M
MXR5[TD>L.W'>+4"7BK$4-W!AAW^$:Z2>X<UZHRN=3?4\;]ZK4<_IAJ5#3\.M
M-)1,YP03N )0'I/(P)^1OBVD#/(V7%5PC]1RI)8CVS;/M1QY$-]"4;&M/0J/
M 9<G=3R%&IZ".X$-X0C-A*$WO_6\,*=]3\D[1!\037[+Q/LS1G]G1MIOCO^^
M<[#[+6'?6T7W#1;,)YYD7E19IU5^*U\= 0STH&T_NO9&7U0"(WD;.%KE%;+]
M+71<;H9>WJUPAN78 G-U^HHIQ,4HCC_1&64,?40X-54T-O<G!6V4&N46+;W-
M=1>+WR.'>6?VI^D,R%OGCC"'%!5*2J_D^<XO@^3#C=)E'J#&>EX?),W2>94&
M6&(8D;]S"/.PW#.TU.U13"<:>S/D-J9,!X:[THB#M \2J[O^W,Y>1J 5:".5
M&C<_I'3JQ!,.V;'.*)W!UF;$%Z'J+HUZ6CNBJL>8:,W+ H<FN6;@,^W7,EVY
M=G,/SAY07PM;?RT<?MMK(4/8#K#<(L=6K !<1"25B@]_L@+^MD(\E.#0(F);
M5N2BTY.6NXW1Q2Q&MD?_H,B^6^8%;G!9S]E?_0X<7V2*;F1-4J6I:I2N-%T3
M9T=_5LI=*C&CZ+F^T4J&(,F2-["X(.N1!WI54&A^OXNE> OH*X2[M4SL74<A
MS=GR-9 (P/VG#(,&2R\I^9T&R!FJ:EU5.TUH"CEPR(SLJO1J6CXF-6M>5@A=
M=G5F\XZ8VZN<]JLNVNV_,IZT(=CY5[MS,7!:?>=\\*'3^[,+@J#?&3@GY[W!
M!^==Y_3\SX;3<BY:?WWLG V<B\M>_[(%_QB<.X,/W;[SL3/X<'[L?+SL#^!I
MIWOF7)YU!YUCIS]H#3I]Y_C\]+35ZSOO_G+:'SKMWYV=/S]TVQ_XA>Y9^_3R
MN ,M=9RSUL>.<WY"_^Y_:/4Z'\Y/CSL]Y_R,?D4O[SK'O=:?9_B[EO.N=?:[
M<WK>;N'7NO+4^=F@>P8=;9WF^O%IY[R'@W(ZI]WWW7>G\&SKK'7<;9TYO4Z_
M>PSO]!LEK=)3K=W/#3U$F(H6OD\ST'%4;FGGOR^[@[^<04\&UG1:9S(OK7;[
M_.-%Z^PO^)73^5>G?4D=NWS7;_>Z%X,N#*?=Z0VZ)UW\+#8,GX&78&$ZQUOF
MK5N65G54IU5A6M7+.JVJEL:5(91BZHGIFDM6\,XFMI/NBY<E(1!Z,*:+IIAG
MZM/U2]4JC2QYOIS,<@[M%$DRS% [EV5SU3;L4_@]J3",-9_Y%%#Q24.LX=PK
MF(9+856,W(,5?@B:K+$_-DN!N;>H3A9?E$1_#^0,%XC/9@@"'B[TO,'@4C=0
MY!*9#3Z/;I$WRZSX5#,#EC>FF\P%92-,4;$NV-8"13-2^0VRQ&--;"T;(462
MBXI2/TSBJ)Z,7XUJ<8OMA+"5<#[(?Q+KMF)$4/9Y,00J?Z[3SI#]-T OC$ZZ
M9A",*)T[@3_U.?>Z8>^=A&#%8>M=N9BIK&8UJ9S6?"%\?@_94[CCAS*(6]@Y
M<+*X;EZ(P>5;NZKFWL.JDI%GUDX6B"ITJG7L!=X-'BU]@(9P[FF,6W8G/VF1
MUS*.&AY&.@%BL!8DX=_/V:KTS'43%*0C3CXRK=Z1F4!6;H>J\S]FO+1T^&_9
MO",0D9+\ARV1+X_PS1.QX,@\]^=B[$&CC&^G*WQ'%=EK"8$,2B,&PPFVU\AL
M3I\@-<8-=:J(:T.1Y&C19U05H[M#7P^9W!HC&B"**)3XWMA Z] S56K>(9-[
MX+FQ HA1"[T&95&-R_"@Q^Y/V!!+X'JSN[TTOQ%_*3F([2B<^*I4#_]J<N^,
MS#]JR@##>Y&GT_+<[-[+CKT)-5D$-5.,$6UOS+SSFJM"_.H1@_Q)C0Y%*M2S
M=$\L>1A&D5SS1"A$FJK;7%_?>9W,]/ (#,V2=@RDEZH&5\(F9O@P,P+U)VY(
MN@*17D1K*S;R>\[OOWFYC$(P7@$D@U_UOH[,Y%EV"L8>DBYZ-O@'!3J*F=K<
MOD(+*7THS]2B>24R_$%F_B)NDU(\H8P]A9QA%1O:2!._77[DJEUSM=A[R* O
MK2.!$H51IK?"UACYJ"5GQR5;H&H7O=JT@H=TEV1O<BJ3BJ!HJNX5,ZYWR\:S
M9!I\3< Z6SPGB<12!&='WQ^^Z(F)-TJ9Q8F+1W"Q<G=&">8/749)0^6]XYZ9
M*%0N,HI\XK:Q&>@U)4ZA:":),,R;(+54HL!PW41A2-"X"HV)"42% >$\PT'2
M'"(Y++8<YID^()K))_^%/, ?0XZAZ9^=3N.<Z5)_(41:7M_!.-KX_K14*<UP
MFDA+5D<V1XM<.L/V[$8:_8XT$%5)Q'M%0QD680KD+R[Y6P1F0.G[\C>N%F'X
M'W&N5(%NYCNJ[5<;@/.WX=MW7+1<N8<+U<P:=4%S+^=GP& $SVWE)-O+3$U-
M#'RTB?26QL 5,^#))[2HM7F--#IS1F[DSBWT0'11H,,G!_-,FN 27Q&ERGAC
MS"VLQ>8&DX\_8""H/^A=MC&XT<\"(-VS]QS@J8A]])W^A_/+TV,,@/0ZK6.G
MW>IU3BY/3_^B:,K)^>GI^9\<F#GN#%K=TZ9S?.Z<G0^<?N>L.J325\&:D\NS
M;0NH//F5E@C@^0DLR6GWCT[O+_QW]5+@0JIPHHKWF0]?]+IM'5WK==]_&, [
M[_'I/[NGIQ0:&]#?.J<=VE_48J_;_UTU)R]Q +'?<-Y=#ISN"6Z1 <8A/\*^
M<;KPJS[L,=B8T)-CV%.##])N56_[^&W52*_SOML?='KP(K;7@&Z?7W1ZL%%A
MYU_"KQO0W<$'>&YPV<,88[L#XX/__^_+#KP'?\:6Z9LM&/\)?*^+39]=?GR'
M44^8S=9?],66['F8D0XUG<USV21AL^W33JO7.FM30%6';GO=\QZ^\DF<+I^=
M3@N'<.8,NA\[#15I[?SKHMMKT<0>PQ0TH0_MUF6_XUR>R<Q 9V"H_?.SUBG'
M9?LP!]";UN^T-J?8K',"7829[W?/.OT^#P:^33UK.'^=7SIPLAV0$>=G[V'2
M+GOO>8C06^A)#_X* WC?H9"MC*!!B]=I@4"!8;6<K#?P3+O5_]#M].3VZW._
M8 WN'VS>,CFQ+/#Z4QUXQ<#KJSKP6E]D55E_@4.J.*G:H&Z.L#A-8:;#NP%Y
M:AJ<G.;/%PU.]*94+LJO9B1CH6A= O,Z]K#:V@]M5U9#B-G57UT;YYI3? DI
MR*<<7D[7(L5;.' 3C#2.?5!S/5VA<>OZ@K4\]LB@P&3Q6-@G:!#HD,,/SJG:
MN^P9<:6!X1%S ;NXL4C]QIE!ZU*BA'IL#0XF<AB$ Z2('.Z-K9G1O"U-RZ2S
M65S*6%VUNP5])BH34R@TX$VC^VB+9^_1?-!;(PR+E Y%&S1Z,$G%%*\+>ZT6
MD4OW:352GE=DYF-S".U7B1)5+U<EC!5:O)I*OMHZIE(!&'D.?1LMMXGK!P2^
M+IVB*3%[MF6WX9,6-F"+G\!E LT[/0^3[]E(KTO<%O)+D'%8,(99[YL<Q+FJ
MC!E'HY2BJ": 7.6Y:5CR: T2(!;E638K^C^B=(Z4RG1>+T.?,G_G3#8DGI-$
MQ&3BB4O,?DS\P"R@CGW>-NR4"M+IT'<U9.P<"6#%#TDAXPA[P7CFXK&QFB8P
M3!^?=5K-B^9YDUW1)_QO&885\U.[UQRU"OMA^(JDAT(8&KFAGKJQE*=PIG6X
M=]GL-V'M8S\9^YE0PX02HT2)P]M&Q0H#L!-IU-R <\^\:.\BS,RY)O@4?=OZ
ME%:L?$I#CWSK&#5/YI8CB[Y 7L=L<.0<I%&-7%H?2>\VFN=K\MY?J'+OS6+O
MQH_2A**FJ*Z6% G0]J2Z-=<)O#E&*6Y\S3+%.0;0O;)5(\=T=!OF''MC'R_[
M8.'L**QO^D5I$T:\%_;7##<P\]6$:KO XGG>G*(7"I.)QN=JQ"4%19-Q1IN@
M- W+:^A-\SE0&F1R22]IH$AM0E%FI83,30Z3"D39A@W#P]5?%@R/Q@1NJ.'!
M-P1GG<"OKFVH=HM%/E0U?(9+W0IBHV/=IV- 0=BIT'*XK')QOIIO5E=0\]53
M84T ;D/EK%]W]HB)?M7,%?) .*- .=Y'WCBEC;9L7IEI>;BP&M.P7LNZ2UQG
MX2A*D=!AS)DX.9S@,DT-%GKB,KW5^,8D-<HG0.0"*I(+ ^+M/RDMN#_5<?5L
MEN8YZ#$A76G>Y6 N/50J K'NN<JO&T>#UGLU'_6QK1XA6='63ZT];E1[;$OX
MKC.=!=$":5LI"#1W+@*7K\ANKP4[)T25@_=MK5UN&/BCB*"@"5,]M2Q#6999
M@#D 1EY@EBZ;"-J:]@9T0ZH_#$"]O/'"%$.Z8SI)!V]>_T1WD2M)@G86UMA(
MO%+A:MV10@=(J*F_]L"<Y8L%X6$BD%U]#ETOG!;KF =O?GYE?UN^V^EU^ZWL
MP[][$<B?"_H:;<.,(]GX2$N%"%4KL%NU^KA#*6"N&IBYLY6<H[1"R:SD*LV2
MAPV])(.0<V_=V- 34_%#9+HFBD)5#$UK2]7-2GF7V\ Z;>9M:N-TSBD+?,Q@
MV15?D*4P6VPZ?UXCG(;[!?]KU;C;[RK5,%B09BW++OZ2RB]*YXA @O*L<%#N
M5VM+2AA=NV]L=CX:,:M/2(@DX(#<%L:.<8.@)D.%TN:WA6C0(R4:OVNMEP-W
M9\!H4:P%]-G/P<+AU?[!CKN;I3G@>"O'R"GU(S=E%0_&_-6?IE/K*6O Z#:Q
MOG9P9'XJNPVEC^*MB=/ 4_<Z+ 71<#1SH\)OXCET":-UZGX1;,+*_9#?3=DE
M3<EJRC( O2+PKL0KB N(9PI4LRS!3K[%9HNU#O4]L+$NVXN=I5#@BL!*3J&O
M5#A!64"9L^$*TQ)"E(:8D(GO:C&E,&H-6<6IKPMD[HI1AXY$*U,&3-'=W. 7
M^+"32,\)?^P?[. T5.PQNGP8_D(8!SY?!4I&7[X;=+60+CF@1P<'YI&AW!\J
MH\D8(V'*42]!NN.$Y6*B[AE")G&"R)7Z$?463 4]:X+W&G)58U=D]<7X!9V*
M5>_T3:9.6O>>N2*F9N/>&OERI!XT9!,SJJQ*/;/,64E@+*BQ]'LS38A*X6(,
MB, 5 X8(^KC*$M"L8XGAA=&U_47"N974REF<$GNFP*' R4P,&6^^I7*V?'TR
MPQLOF>N*#/%PE7IRM--1#K^*+MEW_R#G*Y!+@-B1U:#5<;&F*U-R1J+W,T-A
M0!FMRNN0-6&.:\N.R;)0]\]UJ!M#W4=UJ+N6XQ4UQF::*PEH'3D@77<61]?^
M$,2*DM2Y+-2;*+A1LLM-$F\NV>T%X:W>5[)[IYQ&DG(V)<@JWG)EZ D&&<5$
MB&A"]U;>A?L_LQKD.U4OJP'N8D"8 A/Z)@K8#+CV9XDN.;5ND$:&YY* S9"J
M*J$<E0\K?$0XE)!G%BX1<1&2SI5-9--I4;+JPAPV99$71T27GA=>P?[G, &Q
MOK)NJ1;+&YNM*R//N)<MBRU34V<>V"!S%2E2,6'\F56\DOVQ4\)6K:8R-VE*
M#0"=+&DP%DY5;S-C+6]=$[X-^JFA[WLR;%H$D[D>H<YB 8BCH-(QDC_-5>'[
MJ0L7  6$A-F[HB<C C77RYAY*"X&[4X6XLIYWV5Y*TJT<?+0<J9X54F6/MWY
MJ!CEORWJ27F1-7;(>?UJ[^"5K@O ,VD>53O3!&.J" "',V+LL#B:<&P0+4D\
MS3"N$'8:9H;3-][L[QV8GZ"24M)L%)' +(HP(IHPW5:6 :X:.-A[^=IL 6&H
M#/^-H4,Y6..EWSO:^VG?? ^Z[)5\_@KV2XR]5UXEG'!NX:>]PY=K3\\>S''B
ME4\"3/3A*T-O4XGJ)%@2[9HW1L*]\STI/J=6?CZRIU(7G665(KDJA)P+Y/7.
M<'?GX.==6Q;:#[WY^6AGO+MSN&\Y2[BP4IA=4(S17N)\G*E4)HYH5U)%OB6G
M#3<CLYMHBIC8>%V+W5A8Q"J.&+VJ@]%+1F%UWR0^M591H<^6W#^NDI^LJ1,8
M5T'DPH/_(&6Z3/#NB"V/_!:F^DWQ.<>=3$!8<H#/G3>RH"F%\]1/#1([!O5W
MPAD^.HT(&Q1:MSF]2[Z:*. 4JI#C6>'"W%Q83*%,BYSA8]S(\(XU)WQULU60
MNXYV*;<I6' UN9NPO<ZK3#M5<=*5F%?"G&G>HHX@4-J;I:&9A8Q(O=F0I'5A
MG-X)*-L.\ZEF6!P)OYF"4MJ0M5"!MI$9XB!!&GN$XDJA>)P,$1;LF\^P2["@
MQ->^/YPJQ<NCI*\5@\TN=EW$#)],:*_(2"CFER?UIFB "O@U).8($TR5A+?7
M?N"556U)3;,N>9[ (A$>!?E&$0T$CT,ZA]WW?\F;6'76LFZ#M JOZDK2#7;Y
M.-5Z'1>F?97\3T[E8=>P4IPR-6O"+G)ZQ7<IG\/T912<XG?U_K(BE)%TP2_9
M]E,Z<*F[T-3V&IG4S?3$!*X+S"5!]\YWNXO8<-]P+)<;\\?_?!'_G_W]5R]4
MD'9 ('/G)\Y)1\I0.O^ZZ)SU._TZDKMQJ@P#[@(--I;!5/XZ5FI0 F:>LXA2
MO#WIM( -$NJ#=@/'%[.T1E$B&JBF9R]7"[#%:.2[*J-:KG?6L!WD[BJ4\I(^
M@WO0I=)%)_3FZKIWY^P&5]9F'LMA*IIQG,$]8 H=J=R@B( <67APNOE>NO+)
M/%8UJ)C;H8HJQ_11RM_QQDG.T,E8>?'>G?+4P'UXZTG:,1E),,8IM:1QRK>4
M0/9);VH0+&;*U\!0"CIJ8VZ?''E8\&T$LOX%5?'H5T?\Q6BENK,$NJ7^I5&X
M7^__J-\DU A^=24P-_M-?R7*YZL8SN48OQ+%OSCQU1#,ME>-PY>O&X='1[LE
M4-W5*-\J97IOOWG &-TR13(L_>LB=+>5QTPFZ6GDCIV=$I&CSRQ!Q^S: -UZ
MT5:A=O-GUWV:)O<A.'O61AGG_G[^D9[,$(COL\9_7H.2_E@+J_/=]9&OU_0!
MUO1;G=MC3*W"K.^>9_@&R)(^\9 Q:1L7\BP*O3LNXL[!KO.TCZ9<&3^]_K%L
M'?^( M#.T W4QF2S"P6"02NI?S*O<%C>I30-!S\N7T']6%EW?ECZSIO<.[(!
M]IL_']WC6T0!M+4'<.G"X4VZ?-'N>"0KUJ5D,0Z;1_MW.#RY%=@>8/WGHPX^
MUHY=MN-HTF\][OL0[(:L717K/YA5M0'S@6OSSQ>'>L)+4RX.LI2+JO-=TH\R
M)\R%5F*X0]'DMV'L_.,MK.O<:;%9++]I&=8Q/SR/Y$^6H5PAP/!>V,,=Y6'*
MQVWLSDIGIJ3GUF1M@XQ;,?>\B5IAB G=2JE\5#UC_15:^JTMU10^4E22U+RB
MAK=)'6"-%RL4@4=6Z4N7?NG0/O](!%-;<B"+_>_J9)'0>4?YP-Z8*MJV5.&_
M_S*7K.T#'NY2B?\P9CM%7,K%ZY+>+%_#5;?QW7;$75I[VCOFQYV7CR0-\A^_
MZT8IV6OEB_2P)W_IU?!\+N)BKP<$GBW*#Y40G\\H\\!PL-4B^+$\:GD!"#;O
M@PEDY6BC.H4+G1W5GT>C+^N)9^K=/40JO>>,HQ0LEXW(Z.H&USC>%7->LC->
MO/UQY]4FY.JCGO#O6Y@^L4.WCKBE0/OW=#H?6>;?Y< 7!/_V^!&7U1.]KNN)
ML)[HI[J>Z&ELT%X:>'NJZ^9<B]/C\.C'%V]+=BK-=\%.,[]O?AZG3/YK3IGU
M\>=*AUX*2Z?XS^_%D/X ^3T4MEDS2OHP.7.(=Q13EO4$R0-&U[!"G"N7X,VK
M8(RH"DNC\DMZFP)ATEP%K126%?X\<LJ#VGC/+XNV-9T/T:UW@SGFUM=+O\R%
M19B9Y@62X38EADL#E &_D!5Y<':L?O>64G)G[L+Y >.>1+)DE3@$J:19"/<2
MS)"S(WR*"L:/:!BS$C&&7<*CA648C.:9[&+?-"F"U)G@7/R (;X'_B[!?"62
M0=CW= W(;_[;O[M<8"?[;U7!B%J5.*)"AC2I8OS^CD[WX;<^W4XW6\T647=D
MQ"*XJ_S$.6B"X(6E#IG&TP XU$^Z-[RU;CWO"SR2):QF\,6KGS60DQ42\)#+
M)G*OW+A!ZI7V@WG/I+FI'Z:)X.9.2Q\WRR!WJ"[$_(WWE5$#%!^<>W6%2?=S
M#Y[Z3^J/72ES0D/$$PPY!!!2Z<*)YDZ9:6.%A!87+8U&Z31E2(ZQLFPR3C@-
MB& ( \TH9_9R(O4KTRC4P"'>>+=)J&"DOE%MTM#+"B_)R,)BI>H>&N/@,@'C
MT$^SX-3$II/1J=!W2V+F>C0U-U@4 T:0*L?R#3Q-1??+%3$>H6#RUD 0H)F/
MB\_HBFGLU=*%/-[?3KK(-6)'.32T%RSST"5TQ-#(%7<E@3V?O,Y9ZRK;7 BB
M!&U&:A 97,T7=M=Z]<DO]VWOEF4>&R?V9LA"#HNKP7VX'B^4(FN?JR26B*:J
M1=X>C\23KBT87&ND:G7.6&8SA*NJ>?.^NG@<L407@5]]*AZ]]H(95=%D)314
MEJEO#'U7D((.3S+LH$$,EV-+O178&S>NJ+2IRTHV6E;2X67=ON*1)SVQ=A&:
M'!T'%-^4P$6\1(Z4' X\09D5BK#HS@\'C?W]?5,A\\/\6=$WI>L<*=6=H-;@
MTWXD:C*SA#?_UW:M[@,YHE8G?J[E?EH[RU.%9^X?/5'YD>M&HI3W>+WTSZJT
MS2>3%KI167?@_ 7WBB7JRJ:SJLOK)8G6R_=0R_>2EB^IUV]+U^^H7K^M7K^#
M_:>Q@-N0Z"O:Q-%A:=(R)T/HM(<N$> @<?&3*@++<@KN_+W/3VPHCYU<5\]-
M/3</,S?;Z/ZJ\QWJ? =[G_RO;^VS5BX9P>,21CL#:MO-/->N"D%,4HPX90 W
MCMD2.6.4HY,"B1+D0/S)2103)A#](5=PI[RM,4%MIHRY&8XSC#O;<8[/Q1*=
M9[@Z'7/CD&D365[P ]J])/"Q5P2T3UQ0!'Y+@3<./W+GQTWG8Q1[$25>%*._
MW"KU#R:#_4HKVO:<Z\4,HX:TF]%+):_!O-^&:D)D"FL__Z-M>W;MZR2291$<
M8GY8&N*Y]6+%E$CMC7/KZL#2CU*&DVS8CL];S>23B+\T<79TP)""^NY4MJ<
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M7L$]5Y[ _7!]*2'-VZ\DQMODWEF=M?XW!UT*P9 ?Z";'I),^$"%;8+8E H<
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MTG'E=$UH?^QY4^ZJ9/]'H63EUU*SEIJUU'S>4A/T3DM,W$'_3&<B84UL!A&
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M"+>Y +.(A!L6)K?2^744^W.XN[OAJ"D()BSJCKG)CU2X'>=QP%1:JE1$L6@
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MVA;S"$:/%Y(PFTB:_ *SW[+E9!*-(OK/BG@PIB4&.N($@TV6TXF$I$OBMA@
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M@XJPP/*WPL1P9S3QHH6"W61CDP4^U98@'!E1E(#XK 0G,UJ&[(07Z"2X2BA
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M3;*TT'<(IH4>3"F1<Q1@HZSIU"TEI*D<!\8_K#-"':"73<L$S])HAG83?U*
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MP<W7 K6?:Z^&?:^3$(A*BF3 :RZVDW_953&5XO/J%5/: ']2:OG%+<^=:O:
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MCVBB8Y1M0XLI_O>2;^#A?@_(Y]F/ 1/I?(XQXC%]SW/ ::4>7^Z74Z!Q>?^
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M]D-:>U\\;G'*I=MF!O+J))J@<$8.2#-\H7\_#I>?DM7%/L+V?"[M5W=8@\O
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M4ZTYC?5LEBUO;X(3UY'T'9/T%Z7I=Q93AUSIKA^=^VU0(FN2!HC(@C&JL$;
M'=K@78>E5E3C=&&I+UL#1CC/J21JF-(]CM@Z=0Q?4YU81VYWX97WZ4H3GD=7
MDAQB*<LI</</60GZ/J4^@>%%*D1O;:&P2:Q8ZK3)IN3-%C %6ZJ,F1G41@AV
M,JDB'S22-7T2UXM%*)*IU%JWUD[3V(# =GQR:A$(@4&6!$=7'T)G7GX:X -^
M"D$?3!ZGD[KS&4 @?HLT_Y*],[T:<H6U(8@@+*DZ>J:4C,*5ROK95?O[VP]1
M)VVV-^6S-CJT)=^S-$DS#4?B0_Y-U(W6R( Y5Z%-,J=X_X&Q[)5U*L^Z.A6L
M4WG<U:FLH%#[M?O/!-XE1B$<;R)H-&= A8Q12199^HA[O\*[J Y@,CI8_E/*
M)%RI8[C,'E,ZP]SB2ZQH7U>18RLAI62>+$A21&HEZ1,EUVF,/6B=UK'V4<H"
MHRO-!2EYF3EY8D5:W%H\>RG:-1F'@K>'N65H#O<^]B-NTQ:P"?"@B#/7OM8C
MD!!]@ ^,/=_KV_1B34$584F1OTT7V+A@<C[<BNF?*A82E5C5BXAZNKZ9\ G:
MM:<ZIDY5NZ;^?:214>%NM9:GY_3G#J?33$W)-U/%#++CKP' TN4.MZ1QPZPF
M#%BQJ79NVM?5RKUX(F&QIH3)6\--Z*X4N 6:2GO!J7>J#=.!2<]Y:;5I6*@G
M^Z#!E-")ZE)EO!4R*]94AIOEY-J6HUQVJ?;3(XJ)X7BBV[1^N\>.;?119D#'
MK[:-=FG@"]D/2W6>*#\V-: %RT0PU=TKNH8+W.X2=V>_Q;CLB:!37G.;-]%N
M/$W+HJ/7ZG;X:96,M8K6=+J@9X"@L+[[NJ^('(<[T9[:ZQ$0/?SMTM<TQ;/C
ME '9TA]OL@4VML.J'UQ/9;[2 [9.6CX8F@OX;ZX$_%[&A<%91/Y<Q?'0=0#8
M@%P)6@CNV8V+%1F2=POQ29Q:W8?6..9>DS1"QH?8MPK.T=61NC#%5K?YM54F
M-'J/.(S+A(P<9/ND*, ERF=41*Z]MH*G95U&UI_,=AG7B==KY3%TH452F5C=
M2Q?S7ZT$N<D4""WL%*MED05(1B3+-#9WW_LH!=5)%Q=41BR)R[3&78U$!N\T
MXF\!&Q@OW7(\TIH=H$X/I$"OK0&U20,%P*\E=LDM<BXA5EA1R OPT BH+##4
M["M3Z'-F^,<461.#,, S/>*0TF/.ED?FIK.'Z'<>,+,S&2YK+ IL?.&=C?8
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M6]=4OI@F\E$*!ZX?<=V=<@FN!X6=*JE3K5N+3Q[#ZK;0TO@EPCUH?*B*LFH
M(RVF'R+Y"#1I(Q"*!3^-XI:]]]"=R119P596[,K)Q$5[]KM28ZH._-%82+=(
M\;GEC:B=C(!,D.UIR\'<PVK$*S+Y!0B"63M1LI)OYV9MON-5:[?K=/%Y;*VF
MTR:TFB2U5 JG-HK0:V"9I:7_]M0031>"DW.;ZBG*0B"SH#OMK:<9]EA9"//V
M-DFIHT5$8O/E:E0R1C774"+)5.Y[ ](+L9J\ITO5I$42%[N2GR<B4%^_XY-!
MO*ZPDQSL&XPAY0B<G4<"JASF&C.@L4U5+@X<#%JA'\M@WACDV K,5KVS;@7$
MN-:@JH+=QFA2Z.VTDLRY*K(5!@MZ1<8(MWJ63@7SQDP0B\E#&3GZUA' G4Y,
MZC7O<*WKK=-]Q933,JT8E#H]]Z0(I1>%KIHEO[/TU[5_1MY.]9.<I2(NYC8T
MQ=868SZRXL<WDR.$F0;*=9HI5JDXMV1,6CH! K.X--2<4JPSRPD1$3]A&&77
M^>NA<4F,-'L<P8/X7)4W8:XV:54AT%B(RA4U&2"Z0E.40;7&Z)6.]X+?AL^/
MSX+3LZO@<G#:'L"[U*'!E^].,7S7835L^<#G!AK#]7NNYLR5+-2&[EW-_%H4
M:D&ZTGY0XI]1_KXB+&9:9B/8)-B VN> A@S!/I#"!;Q,);K3!DO.EMGFKN/"
M:3""X_5L5F=$N)3CGA:'V+;"I F:N)J#VA6Z35:M\4_&DC3%O5%C!_+2['-C
MP3H,.XI5F&F45>,(_K@L9A 9:A1BFZ RD9U!!94X-F;M<@(,\EX.DA8!?!S;
MSI-VXEE^Z+W&F?6"95JR7[O(TF0*FV80Z6&VG-.<9=0:@?)\=2Z1KP?;V:#U
M%.:SR)%ZG0:\;7L'[A[1+C%VD,4C+'?4,,'P;DPGW<.6-!'H3LL>9[M1:C/E
M?3-ZIW3M6 %Z" Q>9?,H\4WFGK1UTK^&/K0K9UE1)YZ($J<X[XFT$FF+DF/0
M>1P!IU&FRN<FC 1?=*Q(U4)W$9C<4^Q62XM ^L,/XCUM?D:<,*"29>Q.$@<(
MZ2:X,ZAU2T#8K*W'<6..ZG"L',%RU=C;&>,-V?,8:FY3N%K:?-C>8IFM;^"V
M+1C =J:/-HI]C_:#+Q0RL<:E&&W/+"9OV>);(;T.E<!\T&F4O*_3Z)H3SDT/
M6]F5EJ-H =TD2\ T7FJ7352_ "NO(,XB$YH ER>\89D4;8D[LX[9;!5QZV6:
M*1@^N%"8\<CZ9*>]W7$6])GN.3I.1R7I/$[:2ON]Z7G\2!S%JQ*7;M6A+]@1
MLS(7-IDK<17XCTD"-3.HXXC)!N_[41J#5A6%!CJQP-83XI\A!2_%63"FK^B0
MWM"[7K1+4Z:[(AWP(CT3.8.&%QN%B=F6L63_4I G31Z]V[O<@W,%U74<68:%
M>4%.610KFDX*, ,,4SO8PH$KMOKKBQ1=RS."43*25$J%Q!ZF;H_HU,GP/UP+
MGKY GA:[.'*(T*HP,QGV7H">G.%9!'[T%]J<&HM,74=IF9/:C7'KMC:6E)@?
M@NI9H'/U.J(.@-1QGK1]F%[3J9$S+KU)*DV"QQ$*<M!*=S2>+?VA<0@GT@FT
MLT#BY/8+B287.#RE"DKIUV!LM+Y0G# &9,YID$0;ASEE(4:87'>)FLMF/G!.
M\Q$)'8==0@<F=/S4)73<?T)^8(NHM!S?"U9P/&*:M1;,A=O>H\'5S2:<!^W'
M*70>M-])@@%.C)-H5@G?$%SRL/"236U/4Z?O(Q<@.PY(+Q4$ Q,1B50*H\ZE
M8T7(IAFG.&,.+/(3CMO@\.U;X6T BC0=[-AT]ZAIZKJ=JWEWV!FJ Q<C-2Y)
M:*W:U\8&Y@8;=-5TJ:]G,DI+;'XPELI7[U2;.@7@04]"[OPTOG;[_533B"H!
M*?%P@:KTKY(./)J;Q!*[2T4%OU3ZD>RM%O)^V&*E@+: J)O)Z.JY<31MLU>K
M43/?.Y*97J="7-^X_;-E*_-(PI^#^2).EPJ49PJC%<%Y'+*Z?7+1!_4P0=.$
MZ;:S0N\$[]D+,Q+7T4<RE"-9Q.CZ=5*A;?4$7.<YJ][B,3Q)J)PW!A/T6B6E
M@B-D7.B#GY_]2'(H%+>_G\<X=E(7=:C?3*0V 6)H^M<+58A005"R%/C6)8?]
MET&?[="#GW]ZXG];OCNX.+GLVP__KE+@/>?T-2+!!/2F:%S2<LQ'^CK&JD<!
M2C5FZ XE489Z82Y5:QY'@0)))N>BYX:''?O&!NC"FS!S[,U2?)4NE$=BJE0Y
M7(X5IMK %TG@W317DOH X 45#7&[\+8OR%&X(V)./\(VA>_Q_WLUR/Z[VL2,
MEV2AR[&+3[7UBS(Y:K9 N6*XJ/"#1Y*2@F!<O'Z^$*V852=J@<Q]IW@L#+XC
M@: 60U@,[K>E_Y[B,F'XKG=> <C-F*,BK %<LB^4&<.3_8.=<%>? ))[KWV-
M7&S%L1]\?!Y^H-[8[E/>@M&UZGWMX*G[*2L)98[BT<W*6&F9#D<1<[]P?U7X
M3;R'(8&_S\/W L7<2@]5:K("FE(AM8<!=(I8325R@ >(=PK4,ALMDV^Q^\,[
MATX&;&W*_F';'!0\$3C).<R5ZN@H@\HZ)*>8UY$@-\1L9'S7L"D-<N_P*DX#
M7B+V2(;Z<RH:F39>ZB&I'K_ EYU8>H7YX_R @LM$=UHQ 4_XA6!4(A8%FD>_
M>W%U8IATPP5]>G#@7AF3$NLT4H0M1YU$2H\HLTO+&4)5"N(TE')"_19L!3WK
MHO\[?-6 "MA,5OR"26/K*'V;::.>W'-/Q-5LPALGUY#4@YX0,>DYIM6/9\I*
M +^FPM+?W3PKJK'.,&@*(@:,$/2#-R7O>=<20Y"$&^)\$:>O<4L664E-)06G
M MMQ.#S>?4OGNT7F9B;7*B],CH5XRAL]PB8P(9=?1Z!]V7]5\1.($*"FP7K1
M^KIXVV65G)'H_)QT%%-"K_8XV"'<=7779(O8 &X&)M&_"=Z0*K'(TEDTA%/3
M%Z&2(GF=QM>:-,(\5X7DC-3NAGY?7XV=YHYVE%,H<6X):F@]6I#H*"Q%#8+,
M;.5=8*]6*9/OM+VL%[B+,7F*'YF+'K.6-8L6N2GP]BZHB<N$< 1A4>HRIG \
MCQ*)(5TKD:=X*4&$4&W"*!3O"XDTNY'4AQL6OG2730G.]1413U')-)SR+H74
MAI)%MSXL-79'USJTP_8\A=AJ 0L%*EZA@W4Z+(__9@G:0!\[#3UR]5;*IN5Z
MUS2;!9F'E;2KIFN5X:KU0G7(."A,_I&LFT[!;9B-B#^9 "11\.]8X?[J5+@W
M(:@F%+B3AL(M,QE1CPQSCM8"/+\Z&MA09,6S*>=;+1=QO*=HF5!<L3&#O U;
M"*51=4(B$YJ!#G"6P;,GCPZ>F$1VO*GN!?93@-#IC7!(N$T.W67IA(.VJ+[C
M'4<H0: _3/FC;_R\_^C _01EYI$XD:Q44)!2#%7G> SDC12;6@]P\.CQ,W<$
MQ.!TC&9'< 58"63>>_KHQWWW/9BR:OC\%(@HP]EK4QXWF4?X\='AXXVWYQ'L
M<:Z:-P$V^O")(RQU>C6Q&^L+=5;"LXN48#W0*#\]];?2U)'9TH9*VGS%[GRV
M,]S=.?AIU^>0_D,___1T9[R[<[CO6:A<#RH]N9"Y$2UQHM1<:B>95 D5P^/>
MCF\GY_Z)>J#,>=TPXTQZ-K;<.WK59 FL6(4W?;<SHW>*&EJZ02J%FJNR>H2K
MKC-B>/ 'TF":V/&.&% S'-%16"@@$H23";!0CJB$1<]&O"E^HO_5(UZ4NB5X
ME'IE\KMPP+"$&T[6!]6P@8&<QIS;EG  (5FZQ(4E %J?JVB;CIR&=[P]88'.
MJEA%2.U2TAE,G9)RPYR-)#YEHE3=-[-!I\5YTFM6M@:"SN832\_TA'/2+-R!
M)-\.DRR"F-(@$TY<I;_,TXPR%W#G=61CY/J4B9%B,2,\07D4N!G"+-@A:D&'
ML PB,@X7W"K=4DUS7R_H9<6]J;V&3^9$*[(2"K)4>P^3"U9'6'H2Y($-INJU
MFQF!IVX&9:'KLTWY]@1.CC!AR$N%B#UX1\H"2/+?Y-=INX!V+<#"D@=7N[$R
MN^%QE]V V0W/NNR&SB9LGO)Q:8P4+@#\(/GDG!K(;F1M!5B;8<+N='HE"BF'
MS/5[U!SHM_44LU)ONX+"'YEHM4'7Z%IT39>>51:LT4, U6%&KJ 'QN>V1T7,
M<;8<\^7!HO%_?E?^[_[^C]_I8.Z[2P*W/+\X.QH,CB^[,._62\4H741W0&?M
M/%$%9[&HL7& 4!9R0W_T+XMSS!5;K/](;(YU38J!XFW&=@Z4/ T*LK7G\#-<
M>P"[8]N_ZUPKVZT=M$5RQ'A%+_1-T 7GI!C%&[5)H*$U<ACFQ71DO%4R/K'F
M3)\JFE'?UB7'>=6EK4G$4+D%5&EW<^/A.Q7<=BSRE9&EP8GK,=8-,LS+ DL0
MLXC+GNT;"XP"E0D[S) D(G2DD+&H[PAVZOVP,%@X[)3+"UP484W:1A4X7?S.
M!Z)B]"K-,@5+@6V:Y;\&L_0&4?18H.GO.(4[FTRQBM9RVZU ,Y2L _)K2+&X
M8S3Y?CQG0+CS4<IUEA\*RB?/@SC%:P=*0?1!%HFF6J2#X^D(BX6&RH[70!N<
MKX<V_'48E^H1UATDO)GF6?+.JBFF>:*5-2&#L3YW_JK ^8@MW/#%,1BTIN3:
MIT1#A6"+15B7 $:8AKOE6X1/434M[5XUT.Z&:J2F8!)>IYD$.VV@!'VAZ]>[
M!Q=-V>Q/\_N9?[CG<KA$!X?N@V^I^CB-TZE6!0W!H$M']LBK0S_/4O([E'"6
MYX*R3B:TG5^O^<82ND.$D$G3&7LB"TK]RPHL*9G#O@\+QR,FY1J8CLH!HJ"%
M>Y@HH*8B\V6"D,%D%':I&&P$T'WS0MP;HL4Z8J!(1^\)3IZ!=KDK#SJ0OEE)
M\!D4R9^,(GG4/S^YZK\Y^7]]!"/H],BM"V 'F9#X#OD-N1T0*V-A.2;GT2A<
M1 7,Y=^AJZQQ&1)=FF,UHJY9O!&/#WK!X?[AH:E1"L>X@OI GD:V<;C$*&:1
MQ(,L)P)U=@$B=LY(4&,NQN4HT .[L[9[D-LMJ-I-Z-8K:&T8Y#46JG4/JC:7
M8>=/0Z\@F:SQ#ATLFAO\5.HP'NWO'7!/'CT ]N/!3CT'S:UZ[+8U=<UIG$63
M"XX.XT:AL,5%Q>.6<6&7\'C^\[L?S9XW>A0/K$>Q-G0+)QT^[R-%_S;,@A^>
MUR^2_!VO$W/ 3UBOMSC;7J0[YMHQ'][%,1.@]"T/<</AOZ)=LM+BSK=J\RL
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MUZI/]T4]^B)R_B.(X5#W4+TXNSP?'%V]NPPNWYV?OR'7V<,CX([FMD5S#X6
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M8S4L1.M26!@7:,AIEY$ULJ]BEJ7E=%815%6_"9X@?=_"S, $%(I QPD$AZJ
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M692 9O1O980(DD<L!1361VV**[7]+[[=JD*L'?2MN0I^V  T*BK2(_?*TO4
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MMT:0%T9S#$L/+NTDC:.!F)M!I_\CB*U [3>->U;B<O%M+_<0A<8R?9G@A<B
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MD[7171AD^G-F76)MOG_+M.>-EO<79'N+4QK9@YB\5>]LFJV0]Z L*RDF8:/
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M/ 1A "UBW&E*/>0F+Q$Q0I8!&6I)0GT?- /[4VBO5+1TR@Q]MQS]<P^-*U:
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M"[D"I>(&W$$258S@54C"J*ER3G/JGRV=R4SVW&*  PN2Y?L+4L&MG>*6!WK
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M[B$#JO*H(-UP,Y)XQPW>'5J,@2.AUN\<F&2#+R'>^E2?'_7UGS$/&KGH%'K
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MKD&PT3$VU.O_/?FS<H8GXJ*"B479Y+K>'T"8[WB(7<#'%0;HT+!J=(B$UL4
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M?D"N5J25N=I V!A]GIP:Y934]+=3&U;,F%YVI8VI;3N;[L\T35ES_U0M8,"
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MB$0\M0\+$D$F+Z,.XO>)H?3T/'=S^C$89'@/2B[-AU?P'2R<'EDGV3;/8;!
M@I([KIC)EXU*XR>[#Z-@74NZ)3G%R%;R^K+@>-77%>Z\8@K]KPAJ?BQ-_QFR
M)3^#FPP'%9U!+Q_XE%,&I_Z]8WP$-X_V%[]IRFF>>B(XXE]!ZF<O@_A#NMH<
M>^'/%[(064B:_YFLBTUU6W5&LT?F5IF;]W,](I>^@2$D70F<UZ7Q!VGB\.)H
M0K<LB3YY\M8M6PR)J/1M@]@,#V2"",&=Q':O?\)?>=[B9I[O@03&:\*IL G\
M5@)OKZB]UU .]NIY#*L.5FR2B$(@8\3:.# V!UO2/^+T($0R4T?[2J-P0CKE
MOV6CR]<-_+I-<!L"]LW<L@A 6U@J530D!%X'_9C\:AI4P#=_U79WH[&RTTTQ
MA:RV)4C@#QP 47,' #P^S\II&W5R(YVA#0IBJ#\E?G(1 &ZO$%\YI94$9HVT
M7W;@$I1KQZA]1/ 3D#]#_'Y4$LXE-])84PO5A^CP\?M<0A"Q5JZU3D6J[&:>
MUH/GB!@^27X)N8M.,;7]'Q"O/E2/A_12R=^5;@@;]4K9W::5E3[I4JP@Y\=9
MC9/JTJ5^D?P:Q:%M62XLZPG](V'0/'D-&6% 7PCN&^TB,PFEY%W.1_,S?P?A
M9L,J),N\GL/%FU&WH0DXG=05(TW.*F2/+-P9"#;W=:9<X'LJQIKE-1;L!ZZ'
M62L4(K(A,@+DNVRY39_1RKHYH_.X8]7MK_U760&RA?\<E?'.@S_]#HP42J:G
M_)^R>L]JFGK;Z@%6RC$YQ<QQRZ%LVYQ)GD8,A3[U-E2FQ%H-_G/"5 N>/\-T
MG,9<(*8L/^1++L/\]NCQP5$RP10=&WEH5+I58^.%AX*B3;9-U Q.AQQ*ROH_
M,ITZ[QW:3IV<&J1'7H(U[)TX;$Z5(VLO6;._G+QZ^EH>2RCME\7TP#>\@;^^
M])UMDE?5 4_D55;E)>8:?\DF2#"'3ZY-MSG?EDRK>7[YY>F;[J/A(],QE+8.
MC?:AYTRS5=Y0>I:ZBL&THAP"3^/EQF4])U8F+/M<6'@Y7<]Z5W<%I:2R;+9O
M?Y!58JZ7</I[:_7T=9C1QU;]);:=H?JM(2%EDYU(\,#=@6W!^YR:UE=P[&HB
MLY_G7'U%=KQ\##M?7@JG2E9(B2*\^XZ1?HU(,IT0]I:*"/PH&ND+:H7,YR,G
M)L6@*R?%Z72PP"[#2@T<E\.#PZL=EQ^3=ZZ!+YWPOHB,IIX2+%KG_EJFR7\Y
MMP"SQCR%$ .__OI4JA _8=0'=Z\VZ*V["YN HOKN^;O7OR7_@K]>EN6,3!2I
M;/BOY\]_??Y_]!-N4L\%;XNU#'"F<(&:_4<]BO\[6ZY^%,]T/:0O]!RB/^BJ
MQ3KU/STUS&7XG8]),9R'<IJ3W_E43N@O5=FN.B>]_S5S2K8? 175;$%@$(H4
M6';>JD0#J/;<Z%Q,"+M5B;-.9-U9-<D;3PT$D\;*QX8(D_$'>J'@29"(@#?(
MD>7?63G_9'FY?^4[84#(DTM47:N6T@=H/:/B0/,/-/#T7'I''AX^]JJ^" I.
M]0S^["*O&B8#\#I<-MU;K*6-AK"^IL(;7ZYC"SWA*QO.),WQ'VWANM,;$)9H
M<E1S2N.%Q_X&?D!WC; &Y:^?9G_8M\RNW@IM>3A"6YX</1BA+5\0C=& _4>1
M%S7T,@(4YD5;MG7G+CFKLF7H*AE*"CMX184:<CQZA@W>?9-[H=;+J-I_..@]
M:6OL/\]7#*BQ+*_J[:9KN8AN/02D5XX+]4U//O^"Z'8B,WQ#QWJ!9_8(C_H1
M]8848-Q29--"UV[!49) [F2'22_E'0&U8OJM:"^<A)0/!3TG[CQ;S#L!Y=ND
M?&_T:8F#&B?J]9PH=?,8W-CI<I\$SU,$>N $+;.U;PG<Y6+RX5?5(-*XM/*M
M<.%O1,K)CD%2!CR*^@KA(=[+G2YRX>"$F5-J GZZQRV$:D2)KQ6"C4SR^R;X
M.]A -$11/*4;]3&A "K83[XF(TS>$,2S:HEHDWO]E*B42!E1,FFH-Z&0M9KR
MF.<NETH(Q^WC,?++<=@E-PO2<3+ :%:N\)=U>4?:H8OWLBH)X+T"C>71TI64
MD\_<'-WR"Z=]5JC#!2PC#P$5-6P=M?T@JB8I(&&'8N'TQD!JE<*=E0W;F6 -
MH_Z;*[-YN0A]3\BKD]*/@;?C<M!T*$ -S^'0$"V+HMI"KWCS2-DL6MHHZ"T2
M%K/X2VOX["H2[273"YR711HI!NI%BK-(!$.%C8@9V&VV,UI((FQXLT>0@0>0
MNPN3C['>)A<&:-]M]$;#K.B:$OP9>G05IHUA'GC]Z_)29RI*DX;EP0(%]U[R
MJ_ G>OO&=ET'QO'VUR%5$]4(,(!/D-6M82Q:(83,A4/[1:Y*,I'Q)]TK<Z O
M0T<3;-ZR@0W3R(-V!P\K%1106_B/9ZI;*$\-IZKD.BD[(W&\L+)0MDE)']$P
M(J, MQ".$@P'?@/OQXE+QR^FQY/A82<#&#2W $O)#J._RR+1&,C2H683N8\P
MN@^P_'P6+VCVF]?4KT2DEH:7L+-""F-L)ZB&&I0DL!';@H(I6IG!ZL]<!OCZ
M<CK-R'8[RR]X5SA?A/WFD\PD] S)%.LG77X2_%DN>@4=;;X3I$\I]:WO-Z"S
M&GF@4^9'57_H6DI+8^(D.BX??QZ.K$;;&=#=X37AUO/@RDJZW&-25?*88*#S
M7D>5=5O%/]Z[T>C<W9 #,1DB\(<]I*%8O&\H$L**/8,UA!4W6E<H8'7LWT7N
MW8 WQ-UGLB8.+F_HMIA21ZUH"C,W)=<K=H-2=G^\"D=5&'E"CEPIV[*T[PT)
M4H G18U]Z=@/>9BJ#R,V=.L8$JTF'9U-:$SIH1B=RN!D]K=CXS:(_USOT(&6
M5LCDXM?$F)E5%=+;\:K3NO B\W=2Y??O#\^_1T 4J8]"NZ)=.L99:6HH30+3
MG;9\LYR?8=!E^5[;1*-\40H'8_KX;:Z<K*W:-;ZW45K<]%(V35X#YNJT743P
M=)^GC#OD"45H<@(+[!$BHK=;;Q\._#@(K>'U@^L7J5-7?!P,&HR[Y)(MO< @
MN(^H< ,))GV%TX*TB6*+<BL_ H+$5I(_I6EH>=4K N!5S9<3=),XXC  =_%]
M=FDI3*J#S>!:NFTTH/3_0Q.,$F38)+4L<D7V86-0/$A$/ZB7<*!QWG!>TWC<
M9,38 U#&60\DGL8[B!H=##^/T#:NB_J!KX1;T!:"VGO2X(DV7X5=DSCMKSSK
M'/ONWI.UKI2Y((,S,8O(P4(',+\;O=,PI<*+:2B\\,@?4)W5F?%KX.HJ9WE&
M%;)K2H'ZCQC4B<S:"(9EF!"K/^DYMLJ8*N",M)@!4_6$BC1?VY2(K)PFS_0!
M;YV1X3<+>>7OY0*,1[3WGB+1K^].C5](NW75>D1H+>!:H7P()2YHOX54W>%1
MI00%]PCV8T4YX@99'.0+=<?R'K!!:UE6H\W\RJ-=+NFT\@/W#R+@.,HFXQ=%
MZ(Q^4CV6@M3.'$$S)B4=%J%IQT&1+$10-R\N:1 ('9G%Q>EGKJH\9&Z9U[7$
M(L #)HG0MZ5A>$A!S62G"TD2TAHJFWU6Z+I% ML6TJ5S\&A<R&9BHA'VH%TZ
MPSO!N!1?AJB[<I \X^HR6UD6"M\8/)CE,W:*IQ6R^GY[[WYZ>'BH=\,0:F18
M++E):E>[1Z>IH^IOF9V[-;/U:,QL/3EZ.&:VOJ#,5M_"5HS:!I?)5!]:*YNJ
M(V,B)J6/]EX6ATR]25?AW6&B@$.FPI"!$N@A-G@'HO+6&]5LAJI:=!BR3COW
M?L%3(T4)-EESCA\TMCJD$ES T8%M.2"7D#PBQO+UHQTAG;;Q=WI_2%M6#EL-
MO.J*O;^XNQ?[9<O!KUN8]Q[=+/83N.0(JX7T\#0*CUNT7116H3X$N=H-"W<(
M#'?YN)GU9-HN6RY(44.I)A8 L*]2Y@1!ZUZ>XDGD<21VE-J=CON,^>9FO/"X
MU[2O-MHL89SS_ P-S<MS5X3&+Q*'0BS3T,#A7:996%Z+>8_@R+/\0N_$(;'#
ML#,J:&Z@K;_CZUS??I#\+,AX?(J);[%%#M;2A".Y6'L,3AL^3WJ ;Q8JYHYG
MV)W/Y68-MX2@[,F0ERCP_$]8EWC]MX1,UAJZ!"-COL@YHZ !2WU17L#Y!%_!
M^^ Q@Q;#V7&]8?O(7\ UK1UC^J7/W*9)==;\G7\JKB['/33&(O@L'HT/=/:G
ME0Z,""7V''LPVM?I.*,,-N8DA'F_KA7XI8^AT?:VPR?+)KQHVO<T<N:TUHQG
MARD$6D86K(]%*U8EIKIR)DSJ[Q,5AMGH!)(>+?S"":</]F[E8C,:#/R(&32P
MFR@Q1RE35&^OX'M48*;=D3HKL!7@0+?.C('9LW8Z=)R4<XB$A9M5;#L;>(V"
M:#P%WXRMXK>H!M_X4T"D2?R=YYN^LX$(0G)?K+EA2=MJ6]A%4FS8K44: H4(
M2MSH)83R@@HQX3I:&8ZY^;P6-];A&Z.)%+/<@)A K/BN9PU_F:W\Y4@Y*PQN
MY!@^HLL^'U;_/H!#LB#=3'!3+C-L"$$X/NL.4:2&LPJ;[04/ ^%>&-06FC-J
M\+1%R01;N]I+*GD.5]W&%J:ZG\6V,)K=3SS9$A=21:\F"6BGG!-5I">"YNM)
MS]7?IJV4=K[EV[IQ]+<?@_>U)B21JDPQ!A5:7R+VPP=XPZ&]NC 2_!.M/).8
M(CEBA]F/=O#UM1_ YM.=4Z=[:J *E]F$1SA4R3=M-4_*T7 L2QYX:>E?>LO\
MZQOM$"FUT!4YA?[(6>_J;L\3]%&]VV\3%&SK':@SE/R64DWQ=4'\H#A C1W)
MW'I-U'8TCL$[BP;!]S@9$-\^>OPX??SX\2C\UQX-"+8W^Q"LG2:U.GN[*TJE
M7*/I0$;1<RY2Q3O.D06PT:?(V7Q!KU# 8)1,PK N/OS?[>Q,DTHP5((YH"F9
M72JBC>IW<:QUBYB&&)V$I09TE>@YW!I[L/:G*OD"D49:U17J!Q#ZE6\*5 1#
MN"J17V&MYGS6*1C>L"931\X,X86:K<6+<?(G7$BFG1=-@)O&TTH'FS.>U>UL
MS'RCC^8;@VVBIFZ(<D@WR.$& W@3%(>"+9I"8R,([$P,]QCQC]/U% 'A/QK@
M2[_",OKE]OYV/K(#S^T_Z-E@WO&C!+1[FUEG]VG$<.)](G;3H<8*H!)[PF4<
MF)!2?N+K5L(8 7<.Y*1EIGC;$ZI,^M:-]]8.(="63#]$8"@N0MZ2K4X( 5CM
M(+A1G\?A&?00+K)\0;?+$%%H[9:Y1HHI8TEX88NST.?5^0?VYVJQ,0<JVT;Y
MV*E13YZ@[#3U^MIFW<,>#'Y^Q+?O-H^@7_I <0R*/G][]#"]?^]A^OC!@S3Y
M%GYQ_/!!>O3H+CWT6WCK,=BT]P\/4]72^87#0EJR36SZI9-VZ>=3+-!R%*1=
MEK:\\?@^AI56B>F'-Y:V['JY?\J?,'79B4*D>=EG/WV?/QF7>^?N'T?.P(HO
M+['GQR7[):$CHC13'$#ND]GC#P?_H0K]#J*49%Y$^AA^LJ!<6H+XG[,2HP,_
M?)P;@L="FM5\X<*=Y].%BWH_>B2_OPGD16M6VCQKJB<:FK2?[J;)2)B2O]0U
MLP.@W^OP.??."&D\J:PRV0X.0T;T>NR&LR%"-LT701N]%6[S>(3;/#EZ-,)M
M/J-\LFZ8NL5BA1'YXNQOWQQ^0_\-WYOJ?W_R#$2$$?";K6H8@_[K1U @L^8<
MGW+XW3>T>#\UE;[@ G&2X&RJ]/'.?:-KW,RV'I&C<$2&'R2K<NFP8H^9:&-I
M7[@YK!2**"J@OC$$^O6=RY;)*U),/WW?S/I#&WB%+*T?[I'=CZ%G7-/TM.TY
MGDBBZ1"E_ODF<M4!XXWTTZ1*OG^2_-:&2Z&<RX=]^VEH- /#'QC"]AG]J56!
M4X#'[V_?'']S'2O$%6$;MO.S3WZW$QX2 R_/]%\B"F2QR-_50GGAG C.SV*D
MR'^^"2;*#5W%OT:$AA9MKHOV%ZP9_+_J:I<#W#4PW;,*-GZ&]TU9@6U]-MD[
M/KR7'M]]E![?O[\_<(%T'P9&0X=B_,[AP='Q_;P(FX.W US*^G'WXO!7V_$1
MW&Q=MK\T>?KB9'A]]$;\;KO8;![RT"#NXO7Z-C@90P3</_RI\0R9B?YRA]\>
M'W_\=]&0/_;":UDG?-KNC*QOO7UUE9&I!-O!57@B_.@>[W1T1_<.'BBQVM:!
M7O<6?4QT[GW^87VU0G(WD#7N1$9NHRH?%I,_KW6^D7#?F[)<Q#KY=XGK_/ )
MKQRZQ!]>;;.N;X(W[ICL5($&]M5/.AM_8+G_VLW]RO;Q\=V'R?+/[N.HV/J*
M33VP/ZO&'CTZ&A79-1Z !X%U_7,HLL._4)%]^Z>7_8^,]L\IAW^=YXV[L1JA
M;_D-C&M'DO)I>WU=NN!3'K%%D*YY,I]A_6[>4MW.6_F_W$5>)+\?),\JM^YF
M%G8AP1^)!/U)*;O_N0_H%WU9WSMX]#DOZ^NSQ+ZR?3P.;0U&K^-VA%-&+^1Z
M%=O1GW?#1R]D5!:?(T1Q_.#QJ!RN-=9Z/(8H;JYR&$,48XCB5JS?S5NJVWDK
M/SVO\AJ>A'?H/PZPEUI6G.6W+5+QZ'.?TR_ZSK[_>?.C5P0<C9&*CT<J'HZ1
MBC%2,2JV,5)Q*YR1+U-9["Q2\7#,SXR1BJ]6.8R1BC%2<2O6[^8MU>V\E9]A
MH&"1O#I(7H%6OGUHBNMS8\?;^ILG=Q\?W!]M^9M[77^9MOSU.?[7)T]7G.#G
M$;*;N& W96W& WA]SO188'6MKO3QP8/Q<KZYNF'TI4=?^E:LW\U;JMMY*;\M
M)_#8Y-E!\JNC-CC(4-YCLKCY/O7=SWU2O^AK>R?(]C^^N6.%PDW:Q]NIZ$;W
M_[.Y_\GH_]\D&__+/(&[\O^/[GWV$_=%7T%'#QZ,(8";K!YN=@C@3_C--\V%
M'4, 8PC@)MS+)_5Y7I\GIWEQGMTVMW],I5_K77WWX-YX5=_<J_K+M.1'7WI,
MI8\'\ MPI<>8_'5>SH<CS.TFJX;1C1[=Z%NQ?C=OJ6[GG?Q+6S?919F\R>=9
M48Z.]'A7C_GS<1^_&/4V^ORCSS\:]E_L =Q9^OQS'[<=&:^[NS-^=35VY(6G
M?7MT>)@>'AZ.[OK-.]6CNSZZZ[=B_6[>4MW.Z_0E*.1?LY5;CY[ZZ*D;AKOC
MD0GJ)M_37Z;U/;J_H_L['L OP?V]8F?;\7;^8_'7^^/M?).5P^A%CU[TK5B_
MF[=4M_-6/LVJ+'E^D/RK_/?LUH''/WNL^LN^J^_=.]A!%^;QLO[2=,;H2H^N
M]'@ O]@#N"M7>O2DK_-V/CRX.][-?XUJ^+[))@L'__Z__Z^?5OK;95:=Y?"[
MPUUNJKY>]G/%[_Q?=^XD+W*WF/V0O,G.W(_P\_]I73'%GSTX3.[<T9G-\@L=
MQJ2L9JZZPVOR0_+S I17<KQJDKI<Y+,?$Q[^'3@Y/R0/5HW_0'_P (<39HLC
M_2$IRFJ9+6BL'YM:7V;B=QX.O).6P,Y6Y_EC\FZ]@MF>5-DDG_Z8_)8M':_%
M;R5._^BQ_=7W^C/\$R[B3]_#P@RM4>6R]W<F;EY6\+@5+>T?6I>K+(B7%[O/
MG;'92>#L>&L_D]21T,/>+19R+_WMF\-OZ+_A>U/][T]>!Q%,N$$7V:J&,>B_
M?DPN\UESCD\Y_.Z;JUW* Q?NH. ?!<'?I#5H52X=Z@O\<#$;NE%0\))R#C9J
MU<SA>67R*BM@HZJDK))W+ELFK]QRTB4TCS8I?H5>^3K<H]4&E7G-TU.UCN<,
M)Z@VP.>;R%4'7#;9XJ=)E7S_)/FMQ;7GEY9S^5!G(CLU&Q[-P/ 'AK!]1G]J
M5> 4X/'[VS?'WUS'"B4G=>TV;>=GG_QN)SPD!EZ>Z;]$%$#A-.?R]]E%7I?5
M.GGAG C.SUD-7P'KBO_SC:OF>/W!O7)#5_&O$:&A19OKHOT%:W8[/;:_EY=9
M-4M>'"3_@O^];7'6OZX.>,B&_PJ<N:.#>V.#JC'.,P9:=Z<OQECK> 9O_AG<
M5:SU_N,;<.2^Z"OZ^-[C@T=CQ/7F*H@1NO29H$N;%<+GAN3<V"6\>4MU&R]G
M'S$^/OH.7&Q7S/+DM*VSHBF'5T #S-]]VGH/GE7_\KL8K?XD__L3AS.42O&A
M<OCM%7M'AQ]]Y'U_<)4VJ8'HO3?.1/"C>[S3T2',^8\X]+O>I(_)SA41=-<Y
MK-[S_ZSQ<4U;^D>I0S:MW6W4N&-(8@Q)C!['EWT&=Q62.!ZS!M<<DG@XUE+=
M9/4P!B3&@,1M6<*;MU2W\VK^1UF[U7GR2S9QH)=W?QR_E'JJK_3&OG?W[M@[
MZR;?V5^F23^ZU:-;/9[!+\.M_NNJJK[2.WILRW&CM</H58]>]6U9PINW5+?S
M9GZ53:O,)7OPO_O)Z?K])SFZHV?]-=S:]P^.QUO[YM[:7Z9-/_K5HU\]GL$O
MPZ\^_NMHN;_2*_IXO*,_+V7)'R"KB(?V[[9N\OG:\E=<UQMV)W8_39Z\*1N0
M@3Q;@#U?S!?YM*F1Y. ER@7<W#]]/WG29;_X,U.Z?FZ.&[W@)W52N?G"31NP
MC;))>>'2!%1ULO*D&4LFS:CE'TFF' UYD>"MTH"& *U/OWH!-]@!:/FFA>TK
MJR1;K;(*3:VIW<I<MA*>N$ZR*J]=<GGNX&G]M\* *__D)%O497*>U<DL6]]I
MRCOP/_)%LN?@F:NRJ/-)OH!1.:Y^IT]A>CC$LG XJF59P?_2A:23.4C>G;L:
MIZW"%T:<%]-%.W,_C%*WNV.>/SE9+,II1L(#(O%KOLQ1 O%W209;?=+01N#E
MDS\Y2'YVTZR%_=DNFO _:[^E),=KDK&B;)()/!<Y<D ,D.:@760-?%+#/B]7
M"X?_AIE5\.'9&F4D1PL*9IVX_P%97L!C&_CKM,DO' B$=R'*%8ZF+5C>4%A=
M-CW'&37G96T."[QIB7<%C@,G,<W@K_F<QW@)QP$'-G,7)8YDL> GN+S"]_)"
MZ!DS @]?*@L<6S*'I?>R/ KJ]0NJ<2-?6QE@<7TYWR2I7JY@@(-RM,;N9:P:
M053J-F=J)Q0M$-HF!V&-19Q5XX"8-]E[^%T+PI3-+K*BP1-"8I7%[YN8LV4_
MER%D/'^\'I9E<<;26?%98RFU<@Y_B36K3'V6K*H<]@UV(9FLY3L#Z\-/3(BM
MQ%4IZ0(Y"/,YZ'48R"C@NQ7P4X?7O\CWSU7YWE7?/W/9 K8C5K[PYU?5 4]2
M0%/_^_]Y='ST\$>\)&=YA=?L,OMW6:'XE)<%/.$\7X7['BR&7P[@7RZKIN=I
M\NNO3].$--H:;O4+QV<"/0#4LB#!^-+P _S$?7#3MK$G"[1R46<T_CJR%D8I
MV:F4O&DK5$8H!,_R^1R^"+K@E&_,G,YD_@1N[:3A)VV\J-=PRX$X+//"L2K:
MK A5 :U650G: R]LW&"Z\NIRZ519>%6#?[T\SU%4\%H%8:FF:%V:YT<VXCIE
M389CFH)FY@%-P>_+\F) N=7G9;N8L6*=^458E77.XM>U-\&@S="'!&.C2FJ0
M7#P8<#L4\F T K:OE<I[>!LNP(I>Z?JR;PU</VI>$;*UX2$X,CISU7O7H%*>
M^G74$29RBOCEHACP _,^6CGPB.$8BUT"VPH:WILEQM+VILSM-%"V,GH>C8R>
M3XX/OQ9&SS\DG[<J_I(_^3U#58NG'G0@IE0=G/G@B9UXSWBS*U^Q,3G/BZR8
MYAP*8(MOX@HWS]$?NLCRA;=4AQ4@*STQ.R-%3WI:W#O\LK>XP85KITWKM8X:
MDMY.,=[3W#G5=+V7^^]/S0+(@&HUA'4T>W4+"C:K9>IZ?_B_K]"^ >?/59W7
MD[F\"KQ[=R9$R=?YTO[6&P(NR&4)!A-9Z.C<9A?PT-X8R@LG>\"QCJ''47AE
M\S-MX,?<LL%R\Y>L2@5=$O;;P:['/Z 8>*.>GS/P$!CO*3A=<(4NUJG<-'7.
M#O,2YLCS9+I#,/OB1<;]!:NQ.,?E'0HP^8TVVP!7^!3TM_P8GHCF*,MOY9 :
M$ Y07[8O86(IR M:"#F<$-:!@SM'H;,YO&Y&]D/E0*HD[-2 4N3YT[F(8@AL
MG= +EB6<N1JT0#[/I^#;H5?%1VOXC0?)"XQ-?,@PV)&BK/:B?OD&GU7^M^X:
M%+1?=M7P/&45F B\]K!(*H7X3+)1X%">Y_7WN)+1P;K,P:F<.?@ "2GEK)_G
M[L+'.>R+0!A +L#$J/G+=I$V"+<LV\2)@\%RS7MP]0T09[1R$W'.)_\.EEXO
M<FCUXRTS>6[T'84;;,(OHE)T<S@<PDII5JYPIRG$EY/HK$ HIABJPV^#6S%U
M,[@LY&AE%>N6LT+$8S:KN)V\2R[@<BO;>D,@VX=L^ I4-W3S*'-,"8/X)4NB
MH :Q_7MY">)>I2Q@25Z#N9><M1F<I\:)9T+WS*8IT!DRX1]TLZ:-? L>#8/
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MT23/#I)?75[ 3]#(_XL5_Z:5OYTGH3_J$["AZ_/D-"_./Z4O[FU<U\\EQK^
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M',WMY=O3,#786L0]K;5 HZG*C-M\<&C[( '7JVK)=/)5RV7E\S(U1E*;$**
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MJ*&VJ%!M#?'J.QBSW(JA5 N'+00HN!BI\J+(T%W]8/JYV-*(,M.UL'#H.V^
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M066I3@^='CH]=&XK=/Y]"Z&S73_M-L].!NW&6;?1V2QT6C>R><;X64Z*_G@
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M+^GZNS3^CW,L.?AO^*ES7C]JM)O-71K]0;<!AF:WV3CJU,_J^PHN&R3M+U2
MZ9*T0O9.$OBL(5!.Z"^3K$/GY4'U*G1,[A@8COO)!&6++.G:=7YJS-W&9D1A
M+.T^5):1N@ZU&JD5[B"ZGL_E)(>VK;7HSVLU)4.V7N!U[];R6^D*=+PK\%NK
M[5V!%P&/I ]=;L;;V$PSWHN;FZOWKZ__*[C8YRJR]1_TV.?XXMWEA^#Z_9]7
MMY\^?+RMP3\OCX.+]Z^#BS=OKM]>7WRZXB[UO30XP2]\^OM5\.>'3]?O?P\^
MO EN/G[XK^NKV^##^^#5U=\OWK[!7UZ^O;YZ_\DWMU^O\6"U*IOUTX/VX=&I
M(U>YJ(6487D9GJ2D9(DGK[U J]YK'+6KOZ[[ KO?%H%^5XTPU'=!;7\47#*^
MLU%&(M4XJVS+70FT$I$HWV*/,!$DKFH20XIX7F]^O2YB5I#_UR5OLXQM-P:$
MBPQE_MZ%<<@=5\B#K!GG$NU4N,G;MY?V=[K',2^?B@59DXO@NOBD<B1XX5\2
M_9?@H)^,Q]QX8SQG&UG*4/4EC"P$=F?0RH_!*'DP$M=5\M9H+P]A5295XHN%
ME>9&D?)BFP0RBO%W9G_!C 4/(X6%AG)K4E-D2;%X"+L 3=S\@:0RJ=!1]Z+3
M+:1&8,-KV0P*+;D[3#< GM!+H+$FL6E/92=5-+CP;Z,0!5;9F9!0OOO97^69
M1&J4]S]N6[3X1(3"B*\.)+"F+[(XLEIY(.GRZU.A8<7"(WG.Z13;5V.:H#C!
MHE-)\33!"RP63A5G'-*J[[ "W%VJV*.0_JBBEJH7287^IUXW53KGX*1AKP+6
M>1O#BJ.B2N=1,I3KB-3 *&+R[0Z*B2A6#187Z>KC]>W%X8XAV[;FA"LRO4N
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M0Z0:*U>X.9OU_D)U9?A)&\"MH_-Z^Z!_J,7;WL%7QP@MTGD8D,72A]^&#U^
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M'D3CEPJB#<#)LV;=05%L=W76K3=.!N>MUOFI>/.-Q^B^$D>WOY:O<7@ @U]
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M[^H7M;U?Y&'2P^06P^0>Q8^*?E'WJV!RK6Z1]XL\0'J W&* '.]@F\P[IB6
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MO5P63,#9OLAE?>G:\0&WS0?<SK<AX':CTBR),RS"SU-PX#FLG*3!'Q3(1I(
M&!3R5XZZ6$*%#\'MS,.\3V*?(_"0]8V0U=T&R'H_(Z)2,@S^GHP'PM)R64[R
M"]VTI%5G2M,O^PA7+R<>7+$_GG)X:(X>%-^J!XNE:IM<CL.,5PQJ9RTG#Y0N
M]'PW#^8!W\E__M3\:4T#9\OX)[L3_M9+@Y/?X&3NPX7UMO@"IV[A?MOLJJ^.
MV8O%LN)EKB-@_XPO+HG:GW9J]=,E<='=CMHC-*@%"4^C3?=-#OAS/ZV]\.;N
M1Z263O R\;_O.<$O)[ OD_K[CYG'9NVT\?WG\ONMU;__F&GMP*.=OK0E^L\?
MM42[W?,7O$3?_: ENOX \??P5W8W3O@5_O4/H#*WZMO@8J-FV"2.AC"%9&AX
M9O*N/,P%KGO8DG]>+]:_F6(S4G=6 Z)4?E193KR[5_-Q^) %TS2YCP8<1F'.
M7O:R&7,KTV0MGR:#"3C?ES392UC/7SUY*\=='8!:ZZ%S\?'3]>7;*X N"6?)
M?Z[?O[YZ]_[ZS?7EQ:?K#^]KP<7K/R_>7UX%']X$5_]U<_7^]NHVN'C_&CYX
M^\='_$OAN/J.T[*!PWB]AY.VEA<R!C]J"=]>7>([#1K'0=GFH%J95/7S).7*
M95V4?1Q<Q/-@2HG+X&&4! \8\4^Q/"8$F$GSN?R4CP"!<H5E.<PEGX0#93X3
MH?KXW/E0+4"95*K"28-^,IF.%9Z+(<5::D$VBW+\"QR0?:7P<S6XNZ*"A7YT
M'XUK03^-)E$<PK_" ?Q#"%GWBL9#1>K1'?VBQK4[8<;/B<?T$.X#_PCA#)GU
M1_KQZ)F( !_3S;'D".XWD(G!7R4\+?HZEU(?1&/F>8#_Q2G*L%$S/-W#".O(
MPV=>) AS^E6*J)_EE9_(G*O5]+5J-,\Q_H-*5Q4\M8))3>;X+V3]\1-%@UD_
M"M,Y7CF,$YY/]R'D,MDHFM:"OT@'X!Z^/$N57!FNBW T3:.,IEK?!5YYK(;P
MUJ9C7(K9*!R/N:1 5AHGNQ<>YRZ,8GC2OV:#.RK,HX41CC&Y5(/QQO@?]=C'
MN^7A(_Z4J3P?2Q4?+E5^M>0;F7*&@RCNCV>TOD(1$\W$(B/"WB&NM!D,<6YK
M'F!TA=6P6 )!?UZ^1'7CCN$,'AWV.TXZ7(P*_W%TMESMW>^7;VMEP8"+/KUP
ML(-:-7K-;#C6Z"%+T@O2V!N_0Y_-1PE,$!J7LQS-R52!A?. P\-RY' (;PP?
M"%9T7]%\JJF[ >0EP4;E]P8K Y\KAX>G?>O.BWYC^/MQ!#8,"2S(H[NO-DGY
MNY@<&%&6!#^2*ES4"6Z,_JAPX8=D-AX$M"8?\'7#XLEFO;]P#(4-_!"-QS#%
M <SK\/]O[\J;VD:6^%=1;56JX,4!8\YL]J7*G('E"D>N?UZ-K;&M($M&A\'Y
M]*^[Y]#(DHP!D]A&55LI8"7-U==T_[H;_HCY2L#BS :NAD.J6.W #T/+XVV0
MMF0ZP42 76Y<#G^VG3#@;1;HBA5V3)L/$L-W^RJ?A>/1 ZO0@6!VBV S:T'F
M%\)7@-[PR.5S,KEP<6)1_ZE3'J]$-]:6L*P)TI14?4_5!U;39:B@VHD$E+H6
M18FDLK#I][AX&8C,N$YJ\0E#.Y$KE"J3$[-:@=_-C(?U5GILT)65R(4:R4I&
M4]QUG*X4$7G2+A%L8<*P'6*G$%-R0U.[XW"PSYXL!S,;DO"#NH##ISO^'>^3
M_NQ()2S%4LCY3=XQBB.2'\B3?\RZ@_7 VBT&5**REZ5 :?N^%%APRBY6R='C
MPMP]6THH)8;@8$!ZH>)ND7F3GDJ.7NW 5C0XC-WE$6U;,AO:_(C=2(T5<*":
M1,I+(JM83LL"!1=V2"K'KL@8!'T)1&F#K0:'2;;>J%GC)%"5J(F( U1[#M01
MD %"WX#_7"!7K,+#M9FFTQC1WXGK@BL[?IQ^IAQM^.K?U@);?/R),7B.*&X@
MZ:$K]JF+66B@Y5%%$NOD'"T> IZBL94?K(7&8N9!RB(/8^0WI3==T$Y$F$Z(
MD\S8IO( /B#)+C3!4 &^^NG3/-%HLVYC/XBI?YFM+?8<\8.V.A$_=VB3I>9R
MT'@#WH$)B=T*55X\G)7-6W2HL!^74A+48&\75MXOYI1_2G&>1](G(/:5&V88
M1H;>-";@^=X[(4#T2I0>%=:TT4S!I2PUS! ,.9C\CLE>ONAOI(Q.39UH%80P
M#O%BP/L.: -8!AK_(6ZZ#9K"8GWFN$7G+&D;:)^;9X/'"JOK^6'JMI/(CH >
MD>=*#P"+]_G8L@5-G"&>:V' 1@YF*H6A5TL#9$:7IPR0U26L0M'D-@@-L$ R
M]T$VKDU240:XOJ'A[W03!-F0M1\D08<F40V$:M[VI6!/? 095L-K/(M#+DDT
M41&26:5Q -([Q*XH. N55?Z';T/*KV!JL9"VW G4I=6TSD"M];G6:<4V1+[Z
M49X1WW,'B8(3.HSAA9?AML)]5]:*(\,*: 9$%LR$H0@,Z.3%Y;WAVR@>T.V;
M'*LA>=$7T0C\N-V),M)'Y?PG%_0[J;#Q7@=+3>FFS)V'%!3H/&G]L48H;ELM
M:4CH951(_&I35)&&]#@(&1WWAJ2T<M.$68OLF?,F?]""(Y1U'RZY0J\6:]D'
M=!;M S;V9%ZQRLK56*6PGM'E*6&]ENM)W9,"5[BGZBARX3*9_BL)XC"QTOQ(
MR6VBIY&F79<-AAB@4N@(D\]*PX4L!N).KF>CM$(H!'434:UDY&CYW%/Z"-V:
MD:PCHNI^)&)1VD_3>]VKJ*LI[8"Z?8CY5G(U$XK5MD_>9Z;W4M]?4!XWU:$7
MZ$F8"#R&):L">+9D^!E=GF+X]27K@(,=P]P/EBB?=($((V!O++M#:*,PQRH7
M+"\O#T ?FCU-6B(V[X!N43Z4#@?2ED@!83P@&UA.MPNZ75P,2&UREVLRS(TT
M+,%*'6WC,-UNVB//:(^#FAKR08D+G;CR^#WMSM5O2D-4V""TB-#@ [4*\8ED
M$5A0;9C)S#'%(K&Q CF4<41JDJW"1R"!L#J;F)=LOR#<SW+@'BQ=V#V@HUD[
M8+V.&$>_Z=.'F+!>6G#U [%&?VU&TL/E-Z6#K!=@G6(E+O3:*WK+ KTYXOB'
M#SU]N'D./N$< 8N(=ZD84].-0PIAF=M+5%7)K&-X-&42HN^\DCCLI("4%TW3
MVZ_?E')-WRJ%N,8)D.^"21^ZF U3;=(KVG8R//Q2>9D64\I.,F8(G-HA">XK
M*4KV[9C>5: ([9?'(M)-AA"X:" X;>BK0V$='?A2[X@@':Y [Y%T^*-7PP\=
M8:GBI\6YH3QWO)BKD<P *3J]FIPEKH'\-24?@P\%VON@HFARR1WN!!0 PPK:
M*C9KQ#NEA2 -;C&+UZ9D1F**UDI,$6S ^Q)3-,L4/C?+4V;4!MZ;I&H1NM.4
M[4(LDI>%E#JU!07YV(N#)DA749VRRQPJ VOJ*!#V'-YM*?UI2.4$F9&+GLCZ
MR H0'O"M2@;4\>@/97$B<P/\R(<'L! 6&AE1$#S"XE"DCD8I%2V<F3)DXL=)
M7%Z\0O<_0M'B6\6WX4D&/TU\4R6Q]<A9Y?D&64KSRF_(JL4YT3J,)ZG-HJQJ
MN4O*A,L$E= *) ,.$2PP-O7 P) :1H:U]Q8WRUBFNH:G+5'<6-W*S ([?;XK
M%\SH8OYQ/JJ0G*Y6G0,V'^[.X@/'UY7%G@LWM_Y9=B:!WYR&39JM6A7C#S5'
M30FJ2[4)=QI97QJ9O_.L:4_4]C$ $CLL>&U=(V=T,6B;2DDJ[5*XBP<$1Z60
M'#>PJVA'!.BZIA+9%$Y$ZPX16ZEZV=HW%5HU,E56+=;P^](23H\F/40RL-52
M(=T@(%=",C3\V@5EP&[((P-:7 :'A1V&@,@PQN+=B?V![;6*ZGQW613)6B_*
M!$&C02N2@+LLPFT;-GL0V=;6L8'$":=CG]+5A=:\Q)>BBR5&XR8R_QH9.S$2
M<4K+$'XZ/! 8*.#*%V4XP9*O309FBD-F@:8>S0%-0A45A2L(=:Z0CE_\WQ)Q
M*B(#:>R/G*-6Y_FP5?R(WW )WHXP*"0A^5'3Q%.G-=_VW+1J]]E-BEV9AJ38
M[3A$[+],1J'KZHX65*)71;8189DY.RN+N<KM)(E $=?ITDTV$?1-&?+U@S;S
MX!MFWQ\**TGA24TG\!><QG<_N*E8A/1CH<P'HJ&8I!6I/I([E-"^Z1Z^(/];
MH :4.I>8H 1B#8](GI&Z2R)+L02\FI8.ZY.8'H[KYVU"Y+<%(HGTL=GZ2(8;
M=&BH(;F$%'&+AP)MT_>3D)#PTNB8':HZQ#A%&#/Q&+IW+.ZU65M8)M(TR&$M
M"N5A)*E@.7:LC9X>HGBC.]\:<(;!B\; Z*2D(:^ZA6=A=R>I0:DE9WWWRX@&
MI,--./=VT*3 5C:1.N?L6P;N8*UJ+1@=.F7KSR5KJ[KR;G5SL[HQN;R.J10B
MI0Z=M ZM38,./?833)+LKA+*,@0(\BE[X,W.8LZZ"!RT<\0:**M8HS\D\5&'
M4MG)N)1<I>1ZC.1:G0;)=<(\)AIUXE/"A5(*JUE9S*D?&2&E4@"5 N@Q FAM
M&@30=9+85TJ>V5G,RI+UFH3/C"ZF5I[2#"QF=<ETAJE,9S[G!>IF=#&4 >^3
M(ZRB?'$2 >?XY$J3X':, 5+L*62NS)=I<'Q:)# SA#M'[SC![A&)GD#^Z<;Y
M2AO]/A> 65W*E,7]8Y2RLBBR![ ^$A=$DG2]-[->%=YHI8HU %9U"8!TYM8\
M[]43\.;K)=X<-F"E6@+.9YO(YVB!"[5%4>>FY<I<,IG4JH0>RD!1% 0#9GU1
M6(XR1RF?5>M"6\87S;AA6@M:"S)KK@M:%-$;A+HLU*BB&MJBT,V8?@NDY]BB
M+!W5/Q&9;NTV8C\B3IEG 0\IC&FUP"3#;T68_=1A7INK%\QPVE#";M'$R2+'
M !H50%"1/#/]E;+!F@A7(1"TS>7/\-F^[\9=D0F6J 9?HHT6'+%A$?8%M6QL
M4Q18?>;&12\(? [BGK!,G8(6"?,%$?.B^2X^NBBRH6!F-N\[8D6Z-)8KLX"=
M=L?BGB[WAF4ANU2"N<ONG2ZE^+<$8"N@/91H;4DM21B2"@3!1PRZ>2#L>!&[
MW%JKK5&-A%8EYSCQ5W%TH;&/HD829I\EQ^WY0%(!%9#QK%KUS=")J[7H;R>K
M$E_*D($LR+/#W&;LZBA1BCCV.5>U@8272[Z:D'*J#W*H:.D#KF".Y<G\"\S5
MC(F(+!,@9L"4+<,9J2167::J;D2!TXCI05%.$GC4CT,7*V>$39=J)XV42:I^
MC1Y;TKS*R#6G,EJXS?%9S3\QKJ'TQ'HM8JE.E-06(C2,KD;CD6(B,:FDGX;9
M($I4HRJ;HFL90453I6*3_'V=:H98R]3SBYBJQ:18;7!4,_B,AV7V0A2S0K?U
M*+\J>4\E>)$-(6%!0D [8@"TCV7)"RPF(Q:K4I'%DR)[6"Z,2H3!?&*73)HV
M%58.A()@ULKZ&V S5["?@935>_#0?$N7W!0N1E089%&%D-TD;A$Y3:@LS17*
M]9, Z!*X7/KJ7K$XTS5XBXS4'.0VY;1[,.M\_2_0X48]Y!PCCTQ?QTM*O"1$
MWM(E"Y(FHZIV%6Q/P82$W>L0KJWA>UA)RS:^*DWM>2&$^:+JIKR?=7V@/#+@
M4X35 !. ,P'Z'>&?)%1D:YC@A',SN3/(BP0,AKG#L1?Z<-E091Z3LF0&>),(
M:*(V;4D\$R0>>TR1^+ X5-!:I?N#TJ<]*S;B"MF(:3RWJ,#J4A(TMN^DV_AJ
M=;L\U5&G.C6E(A;JB]8>FB<9AXL$J1LG7>!UP7MLOK5 &5JZ2'JN$</TW4&;
M[&)X8SYW5#.9OJN^*.L:X,597V]_HYMD:HYOWJES.TN=.G8F:$Q22P%IUA8K
M6#QU85V4NL8?-Q>1Z#0A%1$F)9F"-I,)AUJNI<QN<L)(VY<*563GL;).I;T7
MX68-4[F7\[AW%O,TJ4AM47YAT_-2&#',#Q<^P) /L<\_#4U9C8]YS,I9X#I)
MR3#B75'N,>N_Q00?)P@C*T9?E/#X:\N2DL_D1IB.?_&&*NA(/FSF#ONRY<SU
M$:32?]/1AR6K;I0!=(P#K:3*@@S4<>BE.F$8RT)B1K$;47HXN3/1W)FL^H_U
M9S'#B'9$[,V(ZUU^Y./QE[Z18M!,TF51FI]DDG'>'9%6\!)71"J_G5O/V?.-
M61-3.5XQFXK.0&HMZE3&4#SHP](?M_UF++E>95!Q6\1?:&6I/Z?RJAQ/'L2D
MYX>.ITI2^$X9R\(;S,0!B!X0:0Y)EU-,TQ92)-(OMZ4/SP:A+KL':3JA,! +
M]>X\;G%W[-&[KXH0)8=@5-X<M1SLW5!:F3-R=ZB-?W?8^5MXS#(F:5'8K_"J
M.8ZB+]#G%9G[29[>_%?S+SY)#4]Z-5D$5\LH,"WJ%>F-?I;J+K:MG>AA55R*
MY=\BEO4AS+Q$5B:+7M%\1S1&@M(V2E :@M)62E#:[!#TC"YF@0M_]/CNZ$PQ
MO_$=U G@2]QJ4J"+U(VT='I.X6*PW@B==0C3X'9^NH6T 3R!.>B*$J[&/=B,
MK1(Q%'PQG3E>B.-'C"'6F:*J4^87T75 WB0>=7Q;V&FH:SF8A$/W?04%4F1:
M40:V>5]7* UA-U$83JGNA+Y3H;\DOI?T!43(0NS)0O9A9=0&$&"B(?K^N6Y2
M 289#2U8]10U*K"Y=.?13&F>N-QAW\/PA^:;V:8UXW7\H7YK.<TE4>YRIDIJ
M+JPLSD9-39&]PEWJ!!^D,EG2%X[1LG'8=YE @L=UZ1?J[ _F1KZ"Q.%2.LR_
M=*C-B'1H!9Q;RFX9#BSDL7L/>R'+6!8ZR\Q^ B/$!SQ*YA!U4X)/*8$Q&/%2
M6 J&4C#,FV!8G1'!0-:Z'^B>:;J>8I'$H%9?=/ZAK*2?L0&V:L7W]D*!(XL=
MBBA]3H8%:V"OB]&BAZH>)^.93<?&EV%I,$HID4J)-!\2:6U&)%(B@E(>C03-
M(>-_&60)A49&6AH9]\32*^/S&5W,VNNNOZ(C(2_.>U0[97)9-1F$G"]K=^K4
MY,)4XJ& :$%:I!FEI_ZO.DY/'LQ4 656/%@61BM69*(45T9 &)2G= @X-L8"
MDO _1:6=2 )IFRY=OG3<OSAB^Q!Q))&S/T94+Y*J-:*4 (O4R8?YIUYP7@CT
M*SBGY^=Q%6=QY<YF3(3>'Q6 1:0U6\)W752[+[ 8<)\;@^$@E"!E$X7Z!.&H
M^[P3/8,D,F@EIY\9\[R889XK]8<Q;UT::[Q*6.,@^<,ZY@1EP<=[]S)_/)G&
MFK:OG@[8^0/YD2^'?7T=IL5L+4;T2O5;+!"=+-*]NS.=(V6/S(<84-4YZ2$#
MDWD"A*+;.>CVHJ$V*0)?],$0,/,PR[.9VN2Z>DS2(#ZL#+<I3W\">V<W./=D
MEPY;![^)!7I P4EJIK$NG*-F;Z.10VZW<R=IK]F+&Z[3!*T*_V*/4FP4&O#0
MJ$Q!6$T$-HK8<D HH KL+D<#K\FI>B6<C\@]Z&M5S"PP9IPN'<_P!-3H-#OS
M[!8,="99#$PT[LA::K %V9ZF*)R98Z?;J.N3Q/^=/<><8Y0KA]DU82NP Y8-
MPM +=5=ZT5<= 8*.PO7)5JF+M+FJU:MJO#[N5 IZD8U(YLW0CP!!QAZA%[)D
M(XHYQ+ 6@5D0;<X2J@MY%$G3.#4_+.1D$S@BC!O +@)C"5^2R-<>;$$O0!@B
M2 E@0-MIRML[MZB?+RVH(YJZY!(E]DB)'D>:PXAB [S0]OL\,%K-MAP/Y#ZS
M?\:VD[2$$!/!)))2[D_A8C8+[O\"=>/1X<ID)!=X#F;CN G$6\!F;"Z-.WB'
M8T-B$%*WHKX8D&RWA[547+A)!(,*,1R2UIVOVPI9-AN0I$<&<'H2KH[^\8A3
M=R$PF%S5L[HR7$L2;;($Q=NRZK;M(.W!*X?IAC^PP5%,%M$YWAZW+=5<Z87K
M^93D.KG%;(T@5]]S)6HMK\0.2M)NPRB\H.K01'[S1E9#4V%5\3?=($LD"CQ4
MM+;0$6$:XB0-Y>RT0GB,3V*VCNL)*/+-$D6.*/):B2*?'8)^\N:-G'<>T4VX
M <7EX<%I_>KZ8N\RU7WB-R[K!9RB<Z7PZNEJV:-\7:!.2"6I F_XK-&0<$<V
MN#3Z$:;?24VZ ?*U'< MQG[7]%T_^!O3IR,N4 V&"I;;C+K,CD'_-IG ;!?;
M50@64&W#I-](FH^RL;%$$F3#C?)R'*.OC 9C<=3Q VS6J>N>[LADAXL!7*!S
M>G7*^U+M?83)6_3H+IB=W08"R&O5VNI\J]X$C6"B#X;1"<]#(TA5W<0BO+T0
M)J1^>F+[(',W7=XRUI8*ML,HN-;__E7[J_C-":95?-JS#NK;>\?'A];>Y^O#
MJ^_6U<7UY95U>+I3$/M^[L+U/J]7WQ1LPD-OKCWYQ8WTFY-;U>,F-,DCW![\
M/1*WD6MSKB0VYTO.;3E<MH[\CF?M+%G;<)5^&8IZ[-[_J9/*V0GKE6[%>< Q
M9<@3OKCSP/&:3@\N,7OW8!;0O?1,^#]+_,TL+.:)]AW95]J*2ES+PI 2!8.5
M6U:GL:F@BC25F@Q- !HG*=PN7IUR*VDH.CZ+1LU#ND6IW?=O?L,U\+1^LO>H
M=HC* R+W5R]CI9=8#+4'3(VIVH&KPZOCS!9,1KFH^8ZK,";P_-,G_AB31PW\
MGY=;T^3.>%>&!U_N?"<WUSW7^<4:'&0OFCQ^FWF/9,P_1#PONRM#:G^J=Z)D
MHRD@F".&SY\O63N^5W)0R4$E!SUVKOL!\VZLHR5KGW4"[MWXO5;%.DJG=DPO
M"97,5#+3%!',B=/L,.X2._$ @R>.Y\\&_92<5'+2%!',,0]=AUO[P$B^RP>S
M03DE#Y4\-$4$\]5Q78=UD8D^<2>"5\HK4LE')1\].G[3Q@:1)['K,KO41"4'
ME1STV+E>,K?/(NRG"C>C'\ZO7VPVB*=DH^>P$>);,KOUMQ5VF>N^:[)>.$:(
M]J^/A1"9*>=/#>* )['!?1S(PK )GF/?\1C\B!E5\/=Z$S/**(M@)+QCNHCX
MMY[.[V/J1Y/I*V#FU\O+==BHP..#=X[W;I\UHY(QQR'+N<6A&1DO6./FG<IZ
M,=-T%$)F_<U?'W.2G&@!&<8SQS>'QVP;^:^9;9,:_"4KT:5V'?LM#>\Z_LW
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M+E?W=VO[RW'];?VD<]WPJ_\5Y/)_4$L! A0#%     @ D7N=5Z-W*O!L!
MSR   !               ( !     &=A8BTR,#(S,3(R.2YX<V102P$"% ,4
M    " "1>YU7)/;('+8$  "M,0  %               @ &:!   9V%B+3(P
M,C,Q,C(Y7V1E9BYX;6Q02P$"% ,4    " "1>YU71Z6..Y(%  #%1   %
M            @ &""0  9V%B+3(P,C,Q,C(Y7VQA8BYX;6Q02P$"% ,4
M" "1>YU70,*MF4X$  #1+0  %               @ %&#P  9V%B+3(P,C,Q
M,C(Y7W!R92YX;6Q02P$"% ,4    " "1>YU7E@,:62)+  #/] $ (
M        @ '&$P  9V%B96QL:65Q=6ET>71R=7-T7V5X.3EA>'AI=BYH=&U0
M2P$"% ,4    " "1>YU7SF*JI0D^  #+S0$ 'P              @ $F7P
M9V%B96QL:65Q=6ET>71R=7-T7V5X.3EA>'AV+FAT;5!+ 0(4 Q0    ( )%[
MG5>!"-#!L@4  "\:   >              "  6R=  !G86)E;&QI97%U:71Y
M=')U<W1?97@Y.6)I:2YH=&U02P$"% ,4    " "1>YU7ZO7-8<0.  "X40
M'0              @ %:HP  9V%B96QL:65Q=6ET>71R=7-T7V5X.3EL:2YH
M=&U02P$"% ,4    " "1>YU7^!J_%2D$   X%@  '0              @ %9
ML@  9V%B96QL:65Q=6ET>71R=7-T7V5X.3EN:2YH=&U02P$"% ,4    " "1
M>YU7,TYG98$%  !(*P  '@              @ &]M@  9V%B96QL:65Q=6ET
M>71R=7-T7V5X.3EN:6DN:'1M4$L! A0#%     @ D7N=5U6< '5N!P  B8\
M !P              ( !>KP  &=A8F5L;&EE<75I='ET<G5S=%]E>#DY<RYH
M=&U02P$"% ,4    " "1>YU7V3:=DM4I! "-("4 '               @ $B
MQ   9V%B96QL:65Q=6ET>71R=7-T7VXR87-R+FAT;5!+!08     #  , &$#
(   Q[@0    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
